PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Parkinson, G				Parkinson, G			The many faces of poison ivy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Falmouth Pediat Assoc, Falmouth, MA 02540 USA		Parkinson, G (corresponding author), Falmouth Pediat Assoc, Falmouth, MA 02540 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2002	347	1					35	35		10.1056/NEJMicm0010418	http://dx.doi.org/10.1056/NEJMicm0010418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569HA	12097538				2022-12-24	WOS:000176594500006
J	Johnson, KR; Ellis, B				Johnson, KR; Ellis, B			A tropical rainforest in Colorado 1.4 million years after the Cretaceous-Tertiary boundary	SCIENCE			English	Article							EARLY EOCENE; LEAF; PALEOCENE; LARAMIDE; CLIMATE; LEAVES; PLANT	An extremely diverse lower Paleocene (64.1 million years ago) fossil leaf site from Castle Rock, Colorado, contains fossil litter that is similar to the litter of extant equatorial rainforests. The presence of a high-diversity tropical rainforest is unexpected, because other Paleocene floras are species-poor, a feature generally attributed to the Cretaceous-Tertiary (K-T) extinction. The site occurs on the margin of the Denver Basin in synorogenic sedimentary rocks associated with the rise of the Laramide Front Range. Orographic conditions caused by local topography, combined with equable climate, appear to have allowed for the establishment of rainforests within 1.4 million years of the K-T boundary.	Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA		Johnson, KR (corresponding author), Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA.	kjohnson@dmns.org						Archibald J.D., 1987, P24; BARCLAY RS, 2001, GEOL SOC AM ABSTR, V33, pA198; BARCLAY RS, 2002, THESIS U FLORIDA GAI; BROWN RW, 1962, 375 US GEOL SURV, P119; Burnham RJ, 2001, AM J BOT, V88, P1096, DOI 10.2307/2657093; BURNHAM RJ, 1994, REV PALAEOBOT PALYNO, V81, P99, DOI 10.1016/0034-6667(94)90129-5; Burnham Robyn J., 1996, P127; Cherven V. B., 1985, CENOZOIC PALEOGEOGRA, P127; DICKINSON WR, 1988, GEOL SOC AM BULL, V100, P1023, DOI 10.1130/0016-7606(1988)100<1023:PAPSOL>2.3.CO;2; HICKEY LJ, 1980, U MICHIGAN PAPERS PA, V24, P33; HICKS JF, IN PRESS ROCKY MOUNT; HICKS JF, 2002, IN PRESS HELL CREEK, V361; Hopkins Dennis J. Jr., 1997, American Journal of Botany, V84, P135; Johnson K.R., 1989, THESIS YALE U NEW HA; JOHNSON KR, 1992, CRETACEOUS RES, V13, P91, DOI 10.1016/0195-6671(92)90029-P; JOHNSON KR, 1990, GEOLOGICAL SOC AM SP, V247, P433, DOI DOI 10.1130/SPE247-P433; KIRKHAM RM, 1979, RESOURCE SERIES, V5; L.A.W.G. Leaf Architecture Working Group, 1999, MAN LEAF ARCH MORPH; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Morley R.J., 2000, ORIGIN EVOLUTION TRO; NICHOLS DJ, IN PRESS ROCKY MOUNT; OMAR GI, 1994, GEOL SOC AM BULL, V106, P74, DOI 10.1130/0016-7606(1994)106<0074:AFTEFL>2.3.CO;2; Pearson DA, 2001, GEOLOGY, V29, P39, DOI 10.1130/0091-7613(2001)029<0039:PCVRFN>2.0.CO;2; RAYNOLDS RG, 1997, 7 RMSAAPG, P43; RAYNOLDS RG, 2001, 010185 US GEOL SURV; Richards P.W., 1996, TROPICAL RAINFOREST, P775, DOI 10.1017/S0266467400010944; ROBSON SG, 1993, 93442 US GEOL SURV; Sweet AR, 2001, GEOSCI CAN, V28, P127; WARWICK PD, IN PRESS AM ASS PETR; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; WING SL, 1993, PHILOS T ROY SOC B, V341, P243, DOI 10.1098/rstb.1993.0109; Wing SL, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P380; WING SL, 1995, PALAEOGEOGR PALAEOCL, V115, P117, DOI 10.1016/0031-0182(94)00109-L; WOLFE J. A., 1979, GEOLOGICAL SURVEY PR; WOLFE JA, 1987, P NATL ACAD SCI USA, V84, P5096, DOI 10.1073/pnas.84.15.5096; WOLFE JA, 1987, PALEOBIOLOGY, V13, P215	38	95	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2379	2383		10.1126/science.1072102	http://dx.doi.org/10.1126/science.1072102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089439				2022-12-24	WOS:000176467200037
J	Blaser, MJ				Blaser, MJ			The genetic gymnastics of our indigenous microbes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HELICOBACTER-PYLORI; HOST		NYU, Sch Med, New York, NY 10016 USA	New York University	Blaser, MJ (corresponding author), NYU, Sch Med, New York, NY 10016 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53707] Funding Source: Medline; NIGMS NIH HHS [R01 GM63270] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alm RA, 1999, NATURE, V397, P719, DOI 10.1038/17837; Aras RA, 2001, MOL MICROBIOL, V42, P369, DOI 10.1046/j.1365-2958.2001.02637.x; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698	5	9	10	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2002	346	26					2083	2085		10.1056/NEJMcibr020229	http://dx.doi.org/10.1056/NEJMcibr020229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566DN	12087147				2022-12-24	WOS:000176411900012
J	Gribble, PL; Scott, SH				Gribble, PL; Scott, SH			Overlap of internal models in motor cortex for mechanical loads during reaching	NATURE			English	Article							NEURAL ACTIVITY; TASK; SHOULDER; ELBOW; MOVEMENTS	A hallmark of the human motor system is its ability to adapt motor patterns for different environmental conditions, such as when a skilled ice-hockey player accurately shoots a puck with or without protective equipment. Each object (stick, shoulder pad, elbow pad) imparts a distinct load upon the limb, and a key problem in motor neuroscience is to understand how the brain controls movement for different mechanical contexts(1,2). We addressed this issue by training non-human primates to make reaching movements with and without viscous loads applied to the shoulder and/or elbow joints, and then examined neural representations in primary motor cortex (MI) for each load condition. Even though the shoulder and elbow loads are mechanically independent, we found that some neurons responded to both of these single-joint loads. Furthermore, changes in activity of individual neurons during multi-joint loads could be predicted from their response to subordinate single-joint loads. These findings suggest that neural representations of different mechanical contexts in MI are organized in a highly structured manner that may provide a neural basis for how complex motor behaviour is learned from simpler motor tasks.	Queens Univ, Ctr Neurosci Studies, CIHR Grp Sensory Motor Syst, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Ctr Neurosci Studies, CIHR Grp Sensory Motor Syst, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada.			Gribble, Paul/0000-0002-1368-032X				Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Cabel DW, 2001, J NEUROPHYSIOL, V86, P2102, DOI 10.1152/jn.2001.86.4.2102; FITZ EE, 1989, PERIPHERAL CONTROL P, P437; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Gribble PL, 2002, J NEUROSCI METH, V113, P187, DOI 10.1016/S0165-0270(01)00492-7; Humphrey D R, 1983, Adv Neurol, V39, P347; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; McKiernan BJ, 1998, J NEUROPHYSIOL, V80, P1961, DOI 10.1152/jn.1998.80.4.1961; Porter R, 1995, CORTICOSPINAL FUNCTI; Sanes JN, 2001, NEUROIMAGE, V13, P968, DOI 10.1006/nimg.2000.0733; Schmidt R.A., 2000, MOTOR LEARNING PERFO, V2nd ed.; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; WIGHTMAN DC, 1985, HUM FACTORS, V27, P267, DOI 10.1177/001872088502700304; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	22	99	100	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					938	941		10.1038/nature00834	http://dx.doi.org/10.1038/nature00834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087402				2022-12-24	WOS:000176441200036
J	Marchbanks, PA; McDonald, JA; Wilson, HG; Folger, SG; Mandel, MG; Daling, JR; Bernstein, L; Malone, KE; Ursin, G; Strom, BL; Norman, SA; Weiss, LK; Wingo, PA; Burkman, RT; Berlin, JA; Simon, MS; Spirtas, R; Weiss, LK				Marchbanks, PA; McDonald, JA; Wilson, HG; Folger, SG; Mandel, MG; Daling, JR; Bernstein, L; Malone, KE; Ursin, G; Strom, BL; Norman, SA; Weiss, LK; Wingo, PA; Burkman, RT; Berlin, JA; Simon, MS; Spirtas, R; Weiss, LK			Oral contraceptives and the risk of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WOMEN; PROGNOSIS; WHITE	Background: It is uncertain whether the use of an oral contraceptive increases the risk of breast cancer later in life, when the incidence of breast cancer is increased. We conducted a population-based, case-control study to determine the risk of breast cancer among former and current users of oral contraceptives. Methods: We interviewed women who were 35 to 64 years old. A total of 4575 women with breast cancer and 4682 controls were interviewed. Conditional logistic regression was used to calculate odds ratios as estimates of the relative risk (incidence-density ratios) of breast cancer. Results: The relative risk was 1.0 (95 percent confidence interval, 0.8 to 1.3) for women who were currently using oral contraceptives and 0.9 (95 percent confidence interval, 0.8 to 1.0) for those who had previously used them. The relative risk did not increase consistently with longer periods of use or with higher doses of estrogen. The results were similar among white and black women. Use of oral contraceptives by women with a family history of breast cancer was not associated with an increased risk of breast cancer, nor was the initiation of oral-contraceptive use at a young age. Conclusions: Among women from 35 to 64 years of age, current or former oral-contraceptive use was not associated with a significantly increased risk of breast cancer.	Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30333 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Wayne State Univ, Karmanos Canc Inst, Div Epidemiol, Detroit, MI USA; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; Bay State Med Ctr, Dept Obstet & Gynecol, Springfield, MA USA; Wayne State Univ, Karmanos Canc Inst, Div Hematol & Oncol, Detroit, MI USA; NICHHD, Contracept & Reprod Hlth Branch, Populat Res Ctr, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; Fred Hutchinson Cancer Center; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Barbara Ann Karmanos Cancer Institute; Wayne State University; American Cancer Society; Barbara Ann Karmanos Cancer Institute; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Marchbanks, PA (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30333 USA.				DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010, N01PC067006] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033168, N01HD033176, N01HD023166, N01HD033174, F32HD007022, N01HD033175] Funding Source: NIH RePORTER; NCI NIH HHS [N01-PC-67006, N01-PC-67010, N01-CN-65064, N01-CN-0532] Funding Source: Medline; NICHD NIH HHS [Y01-HD-7022, N01-HD-3-3175, N01-HD-3-3176, N01-HD-2-3166, N01-HD-3-3168, N01-HD-3-3174] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEVERLY LN, 1987, AM J PUBLIC HEALTH, V77, P351, DOI 10.2105/AJPH.77.3.351; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Calle EE, 1996, CONTRACEPTION, V54, pS1; CHEN VW, 1994, CANCER EPIDEM BIOMAR, V3, P127; COULTER A, 1986, CONTRACEPTION, V33, P127, DOI 10.1016/0010-7824(86)90079-X; *DEP DRUGS DIV DRU, 1986, DRUG EV; Dickey RP, 2000, MANAGING CONTRACEPTI; DICKEY RP, 1984, MANAGING CONTRACEPTI; Dignam JJ, 2000, CA-CANCER J CLIN, V50, P50, DOI 10.3322/canjclin.50.1.50; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; GREENLAND S, 1982, AM J EPIDEMIOL, V116, P547, DOI 10.1093/oxfordjournals.aje.a113439; GREENLAND S, 1990, AM J EPIDEMIOL, V131, P1102; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Hatcher RA, 1998, CONTRACEPTIVE TECHNO, P405; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Marchbanks PA, 2002, ANN EPIDEMIOL, V12, P213, DOI 10.1016/S1047-2797(01)00274-5; Mosher William D, 1998, FAMILY PLANNING PERS, V30, P46; Piccinino LJ, 1998, FAM PLANN PERSPECT, V30, P4, DOI 10.2307/2991517; Ursin G, 1997, CANCER RES, V57, P3678; Ursin G, 2000, EPIDEMIOLOGY, V11, P615, DOI 10.1097/00001648-200009000-00026; WALLACH M, 2000, MODERN ORAL CONTRACE; West SL, 2000, PHARMACOEPIDEMIOLOGY, V3rd edn, P661; Wingo PA, 1998, CANCER-AM CANCER SOC, V82, P1197, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0; WINGO PA, 1988, AM J EPIDEMIOL, V128, P206, DOI 10.1093/oxfordjournals.aje.a114942; WINGO PA, 1991, OBSTET GYNECOL, V78, P161	27	348	369	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2002	346	26					2025	2032		10.1056/NEJMoa013202	http://dx.doi.org/10.1056/NEJMoa013202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566DN	12087137				2022-12-24	WOS:000176411900002
J	Ekins-Daukes, S; Simpson, CR; Helms, PJ; Taylor, MW; McLay, JS				Ekins-Daukes, S; Simpson, CR; Helms, PJ; Taylor, MW; McLay, JS			Burden of corticosteroids in children with asthma in primary care: retrospective observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Child Hlth, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	McLay, JS (corresponding author), Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland.		Simpson, Colin R/L-7180-2014; Simpson, Colin/I-3974-2019	Simpson, Colin R/0000-0002-5194-8083; Simpson, Colin/0000-0002-5194-8083				Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; *NIH, 1997, 2 NAT ASTHM ED PREV; Patel L, 2001, ARCH DIS CHILD, V85, P330, DOI 10.1136/adc.85.4.330; Wagener JS, 1998, J PEDIATR-US, V132, P381, DOI 10.1016/S0022-3476(98)70003-4; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181	5	14	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2002	324	7350					1374	1374		10.1136/bmj.324.7350.1374	http://dx.doi.org/10.1136/bmj.324.7350.1374			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052808	Green Published, Bronze			2022-12-24	WOS:000176234100023
J	Suarez, PG; Floyd, K; Portocarrero, J; Alarcon, E; Rapiti, E; Ramos, G; Bonilla, C; Sabogal, I; Aranda, E; Dye, C; Raviglione, M; Espinal, MA				Suarez, PG; Floyd, K; Portocarrero, J; Alarcon, E; Rapiti, E; Ramos, G; Bonilla, C; Sabogal, I; Aranda, E; Dye, C; Raviglione, M; Espinal, MA			Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru	LANCET			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; DYNAMICS; HEALTH	Background There are no data on the feasibility and cost-effectiveness of using second-line drugs to treat patients with chronic tuberculosis, many of whom are infected with multidrug resistant (MDR) strains of Mycobacterium tuberculosis, in low or middle-income countries. Methods A national programme to treat chronic tuberculosis patients with a directly observed standardised 18-month daily regimen, consisting of kanamycin (3 months only), ciprofloxacin, ethionamide, pyrazinamide, and ethambutol, was established in Peru in 1997. Compliance and treatment outcomes were analysed for the cohort started on treatment between October, 1997, and March, 1999. Total and average costs were assessed. Cost-effectiveness was estimated as the cost per DALY gained. Findings 466 patients were enrolled; 344 were tested for drug susceptibility and 298 (87%) had MDR tuberculosis. 225 patients (48%) were cured, 57 (12%) died, 131 (28%) did not respond to treatment, and 53 (11%) defaulted. Of the 413 (89%) patients who complied with treatment, 225 (55%) were cured. Among MDR patients, resistance to five or more drugs was significantly associated with an unfavourable outcome (death, non-response to treatment, or default; odds ratio 3.37, 95% CI 1.32-8.60; p=0.01). The programme cost US$0.6 million per year, 8% of the National Tuberculosis Programme budget, and US$2381 per patient for those who completed treatment. The mean cost per DALY gained was $211 ($165 at drug prices projected for 2002). Interpretation Treating chronic tuberculosis patients with high levels of MDR with second-line drugs can be feasible and cost-effective in middle-income countries, provided a strong tuberculosis control programme is in place.	Minist Hlth, Natl TB Control Programme, Lima, Peru		Espinal, MA (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.		Suarez, Pedro G/AAD-2278-2019; BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022; Dye, Christopher/AIC-4659-2022	Suarez, Pedro G/0000-0001-9825-1761; BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939; RAVIGLIONE, Mario/0000-0002-9331-2067; Dye, Christopher/0000-0002-2957-1793				[Anonymous], 1996, GLOBAL BURDEN DIS CO; Avendano M, 2000, Can Respir J, V7, P383; BAYONA J, 1999, INT C I TROP MED TUB; Chaulet P, 1996, DRUGS, V52, P103, DOI 10.2165/00003495-199600522-00021; de Jonghe E, 1994, Int J Health Plann Manage, V9, P151, DOI 10.1002/hpm.4740090204; Drummond MF, 2015, METHODS EC EVALUATIO; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; FARMER PE, 2000, J RESP DIS, V21, P53; Geerligs WA, 2000, INT J TUBERC LUNG D, V4, P758; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Gold MR, 1996, COST EFFECTIVENESS H; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Lew W., 1996, THESIS LONDON SCH HY; LOPEZ AD, 2000, 9 GPE; *MIN SAL, 2000, PROGR NAC CONTR TUB; *MIN SAL, 1997, 1 EST VIG RES MED AN; *MIN SAL, 1998, TUB PER INF 1997; *MIN SAL, 1999, TUB PER INF 1998; *MIN SAL VIG USAID, 2001, IMP EC TUB PER 1999; Ministerio de Salud, 2001, ACT DOCTR NORM PROC; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pathania VS, 1999, VACCINE, V17, P1926, DOI 10.1016/S0264-410X(98)00462-9; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; SHEPARD DS, 1996, AIDS DEV ROL GOV C S; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404; Vynnycky E, 1998, EPIDEMIOL INFECT, V121, P309, DOI 10.1017/S0950268898001113; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; WHO, 1997, GUID MAN DRUG RES TU; *WHO, 1997, GLOB TUB PROGR TREAT; *WHO, 2001, COMM DIS PROGR GLOB; World Bank, 1993, WORLD DEV REP 1993 I; *WORLD BANK, 2001, PER DAT PROF; World Health Organization, 1996, INV HLTH RES DEV REP	39	201	208	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 8	2002	359	9322					1980	1989		10.1016/S0140-6736(02)08830-X	http://dx.doi.org/10.1016/S0140-6736(02)08830-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076553				2022-12-24	WOS:000176232500010
J	[Anonymous]				[Anonymous]			Getting a handle on obesity	LANCET			English	Editorial Material																			0	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2002	359	9322					1955	1955						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076544				2022-12-24	WOS:000176232500001
J	Stoll, S; Delon, J; Brotz, TM; Germain, RN				Stoll, S; Delon, J; Brotz, TM; Germain, RN			Dynamic imaging of T cell-dendritic cell interactions in lymph nodes	SCIENCE			English	Article							IN-VIVO; ANTIGEN PRESENTATION; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTES; ACTIVATION; CD4; REDISTRIBUTION; INFECTION; IMMUNITY; MOESIN	T cell immune responses begin within organized lymphoid tissues. The pace, topology, and outcomes of the cellular interactions that underlie these responses have, so far, been inferred from static imaging of sectioned tissue or from studies of cultured cells. Here we report dynamic visualization of antigen-specific T cells interacting with dendritic cells within intact explanted lymph nodes. We observed immunological synapse formation and prolonged interactions between these two coil types, followed by the activation, dissociation, and rapid migration of T cells away from the antigenic stimulus. This high-resolution spatiotemporal analysis provides insight into the nature of cell interactions critical to early immune responses within lymphoid structures.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Germain, Ronald/ABE-7090-2020; Brotz, Tilmann M/R-6599-2016; Germain, Ronald N./Z-1945-2019	Brotz, Tilmann M/0000-0001-8212-459X; Delon, Jerome/0000-0003-0222-1192	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545, Z01AI000758, ZIAAI000758, Z01AI000545] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; CALDWELLCC, 2001, J IMMUNOL, V167, P6140; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HOLLANDER GA, 1992, J IMMUNOL, V149, P438; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; LIPSKY PE, 1975, J EXP MED, V141, P138, DOI 10.1084/jem.141.1.138; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Sousa CRE, 2001, IMMUNITY, V14, P495; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; STOLL S, UNPUB; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Valitutti S, 1996, EUR J IMMUNOL, V26, P2012, DOI 10.1002/eji.1830260907	28	563	592	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1873	1876		10.1126/science.1071065	http://dx.doi.org/10.1126/science.1071065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052961				2022-12-24	WOS:000176054300050
J	Queitsch, C; Sangster, TA; Lindquist, S				Queitsch, C; Sangster, TA; Lindquist, S			Hsp90 as a capacitor of phenotypic variation	NATURE			English	Article							ARABIDOPSIS-THALIANA; PLASTICITY; POPULATION; EVOLUTION; SELECTION; GENETICS; FAMILY; STRESS	Heat-shock protein 90 (Hsp90) chaperones the maturation of many regulatory proteins and, in the fruitfly Drosophila melanogaster, buffers genetic variation in morphogenetic pathways. Levels and patterns of genetic variation differ greatly between obligatorily outbreeding species such as fruitflies and self-fertilizing species such as the plant Arabidopsis thaliana. Also, plant development is more plastic, being coupled to environmental cues. Here we report that, in Arabidopsis accessions and recombinant inbred lines, reducing Hsp90 function produces an array of morphological phenotypes, which are dependent on underlying genetic variation. The strength and breadth of Hsp90's effects on the buffering and release of genetic variation suggests it may have an impact on evolutionary processes. We also show that Hsp90 influences morphogenetic responses to environmental cues and buffers normal development from destabilizing effects of stochastic processes. Manipulating Hsp90's buffering capacity offers a tool for harnessing cryptic genetic variation and for elucidating the interplay between genotypes, environments and stochastic events in the determination of phenotype.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Comm Genet, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Callahan HS, 1997, BIOESSAYS, V19, P519, DOI 10.1002/bies.950190611; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; Dorn LA, 2000, EVOLUTION, V54, P1982, DOI 10.1111/j.0014-3820.2000.tb01242.x; DURRANT A, 1962, HEREDITY, V17, P27, DOI 10.1038/hdy.1962.2; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Hansen TF, 2000, J THEOR BIOL, V207, P495, DOI 10.1006/jtbi.2000.2189; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Kuittinen H, 1997, HEREDITY, V79, P144, DOI 10.1038/hdy.1997.137; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; MATHER K, 1953, HEREDITY, V7, P297, DOI 10.1038/hdy.1953.41; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; McLaren A, 1999, TRENDS GENET, V15, P169, DOI 10.1016/S0168-9525(99)01732-1; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; Pigliucci M, 1998, BIOL J LINN SOC, V64, P17, DOI 10.1006/bijl.1997.0193; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Stratton DA, 1998, HEREDITY, V81, P144, DOI 10.1046/j.1365-2540.1998.00369.x; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	27	988	1041	1	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					618	624		10.1038/nature749	http://dx.doi.org/10.1038/nature749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050657				2022-12-24	WOS:000176001200039
J	Rozema, J; van Geel, B; Bjorn, LO; Lean, J; Madronich, S				Rozema, J; van Geel, B; Bjorn, LO; Lean, J; Madronich, S			Paleoclimate: Toward solving the UV puzzle	SCIENCE			English	Editorial Material							MAUNDER MINIMUM; COUMARIC ACID; TOTAL OZONE; CLIMATE; SPOROPOLLENIN; VARIABILITY; POLLEN; CYCLE; SUN		Vrije Univ Amsterdam, Dept Syst Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GB Amsterdam, Netherlands; Lund Univ, Dept Plant Physiol, S-22100 Lund, Sweden; EO Hulburt Ctr Space Res, Washington, DC 20375 USA; Div Atmospher Sci, Boulder, CO 80307 USA	Vrije Universiteit Amsterdam; University of Amsterdam; Lund University	Rozema, J (corresponding author), Vrije Univ Amsterdam, Dept Syst Ecol, NL-1081 HV Amsterdam, Netherlands.		Madronich, Sasha/D-3284-2015	Madronich, Sasha/0000-0003-0983-1313; Lean, Judith/0000-0002-0087-9639				BOJKOV RD, 1995, J GEOPHYS RES-ATMOS, V100, P16537, DOI 10.1029/95JD00692; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Chandra S, 1999, GEOPHYS RES LETT, V26, P185, DOI 10.1029/1998GL900272; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Haigh JD, 2001, SCIENCE, V294, P2109, DOI 10.1126/science.1067013; HARRIS N, 1998, 1 SPAARC; HODGSON DA, 2001, SCAR 8 C ABSTR; Labitzke K, 1997, J ATMOS SOL-TERR PHY, V59, P9, DOI 10.1016/S1364-6826(96)00005-3; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Lean J, 2001, SCIENCE, V292, P234, DOI 10.1126/science.1060082; LEAVITT PR, 2002, COMPREHENSIVE SERIES, V2; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Markham KR, 1990, B LIAISON GROUP POLY, P230; McKenzie RL, 2001, J GEOPHYS RES-ATMOS, V106, P24051, DOI 10.1029/2001JD000545; Reid GC, 1999, J ATMOS SOL-TERR PHY, V61, P3, DOI 10.1016/S1364-6826(98)00111-4; Rozema J, 2001, J PHOTOCH PHOTOBIO B, V62, P108, DOI 10.1016/S1011-1344(01)00155-5; Rozema J, 2001, PLANT ECOL, V154, P9, DOI 10.1023/A:1012913608353; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; Staehelin J, 2001, REV GEOPHYS, V39, P231, DOI 10.1029/1999RG000059; WEHLING K, 1989, PLANTA, V179, P376, DOI 10.1007/BF00391083	20	81	86	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1621	1622		10.1126/science.1070024	http://dx.doi.org/10.1126/science.1070024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040167	Green Submitted			2022-12-24	WOS:000175976200030
J	Shao, F; Merritt, PM; Bao, ZQ; Innes, RW; Dixon, JE				Shao, F; Merritt, PM; Bao, ZQ; Innes, RW; Dixon, JE			A Yersinia effector and a pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis	CELL			English	Article							SYRINGAE PV PHASEOLICOLA; DISEASE RESISTANCE; VIRULENCE PLASMID; ESCHERICHIA-COLI; RHO GTPASES; GENE; PSEUDOTUBERCULOSIS; BINDING; KINASE; IDENTIFICATION	A Yersinia effector known as YopT and a Pseudomonas avirulence protein known as AvrPphB define a family of 19 proteins involved in bacterial pathogenesis. We show that both YopT and AvrPphB are cysteine proteases, and their proteolytic activities are dependent upon the invariant C/H/D residues conserved in the entire YopT family. YopT cleaves the posttranslationally modified Rho GTPases near their carboxyl termini, releasing them from the membrane. This leads to the disruption of actin cytoskeleton in host cells. The proteolytic activity of AvrPphB is essential for autoproteolytic cleavage of an AvrPphB precursor as well as for eliciting the hypersensitive response in plants. These findings provide new insights into mechanisms of animal and plant pathogenesis.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Dixon, JE (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	jedixon@umich.edu	Innes, Roger/A-5244-2010	Innes, Roger/0000-0001-9634-1413	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046451, R29GM046451] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46451] Funding Source: Medline; PHS HHS [18024] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boquet P, 2000, MICROBES INFECT, V2, P837, DOI 10.1016/S1286-4579(00)90369-1; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cheng LW, 2000, TRENDS MICROBIOL, V8, P214, DOI 10.1016/S0966-842X(99)01665-0; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Innes RW, 2001, MOL PLANT PATHOL, V2, P109, DOI 10.1046/j.1364-3703.2001.00057.x; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; JENNER C, 1991, MOL PLANT MICROBE IN, V4, P553, DOI 10.1094/MPMI-4-553; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Juris SJ, 2002, CELL MICROBIOL, V4, P201, DOI 10.1046/j.1462-5822.2002.00182.x; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; SASAKI T, 1993, J BIOL CHEM, V268, P23959; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; SMITH MJ, 1993, TETRAHEDRON LETT, V34, P223, DOI 10.1016/S0040-4039(00)60552-X; Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Warren RF, 1999, GENETICS, V152, P401; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289	54	361	382	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2002	109	5					575	588		10.1016/S0092-8674(02)00766-3	http://dx.doi.org/10.1016/S0092-8674(02)00766-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062101	Bronze			2022-12-24	WOS:000175957900007
J	Mercader, J; Panger, M; Boesch, C				Mercader, J; Panger, M; Boesch, C			Excavation of a chimpanzee stone tool site in the African rainforest	SCIENCE			English	Article							OLDOWAN; PLIOCENE; KENYA; ETHIOPIA; TURKANA; WEST	Chimpanzees from the Tai forest of Cote d'lvoire produce unintentional flaked stone assemblages at nut-cracking sites, leaving behind a record of tool use and plant consumption that is recoverable with archaeological methods. About 40 kilograms of nutshell and 4 kilograms of stone were excavated at the Panda 100 site. The data unearthed show that chimpanzees transported stones from outcrops and soils to focal points, where they used them as hammers to process foodstuff. The repeated use of activity areas led to refuse accumulation and site formation. The implications of these data for the interpretation of the earliest hominin archaeological record are explored.	George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	George Washington University; Max Planck Society	Mercader, J (corresponding author), George Washington Univ, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.		Mercader, Julio/G-5182-2010					BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Boesch C, 2000, CHIMPANZEES TAI FORE; Chavaillon J., 1976, EARLIEST MAN ENV LAK, P565; GOODWIN AM, 1991, PRECAMBRIAN GEOLOGY; ISAAC GL, 1976, EARLIEST MAN ENV LAK, P552; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; KIBUNJIA M, 1992, J HUM EVOL, V23, P431, DOI 10.1016/0047-2484(92)90091-M; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; KORTLANDT A, 1986, J HUM EVOL, V15, P77, DOI 10.1016/S0047-2484(86)80068-9; Leakey M.D., 1971, OLDUVAI GORGE; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Merrick H.V., 1976, EARLIEST MAN ENV LAK, P574; PETERS CR, 1987, AM J PHYS ANTHROPOL, V73, P333, DOI 10.1002/ajpa.1330730306; Plummer T, 1999, J HUM EVOL, V36, P151, DOI 10.1006/jhev.1998.0256; POTTS R, 1991, J ANTHROPOL RES, V47, P153, DOI 10.1086/jar.47.2.3630323; ROBYNS W, 1958, FLORE CONGO BELGE RU, P1; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; ROMPAEY RV, 1994, PARC NAT TAI COTE IV, P42; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697	23	173	186	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1452	1455		10.1126/science.1070268	http://dx.doi.org/10.1126/science.1070268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	557LP	12029130				2022-12-24	WOS:000175910300044
J	Enomoto, A; Kimura, H; Chairoungdua, A; Shigeta, Y; Jutabha, P; Cha, SH; Hosoyamada, M; Takeda, M; Sekine, T; Igarashi, T; Matsuo, H; Kikuchi, Y; Oda, T; Ichida, K; Hosoya, T; Shimokata, K; Niwa, T; Kanai, Y; Endou, H				Enomoto, A; Kimura, H; Chairoungdua, A; Shigeta, Y; Jutabha, P; Cha, SH; Hosoyamada, M; Takeda, M; Sekine, T; Igarashi, T; Matsuo, H; Kikuchi, Y; Oda, T; Ichida, K; Hosoya, T; Shimokata, K; Niwa, T; Kanai, Y; Endou, H			Molecular identification of a renal urate-anion exchanger that regulates blood urate levels	NATURE			English	Article							P-AMINOHIPPURATE TRANSPORT; BRUSH-BORDER MEMBRANE; URIC-ACID; KIDNEY; PEROXYNITRITE; HYPERURICEMIA; DYSFUNCTION; EXCRETION; VESICLES; EXERCISE	Urate, a naturally occurring product of purine metabolism, is a scavenger of biological oxidants implicated in numerous disease processes(1-3), as demonstrated by its capacity of neuroprotection(4,5). It is present at higher levels in human blood (200-500 muM) than in other mammals 6, because humans have an effective renal urate reabsorption system, despite their evolutionary loss of hepatic uricase by mutational silencing(6-8). The molecular basis for urate handling in the human kidney remains unclear because of difficulties in understanding diverse urate transport systems and species differences(6,9,10). Here we identify the long-hypothesized(9-11) urate transporter in the human kidney (URAT1, encoded by SLC22A12), a urate-anion exchanger regulating blood urate levels and targeted by uricosuric and anti-uricosuric agents (which affect excretion of uric acid). Moreover, we provide evidence that patients with idiopathic renal hypo-uricaemia (lack of blood uric acid) have defects in SLC22A12. Identification of URAT1 should provide insights into the nature of urate homeostasis, as well as lead to the development of better agents against hyperuricaemia, a disadvantage concomitant with human evolution.	Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; Nagoya Univ, Sch Med, Dept Clin Prevent Med, Nagoya, Aichi 4668560, Japan; Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo 1058461, Japan; Chiba Univ, Sch Med, Dept Urol, Chiba 2608670, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 1138655, Japan; Natl Def Med Coll, Dept Physiol 1, Saitama 3598513, Japan; Natl Def Med Coll, Dept Internal Med 2, Saitama 3598513, Japan; JSDF Kumamoto Hosp, Dept Med, Kumamoto 8620902, Japan	Kyorin University; Nagoya University; Jikei University; Chiba University; University of Tokyo; National Defense Medical College - Japan; National Defense Medical College - Japan	Endou, H (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan.	endouh@kyorin-u.ac.jp	Enomoto, Atsushi/I-7272-2014; Jutabha, Promsuk/AFF-4363-2022; Jutabha, Promsuk/AAE-9872-2022	Enomoto, Atsushi/0000-0002-9206-6116; Oda, Takashi/0000-0002-6131-7752; Matsuo, Hirotaka/0000-0003-4302-8719				ABRAMSON RG, 1990, BASIC PRINCIPLES TRA, V3, P115; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BERLINER RW, 1950, J CLIN INVEST, V29, P396, DOI 10.1172/JCI102271; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; CULLEN JH, 1957, AM J MED, V23, P587, DOI 10.1016/0002-9343(57)90229-2; CUTLER RG, 1991, AM J CLIN NUTR, V53, P373; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; GUGGINO SE, 1983, AM J PHYSIOL, V244, pF612, DOI 10.1152/ajprenal.1983.244.6.F612; HALABE A, 1994, MINER ELECTROL METAB, V20, P424; Halliwell B, 1996, HDB ANTIOXIDANTS, P243; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; IGARASHI T, 1993, PEDIATR NEPHROL, V7, P292, DOI 10.1007/BF00853226; Johnson RJ, 1999, AM J KIDNEY DIS, V33, P225, DOI 10.1016/S0272-6386(99)70295-7; KAHN AM, 1983, AM J PHYSIOL, V245, pF151, DOI 10.1152/ajprenal.1983.245.2.F151; Keller JN, 1998, J NEUROSCI, V18, P687; Kikuchi Y, 2000, CLIN NEPHROL, V53, P467; Koepsell H, 1998, ANNU REV PHYSIOL, V60, P243, DOI 10.1146/annurev.physiol.60.1.243; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lipkowitz MS, 2001, J CLIN INVEST, V107, P1103, DOI 10.1172/JCI12471; Maesaka JK, 1998, AM J KIDNEY DIS, V32, P917, DOI 10.1016/S0272-6386(98)70067-8; MANDEL LJ, 1985, ANNU REV PHYSIOL, V47, P85; RochRamel F, 1996, AM J PHYSIOL-RENAL, V270, pF61, DOI 10.1152/ajprenal.1996.270.1.F61; ROCHRAMEL F, 1994, AM J PHYSIOL, V266, pF797, DOI 10.1152/ajprenal.1994.266.5.F797; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Sica DA, 2000, KIDNEY, P680; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854	30	1005	1124	16	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					447	452		10.1038/nature742	http://dx.doi.org/10.1038/nature742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024214				2022-12-24	WOS:000175730900040
J	Tram, U; Sullivan, W				Tram, U; Sullivan, W			Rote of delayed nuclear envelope breakdown and mitosis in Wolbachia-induced cytoplasmic incompatibility	SCIENCE			English	Article							DROSOPHILA-SIMULANS; CHROMOSOME CONDENSATION; CYCLIN-B; CENTROSOMES; CELL; FERTILIZATION; POPULATIONS; BACTERIA; NASONIA; CROSSES	The bacterium Wolbachia manipulates reproduction in millions of insects worldwide; the most common effect is cytoplasmic incompatibility (CI). We found that CI resulted from delayed nuclear envelope breakdown of the mate pronucleus in Nasonia vitripennis. This caused asynchrony between the male and female pronuclei and, ultimately, loss of paternal chromosomes at the first mitosis. When Wolbachia were present in the egg, synchrony was restored, which explains suppression of CI in these crosses. These results suggest that Wolbachia target cell cycle regulatory proteins. A striking consequence of Cl is that it alters the normal pattern of reciprocal centrosome inheritance in Nasonia.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sullivan, W (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 319 Sinsheimer Labs, Santa Cruz, CA 95064 USA.				NIGMS NIH HHS [GM16409] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Callaini G, 1996, J INVERTEBR PATHOL, V67, P55, DOI 10.1006/jipa.1996.0009; Callaini G, 1997, J CELL SCI, V110, P271; CALLAINI G, 1994, J CELL SCI, V107, P673; CHARLAT S, 2002, SYMBIOSIS MECH MODEL; DEBEC A, 1992, BIOL CELL, V75, P121, DOI 10.1016/0248-4900(92)90131-J; Debec A, 1996, J CELL BIOL, V134, P103, DOI 10.1083/jcb.134.1.103; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Karr TL, 1996, CURR TOP DEV BIOL, V34, P89, DOI 10.1016/S0070-2153(08)60709-7; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; KOSE H, 1995, THESIS U ILLINOIS UR; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; ONeill SL, 1997, INFLUENTIAL PASSENGE; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Presgraves DC, 2000, GENETICS, V154, P771; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; RYAN SL, 1968, MOL GEN GENET, V103, P29, DOI 10.1007/BF00271154; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Tram U, 2000, CURR BIOL, V10, P1413, DOI 10.1016/S0960-9822(00)00795-8; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Yu KR, 2000, NAT CELL BIOL, V2, P609, DOI 10.1038/35023555	30	182	199	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1124	1126		10.1126/science.1070536	http://dx.doi.org/10.1126/science.1070536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004132				2022-12-24	WOS:000175565000055
J	Mandelblatt, JS; Lawrence, WF; Womack, SM; Jacobson, D; Yi, B; Hwang, YT; Gold, K; Barter, J; Shah, K				Mandelblatt, JS; Lawrence, WF; Womack, SM; Jacobson, D; Yi, B; Hwang, YT; Gold, K; Barter, J; Shah, K			Benefits and costs of using HPV testing to screen for cervical cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; CYTOLOGICALLY NORMAL WOMEN; POLYMERASE-CHAIN-REACTION; HIGH-RISK HPV; HYBRID CAPTURE ASSAY; NATURAL-HISTORY; YOUNG-WOMEN; UNDETERMINED SIGNIFICANCE; EPIDEMIOLOGIC EVIDENCE	Context Despite quality assurance standards, Papanicolaou (Pap) test characteristics remain less than optimal. Objective To compare the societal costs and benefits of human papillomavirus (HPV) testing, Pap testing, and their combination to screen for cervical cancer. Design, Setting, and Population A simulation model of neoplasia natural history was used to estimate the societal costs and quality-adjusted life expectancy associated with 18 different general population screening strategies: Pap plus HPV testing, Pap testing alone, and HPV testing alone every 2 or 3 years among hypothetical longitudinal cohorts of US women beginning at age 20 years and continuing to 65 years, 75 years, or death. Main Outcome Measure Discounted costs per quality-adjusted life-year (QALY) saved of each screening strategy. Results Maximal savings in lives were achieved by screening every 2 years until death with combined HPV and Pap testing at an incremental cost of $76183 per QALY compared with Pap testing alone every 2 years. Stopping biennial screening with HPV and Pap testing at age 75 years captures 97.8% of the benefits of lifetime screening at a cost of $70347 per QALY. Combined biennial HPV and Pap testing to age 65 years captures 86.6% of the benefits achievable by continuing to screen until age 75 years. Human papillomavirus screening alone was equally effective as Pap testing alone at any given screening interval or age of screening cessation but was more costly and therefore was dominated. In sensitivity analyses, HPV testing would be more effective and less costly than Pap testing at a cost threshold of $5 for an HPV test. Conclusions Screening with HPV plus Pap tests every 2 years appears to save additional years of life at reasonable costs compared with Pap testing alone. Applying age limits to screening is a viable option to maintain benefits while reducing costs.	Georgetown Univ, Med Ctr & Clin & Econ Outcomes Core, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20007 USA; Georgetown Univ, Med Ctr & Clin & Econ Outcomes Core, Lombardi Canc Ctr, Dept Med, Washington, DC 20007 USA; Georgetown Univ, Med Ctr & Clin & Econ Outcomes Core, Lombardi Canc Ctr, Dept Obstet & Gynecol, Washington, DC 20007 USA; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; Roswell Pk Canc Inst, Dept Canc Prevent Epidemiol & Biostat, Buffalo, NY 14263 USA; Tufts Univ, Dept Community Hlth Family Med, Sch Med, Boston, MA 02111 USA; Georgetown Univ, Sch Med, Dept Biomath & Biostat, Washington, DC USA; Johns Hopkins Sch Med, Dept Microbiol, Baltimore, MD USA; Johns Hopkins Sch Publ Hlth, Dept Microbiol, Baltimore, MD USA	Georgetown University; Georgetown University; Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Tufts University; Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mandelblatt, JS (corresponding author), Georgetown Univ, Med Ctr & Clin & Econ Outcomes Core, Lombardi Canc Ctr, Dept Oncol, 2233 Wisconsin Ave NW,Suite 317, Washington, DC 20007 USA.	mandelbj@georgetown.edu			NATIONAL INSTITUTE ON AGING [R01AG015340] Funding Source: NIH RePORTER; NIA NIH HHS [R01-AG15340] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adam E, 2000, AM J OBSTET GYNECOL, V182, P257, DOI 10.1016/S0002-9378(00)70208-0; BAQUET CR, 1991, J NATL CANCER I, V83, P551, DOI 10.1093/jnci/83.8.551; BAUER HM, 1993, SEX TRANSM DIS, V20, P274, DOI 10.1097/00007435-199309000-00007; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; BORST M, 1991, J REPROD MED, V36, P95; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BOYES DA, 1982, CLIN INVEST MED, V5, P1; Brisson J, 1996, J INFECT DIS, V173, P794, DOI 10.1093/infdis/173.4.794; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; BUR M, 1995, ACTA CYTOL, V39, P631; Burk RD, 1996, SEX TRANSM DIS, V23, P333, DOI 10.1097/00007435-199607000-00013; Clavel C, 1998, INT J CANCER, V75, P525, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;525::AID-IJC6&gt;3.0.CO;2-V; COLGAN TJ, 1995, ACTA CYTOL, V39, P1191; COPPLESON LW, 1975, AM J OBSTET GYNECOL, V122, P127, DOI 10.1016/0002-9378(75)90627-4; Costa S, 2000, ACTA CYTOL, V44, P310, DOI 10.1159/000328471; COX JT, 1995, AM J OBSTET GYNECOL, V172, P946, DOI 10.1016/0002-9378(95)90026-8; CREASMAN WT, 1981, GYNECOL ONCOL, V12, pS306, DOI 10.1016/0090-8258(81)90084-6; Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; Cuzick J, 2000, BRIT J CANCER, V83, P561, DOI 10.1054/bjoc.2000.1375; CUZICK J, 1999, HEALTH TECHNOL ASSES, V3, P1; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EDDY DM, 1987, CANCER, V60, P1117, DOI 10.1002/1097-0142(19870901)60:5<1117::AID-CNCR2820600533>3.0.CO;2-H; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Efron B, 1998, INTRO BOOTSTRAP; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; FINK DJ, 1988, CA-CANCER J CLIN, V38, P127, DOI 10.3322/canjclin.38.2.127; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; GAARENSTROOM KN, 1994, INT J GYNECOL CANCER, V4, P73, DOI 10.1046/j.1525-1438.1994.04020073.x; Gjoen K, 1996, APMIS, V104, P68, DOI 10.1111/j.1699-0463.1996.tb00688.x; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Helms LJ, 1999, MED CARE, V37, P652, DOI 10.1097/00005650-199907000-00005; HERRERO R, 1997, PAN AM J PUBLIC HLTH, V1, P362; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HILDESHEIM A, 1993, SEX TRANSM DIS, V20, P279, DOI 10.1097/00007435-199309000-00008; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Hunink MGM, 1998, MED DECIS MAKING, V18, P337, DOI 10.1177/0272989X9801800312; HUTCHINSON ML, 1992, ACTA CYTOL, V36, P499; Jenkins D, 1996, INT J CANCER, V65, P768; Jenkins D, 2001, CURR OPIN INFECT DIS, V14, P53, DOI 10.1097/00001432-200102000-00010; JONES WB, 1995, CANCER, V76, P1934, DOI 10.1002/1097-0142(19951115)76:10+<1934::AID-CNCR2820761310>3.0.CO;2-8; KATAJA V, 1990, EUR J EPIDEMIOL, V6, P9, DOI 10.1007/BF00155542; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Kiviat N, 1996, AM J OBSTET GYNECOL, V175, P1099, DOI 10.1016/S0002-9378(96)70011-X; KOOPMANSCHAP MA, 1990, INT J CANCER, V45, P410, DOI 10.1002/ijc.2910450305; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; KURMAN RJ, 1994, JAMA-J AM MED ASSOC, V271, P1866, DOI 10.1001/jama.271.23.1866; LEY C, 1991, JNCI-J NATL CANCER I, V83, P997, DOI 10.1093/jnci/83.14.997; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Londesborough P, 1996, INT J CANCER, V69, P364; Lorincz A T, 1996, J Obstet Gynaecol Res, V22, P629; Lorincz AT, 1996, OBSTET GYN CLIN N AM, V23, P707; Luce BR, 1996, COST EFFECTIVENESS H, P176; MANDELBLATT J, 1986, JAMA-J AM MED ASSOC, V256, P367, DOI 10.1001/jama.256.3.367; MANDELBLATT J, IN PRESS J NATL CANC; Mandelblatt J S, 2000, J Am Med Womens Assoc (1972), V55, P210; Mandelblatt JS, 1997, J GEN INTERN MED, V12, P551, DOI 10.1046/j.1525-1497.1997.07107.x; Mandelblatt JS, 1999, CANCER EPIDEM BIOMAR, V8, P97; MANGO LJ, 1994, CANCER LETT, V77, P155, DOI 10.1016/0304-3835(94)90098-1; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; MCCRORY DC, 1999, 5 AG HLTH CAR POL RE; Meijer C J, 1992, IARC Sci Publ, P271; MELKERT PWJ, 1993, INT J CANCER, V53, P919, DOI 10.1002/ijc.2910530609; Mitchell MF, 1998, OBSTET GYNECOL, V92, P737, DOI 10.1097/00006250-199811000-00001; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; MOSCICKI AB, 1993, OBSTET GYNECOL, V82, P578; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121403; MULLER C, 1990, COSTS EFFECTIVENESS; MUNOZ H, 1992, EPIDEMIOLOGY CERVICA, P251; Myers ER, 2000, OBSTET GYNECOL, V96, P645, DOI 10.1016/S0029-7844(00)00979-0; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *NAT CTR HLTH STAT, 1995, NAT HLTH INT SURV 19, V10; *NAT CTR HLTH STAT, 1998, VIT HLTH STAT; *NCI, 2000, SURV EP END RES; *NCI, 1999, SEER CANC INC PUBL U; NELSON JH, 1989, CA-CANCER J CLIN, V39, P157, DOI 10.3322/canjclin.39.3.157; *NIH CONS STAT, 1996, CERV CANC; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; NUOVO G, 1992, GYNECOL ONCOL, V46, P304, DOI 10.1016/0090-8258(92)90221-4; PARKIN DM, 1986, J EPIDEMIOL COMMUN H, V40, P143, DOI 10.1136/jech.40.2.143; Peyton CL, 1998, J CLIN MICROBIOL, V36, P3248, DOI 10.1128/JCM.36.11.3248-3254.1998; RADER JS, 1991, J REPROD MED, V36, P291; RATMAN S, 2000, CANCER EPIDEM BIOMAR, V9, P945; REID R, 1991, AM J OBSTET GYNECOL, V164, P1461, DOI 10.1016/0002-9378(91)91425-V; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; Riethmuller D, 1999, DIAGN MOL PATHOL, V8, P157, DOI 10.1097/00019606-199909000-00009; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Sawaya GF, 2000, ANN INTERN MED, V133, P942, DOI 10.7326/0003-4819-133-12-200012190-00009; SAWAYA GF, IN PRESS J AM GERIAT; Schechter CB, 1996, ACTA CYTOL, V40, P1272; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; SCHIFFMAN MH, 1995, J CLIN MICROBIOL, V33, P545, DOI 10.1128/JCM.33.3.545-550.1995; SCHIFFMAN MH, 1994, CANCER RES, V54, pS1944; Schneider A, 1996, AM J OBSTET GYNECOL, V174, P1534, DOI 10.1016/S0002-9378(96)70602-6; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; Serwadda D, 1999, J INFECT DIS, V180, P1316, DOI 10.1086/315026; Shah KV, 1996, INT J GYNECOL PATHOL, V15, P127, DOI 10.1097/00004347-199604000-00006; SHEN LH, 1995, OBSTET GYNECOL, V86, P499, DOI 10.1016/S0029-7844(95)80004-2; SHERLAWJOHNSON C, 1986, OBSTET GYNECOL, V67, P665; SHERMAN ME, 1994, AM J CLIN PATHOL, V102, P182, DOI 10.1093/ajcp/102.2.182; Sherman ME, 1997, CANCER CYTOPATHOL, V81, P89; SHINGLETON HM, 1987, CANC CERVIX DIAGNOSI; Sigurdsson K, 1997, INT J CANCER, V72, P446, DOI 10.1002/(SICI)1097-0215(19970729)72:3<446::AID-IJC12>3.3.CO;2-Q; Smith CCT, 1996, PLATELETS, V7, P231, DOI 10.3109/09537109609023583; Smith EM, 1997, GYNECOL ONCOL, V65, P441, DOI 10.1006/gyno.1997.4703; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Svare EI, 1998, EUR J CANCER, V34, P1230, DOI 10.1016/S0959-8049(98)00131-2; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANBALLEGOOIJEN M, 1995, EUR J CANCER, V31A, P1672, DOI 10.1016/0959-8049(95)00243-C; vanBallegooijen M, 1997, BRIT J CANCER, V76, P651, DOI 10.1038/bjc.1997.440; VANBALLEGOOIJEN M, 1990, EUR J CANCER, V26, P941, DOI 10.1016/0277-5379(90)90615-Z; VANDENVELDE C, 1992, J MED VIROL, V36, P279, DOI 10.1002/jmv.1890360409; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; WALBOOMERS JMM, 1995, J CLIN PATHOL, V48, P728, DOI 10.1136/jcp.48.8.728; WAUGH N, 1996, CYTOPATHOLOGY, V7, P4; Wheeler CM, 1996, OBSTET GYNECOL, V88, P261, DOI 10.1016/0029-7844(96)00120-2; WHEELER CM, 1993, SEX TRANSM DIS, V20, P286, DOI 10.1097/00007435-199309000-00009; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	132	216	231	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2002	287	18					2372	2381		10.1001/jama.287.18.2372	http://dx.doi.org/10.1001/jama.287.18.2372			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548PF	11988058	Bronze			2022-12-24	WOS:000175397000026
J	Hood, JD; Bednarski, M; Frausto, R; Guccione, S; Reisfeld, RA; Xiang, R; Cheresh, DA				Hood, JD; Bednarski, M; Frausto, R; Guccione, S; Reisfeld, RA; Xiang, R; Cheresh, DA			Tumor regression by targeted gene delivery to the neovasculature	SCIENCE			English	Article							ALPHA(V)BETA(3) ANTAGONISTS; KINASE-ACTIVITY; IN-VIVO; ANGIOGENESIS; GROWTH; INTEGRIN-ALPHA-V-BETA-3; METASTASES; THERAPY; VIRUS	Efforts to influence the biology of blood vessels by gene delivery have been hampered by a lack of targeting vectors specific for endothelial cells in diseased tissues. Here we show that a cationic nanoparticle (NP) coupled to an integrin alphavbeta3-targeting ligand can deliver genes selectively to angiogenic blood vessels in tumor-bearing mice. The therapeutic efficacy of this approach was tested by generating NPs conjugated to a mutant Raf gene, ATP(mu)-Raf, which blocks endothelial signaling and angiogenesis in response to multiple growth factors. Systemic injection of the NP into mice resulted in apoptosis of the tumor-associated endothelium, ultimately leading to tumor cell apoptosis and sustained regression of established primary and metastatic tumors.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Stanford Sch Med, Lucas Magnet Resonance Spect Res Ctr, Stanford, CA 94305 USA	Scripps Research Institute; Stanford University	Cheresh, DA (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cheresh@scripps.edu	Frausto, Ricardo/AAE-3146-2021		NCI NIH HHS [T32 CA09696, CA50286] Funding Source: Medline; NCRR NIH HHS [P41 RR09784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050286, T32CA009696, R37CA050286] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Blezinger P, 1999, NAT BIOTECHNOL, V17, P343, DOI 10.1038/7895; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Carron CP, 1998, CANCER RES, V58, P1930; Duggan ME, 2000, J MED CHEM, V43, P3736, DOI 10.1021/jm000133v; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; Takeshita S, 1996, LAB INVEST, V75, P487; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xiang R, 1997, CANCER RES, V57, P4948; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	19	723	807	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2404	2407		10.1126/science.1070200	http://dx.doi.org/10.1126/science.1070200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089446				2022-12-24	WOS:000176467200045
J	Mahon, MJ; Donowitz, M; Yun, CC; Segre, GV				Mahon, MJ; Donowitz, M; Yun, CC; Segre, GV			Na+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling	NATURE			English	Article							OK CELLS; PROTEIN-BINDING; PHOSPHOLIPASE-C; PEPTIDE; DOMAIN; PDZ; INHIBITION; TRANSPORT; CALCIUM; PTH		Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University	Segre, GV (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.				NIDDK NIH HHS [P01 DK044484, R01 DK061418] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044484, R01DK061418] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bringhurst FR, 2001, PARATHYROIDS BASIC C, P227; CLEMENS TL, 2001, PARATHYROIDS, P261; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; GAICH G, 1993, ENDOCRINOLOGY, V132, P1402, DOI 10.1210/en.132.3.1402; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; Isales CM, 2000, AM J PHYSIOL-ENDOC M, V279, pE654, DOI 10.1152/ajpendo.2000.279.3.E654; KAUFMANN M, 1994, ENDOCRINOLOGY, V134, P1173, DOI 10.1210/en.134.3.1173; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KRAYERPAWLOWSKA D, 1991, J MEMBRANE BIOL, V120, P173, DOI 10.1007/BF01872400; Marcus R, 2001, PARATHYROIDS BASIC C, P93; MCCAULEY LK, 1992, ENDOCRINOLOGY, V130, P300, DOI 10.1210/en.130.1.300; MIYAUCHI A, 1990, AM J PHYSIOL, V259, pF485, DOI 10.1152/ajprenal.1990.259.3.F485; ORLOFF JJ, 1992, AM J PHYSIOL, V262, pE599, DOI 10.1152/ajpendo.1992.262.5.E599; RESHKIN SJ, 1991, J MEMBRANE BIOL, V124, P227, DOI 10.1007/BF01994356; SCHLUTER KD, 1995, BIOCHEM J, V310, P439, DOI 10.1042/bj3100439; Segre G. V., 2001, PARATHYROIDS BASIC C, P245; SMOGORZEWSKI M, 1993, AM J PHYSIOL, V264, pH1998, DOI 10.1152/ajpheart.1993.264.6.H1998; Strewler GJ, 2001, PARATHYROIDS BASIC C, P213; Sutliff RL, 1999, ENDOCRINOLOGY, V140, P2077, DOI 10.1210/en.140.5.2077; TANAKA H, 1995, AM J PHYSIOL-RENAL, V268, pF330, DOI 10.1152/ajprenal.1995.268.2.F330; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF792, DOI 10.1152/ajprenal.2000.278.5.F792; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; YAMAMOTO I, 1988, ENDOCRINOLOGY, V122, P1208, DOI 10.1210/endo-122-4-1208; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	31	237	242	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					858	861		10.1038/nature00816	http://dx.doi.org/10.1038/nature00816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075354				2022-12-24	WOS:000176285600049
J	Biedermann, BC; Sahner, S; Gregor, M; Tsakiris, DA; Jeanneret, C; Pober, JS; Gratwohl, A				Biedermann, BC; Sahner, S; Gregor, M; Tsakiris, DA; Jeanneret, C; Pober, JS; Gratwohl, A			Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease	LANCET			English	Article							BONE-MARROW TRANSPLANTATION; IDENTIFICATION; APOPTOSIS; CELLS; DNA	Background Vascular endothelial cells form the interface between recipient tissues and circulating alloreactive donor T cells after allogeneic stem cell transplantation. Vascular injury has been seen in patients with acute graft versus host disease (GVHD) in the skin. We aimed to see whether vascular injury mediated by cytotoxic T lymphocytes and microvessel loss arises in patients with chronic GVHD. Methods We investigated eight patients with acute GVHD and ten with chronic GVHD for signs of endothelial injury and microvessel loss by measurement of von Willebrand factor (vWF) in plasma and blood vessel density in biopsy samples taken from lesional skin. Controls consisted of nine patients without GVHD who survived for longer than 100 days and nine healthy people. Inflammation and endothelial injury were assessed in selected samples by immunostaining for CD8 T cells, activated cytotoxic T lymphocytes, and vascular endothelial cells. Findings We identified more extensive loss of microvessels in the skin of patients with GVHD (median 66 capilllaries/mm(2); IQR 16-98) than of healthy controls (205 capilliaries/mm(2); 157-226; p=0.005). Patients with GVHD had higher concentrations of vWF (238%; 168-288) than did those without GVHD (102%; 88-118; p=0.0005). Perivascular CD8 T cell infiltrates in skin correlated with vWF plasma concentrations in patients with GVHD (p=0.01), and activated cytotoxic T lymphocytes and endothelial injury were present in these same samples. Interpretation Host endothelial cells are a target of alloreactive donor cytotoxic T lymphocytes. Substantial blood vessel loss may lead to impaired blood perfusion and tissue fibrosis, the hallmark lesion of chronic GVHD.	Univ Hosp Bruderholz, Dept Med, CH-4101 Bruderholz, Switzerland; Univ Hosp, Dept Res, Basel, Switzerland; Univ Hosp, Div Haematol, Basel, Switzerland; Cantonal Inst Pathol, Liestal, Switzerland; Yale Univ, Sch Med, Boyer Ctr Mol Med, New Haven, CT USA	Yale University	Biedermann, BC (corresponding author), Univ Hosp Bruderholz, Dept Med, CH-4101 Bruderholz, Switzerland.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062188] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; ATKINSON K, 1986, BRIT J DERMATOL, V114, P145, DOI 10.1111/j.1365-2133.1986.tb02793.x; BLANN AD, 1995, BRIT J HAEMATOL, V90, P244, DOI 10.1111/j.1365-2141.1995.tb05143.x; Dong CM, 1996, LAB INVEST, V74, P921; DUMLER JS, 1989, AM J PATHOL, V135, P1097; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Goldman JM, 1998, BONE MARROW TRANSPL, V21, P1, DOI 10.1038/sj.bmt.1701089; Gouw ASH, 2002, TRANSPLANTATION, V73, P243, DOI 10.1097/00007890-200201270-00016; GRATWHOL AA, 1977, ANN INTERN MED, V87, P703, DOI 10.7326/0003-4819-87-6-703; HRUBAN RH, 1990, AM J PATHOL, V137, P871; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Majolino I, 1996, BONE MARROW TRANSPL, V17, P555; Meehan SM, 1997, LAB INVEST, V76, P639; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; TSAKIRIS DA, 1995, SCHWEIZ MED WSCHR, V125, P416; Vogelsang GB, 2001, BLOOD, V97, P1196, DOI 10.1182/blood.V97.5.1196; Zecca M, 2000, Paediatr Drugs, V2, P29	21	191	202	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 15	2002	359	9323					2078	2083		10.1016/S0140-6736(02)08907-9	http://dx.doi.org/10.1016/S0140-6736(02)08907-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562JX	12086762				2022-12-24	WOS:000176194600010
J	Ito, J; Ghosh, A; Moreira, LA; Wimmer, EA; Jacobs-Lorena, M				Ito, J; Ghosh, A; Moreira, LA; Wimmer, EA; Jacobs-Lorena, M			Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite	NATURE			English	Article							YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; GERMLINE TRANSFORMATION; GENE-EXPRESSION; BLOOD MEAL; GAMBIAE; VECTOR; GUT	Malaria is estimated to cause 0.7 to 2.7 million deaths per year, but the actual figures could be substantially higher owing to under-reporting and difficulties in diagnosis(1). If no new control measures are developed, the malaria death toll is projected to double in the next 20 years(1). Efforts to control the disease are hampered by drug resistance in the Plasmodium parasites, insecticide resistance in mosquitoes, and the lack of an effective vaccine. Because mosquitoes are obligatory vectors for malaria transmission, the spread of malaria could be curtailed by rendering them incapable of transmitting parasites. Many of the tools required for the genetic manipulation of mosquito competence for malaria transmission have been developed. Foreign genes can now be introduced into the germ line of both culicine(2,3) and anopheline(4) mosquitoes, and these transgenes can be expressed in a tissue-specific manner(5,6). Here we report on the use of such tools to generate transgenic mosquitoes that express antiparasitic genes in their midgut epithelium, thus rendering them inefficient vectors for the disease. These findings have significant implications for the development of new strategies for malaria control.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Bayreuth, Lehrstuhl Genet, D-95447 Bayreuth, Germany	Case Western Reserve University; University of Bayreuth	Jacobs-Lorena, M (corresponding author), Case Western Reserve Univ, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.		Wimmer, Ernst A./I-3333-2019	Wimmer, Ernst A./0000-0002-2480-2804				Breman JG, 2001, AM J TROP MED HYG, V64, P1; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197; Lemos FJA, 1996, INSECT BIOCHEM MOLEC, V26, P651, DOI 10.1016/S0965-1748(96)00014-8; Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895; PRINGLE G, 1966, T ROY SOC TROP MED H, V60, P626, DOI 10.1016/0035-9203(66)90009-5	14	401	437	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					452	455		10.1038/417452a	http://dx.doi.org/10.1038/417452a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024215				2022-12-24	WOS:000175730900041
J	Saneyoshi, T; Kume, S; Amasaki, Y; Mikoshiba, K				Saneyoshi, T; Kume, S; Amasaki, Y; Mikoshiba, K			The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; WNT SIGNALING PATHWAY; TRANSCRIPTION FACTORS; SPEMANN ORGANIZER; AXIS FORMATION; BETA-CATENIN; EXPRESSION; LAEVIS; FAMILY	It is thought that inositol-1,4,5-trisphosphate (Ins(1,4,5) P-3)-Ca2+ signalling has a function in dorsoventral axis formation in Xenopus embryos(1-3;) however, the immediate target of free Ca2+ is unclear. The secreted Wnt protein family comprises two functional groups, the canonical Wnt and Wnt/Ca2+ pathways(4). The Wnt/Ca2+ pathway interferes with the canonical Wnt pathway(5), but the underlying molecular mechanism is poorly understood. Here, we cloned the complementary DNA coding for the Xenopus homologue of nuclear factor of activated T cells (XNF-AT). A gain-of-function, calcineurin-independent active XNF-AT mutation (CA XNF-AT) inhibited anterior development of the primary axis, as well as Xwnt-8-induced ectopic dorsal axis development in embryos. A loss-of-function, dominant negative XNF-AT mutation (DN XNF-AT) induced ectopic dorsal axis formation and expression of the canonical Wnt signalling target molecules siamois and Xnr3 (ref. 4). Xwnt-5A induced translocation of XNF-AT from the cytosol to the nucleus. These data indicate that XNF-AT functions as a downstream target of the Wnt/Ca2+ and Ins(1,4,5) P-3-Ca2+ pathways, and has an essential role in mediating ventral signals in the Xenopus embryo through suppression of the canonical Wnt pathway.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, ERATO, Mikoshiba Calciosignal Net Project, Minato Ku, Tokyo 1080071, Japan; Japan Sci & Technol Corp, ICORP, Calcium Oscillat Project, Minato Ku, Tokyo 1080071, Japan; Univ Tokyo, CREST, Inst Med Sci, Dept Mol & Dev Biol,Minato Ku, Tokyo 1088639, Japan; RIKEN, Brain Res Inst, Wako, Saitama 35101, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; RIKEN	Kume, S (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, Div Stem Cell Biol, Kuhonji 4-24-1, Kumamoto 8620976, Japan.		Saneyoshi, Takeo/AAF-5170-2019; Mikoshiba, Katsuhiko/N-7943-2015; Kume, Shoen/M-4356-2016	Kume, Shoen/0000-0002-4292-205X				Ault KT, 1996, DEVELOPMENT, V122, P2033; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Chow CW, 1999, MOL CELL BIOL, V19, P2300; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kume S, 1999, CELL MOL LIFE SCI, V56, P296, DOI 10.1007/s000180050431; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MOON RT, 1993, DEVELOPMENT, V119, P97; MUSCI TJ, 1990, P NATL ACAD SCI USA, V87, P8365, DOI 10.1073/pnas.87.21.8365; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Saneyoshi T, 2000, BBA-MOL CELL RES, V1499, P164, DOI 10.1016/S0167-4889(00)00083-5; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; TSURUTA L, 1995, J IMMUNOL, V154, P5255; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; WOODLAND HR, 1987, DEVELOPMENT, V101, P925; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	29	234	252	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					295	299		10.1038/417295a	http://dx.doi.org/10.1038/417295a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015605				2022-12-24	WOS:000175592100049
J	Hanayama, R; Tanaka, M; Miwa, K; Shinohara, A; Iwamatsu, A; Nagata, S				Hanayama, R; Tanaka, M; Miwa, K; Shinohara, A; Iwamatsu, A; Nagata, S			Identification of a factor that links apoptotic cells to phagocytes	NATURE			English	Article							VITRONECTIN RECEPTOR; PHOSPHATIDYLSERINE EXPRESSION; ANIONIC PHOSPHOLIPIDS; IN-VIVO; CLEARANCE; SURFACE; INTEGRIN; CLONING; DEATH; FRAGMENTATION	Apoptotic cells are rapidly engulfed by phagocytes to prevent the release of potentially noxious or immunogenic intracellular materials from the dying cells, thereby preserving the integrity and function of the surrounding tissue(1). Phagocytes engulf apoptotic but not healthy cells, indicating that the apoptotic cells present a signal to the phagocytes, and the phagocytes recognize the signal using a specific receptor(2). Here, we report a factor that links apoptotic cells to phagocytes. We found that milk fat globule-EGF-factor 8 (MFG-E8)(3,4), a secreted glycoprotein, was produced by thioglycollate-elicited macrophages. MFG-E8 specifically bound to apoptotic cells by recognizing aminophospholipids such as phosphatidylserine. MFG-E8, when engaged by phospholipids, bound to cells via its RGD (arginine-glycine-aspartate) motif-it bound particularly strongly to cells expressing alpha(v)beta(3) integrin. The NIH3T3 cell transformants that expressed a high level of alpha(v)beta(3) integrin were found to engulf apoptotic cells when MFG-E8 was added. MFG-E8 carrying a point mutation in the RGD motif behaved as a dominant-negative form, and inhibited the phagocytosis of apoptotic cells by peritoneal macrophages in vitro and in vivo. These results indicate that MFG-E8 secreted from activated macrophages binds to apoptotic cells, and brings them to phagocytes for engulfment.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanagawa 2360004, Japan	Osaka University; Japan Science & Technology Agency (JST); Kirin Brewery Company Limited	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Hanayama, Rikinari/AAO-4959-2021; Nagata, Shigekazu/AAG-3203-2019; Hanayama, Rikinari/D-2940-2011	Hanayama, Rikinari/0000-0003-2102-3386; Nagata, Shigekazu/0000-0001-9758-8426; 				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fadok VA, 1999, J MAMMARY GLAND BIOL, V4, P203, DOI 10.1023/A:1011384009787; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M; McIlroy D, 2000, GENE DEV, V14, P549; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Wada J, 1996, J CELL BIOL, V132, P1161, DOI 10.1083/jcb.132.6.1161; Wilde CJ, 1999, J MAMMARY GLAND BIOL, V4, P129, DOI 10.1023/A:1018717006152	30	993	1045	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					182	187		10.1038/417182a	http://dx.doi.org/10.1038/417182a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000961				2022-12-24	WOS:000175460200045
J	Sibert, JR; Lyons, RA; Smith, BA; Cornall, P; Sumner, V; Craven, MA; Kemp, AM				Sibert, JR; Lyons, RA; Smith, BA; Cornall, P; Sumner, V; Craven, MA; Kemp, AM		Safe Water Information Monitor Col	Preventing deaths by drowning in children in the United Kingdom: have we made progress in 10 years? Population based incidence study	BRITISH MEDICAL JOURNAL			English	Article									Univ Wales Coll Med, Collaborat Accid Prevent & Injury Control, Dept Child Hlth, Llandough Hosp, Penarth CF64 2XX, S Glam, Wales; Univ Wales Coll Med, Collaborat Accid Prevent & Injury Control, Dept Epidemiol Stat, Llandough Hosp, Penarth CF64 2XX, S Glam, Wales; Univ Wales Coll Med, Collaborat Accid Prevent & Injury Control, Dept Publ Hlth, Llandough Hosp, Penarth CF64 2XX, S Glam, Wales; Royal Soc Prevent Accid, Water & Leisure, Birmingham B5 7ST, W Midlands, England; Royal Life Saving Soc, Broom B50 4HN, Warwick, England	Cardiff University; Cardiff University; Cardiff University	Sibert, JR (corresponding author), Univ Wales Coll Med, Collaborat Accid Prevent & Injury Control, Dept Child Hlth, Llandough Hosp, Penarth CF64 2XX, S Glam, Wales.		Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X				KEMP A, 1992, BRIT MED J, V304, P1143, DOI 10.1136/bmj.304.6835.1143; KEMP AM, 1991, BRIT MED J, V302, P931, DOI 10.1136/bmj.302.6782.931; KEMP AM, 1993, ARCH DIS CHILD, V68, P684, DOI 10.1136/adc.68.5.684; Webb EVJ, 1997, DEV MED CHILD NEUROL, V39, P150	4	16	16	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2002	324	7345					1070	1071		10.1136/bmj.324.7345.1070	http://dx.doi.org/10.1136/bmj.324.7345.1070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YY	11991912	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000175476500020
J	Lee, SW; Mao, CB; Flynn, CE; Belcher, AM				Lee, SW; Mao, CB; Flynn, CE; Belcher, AM			Ordering of quantum dots using genetically engineered viruses	SCIENCE			English	Article							LIQUID-CRYSTALS; NANOPARTICLES; PHASE	A liquid crystal system was used for the fabrication of a highly ordered composite material from genetically engineered M13 bacteriophage and zinc sulfide (ZnS) nanocrystals. The bacteriophage, which formed the basis of the self-ordering system, were selected to have a specific recognition moiety for ZnS crystal surfaces. The bacteriophage were coupled with ZnS solution precursors and spontaneously evolved a self-supporting hybrid film material that was ordered at the nanoscale and at the micrometer scale into similar to72-micrometer domains, which were continuous over a centimeter length scale. In addition, suspensions were prepared in which the lyotropic liquid crystalline phase behavior of the hybrid material was controlled by solvent concentration and by the use of a magnetic field.	Univ Texas, Inst Cellular & Mol Biol, Ctr Nano & Mol Sci & Technol, Texas Mat Inst,Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn & Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Lee, Seung-Wuk/AAS-3031-2020	Mao, Chuanbin/0000-0002-8142-3659				ALIVISATOS AP, 1996, NATURE, V381, P56; Braun PV, 1999, J AM CHEM SOC, V121, P7302, DOI 10.1021/ja9833725; Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343; Dogic Z, 2000, LANGMUIR, V16, P7820, DOI 10.1021/la000446t; Dogic Z, 1997, PHYS REV LETT, V78, P2417, DOI 10.1103/PhysRevLett.78.2417; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Duan XF, 2000, APPL PHYS LETT, V76, P1116, DOI 10.1063/1.125956; FLYNN CP, UNPUB; Fowler CE, 2001, ADV MATER, V13, P1266, DOI 10.1002/1521-4095(200108)13:16<1266::AID-ADMA1266>3.0.CO;2-9; GRAY GW, 1984, SMECTIC LIQUID CRYST, P23; Issaenko SA, 1999, PHYS REV E, V60, P578, DOI 10.1103/PhysRevE.60.578; LAPOINTE J, 1973, MOL CRYST LIQ CRYST, V19, P269, DOI 10.1080/15421407308084657; MAO C, UNPUB; MATHIAS JP, 1994, J AM CHEM SOC, V116, P4326, DOI 10.1021/ja00089a022; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Norris DJ, 1996, PHYS REV B, V53, P16347, DOI 10.1103/PhysRevB.53.16347; SEMENOV AN, 1986, ZH EKSP TEOR FIZ, V63, P70; SONIN AA, 1998, FREELY SUSPENDED LIQ, P25; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Yu SJM, 1997, NATURE, V389, P167, DOI 10.1038/38254	20	843	902	5	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					892	895		10.1126/science.1068054	http://dx.doi.org/10.1126/science.1068054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988570				2022-12-24	WOS:000175442500039
J	Mennill, DJ; Ratcliffe, LM; Boag, PT				Mennill, DJ; Ratcliffe, LM; Boag, PT			Female eavesdropping on male song contests in songbirds	SCIENCE			English	Editorial Material							BLACK-CAPPED CHICKADEES		Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Mennill, DJ (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.		Boag, Peter T/B-2907-2014	Boag, Peter T/0000-0003-0050-2089; Mennill, Daniel/0000-0001-9314-6700				MCGREGOR PK, 2000, MCGREGOR PK, V2, P71; Otter K, 1998, BEHAV ECOL SOCIOBIOL, V43, P25, DOI 10.1007/s002650050463; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; SMITH SM, 1988, BEHAVIOUR, V107, P15, DOI 10.1163/156853988X00160	4	268	281	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					873	873		10.1126/science.296.5569.873	http://dx.doi.org/10.1126/science.296.5569.873			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988564				2022-12-24	WOS:000175442500033
J	Sun, G; Ji, Q; Dilcher, DL; Zheng, SL; Nixon, KC; Wang, XF				Sun, G; Ji, Q; Dilcher, DL; Zheng, SL; Nixon, KC; Wang, XF			Archaefructaceae, a new basal angiosperm family	SCIENCE			English	Article							SEED PLANT PHYLOGENY; NORTHEAST CHINA; CRETACEOUS AGE; CLADISTICS; GNETALES; ORIGIN; RBCL	Archaefructaceae is proposed as a new basal angiosperm family of herbaceous aquatic plants. This family consists of the fossils Archaefructus liaoningensis and A. sinensis sp. nov. Complete plants from roots to fertile shoots are known. Their age is a minimum of 124.6 million years from the Yixian Formation, Liaoning, China. They are a sister clade to all angiosperms when their characters are included in a combined three-gene molecular and morphological analysis. Their reproductive axes lack petals. and sepals and bear stamens in pairs below conduplicate carpels.	Jilin Univ, Res Ctr Palaeontol, Changchun 130026, Peoples R China; Chinese Acad Geosci, Inst Geol, Beijing 100037, Peoples R China; Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; Shenyang Inst Geol & Mineral Resources, Shenyang 110032, Peoples R China; Cornell Univ, LH Bailey Hortorium, Ithaca, NY 14853 USA; Acad Sinica, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China	Jilin University; Chinese Academy of Geological Sciences; State University System of Florida; University of Florida; Cornell University; Chinese Academy of Sciences	Sun, G (corresponding author), Jilin Univ, Res Ctr Palaeontol, Changchun 130026, Peoples R China.	sunge@jtu.edu.cn; dilcher@ftmnh.ufl.edu						[Anonymous], 1964, YORKSHIRE JURASSIC F; Arber EAN, 1908, ANN BOT-LONDON, V22, P489, DOI 10.1093/oxfordjournals.aob.a089185; Bernhardt Peter, 1996, P192; Burger William, 1996, P111; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; Crepet W.L., 1974, PALAEONTOGRAPHICA AB, V148, P144; Crepet William L., 1996, P25; CRONQUIST A, 1981, INTEGRATED SYSTEM CL; D'Arcy WG., 1996, ANTHER FORM FUNCTION, P1; Delevoryas T., 1968, PALAEONTOGRAPHICA AB, V121, P122; Doludenko MP., 1976, JURASSIC FLORA KARAT; DONOGHUE MJ, 1989, INT CONGR SER, V824, P181; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Doyle JA, 1998, MOL PHYLOGENET EVOL, V9, P448, DOI 10.1006/mpev.1998.0506; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Endress P.K., 1994, DIVERSITY EVOLUTIONA; Endress Peter K., 1996, P92; Friis EM, 2001, NATURE, V410, P357, DOI 10.1038/35066557; Friis EM, 2000, INT J PLANT SCI, V161, pS169, DOI 10.1086/317570; Hagemann W., 1984, CONT PROBLEMS PLANT, P301; Hufford Larry, 1996, P58; Ji Qiang, 1999, Professional Papers of Stratigraphy and Palaeontology, V27, P74; Ji SA, 1999, NATURE, V398, P573, DOI 10.1038/19221; Krassilov VA, 1997, ANGIOSPERM ORIGINS M; LEINS P, 1991, BOT ACTA, V104, P336, DOI 10.1111/j.1438-8677.1991.tb00239.x; LO CH, 1999, GEOCHEMICA, V28, P406; LOCONTE H, 1990, BRITTONIA, V42, P197, DOI 10.2307/2807216; LOCONTE H, 1991, CLADISTICS, V7, P267, DOI 10.1111/j.1096-0031.1991.tb00038.x; Nandi OI, 1998, ANN MO BOT GARD, V85, P137, DOI 10.2307/2992003; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; NIXON KC, 1994, ANN MO BOT GARD, V81, P484, DOI 10.2307/2399901; SMITH PE, 1995, CAN J EARTH SCI, V32, P1426, DOI 10.1139/e95-115; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI [10.1111/j.1095-8339.2000.tb01588.x, 10.1006/bojl.2000.0380]; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; VONWETTSTEIN RR, 1907, HDB SYSTEMATISCHEN B; WANG DF, 1983, B CHINESE ACAD GEOL, V7, P65; WANG SE, 2000, JURASSIC SYSTEM STRA; WARD J V, 1989, Pollen et Spores, V31, P113; ZANE MC, IN PRESS P NATL ACAD; Zhang Jun-Feng, 1999, Palaeoworld, V11, P150	42	334	385	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					899	904		10.1126/science.1069439	http://dx.doi.org/10.1126/science.1069439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988572				2022-12-24	WOS:000175442500041
J	Wong, AM; Wang, JW; Axel, R				Wong, AM; Wang, JW; Axel, R			Spatial representation of the glomerular map in the Drosophila protocerebrum	CELL			English	Article							OCULAR DOMINANCE COLUMNS; OLFACTORY SENSORY MAP; LONG-RANGE ACTION; ANTENNAL LOBE; MORPHOGEN GRADIENT; NEURONAL-ACTIVITY; GENE-EXPRESSION; MICE DEFICIENT; MELANOGASTER; BULB	In the fruit fly, Drosophila, olfactory sensory neurons expressing a given receptor project to spatially invariant loci in the antennal lobe to create a topographic map of receptor activation. We have asked how the map in the antennal lobe is represented in higher sensory centers in the brain. Random labeling of individual projection neurons using the FLP-out technique reveals that projection neurons that innervate the same glomerulus exhibit strikingly similar axonal topography, whereas neurons from different glomeruli display very different patterns of projection in the protocerebrum. These results demonstrate that a topographic map of olfactory information is retained in higher brain centers, but the character of the map differs from that of the antennal lobe, affording an opportunity for integration of olfactory sensory input.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	ra27@columbia.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Axel, Richard/0000-0002-3141-4076	NIMH NIH HHS [MH 50733] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURROWS M, 1982, J COMP PHYSIOL, V145, P447, DOI 10.1007/BF00612810; Cajal S., 1889, MANUAL HISTOLOGIA NO; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; HOMBERG U, 1984, J COMP PHYSIOL, V154, P825, DOI 10.1007/BF00610683; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; RAPER JA, 1983, J NEUROSCI, V3, P20; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RODRIGUES V, 1984, BRAIN RES, V324, P374, DOI 10.1016/0006-8993(84)90053-2; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	55	435	439	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					229	241		10.1016/S0092-8674(02)00707-9	http://dx.doi.org/10.1016/S0092-8674(02)00707-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007409	Bronze			2022-12-24	WOS:000175082600012
J	Rieger, MA; Lamond, M; Preston, C; Powles, SB; Roush, RT				Rieger, MA; Lamond, M; Preston, C; Powles, SB; Roush, RT			Pollen-mediated movement of herbicide resistance between commercial canola fields	SCIENCE			English	Article							RAPE BRASSICA-NAPUS; GENE FLOW; FREQUENCY; RELATIVES; DISTANCE	There is considerable public and scientific debate for and against genetically modified (GM) crops. One of the first GM crops, Brassica napus (oilseed rape or canola) is now widely grown in North America, with proposed commercial release into Australia and Europe. Among concerns of opponents to these crops are claims that pollen movement will cause unacceptable levels of gene flow from GM to non-GM crops or to related weedy species, resulting in genetic pollution of the environment. Therefore, quantifying pollen-mediated gene flow is vital for assessing the environmental impact of GM crops. This study quantifies at a landscape level the gene flow that occurs from herbicide-resistant canola crops to nearby crops not containing herbicide resistance genes.	Univ Adelaide, Cooperat Res Ctr Australian Weed Management, Glen Osmond, SA 5064, Australia; Univ Adelaide, Dept Appl & Mol Ecol, Glen Osmond, SA 5064, Australia; Univ Western Australia, Western Australian Herbicide Resistance Initiat, Nedlands, WA 6907, Australia	University of Adelaide; University of Adelaide; University of Western Australia	Rieger, MA (corresponding author), Univ Adelaide, Cooperat Res Ctr Australian Weed Management, PMB1, Glen Osmond, SA 5064, Australia.	mary.rieger@adelaide.edu.au	Powles, Stephen/A-2558-2008	Preston, Christopher/0000-0002-7588-124X; powles, stephen/0000-0001-6375-1977				Barton JE, 2000, AGRON J, V92, P797, DOI 10.2134/agronj2000.924797x; Champolivier J, 1999, BCPC SYMP SER, P233; Downey RK, 1999, BCPC SYMP SER, P109; Eckert JE, 1933, J AGRIC RES, V47, P0257; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Hall L, 2000, WEED SCI, V48, P688, DOI 10.1614/0043-1745(2000)048[0688:PFBHRB]2.0.CO;2; PAUL E, 1995, EUPHYTICA, V1, P283; Preston C, 2002, HEREDITY, V88, P8, DOI 10.1038/sj.hdy.6800004; RAKOW G, 1987, CAN J PLANT SCI, V67, P147, DOI 10.4141/cjps87-017; Rieger MA, 1999, AUST J AGR RES, V50, P115, DOI 10.1071/A97138; SCHEFFLER JA, 1993, TRANSGENIC RES, V2, P356, DOI 10.1007/BF01976177; SCHEFFLER JA, 1995, PLANT BREEDING, V114, P317, DOI 10.1111/j.1439-0523.1995.tb01241.x; Simpson EC, 1999, BCPC SYMP SER, P75; Staniland BK, 2000, CAN J PLANT SCI, V80, P521, DOI 10.4141/P99-117; STRINGAM GR, 1978, CAN J PLANT SCI, V58, P427, DOI 10.4141/cjps78-065; Thompson CE, 1999, BCPC SYMP SER, P95	16	247	280	0	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2386	2388		10.1126/science.1071682	http://dx.doi.org/10.1126/science.1071682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089441				2022-12-24	WOS:000176467200039
J	Aviles, RJ; Askari, AT; Lindahl, B; Wallentin, L; Jia, G; Ohman, EM; Mahaffey, KW; Newby, LK; Califf, RM; Simoons, ML; Topol, EJ; Lauer, MS; Berger, P				Aviles, RJ; Askari, AT; Lindahl, B; Wallentin, L; Jia, G; Ohman, EM; Mahaffey, KW; Newby, LK; Califf, RM; Simoons, ML; Topol, EJ; Lauer, MS; Berger, P			Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGNOSTIC VALUE; MYOCARDIAL INJURY; SERUM CREATININE; I LEVELS; FAILURE; DISEASE; INSUFFICIENCY; PREDICTION; ELEVATIONS; OUTCOMES	Background: Among patients with suspected acute coronary syndromes, cardiac troponin T levels have prognostic value. However, there is concern that renal dysfunction may impair the prognostic value, because cardiac troponin T may be cleared by the kidney. Methods: We analyzed the outcomes in 7033 patients enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries IV trial who had complete base-line data on troponin T levels and creatinine clearance rates. The troponin T level was considered abnormal if it was 0.1 ng per milliliter or higher, and creatinine clearance was assessed in quartiles. The primary end point was a composite of death or myocardial infarction within 30 days. Results: Death or myocardial infarction occurred in 581 patients. Among patients with a creatinine clearance above the 25th percentile value of 58.4 ml per minute, an abnormally elevated troponin T level was predictive of an increased risk of myocardial infarction or death (7 percent vs. 5 percent; adjusted odds ratio, 1.7; 95 percent confidence interval, 1.3 to 2.2; P<0.001). Among patients with a creatinine clearance in the lowest quartile, an elevated troponin T level was similarly predictive of increased risk (20 percent vs. 9 percent; adjusted odds ratio, 2.5; 95 percent confidence interval, 1.8 to 3.3; P<0.001). When the creatinine clearance rate was considered as a continuous variable and age, sex, ST-segment depression, heart failure, previous revascularization, diabetes mellitus, and other confounders had been accounted for, elevation of the troponin T level was independently predictive of risk across the entire spectrum of renal function. Conclusions: Cardiac troponin T levels predict short-term prognosis in patients with acute coronary syndromes regardless of their level of creatinine clearance.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44951 USA; Uppsala Univ, Dept Cardiol, Uppsala, Sweden; Univ N Carolina, Chapel Hill, NC USA; Duke Clin Res Inst, Durham, NC USA; Univ Rotterdam Hosp, Dept Cardiol, Rotterdam, Netherlands; Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Cleveland Clinic Foundation; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Erasmus University Rotterdam; Erasmus MC; Mayo Clinic	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44951 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Topol, Eric/0000-0002-1478-4729				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Apple FS, 1997, AM J KIDNEY DIS, V29, P399, DOI 10.1016/S0272-6386(97)90201-8; BHAYANA V, 1995, CLIN CHEM, V41, P312; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Braunwald E, 2001, J AM COLL CARDIOL, V38, P294; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; *CAPTURE INV, 1997, LANCET, V350, P744; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collinson PO, 1998, ANN CLIN BIOCHEM, V35, P380, DOI 10.1177/000456329803500306; Coresh J, 1998, J Am Soc Nephrol, V9, pS24; Frankel WL, 1996, AM J CLIN PATHOL, V106, P118; Fuchs S, 2000, AM J CARDIOL, V85, P1077, DOI 10.1016/S0002-9149(00)00699-8; Hallermayer K, 1999, SCAND J CLIN LAB INV, V59, P128; KLOOTWIJK P, 1999, LANCET S2, V353, P10; Levey AS, 1999, NEPHROL DIAL TRANSPL, V14, P828, DOI 10.1093/ndt/14.4.828; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li D, 1996, CLIN CHEM, V42, P114; LI D, 1995, CLIN BIOCHEM, V28, P474, DOI 10.1016/0009-9120(95)00027-7; Lindahl B, 1997, J AM COLL CARDIOL, V29, P43, DOI 10.1016/S0735-1097(96)00447-0; Martin GS, 1998, NEPHROL DIAL TRANSPL, V13, P1709, DOI 10.1093/ndt/13.7.1709; McLaurin MD, 1998, AM J CARDIOL, V82, P973, DOI 10.1016/S0002-9149(98)00515-3; Mockel M, 1999, NEPHROL DIAL TRANSPL, V14, P1489, DOI 10.1093/ndt/14.6.1489; MullerBardorff M, 1997, CLIN CHEM, V43, P458; Musso P, 1999, CLIN BIOCHEM, V32, P125, DOI 10.1016/S0009-9120(98)00089-7; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Simoons ML, 1997, LANCET, V349, P1429; Simoons ML, 2001, LANCET, V357, P1915; Van Lente F, 1999, J AM COLL CARDIOL, V33, P471, DOI 10.1016/S0735-1097(98)00592-0; [No title captured]	31	244	249	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2002	346	26					2047	2052		10.1056/NEJMoa013456	http://dx.doi.org/10.1056/NEJMoa013456			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566DN	12087140				2022-12-24	WOS:000176411900005
J	Hogan, DA; Kolter, R				Hogan, DA; Kolter, R			Pseudomonas-Candida interactions: An ecological role for virulence factors	SCIENCE			English	Article							TWITCHING MOTILITY; CYSTIC-FIBROSIS; AERUGINOSA; PATHOGENICITY; ALBICANS; PLANTS; PROTEINS; BIOFILM; ANIMALS; FLORA	Bacterial-fungal interactions have great environmental, medical, and economic importance, yet few have been well characterized at the molecular level. Here, we describe a pathogenic interaction between Pseudomonas aeruginosa and Candida albicans, two opportunistic pathogens. P. aeruginosa forms a dense biofilm on C. albicans laments and kills the fungus. In contrast, P. aeruginosa neither binds to nor kills yeast-form C. albicans. Several P. aeruginosa virulence factors that are important in disease are involved in the killing of C. albicans laments. We propose that many virulence factors studied in the context of human infection may also have a role in bacterial-fungal interactions.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kolter, R (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	rkolter@hms.harvard.edu		Hogan, Deborah A./0000-0002-6366-2971	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058213] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58213] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; BEATSON SA, IN PRESS J BACTERIOL; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; BROOK I, 1992, CLIN INFECT DIS, V15, P955, DOI 10.1093/clind/15.6.955; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; CHET I, 1994, APPL BIOCHEM BIOTECH, V48, P37, DOI 10.1007/BF02825358; CotaGomez A, 1997, INFECT IMMUN, V65, P2904, DOI 10.1128/IAI.65.7.2904-2913.1997; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Hahn HP, 1997, GENE, V192, P99, DOI 10.1016/S0378-1119(97)00116-9; HEMADY RK, 1995, OPHTHALMOLOGY, V102, P1026; Hendrickson EL, 2001, J BACTERIOL, V183, P7126, DOI 10.1128/JB.183.24.7126-7134.2001; Hermann C, 1999, MYCOSES, V42, P619, DOI 10.1046/j.1439-0507.1999.00519.x; HOGAN D, UNPUB; KERR JR, 1994, J CLIN MICROBIOL, V32, P525, DOI 10.1128/JCM.32.2.525-527.1994; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Odds FC., 1988, CANDIDA CANDIDOSIS; PALLERONI N, 2000, PROKARYOTES; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Titball RW, 1998, J APPL MICROBIOL, V84, p127S; WELCH DF, 1987, J CLIN MICROBIOL, V25, P1730, DOI 10.1128/JCM.25.9.1730-1734.1987; Woods DE, 1997, CAN J MICROBIOL, V43, P541, DOI 10.1139/m97-077	31	431	445	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2002	296	5576					2229	2232		10.1126/science.1070784	http://dx.doi.org/10.1126/science.1070784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077418				2022-12-24	WOS:000176379000061
J	Weihofen, A; Binns, K; Lemberg, MK; Ashman, K; Martoglio, B				Weihofen, A; Binns, K; Lemberg, MK; Ashman, K; Martoglio, B			Identification of signal peptide peptidase, a presenilin-type aspartic protease	SCIENCE			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE; PROTEINS; TRANSPORT	Signal peptide peptidase (SPP) catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein. In humans, SPP activity is required to generate signal sequence-derived human lymphocyte antigen-E epitopes that are recognized by the immune system, and to process hepatitis C virus core protein. We have identified human SPP as a polytopic membrane protein with sequence motifs characteristic of the presenilin-type aspartic proteases. SPP and potential eukaryotic homologs may represent another family of aspartic proteases that promote intramembrane proteolysis to release biologically important peptides.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Martoglio, B (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.	bruno.martoglio@bc.biol.ethz.ch	Weihofen, Andreas/A-1566-2011; Ashman, Keith/G-2328-2011; Lemberg, Marius K/B-8881-2016	Lemberg, Marius K/0000-0002-0996-1268; Weihofen, Andreas/0000-0001-6265-9087				Brachmann CB, 1998, YEAST, V14, P115; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; Chan YM, 1999, NEURON, V23, P201, DOI 10.1016/S0896-6273(00)80771-0; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Huppert S, 2001, DEV CELL, V1, P590, DOI 10.1016/S1534-5807(01)00081-8; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Martoglio B, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P265; MCLAUCHLAN J, UNPUB; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Szelke M., 1985, ASPARTIC PROTEINASES, P421; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	24	442	461	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2002	296	5576					2215	2218		10.1126/science.1070925	http://dx.doi.org/10.1126/science.1070925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077416				2022-12-24	WOS:000176379000057
J	Fletcher, RH; Fairfield, KN				Fletcher, RH; Fairfield, KN			Vitamins for chronic disease prevention in adults - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D DEFICIENCY; FOLIC-ACID; FOLATE; BONE; EAT	Vitamin deficiency syndromes such as scurvy and beriberi are uncommon in Western societies. However, suboptimal intake of some vitamins, above levels causing classic vitamin deficiency, is a risk factor for chronic diseases and common in the general population, especially the elderly. Suboptimal folic acid levels, along with suboptimal levels of vitamins B-6 and B-12, are a risk factor for cardiovascular disease, neural tube defects, and colon and breast cancer; low levels of vitamin D contribute to osteopenia and fractures; and low levels of the antioxidant vitamins (vitamins A, E, and C) may increase risk for several chronic diseases. Most people do not consume an optimal amount of all vitamins by diet alone. Pending strong evidence of effectiveness from randomized trials, it appears prudent for all adults to take vitamin supplements. The evidence base for tailoring the contents of multivitamins to specific characteristics of patients such as age, sex, and physical activity and for testing vitamin levels to guide specific supplementation practices is limited. Physicians should make specific efforts to learn about their patients' use of vitamins to ensure that they are taking vitamins they should, such as folate supplementation for women in the childbearing years, and avoiding dangerous practices such as high doses of vitamin A during pregnancy or massive doses of fat-soluble vitamins at any age.	Harvard Univ, Med Sch Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard Pilgrim Health Care; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Univ, Med Sch Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.							BILEZIKIAN JP, 1994, JAMA-J AM MED ASSOC, V272, P1942, DOI 10.1001/jama.1994.03520240070044; *COMM DIET HLTH NR, 1989, DIET HLTH IMPL RED C; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Flood A, 2000, JNCI-J NATL CANCER I, V92, P1706, DOI 10.1093/jnci/92.21.1706; GLOTH FM, 1995, JAMA-J AM MED ASSOC, V274, P1683, DOI 10.1001/jama.274.21.1683; HILLMAN RS, 1982, ANNU REV MED, V33, P345, DOI 10.1146/annurev.me.33.020182.002021; *I MED, 2000, REF INT VIT C VIT E; *I MED, 2000, DIET REF INT THIAM R; *I MED, 2001, DIET REF INT VIT A V; Institute of Medicine. Food and Nutrition Board, 1999, DIET REF INT CALC PH; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; Oakley GP, 1998, NEW ENGL J MED, V338, P1060, DOI 10.1056/NEJM199804093381509; *OFF DIS PREV HLTH, 2002, HLTH PEOPL; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; Thomas MK, 1998, NEW ENGL J MED, V338, P777, DOI 10.1056/NEJM199803193381201; WALD N, 1991, LANCET, V338, P131; Wald NJ, 2001, LANCET, V358, P2069, DOI 10.1016/S0140-6736(01)07104-5; Ward M, 1997, QJM-MON J ASSOC PHYS, V90, P519, DOI 10.1093/qjmed/90.8.519; Williams PG, 1996, J AM DIET ASSOC, V96, P490, DOI 10.1016/S0002-8223(96)00135-6	23	162	174	2	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2002	287	23					3127	3129		10.1001/jama.287.23.3127	http://dx.doi.org/10.1001/jama.287.23.3127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563NK	12069676	Bronze			2022-12-24	WOS:000176262300028
J	Graham, J; Ramirez, A; Love, S; Richards, M; Burgess, C				Graham, J; Ramirez, A; Love, S; Richards, M; Burgess, C			Stressful life experiences and risk of relapse of breast cancer: observational cohort study	BRITISH MEDICAL JOURNAL			English	Article							SURVIVAL; RECURRENCE; PROGNOSIS; WOMEN	Objective To confirm, using an observational cohort design, the relation between severely stressful life experiences and relapse of breast cancer found in a previous case-control study. Design Prospective Mow up for five years of a cohort of women newly diagnosed as having breast cancer, collecting data on stressful life experiences, depression, and biological prognostic factors. Setting NHS breast clinic, London; 1991-9. Participants A consecutive series of women aged under 60 newly diagnosed as having a primary operable breast tumour 202/222 (91%) eligible women participated in the first life experiences interview 170 (77%) provided complete interview data either up to 5 years after diagnosis or to recurrence. Main outcome measure Recurrence of disease. Results We controlled for biological prognostic factors (lymph node infiltration and tumour histology), and found no increased risk of recurrence in women who had had one or more severely stressful life experiences in the year before diagnosis compared with women who did not (hazard ratio 1.01, 95% confidence interval 0.58 to 1.74, P=0.99). Women who had had one or more severely stressful life experiences in the 5 years after diagnosis had a lower risk of recurrence 0.52, 0.29 to 0.95, P=0.03) than those who did not. Conclusion These data do not confirm an earlier finding from a case-control study that severely stressful life experiences increase the risk of recurrence of breast cancer. Differences in case control and prospective methods may explain the contradictory results. We took the prospective study as the more robust, and the results suggest that women with breast cancer need not fear that stressful experiences will precipitate the return of their disease.	St Thomas Hosp, Guys Kings & St Thomas Sch Med, Adamson Ctr, Canc Res UK London Psychosocial Grp, London SE1 7EH, England; Inst Hlth Sci, Ctr Stat Med, Canc Res UK Med Stat Grp, Oxford OX3 7LF, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; University of Oxford	Graham, J (corresponding author), St Thomas Hosp, Guys Kings & St Thomas Sch Med, Adamson Ctr, Canc Res UK London Psychosocial Grp, London SE1 7EH, England.			Love, Sharon/0000-0002-6695-5390				BARRACLOUGH J, 1992, BRIT MED J, V304, P1078, DOI 10.1136/bmj.304.6834.1078; BARRACLOUGH J, 1993, BRIT MED J, V307, P25; Brown G., 1978, SOCIAL ORIGINS DEPRE; Edelman S, 2000, J PSYCHOSOM RES, V49, P149, DOI 10.1016/S0022-3999(00)00153-7; FAWZY FI, 1993, ARCH GEN PSYCHIAT, V50, P681; FORSEN A, 1991, PSYCHOTHER PSYCHOSOM, V55, P176, DOI 10.1159/000288427; FUNCH DP, 1983, J PSYCHOSOM RES, V27, P77, DOI 10.1016/0022-3999(83)90112-5; Giraldi T, 1997, PSYCHOTHER PSYCHOSOM, V66, P229, DOI 10.1159/000289140; HAYWARD JL, 1978, SEMIN ONCOL, V5, P445; Kiecolt-Glaser JK, 1999, EUR J CANCER, V35, P1603, DOI 10.1016/S0959-8049(99)00197-5; Kvikstad A, 1996, INT J CANCER, V67, P165, DOI 10.1002/(SICI)1097-0215(19960717)67:2<165::AID-IJC2>3.3.CO;2-4; KVIKSTAD A, 1995, BRIT J CANCER, V71, P1343, DOI 10.1038/bjc.1995.261; MAUNSELL E, 1998, PSYCHOONCOLOGY S, V7, P281; RAMIREZ AJ, 1989, BRIT MED J, V298, P291, DOI 10.1136/bmj.298.6669.291; SPIEGEL D, 1989, LANCET, V2, P888; Spitzer RL, 1990, STRUCTURED CLIN INTE	16	44	47	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2002	324	7351					1420	1422		10.1136/bmj.324.7351.1420	http://dx.doi.org/10.1136/bmj.324.7351.1420			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565CQ	12065263	Bronze, Green Published			2022-12-24	WOS:000176351400015
J	Sommers, CL; Park, CS; Lee, J; Feng, CG; Fuller, CL; Grinberg, A; Hildebrand, JA; Lacana, E; Menon, RK; Shores, EW; Samelson, LE; Love, PE				Sommers, CL; Park, CS; Lee, J; Feng, CG; Fuller, CL; Grinberg, A; Hildebrand, JA; Lacana, E; Menon, RK; Shores, EW; Samelson, LE; Love, PE			A LAT mutation that inhibits T cell development yet induces lymphoproliferation	SCIENCE			English	Article							TYROSINE RESIDUES; CD5 EXPRESSION; ACTIVATION; RECEPTOR; LINKER; RAS; PHOSPHORYLATION; SELECTION; APOPTOSIS	Mice homozygous for a single tyrosine mutation in LAT (linker for activation of T cells) exhibited an early block in T cell maturation but later developed a polyclonal lymphoproliferative disorder and signs of autoimmune disease. T cell antigen receptor (TCR)-induced activation of phospholipase C-gamma 1 (PLC-gamma1) and of nuclear factor of activated T cells, calcium influx, interleukin-2 production, and cell death were reduced or abrogated in T cells from LAT mutant mice. In contrast, TCR-induced Erk activation was intact. These results identify a critical role for integrated PLC-gamma1 and Ras-Erk signaling through LAT in T cell development and homeostasis.	NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Love, PE (corresponding author), NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA.	pel@helix.nih.gov		Fuller, Claudette/0000-0003-4741-4609	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; CARRERA AC, 1989, J BIOL CHEM, V264, P15650; Ebinu JO, 2000, BLOOD, V95, P3199; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Kane LP, 1996, J IMMUNOL, V156, P4594; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; SOMMERS CL, UNPUB; vonBoehmer H, 1995, ANN NY ACAD SCI, V766, P52, DOI 10.1111/j.1749-6632.1995.tb26648.x; Weichert TR, 1997, IMMUNOLOGY, V90, P30, DOI 10.1046/j.1365-2567.1997.00133.x; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	20	225	235	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 14	2002	296	5575					2040	2043		10.1126/science.1069066	http://dx.doi.org/10.1126/science.1069066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065840				2022-12-24	WOS:000176273300057
J	Mehta, MR; Lee, AK; Wilson, MA				Mehta, MR; Lee, AK; Wilson, MA			Role of experience and oscillations in transforming a rate code into a temporal code	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; PHASE-PRECESSION; THETA-RHYTHM; RECEPTIVE-FIELDS; PLACE FIELDS; SPATIAL MAP; DYNAMICS; SEQUENCES; NEURONS; V1	In the vast majority of brain areas, the firing rates of neurons, averaged over several hundred milliseconds to several seconds, can be strongly modulated by, and provide accurate information about, properties of their inputs. This is referred to as the rate code. However, the biophysical laws of synaptic plasticity require precise timing of spikes over short timescales (< 10 ms)(1,2). Hence it is critical to understand the physiological mechanisms that can generate precise spike timing in vivo, and the relationship between such a temporal code and a rate code. Here we propose a mechanism by which a temporal code can be generated through an interaction between an asymmetric rate code and oscillatory inhibition. Consistent with the predictions of our model, the rate(3,4) and temporal(5-7) codes of hippocampal pyramidal neurons are highly correlated. Furthermore, the temporal code becomes more robust with experience. The resulting spike timing satisfies the temporal order constraints of hebbian learning. Thus, oscillations and receptive field asymmetry may have a critical role in temporal sequence learning.	MIT, RIKEN MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN	Mehta, MR (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Mehta, Minesh P./AAB-8915-2019	Mehta, Minesh P./0000-0002-4812-5713				Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bose A, 2000, J COMPUT NEUROSCI, V9, P5, DOI 10.1023/A:1008976210366; BUZSAKI G, 1985, ELECTROEN CLIN NEURO, V61, P77, DOI 10.1016/0013-4694(85)91075-2; Chance FS, 1998, J NEUROSCI, V18, P4785; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Hasselmo ME, 2000, ANN NY ACAD SCI, V911, P418; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; KONIG P, 1995, NEURAL COMPUT, V7, P469, DOI 10.1162/neco.1995.7.3.469; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta M. R., 1996, COMPUTATIONAL NEUROS, P741; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mehta MR, 2000, NEUROCOMPUTING, V32, P905, DOI 10.1016/S0925-2312(00)00259-9; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rao RPN, 2001, NOVART FDN SYMP, V239, P208; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zar JH, 1999, BIOSTATISTICAL ANAL	30	463	472	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2002	417	6890					741	746		10.1038/nature00807	http://dx.doi.org/10.1038/nature00807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066185				2022-12-24	WOS:000176154700045
J	Clark, S				Clark, S			HIV/AIDS in Africa, 2002	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Clark, S (corresponding author), Lancet, London NW1 7BY, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 8	2002	359	9322					1960	1960		10.1016/S0140-6736(02)08848-7	http://dx.doi.org/10.1016/S0140-6736(02)08848-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076549				2022-12-24	WOS:000176232500006
J	Gaspoz, J; Coxson, PG; Goldman, PA; Williams, LW; Kuntz, KM; Hunink, MGM; Goldman, L				Gaspoz, J; Coxson, PG; Goldman, PA; Williams, LW; Kuntz, KM; Hunink, MGM; Goldman, L			Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MEDICARE BENEFICIARIES; MORTALITY; STROKE; HEALTH; RISK; PREVALENCE; OUTCOMES; DECLINE; QUALITY	Background: Both aspirin and clopidogrel reduce the rate of cardiovascular events in patients with coronary heart disease. We estimated the cost effectiveness of the increased use of aspirin, clopidogrel, or both for secondary prevention in patients with coronary heart disease. Methods: We used the Coronary Heart Disease Policy Model, a computer simulation of the U.S. population, to estimate the incremental cost effectiveness (in dollars per quality-adjusted years of life gained) of four strategies in patients over 35 years of age with coronary disease from 2003 to 2027: aspirin for all eligible patients (i.e., those who were not allergic to or intolerant of aspirin), aspirin for all eligible patients plus clopidogrel for patients who were ineligible for aspirin, clopidogrel for all patients, and the combination of aspirin for all eligible patients plus clopidogrel for all patients. Results: The extension of aspirin therapy from the current levels of use to all eligible patients for 25 years would have an estimated cost-effectiveness ratio of about $11,000 per quality-adjusted year of life gained. The addition of clopidogrel for the 5 percent of patients who are ineligible for aspirin would cost about $31,000 per quality-adjusted year of life gained. Clopidogrel alone in all patients or in routine combination with aspirin had an incremental cost of more than $130,000 per quality-adjusted year of life gained and remained financially unattractive across a wide range of assumptions. However, clopidogrel alone or in combination with aspirin would cost less than $50,000 per quality-adjusted year of life gained if its price were reduced by 70 to 82 percent, to $1.00 and $0.60 per day, respectively. Conclusions: Increased prescription of aspirin for secondary prevention of coronary heart disease is attractive from a cost-effectiveness perspective. Because clopidogrel is more costly, its incremental cost effectiveness is currently unattractive, unless its use is restricted to patients who are ineligible for aspirin.	Hop Univ, Dept Med, Med Clin 2, CH-1211 Geneva 14, Switzerland; Hop Univ, Div Cardiol, CH-1211 Geneva 14, Switzerland; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Erasmus Univ, Sch Med, Dept Radiol, Rotterdam, Netherlands; Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, Rotterdam, Netherlands	University of Geneva; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus University Rotterdam	Gaspoz, J (corresponding author), Hop Univ, Dept Med, Med Clin 2, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	jean-michel.gaspoz@hcuge.ch			AHRQ HHS [R01 HS06258] Funding Source: Medline; NHLBI NIH HHS [R01 HL46315] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006258] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046315] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALDHOUS P, 1994, SCIENCE, V263, P24, DOI 10.1126/science.8272863; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; *ANT TRIAL COLL, 1998, BMJ-BRIT MED J, V286, P320; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bratzler D W, 1997, J Okla State Med Assoc, V90, P219; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Cairns JA, 1998, CHEST, V114, p611S, DOI 10.1378/chest.114.5_Supplement.611S; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; DOBKIN B, 1995, NEUROLOGY, V45, pS6; EDELSON JT, 1990, JAMA-J AM MED ASSOC, V264, P41, DOI 10.1001/jama.264.1.41; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Goldman L, 2001, J AM COLL CARDIOL, V38, P1012, DOI 10.1016/S0735-1097(01)01512-1; Gorelick PB, 1999, STROKE, V30, P1716, DOI 10.1161/01.STR.30.8.1716; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Hankey GJ, 2000, LANCET, V356, P269, DOI 10.1016/S0140-6736(00)02498-3; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Hugenholtz P G, 1991, Acta Med Port, V4 Suppl 1, p16S; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Krumholz HM, 1996, ANN INTERN MED, V124, P292, DOI 10.7326/0003-4819-124-3-199602010-00002; *MED EC STAFF, 2000, DRUG TOP RED BOOK; Morris S, 1997, HEALTH ECON, V6, P589, DOI 10.1002/(SICI)1099-1050(199711)6:6<589::AID-HEC286>3.0.CO;2-D; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; PATRONO C, 1994, NEW ENGL J MED, V330, P1287; PEDERSEN TR, 1994, LANCET, V344, P1383; Phillips KA, 2000, JAMA-J AM MED ASSOC, V284, P2748, DOI 10.1001/jama.284.21.2748; Rolka DB, 2001, DIABETES CARE, V24, P197, DOI 10.2337/diacare.24.2.197; Sarasin FP, 2000, ARCH INTERN MED, V160, P2773, DOI 10.1001/archinte.160.18.2773; Stafford RS, 2000, CIRCULATION, V101, P1097, DOI 10.1161/01.CIR.101.10.1097; Stinett AA, 1996, COST EFFECTIVENESS H, P349; Tsevat J, 2001, AM HEART J, V141, P727, DOI 10.1067/mhj.2001.114805; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Yusuf S, 2001, NEW ENGL J MED, V345, P494	44	188	195	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2002	346	23					1800	1806		10.1056/NEJM200206063462309	http://dx.doi.org/10.1056/NEJM200206063462309			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559EK	12050341	Bronze			2022-12-24	WOS:000176012500008
J	Richards, HM; Reid, ME; Watt, CM				Richards, HM; Reid, ME; Watt, CM			Socioeconomic variations in responses to chest pain: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE MORTALITY; ANGINA; RATES; REVASCULARIZATION; QUESTIONNAIRE; PREVALENCE; BARRIERS; SERVICES	Objective To explore and explain socioeconomic variations in perceptions of and behavioural responses to chest pain. Design Qualitative interviews. Setting Community based study in Glasgow, Scotland. Participants 30 respondents (15 men and 15 women) from a socioeconomically deprived area of Glasgow and 30 respondents (15 men and 15 women) from an affluent area of Glasgow. Outcome measures Participants' reports of their perceptions of and actions in response to chest pain. Results Residents of the deprived area reported greater perceived vulnerability to heart disease, stemming from greater exposure to heart disease in family members and greater identification with high risk groups and stereotypes of cardiac patients. This greater perceived vulnerability was not associated with more frequent reporting of presenting to a general practitioner. People from the deprived area reported greater exposure to ill health, which allowed them to normalise their chest pain, led to confusion with other conditions, and gave rise to a belief that they were overusing medical services. These factors were associated with a reported tendency not to present with chest pain. Anxiety about presenting among respondents in the deprived area was heightened by self blame and fear that they would be chastised by their general practitioner for their risk behaviours. Conclusions Important socioeconomic variations in responses to chest pain may contribute to the known inequities in uptake of secondary cardiology services' Primary care professionals and health promoters should be aware of die ways in which perceptions of symptoms and illness behaviour are shaped by social and cultural factors.	Univ Aberdeen, Highlands & Isl Hlth Res Inst, Inverness IV2 3ED, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland	UHI Millennium Institute; University of Aberdeen; University of Glasgow; University of Glasgow	Richards, HM (corresponding author), Univ Aberdeen, Highlands & Isl Hlth Res Inst, Green House,Beechwood Business Pk, Inverness IV2 3ED, Scotland.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLACK N, 1995, J EPIDEMIOL COMMUN H, V49, P408, DOI 10.1136/jech.49.4.408; Blaxter M., 1990, HLTH LIFESTYLES; Butler CC, 1998, BMJ-BRIT MED J, V316, P1878; CARTWRIGHT A, 1978, BASIC READINGS MED S, P89; COOK DG, 1989, INT J EPIDEMIOL, V18, P607, DOI 10.1093/ije/18.3.607; CORNWELL J, 1984, HARD EARNED LIVES, P79; COWIE B, 1976, SOC SCI MED, V10, P87, DOI 10.1016/0037-7856(76)90059-7; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Hart CL, 1997, INT J EPIDEMIOL, V26, P508, DOI 10.1093/ije/26.3.508; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; *REG GEN SCOTL, 1998, ANN REP REG GEN BIRT, V3, P156; *REG GEN SCOTL, 1998, ANN REP REG GEN BIRT, P156; Richards H, 2000, J EPIDEMIOL COMMUN H, V54, P714, DOI 10.1136/jech.54.9.714; Richards H, 2000, FAM PRACT, V17, P71, DOI 10.1093/fampra/17.1.71; RICHARDS HM, 2002, IN PRESS J AM MED WO, V57; ROGERS A, 1999, DEMANDING PATIENTS A; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; SMITH WCS, 1990, J CLIN EPIDEMIOL, V43, P637, DOI 10.1016/0895-4356(90)90033-L; Tod AM, 2001, BRIT MED J, V323, P214, DOI 10.1136/bmj.323.7306.214; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0	21	51	52	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1308	1310A		10.1136/bmj.324.7349.1308	http://dx.doi.org/10.1136/bmj.324.7349.1308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039824	Bronze, Green Published			2022-12-24	WOS:000176041500017
J	Baba, T; Takeuchi, F; Kuroda, M; Yuzawa, H; Aoki, K; Oguchi, A; Nagai, Y; Iwama, N; Asano, K; Naimi, T; Kuroda, H; Cui, L; Yamamoto, K; Hiramatsu, K				Baba, T; Takeuchi, F; Kuroda, M; Yuzawa, H; Aoki, K; Oguchi, A; Nagai, Y; Iwama, N; Asano, K; Naimi, T; Kuroda, H; Cui, L; Yamamoto, K; Hiramatsu, K			Genome and virulence determinants of high virulence community-acquired MRSA	LANCET			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STRAINS; GENE; EXPRESSION; SEQUENCE; PROTEIN	Background A new type of meticillin-resistant Staphylococcus aureus (MRSA), designated community-acquired MRSA, is becoming increasingly noticeable in the community, some strains of which cause fatal infections in otherwise healthy individuals. By contrast with hospital-acquired MRSA, community-acquired MRSA is more susceptible to non beta-lactam antibiotics. We investigated the high virulence potential of certain strains of this bacterium. Methods We ascertained the whole genome sequence of MW2, a strain of community-acquired MRSA, by shotgun cloning and sequencing, MW2 caused fatal septicaemia and septic arthritis in a 16-month-old girl in North Dakota, USA, in 1998. The genome of this strain was compared with those of hospital-acquired MRSA strains, including N315 and Mu50. Findings Meticillin resistance gene (mecA) in MW2 was carried by a novel allelic form (type IVa) of staphylococcal cassette chromosome mec (SCCmec), by contrast with type II in N315 and Mu50. Type IVa SCCmec did not carry any of the multiple antibiotic resistance genes reported in type II SCCmec. By contrast, 19 additional virulence genes were recorded in the MW2 genome. All but two of these virulence genes were noted in four of the seven genomic islands of MW2. Interpretation MW2 carried a range of virulence and resistance genes that was distinct from those displayed on the chromosomes of extant S aureus strains. Most genes were carried by specific allelic forms of genomic islands in the MW2 chromosome. The combination of allelic forms of genomic islands is the genetic basis that determines the pathogenicity of medically important phenotypes of S aureus, including those of community-acquired MRSA strains.	Juntendo Univ, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan; Natl Inst Technol & Evaluat, Tokyo, Japan; New Energy & Ind Technol Dev Org, Tokyo, Japan; Int Med Ctr Japan, Res Inst, Tokyo, Japan; Org Pharmaceut Safety & Res, Tokyo, Japan; Minnesota Dept Hlth, Minneapolis, MN USA	Juntendo University; National Center for Global Health & Medicine - Japan; Minnesota Department of Health (MHD)	Hiramatsu, K (corresponding author), Juntendo Univ, Dept Bacteriol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hiram@med.juntendo.ac.jp		cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885; Naimi, Timothy/0000-0001-9849-4413				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRAY N, 2002, AVID GLOBAL ALIGNMEN; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; Cui LZ, 1999, SCAND J INFECT DIS, V31, P208, DOI 10.1080/003655499750006326; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; FULLERPACE FV, 1986, P NATL ACAD SCI USA, V83, P9368, DOI 10.1073/pnas.83.24.9368; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Murphy E, 1989, MOBILE DNA-UK, P269; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Nilsson H, 1999, J IMMUNOL, V163, P6686; *OK U, 2002, STAPH AUR NCTC 8325; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; PATTI JM, 1992, J BIOL CHEM, V267, P4766; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; RAY BK, 1979, MOL GEN GENET, V174, P25, DOI 10.1007/BF00433301; REN KY, 1994, J EXP MED, V180, P1675, DOI 10.1084/jem.180.5.1675; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Yoshida T, 1997, MICROBIOL IMMUNOL, V41, P687, DOI 10.1111/j.1348-0421.1997.tb01912.x	28	1012	2020	1	164	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2002	359	9320					1819	1827		10.1016/S0140-6736(02)08713-5	http://dx.doi.org/10.1016/S0140-6736(02)08713-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044378				2022-12-24	WOS:000175775500011
J	Stenestrand, U; Wallentin, L				Stenestrand, U; Wallentin, L			Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study	LANCET			English	Article							UNSTABLE ANGINA; THROMBOLYTIC THERAPY; CARDIAC-CATHETERIZATION; CONSERVATIVE STRATEGIES; IMMEDIATE ANGIOPLASTY; PLASMINOGEN-ACTIVATOR; CORONARY-ANGIOGRAPHY; OUTCOMES; TRIAL; ORGANIZATION	Background Randomised trials of early revascularisation in acute coronary syndromes have yielded conflicting results with respect to effects on survival. We assessed the association between revascularisation within 14 days after the index event and 1-year mortality in individuals who survived for at least 14 days after an acute myocardial infarction. Methods We studied a prospective cohort of patients admitted to the coronary care units of 61 Swedish hospitals between 1995 and 1998. We obtained 1-year mortality data from the Swedish National Cause of Death Register. We assessed 21912 individuals with first registry-recorded acute myocardial infarction, who were younger than age 80 years, and alive at day 14. Relative risk of 1-year mortality in patients who had revascularisation (n=2554) or those who did not (n=19 358) within 14 days was calculated by Cox regression analysis, adjusting for multiple covariates that affect mortality and with a propensity score that adjusted for covariates that affected the likelihood of early revascularisation. Findings At 1 year, unadjusted mortality was 9.0% (1751 deaths) in the conservative group and 3.3% (84 deaths) in the early revascularisation group. In the Cox regression analysis early revascularisation was associated with a reduction in 1-year mortality (relative risk 0.47; 95% CI 0.37-0.60; p<0.001). This relative reduction of mortality was similar in all subgroups irrespective of age, sex, baseline characteristics, previous disease manifestations, or treatment. Interpretation Early revascularisation in individuals with acute myocardial infarction is associated with substantial reduction in 1-year mortality. Our findings lend support to the use of an invasive approach early after an acute myocardial infarction.	Linkoping Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden; Univ Uppsala Hosp, Dept Cardiol, Uppsala, Sweden	Linkoping University; Uppsala University; Uppsala University Hospital	Stenestrand, U (corresponding author), Linkoping Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden.	Stenestrand@riks-hia.c.se						ALDERMAN EL, 1990, CIRCULATION, V82, P1629, DOI 10.1161/01.CIR.82.5.1629; ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; [Anonymous], 1989, NEW ENGL J MED, V320, P618; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; CALIFF RM, 1991, CIRCULATION, V83, P1543, DOI 10.1161/01.CIR.83.5.1543; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chamberlain DA, 1997, LANCET, V350, P461; Cohen MG, 2001, AM HEART J, V141, P391, DOI 10.1067/mhj.2001.113216; DEBONO DP, 1991, BMJ-BRIT MED J, V302, P555; Ellis SG, 2000, AM HEART J, V139, P1046, DOI 10.1067/mhj.2000.106624; EVERY NR, 1993, NEW ENGL J MED, V329, P546, DOI 10.1056/NEJM199308193290807; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Lupon J, 1999, J AM COLL CARDIOL, V34, P1947, DOI 10.1016/S0735-1097(99)00446-5; Madsen JK, 1997, CIRCULATION, V96, P748; Mulder HJGH, 2000, AM J CARDIOL, V86, P742, DOI 10.1016/S0002-9149(00)01073-0; Piegas LS, 1999, AM J CARDIOL, V84, p7M; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; Serruys PW, 1999, EUR HEART J, V20, P58, DOI 10.1053/euhj.1998.1150; SIMOONS ML, 1988, LANCET, V1, P199; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; TOPOL EJ, 1987, NEW ENGL J MED, V317, P581, DOI 10.1056/NEJM198709033171001; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wallentin L, 1999, LANCET, V354, P708; Ward SR, 1997, AM J CARDIOL, V79, P539, DOI 10.1016/S0002-9149(96)00812-0; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; WILLIAMS DO, 1992, CIRCULATION, V85, P533, DOI 10.1161/01.CIR.85.2.533; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X	30	93	95	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2002	359	9320					1805	1811		10.1016/S0140-6736(02)08710-X	http://dx.doi.org/10.1016/S0140-6736(02)08710-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044375				2022-12-24	WOS:000175775500008
J	Matsubayashi, Y; Ogawa, M; Morita, A; Sakagami, Y				Matsubayashi, Y; Ogawa, M; Morita, A; Sakagami, Y			An LRR receptor kinase involved in perception of a peptide plant hormone, phytosulfokine	SCIENCE			English	Article							LEUCINE-RICH REPEAT; GROWTH-FACTOR; SULFATED PENTAPEPTIDE; MESOPHYLL-CELLS; BINDING-SITES; ALPHA; PROLIFERATION; ARABIDOPSIS; ANALOGS	The sulfated peptide phytosulfokine (PSK) is an intercellular signal that plays a key role in cellular dedifferentiation and proliferation in plants. Using ligand-based affinity chromatography, we purified a 120-kilodalton membrane protein, specifically interacting with PSK, from carrot microsomal fractions. The corresponding complementary DNA encodes a 1021-amino acid receptor kinase that contains extracellular leucine-rich repeats, a single transmembrane domain, and a cytoplasmic kinase domain. Overexpression of this receptor kinase in carrot cells caused enhanced callus growth in response to PSK and a substantial increase in the number of tritium-labeled PSK binding sites, suggesting that PSK and this receptor kinase act as a ligand-receptor pair.	Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119				BELLINCAMPI D, 1987, PLANT SCI, V51, P83, DOI 10.1016/0168-9452(87)90223-8; BIRNBERG PR, 1988, J PLANT PHYSIOL, V132, P316, DOI 10.1016/S0176-1617(88)80113-5; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Hanai H, 2000, PLANT CELL PHYSIOL, V41, P27, DOI 10.1093/pcp/41.1.27; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Kobayashi T, 1999, J EXP BOT, V50, P1123, DOI 10.1093/jexbot/50.336.1123; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Matsubayashi Y, 1999, BIOSCI BIOTECH BIOCH, V63, P1847, DOI 10.1271/bbb.63.1847; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Matsubayashi Y, 1999, EUR J BIOCHEM, V262, P666, DOI 10.1046/j.1432-1327.1999.00409.x; Matsubayashi Y, 1997, P NATL ACAD SCI USA, V94, P13357, DOI 10.1073/pnas.94.24.13357; Matsubayashi Y, 1999, PLANTA, V207, P559, DOI 10.1007/s004250050518; Matsubayashi Y, 1999, PLANT PHYSIOL, V120, P1043, DOI 10.1104/pp.120.4.1043; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 1996, BIOCHEM BIOPH RES CO, V225, P209, DOI 10.1006/bbrc.1996.1155; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452	17	248	273	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1470	1472		10.1126/science.1069607	http://dx.doi.org/10.1126/science.1069607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029134				2022-12-24	WOS:000175910300049
J	Fish, SA; Shepherd, TJ; McGenity, TJ; Grant, WD				Fish, SA; Shepherd, TJ; McGenity, TJ; Grant, WD			Recovery of 16S ribosomal RNA gene fragments from ancient halite	NATURE			English	Article							FLUID INCLUSIONS; SEAWATER CHEMISTRY; SALT; MARINE; HALOBACTERIA; EVAPORITES; EDS	During the last decade, sensitive techniques for detecting DNA have been successfully applied to archaeological and other samples that were a few hundred to a few thousand years old(1,2). Nevertheless, there is still controversy and doubt over claims of exceptionally ancient DNA(3). Additional accounts stretching back nearly a century suggest that microorganisms may survive over geological time in evaporite deposits(4,5). There is, however, often doubt over the age relationship between evaporite formation and the incorporation of microorganisms(6). Here, we have used petrographic and geochemical techniques (laser ablation microprobe-inductively coupled plasma-mass spectrometry) to verify the estimated geological age of halite (NaCl) evaporite samples. Fragments of 16S ribosomal RNA genes were detected by polymerase chain reaction amplification of DNA extracted from halite samples ranging in age from 11 to 425 Myr (millions of years). Haloarchaeal 16S rDNA amplicons were present in one sample (11-16 Myr), whereas other samples (65-425 Myr) yielded only bacterial 16S rDNA amplicons. Terminal restriction fragment length polymorphism analyses indicate complex and different populations of microorganisms or their free DNA in ancient halites of different ages.	Univ Leicester, Dept Microbiol & Immunol, Leicester LE1 9HN, Leics, England; British Geol Survey, Keyworth NG12 5GG, Notts, England; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Essex	Shepherd, TJ (corresponding author), Univ Leicester, Dept Microbiol & Immunol, Leicester LE1 9HN, Leics, England.		McGenity, Terry/B-8661-2011	McGenity, Terence/0000-0002-1497-8822				CANO R J, 1992, Medical Science Research, V20, P249; GEMMELL RT, 1998, ANCIENT BIOMOLECULES, V2, P125; Grant WD, 1998, EXTREMOPHILES, V2, P279, DOI 10.1007/s007920050070; Gunther D, 1998, J ANAL ATOM SPECTROM, V13, P263, DOI 10.1039/a707372k; HARDIE LA, 1984, AM J SCI, V284, P193, DOI 10.2475/ajs.284.3.193; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hazen RM, 2001, NATURE, V411, P155, DOI 10.1038/35075663; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Jukes TH., 1969, MAMMALIAN PROTEIN ME, P21, DOI [DOI 10.1093/BIOINFORMATICS/BTM404, 10.1016/B978-1-4832-3211-9.50009-7]; Kalmbach S, 1999, INT J SYST BACTERIOL, V49, P769, DOI 10.1099/00207713-49-2-769; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; MULLER A, 1953, Z DTSCH GEOL GES, V105, P789; NORTON CF, 1993, J GEN MICROBIOL, V139, P1077, DOI 10.1099/00221287-139-5-1077; NORTON CF, 1988, J GEN MICROBIOL, V134, P1365; ROEDDER E, 1984, AM MINERAL, V69, P413; ROSLER HJ, 1972, GEOCHEMICAL TABLES T; RYCHLIK W, 1995, BIOTECHNIQUES, V18, P84; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shepherd TJ, 1998, EUR J MINERAL, V10, P1097; SMITH A, 1998, GEOSCIENTIST, V7, P8; SOMMERS R, 1989, NUCLEIC ACIDS RES, V17, P674; Timofeeff MN, 2000, CHEM GEOL, V164, P171, DOI 10.1016/S0009-2541(99)00153-9; Timofeeff MN, 2001, GEOCHIM COSMOCHIM AC, V65, P2293, DOI 10.1016/S0016-7037(01)00591-9; TIMOFEEFF MN, 1999, 9 ANN VM GOLDSCHM C, P299; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; WARDLAW NC, 1966, GEOL SOC AM BULL, V77, P331, DOI 10.1130/0016-7606(1966)77[331:HSLITM]2.0.CO;2; WOODWARD SR, 1994, SCIENCE, V266, P1229; Zimmermann H, 2001, GEOCHIM COSMOCHIM AC, V65, P35, DOI 10.1016/S0016-7037(00)00508-1	29	89	101	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					432	436		10.1038/417432a	http://dx.doi.org/10.1038/417432a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024211				2022-12-24	WOS:000175730900036
J	Forcet, C; Stein, E; Pays, L; Corset, R; Llambi, F; Tessler-Lavigne, M; Mehlen, P				Forcet, C; Stein, E; Pays, L; Corset, R; Llambi, F; Tessler-Lavigne, M; Mehlen, P			Netrin-1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation	NATURE			English	Article							RECEPTOR TYROSINE KINASE; ADENOSINE A2B RECEPTOR; ADHESION MOLECULE L1; NEURITE OUTGROWTH; SIGNALING PATHWAY; NETRIN RECEPTOR; GROWTH CONES; PC12 CELLS; DCC-GENE; IN-VIVO	Neuronal growth cones are guided to their targets by attractive and repulsive guidance cues(1). In mammals, netrin-1 is a bifunctional cue, attracting some axons and repelling others(2-5). Deleted in colorectal cancer (Dcc) is a receptor for netrin-1 that mediates its chemoattractive effect on commissural axons(6,7), but the signalling mechanisms that transduce this effect are poorly understood. Here we show that Dcc activates mitogen-activated protein kinase (MAPK) signalling, by means of extracellular signal-regulated kinase (ERK)-1 and -2, on netrin-1 binding in both transfected cells and commissural neurons. This activation is associated with recruitment of ERK-1/2 to a Dcc receptor complex. Inhibition of ERK-1/2 antagonizes netrin-dependent axon outgrowth and orientation. Thus, activation of MAPK signalling through Dcc contributes to netrin signalling in axon growth and guidance.	Univ Lyon, CNRS, UMR 5534,Apoptosis Differentiat Lab, Mol & Cellular Genet Ctr, F-69622 Villeurbanne, France; Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94035 USA	Centre National de la Recherche Scientifique (CNRS); Howard Hughes Medical Institute	Mehlen, P (corresponding author), Univ Lyon, CNRS, UMR 5534,Apoptosis Differentiat Lab, Mol & Cellular Genet Ctr, F-69622 Villeurbanne, France.		Stein, Elke/E-8107-2013	Stein, Elke/0000-0001-8965-5692; Pays, Laurent/0000-0003-0720-2273				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Birkenkamp KU, 2000, BRIT J PHARMACOL, V131, P99, DOI 10.1038/sj.bjp.0703534; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FUKUDA M, 1995, ONCOGENE, V11, P239; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolkova K, 2000, J NEUROSCI, V20, P2238; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmid RS, 2000, J NEUROSCI, V20, P4177; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sgambato V, 1998, J NEUROSCI, V18, P214; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yamashita H, 1999, J BIOL CHEM, V274, P15059, DOI 10.1074/jbc.274.21.15059	29	199	212	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					443	447		10.1038/nature748	http://dx.doi.org/10.1038/nature748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	11986622				2022-12-24	WOS:000175730900039
J	Darby, C; Hsu, JW; Ghori, N; Falkow, S				Darby, C; Hsu, JW; Ghori, N; Falkow, S			Caenorhabditis elegans - Plague bacteria biofilm blocks food intake	NATURE			English	Article							YERSINIA-PESTIS; STAPHYLOCOCCUS-EPIDERMIDIS		Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Darby, C (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.							AVERY L, 1993, GENETICS, V133, P897; Bacot A. W., 1914, Journal of Hygiene Cambridge Plague Suppl, V3; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 1997, J MOL MED, V75, P645, DOI 10.1007/s001090050148; Jones HA, 1999, MICROBIOL-SGM, V145, P2117, DOI 10.1099/13500872-145-8-2117	10	205	223	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					243	244		10.1038/417243a	http://dx.doi.org/10.1038/417243a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015591				2022-12-24	WOS:000175592100035
J	Sun, Y; Olson, R; Horning, M; Armstrong, N; Mayer, M; Gouaux, E				Sun, Y; Olson, R; Horning, M; Armstrong, N; Mayer, M; Gouaux, E			Mechanism of glutamate receptor desensitization	NATURE			English	Article							LIGAND-BINDING CORE; AMPA RECEPTOR; ION CHANNELS; TETRAMERIC STRUCTURE; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; CYCLOTHIAZIDE; KAINATE; CELLS; SELECTIVITY	Ligand-gated ion channels transduce chemical signals into electrical impulses by opening a transmembrane pore in response to binding one or more neurotransmitter molecules. After activation, many ligand-gated ion channels enter a desensitized state in which the neurotransmitter remains bound but the ion channel is closed. Although receptor desensitization is crucial to the functioning of many ligand-gated ion channels in vivo, the molecular basis of this important process has until now defied analysis. Using the GluR2 AMPA-sensitive glutamate receptor, we show here that the ligand-binding cores form dimers and that stabilization of the intradimer interface by either mutations or allosteric modulators reduces desensitization. Perturbations that destabilize the interface enhance desensitization. Receptor activation involves conformational changes within each subunit that result in an increase in the separation of portions of the receptor that are linked to the ion channel. Our analysis defines the dimer interface in the resting and activated state, indicates how ligand binding is coupled to gating, and suggests modes of dimer-dimer interaction in the assembled tetramer. Desensitization occurs through rearrangement of the dimer interface, which disengages the agonist-induced conformational change in the ligand-binding core from the ion channel gate.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.		Gouaux, Eric/Y-4370-2019; Mayer, Mark/AAE-7356-2019; Mayer, Mark L/H-5500-2013	Gouaux, Eric/0000-0002-8549-2360; Mayer, Mark/0000-0003-4378-8451; 				Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ANSEVIN AT, 1970, ANAL BIOCHEM, V34, P237, DOI 10.1016/0003-2697(70)90103-X; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; AYOLAN G, 2001, NEURON, V31, P103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Clark RB, 1999, TRENDS PHARMACOL SCI, V20, P279, DOI 10.1016/S0165-6147(99)01351-6; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; CORDI AA, 1994, BIOORG MED CHEM LETT, V4, P1957, DOI 10.1016/S0960-894X(01)80542-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HALL RA, 1993, BRAIN RES, V628, P345, DOI 10.1016/0006-8993(93)90978-V; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; Kleywegt GJ, 1994, CCP4 ESF EACBM NEWSL, P9; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Laube B, 1998, J NEUROSCI, V18, P2954; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; MAYER ML, 1995, EXCITATORY AMINO ACI, P89; Nagarajan N, 2001, NEUROPHARMACOLOGY, V41, P650, DOI 10.1016/S0028-3908(01)00133-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Partin KM, 2001, J NEUROSCI, V21, P1939, DOI 10.1523/JNEUROSCI.21-06-01939.2001; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	46	575	600	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					245	253		10.1038/417245a	http://dx.doi.org/10.1038/417245a			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015593				2022-12-24	WOS:000175592100037
J	Yuan, L; Liu, JG; Hoja, MR; Wilbertz, J; Nordqvist, K; Hoog, C				Yuan, L; Liu, JG; Hoja, MR; Wilbertz, J; Nordqvist, K; Hoog, C			Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specific protein SCP3	SCIENCE			English	Article							SYNAPTONEMAL COMPLEX PROTEIN; SACCHAROMYCES-CEREVISIAE; CROSSOVER INTERFERENCE; LOCALIZATION	Aneuploidy (trisomy or monosomy) is the leading genetic cause of pregnancy loss in humans and results from errors in meiotic chromosome segregation. Here, we show that the absence of synaptonemal complex protein 3 (SCP3) promotes aneuploidy in murine oocytes by inducing defective meiotic chromosome segregation. The abnormal oocyte karyotype is inherited by embryos, which die in utero at an early stage of development. In addition, embryo death in SCP3-deficient females increases with advancing maternal age. We found that SCP3 is required for chiasmata formation and for the structural integrity of meiotic chromosomes, suggesting that altered chromosomal structure triggers nondisjunction. SCP3 is thus linked to inherited aneuploidy in female germ cells and provides a model system for studying age-dependent degeneration in oocytes.	Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hoog, C (corresponding author), Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden.		Dalton-O'Reilly, Jessica/AAM-8569-2021; Nordqvist, Katarina/B-7964-2016	Nordqvist, Katarina/0000-0001-9561-5590				Anderson LK, 1999, GENETICS, V151, P1569; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hodges CA, 2001, J CELL SCI, V114, P2417; HOJA MR, UNPUB; Kaback DB, 1999, GENETICS, V152, P1475; Kline J, 2000, AM J HUM GENET, V67, P395, DOI 10.1086/303009; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; LAWRIE NM, 1995, CHROMOSOMA, V140, P308; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Peltier JW, 2000, MARK HEALTH SERV, V20, P5; Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340; SCHMEKEL K, 1995, TRENDS CELL BIOL, V5, P239, DOI 10.1016/S0962-8924(00)89017-0; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tung KS, 1998, GENETICS, V149, P817; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	18	266	291	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1115	1118		10.1126/science.1070594	http://dx.doi.org/10.1126/science.1070594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004129				2022-12-24	WOS:000175565000052
J	Anetseder, M; Hager, M; Muller, CR; Roewer, N				Anetseder, M; Hager, M; Muller, CR; Roewer, N			Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test	LANCET			English	Article								Susceptibility to malignant hyperthermia is diagnosed by contracture test, which requires an open muscle biopsy sample. We postulated that Intramuscular injection of caffeine Increases local carbon dioxide pressure (pCO(2)) In Individuals susceptible to malignant hyperthermia but not in those who are non-susceptible or In healthy Individuals. We measured pCO(2) in the rectus femoris muscle during local stimulation with 500 muL caffeine 80 mmol/L In 12 patients susceptible to malignant hyperthermia, eight non-susceptible Individuals, and seven healthy controls. In susceptible individuals, pCO(2) temporarily Increased to a maximum of 63 mm Hg (IQR 61-69) compared with 44 mm Hg (43-47) In non-susceptible participants (p=0.003) and 42 mm Hg (41-46) in controls (p=0.003). There were no systemic side-effects. Metabolic monitoring of the highly diffusible CO2 stimulated by caffeine might allow a minimally Invasive test for susceptibility to malignant hyperthermia.	Univ Wurzburg, Dept Anaesthesiol, D-97080 Wurzburg, Germany	University of Wurzburg	Anetseder, M (corresponding author), Univ Wurzburg, Dept Anaesthesiol, J Schneider Str 2, D-97080 Wurzburg, Germany.	anets@anaesthesie.uni-wuerzburg.de						Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5; ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267; Girard T, 2001, Hum Mutat, V18, P357, DOI 10.1002/humu.1203; GRONERT GA, 1976, ANESTHESIOLOGY, V44, P36, DOI 10.1097/00000542-197601000-00008; Urwyler A, 2001, BRIT J ANAESTH, V86, P283, DOI 10.1093/bja/86.2.283	5	37	41	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2002	359	9317					1579	1580		10.1016/S0140-6736(02)08506-9	http://dx.doi.org/10.1016/S0140-6736(02)08506-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047971				2022-12-24	WOS:000175460700015
J	Zhu, S; Stavrovskaya, IG; Drozda, M; Kim, BYS; Ona, V; Li, MW; Sarang, S; Liu, AS; Hartley, DM; Du, CW; Gullans, S; Ferrante, RJ; Przedborski, S; Kristal, BS; Friedlander, RM				Zhu, S; Stavrovskaya, IG; Drozda, M; Kim, BYS; Ona, V; Li, MW; Sarang, S; Liu, AS; Hartley, DM; Du, CW; Gullans, S; Ferrante, RJ; Przedborski, S; Kristal, BS; Friedlander, RM			Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice	NATURE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSGENIC MOUSE MODEL; CELL-DEATH; ACTIVATION; DISEASE; DEGENERATION; EXPRESSION; CASPASE-1; APOPTOSIS; MUTATION	Minocycline mediates neuroprotection in experimental models of neurodegeneration. It inhibits the activity(1-6) of caspase-1, caspase-3, inducible form of nitric oxide synthetase (iNOS) and p38 mitogen-activated protein kinase (MAPK). Although minocycline does not directly inhibit these enzymes, the effects may result from interference with upstream mechanisms resulting in their secondary activation. Because the above-mentioned factors are important in amyotrophic lateral sclerosis (ALS), we tested minocycline in mice with ALS(7-9). Here we report that minocycline delays disease onset and extends survival in ALS mice. Given the broad efficacy of minocycline, understanding its mechanisms of action is of great importance. We find that minocycline inhibits mitochondrial permeability-transition-mediated cytochrome c release. Minocycline-mediated inhibition of cytochrome c release is demonstrated in vivo, in cells, and in isolated mitochondria. Understanding the mechanism of action of minocycline will assist in the development and testing of more powerful and effective analogues. Because of the safety record of minocycline, and its ability to penetrate the blood-brain barrier, this drug may be a novel therapy for ALS(10).	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,Neuroapoptosis Lab, Boston, MA 02115 USA; Burke Med Res Inst, White Plains, NY 10605 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Vedford VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bedford, MA 01730 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurosci, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; Columbia University; Geriatric Research Education & Clinical Center; Boston University; Boston University; Boston University; Cornell University; Cornell University	Friedlander, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,Neuroapoptosis Lab, Boston, MA 02115 USA.		Friedlander, Robert M/A-2845-2016	Friedlander, Robert M/0000-0003-4423-9219; Kim, Betty Y.S./0000-0001-6890-8355				Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BROGDEN RN, 1975, DRUGS, V9, P251, DOI 10.2165/00003495-197509040-00005; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Krasnikov BF, 1997, FEBS LETT, V419, P137, DOI 10.1016/S0014-5793(97)01450-6; Kristal BS, 2000, DEV NEUROSCI-BASEL, V22, P376, DOI 10.1159/000017463; Kristal BS, 1997, J NEUROCHEM, V69, P524; Kristal BS, 1999, J BIOL CHEM, V274, P23169, DOI 10.1074/jbc.274.33.23169; Lai J C, 1979, Methods Enzymol, V55, P51; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030	30	861	911	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					74	78		10.1038/417074a	http://dx.doi.org/10.1038/417074a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986668				2022-12-24	WOS:000175307200040
J	Yin, YH; Wang, ZY; Mora-Garcia, S; Li, JM; Yoshida, S; Asami, T; Chory, J				Yin, YH; Wang, ZY; Mora-Garcia, S; Li, JM; Yoshida, S; Asami, T; Chory, J			BES1 accumulates in the nucleus in response to brassinosteroids to regulate gene expression and promote stem elongation	CELL			English	Article							PLANT-GROWTH; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; CELL ELONGATION; KINASE; CYTOCHROME-P450; TRANSFORMATION; PATHWAYS; CATENIN; MUTANT	Plant steroid hormones, known as brassinosteroids (BRs), signal through a plasma membrane localized receptor kinase BRI1. We identified bes1, a semidominant suppressor of bri1, which exhibits constitutive BR response phenotypes including long and bending petioles, curly leaves, accelerated senescence, and constitutive expression of BR-response genes. BES1 accumulates in the nucleus in response to BRs. BES1 is phosphorylated and appears to be destabilized by the glycogen synthase kinase-3 (GSK-3) BIN2, a negative regulator of the BR pathway. These results establish a signaling cascade for BRs with similarities to the Wnt pathway, in which signaling through cell surface receptors leads to inactivation of a GSK-3 allowing accumulation of a nuclear protein that regulates target gene expression.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; RIKEN, Inst Phys & Chem Res, Plant Funct Lab, Wako, Saitama 3510198, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Michigan System; University of Michigan; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Li, Jianming/O-1772-2014; Wang, Zhi-Yong/E-3810-2012	Li, Jianming/0000-0003-3231-0778; Wang, Zhi-Yong/0000-0003-4602-3390	NIGMS NIH HHS [F32 GM020558, R01 GM060519] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Darley CP, 2001, PLANT MOL BIOL, V47, P179, DOI 10.1023/A:1010687600670; Dornelas MC, 1998, GENE, V212, P249, DOI 10.1016/S0378-1119(98)00147-4; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Friedrichsen D, 2001, BIOESSAYS, V23, P1028, DOI 10.1002/bies.1148; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kang JG, 2001, CELL, V105, P625, DOI 10.1016/S0092-8674(01)00370-1; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Lamport DTA, 2001, CELL MOL LIFE SCI, V58, P1363, DOI 10.1007/PL00000782; LI J, 1999, J EXP BOT, V50, P332; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MUSSIG C, 1999, PLANT PHYSIOL BIOCH, V37, P757; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Noguchi T, 2000, PLANT PHYSIOL, V124, P201, DOI 10.1104/pp.124.1.201; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; POCH HLC, 1993, PLANT J, V4, P671, DOI 10.1046/j.1365-313X.1993.04040671.x; Polakis P, 2000, GENE DEV, V14, P1837; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/0968-0004(96)10031-1; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sharpe C, 2001, BIOESSAYS, V23, P311, DOI 10.1002/bies.1045; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; WANG ZY, 2002, IN PRESS DEV CELL; WOODGETT JR, 2001, JUDGING PROTEIN MORE; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161	45	794	865	22	188	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					181	191		10.1016/S0092-8674(02)00721-3	http://dx.doi.org/10.1016/S0092-8674(02)00721-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007405	Bronze			2022-12-24	WOS:000175082600008
J	Xu, HX; Ramsey, IS; Kotecha, SA; Moran, MM; Chong, JHA; Lawson, D; Ge, P; Lilly, J; Silos-Santiago, I; Xie, Y; DiStefano, PS; Curtis, R; Clapham, DE				Xu, HX; Ramsey, IS; Kotecha, SA; Moran, MM; Chong, JHA; Lawson, D; Ge, P; Lilly, J; Silos-Santiago, I; Xie, Y; DiStefano, PS; Curtis, R; Clapham, DE			TRPV3 is a calcium-permeable temperature-sensitive cation channel	NATURE			English	Article							RAT SENSORY NEURONS; CAPSAICIN-RECEPTOR; ION CHANNELS; NOXIOUS HEAT; CURRENTS; DEPENDENCE; CELLS	Transient receptor potential (TRP) proteins are cation-selective channels that function in processes as diverse as sensation and vasoregulation. Mammalian TRP channels that are gated by heat and capsaicin (> 43 degreesC; TRPV1 (ref. 1)), noxious heat (> 52 degreesC; TRPV2 (ref. 2)), and cooling (< 22 degrees C; TRPM8 (refs 3, 4)) have been cloned; however, little is known about the molecular determinants of temperature sensing in the range between similar to 22 degrees C and 40 degrees C. Here we have identified a member of the vanilloid channel family, human TRPV3 (hTRPV3) that is expressed in skin, tongue, dorsal root ganglion, trigeminal ganglion, spinal cord and brain. Increasing temperature from 22 degrees C to 40 degrees C in mammalian cells transfected with hTRPV3 elevated intracellular calcium by activating a nonselective cationic conductance. As in published recordings from sensory neurons, the current was steeply dependent on temperature, sensitized with repeated heating, and displayed a marked hysteresis on heating and cooling(5-10). On the basis of these properties, we propose that hTRPV3 is thermosensitive in the physiological range of temperatures between TRPM8 and TRPV1.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrew D, 2001, J PHYSIOL-LONDON, V537, P489, DOI 10.1111/j.1469-7793.2001.00489.x; BRENGELMANN GL, 1989, TXB PHYSL, V2, P1584; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1999, P NATL ACAD SCI USA, V96, P7658, DOI 10.1073/pnas.96.14.7658; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; FUNDIN BT, 1994, EXP BRAIN RES, V99, P233; Gotoh H, 1998, BRAIN RES, V796, P319, DOI 10.1016/S0006-8993(98)00355-2; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hori A, 1999, NEUROSCI LETT, V275, P93, DOI 10.1016/S0304-3940(99)00732-6; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu L, 2000, PHYSIOL BEHAV, V69, P363, DOI 10.1016/S0031-9384(00)00209-2; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SPRAY DC, 1986, ANNU REV PHYSIOL, V48, P625; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200	30	618	663	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2002	418	6894					181	186		10.1038/nature00882	http://dx.doi.org/10.1038/nature00882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12077604				2022-12-24	WOS:000176710400040
J	Lain, KY; Roberts, JM				Lain, KY; Roberts, JM			Contemporary concepts of the pathogenesis and management of preeclampsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDOTHELIAL DYSFUNCTION; SPIRAL ARTERIES; PREGNANCY; WOMEN; RISK; HYPERTENSION; ECLAMPSIA; INVASION		Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA; Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lain, KY (corresponding author), Magee Womens Hosp, 300 Halket St, Pittsburgh, PA 15213 USA.		Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207				*ACOG, 2002, ACOG PRACT B, V33, P1; *ACOG, 2001, ACOG PRACT B, V29, P1; ARIAS F, 1993, AM J OBSTET GYNECOL, V168, P585, DOI 10.1016/0002-9378(93)90499-9; BROWN MA, 1994, CLIN SCI, V86, P251, DOI 10.1042/cs0860251; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; CLARK SL, 1988, AM J OBSTET GYNECOL, V158, P453, DOI 10.1016/0002-9378(88)90003-8; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, MAGNESIUM SULPHATE V; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Hubel CA, 2000, BRIT J OBSTET GYNAEC, V107, P776, DOI 10.1111/j.1471-0528.2000.tb13340.x; HUBEL CA, 1999, CHESLEYS HYPERTENSIV; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Laivuori H, 1996, J CLIN ENDOCR METAB, V81, P2908, DOI 10.1210/jc.81.8.2908; Martin JN, 1999, AM J OBSTET GYNECOL, V180, P1407, DOI 10.1016/S0002-9378(99)70026-8; Matijevic R, 1999, BRIT J OBSTET GYNAEC, V106, P78, DOI 10.1111/j.1471-0528.1999.tb08089.x; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROBERTS JM, 1998, MATERNAL FETAL MED; SCHIFF E, 1994, OBSTET GYNECOL, V84, P626; SIBAI BM, 1983, OBSTET GYNECOL, V61, P571; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I	29	260	276	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2002	287	24					3183	3186		10.1001/jama.287.24.3183	http://dx.doi.org/10.1001/jama.287.24.3183			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566FF	12076198				2022-12-24	WOS:000176415800002
J	Kihm, AJ; Kong, Y; Hong, W; Russell, JE; Rouda, S; Adachi, K; Simon, MC; Blobel, GA; Weiss, MJ				Kihm, AJ; Kong, Y; Hong, W; Russell, JE; Rouda, S; Adachi, K; Simon, MC; Blobel, GA; Weiss, MJ			An abundant erythroid protein that stabilizes free alpha-haemoglobin	NATURE			English	Article							SEVERE BETA-THALASSEMIA; EMBRYONIC STEM-CELLS; MEMBRANE SKELETON; MOUSE MODEL; PRECURSORS; APOPTOSIS; GATA-1; DIFFERENTIATION; CHAINS	The development of red blood cells (erythrocytes) is distinguished by high-level production of the oxygen carrier, haemoglobin A (HbA), a heterotetramer of alpha- and beta-haemoglobin subunits. HbA synthesis is coordinated to minimize the accumulation of free subunits that form cytotoxic precipitates(1-3). Molecular chaperones that regulate globin subunit stability, folding or assembly have been proposed to exist but have never been identified. Here we identify a protein stabilizing free a- haemoglobin by using a screen for genes induced by the essential erythroid transcription factor GATA-1 (refs 4, 5). Alpha Haemoglobin Stabilizing Protein (AHSP) is an abundant, erythroid-specific protein that forms a stable complex with free alpha- haemoglobin but not with beta-haemoglobin or haemoglobin A (alpha(2)beta(2)). Moreover, AHSP specifically protects free alpha- haemoglobin from precipitation in solution and in live cells. AHSP-gene-ablated mice exhibit reticulocytosis and abnormal erythrocyte morphology with intracellular inclusion bodies that stain positively for denatured haemoglobins. Hence, AHSP is required for normal erythropoiesis, probably acting to block the deleterious effects of free alpha- haemoglobin precipitation. Accordingly, AHSP gene dosage is predicted to modulate pathological states of alpha-haemoglobin excess, such as beta-thalassaemia.	Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.		Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013	Weiss, Mitchell J/0000-0003-2460-3036; 	NIDDK NIH HHS [R01 DK061692] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACHMILEWITZ E, 2001, DISORDERS HAEMOGLOBI, P233; BAGLIONI C, 1966, BIBL HAEMATOL, V29, P1056; BANK A, 1969, NATURE, V222, P295, DOI 10.1038/222295a0; Centis F, 2000, BLOOD, V96, P3624; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Huang S-C, 2001, DISORDERS HEMOGLOBIN, P146; IKEDASAITO M, 1981, HEMOGLOBINS, P113; Miele G, 2001, NAT MED, V7, P361, DOI 10.1038/85515; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; NATHAN DG, 1969, J CLIN INVEST, V48, P33, DOI 10.1172/JCI106156; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; RACHMILEWITZ EA, 1974, SEMIN HEMATOL, V11, P441; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; SHAEFFER JR, 1967, BIOCHEM BIOPH RES CO, V28, P647, DOI 10.1016/0006-291X(67)90363-4; SHAEFFER JR, 1983, J BIOL CHEM, V258, P3172; SHINAR E, 1987, BLOOD, V70, P158; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; SORENSEN S, 1990, BLOOD, V75, P1333; Tavill A S, 1967, Trans Assoc Am Physicians, V80, P305; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; WICKRAMASINGHE SN, 1980, BRIT J HAEMATOL, V46, P401, DOI 10.1111/j.1365-2141.1980.tb05986.x; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; YUAN J, 1993, BLOOD, V82, P374, DOI 10.1182/blood.V82.2.374.bloodjournal822374; YUAN J, 1995, BLOOD, V86, P3945, DOI 10.1182/blood.V86.10.3945.bloodjournal86103945	29	220	239	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2002	417	6890					758	763		10.1038/nature00803	http://dx.doi.org/10.1038/nature00803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066189				2022-12-24	WOS:000176154700049
J	van Maarle, MC; Stouthard, MEA; Marang-van de Mheen, PJ; Klazinga, NS; Bonsel, GJ				van Maarle, MC; Stouthard, MEA; Marang-van de Mheen, PJ; Klazinga, NS; Bonsel, GJ			Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1100 DE Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Maarle, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Social Med, POB 22700, NL-1100 DE Amsterdam, Netherlands.	m.c.vanmaarle@amc.uva.nl	Stouthard, Marlies/GZG-4146-2022; de Mheen, Perla J. Marang-van/I-2783-2015	de Mheen, Perla J. Marang-van/0000-0003-1439-0989				*DUTCH I HLTH CAR, 1998, TREATM PREV COR HEAR; Goldstein J.L., 2001, METABOLIC MOL BASES, V11, P2863; PEDERSEN TR, 1994, LANCET, V344, P1383; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Umans-Eckenhausen M A, 1999, Ned Tijdschr Geneeskd, V143, P1157	5	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2002	324	7350					1367	1368		10.1136/bmj.324.7350.1367	http://dx.doi.org/10.1136/bmj.324.7350.1367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052805	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000176234100020
J	Oliver, A; Healey, A; Donaldson, C				Oliver, A; Healey, A; Donaldson, C			Choosing the method to match the perspective: economic assessment and its implications for health-services efficiency	LANCET			English	Editorial Material							WILLINGNESS-TO-PAY; CARE		Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, London WC2A 2AE, England; Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of London; London School Economics & Political Science; University of Calgary; University of Calgary	Oliver, A (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, Houghton St, London WC2A 2AE, England.		Oliver, Adam/CAG-2031-2022	Donaldson, Cam/0000-0003-4670-5340; Healey, Andrew/0000-0003-2013-3161				CULYER AJ, 1995, ECONOMICS; Donaldson C, 1999, SOC SCI MED, V49, P551, DOI 10.1016/S0277-9536(99)00173-2; Donaldson C, 1997, HEALTH CARE ANAL, V5, P7, DOI 10.1007/BF02678452; Donaldson C, 1996, HEALTH ECON, V5, P267, DOI 10.1002/(SICI)1099-1050(199605)5:3<267::AID-HEC209>3.0.CO;2-X; Donaldson C, 1998, PHARMACOECONOMICS, V13, P389, DOI 10.2165/00019053-199813040-00002; DONALDSON C, 1998, 9810 MCMAST U CTR HL; Drummond MF, 2015, METHODS EC EVALUATIO; Gerard K, 1993, Health Econ, V2, P59, DOI 10.1002/hec.4730020108; *MIN HLTH, 1994, ONT GUID EC AN PHARM; *NAT I CLIN EXC, 2001, COMPL TECHN APPR 200; National Institute for Clinical Excellence, 2001, TECHN GUID MAN SPONS; *NORW MED CONTR AU, 1999, NORW GUID PHARM AN C; *OHE HEED, 2000, HLTH EC EV DAT; Olsen JA, 1998, SOC SCI MED, V46, P1, DOI 10.1016/S0277-9536(97)00129-9; *SICKN FUNDS COUNC, 1999, DUTCH GUID PHARM RES; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; 1995, GUIDELINES PHARM IND	17	25	25	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 18	2002	359	9319					1771	1774		10.1016/S0140-6736(02)08664-6	http://dx.doi.org/10.1016/S0140-6736(02)08664-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554MV	12049884				2022-12-24	WOS:000175740500032
J	Williams, RSB; Cheng, LL; Mudge, AW; Harwood, AJ				Williams, RSB; Cheng, LL; Mudge, AW; Harwood, AJ			A common mechanism of action for three mood-stabilizing drugs	NATURE			English	Article							PROLYL ENDOPEPTIDASE; VALPROIC ACID; LITHIUM; DICTYOSTELIUM; PEPTIDASES; DEPRESSION; INHIBITORS; DECREASE; INCREASE; CATENIN	Lithium, carbamazepine and valproic acid are effective mood-stabilizing treatments for bipolar affective disorder. The molecular mechanisms underlying the actions of these drugs and the illness itself are unknown. Berridge and colleagues(1) suggested that inositol depletion may be the way that lithium works in bipolar affective disorder, but others have suggested that glycogen synthase kinase(2,3) (GSK3) may be the relevant target. The action of valproic acid has been linked to both inositol depletion(4,5) and to inhibition of histone deacetylase(6) (HDAC). We show here that all three drugs inhibit the collapse of sensory neuron growth cones and increase growth cone area. These effects do not depend on GSK3 or HDAC inhibition. Inositol, however, reverses the effects of the drugs on growth cones, thus implicating inositol depletion in their action. Moreover, the development of Dictyostelium is sensitive to lithium(7) and to valproic acid, but resistance to both is conferred by deletion of the gene that codes for prolyl oligopeptidase, which also regulates inositol metabolism. Inhibitors of prolyl oligopeptidase reverse the effects of all three drugs on sensory neuron growth cone area and collapse. These results suggest a molecular basis for both bipolar affective disorder and its treatment.	UCL, MRC, Mol Cell Biol Lab, Intracellular Signalling Grp, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, Cellular Neurobiol Grp, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Mudge, AW (corresponding author), UCL, MRC, Mol Cell Biol Lab, Intracellular Signalling Grp, Gower St, London WC1E 6BT, England.	a.mudge@ucl.ac.uk	Williams, Robin/G-6807-2011; Harwood, Adrian/A-4350-2010	Harwood, Adrian/0000-0003-3124-5169				AUGUSTYNS K, 1995, BIOORG MED CHEM LETT, V5, P1265, DOI 10.1016/0960-894X(95)00206-9; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Cheng LL, 1996, NEURON, V16, P309, DOI 10.1016/S0896-6273(00)80049-5; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; DEMUTH HU, 1993, FEBS LETT, V320, P23, DOI 10.1016/0014-5793(93)81649-K; Goold RG, 1999, J CELL SCI, V112, P3373; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HARWOOD AJ, 1995, CELL, V80, P139, DOI 10.1016/0092-8674(95)90458-1; Kerwin R, 1999, BETHLEM MAUDSLEY NHS; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; MAES M, 1994, BIOL PSYCHIAT, V35, P545, DOI 10.1016/0006-3223(94)90101-5; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; O'Donnell T, 2000, BRAIN RES, V880, P84, DOI 10.1016/S0006-8993(00)02797-9; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Sambrook JFE, 1989, MOL CLONING LAB MANU; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tillner J, 1998, TOXICOL IN VITRO, V12, P463, DOI 10.1016/S0887-2333(98)00016-2; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	23	503	521	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					292	295		10.1038/417292a	http://dx.doi.org/10.1038/417292a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015604				2022-12-24	WOS:000175592100048
J	Wong, TY; Klein, R; Sharrett, AR; Schmidt, MI; Pankow, JS; Couper, DJ; Klein, BEK; Hubbard, LD; Duncan, BB				Wong, TY; Klein, R; Sharrett, AR; Schmidt, MI; Pankow, JS; Couper, DJ; Klein, BEK; Hubbard, LD; Duncan, BB		ARIC Investigators	Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MUSCLE BLOOD-FLOW; ATHEROSCLEROSIS RISK; MICROVASCULAR ABNORMALITIES; INSULIN-RESISTANCE; CIGARETTE-SMOKING; COMMUNITIES; HYPERTENSION; ADULTS; NIDDM	Context Microvascular processes have been hypothesized to play a role in the pathogenesis of type 2 diabetes mellitus, but prospective clinical data regarding this hypothesis are unavailable. Objective To examine the relation of retinal arteriolar narrowing, a marker of microvascular damage from aging, hypertension, and inflammation, to incident diabetes in healthy middle-aged persons. Design, Setting, and Participants The Atherosclerosis Risk in Communities Study, an ongoing population-based, prospective cohort study in 4 US communities that began in 1987-1989. Included in this analysis were 7993 persons aged 49 to 73 years without diabetes, of whom retinal photographs were taken during the third examination (1993-1995). Main Outcome Measures Incident diabetes (defined as fasting glucose levels of greater than or equal to126 mg/dL [7.0 mmol/L], casual levels of greater than or equal to200 mg/dL [11.1 mmol/L], diabetic medications use, or physician diagnosis of diabetes at the fourth examination) by quartile of retinal arteriole-to-venule ratio (AVR). Results After a median follow-up of 3.5 years, 291 persons (3.6%) had incident diabetes. The incidence of diabetes was higher in persons with lower AVR at baseline (2.4%, 3.1%,4.0%, and 5.2%, from highest to lowest AVR quartile; P for trend<.001). After controlling for fasting glucose and insulin levels, family history of diabetes, adiposity, physical activity, blood pressure, and other factors, persons in the lowest quartile of AVR were 71 % more likely to develop diabetes than those in the highest quartile (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.13-2.57; P for trend=.002). This association persisted with different diagnostic criteria (OR, 1.92; 95% CI, 1.10-3.36; P for trend=.01, using a fasting glucose level of &GE;141 mg/dL [7,8 mmol/L] as a cutoff), and was seen even in people at lower risk of diabetes, including those without a family history of diabetes, without impaired fasting glucose, and with lower measures of adiposity. Conclusions Retinal arteriolar narrowing is independently associated with risk of diabetes, supporting a microvascular role in the development of clinical diabetes.	Univ Wisconsin, Dept Ophthalmol, Madison, WI USA; Singapore Natl Eye Ctr, Singapore, Singapore; NHLBI, Bethesda, MD 20892 USA; Univ Fed Rio Grande Sul, Sch Med, Dept Social Med, Porto Alegre, RS, Brazil; Univ Minnesota, Div Epidemiol, Minneapolis, MN USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of Wisconsin System; University of Wisconsin Madison; Singapore National Eye Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidade Federal do Rio Grande do Sul; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill	Wong, TY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Duncan, Bruce B/L-4140-2016; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022; Wong, Tien Yin/AAC-9724-2020; Schmidt, Maria/V-3196-2019	Duncan, Bruce B/0000-0002-7491-2630; Schmidt, Maria Inês/0000-0002-3837-0731; Wong, Tien Yin/0000-0002-8448-1264; Klein, Ronald/0000-0002-4428-6237; Pankow, James/0000-0001-7076-483X; Couper, David/0000-0002-4313-9235	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035126, N01HC055018, N01HC055022, N01HC055019, N01HC055021, N01HC055016, N01HC035125, N01HC055015, N01HC055020] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55015, N1-HC-55021, N01-HC-55019, NN01-HC-35126, N01-HC-35125, N01-HC-55020, N01-HC-55018, N01-HC-55022, N01-HC-55016] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Baron AD, 1997, ANNU REV NUTR, V17, P487, DOI 10.1146/annurev.nutr.17.1.487; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; FELDMAN RD, 1993, LANCET, V342, P707, DOI 10.1016/0140-6736(93)91708-T; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hsueh WA, 1998, J INVEST MED, V46, P387; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; HULTHEN UL, 1995, HYPERTENSION, V25, P214, DOI 10.1161/01.HYP.25.2.214; JAAP AJ, 1994, DIABETIC MED, V11, P883, DOI 10.1111/j.1464-5491.1994.tb00373.x; JAAP AJ, 1994, DIABETOLOGIA, V37, P214, DOI 10.1007/s001250050096; Jaap AJ, 1997, DIABETOLOGIA, V40, P238, DOI 10.1007/s001250050669; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; LAAKSO M, 1992, DIABETES, V41, P1076, DOI 10.2337/diabetes.41.9.1076; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MORALES PA, 1993, DIABETES, V42, P154, DOI 10.2337/diabetes.42.1.154; MORRIS SJ, 1995, DIABETOLOGIA, V38, P1337, DOI 10.1007/BF00401767; PAPP AC, 1989, THROMB HAEMOSTASIS, V61, P15; PELL SIDNEY, 1967, J AMER MED ASS, V202, P104, DOI 10.1001/jama.202.1.104; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; TOOKE JE, 1993, DIABETES METAB REV, V9, P57, DOI 10.1002/dmr.5610090106; TOOKE JE, 1995, DIABETES, V44, P721, DOI 10.2337/diabetes.44.7.721; *U NC SCH PUBL HLT, 1988, ATH RISK COMM STUD O, V2; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	34	240	248	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2528	2533		10.1001/jama.287.19.2528	http://dx.doi.org/10.1001/jama.287.19.2528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020333				2022-12-24	WOS:000175566200021
J	Weinrauch, Y; Drujan, D; Shapiro, SD; Weiss, J; Zychlinsky, A				Weinrauch, Y; Drujan, D; Shapiro, SD; Weiss, J; Zychlinsky, A			Neutrophil elastase targets virulence factors of enterobacteria	NATURE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; III SECRETION SYSTEMS; SHIGELLA-FLEXNERI; PROTEINS; DESTRUCTION; ACTIVATION; INHIBITORS; EFFECTORS; CELLS; PART	Shigellae cause bacillary dysentery, a bloody form of diarrhoea that affects almost 200 million people and causes nearly 2 million deaths per year(1). Shigella invades the colonic mucosa, where it initiates an acute inflammation, rich in neutrophils, that initially contributes to tissue damage and eventually resolves the infection(2). Neutrophils are phagocytic cells that kill microorganisms(3,4) but it is unclear how neutrophils control pathogenic bacteria expressing virulence factors that manipulate host cells. In contrast to other cells, neutrophils prevent the escape of Shigella from phagocytic vacuoles in which the bacteria are killed(5). Here we identify human neutrophil elastase (NE) as a key host defence protein: NE degrades Shigella virulence factors at a 1,000-fold lower concentration than that needed to degrade other bacterial proteins. In neutrophils in which NE is inactivated pharmacologically or genetically, Shigella escapes from phagosomes, increasing bacterial survival. NE also preferentially cleaves virulence factors of Salmonella and Yersinia. These findings establish NE as the first neutrophil factor that targets bacterial virulence proteins.	NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; Univ Iowa, Coll Med, Iowa City Vet Adm Med Ctr, Dept Microbiol,Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Iowa City Vet Adm Med Ctr, Dept Internal Med,Inflammat Program, Iowa City, IA 52242 USA; Max Planck Inst Infect Biol, D-10117 Berlin, Germany	New York University; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Iowa; University of Iowa; Max Planck Society	Zychlinsky, A (corresponding author), NYU, Sch Med, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.			Weiss, Jerrold/0000-0003-1476-4485				Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Elsbach P, 1999, INFLAMMATION BASIC P, P801; Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000; GBARAH A, 1993, INFECT IMMUN, V61, P1687, DOI 10.1128/IAI.61.5.1687-1693.1993; GINOCCHIO CC, 1995, INFECT IMMUN, V63, P729, DOI 10.1128/IAI.63.2.729-732.1995; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Huang YI, 1998, J LEUKOCYTE BIOL, V64, P322, DOI 10.1002/jlb.64.3.322; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; MandicMulec I, 1997, INFECT IMMUN, V65, P110, DOI 10.1128/IAI.65.1.110-115.1997; MENARD R, 1993, J BACTERIOL, V175, P5899; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Panyutich A, 1997, INFECT IMMUN, V65, P978, DOI 10.1128/IAI.65.3.978-985.1997; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Veale CA, 1997, J MED CHEM, V40, P3173, DOI 10.1021/jm970250z; WEISS J, 1985, J CLIN INVEST, V76, P206, DOI 10.1172/JCI111947; WEISS J, 1978, J BIOL CHEM, V253, P2664; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108	30	224	239	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					91	94		10.1038/417091a	http://dx.doi.org/10.1038/417091a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	12018205				2022-12-24	WOS:000175307200044
J	Gendrel, AV; Lippman, Z; Yordan, C; Colot, V; Martienssen, RA				Gendrel, AV; Lippman, Z; Yordan, C; Colot, V; Martienssen, RA			Dependence of heterochromatic histone H3 methylation patterns on the Arabidopsis gene DDM1	SCIENCE			English	Article							DNA METHYLATION; CHROMOSOMAL-PROTEINS; A-THALIANA; CHROMATIN; SWI/SNF; GENOME; RETROTRANSPOSONS; MOBILIZATION; MAINTENANCE; TRANSPOSONS	The Arabidopsis gene DDM1 is required to maintain DNA methylation levels and is responsible for transposon and transgene silencing. However, rather than encoding a DNA methyltransferase, DDM1 has similarity to the SWI/SNF family of adenosine triphosphate dependent chromatin remodeling genes, suggesting an indirect role in DNA methylation. Here we show that DDM1 is also required to maintain histone H3 methylation patterns. In wild-type heterochromatin, transposons and silent genes are associated with histone H3 methylated at lysine 9, whereas known genes are preferentially associated with methylated lysine 4. In ddm1 heterochromatin, DNA methylation is lost, and methylation of lysine 9 is largely replaced by methylation of lysine 4. Because DNA methylation has recently been shown to depend on histone H3 lysine 9 methylation, our results suggest that transposon methylation may be guided by histone H3 methylation in plant genomes. This would account for the epigenetic inheritance of hypomethylated DNA once histone H3 methylation patterns are altered.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; INRA CNRS, Unite Rech Genom Vegetale, F-91057 Evry, France	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Colot, V (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Gendrel, Anne-Valerie/E-5584-2017	Gendrel, Anne-Valerie/0000-0003-4510-0024; Lippman, Zachary/0000-0001-7668-9025				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Ascenzi R, 1999, CHROMOSOMA, V108, P345, DOI 10.1007/s004120050386; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Langst G, 2001, J CELL SCI, V114, P2561; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; MOEHS CP, 1988, PLANT MOL BIOL, V11, P507, DOI 10.1007/BF00039031; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Verbsky ML, 2001, CURR OPIN PLANT BIOL, V4, P494, DOI 10.1016/S1369-5266(00)00206-5; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	31	350	367	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1871	1873		10.1126/science.1074950	http://dx.doi.org/10.1126/science.1074950			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12077425				2022-12-24	WOS:000177955000044
J	Boynton, WV; Feldman, WC; Squyres, SW; Prettyman, TH; Bruckner, J; Evans, LG; Reedy, RC; Starr, R; Arnold, JR; Drake, DM; Englert, PAJ; Metzger, AE; Mitrofanov, I; Trombka, JI; d'Uston, C; Wanke, H; Gasnault, O; Hamara, DK; Janes, DM; Marcialis, RL; Maurice, S; Mikheeva, I; Taylor, GJ; Tokar, R; Shinohara, C				Boynton, WV; Feldman, WC; Squyres, SW; Prettyman, TH; Bruckner, J; Evans, LG; Reedy, RC; Starr, R; Arnold, JR; Drake, DM; Englert, PAJ; Metzger, AE; Mitrofanov, I; Trombka, JI; d'Uston, C; Wanke, H; Gasnault, O; Hamara, DK; Janes, DM; Marcialis, RL; Maurice, S; Mikheeva, I; Taylor, GJ; Tokar, R; Shinohara, C			Distribution of hydrogen in the near surface of Mars: Evidence for subsurface ice deposits	SCIENCE			English	Article							GROUND ICE; WATER	Using the Gamma-Ray Spectrometer on the Mars Odyssey, we have identified two regions near the poles that are enriched in hydrogen. The data indicate the presence of a subsurface layer enriched in hydrogen overlain by a hydrogen-poor layer. The thickness of the upper layer decreases with decreasing distance to the pole, ranging from a column density of about 150 grams per square centimeter at -42degrees latitude to about 40 grams per square centimeter at -77degrees. The hydrogen-rich regions correlate with regions of predicted ice stability. We suggest that the host of the hydrogen in the subsurface layer is ice, which constitutes 35 +/- 15% of the layer by weight.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Max Planck Inst Chem, D-55020 Mainz, Germany; Comp Sci Corp, Sci Programs, Lanham, MD 20706 USA; Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; TechSource, Santa Fe, NM 87505 USA; Victoria Univ Wellington, Wellington, New Zealand; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Russian Acad Sci, Inst Space Res, Moscow, Russia; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Ctr Etud Spatiale Rayonnements, Toulouse, France; Observ Midi Pyrenees, F-31400 Toulouse, France; Univ Hawaii, Honolulu, HI 96822 USA	University of Arizona; United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University; Max Planck Society; University of New Mexico; Catholic University of America; University of California System; University of California San Diego; Victoria University Wellington; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hawaii System	Boynton, WV (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Gasnault, Olivier/F-4327-2010	Gasnault, Olivier/0000-0002-6979-9012; Prettyman, Thomas/0000-0003-0072-2831; Reedy, Robert/0000-0002-2189-1303; Mitrofanov, Igor/0000-0001-7204-2101				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; BOYNTON W, UNPUB; BOYNTON WV, 1992, J GEOPHYS RES-PLANET, V97, P7681, DOI 10.1029/92JE00538; BOYNTON WV, 1993, REMOTE GEOCHEMICAL A, pCH17; Carr M.H, 1996, WATER MARS; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FELDMAN WC, 1993, REMOTE GEOCHEMICAL A, pCH10; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; MOORE HJ, 1989, ICARUS, V81, P164, DOI 10.1016/0019-1035(89)90132-2; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; PAIGE DA, 1994, J GEOPHYS RES, V99, P26013; PRETTYMAN TH, 2002, LUNAR PLANET SCI C, V33; SQUYRES SW, 1992, MARS, pCH16; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; WATERS LS, 1999, MCNPX USERS GUIDE	21	710	726	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					81	85		10.1126/science.1073722	http://dx.doi.org/10.1126/science.1073722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040090				2022-12-24	WOS:000176711000036
J	Coolen, MJL; Cypionka, H; Sass, AM; Sass, H; Overmann, J				Coolen, MJL; Cypionka, H; Sass, AM; Sass, H; Overmann, J			Ongoing modification of Mediterranean Pleistocene sapropels mediated by prokaryotes	SCIENCE			English	Article							GRADIENT GEL-ELECTROPHORESIS; GREEN NONSULFUR BACTERIA; PURPLE SULFUR BACTERIA; DEEP-SEA SEDIMENTS; 16S RIBOSOMAL-RNA; ORGANIC-MATTER; HYDROLYTIC POTENTIALS; CONTINENTAL-SLOPE; GENE FRAGMENTS; LAKE	Late Pleistocene organic-rich sediments (sapropels) from the eastern Mediterranean Sea harbor unknown, metabolically active chemoorganotrophic prokaryotes. As compared to the carbon-lean intermediate layers, sapropels exhibit elevated cell numbers, increased activities of hydrolytic exoenzymes, and increased anaerobic glucose degradation rates, suggesting that microbial carbon substrates originate from sapropel layers up to 217,000 years old. 16 S ribosomal RNA gene analyses revealed that as-yet-uncultured green nonsulfur bacteria constitute up to 70% of the total microbial biomass. Crenarchaeota constitute a smaller fraction (on average, 16%). A slow but significant turnover of glucose could be detected. Apparently, sapropels are still altered by the metabolic activity of green nonsulfur bacteria and crenarchaeota.	Carl von Ossietzky Univ Oldenburg, Inst Chem Biol & Marine Environm, Paleomicrobiol Grp, D-26111 Oldenburg, Germany; Royal Netherlands Inst Sea Res, Dept Biogeochem & Toxicol, NL-1797 SZ Den Hoorn, Netherlands; Univ Munich, Inst Genet & Microbiol, D-80638 Munich, Germany	Carl von Ossietzky Universitat Oldenburg; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Munich	Overmann, J (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem Biol & Marine Environm, Paleomicrobiol Grp, POB 2503, D-26111 Oldenburg, Germany.	j.overmann@LRZ.uni-muenchen.de	Sass, Henrik/B-8817-2009; Coolen, Marco J. L./B-8263-2015; Sass, Andrea Michaela/G-6537-2014	Sass, Henrik/0000-0001-8740-4224; Coolen, Marco J. L./0000-0002-0417-920X; Sass, Andrea Michaela/0000-0001-9396-7648; Overmann, Jorg/0000-0003-3909-7201				Aksu AE, 1999, MAR GEOL, V153, P303, DOI 10.1016/S0025-3227(98)00077-2; [Anonymous], 1978, P OCEAN DRILLING PRO, DOI [DOI 10.2973/DSDP.PROC.42-1.113.1978, DOI 10.2973/DSDP.PROC.42-1.113-1]; Bidle KA, 1999, FEMS MICROBIOL LETT, V177, P101, DOI 10.1111/j.1574-6968.1999.tb13719.x; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Boetius A, 1996, MAR ECOL PROG SER, V140, P239, DOI 10.3354/meps140239; Chandler DP, 1998, MICROBIAL ECOL, V36, P37, DOI 10.1007/s002489900091; CHROST RJ, 1991, BROCK SPR S, P29; Coolen MJL, 1998, APPL ENVIRON MICROB, V64, P4513; Coolen MJL, 2000, APPL ENVIRON MICROB, V66, P2589, DOI 10.1128/AEM.66.6.2589-2598.2000; EMEIS KC, COMMUNICATION; Gich F, 2001, ARCH MICROBIOL, V177, P1, DOI 10.1007/s00203-001-0354-6; Hein I, 2001, APPL ENVIRON MICROB, V67, P3122, DOI 10.1128/AEM.67.7.3122-3126.2001; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Norland S., 1993, HDB METHODS AQUATIC, P303, DOI DOI 10.1201/9780203752746-36; Overmann J, 1999, ARCH MICROBIOL, V172, P83, DOI 10.1007/s002030050744; Overmann J, 1996, APPL ENVIRON MICROB, V62, P3251, DOI 10.1128/AEM.62.9.3251-3258.1996; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Petsch ST, 2001, SCIENCE, V292, P1127, DOI 10.1126/science.1058332; POREMBA K, 1995, MAR ECOL PROG SER, V118, P237, DOI 10.3354/meps118237; Ruddy G., 1997, BIOGEOCHEMISTRY INTE, P99; RYAN WBF, 1977, MAR GEOL, V23, P197, DOI 10.1016/0025-3227(77)90089-5; Scholten JCM, 2000, APPL ENVIRON MICROB, V66, P2934, DOI 10.1128/AEM.66.7.2934-2942.2000; Sekiguchi Y, 2001, APPL ENVIRON MICROB, V67, P5740, DOI 10.1128/AEM.67.12.5740-5749.2001; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; TENHAVEN HL, 1987, MAR GEOL, V75, P137, DOI 10.1016/0025-3227(87)90100-9; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; WRIGHT RT, 1966, ECOLOGY, V47, P447, DOI 10.2307/1932984; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777	35	120	131	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2407	2410		10.1126/science.1071893	http://dx.doi.org/10.1126/science.1071893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089447				2022-12-24	WOS:000176467200046
J	Nagel, G; Ollig, D; Fuhrmann, M; Kateriya, S; Mustl, AM; Bamberg, E; Hegemann, P				Nagel, G; Ollig, D; Fuhrmann, M; Kateriya, S; Mustl, AM; Bamberg, E; Hegemann, P			Channelrhodopsin-1: A light-gated proton channel in green algae	SCIENCE			English	Article							VOLTAGE-DEPENDENCE; BACTERIORHODOPSIN; RHODOPSIN; CHLAMYDOMONAS; PHOTORECEPTOR; PHOTOTAXIS; PROTEIN	Phototaxis and photophobic responses of green algae are mediated by rhodopsins with microbial-type chromophores. We report a complementary DNA sequence in the green alga Chlamydomonas reinhardtii that encodes a microbial opsin-related protein, which we term Channelopsin-1. The hydrophobic core region of the protein shows homology to the light-activated proton pump bacteriorhodopsin. Expression of Channelopsin-1, or only the hydrophobic core, in Xenopus laevis oocytes in the presence of all-trans retinal produces a light-gated conductance that shows characteristics of a channel selectively permeable for protons. We suggest that Channelrhodopsins are involved in phototaxis of green algae.	Max Planck Inst Biophys, D-60596 Frankfurt, Germany; Univ Regensburg, Inst Biochem, D-93040 Regensburg, Germany; Univ Calabria, Dipartimento Farmacobiol, I-87036 Arcavacata Di Rende, Italy	Max Planck Society; University of Regensburg; University of Calabria	Nagel, G (corresponding author), Max Planck Inst Biophys, Kennedyallee 70, D-60596 Frankfurt, Germany.	nagel@mpibp-frankfurt.mpg.de	Musti, Anna Maria/M-2520-2019	MUSTI, Anna Maria/0000-0003-1443-2739; Nagel, Georg/0000-0001-8174-8712; Kateriya, Suneel/0000-0001-5428-4297				Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BUTT HJ, 1989, EMBO J, V8, P1657, DOI 10.1002/j.1460-2075.1989.tb03556.x; Ehlenbeck S, 2002, BIOPHYS J, V82, P740, DOI 10.1016/S0006-3495(02)75436-2; FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0; Fuhrmann M, 2001, J CELL SCI, V114, P3857; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2; Holland EM, 1996, BIOPHYS J, V70, P924, DOI 10.1016/S0006-3495(96)79635-2; Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323; Lanyi JK, 2001, CURR OPIN STRUC BIOL, V11, P415, DOI 10.1016/S0959-440X(00)00226-8; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Nagel G, 1995, FEBS LETT, V377, P263, DOI 10.1016/0014-5793(95)01356-3; Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SINESHCHEKOV OA, 1990, BIOPHYS J, V57, P33, DOI 10.1016/S0006-3495(90)82504-2; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; UHL R, 1990, BIOPHYS J, V58, P1295, DOI 10.1016/S0006-3495(90)82469-3	22	727	805	8	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2395	2398		10.1126/science.1072068	http://dx.doi.org/10.1126/science.1072068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089443				2022-12-24	WOS:000176467200042
J	Haffner, SM				Haffner, SM			Glucose-tolerance testing in acute myocardial infarction	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; MORTALITY; TRIAL; RISK		Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Haffner, SM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.							Borch-Johnsen K, 1999, LANCET, V354, P617; FULLER JH, 1980, LANCET, V1, P1373; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.975; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	10	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 22	2002	359	9324					2127	2128		10.1016/S0140-6736(02)09112-2	http://dx.doi.org/10.1016/S0140-6736(02)09112-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566RJ	12090974				2022-12-24	WOS:000176441800003
J	Vulliamy, T; Marrone, A; Dokal, I; Mason, PJ				Vulliamy, T; Marrone, A; Dokal, I; Mason, PJ			Association between aplastic anaemia and mutations in telomerase RNA	LANCET			English	Article								The main cause of aplastic anaemia remains elusive. Germline mutations in the gene encoding the RNA component of telomerase (hTR) have been seen in the autosomal dominant form of dyskeratosis congenita-an Inherited syndrome characterised by aplastic anaemia. By screening the hTR gene, we Identified mutations in two of 17 patients with Idiopathic aplastic anaemia, three of 27 patients with constitutional aplastic anaemia, but In none of 214 normal controls (p<0.0001). Furthermore, patients with hTR mutations had significantly shorter telomeres than age-matched controls (p=0.027). These data indicate that, In a subset of patients with aplastic anaemia, the disorder might be associated with a genetic lesion In the telomere maintenance pathway.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Haematol,Div Invest Sci, London W12 0NN, England	Imperial College London	Dokal, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Haematol,Div Invest Sci, London W12 0NN, England.		Mason, Philip J/B-1087-2008	Dokal, Inderjeet/0000-0003-4462-4782				Ball SE, 1998, BLOOD, V91, P3582; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Young NS., 2000, REV CLIN EXP HEMATOL, V4, P236, DOI [10.1046/j.1468-0734.2000.00017.x, DOI 10.1046/J.1468-0734.2000.00017.X]	5	214	228	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 22	2002	359	9324					2168	2170		10.1016/S0140-6736(02)09087-6	http://dx.doi.org/10.1016/S0140-6736(02)09087-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566RJ	12090986				2022-12-24	WOS:000176441800015
J	Lyle, JM; Bullitt, E; Bienz, K; Kirkegaard, K				Lyle, JM; Bullitt, E; Bienz, K; Kirkegaard, K			Visualization and functional analysis of RNA-dependent RNA polymerase lattices	SCIENCE			English	Article							POLIOVIRUS REPLICATION COMPLEX; ESCHERICHIA-COLI; PROTEIN 3AB; SHEETS; OLIGOMERIZATION; POLYMERIZATION; ORGANIZATION; ASSOCIATION; EXPRESSION; INFECTION	Positive-strand RNA viruses such as poliovirus replicate their genomes on intracellular membranes of their eukaryotic hosts. Electron microscopy has revealed that purified poliovirus RNA-dependent RNA polymerase forms planar and tubular oligomeric arrays. The structural integrity of these arrays correlates with cooperative RNA binding and RNA elongation and is sensitive to mutations that disrupt intermolecular contacts predicted by the polymerase structure. Membranous vesicles isolated from poliovirus-infected cells contain structures consistent with the presence of two-dimensional polymerase arrays on their surfaces during infection. Therefore, host cytoplasmic membranes may function as physical foundations for two-dimensional polymerase arrays, conferring the advantages of surface catalysis to viral RNA replication.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; Univ Basel, Inst Med Microbiol, CH-4003 Basel, Switzerland	Stanford University; Boston University; University of Basel	Kirkegaard, K (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	karlak@leland.stanford.edu		Bullitt, Esther/0000-0003-2447-6209	NIAID NIH HHS [AI-42119] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042119] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beckman MTL, 1998, J BIOL CHEM, V273, P6724, DOI 10.1074/jbc.273.12.6724; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; Bravo A, 1998, EMBO J, V17, P6096, DOI 10.1093/emboj/17.20.6096; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; DIAMOND SE, 1994, J VIROL, V68, P863, DOI 10.1128/JVI.68.2.863-876.1994; DOEDENS J, 1994, ARCH VIROL, P159; Egger D, 1996, J VIROL, V70, P8675, DOI 10.1128/JVI.70.12.8675-8683.1996; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hill AR, 1998, ORIGINS LIFE EVOL B, V28, P235; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; HOBSON SD, 2000, THESIS U COLORADO BU; Hope DA, 1997, J VIROL, V71, P9490, DOI 10.1128/JVI.71.12.9490-9498.1997; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Klymkowsky MW, 1999, NAT CELL BIOL, V1, pE121, DOI 10.1038/12950; LAMA J, 1994, J BIOL CHEM, V269, P66; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lyle JM, 2002, J BIOL CHEM, V277, P16324, DOI 10.1074/jbc.M112429200; LYLE JM, UNPUB; Nelsestuen GL, 1999, CHEM PHYS LIPIDS, V101, P37, DOI 10.1016/S0009-3084(99)00053-5; PATA JD, 1995, RNA, V1, P466; Paul AV, 2000, VIROLOGY, V272, P72, DOI 10.1006/viro.2000.0354; PLOTCH SJ, 1989, J VIROL, V63, P216, DOI 10.1128/JVI.63.1.216-225.1989; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; VANDYKE TA, 1980, J VIROL, V35, P732, DOI 10.1128/JVI.35.3.732-740.1980; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; WINSTON S, 1980, P NATL ACAD SCI-BIOL, V77, P2834, DOI 10.1073/pnas.77.5.2834; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998	37	129	133	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2002	296	5576					2218	2222		10.1126/science.1070585	http://dx.doi.org/10.1126/science.1070585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077417				2022-12-24	WOS:000176379000058
J	Fu, YX; Djupsund, K; Gao, HF; Hayden, B; Shen, K; Dan, Y				Fu, YX; Djupsund, K; Gao, HF; Hayden, B; Shen, K; Dan, Y			Temporal specificity in the cortical plasticity of visual space representation	SCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; LONG-TERM POTENTIATION; CAT STRIATE CORTEX; SYNAPTIC PLASTICITY; RECEPTIVE-FIELDS; DYNAMIC CHANGES; CELLS; CONNECTIVITY; ORIENTATION; DEPRESSION	The circuitry and function of mammalian visual cortex are shaped by patterns of visual stimuli, a plasticity likely mediated by synaptic modifications. In the adult cat, asynchronous visual stimuli in two adjacent retinal regions controlled the relative spike timing of two groups of cortical neurons with high precision. This asynchronous pairing induced rapid modifications of intracortical connections and shifts in receptive fields. These changes depended on the temporal order and interval between visual stimuli in a manner consistent with spike timing-dependent synaptic plasticity. Parallel to the cortical modifications found in the cat, such asynchronous visual stimuli also induced shifts in human spatial perception.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	ydan@uclink4.berkeley.edu	Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281; Dan, Yang/0000-0002-3818-877X				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Bair W, 1999, CURR OPIN NEUROBIOL, V9, P447, DOI 10.1016/S0959-4388(99)80067-1; Boettiger CA, 2001, NEURON, V31, P809, DOI 10.1016/S0896-6273(01)00403-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 1998, J NEUROSCI, V18, P4785; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; DEANGELIS GC, 1995, P NATL ACAD SCI USA, V92, P9682, DOI 10.1073/pnas.92.21.9682; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; Efron Bradley., 1994, INTRO BOOTSTRAP; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; FU YL, UNPUB; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; KAPADIA MK, 1994, J NEUROSCI, V14, P451; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARLIN S, 1993, J NEUROPHYSIOL, V69, P2209, DOI 10.1152/jn.1993.69.6.2209; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RAO RPN, 2000, ADV NEURAL INFORMATI; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	39	114	114	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					1999	2003		10.1126/science.1070521	http://dx.doi.org/10.1126/science.1070521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065829				2022-12-24	WOS:000176273300044
J	Ahn, DG; Kourakis, MJ; Rohde, LA; Silver, LM; Ho, RK				Ahn, DG; Kourakis, MJ; Rohde, LA; Silver, LM; Ho, RK			T-box gene tbx5 is essential for formation of the pectoral limb bud	NATURE			English	Article							HOLT-ORAM-SYNDROME; SONIC-HEDGEHOG; FIN BUD; EXPRESSION; EVOLUTION; IDENTITY; SPECIFICATION; MUTATIONS	The T-box genes Tbx4 and Tbx5 have been shown to have key functions in the specification of the identity of the vertebrate forelimb (Tbx5) and hindlimb (Tbx4)(1,2). Here we show that in zebrafish, Tbx5 has an additional early function that precedes the formation of the limb bud itself. Functional knockdown of zebrafish tbx5 through the use of an antisense oligonucleotide resulted in a failure to initiate fin bud formation, leading to the complete loss of pectoral fins. The function of the tbx5 gene in the development of zebrafish forelimbs seems to involve the directed migration of individual lateral-plate mesodermal cells into the future limb-bud-producing region. The primary defect seen in the tbx5-knockdown phenotype is similar to the primary defects described in known T-box-gene mutants such as the spadetail mutant of zebrafish(3,4) and the Brachyury mutant of the mouse 5, which both similarly exhibit an altered migration of mesodermal cells. A common function for many of the T-box genes might therefore be in mediating the proper migration and/or changes in adhesive properties of early embryonic cells.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Chicago; Princeton University	Ahn, DG (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	dahn@midway.uchicago.edu	Rohde, Luis Augusto P/A-6426-2008	Rohde, Luis Augusto P/0000-0002-4552-4188; Rohde, Laurel/0000-0002-4329-9116				Ahn D, 2000, MECH DEVELOP, V95, P253, DOI 10.1016/S0925-4773(00)00346-4; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Begemann G, 2000, MECH DEVELOP, V90, P299, DOI 10.1016/S0925-4773(99)00246-4; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cohn MJ, 1999, CELL TISSUE RES, V296, P3, DOI 10.1007/s004410051261; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Isaac A, 1998, DEVELOPMENT, V125, P1867; Li QY, 1997, NAT GENET, V15, P21; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Ohuchi H, 1998, DEVELOPMENT, V125, P51; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Ros MA, 1996, DEVELOPMENT, V122, P2319; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Takabatake Y, 2000, MECH DEVELOP, V91, P433, DOI 10.1016/S0925-4773(99)00329-9; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; TICKLE C, 1994, ANNU REV CELL BIOL, V10, P121; WILSON V, 1995, DEVELOPMENT, V121, P877	26	169	173	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					754	758		10.1038/nature00814	http://dx.doi.org/10.1038/nature00814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066188				2022-12-24	WOS:000176154700048
J	Cox, SR				Cox, SR			Everything	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2002	287	22					2913	2914		10.1001/jama.287.22.2913	http://dx.doi.org/10.1001/jama.287.22.2913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561EY	12052101				2022-12-24	WOS:000176128300001
J	Grundmann, H; Tami, A; Hori, S; Halwani, M; Slack, S				Grundmann, H; Tami, A; Hori, S; Halwani, M; Slack, S			Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community	BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol & Infect Dis, Nottingham NG7 2UH, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Nottingham, Nottingham NG7 2RD, England; Nottingham Hlth Author, Nottingham, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham	Grundmann, H (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol & Infect Dis, Nottingham NG7 2UH, England.			Tami, Adriana/0000-0002-1918-9144; HORI, Satoshi/0000-0001-5205-1270				Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Hori S, 2002, J HOSP INFECT, V50, P25, DOI 10.1053/jhin.2001.1130; JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705; *NOTT HLTH AUTH, 1995, AIM HLTH YEAR 2000 A, P3; Public Health Laboratory Service, 1997, COMMUN DIS REP CDR W, V7, P191	5	45	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2002	324	7350					1365	1366		10.1136/bmj.324.7350.1365	http://dx.doi.org/10.1136/bmj.324.7350.1365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052803	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000176234100018
J	van Schayck, CP; Loozen, JMC; Wagena, E; Akkermans, RP; Wesseling, GJ				van Schayck, CP; Loozen, JMC; Wagena, E; Akkermans, RP; Wesseling, GJ			Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FLUTICASONE PROPIONATE; RESPIRATORY SYMPTOMS; CONTROLLED-TRIAL; ASTHMA; SMOKING; POPULATION; PREVALENCE; MODERATE; ADULTS; COPD	Objectives To investigate the effectiveness of case finding of patients at risk of developing chronic obstructive pulmonary disease, whether the method is suitable for use in general practice, how patients should be selected, and the time required. Design Cross sectional study. Setting Two semirural general practices in the Netherlands. Participants 651 smokers aged 35 to 70 years. Main outcome measures Short standardised questionnaire on bronchial symptoms for current smokers, lung function with a spirometer, and the quality of the spirometric curve. Results Of the 201 smokers not taking drugs for a pulmonary condition, 169 produced an acceptable curve (fulfilling American Thoracic Society criteria). Of these, 30 (18%, 95% confidence interval 12% to 24%) had a forced expiratory volume in one second (FEV1) <80% of predicted. When smokers were preselected on the basis of chronic cough, the proportion with an FEV1 < 80% of predicted increased to 27% (17 of 64; 12% to 38%). Chronic cough was a better predictor of airflow obstruction than other symptoms, such as wheeze and dyspnoea. The presence of two symptoms was a slightly better predictor than cough only (odds ratio 3.02 (1.37 to 6.64) v 2.50 (1.14 to 5.52)). Age was also a good predictor of obstruction; smokers over 60 with cough had a 48% chance of having an obstruction. The mean time needed for spirometry was four minutes. Detecting one smoker with an FEV1 < 80% of predicted cost 65 to E10. Conclusions Trained practice assistants could check all patients who smoke for chronic obstructive pulmonary disease at little cost to the practice. Cough and age are the most important predictors of the disease. By testing one smoker a day, an average practice could identify one patient at risk a week.	Univ Maastricht, Res Inst ExTra, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Gen Practice & Family & Social Med, Nijmegen, Netherlands	Maastricht University; Radboud University Nijmegen	van Schayck, CP (corresponding author), Univ Maastricht, Res Inst ExTra, Dept Gen Practice, Postbox 616, NL-6200 MD Maastricht, Netherlands.	Onno.vanschayck@hag.unimaas.nl						[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Anthonisen NR, 1995, JAMA-J AM MED ASSOC, V273, P1497; BARNES PJ, 1992, THORAX, V47, P408, DOI 10.1136/thx.47.6.408; BURDON JGW, 1994, EUR RESPIR J, V7, P1342, DOI 10.1183/09031936.94.07071342; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; CRAPO RO, 1998, TEST REPORT MICRO ME; denOtter JJ, 1997, BRIT J GEN PRACT, V47, P41; DOMPELING E, 1993, ANN INTERN MED, V118, P770, DOI 10.7326/0003-4819-118-10-199305150-00003; *FDN PUBL HLTH SMO, 1996, NIPO SURV SMOK AD; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; GEIJER RMM, 1997, HUISARTS WET, V40, P430; Humerfelt S, 1998, EUR RESPIR J, V11, P284, DOI 10.1183/09031936.98.11020284; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Murray RP, 1998, J CLIN EPIDEMIOL, V51, P1317, DOI 10.1016/S0895-4356(98)00120-6; Paggiaro PL, 1998, LANCET, V351, P773, DOI 10.1016/S0140-6736(97)03471-5; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Renwick DS, 1996, THORAX, V51, P164, DOI 10.1136/thx.51.2.164; Schewe CD, 2000, MARK MANAG, V9, P48; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; Thiadens HA, 1998, BMJ-BRIT MED J, V316, P1286, DOI 10.1136/bmj.316.7140.1286; Thoracic Society of Australia and New Zealand, 1995, MOD MED AUST, V38, P132; Tirimanna PRS, 1996, BRIT J GEN PRACT, V46, P277; van den Boom G, 1998, AM J RESP CRIT CARE, V158, P1730, DOI 10.1164/ajrccm.158.6.9709003; van den Boom G, 1998, EUR RESPIR J, V11, P67, DOI 10.1183/09031936.98.11010067; Van den Boom G, 2001, AM J RESP CRIT CARE, V164, P2057, DOI 10.1164/ajrccm.164.11.2003151; van Schayck CP, 2000, THORAX, V55, P562, DOI 10.1136/thorax.55.7.562; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; XU XP, 1992, AM REV RESPIR DIS, V146, P1345, DOI 10.1164/ajrccm/146.5_Pt_1.1345; Zielinski J, 2001, CHEST, V119, P731, DOI 10.1378/chest.119.3.731	31	168	172	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2002	324	7350					1370	1373		10.1136/bmj.324.7350.1370	http://dx.doi.org/10.1136/bmj.324.7350.1370			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052807	Green Published, Bronze			2022-12-24	WOS:000176234100022
J	Liphardt, J; Dumont, S; Smith, SB; Tinoco, I; Bustamante, C				Liphardt, J; Dumont, S; Smith, SB; Tinoco, I; Bustamante, C			Equilibrium information from nonequilibrium measurements in an experimental test of Jarzynski's equality	SCIENCE			English	Article							FREE-ENERGY DIFFERENCES; FLUCTUATION THEOREM; DRIVEN	Recent advances in statistical mechanical theory can be used to solve a fundamental problem in experimental thermodynamics. In 1997, Jarzynski proved an equality relating the irreversible work to the equilibrium free energy difference, DeltaG. This remarkable theoretical result states that it is possible to obtain equilibrium thermodynamic parameters from processes carried out arbitrarily far from equilibrium. We test Jarzynski's equality by mechanically stretching a single molecule of RNA reversibly and irreversibly between two conformations. Application of this equality to the irreversible work trajectories recovers the DeltaG profile of the stretching process to within k(B)T/2 (half the thermal energy) of its best independent estimate, the mean work of reversible stretching. The implementation and test of Jarzynski's equality provides the first example of its use as a bridge between the statistical mechanics of equilibrium and nonequilibrium systems. This work also extends the thermodynamic analysis of single molecule manipulation data beyond the context of equilibrium experiments.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Liphardt, Jan/A-5906-2012	Liphardt, Jan/0000-0003-2835-5025; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM010840, R37GM032543, R01GM032543, R01GM010840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840-44, GM-10840, R01 GM010840, GM-32543, R01 GM010840-43] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CALLEN HB, 1951, PHYS REV, V83, P34, DOI 10.1103/PhysRev.83.34; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Crooks GE, 2000, PHYS REV E, V61, P2361, DOI 10.1103/PhysRevE.61.2361; Crooks GE, 1998, J STAT PHYS, V90, P1481, DOI 10.1023/A:1023208217925; EVANS DJ, 1993, PHYS REV LETT, V71, P2401, DOI 10.1103/PhysRevLett.71.2401; EVANS DJ, 1994, PHYS REV E, V50, P1645, DOI 10.1103/PhysRevE.50.1645; GALLAVOTTI G, 1995, PHYS REV LETT, V74, P2694, DOI 10.1103/PhysRevLett.74.2694; Hendrix DA, 2001, J CHEM PHYS, V114, P5974, DOI 10.1063/1.1353552; HERMANS J, 1991, J PHYS CHEM-US, V95, P9029, DOI 10.1021/j100176a002; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 2001, P NATL ACAD SCI USA, V98, P3636, DOI 10.1073/pnas.081074598; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Kurchan J, 1998, J PHYS A-MATH GEN, V31, P3719, DOI 10.1088/0305-4470/31/16/003; Lebowitz JL, 1999, J STAT PHYS, V95, P333, DOI 10.1023/A:1004589714161; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Maes C, 1999, J STAT PHYS, V95, P367, DOI 10.1023/A:1004541830999; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; WOOD RH, 1991, J PHYS CHEM-US, V95, P6670, DOI 10.1021/j100170a054; YAMADA T, 1967, PROG THEOR PHYS, V38, P1031, DOI 10.1143/PTP.38.1031	21	915	923	7	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2002	296	5574					1832	1835		10.1126/science.1071152	http://dx.doi.org/10.1126/science.1071152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052949				2022-12-24	WOS:000176054300037
J	Song, XQ; Zhu, CH; Doan, C; Xie, T				Song, XQ; Zhu, CH; Doan, C; Xie, T			Germline, stem cells anchored by adherens junctions in the Drosophila ovary niches	SCIENCE			English	Article							E-CADHERIN; REARRANGEMENT; MECHANISMS; DIVISIONS; ARMADILLO; ENCODES	How stem cells are recruited to and maintained in their niches is crucial to understanding their regulation and use in regenerative medicine. Here, we demonstrate that DE-cadherin-mediated cell adhesion is required for anchoring germline stem cells (GSCs) in their niches in the Drosophila ovary. Two major components of this adhesion process, DE-cadherin and Armadillo/beta-catenin, accumulate at high levels in the junctions between GSCs and cap cells, one of the niche components. Removal of these proteins from GSCs results in stem cell loss. Furthermore, DE-cadherin is required for recruiting GSCs to their niche. Our study demonstrates that anchorage of GSCs in their niche by DE-cadherin-mediated adhesion is important for stem cell maintenance and function.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tgx@stowers-institute.org			NICHD NIH HHS [HD 17608] Funding Source: Medline; NIGMS NIH HHS [R01 GM064428, 1R01 GM64428-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cox DN, 2000, DEVELOPMENT, V127, P503; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lin HF, 1998, CURR OPIN CELL BIOL, V10, P687, DOI 10.1016/S0955-0674(98)80108-7; LIN HF, 1994, DEVELOPMENT, V120, P947; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; SONG X, UNPUB; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T, 2001, COLD SPRING HARBOR M, P129; XU T, 1993, DEVELOPMENT, V117, P1223	26	366	379	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2002	296	5574					1855	1857		10.1126/science.1069871	http://dx.doi.org/10.1126/science.1069871			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052957				2022-12-24	WOS:000176054300045
J	Okuse, K; Malik-Hall, M; Baker, MD; Poon, WYL; Kong, HY; Chao, MV; Wood, JN				Okuse, K; Malik-Hall, M; Baker, MD; Poon, WYL; Kong, HY; Chao, MV; Wood, JN			Annexin II light chain regulates sensory neuron-specific sodium channel expression	NATURE			English	Article							NERVE GROWTH-FACTOR; EPITHELIAL-CELLS; PHOSPHOLIPASE A(2); PAIN PATHWAYS; NITRIC-OXIDE; SNS; CURRENTS; P11; PROTEIN; RAT	The tetrodotoxin-resistant sodium channel Na(V)1.8/SNS is expressed exclusively in sensory neurons and appears to have an important role in pain pathways(1,2). Unlike other sodium channels, Na(V)1.8 is poorly expressed in cell lines even in the presence of accessory beta-subunits(3). Here we identify annexin II light chain(4,5) (p11) as a regulatory factor that facilitates the expression of Na(V)1.8. p11 binds directly to the amino terminus of Na(V)1.8 and promotes the translocation of Na(V)1.8 to the plasma membrane, producing functional channels. The endogenous Na(V)1.8 current in sensory neurons is inhibited by antisense downregulation of p11 expression. Because direct association with p11 is required for functional expression of Na(V)1.8, disrupting this interaction may be a useful new approach to downregulating Na(V)1.8 and effecting analgesia(6).	UCL, Dept Biol, London WC1E 6BT, England; NYU, Sch Med, Dept Cell Biol & Physiol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosci, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA	University of London; University College London; New York University; New York University	Wood, JN (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.	J.Wood@ucl.ac.uk		Chao, Moses/0000-0002-6969-3744				Akiba S, 2000, BRIT J PHARMACOL, V131, P1004, DOI 10.1038/sj.bjp.0703637; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Aley KO, 1998, J NEUROSCI, V18, P7008; Baker MD, 2001, TRENDS PHARMACOL SCI, V22, P27, DOI 10.1016/S0165-6147(00)01585-6; Black JA, 1997, NEUROREPORT, V8, P2331, DOI 10.1097/00001756-199707070-00046; England S, 1998, J PHYSIOL-LONDON, V511P, p124P; FANG X, 2001, SOC NEUR ABSTR; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Fjell J, 1999, J NEUROPHYSIOL, V81, P803, DOI 10.1152/jn.1999.81.2.803; GARBER SS, 1989, J NEUROSCI, V9, P3976; Gold MS, 1999, P NATL ACAD SCI USA, V96, P7645, DOI 10.1073/pnas.96.14.7645; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; Nilius B, 1996, J BIOL CHEM, V271, P30631, DOI 10.1074/jbc.271.48.30631; Okuse K, 1997, MOL CELL NEUROSCI, V10, P196, DOI 10.1006/mcne.1997.0657; OSBORN M, 1988, EXP CELL RES, V175, P81, DOI 10.1016/0014-4827(88)90257-1; Pawliczak R, 2001, J BIOL CHEM, V276, P44613, DOI 10.1074/jbc.M104993200; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Waxman SG, 1999, MUSCLE NERVE, V22, P1177, DOI 10.1002/(SICI)1097-4598(199909)22:9<1177::AID-MUS3>3.3.CO;2-G; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202	27	207	216	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					653	656		10.1038/nature00781	http://dx.doi.org/10.1038/nature00781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050667				2022-12-24	WOS:000176001200049
J	Dickersin, K; Olson, CM; Rennie, D; Cook, D; Flanagin, A; Zhu, Q; Reiling, J; Pace, B				Dickersin, K; Olson, CM; Rennie, D; Cook, D; Flanagin, A; Zhu, Q; Reiling, J; Pace, B			Association between time interval to publication and statistical significance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				BIAS	Context Studies have shown that reports from clinical trials with statistically significant results tend to be submitted and published more rapidly than reports from studies with null or nonsignficant findings. Methods We wanted to determine whether manuscripts reporting positive results from controlled clinical trials are published more quickly than those reporting negative results. We tracked manuscripts from submission to JAMA until the publication decision. We classified results as positive if a statistically significant difference was reported for the primary outcome. Manuscripts were further classified according to indicators of methodologic quality and other study characteristics. We included manuscripts if they were submitted from February 1996 through August 1999, reported results of a prospective study in which participants were assigned to a treatment or comparison group, used statistical tests to compare differences between groups, and were accepted for publication. Results One hundred thirty-three manuscripts met our inclusion criteria, 78 (59%) reported positive results, 51 (38%) reported negative results. We were unable to classify the direction of results for 4 articles (3%). The time interval between submission and publication was not associated with positive results: median time between submission and publication was 7.8 months for reports with positive vs 7.6 months for reports with negative results (P=.44). Time to publication also was not associated with any marker of study quality or study characteristic. Conclusions Among 133 published controlled trials, time to publication was not associated with statistical significance, methodologic quality, or other study characteristics.	Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, Dept Community Hlth, Providence, RI 02912 USA; JAMA, Chicago, IL USA; Univ Washington, Dept Med, Div Emergency Med, Seattle, WA USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Brown University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; McMaster University; McMaster University	Dickersin, K (corresponding author), Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, Dept Community Hlth, 169 Angell St,Box G-S2, Providence, RI 02912 USA.		Dickersin, Kay/A-4576-2008					Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640	5	42	42	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2829	2831		10.1001/jama.287.21.2829	http://dx.doi.org/10.1001/jama.287.21.2829			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559AP	12038925	Bronze			2022-12-24	WOS:000176002200022
J	Camfield, CS; Camfield, PR; Veugelers, PJ				Camfield, CS; Camfield, PR; Veugelers, PJ			Death in children with epilepsy: a population-based study	LANCET			English	Article							LONG-TERM PROGNOSIS; SUDDEN UNEXPECTED DEATH; CHILDHOOD EPILEPSY; NOVA-SCOTIA; MORTALITY; SURVIVAL	Background Families of children with newly diagnosed epilepsy worry about death during a seizure. We aimed to assess the frequency and causes of death of children with epilepsy. Method We did a population-based cohort study. The Nova Scotia epilepsy cohort includes all children who developed epilepsy during 1977-85. In 1999, we matched names and birth dates with provincial health-care, death, and marriage registries. We examined death certificates, necropsy reports, and physician records of children who had died and contacted families if sudden unexpected death in epilepsy could have occurred. We measured the effect of sex, age, epilepsy type, and disorder sufficient to cause functional neurological deficit on death rate. We compared cohort mortality with rates in a reference population matched for age and sex. Findings 26 (3.8%) of 692 children with epilepsy died. Frequency of death was 5.3 times higher (95% Cl 2.29-8-32) than in the reference population in the 1980s and 8.8 times higher (4.16-13.43) in the 1990s. Kaplan-Meier curves showed 6.1% mortality 20 years after onset compared with 0.88% in the reference population, Deaths occurred in one (1%) of 97 children with absence epilepsy, 12 (2%) of 510 with partial and primary generalised epilepsy, and 13 (15%) of 85 with secondary generalised epilepsy. 22 deaths were caused by disorders sufficient to cause functional neurological deficit, one by probable sudden unexpected death in epilepsy, two by suicide, and one by homicide. Functional neurological deficit was the only independent determinant of mortality. Interpretation Death from epilepsy is uncommon in children without a severe neurological disorder sufficient to cause functional neurological deficit and sudden unexpected death in epilepsy is rare.	Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Camfield, CS (corresponding author), IWK Hlth Ctr, Div Child Neurol, Halifax, NS B3J 3G9, Canada.	Camfield@is.dal.ca		Veugelers, Paul/0000-0001-8996-0822				[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BAUMER JH, 1981, DEV MED CHILD NEUROL, V23, P462; BRORSON LO, 1987, EPILEPSIA, V28, P324, DOI 10.1111/j.1528-1157.1987.tb03651.x; CAMFIELD C, 1993, J PEDIATR-US, V122, P861, DOI 10.1016/S0022-3476(09)90008-7; Camfield CS, 1996, EPILEPSIA, V37, P19, DOI 10.1111/j.1528-1157.1996.tb00506.x; Camfield PR, 1996, EPILEPSIA, V37, pS60, DOI 10.1111/j.1528-1157.1996.tb06023.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; HARVEY AS, 1993, EPILEPSIA, V34, P597, DOI 10.1111/j.1528-1157.1993.tb00434.x; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; Hauser WA, 1997, EPILEPSIA, V38, pS26, DOI 10.1111/j.1528-1157.1997.tb06120.x; HAUSER WA, 1990, EPILEPSY FREQUENCY C, P297; Kurtz Z, 1998, BMJ-BRIT MED J, V316, P339, DOI 10.1136/bmj.316.7128.339; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; SILLANPAA M, 1995, ARCH NEUROL-CHICAGO, V52, P589, DOI 10.1001/archneur.1995.00540300063014; Strauss D, 1997, J PEDIATR-US, V131, P712, DOI 10.1016/S0022-3476(97)70098-2; Wirrell EC, 1996, NEUROLOGY, V47, P912, DOI 10.1212/WNL.47.4.912	17	138	141	2	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2002	359	9321					1891	1895		10.1016/S0140-6736(02)08779-2	http://dx.doi.org/10.1016/S0140-6736(02)08779-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057550				2022-12-24	WOS:000175975700007
J	Horton, R				Horton, R			Nurse-prescribing in the UK: right but also wrong	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Buchan J, 2002, BMJ-BRIT MED J, V324, P751, DOI 10.1136/bmj.324.7340.751; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; Jones AC, 2002, RHEUMATOLOGY, V41, P14, DOI 10.1093/rheumatology/41.1.14; Leathard HL, 2001, NURS EDUC TODAY, V21, P266, DOI 10.1054/nedt.2001.0553; McCann T V, 2002, J Psychiatr Ment Health Nurs, V9, P175, DOI 10.1046/j.1365-2850.2002.00454.x; Moher M, 2001, BMJ-BRIT MED J, V322, P1338, DOI 10.1136/bmj.322.7298.1338; Nolan P, 2001, J ADV NURS, V36, P527, DOI 10.1046/j.1365-2648.2001.02005.x; Shell R C, 2001, Nurse Pract, V26, P42; 2002, NURSE PRESCRIBING RO; 2002, BMA NEWS        0309, P3	10	27	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2002	359	9321					1875	1876		10.1016/S0140-6736(02)08786-X	http://dx.doi.org/10.1016/S0140-6736(02)08786-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057548				2022-12-24	WOS:000175975700005
J	Qasim, A; Malpass, K; O'Gorman, DJ; Heber, ME				Qasim, A; Malpass, K; O'Gorman, DJ; Heber, ME			Quality improvement report - Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DELAY	Problem Delay in starting thrombolytic treatment in patients arriving at hospital with chest pain who are diagnosed as having acute myocardial infarction. Design Audit of "door to needle times" for patients presenting with chest pain and an electrocardiogram on admission that confirmed acute myocardial infarction. A one year period in each of three phases of development was studied. Background and setting The goal of the national service framework for coronary heart disease is that by April 2002, 75% of eligible patients should receive thrombolysis within 30 minutes of arriving at hospital. A district general hospital introduced a strategy to improve door to needle times. In phase 1 (1989-95), patients with suspected acute myocardial infarction, referred by general practitioners, were assessed in the coronary care unit; all other patients were seen first in the accident and emergency department. In phase 2 (1995-7), all patients with suspected acute myocardial infarction were transferred directly to a fast track area within the coronary care unit, where nurses assess patients and doctors started treatment. Key measures for improvement Median door to needle time in phase 1 of 45 minutes (range 5-300 minutes), with 38% of patients treated within 30 minutes. Median door to needle time in phase 2 of 40 minutes (range 5-180 minutes), with 47% treated within 30 minutes. Strategies for change In phase 3 (1997-2001), all patients with suspected acute myocardial infarction were transferred directly to the fast truck area and assessed by a "coronary care thrombolysis nurse," If electrocardiography confirmed the diagnosis of acute myocardial infarction, the nurse could initiate thrombolytic therapy (subject to guidelines and exclusions determined by the consultant cardiologists). Effects of change Median door to needle time in phase 3 of 15 minutes (range 5-70 minutes), with 80% of patients treated within 30 minutes. Systematic clinical review showed no cases in which a nurse initiated inappropriate thrombolysis. Lessons learnt Thrombolysis started by nurses is safe and effective in patients with acute myocardial infarction. It may provide a way by which tire national service framework's targets for door to needle times can be achieved.	Princess Royal Hosp, Dept Cardiol, Coronary Care Unit, Telford TF6 6TF, Shrops, England		Qasim, A (corresponding author), Princess Royal Hosp, Dept Cardiol, Coronary Care Unit, Apley Castle, Telford TF6 6TF, Shrops, England.	dr@asifqasim.freeserve.co.uk		Qasim, Asif/0000-0003-2394-5819				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BIRKHEAD JS, 1992, BMJ-BRIT MED J, V305, P445, DOI 10.1136/bmj.305.6851.445; *DEP HLTH, 2000, NAT SERV FRAM COR HE; FOSTER DB, 1994, AM J EMERG MED, V12, P25, DOI 10.1016/0735-6757(94)90192-9; GATENBY R, 1992, BMJ-BRIT MED J, V305, P548; PELL ACH, 1992, BMJ-BRIT MED J, V304, P83, DOI 10.1136/bmj.304.6819.83; Quinn T, 1998, Intensive Crit Care Nurs, V14, P219, DOI 10.1016/S0964-3397(98)80614-9; Somauroo JD, 1999, J ROY COLL PHYS LOND, V33, P46; WESTON C, 1991, J ROY COLL PHYS LOND, V25, P312; WESTON CFM, 1994, BMJ-BRIT MED J, V308, P767, DOI 10.1136/bmj.308.6931.767	12	22	22	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1328	1331		10.1136/bmj.324.7349.1328	http://dx.doi.org/10.1136/bmj.324.7349.1328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039831	Green Published			2022-12-24	WOS:000176041500024
J	Ahmad, SM; Baker, BS				Ahmad, SM; Baker, BS			Sex-specific deployment of FGF signaling in Drosophila recruits mesodermal cells into the male genital imaginal disc	CELL			English	Article							FIBROBLAST GROWTH-FACTOR; DOUBLESEX PROTEINS; COMPARTMENTAL ORGANIZATION; RECEPTOR HOMOLOG; GENE-EXPRESSION; GLIAL-CELLS; MELANOGASTER; MIGRATION; WINGLESS; TRACHEAL	A central issue in developmental biology is how the deployment of generic signaling proteins produces diverse specific outcomes, We show that Drosophila FGF is used, only in males, to recruit mesodermal cells expressing its receptor to become part of the genital imaginal disc. Male-specific deployment of FGF signaling is controlled by the sex determination regulatory gene doublesex. The recruited mesodermal cells become epithelial and differentiate into parts of the internal genitalia. Our results provide exceptions to two basic tenets of imaginal disc biology-that imaginal disc cells are derived from the embryonic ectoderm and belong to either an anterior or posterior compartment. The recruited mesodermal cells migrate into the disc late in development and are neither anterior nor posterior.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			Ahmad, Shaad/0000-0001-5373-1710				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Bate Michael, 1993, P1013; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; BELOTE JM, 1985, CELL, V40, P339, DOI 10.1016/0092-8674(85)90148-5; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; Burtis K.C., 1992, SEMIN DEV BIOL, V3, P331; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Casares F, 1997, DEV GENES EVOL, V207, P216, DOI 10.1007/s004270050110; CHAPMAN KB, 1988, DEV BIOL, V126, P195, DOI 10.1016/0012-1606(88)90253-9; Chen EH, 1997, DEVELOPMENT, V124, P205; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cohen Stephen M., 1993, P747; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; DIBENEDETTO AJ, 1987, DEV BIOL, V119, P242, DOI 10.1016/0012-1606(87)90225-9; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; Emerald BS, 1998, DEV GENES EVOL, V208, P504, DOI 10.1007/s004270050209; EPPER F, 1981, DEV BIOL, V88, P104, DOI 10.1016/0012-1606(81)90222-0; EPPER F, 1980, THESIS U ZURICH SWIT; Erdman SE, 1996, GENETICS, V144, P1639; FEHON RG, 1994, DEVELOPMENT, V120, P545; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Freeland DE, 1996, MECH DEVELOP, V56, P61, DOI 10.1016/0925-4773(96)00511-4; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; HAYASHI S, 1993, DEVELOPMENT, V118, P105; HILDRETH PE, 1965, GENETICS, V51, P659; Ito K, 1997, DEVELOPMENT, V124, P761; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Keisman EL, 2001, DEV CELL, V1, P215, DOI 10.1016/S1534-5807(01)00027-2; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; Kozopas KM, 1998, GENE DEV, V12, P1155, DOI 10.1101/gad.12.8.1155; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Michelson AM, 1998, DEVELOPMENT, V125, P4379; NOTHIGER R, 1977, ROUX ARCH DEV BIOL, V181, P367, DOI 10.1007/BF00848062; PERANTONI AO, 1995, P NATL ACAD SCI USA, V92, P4696, DOI 10.1073/pnas.92.10.4696; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sanchez L, 1997, DEV GENES EVOL, V207, P229, DOI 10.1007/s004270050111; Sanchez L, 2001, BIOESSAYS, V23, P698, DOI 10.1002/bies.1099; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1621; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Spradling AC, 1999, GENETICS, V153, P135; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; XU T, 1993, DEVELOPMENT, V117, P1223	58	76	77	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 31	2002	109	5					651	661		10.1016/S0092-8674(02)00744-4	http://dx.doi.org/10.1016/S0092-8674(02)00744-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062107	Bronze			2022-12-24	WOS:000175957900013
J	Day, JJ; Upchurch, P; Norman, DB; Gale, AS; Powell, HP				Day, JJ; Upchurch, P; Norman, DB; Gale, AS; Powell, HP			Sauropod trackways, evolution, and behavior	SCIENCE			English	Article							DINOSAURS		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Greenwich, Sch Earth & Environm Sci, Greenwich HE4 4TB, Kent, England; Univ Oxford, Museum Hist Nat, Oxford OX1 3PW, England	University of Cambridge; University of Greenwich; University of Oxford	Day, JJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.		Upchurch, Paul/C-1654-2008	Day, Julia/0000-0002-6765-7782				Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; HARLAND WB, 1992, GEOLOGIC TIME SCALE; Ishigaki S., 1989, P83; SANTOS VF, 1994, GAIA, V10, P5; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543	8	73	76	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1659	1659		10.1126/science.1070167	http://dx.doi.org/10.1126/science.1070167			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040187	Green Submitted			2022-12-24	WOS:000175976200050
J	Nadeau, JA; Sack, FD				Nadeau, JA; Sack, FD			Control of stomatal distribution on the Arabidopsis leaf surface	SCIENCE			English	Article							RECEPTOR-LIKE KINASE; RICH REPEAT PROTEINS; GENE ENCODES; 4 LIPS; RESISTANCE; MOUTHS; TOO; ORGAN	Stomata regulate gas exchange and are distributed across the leaf epidermis with characteristic spacing. Arabidopsis stomata are produced by asymmetric cell divisions. Mutations in the gene TOO MANY MOUTHS (TMM) disrupt patterning by randomizing the plane of formative asymmetric divisions and by permitting ectopic divisions. TMM encodes a leucine-rich repeat-containing receptor-like protein expressed in proliferative postprotodermal cells. TMM appears to function in a position-dependent signaling pathway that controls the plane of patterning divisions as well as the balance between stem cell renewal and differentiation in stomatal and epidermal development.	Ohio State Univ, Dept Plant Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sack, FD (corresponding author), Ohio State Univ, Dept Plant Biol, 1735 Neil Ave, Columbus, OH 43210 USA.							Berger D, 2000, GENE DEV, V14, P1119; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; GEISLER MJ, UNPUB; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jinn TL, 2000, GENE DEV, V14, P108; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Nadeau JA, 2002, THE ARABIDOPSIS BOOK; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Wang GL, 1996, MOL PLANT MICROBE IN, V9, P850, DOI 10.1094/MPMI-9-0850; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	20	377	409	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1697	1700		10.1126/science.1069596	http://dx.doi.org/10.1126/science.1069596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040198				2022-12-24	WOS:000175976200062
J	Brand, A; Behrend, O; Marquardt, T; McAlpine, D; Grothe, B				Brand, A; Behrend, O; Marquardt, T; McAlpine, D; Grothe, B			Precise inhibition is essential for microsecond interaural time difference coding	NATURE			English	Article							MEDIAL SUPERIOR OLIVE; AUDITORY-NERVE FIBERS; COCHLEAR NUCLEUS; TRAPEZOID BODY; SOUND LOCALIZATION; DELAY-LINES; NEURONS; PROJECTIONS; CELLS; SENSITIVITY	Microsecond differences in the arrival time of a sound at the two ears (interaural time differences, ITDs) are the main cue for localizing low-frequency sounds in space. Traditionally, ITDs are thought to be encoded by an array of coincidence-detector neurons, receiving excitatory inputs from the two ears via axons of variable length ('delay lines'), to create a topographic map of azimuthal auditory space(1,2). Compelling evidence for the existence of such a map in the mammalian ITD detector, the medial superior olive (MSO), however, is lacking. Equally puzzling is the role of a-temporally very precise(3)-glycine-mediated inhibitory input to MSO neurons. Using in vivo recordings from the MSO of the Mongolian gerbil, we found the responses of ITD-sensitive neurons to be inconsistent with the idea of a topographic map of auditory space. Moreover, local application of glycine and its antagonist strychnine by iontophoresis (through glass pipette electrodes, by means of an electric current) revealed that precisely timed glycine-controlled inhibition is a critical part of the mechanism by which the physiologically relevant range of ITDs is encoded in the MSO. A computer model, simulating the response of a coincidence-detector neuron with bilateral excitatory inputs and a temporally precise contralateral inhibitory input, supports this conclusion.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; UCL, Dept Physiol, London WC1E 6BT, England	Max Planck Society; University of London; University College London	Grothe, B (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.	bgrothe@neuro.mpg.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615; McAlpine, David/0000-0001-5467-6725				Brand A, 2000, J NEUROPHYSIOL, V84, P1790, DOI 10.1152/jn.2000.84.4.1790; Brughera AR, 1996, AUDIT NEUROSCI, V2, P219; CANT NB, 1992, HEARING RES, V58, P26, DOI 10.1016/0378-5955(92)90005-8; CARNEY LH, 1993, J ACOUST SOC AM, V93, P401, DOI 10.1121/1.405620; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; GROTHE B, 1993, J NEUROPHYSIOL, V69, P1192, DOI 10.1152/jn.1993.69.4.1192; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; Grothe B, 1998, J NEUROSCI, V18, P6608; Grothe B, 1997, J NEUROPHYSIOL, V77, P1553, DOI 10.1152/jn.1997.77.3.1553; GROTHE B, 1994, J NEUROPHYSIOL, V71, P706, DOI 10.1152/jn.1994.71.2.706; HAVEY DC, 1980, ELECTROEN CLIN NEURO, V48, P249, DOI 10.1016/0013-4694(80)90313-2; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Klumpp R, 1956, J ACOUST SOC AM, V28, P215; KUWABARA N, 1992, J COMP NEUROL, V324, P522, DOI 10.1002/cne.903240406; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; OVERHOLT EM, 1992, J NEUROSCI, V12, P1698; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; SPITZER MW, 1995, J NEUROPHYSIOL, V73, P1668, DOI 10.1152/jn.1995.73.4.1668; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Willott JF, 1997, J COMP NEUROL, V385, P405; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1020, DOI 10.1152/jn.1983.50.4.1020	30	424	430	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					543	547		10.1038/417543a	http://dx.doi.org/10.1038/417543a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037566				2022-12-24	WOS:000175860300041
J	GrandPre, T; Li, SX; Strittmatter, SM				GrandPre, T; Li, SX; Strittmatter, SM			Nogo-66 receptor antagonist peptide promotes axonal regeneration	NATURE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE GROWTH-INHIBITORS; FUNCTIONAL RECOVERY; IDENTIFICATION; PLASTICITY; OUTGROWTH; INJURY; SITES; RATS	Myelin-derived axon outgrowth inhibitors, such as Nogo, may account for the lack of axonal regeneration in the central nervous system (CNS) after trauma in adult mammals. A 66-residue domain of Nogo (Nogo-66) is expressed on the surface of oligodendrocytes(1) and can inhibit axonal outgrowth through an axonal Nogo-66 receptor (NgR)(2). The IN-1 monoclonal antibody recognizes Nogo-A and promotes corticospinal tract regeneration and locomotor recovery(3-5); however, the undefined nature of the IN-1 epitope in Nogo, the limited specificity of IN-1 for Nogo, and nonspecific anti-myelin effects have prevented a firm conclusion about the role of Nogo-66 or NgR. Here, we identify competitive antagonists of NgR derived from amino-terminal peptide fragments of Nogo-66. The Nogo-66(1-40) antagonist peptide (NEP1-40) blocks Nogo-66 or CNS myelin inhibition of axonal outgrowth in vitro, demonstrating that NgR mediates a significant portion of axonal outgrowth inhibition by myelin. Intrathecal administration of NEP1-40 to rats with mid-thoracic spinal cord hemisection results in significant axon growth of the corticospinal tract, and improves functional recovery. Thus, Nogo-66 and NgR have central roles in limiting axonal regeneration after CNS injury, and NEP1-40 provides a potential therapeutic agent.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, POB 208018, New Haven, CT 06520 USA.		Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Takahashi T, 1997, J NEUROSCI, V17, P9183; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	14	579	678	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					547	551		10.1038/417547a	http://dx.doi.org/10.1038/417547a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037567				2022-12-24	WOS:000175860300042
J	Dziak, RP; Johnson, HP				Dziak, RP; Johnson, HP			Hydrothermal systems - Stirring the oceanic incubator	SCIENCE			English	Editorial Material							EAST PACIFIC RISE; MIDOCEAN RIDGE; WATER-LEVEL; EARTHQUAKE; SEISMICITY; CALIFORNIA		Oregon State Univ, NOAA, Newport, OR 97365 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; University of Washington; University of Washington Seattle	Dziak, RP (corresponding author), Oregon State Univ, NOAA, Newport, OR 97365 USA.		Dziak, Robert/AAC-6107-2020					Brodsky EE, 2000, GEOPHYS RES LETT, V27, P2741, DOI 10.1029/2000GL011534; BRODSKY EE, 2001, EOS S, V82, pF830; Davis EE, 2001, J GEOPHYS RES-SOL EA, V106, P21953, DOI 10.1029/2000JB000040; DZIAK RP, 2001, EOS S, V82, pF832; Fisher AT, 2000, NATURE, V403, P71, DOI 10.1038/47463; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Hooft EEE, 1996, EARTH PLANET SC LETT, V142, P289, DOI 10.1016/0012-821X(96)00101-X; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Johnson H.P., 2001, EOS T AM GEOPHYS UN, V82, P233; Johnson HP, 2000, NATURE, V407, P174, DOI 10.1038/35025040; MATSUMOTO N, 1992, GEOPHYS RES LETT, V19, P1193, DOI 10.1029/92GL01042; *NOAA, 2466 NOAA; Roeloffs E, 1996, ADV GEOPHYS, V37, P135, DOI 10.1016/S0065-2687(08)60270-8; Roeloffs EA, 1998, J GEOPHYS RES-SOL EA, V103, P869, DOI 10.1029/97JB02335; Sohn RA, 1998, NATURE, V396, P159, DOI 10.1038/24146; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; [No title captured]	17	14	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1406	1407		10.1126/science.1072075	http://dx.doi.org/10.1126/science.1072075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029115				2022-12-24	WOS:000175910300027
J	Veldink, JH; Wokke, JHJ; van der Wal, G; de Jong, JMBV; van den Berg, LH				Veldink, JH; Wokke, JHJ; van der Wal, G; de Jong, JMBV; van den Berg, LH			Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the netherlands.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-LIFE DECISIONS; MEDICAL-PRACTICE; END; CARE; ALS; EXPERIENCES; POPULATION; NEUROLOGY; ATTITUDES; OUTCOMES	Background: Amyotrophic lateral sclerosis (ALS) is a disease that causes progressive paralysis leading to respiratory failure. Patients with ALS may consider physician-assisted suicide. However, it is not known how many patients, if given the option, would actually decide to end their lives by physician-assisted suicide or euthanasia nor at what stage of the disease they would choose to do so. Methods: We identified physicians of 279 patients in the Netherlands with a diagnosis of ALS who died between 1994 and 1999. Physicians were asked to fill out a validated questionnaire about the end-of-life decisions that were made. Of 241 eligible physicians, 203 returned the questionnaire (84 percent). Results: Of the 203 patients, 35 (17 percent) chose euthanasia and died that way. An additional six patients (3 percent) died as a result of physician-assisted suicide. Patients to whom religion was important were less likely to have died as a result of euthanasia or physician-assisted suicide. The choice of euthanasia or physician-assisted suicide was not associated with any particular characteristics of the disease or of the patient's care, nor was it associated with income or educational level. Disability before death was significantly more severe in patients who died as a result of euthanasia than among those who died in other ways. Physician-assisted suicide appeared to occur somewhat earlier in the course of the disease than did euthanasia. An additional 48 patients (24 percent) received palliative treatment, which probably shortened their lives. Conclusions: In the Netherlands, we found that one in five patients with ALS died as a result of euthanasia or physician-assisted suicide. (N Engl J Med 2002;346:1638-44.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Med Ctr Utrecht, Dept Neurol, NL-3508 GA Utrecht, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Social Med, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Berg, LH (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, G-03-228,POB 85500, NL-3508 GA Utrecht, Netherlands.			Veldink, Jan/0000-0001-5572-9657				Albert SM, 1999, J NEUROL SCI, V169, P108, DOI 10.1016/S0022-510X(99)00227-0; Bannink M, 2000, LANCET, V356, P2067, DOI 10.1016/S0140-6736(00)03407-3; Bindels PJE, 1996, LANCET, V347, P499, DOI 10.1016/S0140-6736(96)91138-1; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Carver AC, 1999, NEUROLOGY, V53, P284, DOI 10.1212/WNL.53.2.284; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hendin H, 1997, JAMA-J AM MED ASSOC, V277, P1720, DOI 10.1001/jama.277.21.1720; Horikx A, 2000, Ned Tijdschr Geneeskd, V144, P2497; Jochemsen H, 1999, J MED ETHICS, V25, P16, DOI 10.1136/jme.25.1.16; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; Lacomblez L, 1996, NEUROLOGY, V47, pS242, DOI 10.1212/WNL.47.6_Suppl_4.242S; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Murphy PL, 2000, NEUROLOGY, V55, P1581, DOI 10.1212/WNL.55.10.1581; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; Voltz R, 1997, J NEUROL, V244, pS2, DOI 10.1007/PL00007721	22	93	93	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1638	1644		10.1056/NEJMsa012739	http://dx.doi.org/10.1056/NEJMsa012739			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023997				2022-12-24	WOS:000175728600007
J	Zindrou, D; Taylor, KM; Bagger, JP				Zindrou, D; Taylor, KM; Bagger, JP			Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery	LANCET			English	Article								We did an observational study in 2059 patients undergoing coronary artery bypass surgery to assess the effect of haemoglobin concentration on in-hospital mortality. We noted that Individuals with a preoperative haemoglobin concentration of 100 g/L or less had a five-fold higher In-hospital mortality rate after surgery than those with a higher haemoglobin concentration, despite having had blood transfusions or the pump primed with blood preoperatively as a routine precaution. Our findings suggest that a low haemoglobin concentration Is a marker of disease severity or comorbidity that has a major effect on survival rate.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Cardiothorac Directorate, London W12 0NN, England	Imperial College London	Zindrou, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Cardiothorac Directorate, London W12 0NN, England.							BEUTLER E, 1995, WILLIAMS HEMATOLOGY, P1622; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; HAGL S, 1977, BASIC RES CARDIOL, V72, P344, DOI 10.1007/BF02023594; MEHTA AB, 1999, POSTGRADUATE HAEMATO, P675	5	114	120	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 18	2002	359	9319					1747	1748		10.1016/S0140-6736(02)08614-2	http://dx.doi.org/10.1016/S0140-6736(02)08614-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554MV	12049866				2022-12-24	WOS:000175740500014
J	Attrill, MJ; Power, M				Attrill, MJ; Power, M			Climatic influence on a marine fish assemblage	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; TEMPORAL ABUNDANCE; GROWTH; VARIABILITY; ESTUARINE; SEA	Understanding the fluctuations in marine fish stocks is important for the management of fisheries, and attempts have been made to demonstrate links with oceanographic and climatic variability(1-3), including the North Atlantic Oscillation (NAO)(4,5). The NAO has been correlated with a range of long-term ecological measures(6,7), including certain fish stocks(8,9). Such environmental influences are most likely to affect susceptible juveniles(10) during estuarine residency, as estuaries are critical juvenile nursery or over-wintering habitats(11). Here we show that, during a 16-year period, climatic forcing (by means of the NAO) is consistently the most important parameter explaining variation in assemblage composition, abundance and growth of juvenile marine fish during estuarine residency. A possible mechanism for the effect of the NAO is a temperature differential between estuarine and marine waters that allows fish to facultatively exploit optimal thermal habitats. The connection has potentially important implications for the size and numbers of individuals recruited to the fishery, for understanding and predicting the composition of juvenile fish stocks using estuaries, and for the appropriate conservation of estuarine systems in relation to fish stocks.	Univ Plymouth, Dept Biol Sci, Plymouth PL4 8AA, Devon, England; Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Plymouth; University of Waterloo	Attrill, MJ (corresponding author), Univ Plymouth, Dept Biol Sci, Drake Circus, Plymouth PL4 8AA, Devon, England.	mattrill@plymouth.ac.uk		Attrill, Martin/0000-0002-4039-031X				Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Attrill MJ, 2000, MAR ECOL PROG SER, V203, P133, DOI 10.3354/meps203133; Bettoso N, 1999, J MAR BIOL ASSOC UK, V79, P1145, DOI 10.1017/S0025315499001496; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BLAXTER JHS, 1982, ADV MAR BIOL, V20, P3; BRANDER KM, 1995, ICES J MAR SCI, V52, P1, DOI 10.1016/1054-3139(95)80010-7; Corten A, 1996, ICES J MAR SCI, V53, P1113, DOI 10.1006/jmsc.1996.0137; DIPPNER J. W., 1997, DTSCH HYDROGR Z, V49, P277; DRINKWATER KF, 1987, CAN J FISH AQUAT SCI, V44, P1568, DOI 10.1139/f87-189; ELLIOTT M, 1989, P 21 EUR MAR BIOL S; Haddon M., 2011, MODELLING QUANTITATI; HILBORN R, 1992; HOVGARD H, 1992, LARGE MARINE ECOSYST, P36; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Kroncke I, 1998, MAR ECOL PROG SER, V167, P25, DOI 10.3354/meps167025; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; POTTER IC, 1988, J MAR BIOL ASSOC UK, V68, P295, DOI 10.1017/S0025315400052206; Power M, 2000, J FISH BIOL, V56, P1408; Reid PC, 1998, FISH OCEANOGR, V7, P282, DOI 10.1046/j.1365-2419.1998.00073.x; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; ROGERS JC, 1984, MON WEATHER REV, V112, P1999, DOI 10.1175/1520-0493(1984)112<1999:TABTNA>2.0.CO;2; Thomas M, 1998, REHABILITATED ESTUARINE ECOSYSTEMS, P115; Wheeler A.C., 1969, FISHES BRIT ISLES N; Wootton R.J., 1990, ECOLOGY TELEOST FISH	27	236	242	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					275	278		10.1038/417275a	http://dx.doi.org/10.1038/417275a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015600				2022-12-24	WOS:000175592100044
J	Geng, E; Kreiswirth, B; Driver, C; Li, JH; Burzynski, J; DellaLatta, P; LaPaz, A; Schluger, NW				Geng, E; Kreiswirth, B; Driver, C; Li, JH; Burzynski, J; DellaLatta, P; LaPaz, A; Schluger, NW			Changes in the transmission of tuberculosis in New York City from 1990 to 1999.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; SAN-FRANCISCO; COMPLEX STRAINS; EPIDEMIOLOGY; IS6110; STATES	Background: Over the past decade, there has been a reduction in the incidence of tuberculosis in New York City and in the United States. However, the reduction has been confined mainly to U.S.-born persons. Understanding the reasons for the lack of reduction among non-U.S>born persons may lead to new strategies for tuberculosis control. Methods: We performed DNA fingerprinting with the IS6110 insertion sequence of the organisms isolated from patients with culture-positive tuberculosis in northern Manhattan from 1990 to 1999. The goal was to identify the strains responsible for multiple infections, presumably through recent transmission (clusters of cases), as well as the strains found in only one patient, presumably representing reactivation of latent infection. Results: Of 546 available isolates of Mycobacterium tuberculosis, 261 (48 percent) belonged to a cluster and 285 (52 percent) did not. In multivariate analysis, significant predictors of noncluster status included birth outside the United States (odds ratio for a strain causing a cluster among non-Hispanic foreign-born patients, 0.31; 95 percent confidence interval, 0.14 to 0.66; odds ratio among Hispanic foreign-born patients, 0.51; 95 percent confidence interval, 0.30 to 0.88), age greater than 60 years (odds ratio, 0.37), and diagnosis after 1993 (odds ratio, 0.50). All these characteristics appeared to be associated with reactivation disease rather than with tuberculosis due to recent transmission. Homelessness was associated with clustering (odds ratio, 1.78; 95 percent confidence interval, 0.99 to 3.20) and therefore with recent transmission. Conclusions: These findings from northern Manhattan suggest that among foreign-born persons, tuberculosis is largely caused by reactivation of latent infection, whereas among U.S.-born persons, many cases result from recent transmission. Strategies for the control and elimination of tuberculosis among foreign-born persons at high risk should be directed toward the treatment of latent tuberculosis infection.	Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Publ Hlth Res Inst, New York, NY USA; New York City Dept Hlth, TB Control Program, New York, NY 10013 USA	Columbia University; Columbia University; New York City Department of Health & Mental Hygiene	Schluger, NW (corresponding author), Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, PH-8 Ctr,622 W 168th St, New York, NY 10032 USA.		Schluger, Neil/ABA-1793-2021	Li, Jiehui/0000-0002-7812-8878	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004074] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL04074] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; *AM THOR SOC, 2001, AM J RESP CRIT CARE, V164, P1319; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P287; *CDCP, 2001, REP TUB US 2000; *CDCP, 2000, REP TUB US 1999; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Geiter L, 2000, ENDING NEGLECT ELIMI, P292; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; LOBO PA, 1996, NEWEST NEW YORKERS 1, P298; SAHLY HM, 2001, J INFECT DIS, V183, P461; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SNIDER DE, 1984, AM REV RESPIR DIS, V130, P355; Soini H, 2001, J CLIN MICROBIOL, V39, P217, DOI 10.1128/JCM.39.1.217-221.2001; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; Tornieporth NG, 1997, INT J TUBERC LUNG D, V1, P528; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Wells CD, 1999, AM J RESP CRIT CARE, V159, P834, DOI 10.1164/ajrccm.159.3.9712122; Yamada S, 1999, Fam Med, V31, P477; 2000, AM J RESP CRIT CAR S, V161, pS221	23	186	189	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1453	1458		10.1056/NEJMoa012972	http://dx.doi.org/10.1056/NEJMoa012972			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000815				2022-12-24	WOS:000175433200004
J	Douek, DC; Brenchley, JM; Betts, MR; Ambrozak, DR; Hill, BJ; Okamoto, Y; Casazza, JP; Kuruppu, J; Kuntsman, K; Wolinsky, S; Grossman, Z; Dybul, M; Oxenius, A; Price, DA; Connors, M; Koup, RA				Douek, DC; Brenchley, JM; Betts, MR; Ambrozak, DR; Hill, BJ; Okamoto, Y; Casazza, JP; Kuruppu, J; Kuntsman, K; Wolinsky, S; Grossman, Z; Dybul, M; Oxenius, A; Price, DA; Connors, M; Koup, RA			HIV preferentially infects HIV-specific CD4(+) T cells	NATURE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ANTIGENIC-STIMULATION; IMMUNE-RESPONSES; CD8(+); DISCONTINUATION; IDENTIFICATION; INDIVIDUALS; REPLICATION; RESERVOIR; DYNAMICS	HIV infection is associated with the progressive loss of CD4(+) T cells through their destruction or decreased production(1,2). A central, yet unresolved issue of HIV disease is the mechanism for this loss, and in particular whether HIV-specific CD4(+) T cells are preferentially affected(3-5). Here we show that HIV-specific memory CD4(+) T cells in infected individuals contain more HIV viral DNA than other memory CD4(+) T cells, at all stages of HIV disease. Additionally, following viral rebound during interruption of antiretroviral therapy, the frequency of HIV viral DNA in the HIV-specific pool of memory CD4(+) T cells increases to a greater extent than in memory CD4(+) T cells of other specificities. These findings show that HIV-specific CD4(+) T cells are preferentially infected by HIV in vivo. This provides a potential mechanism to explain the loss of HIV-specific CD4(+) T-cell responses, and consequently the loss of immunological control of HIV replication(6). Furthermore, the phenomenon of HIV specifically infecting the very cells that respond to it adds a cautionary note to the practice of structured therapy interruption.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; NCI, Dept Expt Transplantat & Immunol, Med Branch, NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA; Northwestern Univ, Sch Med, Dept Infect Dis, Chicago, IL 60611 USA; Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Northwestern University; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford	Douek, DC (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	ddouek@mail.nih.gov	Brenchley, Jason/AAC-5085-2019; Price, David A/C-7876-2013; Wolinsky, Steven/B-2893-2012; Grossman, Zvi/A-9643-2008; Oxenius, Annette/G-7794-2015	Price, David A/0000-0001-9416-2737; Kuruppu, Janaki/0000-0003-0833-6126; Brenchley, Jason/0000-0001-8357-2984; Wolinsky, Steven/0000-0002-9625-6697	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005034, ZIAAI005034, Z01AI005014, ZIAAI005014, Z01AI000855, ZIAAI000855] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altfeld M, 2001, NAT MED, V7, P881, DOI 10.1038/90901; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Blancou P, 2001, P NATL ACAD SCI USA, V98, P13237, DOI 10.1073/pnas.231348598; CARCHEDI G, 1975, ECON SOC, V4, P1, DOI 10.1080/03085147500000001; Cheynier R, 1998, NAT MED, V4, P421, DOI 10.1038/nm0498-421; Chun TW, 1997, J VIROL, V71, P4436, DOI 10.1128/JVI.71.6.4436-4444.1997; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grossman Z, 1998, P NATL ACAD SCI USA, V95, P6314, DOI 10.1073/pnas.95.11.6314; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rowland-Jones S, 1999, LANCET, V354, P5, DOI 10.1016/S0140-6736(99)90017-X; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Wilson JDK, 2000, J INFECT DIS, V182, P792, DOI 10.1086/315764; Zhang ZQ, 1998, P NATL ACAD SCI USA, V95, P1154, DOI 10.1073/pnas.95.3.1154	32	950	980	5	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 2	2002	417	6884					95	98		10.1038/417095a	http://dx.doi.org/10.1038/417095a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986671				2022-12-24	WOS:000175307200045
J	Bhunia, AK; Piontek, K; Boletta, A; Liu, LJ; Qian, F; Xu, PN; Germino, FJ; Germino, GG				Bhunia, AK; Piontek, K; Boletta, A; Liu, LJ; Qian, F; Xu, PN; Germino, FJ; Germino, GG			PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2	CELL			English	Article							POLYCYSTIC KIDNEY-DISEASE; JANUS TYROSINE KINASE; TARGETED DISRUPTION; GROWTH-FACTOR; CYTOKINE RECEPTORS; GENE-PRODUCT; C-MYC; PROTEIN; INDUCTION; APOPTOSIS	Autosomal dominant polycystic kidney disease is characterized by cyst formation in the kidney and other organs and results from mutations of PKD1 or PKD2. Previous studies suggest that their gene products have an important role in growth regulation. We now show that expression of polycystin-1 activates the JAK-STAT pathway, thereby upregulating p21(waf1) and inducing cell cycle arrest in G0/G1. This process requires polycystin-2, a channel protein, as an essential cofactor. Mutations that disrupt polycystin-1/2 binding prevent activation of the pathway. Mouse embryos lacking Pkd1 have defective STAT1 phosphorylation and p21(waf1) induction. These results suggest that one function of the polycystin-1/2 complex is to regulate the JAK/STAT pathway and explain how mutations of either gene can result in dysregulated growth.	Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; Univ Med & Dent New Jersey, Dept Med, Div Oncol, New Brunswick, NJ 08901 USA	Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Germino, GG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA.			Germino, Gregory/0000-0002-3609-5588	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057325, T32DK007712, R01DK048006] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 48006, P50 DK 57325, T32 DK 07712] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bromberg JF, 1998, CELL GROWTH DIFFER, V9, P505; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Duncan SA, 1997, DEV DYNAM, V208, P190, DOI 10.1002/(SICI)1097-0177(199702)208:2<190::AID-AJA6>3.0.CO;2-D; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; KLINGEL R, 1992, AM J KIDNEY DIS, V19, P22, DOI 10.1016/S0272-6386(12)70198-1; Krebs DL, 2000, J CELL SCI, V113, P2813; Lanoix J, 1996, ONCOGENE, V13, P1153; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; TORRES VE, 1990, CYSTIC KIDNEY; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; WARD CJ, 1994, CELL, V77, P881; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392	53	336	346	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					157	168		10.1016/S0092-8674(02)00716-X	http://dx.doi.org/10.1016/S0092-8674(02)00716-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007403	Bronze			2022-12-24	WOS:000175082600006
J	Jorgensen, P; Nishikawa, JL; Breitkreutz, BJ; Tyers, M				Jorgensen, P; Nishikawa, JL; Breitkreutz, BJ; Tyers, M			Systematic identification of pathways that couple cell growth and division in yeast	SCIENCE			English	Article							LHERMITTE-DUCLOS-DISEASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; RETINOBLASTOMA PROTEIN; DELETION MUTANTS; GENETIC-ANALYSIS; RNA-POLYMERASE; SIZE-CONTROL; SOMA SIZE; CYCLE	Size homeostasis in budding yeast requires that cells grow to a critical size before commitment to division in the late prereplicative growth phase of the cell cycle, an event termed Start. We determined cell size distributions for the complete set of similar to6000 Saccharomyces cerevisiae gene deletion strains and identified similar to500 abnormally small (whi) or large (lge) mutants. Genetic analysis revealed a complex network of newly found factors that govern critical cell size at Start, the most potent of which were Sfp1, Sch9, Cdh1, Prs3, and Whi5. Ribosome biogenesis is intimately linked to cell size through Sfp1, a transcription factor that controls the expression of at least 60 genes implicated in ribosome assembly. Cell growth and division appear to be coupled by multiple conserved mechanisms.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Tyers, M (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 100 Coll St, Toronto, ON M5S 1A8, Canada.		Tyers, Michael/ABE-3194-2021					Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Binley KM, 1999, YEAST, V15, P1459, DOI 10.1002/(SICI)1097-0061(199910)15:14<1459::AID-YEA472>3.0.CO;2-A; Breitkreutz BJ, 2001, GENOME BIOL, V2; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Gari E, 2001, GENE DEV, V15, P2803; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JOHNSTON GC, 1979, J BACTERIOL, V137, P1; KILLANDER D, 1965, EXP CELL RES, V40, P12, DOI 10.1016/0014-4827(65)90285-5; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nash RS, 2001, GENETICS, V157, P1469; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; SMID A, 1995, J BIOL CHEM, V270, P13534, DOI 10.1074/jbc.270.22.13534; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SUDBERY PE, 1980, NATURE, V288, P401, DOI 10.1038/288401a0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; White RJ, 1997, TRENDS BIOCHEM SCI, V22, P77, DOI 10.1016/S0968-0004(96)10067-0; Wijnen H, 1999, GENETICS, V153, P1131; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu ZH, 1998, GENETICS, V150, P1419; YEN A, 1975, EXP CELL RES, V95, P295, DOI 10.1016/0014-4827(75)90554-6	49	588	596	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					395	400		10.1126/science.1070850	http://dx.doi.org/10.1126/science.1070850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12089449				2022-12-24	WOS:000176892600050
J	Hon, WC; Wilson, MI; Harlos, K; Claridge, TDW; Schofield, CJ; Pugh, CW; Maxwell, PH; Ratcliffe, PJ; Stuart, DI; Jones, EY				Hon, WC; Wilson, MI; Harlos, K; Claridge, TDW; Schofield, CJ; Pugh, CW; Maxwell, PH; Ratcliffe, PJ; Stuart, DI; Jones, EY			Structural basis for the recognition of hydroxyproline in alpha IF-1 alpha by pVHL	NATURE			English	Article							INDUCIBLE FACTOR-I; HIF-ALPHA; VHL; COMPLEX; DESTRUCTION; SOFTWARE; DOMAINS; BINDING; FAMILY	Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability(1). HIF-1alpha is the oxygen-regulated subunit of HIF-1, an alphabeta heterodimeric complex(1). HIF-1alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel-Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex(2,3). Capture of HIF-1alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1alpha(4-7). The crystal structure of a hydroxylated HIF-1alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.	Div Struct Biol, Oxford OX3 7BN, England; Cellular Physiol Grp, Oxford OX3 7BN, England; Oxford Ctr Mol Sci, Oxford OX1 3QY, England; Dyson Perrins Lab, Oxford OX1 3QY, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Jones, EY (corresponding author), Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	peter.ratcliffe@ndm.ox.ac.uk; yvonne@strubi.ox.ac.uk	Claridge, Tim/A-8324-2018; Maxwell, Patrick H/C-5557-2008; Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Claridge, Tim/0000-0001-5583-6460; Maxwell, Patrick H/0000-0002-0338-2679; Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Pugh, Chris/0000-0002-5170-1662; Stuart, David/0000-0002-3426-4210; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbard S., 1996, NACCESS COMPUTER PRO; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	29	525	563	6	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2002	417	6892					975	978		10.1038/nature00767	http://dx.doi.org/10.1038/nature00767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12050673				2022-12-24	WOS:000176441200045
J	Engelhart, MJ; Geerlings, MI; Ruitenberg, A; van Swieten, JC; Holman, A; Witteman, JCM; Breteler, MMB				Engelhart, MJ; Geerlings, MI; Ruitenberg, A; van Swieten, JC; Holman, A; Witteman, JCM; Breteler, MMB			Dietary intake of antioxidants and risk of Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C SUPPLEMENT USE; VITAMIN-E; APOLIPOPROTEIN-E; OXIDATIVE STRESS; MENTAL STATE; ROTTERDAM; DEMENTIA; DIAGNOSIS; ATHEROSCLEROSIS; QUESTIONNAIRE	Context Laboratory findings have suggested that oxidative stress may contribute to the pathogenesis of Alzheimer disease. Therefore, the risk of Alzheimer disease might be reduced by intake of antioxidants that counteract the detrimental effects of oxidative stress. Objective To determine whether dietary intake of antioxidants is related to risk of Alzheimer disease. Design and Setting The Rotterdam Study, a population-based, prospective cohort study conducted in the Netherlands. Participants A total of 5395 participants who, at baseline (1990-1993), were aged at least 55 years, free of dementia, and noninstitutionalized and had reliable dietary assessment. Participants were reexamined in 1993-1994 and 1997-1999 and were continuously monitored for incident dementia. Main Outcome Measures Incidence of Alzheimer disease, based on Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) criteria and National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) criteria, associated with dietary intake of beta carotene, flavonoids, vitamin C, and vitamin E. Results After a mean follow-up of 6 years, 197 participants developed dementia, of whom 146 had Alzheimer disease. When adjustments were made for age, sex, baseline Mini-Mental State Examination score, alcohol intake, education, smoking habits, pack-years of smoking, body mass index, total energy intake, presence of carotid plaques, and use of antioxidative supplements, high intake of vitamin C and vitamin E was associated with lower risk of Alzheimer disease (rate ratios [RRs] per 1-SD increase in intake were 0.82 [95% confidence interval {CI}, 0.68-0.99] and 0.82 [95% CI, 0.66-1.00], respectively). Among current smokers, this relationship was most pronounced (RRs, 0.65 [95% CI, 0.37-1.14] and 0.58 [95% CI, 0.30-1.12], respectively) and also was present for intake of beta carotene (RR, 0.49 [95% CI, 0.27-0.92]) and flavonoids (RR, 0.54 [95% CI, 0.31-0.96]). The associations did not vary by education or apolipoprotein E genotype. Conclusion High dietary intake of vitamin C and vitamin E may lower the risk of Alzheimer disease.	Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Neurol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Breteler, MMB (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	breteler@epib.fgg.eur.nl	Geerlings, Mirjam I/F-4087-2015; Breteler, Monique M.B./J-5058-2014; Zito, Giancarlo/F-9008-2010	Geerlings, Mirjam I/0000-0002-4037-036X; Breteler, Monique M.B./0000-0002-0626-9305; van Swieten, John/0000-0001-6278-6844				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; BENDER MM, 1992, J AM DIET ASSOC, V92, P1096; BOTS ML, 1993, LANCET, V341, P1232, DOI 10.1016/0140-6736(93)91144-B; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; BRONNER F, 1993, J NUTR, V123, P797, DOI 10.1093/jn/123.5.797; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DUTHIE GG, 1993, ANN NY ACAD SCI, V686, P120, DOI 10.1111/j.1749-6632.1993.tb39165.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Food and Nutrition Council, 1993, DUTCH FOOD COMP TABL; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Grundman M, 2000, AM J CLIN NUTR, V71, p630S; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kirk SFL, 1999, PUBLIC HEALTH NUTR, V2, P69, DOI 10.1017/S1368980099000099; Klipstein-Grobusch K, 1999, AM J CLIN NUTR, V69, P261; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Launer L J, 2000, J Nutr Health Aging, V4, P197; Masaki KH, 2000, NEUROLOGY, V54, P1265, DOI 10.1212/WNL.54.6.1265; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEYDANI M, 1995, LANCET, V345, P170, DOI 10.1016/S0140-6736(95)90172-8; Morris MC, 1998, ALZ DIS ASSOC DIS, V12, P121, DOI 10.1097/00002093-199809000-00001; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Ott A, 1998, AM J EPIDEMIOL, V147, P574; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	34	733	772	2	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2002	287	24					3223	3229		10.1001/jama.287.24.3223	http://dx.doi.org/10.1001/jama.287.24.3223			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566FF	12076218	Green Published			2022-12-24	WOS:000176415800026
J	Smith, AH; Lopipero, PA; Bates, MN; Steinmaus, CM				Smith, AH; Lopipero, PA; Bates, MN; Steinmaus, CM			Public health - Arsenic epidemiology and drinking water standards	SCIENCE			English	Editorial Material							CANCER RISK ASSESSMENT; DISEASE ENDEMIC AREA; MALIGNANT NEOPLASMS; INTERNAL CANCERS; BLADDER-CANCER; LUNG-CANCER; WELL WATER; MORTALITY; TAIWAN; METHYLATION		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Smith, AH (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.		Smith, Allan H/F-9249-2011; Bates, Michael/ABC-2050-2021		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, P30ES001896] Funding Source: NIH RePORTER; NIEHS NIH HHS [P42ES04705, P30ES01896] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Abernathy CO, 1996, FUND APPL TOXICOL, V29, P168, DOI 10.1006/faat.1996.0018; AXELSON O, 1978, BRIT J IND MED, V35, P8; BATES MN, 1992, AM J EPIDEMIOL, V135, P462, DOI 10.1093/oxfordjournals.aje.a116313; BERGOGLIO R M, 1964, Prensa Med Argent, V51, P994; Biagini R E, 1966, Arch Argent Dermatol, V16, P172; CARLSONLYNCH H, 1994, ENVIRON HEALTH PERSP, V102, P354, DOI 10.2307/3431620; CHEN CJ, 1986, BRIT J CANCER, V53, P399, DOI 10.1038/bjc.1986.65; CHEN CJ, 1985, CANCER RES, V45, P5895; CHEN CJ, 1990, CANCER RES, V50, P5470; CHEN CJ, 1988, LANCET, V1, P414; CHIOU HY, 1995, CANCER RES, V55, P1296; Chiou HY, 2001, AM J EPIDEMIOL, V153, P411, DOI 10.1093/aje/153.5.411; Concha G, 1998, ENVIRON HEALTH PERSP, V106, P355, DOI 10.2307/3434042; *EPA, 1988, SPEC REP ING IN ARS; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; HopenhaynRich C, 1996, ENVIRON HEALTH PERSP, V104, P1200, DOI 10.2307/3432913; HOPENHAYNRICH C, 1993, ENVIRON RES, V60, P161, DOI 10.1006/enrs.1993.1024; HopenhaynRich C, 1996, EPIDEMIOLOGY, V7, P117, DOI 10.1097/00001648-199603000-00003; HopenhaynRich C, 1996, ENVIRON HEALTH PERSP, V104, P620, DOI 10.2307/3433091; Hsueh YM, 1998, J TOXICOL ENV HEAL A, V54, P431, DOI 10.1080/009841098158728; Hutchinson J., 1887, BRIT MED J, V2, P1280; Hutchinson J, 1888, T PATH SOC LONDON, V39, P352; *INT AG RES CANC, 1980, EV CARC RISK CHEM MA; Kurttio P, 1998, ARCH ENVIRON CON TOX, V34, P297, DOI 10.1007/s002449900321; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; Morales KH, 2000, ENVIRON HEALTH PERSP, V108, P655, DOI 10.2307/3434887; MUSHAK P, 1995, ENVIRON HEALTH PERSP, V103, P684, DOI 10.2307/3432859; Nakadaira H, 2002, J OCCUP ENVIRON MED, V44, P291, DOI 10.1097/00043764-200203000-00017; National Research Council (NRC), 2001, ARS DRINK WAT 2001 U; NEUBAUER O, 1947, BRIT J CANCER, V1, P192, DOI 10.1038/bjc.1947.22; NRC, 1999, ARS DRINK WAT; NRC (National Research Council), 1986, ENV TOB SMOK MEAS EX; Slayton TM, 1996, ENVIRON HEALTH PERSP, V104, P1012, DOI 10.2307/3433100; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smith AH, 1999, ARSENIC EXPOSURE AND HEALTH EFFECTS, P191, DOI 10.1016/B978-008043648-7/50022-4; SMITH AH, 1988, ARCH ENVIRON HEALTH, V43, P124, DOI 10.1080/00039896.1988.9935838; Steinmaus CM, 2000, AM J EPIDEMIOL, V151, P693, DOI 10.1093/oxfordjournals.aje.a010264; STOHRER G, 1995, REGUL TOXICOL PHARM, V22, P118, DOI 10.1006/rtph.1995.1077; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; TSENG WP, 1968, J NATL CANCER I, V40, P453; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; US Environmental Protection Agency (EPA), 2001, FED REGISTER, V66, P6976; *USPHS, 1962, FED REGISTER, V42, P2152; WARNER ML, 1994, CANCER EPIDEM BIOMAR, V3, P583; *WHO, 1993, GUID DRINK WAT QUAL, V1; [No title captured]	50	444	468	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2145	2146		10.1126/science.1072896	http://dx.doi.org/10.1126/science.1072896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077388				2022-12-24	WOS:000176379000027
J	Urano, T; Saito, T; Tsukui, T; Fujita, M; Hosoi, T; Muramatsu, M; Ouchi, Y; Inoue, S				Urano, T; Saito, T; Tsukui, T; Fujita, M; Hosoi, T; Muramatsu, M; Ouchi, Y; Inoue, S			Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth	NATURE			English	Article							UBIQUITIN-PROTEIN LIGASE; ESTROGEN-RESPONSIVE GENE; FINGER PROTEIN; DNA-DAMAGE; CELL-CYCLE; RING; P53; PROTEASOME; INHIBITOR; CLONING	Oestrogen exerts its influence on target organs through activating oestrogen receptors (ERs) and regulating downstream genes by means of their oestrogen-responsive elements. Efp, a target gene product of ERalpha(1-3), is a member of the RING-finger B-box coiled-coil (RBCC) motif family(4). Efp is predominantly expressed in various female organs 2 as well as in breast cancers 5, and is thought to be essential for oestrogen-dependent cell proliferation and organ development-Efp-disrupted mice display underdeveloped uteri and reduced oestrogen responsiveness(6). Here we show that Efp is a RING-finger-dependent ubiquitin ligase (E3) that targets proteolysis of 14-3-3sigma, a negative cell cycle regulator that causes G2 arrest(7). We demonstrate that tumour growth of breast cancer MCF7 cells implanted in female athymic mice is reduced by treatment with antisense Efp oligonucleotide. Efp-overexpressing MCF7 cells in ovariectomized athymic mice generate tumours in the absence of oestrogen. Loss of Efp function in mouse embryonic fibroblasts results in an accumulation of 14-3-3sigma, which is responsible for reduced cell growth. These data provide an insight into the cell-cycle machinery and tumorigenesis of breast cancer by identifying 14-3-3sigma as a target for proteolysis by Efp, leading to cell proliferation.	Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; Saitama Med Sch, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; Saitama Med Sch, Dept Mol Biol, Hidaka, Saitama 3501241, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Saitama Medical University; Saitama Medical University; Japan Science & Technology Agency (JST)	Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Urano, Tomohiko/AFS-9574-2022					Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; COX LS, 1995, BIOESSAYS, V17, P501, DOI 10.1002/bies.950170606; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Ikeda K, 2000, FEBS LETT, V472, P9, DOI 10.1016/S0014-5793(00)01421-6; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Muramatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P1, DOI 10.1006/bbrc.2000.2214; ORIMO A, 1995, J BIOL CHEM, V270, P24406, DOI 10.1074/jbc.270.41.24406; Orimo A, 1999, P NATL ACAD SCI USA, V96, P12027, DOI 10.1073/pnas.96.21.12027; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Urano T, 1999, J BIOL CHEM, V274, P12197, DOI 10.1074/jbc.274.18.12197	30	285	306	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					871	875		10.1038/nature00826	http://dx.doi.org/10.1038/nature00826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075357				2022-12-24	WOS:000176285600052
J	Tomita, H; Yamada, K; Ghadami, M; Ogura, T; Yanai, Y; Nakatomi, K; Sadamatsu, M; Masui, A; Kato, N; Niikawa, N				Tomita, H; Yamada, K; Ghadami, M; Ogura, T; Yanai, Y; Nakatomi, K; Sadamatsu, M; Masui, A; Kato, N; Niikawa, N			Mapping of the wet/dry earwax locus to the pericentromeric region of chromosome 16	LANCET			English	Article							PAROXYSMAL KINESIGENIC CHOREOATHETOSIS	Human earwax Is a one-gene trait comprising two phenotypically distinct forms-wet and dry. This trait Is attributed to secretory products of the ceruminous apocrine glands, and frequencies of phenotypes vary between ethnic groups. We did linkage analysis of eight Japanese families segregating earwax dimorphism. We assigned the earwax locus within a similar to7.42-cM region between the loci D16S3093 and D16S3080 on chromosome 16p11.2-16q12.1, with a maximum two-point LOD score of 11.15 (theta=0.00) at the locus D16S3044. Identification of the earwax locus could contribute to further anthropogenetic studies and physiological and pathological understanding of the apocrine-gland development.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Japan; Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan; Univ Tokyo, Hlth Serv Ctr, Tokyo, Japan; Shiga Univ Med Sci, Dept Psychiat, Otsu, Shiga 52021, Japan; Univ Tokyo, Fac Med, Dept Neuropsychiat, Tokyo 113, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Nagasaki University; University of Tokyo; Shiga University of Medical Science; University of Tokyo	Tomita, H (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, D346 MED SCI I, Irvine, CA 92697 USA.			Tomita, Hiroaki/0000-0003-2628-880X				IBRAIMOV AI, 1991, AM J PHYS ANTHROPOL, V84, P209, DOI 10.1002/ajpa.1330840210; MATSUNAGA E, 1962, ANN HUM GENET, V25, P273, DOI 10.1111/j.1469-1809.1962.tb01766.x; PETRAKIS NL, 1986, BREAST CANCER RES TR, V8, P7, DOI 10.1007/BF01805919; Sadamatsu M, 1999, EPILEPSIA, V40, P942, DOI 10.1111/j.1528-1157.1999.tb00801.x; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682	5	13	13	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 8	2002	359	9322					2000	2002		10.1016/S0140-6736(02)08835-9	http://dx.doi.org/10.1016/S0140-6736(02)08835-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563BA	12076558				2022-12-24	WOS:000176232500015
J	Bharathan, G; Goliber, TE; Moore, C; Kessler, S; Pham, T; Sinha, NR				Bharathan, G; Goliber, TE; Moore, C; Kessler, S; Pham, T; Sinha, NR			Homologies in leaf form inferred from KNOXI gene expression during development	SCIENCE			English	Article							HOMEOBOX GENE; COMPOUND LEAF; MORPHOGENESIS; ANGIOSPERMS; EVOLUTION; PHYLOGENY; DIFFERENTIATION; OVEREXPRESSION; EMBRYOGENESIS; BRASSICACEAE	KNOTTEDI-like homeobox (KNOXI) genes regulate development of the leaf from the shoot apical meristem (SAM) and may regulate leaf form. We examined KNOXI expression in SAMs of various vascular plants and found that KNOXI expression correlated with complex leaf primordia. However, complex primordia may mature into simple leaves. Therefore, not all simple leaves develop similarly, and final leaf morphology may not be an adequate predictor of homology.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sinha, NR (corresponding author), Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA.		Kessler, Sharon A/T-4784-2017; R, Geeta/AAI-3545-2020	Kessler, Sharon A/0000-0002-7964-0451; R, Geeta/0000-0002-8498-470X; Sinha, Neelima/0000-0002-1494-7065				Abouheif E, 1997, TRENDS GENET, V13, P432, DOI 10.1016/S0168-9525(97)01271-7; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Banks Joseph, COMMUNICATION; Bowman JL, 1999, INT J PLANT SCI, V160, P917, DOI 10.1086/314194; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Chory J, 1997, PLANT CELL ENVIRON, V20, P801, DOI 10.1046/j.1365-3040.1997.d01-99.x; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Dengler NG, 2001, INT J PLANT SCI, V162, P459, DOI 10.1086/320145; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Gleissberg S, 1999, INT J PLANT SCI, V160, P787, DOI 10.1086/314165; Gourlay CW, 2000, PLANT CELL, V12, P1279, DOI 10.1105/tpc.12.8.1279; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kenrick P., 1997, ORIGIN EARLY DIVERSI, P441, DOI DOI 10.1038/37918; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; MA YL, 1992, ANN BOT-LONDON, V70, P277, DOI 10.1093/oxfordjournals.aob.a088470; MADDISON WP, 1992, INTERACTIVE ANAL PHY; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Mummenhoff K, 2001, AM J BOT, V88, P2051, DOI 10.2307/3558431; MUMMENHOFF K, COMMUNICATION; Nishimura A, 1999, PLANT J, V18, P337, DOI 10.1046/j.1365-313X.1999.00457.x; Nishimura Asuka, 1998, Plant and Cell Physiology, V39, pS60; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; Sinha N. K., UNPUB; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; SMITH LG, 1995, DEV GENET, V16, P344, DOI 10.1002/dvg.1020160407; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI [10.1111/j.1095-8339.2000.tb01588.x, 10.1006/bojl.2000.0380]; Taylor D.W., 1996, FLOWERING PLANT ORIG; Troll W., 1939, VERGLEICHENDE MORPHO, V1; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7	35	329	352	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1858	1860		10.1126/science.1070343	http://dx.doi.org/10.1126/science.1070343			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052958				2022-12-24	WOS:000176054300046
J	Wynia, MK; Gostin, L				Wynia, MK; Gostin, L			Medicine - The bioterrorist threat and access to health care	SCIENCE			English	Editorial Material									Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; Univ Chicago, Div Infect Dis, Chicago, IL 60637 USA; Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC 20001 USA; Johns Hopkins Univ, Baltimore, MD USA	American Medical Association; University of Chicago; Georgetown University; Johns Hopkins University	Wynia, MK (corresponding author), Amer Med Assoc, Inst Eth, 515 N State St, Chicago, IL 60610 USA.		Wynia, Matthew/T-2210-2019					BREWER S, 2001, HOUSTON CHRONIC 1211, pA1; *COMM CONS UN BOAR, IN PRESS CARE COVERA; HALSTEAD T, 2001, US TODAY        1112, pA17; JANISON D, 2002, NEWSDAY         0307, pA5; NOVELLO A, 2001, AM PUBL HLTH ASS 129; YARDLEY J, 2001, NY TIMES        0812, pA18; ZIV TA, 1995, NEW ENGL J MED, V332, P1095, DOI 10.1056/NEJM199504203321612	7	8	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1613	1613		10.1126/science.1072921	http://dx.doi.org/10.1126/science.1072921			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040164				2022-12-24	WOS:000175976200025
J	Singh, PK; Parsek, MR; Greenberg, EP; Welsh, MJ				Singh, PK; Parsek, MR; Greenberg, EP; Welsh, MJ			A component of innate immunity prevents bacterial biofilm development	NATURE			English	Article							LOWER RESPIRATORY-TRACT; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; ANTIMICROBIAL ACTIVITY; CHRONIC-BRONCHITIS; LACTOFERRIN; IRON; LYSOZYME; TRANSFERRIN; INFECTION	Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infection(1-3). These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infections(1-4). In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistence(5-7). The transition from a free-living, independent existence to a biofilm lifestyle can be devastating, because biofilms notoriously resist killing by host defence mechanisms and antibiotics(5,8). We hypothesized that the innate immune system possesses specific activity to protect against biofilm infections. Here we show that lactoferrin, a ubiquitous and abundant constituent of human external secretions, blocks biofilm development by the opportunistic pathogen Pseudomonas aeruginosa. This occurs at lactoferrin concentrations below those that kill or prevent growth. By chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing the bacteria to wander across the surface instead of forming cell clusters and biofilms. These findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in biofilm development, the time bacteria stop roaming as individuals and aggregate into durable communities.	Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA; WM Keck Fdn Microbial Communities & Cell Signalin, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Northwestern University	Singh, PK (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.			Greenberg, Everett/0000-0001-9474-8041; Welsh, Michael/0000-0002-1646-6206	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102246] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL102246] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe T, 1999, BRIT J OPHTHALMOL, V83, P684, DOI 10.1136/bjo.83.6.684; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Coonrod J D, 1986, Semin Respir Infect, V1, P118; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; ELLISON RT, 1994, ADV EXP MED BIOL, V357, P71; Ganz T, 2001, Semin Respir Infect, V16, P4; HARBITZ O, 1984, EUR J RESPIR DIS, V65, P512; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HIRAI Y, 1990, J NUTR SCI VITAMINOL, V36, P531, DOI 10.3177/jnsv.36.531; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Leitch EC, 1999, CURR EYE RES, V19, P12, DOI 10.1076/ceyr.19.1.12.5342; MARTIN PR, 1995, MOL MICROBIOL, V16, P497, DOI 10.1111/j.1365-2958.1995.tb02414.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; SAMSON RR, 1979, IMMUNOLOGY, V38, P367; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SOHNLE PG, 1991, J INFECT DIS, V164, P137, DOI 10.1093/infdis/164.1.137; Stites SW, 1999, AM J RESP CRIT CARE, V160, P796, DOI 10.1164/ajrccm.160.3.9811018; Stites SW, 1998, CHEST, V114, P814, DOI 10.1378/chest.114.3.814; THOMPSON AB, 1990, J LAB CLIN MED, V115, P148; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Ward CG, 1996, J TRAUMA, V41, P356, DOI 10.1097/00005373-199608000-00030; Xiao R, 1997, MICROBIOL-UK, V143, P2509, DOI 10.1099/00221287-143-7-2509; Xu KD, 2000, MICROBIOL-UK, V146, P547, DOI 10.1099/00221287-146-3-547	30	751	810	5	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					552	555		10.1038/417552a	http://dx.doi.org/10.1038/417552a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037568				2022-12-24	WOS:000175860300043
J	Jewkes, R; Brown, H; Dickson-Tetteh, K; Levin, J; Rees, H				Jewkes, R; Brown, H; Dickson-Tetteh, K; Levin, J; Rees, H			Prevalence of morbidity associated with abortion before and after legalisation in South Africa	BRITISH MEDICAL JOURNAL			English	Article							INCOMPLETE ABORTION		MRC, Gender & Hlth Grp, ZA-0001 Pretoria, South Africa; MRC, Biostat Unit, ZA-0001 Pretoria, South Africa; Baragwanath Hosp, Reprod Hlth Res Unit, ZA-2013 Johannesburg, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Grp, Private Bag X385, ZA-0001 Pretoria, South Africa.			Jewkes, Rachel/0000-0002-4330-6267; Rees, Helen/0000-0003-1442-6734				Brown H, 2002, EPIDEMIOLOGY INCOMPL; Jewkes RK, 1997, STUD FAMILY PLANN, V28, P228, DOI 10.2307/2137890; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rees H, 1997, S AFR MED J, V87, P432; *REPR RIGHTS ALL, 1999, BAROMETER, V3, P4	5	47	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1252	1253		10.1136/bmj.324.7348.1252	http://dx.doi.org/10.1136/bmj.324.7348.1252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028979	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000175894900020
J	Burnham, D; Kitamura, C; Vollmer-Conna, U				Burnham, D; Kitamura, C; Vollmer-Conna, U			What's new, pussycat? On talking to babies and animals	SCIENCE			English	Article							MOTHERESE		Univ Western Sydney, MARCS Auditory Labs, Sydney, NSW 1797, Australia; Univ New S Wales, Sch Psychiat, Dept Human Behav, Sydney, NSW 2052, Australia	Western Sydney University; University of New South Wales Sydney	Burnham, D (corresponding author), Univ Western Sydney, MARCS Auditory Labs, POB 1797, Sydney, NSW 1797, Australia.			Burnham, Denis/0000-0002-1980-3458				Andruski J.E., 1999, J ACOUST SOC AM, V105, P1095, DOI [10.1121/1.425135, DOI 10.1121/1.425135]; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; HIRSHPASEK K, 1982, J CHILD LANG, V9, P229, DOI 10.1017/S0305000900003731; Kitamura C., 1998, ADV INFANCY RES, V12, P221; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684	5	251	255	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1435	1435		10.1126/science.1069587	http://dx.doi.org/10.1126/science.1069587			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	557LP	12029126				2022-12-24	WOS:000175910300038
J	Wylie, G; Hungin, APS; Neely, J				Wylie, G; Hungin, APS; Neely, J			Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE; HEALTH; CARE; PREVENTION; GUIDELINES; PEOPLE; TRIAL; DIET	Objective To investigate general practitioners' knowledge of and attitudes to impaired glucose tolerance. Design Mixed methodology qualitative and quantitative study with semistructured interviews, focus groups, and questionnaires. Setting 34 general practitioners in live primary care groups in the north east of England. Results All the general practitioners had knowledge of impaired glucose tolerance as a clinical entity, but they had little awareness of the clinical Significance of impaired glucose tolerance and were uncertain about managing and following up these patients. Attitudes to screening were mixed and were associated with reservations about increased workload, concern about lack of resources, and pessimism about the effectiveness of lifestyle interventions. Some general practitioners felt strongly that screening patients for impaired glucose tolerance and subsequent lifestyle intervention medicalised an essentially social problem and that a health educational approach, involving schools and the media, should be adopted instead. A minority expressed a positive attitude towards a pharmacological approach. Conclusion Awareness of impaired glocose tolerance needs to be raised, and guidelines for management are needed. General practitioners remain to be convinced that they have a role in attempting to reduce the incidence of type 2 diabetes by targeting interventions at patients with impaired glucose tolerance.	Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England	Durham University	Wylie, G (corresponding author), Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England.	graeme.wylie@dur.ac.uk		hungin, amritpal Pali/0000-0001-7275-8927				Alberti KGMM, 1998, DIABETES RES CLIN PR, V40, pS3; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; BOULTON M, 1994, SOCIOLOGY HLTH ILLNE, V16, P372; Bourn DM, 1996, DIABETIC MED, V13, P938, DOI 10.1002/(SICI)1096-9136(199611)13:11<938::AID-DIA274>3.0.CO;2-P; COULTER A, 1991, BRIT J GEN PRACT, V41, P140; Davies MJ, 1996, BRIT MED J, V312, P264; *DEP HLTH, 2000, COMP CLIN HLTH IND 2; Dixon S, 2000, DIABETIC MED, V17, P820, DOI 10.1046/j.1464-5491.2000.00391.x; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; Glaser B. G., 1978, AWARENESS DYING; Goyder E, 1998, BMJ-BRIT MED J, V317, P1644, DOI 10.1136/bmj.317.7173.1644; Khunti K, 2000, J ROY SOC MED, V93, P183, DOI 10.1177/014107680009300407; Lawlor DA, 2000, BRIT J GEN PRACT, V50, P455; Li CL, 1999, DIABETIC MED, V16, P477, DOI 10.1046/j.1464-5491.1999.00090.x; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McAvoy BR, 1999, BRIT J GEN PRACT, V49, P187; Melia K.M, 1997, CONTEXT METHOD QUALI, P26; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patton M.Q., 2015, QUALITATIVE RES EVAL, V4th edition; Pierce M, 2000, BRIT J GEN PRACT, V50, P542; Pill R, 1998, FAM PRACT, V15, P229, DOI 10.1093/fampra/15.3.229; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Watkins C, 1999, BRIT J GEN PRACT, V49, P11; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	25	44	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2002	324	7347					1190	1192		10.1136/bmj.324.7347.1190	http://dx.doi.org/10.1136/bmj.324.7347.1190			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016185	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000175763200020
J	Li, HW; Li, WX; Ding, SW				Li, HW; Li, WX; Ding, SW			Induction and suppression of RNA silencing by an animal virus	SCIENCE			English	Article							RESISTANCE; DEFENSE; SPREAD; PLANTS	RNA silencing is a sequence-specific RNA degradation mechanism that is operational in plants and animals. Here, we show that flock house virus (FHV) is both an initiator and a target of RNA silencing in Drosophila host cells and that FHV infection requires suppression of RNA silencing by an FHV-encoded protein, B2. These findings establish RNA silencing as an adaptive antiviral defense in animal cells. B2 also inhibits RNA silencing in transgenic plants, providing evidence for a conserved RNA silencing pathway in the plant and animal kingdoms.	Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ding, SW (corresponding author), Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA.	shou-wei.ding@ucr.edu	Ding, Shou Wei/AAC-2533-2020	Ding, SW/0000-0002-4697-8413				Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x; BALL LA, 1995, J VIROL, V69, P720, DOI 10.1128/JVI.69.2.720-727.1995; BALL LA, 2000, VIRUS TAXONOMY, P747; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billecocq A, 2000, J GEN VIROL, V81, P2161, DOI 10.1099/0022-1317-81-9-2161; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Dasgupta R, 2001, P NATL ACAD SCI USA, V98, P4910, DOI 10.1073/pnas.081288198; Ding SW, 1996, P NATL ACAD SCI USA, V93, P7470, DOI 10.1073/pnas.93.15.7470; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Johnson KL, 1999, J VIROL, V73, P7933, DOI 10.1128/JVI.73.10.7933-7942.1999; Li HW, 1999, EMBO J, V18, P2683, DOI 10.1093/emboj/18.10.2683; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; WHITTON JL, FIELDS VIROLOGY, V1, pCH11	23	655	725	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1319	1321		10.1126/science.1070948	http://dx.doi.org/10.1126/science.1070948			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016316				2022-12-24	WOS:000175713000055
J	Murakami, KS; Masuda, S; Darst, SA				Murakami, KS; Masuda, S; Darst, SA			Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 angstrom resolution	SCIENCE			English	Article							SIGMA(70) SUBUNIT; ABORTIVE INITIATION; SIGMA-70 SUBUNIT; IN-VITRO; PROMOTER; RECOGNITION; BINDING; MUTANT; SPECIFICITY; REGIONS	The crystal structure of the initiating form of Thermus aquaticus RNA polymerase, containing core RNA polymerase (alpha(2)betabeta'omega) and the promoter specificity or subunit, has been determined at 4 angstrom resolution. Important structural features of the RNA polymerase and their roles in positioning or within the initiation complex are delineated, as well as the role played by or in modulating the opening of the RNA polymerase active-site channel. The two carboxyl-terminal domains of a are separated by 45 angstroms on the surface of the RNA polymerase, but are linked by an extended loop. The loop winds near the RNA polymerase active site, where it may play a role in initiating nucleotide substrate binding, and out through the RNA exit channel. The advancing RNA transcript must displace the loop, leading to abortive initiation and ultimately to a release.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu		Murakami, Katsuhiko/0000-0003-2244-0501	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061898, R01GM053759] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Bhargava P, 1999, J BIOL CHEM, V274, P26550, DOI 10.1074/jbc.274.37.26550; CAMARERO JA, IN PRESS P NATL ACAD; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; DARST SA, 1997, NUCL ACIDS MOL BIOL, V11, P27; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 1997, J BACTERIOL, V179, P1734, DOI 10.1128/jb.179.5.1734-1747.1997; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 2001, CURR OPIN MICROBIOL, V4, P119, DOI 10.1016/S1369-5274(00)00176-4; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI [DOI 10.1128/JB.174.12.3843-3849.1992, 10.1128/jb.174.12.3843-3849.1992, :10.1128/jb.174.12.3843-3849.1992]; LUSE DS, 1987, J BIOL CHEM, V262, P14990; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nagai H, 1997, GENES CELLS, V2, P725, DOI 10.1046/j.1365-2443.1997.1600357.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Sen R, 1998, J BIOL CHEM, V273, P9872, DOI 10.1074/jbc.273.16.9872; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Vuthoori S, 2001, J MOL BIOL, V309, P561, DOI 10.1006/jmbi.2001.4690; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	43	441	462	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1280	1284		10.1126/science.1069594	http://dx.doi.org/10.1126/science.1069594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016306				2022-12-24	WOS:000175713000044
J	Spoor, F; Bajpal, S; Hussaim, ST; Kumar, K; Thewissen, JGM				Spoor, F; Bajpal, S; Hussaim, ST; Kumar, K; Thewissen, JGM			Vestibular evidence for the evolution of aquatic behaviour in early cetaceans	NATURE			English	Article							INNER-EAR; LOCOMOTOR EVOLUTION; HEARING; PETROSAL; WHALE; ORIGIN; FEET	Early cetaceans evolved from terrestrial quadrupeds to obligate swimmers, a change that is traditionally studied by functional analysis of the postcranial skeleton(1). Here we assess the evolution of cetacean locomotor behaviour from an independent perspective by looking at the semicircular canal system, one of the main sense organs involved in neural control of locomotion(2). Extant cetaceans are found to be unique in that their canal arc size, corrected for body mass, is approximately three times smaller than in other mammals. This reduces the sensitivity of the canal system, most plausibly to match the fast body rotations that characterize cetacean behaviour. Eocene fossils show that the new sensory regime, incompatible with terrestrial competence, developed quickly and early in cetacean evolution, as soon as the taxa are associated with marine environments. Dedicated agile swimming of cetaceans thus appeared to have originated as a rapid and fundamental shift in locomotion rather than as the gradual transition suggested by postcranial evidence. We hypothesize that the unparalleled modification of the semicircular canal system represented a key 'point of no return' event in early cetacean evolution, leading to full independence from life on land.	Indian Inst Technol, Dept Earth Sci, Roorkee 247667, Uttar Pradesh, India; UCL, Dept Anat & Dev Biol, London WC1E 6JJ, England; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India; Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of London; University College London; Howard University; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG); Northeast Ohio Medical University (NEOMED)	Spoor, F (corresponding author), Indian Inst Technol, Dept Earth Sci, Roorkee 247667, Uttar Pradesh, India.	f.spoor@ucl.ac.uk	Spoor, Fred/C-1718-2008; KUMAR, Kishor/H-7232-2013	KUMAR, Kishor/0000-0003-0875-9735; Thewissen, J. G. M./0000-0002-0973-4137				Bajpai S, 2000, CURR SCI INDIA, V79, P1478; Buchholtz EA, 1998, ADV VERT PALEOBIOL, P325; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Geisler JH, 1996, J PALEONTOL, V70, P1045, DOI 10.1017/S0022336000038749; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; GRAY AA, 1908, LABYRINTH ANIMALS, V2; HOHNE KH, 1995, NAT MED, V1, P506, DOI 10.1038/nm0695-506; Hulbert RC, 1998, ADV VERT PALEOBIOL, P235; Hyrtl J., 1845, VERGLEICHEND ANATOMI; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P53; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P431, DOI 10.1080/02724634.1995.10011239; Luo ZX, 1996, J VERTEBR PALEONTOL, V16, P328, DOI 10.1080/02724634.1996.10011320; Madar SI, 1998, ADV VERT PALEOBIOL, P353; Marino Lori, 2000, Journal of Mammalian Evolution, V7, P81, DOI 10.1023/A:1009417831601; MULLER M, 1994, J THEOR BIOL, V167, P239, DOI 10.1006/jtbi.1994.1066; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Schwarz DWF, 1994, NEUROTOLOGY, P59; SPOOR F, 1995, J ANAT, V186, P271; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; SPOOR F, IN PRESS COURIER FOR; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 1998, ADV VERT PALEOBIOL, P451; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Williams EM, 1998, ADV VERT PALEOBIOL, P1; Yamada M., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P291	30	169	178	10	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					163	166		10.1038/417163a	http://dx.doi.org/10.1038/417163a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000957				2022-12-24	WOS:000175460200040
J	Fong, YY; Bender, L; Wang, WC; Strome, S				Fong, YY; Bender, L; Wang, WC; Strome, S			Regulation of the different chromatin states of autosomes and X chromosomes in the germ line of C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; POLYCOMB GROUP; GENE; MES-3; PROTEIN; PROLIFERATION; MAINTENANCE; EXPRESSION; ANTIBODIES; VIABILITY	The Maternal-Effect Sterile (MES) proteins are essential for germline viability in Caenorhabditis elegans. Here, we report that MES-4, a SET-domain protein, binds to the autosomes but not to the X chromosomes. MES-2, MES-3, and MES-6 are required to exclude MES-4 and markers of active chromatin from the X chromosomes. These findings strengthen the emerging view that in the C. elegans germ line, the X chromosomes differ in chromatin state from the autosomes and are generally silenced. We propose that all four MES proteins participate in X-chromosome silencing, and that the role of MES-4 is to exclude repressors from the autosomes, thus enabling efficient repression of the Xs.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Strome, S (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034059] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034059, R01 GM034059-16, GM34059] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEANAN MJ, 1992, DEVELOPMENT, V116, P755; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Davies AG, 1999, GENETICS, V153, P117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FONG Y, UNPUB; Garvin C, 1998, GENETICS, V148, P167; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; HERMAN RK, 1979, GENETICS, V92, P419; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Korf I, 1998, DEVELOPMENT, V125, P2469; Marin I, 2000, BIOESSAYS, V22, P1106, DOI 10.1002/1521-1878(200012)22:12&lt;1106::AID-BIES8&gt;3.0.CO;2-W; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MONESTIER M, 1994, EUR J IMMUNOL, V24, P723, DOI 10.1002/eji.1830240335; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; PAULSEN JE, 1995, GENETICS, V141, P1383; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; SIMON J, COMMUNICATION; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Xu L, 2001, GENETICS, V159, P1007; Xu L, 2001, P NATL ACAD SCI USA, V98, P5061, DOI 10.1073/pnas.081016198	30	95	106	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2235	2238		10.1126/science.1070790	http://dx.doi.org/10.1126/science.1070790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077420	Green Accepted			2022-12-24	WOS:000176379000063
J	McTigue, KM; Garrett, JM; Popkin, BM				McTigue, KM; Garrett, JM; Popkin, BM			The natural history of the development of obesity in a cohort of young US adults between 1981 and 1998	ANNALS OF INTERNAL MEDICINE			English	Article							SELF-REPORTED WEIGHT; BODY-MASS INDEX; OVERWEIGHT; HEALTH; HEIGHT; VALIDITY; GAIN	Background: understanding the natural history of obesity in a population may be a critical step toward developing effective interventions. Objective: To assess the development of body mass and examine the role of race or ethnicity, sex, and birth year in obesity onset in young U.S. adults. Design: Prospective cohort study. Setting: The National Longitudinal Survey of Youth 1979, a national sample with oversampling of minority ethnic groups. Participants: 9179 persons. Measurements: Body mass index (BMI) calculated from 12 self-reported height and weight samples recorded between 1981 and 1998. Logistic regression identified predictors of obesity at age 35 to 37 years. Cox proportional hazards models compared the incidence of obesity by ethnicity and birth year. Results: Overall, 26% of men and 28% of women were obese (BMI greater than or equal to 30 kg/m(2)) by age 35 to 37 years. Race or ethnicity and baseline BMI were significant predictors of obesity. Obesity onset was 2.1 (95% Cl, 1.6 to 2.7) times faster for black women and 1.5 (Cl, 1.1 to 2.0) times faster for Hispanic women than for white women. The pattern for men differed: Overall, obesity developed most rapidly in Hispanic men, but relative rates of obesity onset for white men compared with black men varied according to age. The rate of obesity onset increased 26% to 28% over an 8-year span in birth year. Conclusions: Marked ethnic-based differences were found in rates of weight accumulation in young U.S. adults, with later birth cohorts experiencing earlier onset of obesity. To alter the course of obesity in the United States, interventions should target young adults, especially those of minority ethnic groups.	Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	McTigue, KM (corresponding author), Univ N Carolina, 5034 Old Clin Bldg,CB 7105, Chapel Hill, NC 27599 USA.	kathleen_mctigue@unc.edu	Popkin, Barry/T-6633-2019		NICHD NIH HHS [R01-HD39183] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039183] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allison DB, 2000, MED CLIN N AM, V84, P305, DOI 10.1016/S0025-7125(05)70223-6; Cawley J, 2000, HEALTH SERV RES, V35, P1159; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Guo G, 2000, DEMOGRAPHY, V37, P431, DOI 10.2307/2648070; Johnson TP, 2001, ADDICTION, V96, P1187, DOI 10.1046/j.1360-0443.2001.968118711.x; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; KUSKOWSKAWOLK A, 1989, INT J OBESITY, V13, P441; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NAJJAR MF, 1989, DHHS PUBLICATION PHS; *NAT CTR HLTH STAT, 2001, NAT VIT STAT REP, V49; *NAT I DIAB DIG KI, 1998, NIH PUBL; Nieto-Garcia F J, 1990, Epidemiology, V1, P146, DOI 10.1097/00001648-199003000-00011; *OH STAT U, 1999, US GUID GUID 1979 19; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; PRSONS TJ, 1999, INT J OBES RELAT S8, V23, pS1; RISSANEN A, 1988, INT J OBESITY, V12, P391; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; *US DEP HHS, 2000, DHHS PUBL PHS; *US DEP HHS, 2000, PREV OV OB AD US 199; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665	23	195	199	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2002	136	12					857	864		10.7326/0003-4819-136-12-200206180-00006	http://dx.doi.org/10.7326/0003-4819-136-12-200206180-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563JL	12069559				2022-12-24	WOS:000176252500001
J	Lopert, R; Lang, DL; Hill, SR; Henry, DA				Lopert, R; Lang, DL; Hill, SR; Henry, DA			Differential pricing of drugs: a role for cost-effectiveness analysis?	LANCET			English	Article; Proceedings Paper	Workshop on Differential Pricing and Financing of Essential Drugs	APR 08-11, 2001	NORWEGIAN FOREIGN AFFAIRS MINIST, HOSBJOR, NORWAY	Global Hlth Council, WHO, World Trade Org Secretariats	NORWEGIAN FOREIGN AFFAIRS MINIST		ECONOMIC-EVALUATION GUIDELINES; SURVIVAL	Internationally, the high costs of pharmaceutical products limit access to treatment. The principle of differential pricing is that drug prices should vary according to some measure of affordability. How differential prices should be determined is, however, unclear. Here we describe a method whereby differential prices for essential drugs could be derived in countries of variable national wealth, and, using angiotensin-converting enzyme inhibitors provide an example of how the process might work. Indicative prices for drugs can be derived by cost-effectiveness analysis that incorporates a measure of national wealth, Such prices could be used internationally as a basis of differential price negotiations.	Univ Newcastle, Fac Hlth, Sch Med Practice & Populat Hlth, WHO Collaborating Ctr Training Pharmacol & Rat Dr, Newcastle, NSW 2308, Australia	University of Newcastle	Henry, DA (corresponding author), Newcastle Mater Hosp, Waratah, NSW 2298, Australia.	mddah@mail.newcastle.edu.au	Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; Lang, Danielle/0000-0002-3703-8112; Lopert, Ruth/0000-0002-0882-4288				Baladi JF, 1998, HEALTH ECON, V7, P221, DOI 10.1002/(SICI)1099-1050(199805)7:3<221::AID-HEC341>3.0.CO;2-N; Binswanger HP, 2001, SCIENCE, V292, P221, DOI 10.1126/science.1057504; DRUMMOND MF, 1992, HEALTH AFFAIR, V11, P191, DOI 10.1377/hlthaff.11.4.191; Gottlieb S, 2001, BRIT MED J, V322, P692; HENRY D, 1994, AUST PRESCRIBER S1, V17, P32; Kanavos P, 2000, INT J TECHNOL ASSESS, V16, P1179, DOI 10.1017/S0266462300103216; MCNEIL DG, 2001, NY TIMES        0207, P1; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; VELASQUEZ G, 2001, WHODAP989; *WHO, 1999, WHO DRUG INFORMATION, V13, P249; WHO/ WTO [World Health Organization/ World Trade Organization Secretariats], 2001, WORKSH DIFF PRIC FIN; *WORLD TRAD ORG, 2001, DOH WTO MIN; WorldHealthOrganization, 2001, B WHO; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; 2001, WORLD BANK COUNTRY D; 2001, GLOBAL ALLIANCE VACC	18	22	22	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2002	359	9323					2105	2107		10.1016/S0140-6736(02)08911-0	http://dx.doi.org/10.1016/S0140-6736(02)08911-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	562JX	12086780				2022-12-24	WOS:000176194600027
J	Roy, S; Hill, AVS; Knox, K; Griffiths, D; Crook, D				Roy, S; Hill, AVS; Knox, K; Griffiths, D; Crook, D			Association of common genetic variant with susceptibility to invasive pneumococcal disease	BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; POLYSACCHARIDE		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Hill, AVS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.		HILL, Adrian V>S>/C-1306-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		HOROWITZ J, 1987, J IMMUNOL, V138, P2598; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612	3	30	33	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2002	324	7350					1369	1369		10.1136/bmj.324.7350.1369	http://dx.doi.org/10.1136/bmj.324.7350.1369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052806	Green Published, Bronze			2022-12-24	WOS:000176234100021
J	Lachmann, HJ; Booth, DR; Booth, SE; Bybee, A; Gilbertson, JA; Gillmore, JD; Pepys, MB; Hawkins, PN				Lachmann, HJ; Booth, DR; Booth, SE; Bybee, A; Gilbertson, JA; Gillmore, JD; Pepys, MB; Hawkins, PN			Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; FIBRINOGEN ALPHA-CHAIN; RENAL AMYLOIDOSIS; TRANSTHYRETIN AMYLOIDOSIS; CARDIAC AMYLOIDOSIS; APOLIPOPROTEIN AL; ENGLISH FAMILY; P COMPONENT; CONGO RED; VARIANT	Background: Hereditary, autosomal dominant amyloidosis, caused by mutations in the genes encoding transthyretin, fibrinogen A alpha-chain, lysozyme, or apolipoprotein A-I, is thought to be extremely rare and is not routinely included in the differential diagnosis of systemic amyloidosis unless there is a family history. Methods: We studied 350 patients with systemic amyloidosis, in whom a diagnosis of the light-chain (AL) type of the disorder had been suggested by clinical and laboratory findings and by the absence of a family history, to assess whether they had amyloidogenic mutations. Results: Amyloidogenic mutations were present in 34 of the 350 patients (9.7 percent), most often in the genes encoding fibrinogen A alpha-chain (18 patients) and transthyretin (13 patients). In all 34 of these patients, the diagnosis of hereditary amyloidosis was confirmed by additional investigations. A low-grade monoclonal gammopathy was detected in 8 of the 34 patients (24 percent). Conclusions: A genetic cause should be sought in all patients with amyloidosis that is not the reactive systemic amyloid A type and in whom confirmation of the AL type cannot be obtained.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Natl Amyloidosis Ctr, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Hawkins, PN (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Natl Amyloidosis Ctr, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	p.n.hawkins@rfc.ucl.ac.uk	Hawkins, Philip N/C-5573-2008	Lachmann, Helen/0000-0001-8378-2498				Asl LH, 1999, AM J PATHOL, V154, P221, DOI 10.1016/S0002-9440(10)65268-6; BENSON MD, 1993, NAT GENET, V3, P252, DOI 10.1038/ng0393-252; Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354; Benson MD, 2001, GENOMICS, V72, P272, DOI 10.1006/geno.2000.6499; BOOTH DR, 1995, CIRCULATION, V91, P962, DOI 10.1161/01.CIR.91.4.962; Connors LH, 2000, AMYLOID, V7, P54, DOI 10.3109/13506120009146826; Davison A M, 1985, Contrib Nephrol, V48, P24; de Sousa MM, 2000, AM J PATHOL, V156, P1911, DOI 10.1016/S0002-9440(10)65064-X; Gertz MA, 2000, BONE MARROW TRANSPL, V25, P465, DOI 10.1038/sj.bmt.1702178; Gillmore JD, 1999, NEPHROL DIAL TRANSPL, V14, P2639, DOI 10.1093/ndt/14.11.2639; Gillmore JD, 1998, BRIT J HAEMATOL, V100, P226, DOI 10.1046/j.1365-2141.1998.00527.x; Gillmore JD, 2000, QJM-INT J MED, V93, P269, DOI 10.1093/qjmed/93.5.269; HAWKINS PN, 1994, CLIN SCI, V87, P289, DOI 10.1042/cs0870289; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; LINKE RP, 1995, J HISTOCHEM CYTOCHEM, V43, P863, DOI 10.1177/43.9.7642960; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; SOUTAR AK, 1992, P NATL ACAD SCI USA, V89, P7389, DOI 10.1073/pnas.89.16.7389; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; Tennent GA, 1999, METHOD ENZYMOL, V309, P26; UEMICHI T, 1994, J CLIN INVEST, V93, P731, DOI 10.1172/JCI117027; Uemichi T, 1996, QJM-MON J ASSOC PHYS, V89, P745, DOI 10.1093/qjmed/89.10.745; VIGUSHIN DM, 1994, Q J MED, V87, P149; Wardley AM, 1998, BRIT J CANCER, V78, P774, DOI 10.1038/bjc.1998.577	31	440	468	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2002	346	23					1786	1791		10.1056/NEJMoa013354	http://dx.doi.org/10.1056/NEJMoa013354			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559EK	12050338	Green Published			2022-12-24	WOS:000176012500004
J	Elderfield, H				Elderfield, H			Climate change: Carbonate mysteries	SCIENCE			English	Editorial Material							CALCIFICATION		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.							Anderson DM, 2002, NATURE, V416, P70, DOI 10.1038/416070a; Broecker WS, 2001, SCIENCE, V294, P2152, DOI 10.1126/science.1064171; BROECKER WS, 2002, GEOCHEM GEOPHYS GEOS, V3; ELDERFIELD H, 2001, EOS T AGU S, V82; Houghton JT., 1995, CLIMATE CHANGE 1994; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321	10	41	57	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1618	+		10.1126/science.1072079	http://dx.doi.org/10.1126/science.1072079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040166				2022-12-24	WOS:000175976200029
J	Gupta, R; He, ZY; Luan, S				Gupta, R; He, ZY; Luan, S			Functional relationship of cytochrome c(6) and plastocyanin in Arabidopsis	NATURE			English	Article							PROTEIN PHOSPHATASE; GENE-EXPRESSION; PHOTOSYSTEM-I; COPPER; CYANOBACTERIUM; SPECIFICITY	Photosynthetic electron carriers are important in converting light energy into chemical energy in green plants. Although protein components in the electron transport chain are largely conserved among plants, algae and prokaryotes, there is thought to be a major difference concerning a soluble protein in the thylakoid lumen. In cyanobacteria and eukaryotic algae, both plastocyanin and cytochrome c(6) mediate electron transfer from cytochrome b(6)f complex to photosystem I1-4. In contrast, only plastocyanin has been found to play the same role in higher plants. It is widely accepted that cytochrome c(6) has been evolutionarily eliminated from higher-plant chloroplasts(5,6). Here we report characterization of a cytochrome c(6)-like protein from Arabidopsis (referred to as Atc6). Atc6 is a functional cytochrome c localized in the thylakoid lumen. Electron transport reconstruction assay showed that Atc6 replaced plastocyanin in the photosynthetic electron transport process. Genetic analysis demonstrated that neither plastocyanin nor Atc6 was absolutely essential for Arabidopsis growth and development. However, plants lacking both plastocyanin and Atc6 did not survive.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Luan, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	sluan@nature.berkeley.edu		Gupta, Rajeev/0000-0002-1451-215X				ATTAASAFOADJEI E, 1985, ARCH BIOCHEM BIOPHYS, V243, P660, DOI 10.1016/0003-9861(85)90544-2; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crofts A. R., 1978, CURR TOP BIOENERG, V7, P175; De la Cerda B, 1999, J BIOL CHEM, V274, P13292, DOI 10.1074/jbc.274.19.13292; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Gupta R, 1998, PLANT J, V16, P581, DOI 10.1046/j.1365-313x.1998.00327.x; HAUSKA GA, 1971, J BIOL CHEM, V246, P3524; HERVAS M, 1993, FEBS LETT, V319, P257, DOI 10.1016/0014-5793(93)80558-C; Hippler M, 1999, J BIOL CHEM, V274, P4180, DOI 10.1074/jbc.274.7.4180; KATOH SJ, 1959, BIOCHEMISTRY-US, V46, P629; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; LUAN S, 1992, PLANT CELL, V4, P971, DOI 10.1105/tpc.4.8.971; MALKIN R, 2000, PLANT BIOCH MOL BIOL, P568; Merchant S, 1997, CH MICROBIOL SER, P450; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sigfridsson K, 1998, PHOTOSYNTH RES, V57, P1, DOI 10.1023/A:1006067631076; SOMERVILLE CR, 1981, PLANT SCI LETT, V21, P89, DOI 10.1016/0304-4211(81)90073-0; TOBIN EM, 1985, ANNU REV PLANT PHYS, V36, P569, DOI 10.1146/annurev.pp.36.060185.003033; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; ZHANG L, 1992, J BIOL CHEM, V267, P19054	27	74	85	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					567	571		10.1038/417567a	http://dx.doi.org/10.1038/417567a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037572				2022-12-24	WOS:000175860300047
J	Horrobin, DF				Horrobin, DF			Effective clinical innovation: an ethical imperative	LANCET			English	Article									Laxdale, Stirling FK7 9QL, Scotland		Horrobin, DF (corresponding author), Laxdale, Pk House,Laurelhill Business Pk,Polmaise Rd, Stirling FK7 9QL, Scotland.								0	26	26	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 25	2002	359	9320					1857	1858		10.1016/S0140-6736(02)08707-X	http://dx.doi.org/10.1016/S0140-6736(02)08707-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044395				2022-12-24	WOS:000175775500028
J	Hippisley-Cox, J; Groom, L; Kendrick, D; Coupland, C; Webber, E; Savelyich, B				Hippisley-Cox, J; Groom, L; Kendrick, D; Coupland, C; Webber, E; Savelyich, B			Cross sectional survey of socioeconomic variations in severity and mechanism of childhood injuries in Trent 1992-7	BRITISH MEDICAL JOURNAL			English	Article							ACCIDENTAL INJURY; SOCIAL-CLASS; EMERGENCY; MORTALITY; CHILDREN; HOME	Objective To determine the relation between morbidity from injury and deprivation for different levels of injury severity and for different injury mechanisms for children aged 0-14 years. Design Cross sectional survey of routinely collected hospital admission data for injury 1992-7. Setting 862 electoral wards in Trent Region. Subjects 21 587 injury related hospital admissions for children aged 04 years and 35 042 admissions for children aged 5-14. Main outcome measures Rate ratios for hospital admission for all injuries,all injuries involving long bone fracture, and all injuries invoking long bone fracture requiring an operation; rate ratios for hospital admission for six tapes of injury mechanism divided by quintiles of the electoral wards' Townsend scores for deprivation. Rate ratios calculated by Poisson regression, with adjustment for distance from nearest hospital admitting patients with injuries, rurality, ethnicity, mid percentage of males in cacti electoral ward. Results Both total number of admissions for injury and admissions for injuries of higher severity increased with increasing socioeconomic deprivation. These gradients were more marked for 0-4 year old children than 5-14 year olds. In terms of injury mechanisms, the steepest socioeconomic gradients ( where the rate for the fifth of electoral wards with die highest deprivation scores was greater than or equal to3 times that of the fifth with the lowest scores) were for pedestrian injuries (adjusted rate ratio 3.65 (9511,0 confidence interval 2.94 to 4.54)), burns and scalds (adjusted rate ratio 3.49 (2.81 to 4.34)), and poisoning (adjusted rate ratio 2.98 (2.65 to 3.34)). Conclusion There are steep socioeconomic gradients for injury morbidity including die most common mechanisms of injury. This has implications for targeting injury prevention interventions mid resources.	Div Gen Practice, Nottingham NG7 2RD, England		Hippisley-Cox, J (corresponding author), Div Gen Practice, Tower Bldg,Univ Pk, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Kendrick, Denise/0000-0003-3603-6542; Coupland, Carol/0000-0002-2327-3306				ALWASH R, 1988, ARCH DIS CHILD, V63, P635, DOI 10.1136/adc.63.6.635; ALWASH R, 1988, BRIT MED J, V296, P1450, DOI 10.1136/bmj.296.6634.1450; *BRIT MED ASS, 2001, INJ PREV; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Carstairs V, 1991, DEPRIVATION HLTH; Cryer PC, 2000, PUBLIC HEALTH, V114, P232; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Gorman DR, 1999, PUBLIC HEALTH, V113, P285, DOI 10.1016/S0033-3506(99)00181-X; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; KENDRICK D, 1993, J PUBLIC HEALTH MED, V15, P171; Laing GJ, 1999, PUBLIC HEALTH, V113, P291, DOI 10.1016/S0033-3506(99)00182-1; LANGLEY J, 1983, AUST PAEDIATR J, V19, P237; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; MAJEED FA, 1994, BMJ-BRIT MED J, V308, P1426, DOI 10.1136/bmj.308.6941.1426; MCKEE CM, 1990, BRIT J GEN PRACT, V40, P150; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; Townsend P, 1982, THE BLACK REPORT; Walsh S S, 1996, Inj Prev, V2, P16, DOI 10.1136/ip.2.1.16; WALSH SS, 1992, J EPIDEMIOL COMMUN H, V46, P26, DOI 10.1136/jech.46.1.26; Williams JM, 1997, SOC SCI MED, V44, P1881, DOI 10.1016/S0277-9536(96)00297-3	24	142	144	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1132	1134C		10.1136/bmj.324.7346.1132	http://dx.doi.org/10.1136/bmj.324.7346.1132			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552LX	12003886	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000175622800024
J	Kaeberlein, T; Lewis, K; Epstein, SS				Kaeberlein, T; Lewis, K; Epstein, SS			Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment	SCIENCE			English	Article							MICROBIAL DIVERSITY; SEDIMENTS; DNA	The majority (>99%) of microorganisms from the environment resist cultivation in the laboratory. Ribosomal RNA analysis suggests that uncultivated organisms are found in nearly every prokaryotic group, and several divisions have no known cultivable representatives. We designed a diffusion chamber that allowed the growth of previously uncultivated microorganisms in a simulated natural environment. Colonies of representative marine organisms were isolated in pure culture. These isolates did not grow on artificial media alone but formed colonies in the presence of other microorganisms. This observation may help explain the nature of microbial uncultivability.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University; Northeastern University	Epstein, SS (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu	chen, qi/C-8585-2011					Allsopp D., 1995, MICROBIAL DIVERSITY; Barer MR, 1999, ADV MICROB PHYSIOL, V41, P93, DOI 10.1016/S0065-2911(08)60166-6; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Bergey DH., 2001, BERGEYS MANUAL SYSTE; BUTKEVICH VL. S., 1932, TRUDY GOS SUDARSTVENNOGO OKEANOGRAFICHESKOGO INSTITUTA [TRANS OCEANOGR INST [MOSCOW]], V2, P5; Cifuentes A, 2000, APPL ENVIRON MICROB, V66, P1715, DOI 10.1128/AEM.66.4.1715-1719.2000; Colwell RR, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P1; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dojka MA, 2000, APPL ENVIRON MICROB, V66, P1617, DOI 10.1128/AEM.66.4.1617-1621.2000; Dunny GM, 1999, CELL-CELL SIGNALING IN BACTERIA, P1; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Epstein SS, 1997, MICROBIAL ECOL, V34, P199, DOI 10.1007/s002489900049; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Giovannoni S., 2000, P47; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Grimes DJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P209; JANNASCH HW, 1959, LIMNOL OCEANOGR, V4, P128, DOI 10.4319/lo.1959.4.2.0128; LEWIN RA, 1970, CAN J MICROBIOL, V16, P517, DOI 10.1139/m70-087; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; MEYERREIL LA, 1978, APPL ENVIRON MICROB, V36, P506, DOI 10.1128/AEM.36.3.506-512.1978; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Staley J. T., 1989, BERGEYS MANUAL SYSTE; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Tenover F. C., 1992, The Prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. Volume IV.., P3488; TIEDJE JM, 1994, ASM NEWS, V60, P524; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Young P, 1997, ASM NEWS, V63, P417; ZoBell C., 1946, MARINE MICROBIOLOGY	29	793	907	39	516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1127	1129		10.1126/science.1070633	http://dx.doi.org/10.1126/science.1070633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004133				2022-12-24	WOS:000175565000056
J	Zorzi, M; Priftis, K; Umilta, C				Zorzi, M; Priftis, K; Umilta, C			Brain damage - Neglect disrupts the mental number line	NATURE			English	Article							REPRESENTATION		Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Padua; Vita-Salute San Raffaele University	Zorzi, M (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.		Zorzi, Marco/B-7863-2008; Priftis, Konstantinos/B-7862-2008	Zorzi, Marco/0000-0002-4651-6390; Priftis, Konstantinos/0000-0002-5215-4621				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Bisiach E., 2000, HDB NEUROPSYCHOLOGY, P459; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; CARAMAZZA A, 1990, NATURE, V346, P267, DOI 10.1038/346267a0; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0096-3445.122.3.371; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; HADAMARD J, 1996, MATH MIND PSYCHOL IN; MARSHALL JC, 1989, CORTEX, V25, P503, DOI 10.1016/S0010-9452(89)80065-6; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; SERON X, 1992, COGNITION, V44, P159, DOI 10.1016/0010-0277(92)90053-K	13	503	517	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					138	139		10.1038/417138a	http://dx.doi.org/10.1038/417138a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549RH	12000950				2022-12-24	WOS:000175460200031
J	Kapranov, P; Cawley, SE; Drenkow, J; Bekiranov, S; Strausberg, RL; Fodor, SPA; Gingeras, TR				Kapranov, P; Cawley, SE; Drenkow, J; Bekiranov, S; Strausberg, RL; Fodor, SPA; Gingeras, TR			Large-scale transcriptional activity in chromosomes 21 and 22	SCIENCE			English	Article							DNA-SEQUENCE; DIGEORGE; GENES; MAP	The sequences of the human chromosomes 21 and 22 indicate that there are approximately 770 well-characterized and predicted genes. In this study, empirically derived maps identifying active areas of RNA transcription on these chromosomes have been constructed with the use of cytosolic polyadenylated RNA obtained from 11 human cell lines. Oligonucleotide arrays containing probes spaced on average every 35 base pairs along these chromosomes were used. When compared with the sequence annotations available for these chromosomes, it is noted that as much as an order of magnitude more of the genomic sequence is transcribed than accounted for by the predicted and characterized exons.	Affymetrix, Santa Clara, CA 95051 USA; NCI, Bethesda, MD 20892 USA	Affymetrix; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gingeras, TR (corresponding author), Affymetrix, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com						BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 2001, GENOME RES, V11, P208, DOI 10.1101/gr.GR-1431R; Erdmann VA, 2001, CELL MOL LIFE SCI, V58, P960, DOI 10.1007/PL00000913; Gong WK, 1996, HUM MOL GENET, V5, P789, DOI 10.1093/hmg/5.6.789; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Li M., 1994, American Journal of Human Genetics, V55, pA10; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Wright FA, 2001, GENOME BIOL, V2	14	653	688	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2002	296	5569					916	919		10.1126/science.1068597	http://dx.doi.org/10.1126/science.1068597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988577				2022-12-24	WOS:000175442500046
J	Gillooly, JF; Charnov, EL; West, GB; Savage, VM; Brown, JH				Gillooly, JF; Charnov, EL; West, GB; Savage, VM; Brown, JH			Effects of size and temperature on developmental time	NATURE			English	Article							EMBRYONIC-DEVELOPMENT TIME; N-P STOICHIOMETRY; INCUBATION-TEMPERATURE; LIFE-HISTORY; BODY-SIZE; EGG SIZE; ZOOPLANKTON; GROWTH; REPRODUCTION; LONGEVITY	Body size and temperature are the two most important variables affecting nearly all biological rates and times(1-7). The relationship of size and temperature to development is of particular interest, because during ontogeny size changes and temperature often varies(8-12).Here we derive a general model, based on first principles of allometry and biochemical kinetics, that predicts the time of ontogenetic development as a function of body mass and temperature. The model fits embryonic development times spanning a wide range of egg sizes and incubation temperatures for birds and aquatic ectotherms (fish, amphibians, aquatic insects and zooplankton). The model also describes nearly 75% of the variation in post-embryonic development among a diverse sample of zooplankton. The remaining variation is partially explained by stoichiometry, specifically the whole-body carbon to phosphorus ratio. Development in other animals at other life stages is also described by this model. These results suggest a general definition of biological time that is approximately invariant and common to all organisms.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA	University of New Mexico; The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Washington University (WUSTL)	Gillooly, JF (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	gillooly@unm.edu						ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; ANDERSON DH, 1994, LIMNOL OCEANOGR, V39, P1517, DOI 10.4319/lo.1994.39.7.1517; Calder W.A. III., 1974, Publications Nuttall Orn Club, VNo. 15, P86; Calder WA., 1984, SIZE FUNCTION LIFE H; COSSINS AH, 1987, TEMEPRATURE BIOL ANI; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; FORAN JA, 1986, OIKOS, V46, P185, DOI 10.2307/3565466; GEILING WT, 1972, LIMNOL OCEANOGR, V17, P304, DOI 10.4319/lo.1972.17.2.0304; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2000, FRESHWATER BIOL, V44, P595, DOI 10.1046/j.1365-2427.2000.00607.x; Gillooly JF, 2000, J ZOOL, V251, P369, DOI 10.1017/S095283690000710X; Gillooly JF, 2000, J PLANKTON RES, V22, P241, DOI 10.1093/plankt/22.2.241; HANAZATO T, 1985, Japanese Journal of Limnology, V46, P185; Heinroth O., 1922, Journal fuer Ornithologie Leipzig, V70, P172, DOI 10.1007/BF02537515; HESSEN DO, 1991, ARCH HYDROBIOL, V121, P343; KANKAALA P, 1981, OIKOS, V36, P137, DOI 10.2307/3544438; LINDSTEDT SL, 1981, Q REV BIOL, V56, P1, DOI 10.1086/412080; MAIER G, 1990, HYDROBIOLOGIA, V203, P165, DOI 10.1007/BF00005685; Main TM, 1997, LIMNOL OCEANOGR, V42, P1474, DOI 10.4319/lo.1997.42.6.1474; McLeese JM, 1996, GEN COMP ENDOCR, V102, P47, DOI 10.1006/gcen.1996.0045; MUNRO IG, 1974, OECOLOGIA, V16, P355, DOI 10.1007/BF00344742; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; SCHMIDTNIELSEN K, 1983, SCALING WHY IS ANIMA; Scott W.B., 1988, CAN B FISH AQUAT SCI, V219; Somero G. N., 1997, HDB PHYSL, P1391; VETTER RAH, 1995, J COMP PHYSIOL B, V165, P46, DOI 10.1007/BF00264685; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	30	580	608	8	417	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2002	417	6884					70	73		10.1038/417070a	http://dx.doi.org/10.1038/417070a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986667	Green Published			2022-12-24	WOS:000175307200039
J	Artsimovitch, I; Landick, R				Artsimovitch, I; Landick, R			The transcriptional regulator RfaH stimulates RNA chain synthesis after recruitment to elongation complexes by the exposed nontemplate DNA strand	CELL			English	Article							ESCHERICHIA-COLI HEMOLYSIN; SALMONELLA-TYPHIMURIUM; TERMINATION EFFICIENCY; POLYMERASE-II; GENE-CLUSTER; PROTEIN; ANTITERMINATION; EXPRESSION; MUTANTS; MECHANISM	The transcriptional regulatory protein RfaH controls expression of several operons that encode extracytoplasmic components in bacteria. Regulation by RfaH occurs during transcript elongation and depends on a 5'-proximal, transcribed nucleic acid sequence called ops that induces transcriptional pausing in vitro and in vivo. We report that RfaH recognizes RNA polymerase transcribing RfaH-regulated operons by interacting with the ops sequence in the exposed nontemplate DNA strand of ops-paused transcription complexes. Although RfaH delays escape from the ops pause, once escape occurs, RfaH enhances elongation by suppressing pausing and p-dependent termination without apparent involvement of other accessory proteins. This activity predicts a cumulative antitermination model for RfaH's regulation of ops-containing operons in vivo.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	landick@bact.wisc.edu	Artsimovitch, Irina/L-3467-2019		NIGMS NIH HHS [GM 38660] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R29GM038660, R01GM038660] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bailey MJA, 1996, MOL MICROBIOL, V22, P729, DOI 10.1046/j.1365-2958.1996.d01-1726.x; Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Bailey MJA, 2000, MOL GEN GENET, V262, P1052, DOI 10.1007/PL00008648; BENTLEY DL, 1995, CURR OPIN GENET DEV, V5, P210, DOI 10.1016/0959-437X(95)80010-7; BEUTIN L, 1979, J BACTERIOL, V139, P730, DOI 10.1128/JB.139.3.730-737.1979; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; Choy HE, 1996, METHOD ENZYMOL, V274, P3; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; DENISOVA LJ, 1982, DOKL AKAD NAUK SSSR+, V267, P475; FAREWELL A, 1991, J BACTERIOL, V173, P5188, DOI 10.1128/jb.173.16.5188-5193.1991; FRIEDEN C, 1994, METHOD ENZYMOL, V240, P311; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gorke B, 2001, J MOL BIOL, V308, P131, DOI 10.1006/jmbi.2001.4590; GRAYHACK EJ, 1985, CELL, V42, P259, DOI 10.1016/S0092-8674(85)80121-5; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KORONAKIS V, 1988, NUCLEIC ACIDS RES, V16, P4789, DOI 10.1093/nar/16.11.4789; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Landick R, 1996, METHOD ENZYMOL, V274, P334; LAU LF, 1983, J BIOL CHEM, V258, P9391; Leeds JA, 1997, J BACTERIOL, V179, P3519, DOI 10.1128/jb.179.11.3519-3527.1997; Leeds JA, 1996, J BACTERIOL, V178, P1850, DOI 10.1128/jb.178.7.1850-1857.1996; MASON SW, 1992, J BIOL CHEM, V267, P19418; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Nagy G, 2001, INFECT IMMUN, V69, P1924, DOI 10.1128/IAI.69.3.1924-1928.2001; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; NunezValdez ME, 1996, GENE, V172, P75, DOI 10.1016/0378-1119(96)00055-8; Opalka N, 2000, P NATL ACAD SCI USA, V97, P617, DOI 10.1073/pnas.97.2.617; Paitan Y, 1999, FEMS MICROBIOL LETT, V170, P221, DOI 10.1111/j.1574-6968.1999.tb13377.x; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rees WA, 1997, J MOL BIOL, V273, P797, DOI 10.1006/jmbi.1997.1327; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; Stevens MP, 1997, MOL MICROBIOL, V24, P1001, DOI 10.1046/j.1365-2958.1997.4241780.x; STOCKER BAD, 1980, J GEN MICROBIOL, V116, P17; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; Wang L, 1998, FEMS MICROBIOL LETT, V165, P201, DOI 10.1016/S0378-1097(98)00264-X; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; WILKINSON RG, 1972, J GEN MICROBIOL, V70, P527, DOI 10.1099/00221287-70-3-527; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	56	192	195	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					193	203		10.1016/S0092-8674(02)00724-9	http://dx.doi.org/10.1016/S0092-8674(02)00724-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007406	Bronze			2022-12-24	WOS:000175082600009
J	Liu, BP; Fournier, A; GrandPre, T; Strittmatter, SM				Liu, BP; Fournier, A; GrandPre, T; Strittmatter, SM			Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor	SCIENCE			English	Article							AXON REGENERATION; NEURITE OUTGROWTH; INHIBITION; BINDING; GANGLIOSIDES; SIALOADHESIN; INTERACTS; PROTEIN; ANALOGS; FAMILY	Axonal regeneration in the adult central nervous system (CNS) is limited by two proteins in myelin, Nogo and myelin-associated glycoprotein (MAG). The receptor for Nogo (NgR) has been identified as an axonal glycosyl-phosphatidylinositol (GPI) anchored protein, whereas the MAG receptor has remained elusive. Here, we show that MAG binds directly, with high affinity, to NgR. Cleavage of GPI-linked proteins from axons protects growth cones from MAG-induced collapse, and dominant-negative NgR eliminates MAG inhibition of neurite outgrowth. MAG-resistant embryonic neurons are rendered MAG-sensitive by expression of NgR. MAG and Nogo-66 activate NgR independently and serve as redundant NgR ligands that may limit axonal regeneration after CNS injury.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.		Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Collins BE, 1999, J BIOL CHEM, V274, P37637, DOI 10.1074/jbc.274.53.37637; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Filbin MT, 2000, CURR BIOL, V10, pR100, DOI 10.1016/S0960-9822(00)00302-X; FOURNIER A, UNPUB; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KIM J, UNPUB; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.0.CO;2-K; Liu B. J., UNPUB; McKerracher L, 2001, NEUROBIOL DIS, V8, P11, DOI 10.1006/nbdi.2000.0359; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Sawada N, 1999, CARBOHYD RES, V316, P1, DOI 10.1016/S0008-6215(99)00081-6; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Wang XX, 2002, J NEUROSCI, V22, P5505; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814	24	462	513	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1190	1193		10.1126/science.1073031	http://dx.doi.org/10.1126/science.1073031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12089450				2022-12-24	WOS:000177447600053
J	Mitrofanov, I; Anfimov, D; Kozyrev, A; Litvak, M; Sanin, A; Tret'yakov, V; Krylov, A; Shvetsov, V; Boynton, W; Shinohara, C; Hamara, D; Saunders, RS				Mitrofanov, I; Anfimov, D; Kozyrev, A; Litvak, M; Sanin, A; Tret'yakov, V; Krylov, A; Shvetsov, V; Boynton, W; Shinohara, C; Hamara, D; Saunders, RS			Maps of subsurface hydrogen from the high energy neutron detector, Mars Odyssey	SCIENCE			English	Article							ORBITER LASER ALTIMETER; WATER; ICE	After 55 days of mapping by the High Energy Neutron Detector onboard Mars Odyssey, we found deficits of high-energy neutrons in the southern highlands and northern lowlands of Mars. These deficits indicate that hydrogen is concentrated in the subsurface. Modeling suggests that water ice rich layers that are tens of centimeters in thickness provide one possible fit to the data.	Inst Space Res, Moscow 117997, Russia; Joint Inst Nucl Res, Dubna 141980, Russia; Univ Arizona, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Joint Institute for Nuclear Research - Russia; University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Mitrofanov, I (corresponding author), Inst Space Res, Moscow 117997, Russia.		Litvak, Maxim/C-6453-2017; Sanin, Anton/T-9393-2017	Mitrofanov, Igor/0000-0001-7204-2101				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; BOYNTON W, UNPUB; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; DRAKE DM, 1986, P LUNAR PLANET SCI C, V17, pD186; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Masarik J, 1996, J GEOPHYS RES-PLANET, V101, P18891, DOI 10.1029/96JE01563; MOHLMAN D, 2002, P WORKSH POTSD GERM; SAUNDERS RS, 2001, AGU FALL M 2001; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053	15	309	318	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					78	81		10.1126/science.1073616	http://dx.doi.org/10.1126/science.1073616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040089				2022-12-24	WOS:000176711000035
J	Infante-Rivard, C; Rivard, GE; Yotov, WV; Genin, E; Guiguet, M; Weinberg, C; Gauthier, R; Feoli-Fonseca, JC				Infante-Rivard, C; Rivard, GE; Yotov, WV; Genin, E; Guiguet, M; Weinberg, C; Gauthier, R; Feoli-Fonseca, JC			Absence of association of thrombophilia polymorphisms with intrauterine growth restriction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; BIRTH-WEIGHT; VASCULAR-DISEASE; PROTHROMBIN GENE; COMMON MUTATION; RISK FACTOR; FETAL LOSS; HOMOCYSTEINE; THROMBOSIS; PREGNANCY	Background: Previous data have demonstrated associations between thrombophilia polymorphisms in pregnant women and an increased risk of intrauterine growth restriction in their offspring, but this finding remains uncertain. Methods: We performed a hospital-based case-control study and a family-based study including 493 newborns with intrauterine growth restriction (defined by birth weight below the 10th percentile for gestational age and sex according to Canadian norms) and 472 controls (with birth weight at or above the 10th percentile). We determined the presence or absence in newborns and their parents of the following polymorphisms: methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C, factor V Leiden G1691A, and prothrombin G20210A. Mothers were interviewed to obtain information on other risk factors for intrauterine growth restriction. Results: The risk of intrauterine growth restriction was not increased among mothers carrying a polymorphism associated with thrombophilia. In the case-control study, the odds ratios associated with two copies of the variant, after adjustment for newborn genotype and other risk factors, were 1.55 for MTHFR C677T (95 percent confidence interval, 0.83 to 2.90) and 0.49 for MTHFR A1298C (95 percent confidence interval, 0.25 to 0.93); heterozygotes for factor V Leiden had an odds ratio of 1.18 (95 percent confidence interval, 0.54 to 2.55), and heterozygotes for prothrombin G20210A had an odds ratio of 0.92 (95 percent confidence interval, 0.36 to 2.35). These polymorphisms in the newborn were not associated with an increased risk. Newborns who were homozygous for the MTHFR C677T variant had a decreased risk of intrauterine growth restriction (odds ratio after adjustment for mother's genotype and other confounders, 0.52 [95 percent confidence interval, 0.29 to 0.94]). The results of the family-based study supported those of the case-control study. Conclusions: Our findings do not indicate that there are associations between maternal or newborn polymorphisms associated with thrombophilia and an increased risk of intrauterine growth restriction.	McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A3, Canada; Univ Montreal, Hop St Justine, Ctr Hosp Univ Mere Enfant, Res Ctr, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Hop St Justine, Ctr Hosp Univ Mere Enfant, Div Hematol & Oncol, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Hop St Justine, Ctr Hosp Univ Mere Enfant, Dept Obstet, Montreal, PQ H3T 1C5, Canada; INSERM, U535, Paris, France; NIEHS, Res Triangle Pk, NC 27709 USA	McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Infante-Rivard, C (corresponding author), McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, 1130 Pine Ave W, Montreal, PQ H3A 1A3, Canada.		Genin, Emmanuelle/C-4974-2013; Guiguet, Marguerite/L-8480-2018	Genin, Emmanuelle/0000-0003-4117-2813; Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100490, ZIAES040007, Z01ES040007] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*ACOG, 2000, ACOG PRACT B, V12, P1; ARBUCKLE TE, 1993, OBSTET GYNECOL, V81, P39; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Brenner B, 2000, CURR OPIN HEMATOL, V7, P290, DOI 10.1097/00062752-200009000-00006; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; INFANTERIVARD C, 1991, NEW ENGL J MED, V325, P1063, DOI 10.1056/NEJM199110103251503; Kupferminc MJ, 2000, ACTA OBSTET GYN SCAN, V79, P963, DOI 10.1034/j.1600-0412.2000.079011963.x; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Martinelli P, 2001, HAEMATOLOGICA, V86, P428; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rozen R, 2000, SEMIN THROMB HEMOST, V26, P255, DOI 10.1055/s-2000-8470; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Seeds JW, 1998, AM J OBSTET GYNECOL, V178, P658, DOI 10.1016/S0002-9378(98)70475-2; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Szczeklik A, 2001, AM J MED GENET, V101, P36, DOI 10.1002/ajmg.1315; Ueland PM, 2000, AM J CLIN NUTR, V72, P324; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Zietkiewicz E, 1997, GENE, V205, P161	30	186	194	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2002	347	1					19	25		10.1056/NEJM200207043470105	http://dx.doi.org/10.1056/NEJM200207043470105			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569HA	12097536	Bronze			2022-12-24	WOS:000176594500004
J	Cox, B; Sneyd, MJ; Paul, C; Delahunt, B; Skegg, DCG				Cox, B; Sneyd, MJ; Paul, C; Delahunt, B; Skegg, DCG			Vasectomy and risk of prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES MEN; RETROSPECTIVE COHORT; SERUM; ASSOCIATION; ANDROGENS; CANADA	Context Vasectomy is a common method of contraception, but concern exists about a reported association with risk of prostate cancer. Objective To examine whether vasectomy increases risk of prostate cancer. Design, Setting, and Participants National population-based case-control study of 923 new cases of prostate cancer among men aged 40 to 74 years from the New Zealand Cancer Registry who were on the general electoral roll. Controls (n = 1224) were randomly selected from the general electoral roll, with frequency matching to cases in 5-year age groups. Cases (3-15 months after diagnosis) and controls were interviewed by telephone between January 1997 and November 1999. Main Outcome Measures Relative risk (RR) of prostate cancer for men who had had a vasectomy vs those who had not. Results There was no association between prostate cancer and vasectomy (RR, 0.92; 95% confidence interval [CI], 0,75-1.14) nor with time since vasectomy (RR, 0.92; 95% CI, 0.68-1.23 for greater than or equal to25 years since vasectomy). Adjustment for social class, geographic region, religious affiliation, and a family history of prostate cancer did not affect these RRs. Conclusions Vasectomy does not increase the risk of prostate cancer, even after 25 years or more.	Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Otago, Wellington Sch Med, Dept Pathol, Dunedin, New Zealand	University of Otago; University of Otago	Cox, B (corresponding author), Univ Otago, Sch Med, Dept Prevent & Social Med, Hugh Adam Canc Epidemiol Unit, POB 913, Dunedin, New Zealand.	brian.cox@stonebow.otago.ac.nz	Cox, Brian/I-4510-2015; Delahunt, Brett/AAG-2382-2019		NICHD NIH HHS [Y1-HD-7053] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bernal-Delgado E, 1998, FERTIL STERIL, V70, P191, DOI 10.1016/S0015-0282(98)00142-3; Breslow RA, 1998, NUTR CANCER, V30, P1, DOI 10.1080/01635589809514633; Dillner J, 1998, INT J CANCER, V75, P564, DOI 10.1002/(SICI)1097-0215(19980209)75:4<564::AID-IJC12>3.0.CO;2-9; Dorgan JP, 1998, CANCER EPIDEM BIOMAR, V7, P1069; ELLEY WB, 1985, NEW ZEAL J EDUC STUD, V20, P115; Ghadirian P, 1996, CANCER CAUSE CONTROL, V7, P428, DOI 10.1007/BF00052669; GIOVANNUCCI E, 1993, JAMA-J AM MED ASSOC, V269, P873, DOI 10.1001/jama.269.7.873; GIOVANNUCCI E, 1993, JAMA-J AM MED ASSOC, V269, P878, DOI 10.1001/jama.269.7.878; Guess HA, 1997, CANCER EPIDEM BIOMAR, V6, P21; GUESS HA, 1990, AM J EPIDEMIOL, V132, P1062, DOI 10.1093/oxfordjournals.aje.a115748; HAYES RB, 1993, AM J EPIDEMIOL, V137, P263, DOI 10.1093/oxfordjournals.aje.a116673; HOWARDS SS, 1993, EUR J CANCER, V29A, P1060, DOI 10.1016/S0959-8049(05)80224-2; HSING AW, 1994, CANCER EPIDEM BIOMAR, V3, P285; JOHN EM, 1995, J NATL CANCER I, V87, P662, DOI 10.1093/jnci/87.9.662; Lesko SM, 1999, J UROLOGY, V161, P1848, DOI 10.1016/S0022-5347(05)68824-6; METTLIN C, 1990, AM J EPIDEMIOL, V132, P1056, DOI 10.1093/oxfordjournals.aje.a115747; MOLLER H, 1994, BRIT MED J, V309, P295, DOI 10.1136/bmj.309.6950.295; NEWELL GR, 1989, AM J EPIDEMIOL, V130, P395, DOI 10.1093/oxfordjournals.aje.a115346; NIENHUIS H, 1992, BRIT MED J, V304, P743, DOI 10.1136/bmj.304.6829.743; Nomura AMY, 1997, CANCER EPIDEM BIOMAR, V6, P487; Norrish AE, 2000, AM J EPIDEMIOL, V151, P119, DOI 10.1093/oxfordjournals.aje.a010176; PERLMAN JA, 1991, AM J EPIDEMIOL, V134, P107, DOI 10.1093/oxfordjournals.aje.a115985; Platz EA, 1997, INT J EPIDEMIOL, V26, P933, DOI 10.1093/ije/26.5.933; *POP INF PROGR, 1992, VAS NEW OPP, P17; Rohan TE, 1997, EUR J CANCER PREV, V6, P382, DOI 10.1097/00008469-199708000-00011; ROSENBERG L, 1990, AM J EPIDEMIOL, V132, P1051, DOI 10.1093/oxfordjournals.aje.a115746; ROSENBERG L, 1994, AM J EPIDEMIOL, V140, P431, DOI 10.1093/oxfordjournals.aje.a117265; Sandlow JI, 1996, FERTIL STERIL, V66, P281, DOI 10.1016/S0015-0282(16)58454-4; SCHRODER FH, 1992, PROSTATE, P129; Schwingl PJ, 2000, FERTIL STERIL, V73, P923, DOI 10.1016/S0015-0282(00)00482-9; SIDNEY S, 1991, CANCER CAUSE CONTROL, V2, P113, DOI 10.1007/BF00053130; SKEGG DCG, 1993, EUR J CANCER, V29A, P935, DOI 10.1016/S0959-8049(05)80196-0; Sneyd MJ, 2001, CONTRACEPTION, V64, P155, DOI 10.1016/S0010-7824(01)00242-6; Stanford JL, 1999, CANCER EPIDEM BIOMAR, V8, P881; Vatten LJ, 1997, CANCER EPIDEM BIOMAR, V6, P967; Willett WC, 1997, AM J CLIN NUTR, V66, P1557; World Health Organization, 1977, INT CLASS DIS MAN IN; Yoshizawa K, 1998, JNCI-J NATL CANCER I, V90, P1219, DOI 10.1093/jnci/90.16.1219; Zhu KM, 1996, AM J EPIDEMIOL, V144, P717, DOI 10.1093/oxfordjournals.aje.a008994	39	48	50	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2002	287	23					3110	3115		10.1001/jama.287.23.3110	http://dx.doi.org/10.1001/jama.287.23.3110			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563NK	12069674	Bronze			2022-12-24	WOS:000176262300026
J	Roubik, DW				Roubik, DW			Tropical agriculture - The value of bees to the coffee harvest	NATURE			English	Article									Smithsonian Trop Res Inst, Unit 0948, APO, AA 34002 USA	Smithsonian Institution; Smithsonian Tropical Research Institute	Roubik, DW (corresponding author), Smithsonian Trop Res Inst, Unit 0948, APO, AA 34002 USA.	roubikd@tivoli.si.edu						FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Lyngbaek AE, 2001, AGROFOREST SYST, V53, P205, DOI 10.1023/A:1013332722014; MUNSCHLER RG, 2001, AGROFOREST SYST, V51, P131; ROUBIK DW, 1978, SCIENCE, V201, P1030, DOI 10.1126/science.201.4360.1030; ROUBIK DW, IN PRESS INT WORKSH	5	120	125	2	62	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					708	708		10.1038/417708a	http://dx.doi.org/10.1038/417708a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066176				2022-12-24	WOS:000176154700035
J	Plasterk, RHA				Plasterk, RHA			RNA silencing: The genome's immune system	SCIENCE			English	Editorial Material							DNA METHYLATION; C-ELEGANS; GENE; INTERFERENCE; TRANSGENE; PLANTS; ARABIDOPSIS; SUPPRESSION; HELICASE; PETUNIA	Genomes are databases sensitive to invasion by viruses. In recent years, a defense mechanism has been discovered, which turns out to be conserved among eukaryotes. The system can be compared to the immune system in several ways: It has specificity against foreign elements and the ability to amplify and raise a massive response against an invading nucleic acid. The latter property is beginning to be understood at the molecular level.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.							Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 1997, TRENDS GENET, V13, P469, DOI 10.1016/S0168-9525(97)01310-3; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRISHOK A, UNPUB; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; KETTING R, UNPUB; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; LINDBO JA, 1992, VIROLOGY, V189, P725, DOI 10.1016/0042-6822(92)90595-G; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIJEN T, UNPUB; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; VAISTIJ FE, IN PRESS PLANT CELL; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	32	311	379	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1263	1265		10.1126/science.1072148	http://dx.doi.org/10.1126/science.1072148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016302				2022-12-24	WOS:000175713000039
J	Baron, R; Schattschneider, J; Binder, A; Siebrecht, D; Wasner, G				Baron, R; Schattschneider, J; Binder, A; Siebrecht, D; Wasner, G			Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study	LANCET			English	Article							DYSTROPHY CRPS-I; VASCULAR ABNORMALITIES; EVOKED PAIN; MECHANISMS; ACTIVATION; CAUSALGIA; INJECTION; SUDOMOTOR; NEURONS	Background Complex regional pain syndromes can be relieved by sympathetic blockage. The mechanisms of sympathetically maintained pain (SMP) are unclear. We aimed to establish the effect of physiological sympathetic cutaneous vasoconstrictor activity on pain and hyperalgesia in patients with complex regional pain syndromes. Methods High and low cutaneous vasoconstrictor activity was produced by whole-body cooling and warming (thermal suit) in 13 patients with type I disease and in ten controls. The degree of cutaneous vasoconstrictor discharge was monitored by measurement of skin blood flow and temperature at the arm and leg. Local skin temperature at the affected region was fixed at 35 C. Pain was quantified during high and low cutaneous vasoconstrictor activity (intensity of spontaneous pain, area of mechanical hyperalgesias, heat-pain thresholds). Furthermore, pain was measured before and after diagnostic sympathetic blockage to identify patients with SMP and sympathetically independent pain. Findings In patients with SMP, intensity of spontaneous pain significantly increased, by 22%, and spatial distribution of mechanical dynamic and punctate hyperalgesia increased by 42% and 27%, respectively, during high sympathetic activity compared with low activity. Heat-pain thresholds did not differ during high and low cutaneous vasoconstrictor activity (cold and warm state, 43.6degreesC vs 44.6degreesC). Pain relief after sympathetic blockage correlated with augmentation of spontaneous pain after experimental stimulation of cutaneous vasoconstrictor activity (r=0.6, p=0.0244). Interpretation We have shown that in complex regional pain syndromes with SMP, physiological activation of cutaneous vasoconstrictor neurons projecting to the painful arm or leg enhances spontaneous pain and hyperalgesia. We postulate that there is a pathological interaction between sympathetic and afferent neurons within the skin.	Univ Kiel, Neurol Klin, D-24105 Kiel, Germany; Univ Kiel, Klin Anasthesiol & Operat Intens Med, D-24105 Kiel, Germany	University of Kiel; University of Kiel	Baron, R (corresponding author), Univ Kiel, Neurol Klin, Niemannsweg 147, D-24105 Kiel, Germany.	r.baron@neurologie.uni-kiel.de	Baron, Ralf/E-4298-2010					Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; Baron R, 1999, NEUROLOGY, V52, P923, DOI 10.1212/WNL.52.5.923; Baron R, 2001, Curr Pain Headache Rep, V5, P114, DOI 10.1007/s11916-001-0079-x; Baron R, 1999, MUSCLE NERVE, V22, P678, DOI 10.1002/(SICI)1097-4598(199906)22:6<678::AID-MUS4>3.0.CO;2-P; Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; BINI G, 1980, J PHYSIOL-LONDON, V306, P537, DOI 10.1113/jphysiol.1980.sp013413; BONICA JJ, 1990, MANAGEMENT PAIN, V2, P220; CHABAL C, 1992, PAIN, V49, P9, DOI 10.1016/0304-3959(92)90181-A; Choi B, 1997, PAIN, V69, P55, DOI 10.1016/S0304-3959(96)03245-9; Drummond PD, 1996, CLIN SCI, V91, P73, DOI 10.1042/cs0910073; EVANS JA, 1946, SURG CLIN N AM, V26, P780; Fields H. L., 1987, PAIN; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Janig W, 1996, PROG BRAIN RES, V113, P161, DOI 10.1016/S0079-6123(08)61087-0; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; LEVINE JD, 1986, NATURE, V323, P158, DOI 10.1038/323158a0; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Price DD, 1998, CLIN J PAIN, V14, P216, DOI 10.1097/00002508-199809000-00008; RAJA SN, 1991, ANESTHESIOLOGY, V74, P691, DOI 10.1097/00000542-199104000-00012; RAJA SN, 1998, ANESTHESIOLOGY, V89, pA1083; Shi TJS, 2000, PAIN, V84, P319, DOI 10.1016/S0304-3959(99)00224-9; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; TOREBJORK E, 1995, PAIN, V63, P11, DOI 10.1016/0304-3959(95)00140-N; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wasner G, 1998, NEUROL CLIN, V16, P851, DOI 10.1016/S0733-8619(05)70101-8; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Wasner G, 1999, ARCH NEUROL-CHICAGO, V56, P613, DOI 10.1001/archneur.56.5.613; Wasner G, 2000, PAIN, V84, P331, DOI 10.1016/S0304-3959(99)00222-5; Wu G, 2001, J NEUROSCI, V21	29	171	174	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1655	1660		10.1016/S0140-6736(02)08589-6	http://dx.doi.org/10.1016/S0140-6736(02)08589-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020526				2022-12-24	WOS:000175593300009
J	Mehta, SH; Cox, A; Hoover, DR; Wang, XH; Mao, Q; Ray, S; Strathdee, SA; Vlahov, D; Thomas, DL				Mehta, SH; Cox, A; Hoover, DR; Wang, XH; Mao, Q; Ray, S; Strathdee, SA; Vlahov, D; Thomas, DL			Protection against persistence of hepatitis C	LANCET			English	Article							INJECTION-DRUG USERS; VIRUS-INFECTION; INTERFERON-ALPHA-2B; CHIMPANZEES; VACCINATION; REINFECTION; PREVALENCE; RIBAVIRIN; CHILDREN; IMMUNITY	Background Neither previous hepatitis C virus (HCV) infection nor vaccination with HCV-derived antigens protects against reinfection. However, HCV infection and vaccination in chimpanzees has been shown to reduce the magnitude and duration of viraemia with re-challenge. We aimed to establish whether similar immunity could be achieved in man. Methods From a study of injecting drug users, we identified 164 people who had no evidence of previous HCV infection and 98 individuals who had been previously, but were not currently, infected with HCV. We compared the incidence and persistence of HCV viraemia in these two groups over four consecutive 6-month periods. Findings Of participants without previous infection, the incidence of HCV infection was 21% (35/164). By contrast, people previously infected were half as likely to develop new viraemia (12% [12/98]), even after accounting for risk behaviour (hazard ratio, 0.45: 95% CI 0.23-0.88). Furthermore, in HIV-1-negative people, those previously infected were 12 times less likely than people infected for the first time to develop persistent infection (odds ratio 0.05, 95% CI 0.01-0.30), and median peak HCV RNA concentration was two logs lower. HCV persisted in six of six HIV-1-positive people, even in one man who had previously cleared HCV infection when he was HIV-1 negative. Interpretation There is an alarming frequency of HCV infection and persistence among injecting drug users. Our data suggest that immunity against viral persistence can be acquired, and that vaccines should be tested to reduce the burden of HCV-related liver disease.	Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; Rutgers State Univ, Dept Stat, Newark, NJ 07102 USA; Rutgers State Univ, Ctr Hlth Hlth Care Policy & Aging Res, Newark, NJ 07102 USA; New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; Third Mil Med Univ, SW Hosp, Chongqing, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; New York Academy of Medicine; Army Medical University	Thomas, DL (corresponding author), 424 N Bond St,Room 102, Baltimore, MD 21231 USA.		Ray, Stuart C./B-7527-2008; Strathdee, Steffanie A/B-9042-2009	Ray, Stuart C./0000-0002-1051-7260; Cox, Andrea/0000-0002-9331-2462	NIAID NIH HHS [AI 40035, U19 AI040035] Funding Source: Medline; NIDA NIH HHS [DA 08009, DA 10627, DA 06007, DA 04334] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010627, F31DA006007, R01DA004334, R37DA004334, R56DA004334] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Forns X, 2000, HEPATOLOGY, V32, P618, DOI 10.1053/jhep.2000.9877; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Global surveillance and control of hepatitis C, 1999, J VIRAL HEPAT, V6, P35; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; LAI ME, 1994, LANCET, V343, P388, DOI 10.1016/S0140-6736(94)91224-6; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Payen JL, 1998, GASTROEN CLIN BIOL, V22, P469; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; PRINCE AM, 1992, J INFECT DIS, V165, P438, DOI 10.1093/infdis/165.3.438; Proust B, 2000, J CLIN MICROBIOL, V38, P3125, DOI 10.1128/JCM.38.8.3125-3127.2000; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Saldanha J, 2002, VOX SANG, V82, P24, DOI 10.1046/j.1423-0410.2002.00132.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; Vlahov D, 1991, NIDA Res Monogr, V109, P75; 1997, HEPATOLOGY S1, V26, pS2; 1997, WKLY EPIDEMIOL REC, V72, P341	26	355	370	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 27	2002	359	9316					1478	1483		10.1016/S0140-6736(02)08435-0	http://dx.doi.org/10.1016/S0140-6736(02)08435-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546NA	11988247				2022-12-24	WOS:000175279100011
J	Terlau, H; Shon, KJ; Grilley, M; Stocker, M; Stuhmer, W; Olivera, BM				Terlau, H; Shon, KJ; Grilley, M; Stocker, M; Stuhmer, W; Olivera, BM			Strategy for rapid immobilization of prey by a fish-hunting marine snail	NATURE			English	Article							AMINO-ACID-SEQUENCE; POTASSIUM CHANNEL; DROSOPHILA; DIVERSITY; SHAKER; GENE; PATCHES; TOXIN; BRAIN	SOME venomous animals capture prey with remarkable efficiency and speed. The purple cone, Conus purpurascens, uses two parallel physiological mechanisms requiring multiple neurotoxins to immobilize fish rapidly: neuromuscular block(1), and excitotoxic shock, The latter requires the newly characterized peptide kappa-conotoxin PVIIA, which inhibits the Shaker potassium channel(2-4), and delta-conotoxin PVIA(5), which delays sodium-channel inactivation, Despite the extreme biochemical diversity in venoms, the number of effective strategic alternatives for prey capture are limited. How securely prey is initially tethered may strongly influence the venom strategy evolved by a predator.	MAX PLANCK INST EXPTL MED, MOL BIOL NEURONALER SIGNALE, D-37075 GOTTINGEN, GERMANY; UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA	Max Planck Society; Utah System of Higher Education; University of Utah			Stuehmer, Walter/A-2176-2009; Stocker, Martin/C-1844-2008	Stuehmer, Walter/0000-0002-0642-7764; 				ANEIROS A, 1993, BIOCHIM BIOPHYS ACTA, V1157, P86, DOI 10.1016/0304-4165(93)90082-J; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BERESS L, 1977, H-S Z PHYSIOL CHEM, V358, P985, DOI 10.1515/bchm2.1977.358.2.985; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOPKINS C, 1995, J BIOL CHEM, V270, P22361, DOI 10.1074/jbc.270.38.22361; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KARLSSON E, 1991, TOXICON, V29, P521, DOI 10.1016/0041-0101(91)90027-O; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LAZDUNSKI M, 1986, ANN NY ACAD SCI, V479, P204, DOI 10.1111/j.1749-6632.1986.tb15571.x; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Rathmayer W, 1979, Adv Cytopharmacol, V3, P335; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SEIFERT W, 1983, NEUROBIOLOGY HIPPOCA, P109; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; STUHMER W, 1992, METHOD ENZYMOL, V207, P319	24	241	255	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	1996	381	6578					148	151		10.1038/381148a0	http://dx.doi.org/10.1038/381148a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UK139	12074021				2022-12-24	WOS:A1996UK13900047
J	Zhang, RG; Pappas, T; Brace, JL; Miller, PC; Oulmassov, T; Molyneauz, JM; Anderson, JC; Bashkin, JK; Winans, SC; Joachimiak, A				Zhang, RG; Pappas, T; Brace, JL; Miller, PC; Oulmassov, T; Molyneauz, JM; Anderson, JC; Bashkin, JK; Winans, SC; Joachimiak, A			Structure of a bacterial quorum-sensing transcription factor complexed with pheromone and DNA	NATURE			English	Article							C-TERMINAL REGION; VIBRIO-FISCHERI; AUTOINDUCER-BINDING; TI PLASMID; IN-VITRO; PROTEIN; LUXR; TRAR; ACTIVATOR; DIMERIZATION	Many proteobacteria are able to monitor their population densities through the release of pheromones known as N-acylhomoserine lactones. At high population densities, these pheromones elicit diverse responses that include bioluminescence, biofilm formation, production of antimicrobials, DNA exchange, pathogenesis and symbiosis(1). Many of these regulatory systems require a pheromone-dependent transcription factor similar to the LuxR protein of Vibrio fischeri. Here we present the structure of a LuxR-type protein. TraR of Agrobacterium tumefaciens was solved at 1.66 Angstrom as a complex with the pheromone N-3-oxooctanoyl-L-homoserine lactone (OOHL) and its TraR DNA-binding site. The amino-terminal domain of TraR is an alpha/beta/alpha sandwich that binds OOHL, whereas the carboxy-terminal domain contains a helix-turn-helix DNA-binding motif. The TraR dimer displays a two-fold symmetry axis in each domain; however, these two axes of symmetry are at an approximately 90degrees angle, resulting in a pronounced overall asymmetry of the complex. The pheromone lies fully embedded within the protein with virtually no solvent contact, and makes numerous hydrophobic contacts with the protein as well as four hydrogen bonds: three direct and one water-mediated.	Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; Monsanto Co, St Louis, MO 63167 USA	United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; Monsanto	Joachimiak, A (corresponding author), Argonne Natl Lab, Biosci Div, Struct Biol Ctr, 9700 S Cass Ave, Argonne, IL 60439 USA.		Bashkin, James K./F-5327-2010	Bashkin, James K./0000-0001-6735-4733; Brace, Jennifer/0000-0002-7734-2450				Baikalov I, 1998, BIOCHEMISTRY-US, V37, P3665, DOI 10.1021/bi972365a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai Y, 2001, MOL MICROBIOL, V40, P414, DOI 10.1046/j.1365-2958.2001.02385.x; Choi S. H., 1992, Molecular Marine Biology and Biotechnology, V1, P408; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; Egland KA, 2000, J BACTERIOL, V182, P805, DOI 10.1128/JB.182.3.805-811.2000; Egland KA, 2001, J BACTERIOL, V183, P382, DOI 10.1128/JB.183.1.382-386.2001; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; JOACHIMIAK A, 1991, METHOD ENZYMOL, V208, P82; Luo ZQ, 2000, J BIOL CHEM, V275, P7713, DOI 10.1074/jbc.275.11.7713; Luo ZQ, 1999, P NATL ACAD SCI USA, V96, P9009, DOI 10.1073/pnas.96.16.9009; *MOL SIM INC, 2000, QUANTA; NELSON HCM, 1995, CURR OPIN GENET DEV, V5, P180, DOI 10.1016/0959-437X(95)80006-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; STEVENS AM, 1994, P NATL ACAD SCI USA, V91, P12619, DOI 10.1073/pnas.91.26.12619; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; von Bodman SB, 1998, P NATL ACAD SCI USA, V95, P7687, DOI 10.1073/pnas.95.13.7687; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1726, DOI 10.1107/S0907444999008392; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	28	349	377	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					971	974		10.1038/nature00833	http://dx.doi.org/10.1038/nature00833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087407				2022-12-24	WOS:000176441200044
J	Schwartz, LM; Woloshin, S				Schwartz, LM; Woloshin, S			News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA IN-SITU; DEBATE; TRIAL	Context In the late 1990s, 3 events pertaining to breast cancer prevention received considerable attention in the US news media: a National Institutes of Health (NIH) consensus panel recommended against routine screening mammography for women in their 40s (January 1997), the National Cancer Institute (NCI) subsequently reversed the recommendation (March 1997), and an NCI-sponsored study demonstrated the efficacy of tamoxifen in the primary prevention of breast cancer (April 1998). Objective To examine how the major US news media covered the potential benefits and harms of 2 breast cancer preventive strategies. Design and Setting Content analysis of US news stories reporting on the breast cancer prevention events. We used Lexis-Nexis to search for print news stories in the 10 highest-circulation US newspapers and requested transcripts from 3 major television networks to obtain all relevant news coverage in the 2 weeks following each event. Main Outcome Measures Attitude toward preventive strategy (encourage, neutral, discourage); level of uncertainty about benefit and how benefits and harms were presented. Results Twenty-seven stories about the NIH consensus panel, 24 about the NCI reversal, and 34 about tamoxifen appeared in high-profile news media within 2 weeks of each event. Sixty-seven percent of NIH consensus panel stories left the impression that there was a lot of uncertainty about whether women aged 40 to 49 years should undergo screening, but 59% suggested that women should probably or definitely be screened. Only 4 stories suggested that women faced a genuine decision about what to do. The level of uncertainty reported was substantially lower following the NCI reversal (21% suggested a lot of uncertainty), and most stories (96%) suggested that women should be screened. In contrast, tamoxifen stories highlighted uncertainty about what women at high risk should do (62% suggested there was a lot of uncertainty), and none left the impression that women should definitely take the drug (24% suggested they probably should). Sixty-five percent of these stories suggested that women faced a genuine choice and would have to weigh the risks and benefits themselves. Conclusions Most news stories favored routine use of screening mammography and urged caution about using tamoxifen. Almost all noted the potential harms of each preventive strategy; however, the negative aspects of tamoxifen received greater emphasis. Whereas taking tamoxifen was presented as a difficult decision, having a mammogram was presented as something women ought to do.	Dept Vet Affairs Med Ctr, VA Outcome Grp 111B, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Woloshin, S (corresponding author), Dept Vet Affairs Med Ctr, VA Outcome Grp 111B, White River Jct, VT 05009 USA.				NCI NIH HHS [R18 CA91052-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baxter N, 2001, CAN MED ASSOC J, V164, P1837; Centers for Disease Control and Prevention, 2002, BEH RISK FACT SURV S; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; FISHER B, 1992, NAT SURG ADJ BREAST; Fletcher SW, 1997, NEW ENGL J MED, V336, P1180, DOI 10.1056/NEJM199704173361612; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; *MED RES INC, 1998, MED RES MAG TOT AUD; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; O'Malley M S, 1987, JAMA, V257, P2196, DOI 10.1001/jama.257.16.2196; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; *US DEP HHS, 1997, BREAST CANC SCREEN W; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Woloshin S, 2000, ARCH INTERN MED, V160, P1434, DOI 10.1001/archinte.160.10.1434	22	63	63	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2002	287	23					3136	3142		10.1001/jama.287.23.3136	http://dx.doi.org/10.1001/jama.287.23.3136			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563NK	12069679	Bronze			2022-12-24	WOS:000176262300031
J	Peier, AM; Reeve, AJ; Andersson, DA; Moqrich, A; Earley, TJ; Hergarden, AC; Story, GM; Colley, S; Hogenesch, JB; McIntyre, P; Bevan, S; Patapoutian, A				Peier, AM; Reeve, AJ; Andersson, DA; Moqrich, A; Earley, TJ; Hergarden, AC; Story, GM; Colley, S; Hogenesch, JB; McIntyre, P; Bevan, S; Patapoutian, A			A heat-sensitive TRP channel expressed in keratinocytes	SCIENCE			English	Article							CAPSAICIN-RECEPTOR; MICE LACKING; NOXIOUS HEAT; CA2+ CHANNEL; ION-CHANNEL; PAIN; CURRENTS; HOMOLOG; RAT	Mechanical and thermal cues stimulate a specialized group of sensory neurons that terminate in the skin. Three members of the transient receptor potential (TRP) family of channels are expressed in subsets of these neurons and are activated at distinct physiological temperatures. Here, we describe the cloning and characterization of a novel thermosensitive TRP channel. TRPV3 has a unique threshold: It is activated at innocuous (warm) temperatures and shows an increased response at noxious temperatures. TRPV3 is specifically expressed in keratinocytes; hence, skin cells are capable of detecting heat via molecules similar to those in heat-sensing neurons.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Novartis Inst Med Sci, London WC1E 6BN, England; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	ardem@scripps.edu	Andersson, David A/C-3435-2008; Mcintyre, Peter/N-4109-2013; Bevan, Stuart/A-8821-2008	Andersson, David A/0000-0001-7451-8548; McIntyre, Peter/0000-0001-9506-5998; moqrich, aziz/0000-0002-1937-1675; Bevan, Stuart John/0000-0002-8977-1797				Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; CAUNA N, 1973, J ANAT, V115, P277; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; HENSEL H, 1969, J PHYSIOL-LONDON, V204, P99, DOI 10.1113/jphysiol.1969.sp008901; HENSEL H, 1971, PFLUG ARCH EUR J PHY, V329, P1, DOI 10.1007/BF00586896; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peng JB, 2001, GENOMICS, V76, P99, DOI 10.1006/geno.2001.6606; ROZA C, 2001, ANN M SOC NEUR SAN D; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; WILKENSEN DG, 1993, ESSENTIAL DEV BIOL P, P258	24	638	683	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2046	2049		10.1126/science.1073140	http://dx.doi.org/10.1126/science.1073140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12016205				2022-12-24	WOS:000176273300059
J	Chandler, D				Chandler, D			Hydrophobicity: Two faces of water	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Chandler, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.							Ball Philip., 1999, H2O BIOGRAPHY WATER; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; Tanford C., 2001, NATURES ROBOTS HIST, Vfirst	5	288	294	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					491	491		10.1038/417491a	http://dx.doi.org/10.1038/417491a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037545	Bronze			2022-12-24	WOS:000175860300021
J	Maiden, MCJ; Stuart, JM				Maiden, MCJ; Stuart, JM		UK Meningococcal Carriage Grp	Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination	LANCET			English	Article							VACCINES	The UK was the first place to introduce meningococcal serogroup C conjugate (MCC) vaccines. From November, 1999, all people younger than 18 years, about 14 million individuals, were offered MCC immunisation. The uptake rate was more than 70% by November, 2000. We compared the carriage of meningococci in isolates we obtained from 14 064 students aged 15-17 years during vaccination in 1999, with those from 16 583 students of the same age surveyed 1 year later. Carriage of serogroup C meningococci was reduced by 66% (p=0.004). Our results show that MCC vaccines protect against carriage of meningococci that express serogroup C polysaccharide capsules.	Univ Oxford, Dept Zool, Oxford OX1 3SY, England; Gloucester Royal Hosp, Publ Hlth Lab, Communicable Dis Surveillance Ctr SW, Gloucester, England	University of Oxford	Maiden, MCJ (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg Pathogen Res,S Parks Rd, Oxford OX1 3SY, England.		Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; Evans, Meirion/C-2990-2008	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Evans, Meirion/0000-0003-3578-1866	Wellcome Trust [062057] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		COLLETT D, 1991, MODELLING BINARY DAT, P199; Maiden MCJ, 1999, LANCET, V354, P615, DOI 10.1016/S0140-6736(99)00252-4; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Pollard AJ, 2000, PEDIATR INFECT DIS J, V19, P333, DOI 10.1097/00006454-200004000-00015; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7	5	319	330	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 25	2002	359	9320					1829	1830		10.1016/S0140-6736(02)08679-8	http://dx.doi.org/10.1016/S0140-6736(02)08679-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044380				2022-12-24	WOS:000175775500013
J	Sandhu, MS; Heald, AH; Gibson, JM; Cruickshank, JK; Dunger, DB; Wareham, NJ				Sandhu, MS; Heald, AH; Gibson, JM; Cruickshank, JK; Dunger, DB; Wareham, NJ			Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study	LANCET			English	Article							FACTOR BINDING PROTEIN-1; IMPROVES GLYCEMIC CONTROL; IGF-I; SENSITIVITY; RISK; PROINSULIN; ADULTS; ASSAYS; GENE	Background Results of experimental and clinical studies suggest that insulin-like growth factor-I (IGF-I) and IGF binding protein-1 (IGFBP-1) could be important determinants of glucose homoeostasis. However, experimental models might also reflect compensatory and adaptive metabolic processes, We therefore prospectively examined the associations between circulating concentrations of IGF-I and IGFBP-1 and development of glucose tolerance. Methods Participants in this cohort study were a random sample of 615 normoglycaemic men and women aged 45-65 years. Participants underwent oral glucose tolerance testing based on WHO definitions and criteria in 1990-92 and 1994-96. At the baseline visit, we measured serum concentrations of IGF-I and IGFBP-1, and assessed the relation between these peptides and subsequent glucose intolerance. Findings At 4.5 years of follow-up, 51 (8%) of 615 participants developed impaired glucose tolerance or type-2 diabetes. After adjustment for correlates of IGF-I and risk factors for glucose intolerance, the odds ratio for risk of impaired glucose tolerance or type-2 diabetes for participants with IGF-I concentrations above the median ( greater than or equal to152 mug/L) compared with those with concentrations below the median (<152 mu g/L) was 0.50 (0.26-0.95). Consistent with this finding. IGF-I also showed a significant inverse association with subsequent 2-h glucose concentrations, which was independent of correlates of IGF-I and risk factors for glucose tolerance (p for linear trend=0.026). We also found that this inverse association was independently modified by IGFBP-1 (p for interaction=0.011). Interpretation These data show that circulating IGF-I and its interaction with IGFBP-1 could be important determinants of glucose homoeostasis and provide further evidence for the possible protective role of IGF-I against development of glucose intolerance.	Univ Cambridge, Inst Publ Hlth, Dept Hlth & Primary Care, Cambridge CB2 2SR, England; Univ Manchester, Dept Med, Endocrine Sci Res Grp, Manchester M13 9PL, Lancs, England; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England	University of Cambridge; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wareham, NJ (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Hlth & Primary Care, Univ Forvie Site, Cambridge CB2 2SR, England.	njw1004@medschl.cam.ac.uk		Dunger, Professor David/0000-0002-2566-9304; gibson, martin/0000-0002-1331-1524				Acerini CL, 1998, METABOLISM, V47, P1481, DOI 10.1016/S0026-0495(98)90074-9; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALPHA B, 1992, EUR J CLIN CHEM CLIN, V30, P27; Bavenholm PN, 2001, DIABETES, V50, P1449, DOI 10.2337/diabetes.50.6.1449; Carroll PV, 2000, DIABETES, V49, P789, DOI 10.2337/diabetes.49.5.789; Clauson PG, 1998, SCAND J CLIN LAB INV, V58, P353, DOI 10.1080/00365519850186544; Crossey PA, 2000, DIABETES, V49, P457, DOI 10.2337/diabetes.49.3.457; Crowne EC, 2001, J CLIN ENDOCR METAB, V86, P3686, DOI 10.1210/jc.86.8.3686; Cruickshank JK, 2001, AM J EPIDEMIOL, V154, P504, DOI 10.1093/aje/154.6.504; Dunger DB, 1997, DIABETIC MED, V14, P723, DOI 10.1002/(SICI)1096-9136(199709)14:9<723::AID-DIA480>3.0.CO;2-S; Ferry RJ, 1999, HORM RES, V51, P53; Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.3.CO;2-5; Heald AH, 2001, DIABETOLOGIA, V44, P333, DOI 10.1007/s001250051623; HUSSAIN MA, 1993, LANCET, V341, P1536, DOI 10.1016/0140-6736(93)90674-6; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; MORROW LA, 1994, J CLIN ENDOCR METAB, V79, P205, DOI 10.1210/jc.79.1.205; Mortensen DL, 1997, ENDOCRINOLOGY, V138, P2073, DOI 10.1210/en.138.5.2073; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; Quattrin T, 1997, DIABETES CARE, V20, P374, DOI 10.2337/diacare.20.3.374; *RH IGF I NIDDM ST, 1996, DIABETES S2, V45, pA27; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Thrailkill K M, 2000, Diabetes Technol Ther, V2, P69, DOI 10.1089/152091599316775; Vaessen N, 2001, DIABETES, V50, P637, DOI 10.2337/diabetes.50.3.637; VAESSEN N, 2001, THESIS ROTTERDAM NET; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; *WHO STUD GROUP, 1985, DIAB MELL; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110	35	379	391	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2002	359	9319					1740	1745		10.1016/S0140-6736(02)08655-5	http://dx.doi.org/10.1016/S0140-6736(02)08655-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554MV	12049864				2022-12-24	WOS:000175740500012
J	Makishima, M; Lu, TT; Xie, W; Whitfield, GK; Domoto, H; Evans, RM; Haussler, MR; Mangelsdorf, DJ				Makishima, M; Lu, TT; Xie, W; Whitfield, GK; Domoto, H; Evans, RM; Haussler, MR; Mangelsdorf, DJ			Vitamin D receptor as an intestinal bile acid sensor	SCIENCE			English	Article							LITHOCHOLIC ACID; NUCLEAR RECEPTORS; INTRARECTAL INSTILLATION; COLON CARCINOGENESIS; RATS; IDENTIFICATION; CALCIUM; CYP3A4; CANCER	The vitamin D receptor (VDR) mediates the effects of the calcemic hormone 1alpha-,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3]. We show that VDR also functions as a receptor for the secondary bile acid lithocholic acid (LCA), which is hepatotoxic and a potential enteric carcinogen. VDR is an order of magnitude more sensitive to LCA and its metabolites than are other nuclear receptors. Activation of VDR by LCA or vitamin D induced expression in vivo of CYP3A, a cytochrome P450 enzyme that detoxifies LCA in the liver and intestine. These studies offer a mechanism that may explain the proposed protective effects of vitamin D and its receptor against colon cancer.	Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, San Diego, CA 92186 USA; Univ Arizona, Coll Med, Dept Biochem & Mol Biophys, Tucson, AZ 85724 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Salk Institute; University of Arizona	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Xie, Wen/M-1768-2016; Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Mangelsdorf, David/0000-0002-4355-0796; Haussler, Mark/0000-0002-7097-1801				Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Garland CF, 1999, ANN NY ACAD SCI, V889, P107, DOI 10.1111/j.1749-6632.1999.tb08728.x; HAMADA K, 1994, CARCINOGENESIS, V15, P1911, DOI 10.1093/carcin/15.9.1911; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; KAWAURA A, 1989, CARCINOGENESIS, V10, P647, DOI 10.1093/carcin/10.4.647; Kissmeyer AM, 1997, BIOCHEM PHARMACOL, V53, P1087, DOI 10.1016/S0006-2952(96)00816-7; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lipkin M, 1999, ANNU REV NUTR, V19, P545, DOI 10.1146/annurev.nutr.19.1.545; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; NARISAWA T, 1974, JNCI-J NATL CANCER I, V53, P1093, DOI 10.1093/jnci/53.4.1093; Ogawa A, 1998, JPN J CANCER RES, V89, P1154, DOI 10.1111/j.1349-7006.1998.tb00510.x; OWEN R W, 1987, Nutrition and Cancer, V9, P73; PENCE BC, 1988, CARCINOGENESIS, V9, P187, DOI 10.1093/carcin/9.1.187; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; Sippel CJ, 1997, J BIOL CHEM, V272, P18290, DOI 10.1074/jbc.272.29.18290; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398	23	868	897	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1313	1316		10.1126/science.1070477	http://dx.doi.org/10.1126/science.1070477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016314				2022-12-24	WOS:000175713000053
J	Taniguchi, T; Garcia-Higuera, I; Xu, B; Andreassen, PR; Gregory, RC; Kim, ST; Lane, WS; Kastan, MB; D'Andrea, AD				Taniguchi, T; Garcia-Higuera, I; Xu, B; Andreassen, PR; Gregory, RC; Kim, ST; Lane, WS; Kastan, MB; D'Andrea, AD			Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways	CELL			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DNA-DAMAGE RESPONSE; ATM-DEPENDENT PHOSPHORYLATION; TARGETED DISRUPTION; CHECKPOINT PATHWAY; IONIZING-RADIATION; X-IRRADIATION; NUCLEAR-COMPLEX; MAMMALIAN-CELLS; S-PHASE	Fanconi anemia (FA) and ataxia telangiectasia (AT) are clinically distinct autosomal recessive disorders characterized by spontaneous chromosome breakage and hematological cancers. FA cells are hypersensitive to mitomycin C (MMC), while AT cells are hypersensitive to ionizing radiation (IR). Here, we identify the Fanconi anemia protein, FANCD2, as a link between the FA and ATM damage response pathways. ATM phosphorylates FANCD2 on serine 222 in vitro. This site is also phosphorylated in vivo in an ATM-dependent manner following IR. Phosphorylation of FANCD2 is required for activation of an S phase checkpoint. The ATM-dependent phosphorylation of FANCD2 on S222 and the FA pathway-dependent monoubiquitination of FANCD2 on K561 are independent posttranslational modifications regulating discrete cellular signaling pathways. Biallelic disruption of FANCD2 results in both MMC and IR hypersensitivity.	Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Harvard Univ, Harvard Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; St Jude Children's Research Hospital; Harvard University	D'Andrea, AD (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Garcia-Higuera, Irene/L-5004-2014; Kim, Seong-Tae/A-9917-2013; Taniguchi, Toshiyasu/ADD-8489-2022	Garcia-Higuera, Irene/0000-0001-6331-075X; Taniguchi, Toshiyasu/0000-0002-7746-3658	NCI NIH HHS [CA71387, CA21765] Funding Source: Medline; NHLBI NIH HHS [R01HL52725, P01HL54785] Funding Source: Medline; NIDDK NIH HHS [R01DK43889] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071387, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054785, R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn JY, 2000, CANCER RES, V60, P5934; Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; Andreassen PR, 2001, CANCER RES, V61, P7660; ANDREASSEN PR, 1994, J CELL BIOL, V127, P789, DOI 10.1083/jcb.127.3.789; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BIGELOW SB, 1979, MUTAT RES, V63, P189, DOI 10.1016/0027-5107(79)90115-5; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Carreau M, 1999, MUTAT RES-DNA REPAIR, V435, P103, DOI 10.1016/S0921-8777(99)00041-5; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Djuzenova CS, 2001, LAB INVEST, V81, P185, DOI 10.1038/labinvest.3780226; DUCKWORTHRYSIECKI G, 1985, CANCER RES, V45, P416; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Girard PM, 2000, CANCER RES, V60, P4881; GLUCKMAN E, 1983, BRIT J HAEMATOL, V54, P431, DOI 10.1111/j.1365-2141.1983.tb02117.x; Grompe M, 2001, HUM MOL GENET, V10, P2253, DOI 10.1093/hmg/10.20.2253; HOUGHTALING S, 2001, AM SOC HUM GEN 51 AN; Jakobs PM, 1996, SOMAT CELL MOLEC GEN, V22, P151, DOI 10.1007/BF02369905; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KHANNA K, 1999, DNA DAMAGE REPAIR; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; KNOX SJ, 1981, BLOOD, V57, P1043; Kupfer GM, 1997, BLOOD, V90, P1047, DOI 10.1182/blood.V90.3.1047.1047_1047_1054; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Marcou Y, 2001, RADIOTHER ONCOL, V60, P75, DOI 10.1016/S0167-8140(01)00370-X; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Naf D, 1998, MOL CELL BIOL, V18, P5952; Nakanishi K, 2001, EXP HEMATOL, V29, P842, DOI 10.1016/S0301-472X(01)00663-4; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Whitney MA, 1996, BLOOD, V88, P49; Wu X, 2000, Science, V289, P11; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	62	350	358	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2002	109	4					459	472		10.1016/S0092-8674(02)00747-X	http://dx.doi.org/10.1016/S0092-8674(02)00747-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086603	Bronze			2022-12-24	WOS:000175696800008
J	Shaw, PJ; Tononi, G; Greenspan, RJ; Robinson, DF				Shaw, PJ; Tononi, G; Greenspan, RJ; Robinson, DF			Stress response genes protect against lethal effects of sleep deprivation in Drosophila	NATURE			English	Article							HEAT-SHOCK; MELANOGASTER; TRANSCRIPTION; TIMELESS; MUTANTS; RATS; HOMEOSTASIS; RHYTHMS; LESIONS; PERIOD	Sleep is controlled by two processes: a homeostatic drive that increases during waking and dissipates during sleep, and a circadian pacemaker that controls its timing(1). Although these two systems can operate independently(2,3), recent studies indicate a more intimate relationship(4,5). To study the interaction between homeostatic and circadian processes in Drosophila, we examined homeostasis in the canonical loss-of-function clock mutants period (per(01)), timeless (tim(01)), clock (Clk(jrk)) and cycle (cyc(01))(6-9). cyc(01) mutants showed a disproportionately large sleep rebound and died after 10 hours of sleep deprivation, although they were more resistant than other clock mutants to various stressors. Unlike other clock mutants, cyc(01) flies showed a reduced expression of heat-shock genes after sleep loss. However, activating heat-shock genes before sleep deprivation rescued cyc(01) flies from its lethal effects. Consistent with the protective effect of heat-shock genes, was the observation that flies carrying a mutation for the heat-shock protein Hsp83 (Hsp83(08445))(10) showed exaggerated homeostatic response and died after sleep deprivation. These data represent the first step in identifying the molecular mechanisms that constitute the sleep homeostat.	Inst Neurosci, San Diego, CA 92121 USA		Shaw, PJ (corresponding author), Inst Neurosci, 10640 John J Hopkins Dr, San Diego, CA 92121 USA.		Tononi, Giulio/B-8387-2009					Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antle MC, 2000, J NEUROSCI, V20, P9326; Armitage R., 2001, SLEEP, V4, P33; ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; CASTRILLON DH, 1993, GENETICS, V135, P489; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; CORNELIUS G, 1995, CELL SIGNAL, V7, P611, DOI 10.1016/0898-6568(95)00027-M; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; HOMYK T, 1980, MOL GEN GENET, V177, P553; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Ma E, 1999, MOL BRAIN RES, V73, P11, DOI 10.1016/S0169-328X(99)00224-7; Marchler G, 2001, EMBO J, V20, P499, DOI 10.1093/emboj/20.3.499; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Naylor E, 2000, J NEUROSCI, V20, P8138; ORNELLES DA, 1990, J CELL SCI, V95, P393; Perezgasga L, 1999, FEBS LETT, V456, P269, DOI 10.1016/S0014-5793(99)00963-1; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RECHTSCHAFFEN A, 1989, SLEEP, V12, P68; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sapolsky RM, 2000, NEUROBIOL DIS, V7, P540, DOI 10.1006/nbdi.2000.0350; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; Yoshida EN, 1999, GENOME, V42, P1077, DOI 10.1139/gen-42-6-1077	30	321	339	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					287	291		10.1038/417287a	http://dx.doi.org/10.1038/417287a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015603				2022-12-24	WOS:000175592100047
J	Darveau, CA; Suarez, RK; Andrews, RD; Hochachka, PW				Darveau, CA; Suarez, RK; Andrews, RD; Hochachka, PW			Allometric cascade as a unifying principle of body mass effects on metabolism	NATURE			English	Article							OXYGEN-CONSUMPTION; SKELETAL-MUSCLE; ATP UTILIZATION; MAMMALS; TURNOVER; BIRDS; HEART; CAPACITIES; ANIMALS; RATES	The power function of basal metabolic rate scaling is expressed as aM(b), where a corresponds to a scaling constant (intercept), M is body mass, and b is the scaling exponent. The 3/4 power law (the best-fit b value for mammals) was developed from Kleiber's original analysis(1) and, since then, most workers have searched for a single cause to explain the observed allometry. Here we present a multiple-causes model of allometry, where the exponent b is the sum of the influences of multiple contributors to metabolism and control. The relative strength of each contributor, with its own characteristic exponent value, is determined by the control contribution. To illustrate its use, we apply this model to maximum versus basal metabolic rates to explain the differing scaling behaviour of these two biological states in mammals. The main difference in scaling is that, for the basal metabolic rate, the O-2 delivery steps contribute almost nothing to the global b scaling exponent, whereas for the maximum metabolic rate, the O-2 delivery steps significantly increase the global b value.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of British Columbia; University of California System; University of California Santa Barbara	Hochachka, PW (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	pwh@zoology.ubc.ca		Andrews, Russel/0000-0002-4545-137X				ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bishop CM, 1997, PHILOS T R SOC B, V352, P447, DOI 10.1098/rstb.1997.0032; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Brody S., 1945, BIOENERGETICS GROWTH; Fuery CJ, 1998, COMP BIOCHEM PHYS A, V119, P459, DOI 10.1016/S1095-6433(97)00452-2; HAMILTON N, 1991, MOL CELL BIOCHEM, V106, P133; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HOCHACHKA PW, 1991, P NATL ACAD SCI USA, V88, P5764, DOI 10.1073/pnas.88.13.5764; Hochachka PW., 1994, MUSCLES MOL METABOLI; HOCHACHKA PW, 2002, ADAPTATION MECH PROC; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813; Jones JH, 1998, COMP BIOCHEM PHYS B, V120, P125, DOI 10.1016/S0305-0491(98)00027-3; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LINDSTEDT SL, 1985, AM J PHYSIOL, V249, pR699, DOI 10.1152/ajpregu.1985.249.6.R699; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Szentesi P, 2001, J PHYSIOL-LONDON, V531, P393, DOI 10.1111/j.1469-7793.2001.0393i.x; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; WAGNER PD, 1993, RESP PHYSIOL, V93, P221, DOI 10.1016/0034-5687(93)90007-W; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; Weber JM, 1997, COMP BIOCHEM PHYS A, V118, P713, DOI 10.1016/S0300-9629(97)00020-0; Weibel E.R., 2000, SYMMORPHOSIS FORM FU; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677	30	364	378	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					166	170		10.1038/417166a	http://dx.doi.org/10.1038/417166a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000958				2022-12-24	WOS:000175460200041
J	McQuillan, GM; Kruszon-Moran, D; Deforest, A; Chu, SY; Wharton, M				McQuillan, GM; Kruszon-Moran, D; Deforest, A; Chu, SY; Wharton, M			Serologic immunity to diphtheria and tetanus in the United States	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Serologic data on diseases that are preventable by vaccine are useful to evaluate the success of immunization programs and to identify susceptible subgroups. Objective: To provide national estimates of immunity to diphtheria and tetanus by measurement of serum antibody levels. Design: Examination of data from the Third National Health and Nutrition Examination Survey, a representative cross-sectional sample of the U.S. population. Setting: 89 randomly selected locations throughout the United States. Participants: 18 045 persons 6 years of age or older who were examined from 1988 to 1994. Measurements: Serum samples obtained at a single time point were tested for diphtheria and tetanus antitoxin. Results: Overall, 60.5% of Americans 6 years of age or older had fully protective levels of diphtheria antibody (greater than or equal to0.10 IU/mL) and 72.3% had protective levels of tetanus antibody (>0.15 IU/mL). Ninety-one percent of Americans 6 to 11 years of age had protective levels of both diphtheria and tetanus antibody; this proportion decreased to approximately 30% among persons 70 years of age (29.5% for diphtheria and 31.0% for tetanus). Adult Mexican-Americans were slightly less likely to have protective levels of antibody to both toxins. Only 47% of persons 20 years of age or older had levels that were protective against both diseases, and only 63% of adults who were protected against tetanus were also protected against diphtheria. Conclusions: A substantial proportion of adults in the United States do not have antibody levels that are protective against diphtheria and tetanus. In addition, although the recommended vaccine is a combination of tetanus and diphtheria, only 63% of adults with protective antibody to tetanus also had protective antibody to diphtheria.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Examinat Stat, Hyattsville, MD 20782 USA; St Christophers Hosp Children, Philadelphia, PA 19133 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	McQuillan, GM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Examinat Stat, 6525 Belcrest Rd,Room 1000, Hyattsville, MD 20782 USA.	gmm2@cdc.gov						*ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1994, VITAL HLTH STAT, P1; BALESTRA DJ, 1993, J GEN INTERN MED, V8, P405, DOI 10.1007/BF02599616; DEFOREST A, 1988, PEDIATRICS, V81, P237; EZZATI T, 1993, 1992 P SURV RES METH, P339; GERGEN P, 1995, NEW ENGL J MED, V332, P761, DOI 10.1056/NEJM199503233321201; IPSEN J, 1954, NEW ENGL J MED, V251, P459, DOI 10.1056/NEJM195409162511202; IPSEN J, 1946, J IMMUNOL, V54, P325; Kahn HA, 1989, STAT METHODS EPIDEMI; MIYAMURA K, 1974, J BIOL STAND, V2, P189, DOI 10.1016/0092-1157(74)90015-8; MOHADJER L, 1996, NATL HLTH NUTR EXAMI; ORENSTEIN WA, 1983, SCI PUBLICATION, V451, P30; SHAH BV, 1991, SUDAAN USERS MANUAL; SIMONSEN O, 1986, J BIOL STAND, V14, P231, DOI 10.1016/0092-1157(86)90008-9; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; VIRELLA G, 1991, J CLIN LAB ANAL, V5, P43, DOI 10.1002/jcla.1860050108; Vitek CR, 1998, EMERG INFECT DIS, V4, P539, DOI 10.3201/eid0404.980404; 1997, MMWR MORB MORTAL WKL, V46, P506; 2001, MMWR MORB MORTAL WKL, V50, P19; 2001, MMWR MORB MORTAL WKL, V50, P7; 2000, MMWR MORB MORTAL WKL, V49, P39; 2000, MMWR MORB MORTAL WKL, V49, P585; 2002, MMWR MORB MORTAL WKL, V50, P1159	24	124	136	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					660	666		10.7326/0003-4819-136-9-200205070-00008	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547XK	11992301				2022-12-24	WOS:000175357900003
J	Clark, TA; Sugnet, CW; Ares, M				Clark, TA; Sugnet, CW; Ares, M			Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays	SCIENCE			English	Article							CAP-BINDING COMPLEX; NUCLEAR RIBONUCLEOPROTEIN PARTICLE; SACCHAROMYCES-CEREVISIAE; DEBRANCHING ENZYME; GENE-EXPRESSION; PROTEIN; COMMITMENT; SEQUENCES; INTRONS; PRP4	Introns interrupt almost every eukaryotic protein-coding gene, yet how the splicing apparatus interprets the genome during messenger RNA (mRNA) synthesis is poorly understood. We designed microarrays to distinguish spliced from unspliced RNA for each intron-containing yeast gene and measured genomewide effects on splicing caused by loss of 18 different mRNA processing factors. After accommodating changes in transcription and decay by using gene-specific indexes, functional relationships between mRNA processing factors can be identified through their common effects on spliced and unspliced RNA. Groups of genes with different dependencies on mRNA processing factors are also apparent. Quantitative polymerase chain reactions confirm the array-based finding that Prp17p and Prp18p are not dispensable for removal of introns with short branchpoint-to-3' splice site distances.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Baskin Sch Engn, Dept Comp Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Baskin Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Ares, M (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	ares@biology.ucsc.edu		Clark, Tyson/0000-0002-7779-3227; Ares, Manny/0000-0002-2552-9168	NCI NIH HHS [CA77813] Funding Source: Medline; NIGMS NIH HHS [GM40478] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA077813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040478] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANROQUES J, 1989, MOL CELL BIOL, V9, P3710, DOI 10.1128/MCB.9.9.3710; BJORN SP, 1989, MOL CELL BIOL, V9, P3698, DOI 10.1128/MCB.9.9.3698; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; CLARK T, UNPUB; Colot HV, 1996, GENE DEV, V10, P1699, DOI 10.1101/gad.10.13.1699; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fortes P, 1999, MOL CELL BIOL, V19, P6543; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Ooi SL, 1998, RNA, V4, P1096, DOI 10.1017/S1355838298980785; Perriman R, 2000, GENE DEV, V14, P97; PIKIELNY CW, 1985, CELL, V41, P119, DOI 10.1016/0092-8674(85)90066-2; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Rain JC, 1997, EMBO J, V16, P1759, DOI 10.1093/emboj/16.7.1759; Shen EC, 2000, J BIOL CHEM, V275, P23718, DOI 10.1074/jbc.M002312200; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Zhang XP, 1997, NUCLEIC ACIDS RES, V25, P2146, DOI 10.1093/nar/25.11.2146	27	292	309	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					907	910		10.1126/science.1069415	http://dx.doi.org/10.1126/science.1069415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988574				2022-12-24	WOS:000175442500043
J	Zacharias, DA; Violin, JD; Newton, AC; Tsien, RY				Zacharias, DA; Violin, JD; Newton, AC; Tsien, RY			Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; RESONANCE ENERGY-TRANSFER; GPI-ANCHORED PROTEINS; CAVEOLAE; RAFTS; RECEPTORS; DOMAINS; SURFACE	Many proteins associated with the plasma membrane are known to partition into submicroscopic sphingolipid- and cholesterol-rich domains called lipid rafts, but the determinants dictating this segregation of proteins in the membrane are poorly understood. We suppressed the tendency of Aequorea fluorescent proteins to dimerize and targeted these variants to the plasma membrane using several different types of lipid anchors. Fluorescence resonance energy transfer measurements in living cells revealed that acyl but not prenyl modifications promote clustering in lipid rafts. Thus the nature of the lipid anchor on a protein is sufficient to determine submicroscopic localization within the plasma membrane.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	rtsien@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54441] Funding Source: Medline; NIGMS NIH HHS [2T32 GM07752] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Phillips GN, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P77; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Pyenta PS, 2001, BIOPHYS J, V80, P2120, DOI 10.1016/S0006-3495(01)76185-1; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	22	1701	1746	3	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2002	296	5569					913	916		10.1126/science.1068539	http://dx.doi.org/10.1126/science.1068539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988576				2022-12-24	WOS:000175442500045
J	Sulkowski, MS; Moore, RD; Mehta, SH; Chaisson, RE; Thomas, DL				Sulkowski, MS; Moore, RD; Mehta, SH; Chaisson, RE; Thomas, DL			Hepatitis C and progression of HIV disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; INJECTING DRUG-USERS; NATURAL-HISTORY; LIVER-DISEASE; INFECTION; COINFECTION; MORTALITY; PREVALENCE; HEPATOTOXICITY	Context Conflicting reports exist regarding the effect of hepatitis C virus (HCV) on the progression of human immunodeficiency virus (HIV) disease. Objective To assess the effect of HCV infection on clinical and immunologic progression of HIV disease and immunologic response to highly active antiretroviral therapy (HAART). Design Prospective cohort study. Setting University-based, urban HIV clinic in the United States. Patients There were 1955 patients enrolled between January 1995 and January 2001 who were eligible for analysis because of having at least 1 return visit to the clinic and being free of acquired immunodeficiency syndrome (AIDS) at enrollment. Median (interquartile range) length,of follow-up was 2.19 (1.00-3.50) years for HCV-infected and 2.00 (1.00-3.00) years for HCV-uninfected patients. Main Outcome Measures Progression to an AIDS-defining illness, survival, and progression to a CD4 cell count below 200/muL; CD4 cell count change following initiation of effective HAART (resulting in a viral load of <400 copies/mL recorded at >= 75% of measurements). Results No difference was detected in the risk of acquiring an AIDS-defining illness (HCV-infected patients, 231,events [26.4%] and HCV-uninfected patients, 264 events [24.4%]; relative hazard [RH], 1.03; 95% confidence interval [CI], 0.86-1.23) or in the risk of death (HCV-infected patients, 153 deaths [17.5%] and HCV-uninfected patients, 168 deaths [15.5%]; RH, 1.05; 95% Cl, 0.85-1.30). Although an increased risk of death was detected in the subgroup of 429 HCV-infected patients with a baseline CD4 cell count of 50/mu L through 200/mu L (RH, 1.51; 95% Cl, 1.01-2.27), after adjustment for exposure to HAART and its effectiveness in a multivariate Cox regression analysis, death was not independently associated with HCV infection in this subgroup (RH, 1.01; 5% Cl, 0.65-1.56). Similarly, in those receiving effective HAART (n=208), there was no difference in the increase in CD4 cell count or CD4 percentage during HAART in HCV-infected compared with HCV-uninfected patients. Conclusions Among patients in this urban US cohort, we did not detect evidence that HCV infection substantially alters the risk of dying, developing AIDS, or responding immunologically to HAART, especially after accounting for differences in its administration and effectiveness.	Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch PUbl Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sulkowski, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, 1830 E Monument St,Room 448, Baltimore, MD 21287 USA.	msulkows@jhmi.edu			NIAID NIH HHS [K24 AI-01637] Funding Source: Medline; NIDA NIH HHS [K24 DA-00342, R01 DA-13806, R01 DA-11602] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, R01DA013806] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1997, HEPATOLOGY, V26, pS2; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Broers B, 1998, AIDS, V12, P2059, DOI 10.1097/00002030-199815000-00018; Celentano DD, 1998, JAMA-J AM MED ASSOC, V280, P544, DOI 10.1001/jama.280.6.544; Christensen JK, 2000, J INFECT DIS, V181, P1796, DOI 10.1086/315440; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; DORRUCCI M, 1995, J INFECT DIS, V172, P1503, DOI 10.1093/infdis/172.6.1503; Escaffre N, 2000, AIDS CARE, V12, P723, DOI 10.1080/09540120020014264; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Goedert JI, 2001, AIDS, V15, P1295, DOI 10.1097/00002030-200107060-00012; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Haydon GH, 1998, EUR J GASTROEN HEPAT, V10, P485, DOI 10.1097/00042737-199806000-00009; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; HUGHES MD, 1994, J INFECT DIS, V169, P28, DOI 10.1093/infdis/169.1.28; Lesens O, 1999, J INFECT DIS, V179, P1254, DOI 10.1086/314720; Lok ASF, 1997, HEPATOLOGY, V26, pS48, DOI 10.1002/hep.510260709; Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006; Macias J, 1998, EUR J CLIN MICROBIOL, V17, P167, DOI 10.1007/BF01691112; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Prins M, 1997, AIDS, V11, P1747, DOI 10.1097/00002030-199714000-00012; QUAN CM, 1993, CLIN INFECT DIS, V17, P117, DOI 10.1093/clinids/17.1.117; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; SHERMAN KE, 1993, J CLIN MICROBIOL, V31, P2679, DOI 10.1128/JCM.31.10.2679-2682.1993; Staples CT, 1999, CLIN INFECT DIS, V29, P150, DOI 10.1086/520144; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thio CL, 2000, J CLIN MICROBIOL, V38, P575, DOI 10.1128/JCM.38.2.575-577.2000; Thomas DL, 2000, J INFECT DIS, V181, P844, DOI 10.1086/315314; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; WRIGHT TL, 1994, HEPATOLOGY, V20, P1152; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	46	332	352	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2002	288	2					199	206		10.1001/jama.288.2.199	http://dx.doi.org/10.1001/jama.288.2.199			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	571HC	12095384	Bronze			2022-12-24	WOS:000176711100020
J	Eiserich, JP; Baldus, S; Brennan, ML; Ma, WX; Zhang, CX; Tousson, A; Castro, L; Lusis, AJ; Nauseef, WM; White, CR; Freeman, BA				Eiserich, JP; Baldus, S; Brennan, ML; Ma, WX; Zhang, CX; Tousson, A; Castro, L; Lusis, AJ; Nauseef, WM; White, CR; Freeman, BA			Myeloperoxidase, a leukocyte-derived vascular NO oxidase	SCIENCE			English	Article							NITRIC-OXIDE; MISSENSE MUTATION; COMPOUNDS I; OXIDATION; TYROSINE; ATHEROSCLEROSIS; KINETICS; INJURY	Myeloperoxidase (MPO) is an abundant mammalian phagocyte hemoprotein thought to primarily mediate host defense reactions. Although its microbicidal functions are well established in vitro, humans deficient in MPO are not at unusual risk of infection. MPO was observed herein to modulate the vascular signaling and vasodilatory functions of nitric oxide (NO) during acute inflammation. After leukocyte degranulation, MPO localized in and around vascular endothelial cells in a rodent model of acute endotoxemia and impaired endothelium-dependent relaxant responses, to which MPO-deficient mice were resistant. Altered vascular responsiveness was due to catalytic consumption of NO by substrate radicals generated by MPO. Thus MPO can directly modulate vascular inflammatory responses by regulating NO bioavailability.	Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; Univ Calif Davis, Dept Human Physiol, Div Nephrol, Davis, CA 95616 USA; Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Imaging Facil, Birmingham, AL 35233 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Iowa, Iowa City, IA 52242 USA; Vet Adm Med Ctr, Dept Med, Iowa City, IA 52242 USA; Vet Adm Med Ctr, Inflammat Program, Iowa City, IA 52242 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Eiserich, JP (corresponding author), Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA.	jpeiserich@ucdavis.edu; bruce.freeman@ccc.uab.edu	Freeman, Bruce A/H-9342-2012; zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495; Nauseef, William/0000-0003-4032-757X	FOGARTY INTERNATIONAL CENTER [R03TW005682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067930] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW005682] Funding Source: Medline; NHLBI NIH HHS [R01 HL067930] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BLRD VA		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Baldus S, 2001, J CLIN INVEST, V108, P1759; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Deby-Dupont G., 1999, Intensivmedizin und Notfallmedizin, V36, P500, DOI 10.1007/s003900050270; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; EISERICH JP, 1995, BIOCHEM J, V310, P745, DOI 10.1042/bj3100745; EISERICH JP, UNPUB; Glover RE, 1999, NITRIC OXIDE-BIOL CH, V3, P439, DOI 10.1006/niox.1999.0256; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Houston M, 1999, J BIOL CHEM, V274, P4985, DOI 10.1074/jbc.274.8.4985; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; Klebanoff S. J, 1991, PEROXIDASES CHEM BIO, V1, P1; Lanza F, 1998, J MOL MED-JMM, V76, P676, DOI 10.1007/s001090050267; Lefer DJ, 1996, AM J PHYSIOL-HEART C, V271, pH2421, DOI 10.1152/ajpheart.1996.271.6.H2421; Lentsch AB, 2000, J PATHOL, V190, P343; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Murray PT, 2000, ANESTH ANALG, V90, P89, DOI 10.1097/00000539-200001000-00021; Nauseef WM, 1996, J BIOL CHEM, V271, P9546, DOI 10.1074/jbc.271.16.9546; NAUSEEF WM, 1994, J BIOL CHEM, V269, P1212; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Rubbo H, 2000, J BIOL CHEM, V275, P10812, DOI 10.1074/jbc.275.15.10812; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; SUN WM, 1993, BIOCHEM BIOPH RES CO, V194, P306, DOI 10.1006/bbrc.1993.1820; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Winterbourn CC, 2000, CURR OPIN HEMATOL, V7, P53, DOI 10.1097/00062752-200001000-00010	26	535	572	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2391	2394		10.1126/science.1106830	http://dx.doi.org/10.1126/science.1106830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089442				2022-12-24	WOS:000176467200041
J	Jesson, LK; Barrett, SCH				Jesson, LK; Barrett, SCH			Enantiostyly: Solving the puzzle of mirror-image flowers	NATURE			English	Article							EVOLUTION		Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	University of Toronto	Jesson, LK (corresponding author), Univ Toronto, Dept Bot, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	barrett@botany.utoronto.ca	Barrett, Spencer C.H./S-5782-2019; Jesson, Linley/G-3285-2018; Barrett, Spencer CH/M-3751-2013	Barrett, Spencer C.H./0000-0002-7762-3455; Jesson, Linley/0000-0003-4969-160X; 				Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 2000, ANN BOT-LONDON, V85, P253, DOI 10.1006/anbo.1999.1067; BOWERS KAW, 1975, AM J BOT, V62, P633, DOI 10.2307/2441943; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Jesson LK, 2002, AM J BOT, V89, P253, DOI 10.3732/ajb.89.2.253; Todd J.E., 1882, AM NAT, V16, P281, DOI DOI 10.1086/273056	6	86	102	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					707	707		10.1038/417707a	http://dx.doi.org/10.1038/417707a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066175	Bronze			2022-12-24	WOS:000176154700034
J	Conte, MH; Weber, JC				Conte, MH; Weber, JC			Plant biomarkers in aerosols record isotopic discrimination of terrestrial photosynthesis	NATURE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; ORGANIC-MATTER; LIPIDS; DELTA-C-13; BIOSPHERE; TRENDS; CYCLE	Carbon uptake by the oceans and by the terrestrial biosphere can be partitioned using changes in the C-12/C-13 isotopic ratio (delta(13)C) of atmospheric carbon dioxide(1-4), because terrestrial photosynthesis strongly discriminates against (CO2)-C-13,whereas ocean uptake does not. This approach depends on accurate estimates of the carbon isotopic discrimination of terrestrial photosynthesis (Delta; ref. 5) at large regional scales(6), yet terrestrial ecosystem heterogeneity(7) makes such estimates problematic. Here we show that ablated plant wax compounds in continental air masses can be used to estimate Delta over large spatial scales and at less than monthly temporal resolution. We measured plant waxes in continental air masses advected to Bermuda, which are mainly of North American origin, and used the wax isotopic composition to estimate Delta simply. Our estimates indicate a large (5-6parts per thousand) seasonal variation in Delta of the temperate North American biosphere, with maximum discrimination occurring in late spring, coincident with the onset of production. We suggest that the observed seasonality arises from several factors, including seasonal shifts in the proportions of production by C-3 and C-4 plants, and environmentally controlled adjustments in the photosynthetic discrimination of C-3-plant-dominated ecosystems.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Conte, MH (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.							Bakwin PS, 1998, GLOBAL BIOGEOCHEM CY, V12, P555, DOI 10.1029/98GB02265; Ballentine DC, 1996, ORG GEOCHEM, V25, P97, DOI 10.1016/S0146-6380(96)00110-6; CIAIS P, 1995, J GEOPHYS RES-ATMOS, V100, P5051, DOI 10.1029/94JD02847; COLLISTER JW, 1994, ORG GEOCHEM, V21, P619, DOI 10.1016/0146-6380(94)90008-6; CONTE MH, 2001, EOS T AGU, V82, pS77; CONTE MH, 2001, IN PRESS ORG GEOCHEM; EHLERINGER JR, 1993, OECOLOGIA, V95, P340, DOI 10.1007/BF00320986; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; Flanagan LB, 1998, TRENDS ECOL EVOL, V13, P10, DOI 10.1016/S0169-5347(97)01275-5; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; Fung I, 1997, GLOBAL BIOGEOCHEM CY, V11, P507, DOI 10.1029/97GB01751; GULZ PG, 1994, J PLANT PHYSIOL, V143, P453, DOI 10.1016/S0176-1617(11)81807-9; HADLEY JL, 1989, ARCTIC ALPINE RES, V21, P392, DOI 10.2307/1551648; Kawamura, 1995, BIOGEOCHEMICAL PROCE, P31; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Lockheart MJ, 1997, ORG GEOCHEM, V26, P137, DOI 10.1016/S0146-6380(96)00135-0; MARSHALL JD, 1994, ECOLOGY, V75, P1887, DOI 10.2307/1941593; MOODY JL, 1995, J GEOPHYS RES-ATMOS, V100, P7179, DOI 10.1029/94JD02830; Peltzer E.T., 1989, CHEM OCEANOGR, V10, P282; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; ROGGE WF, 1994, ENVIRON SCI TECHNOL, V28, P1375, DOI 10.1021/es00056a030; SIMONEIT BRT, 1989, J ATMOS CHEM, V8, P251, DOI 10.1007/BF00051497; SMEDLEY MP, 1991, OECOLOGIA, V85, P314, DOI 10.1007/BF00320605; STILL CJ, 1999, EOS T AGU, V80, pF93; TANS PP, 1993, GLOBAL BIOGEOCHEM CY, V7, P353, DOI 10.1029/93GB00053; Vogel J., 1993, STABLE ISOTOPES PLAN, P26; ZAFIRIOU OC, 1985, J GEOPHYS RES-ATMOS, V90, P2409, DOI 10.1029/JD090iD01p02409	30	86	91	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					639	641		10.1038/nature00777	http://dx.doi.org/10.1038/nature00777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050663				2022-12-24	WOS:000176001200045
J	Duncan, RP; Williams, PA				Duncan, RP; Williams, PA			Ecology - Darwin's naturalization hypothesis challenged	NATURE			English	Article									Lincoln Univ, Soil Plant & Ecol Sci Div, Ecol & Entomol Grp, Canterbury, New Zealand; Landcare Res, Nelson, New Zealand	Lincoln University - New Zealand; Landcare Research - New Zealand	Duncan, RP (corresponding author), Lincoln Univ, Soil Plant & Ecol Sci Div, Ecol & Entomol Grp, POB 84, Canterbury, New Zealand.		Duncan, Richard P/E-7899-2013; Duncan, Richard/ABD-4099-2020	Duncan, Richard P/0000-0003-2295-449X; Duncan, Richard/0000-0003-2295-449X				Daehler CC, 2001, AM NAT, V158, P324, DOI 10.1086/321316; Darwin C., 1859, ORIGIN SPECIES FACSI; Heenan PB, 1998, NEW ZEAL J BOT, V36, P155, DOI 10.1080/0028825X.1998.9512556; Jackson B. D., 1895, INDEX KEWENSIS PLANT; Mabberley DJ, 1987, PLANT BOOK PORTABLE; MACK RN, 1995, BRIT CROP PROTECTION, V64, P65; Rejmanek M., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P79; SAS Institute, 1999, SAS STAT VERS 8; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Williams C. B., 1947, JOUR ANIMAL ECOL, V16, P11, DOI 10.2307/1502; Williamson M, 1996, BIOL INVASIONS	12	187	192	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					608	609		10.1038/417608a	http://dx.doi.org/10.1038/417608a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050652				2022-12-24	WOS:000176001200034
J	Mahajna, A; Aboud, N; Harbaji, I; Agbaria, A; Lankovsky, Z; Michaelson, M; Fisher, D; Krausz, MM				Mahajna, A; Aboud, N; Harbaji, I; Agbaria, A; Lankovsky, Z; Michaelson, M; Fisher, D; Krausz, MM			Blunt and penetrating injuries caused by rubber bullets during the Israeli-Arab conflict in October, 2000: a retrospective study	LANCET			English	Article							PLASTIC BULLETS; BALLISTICS; MECHANISMS; INTIFADA; CHILDREN; WOUNDS	Background Low-velocity rubber bullets were used by Israeli police to control riots by Israeli-Arabs in early October, 2000. We aimed to establish the factors that contribute to severity of blunt and penetrating injuries caused by these missiles. Methods We analysed medical records of 595 casualties admitted. We assessed relation of severity of injury to type of bullet, anatomical region of injury, and final outcome. Severity of injury was established by the abbreviated injury scale, and we calculated injury severity score. Findings 151 males and one female (age range 11-59 years) were included in the study, in whom 201 proven injuries by rubber bullets were detected. Injuries were distributed randomly over the body surface and were mostly located in the limbs (n=73), but those to the head, neck, and face (61), chest (39), back (16), and abdomen (12) were also frequently noted. 93 (61%) patients had blunt injuries and 59 (39%) penetrating ones. Severity of injury was dependent on ballistic features of the bullet, firing range, and anatomic site of impact. Two casualties died after a penetrating ocular injury into the brain and one died as a result of postoperative aspiration after a knee injury. Interpretation Resistance of the body surface at the site of impact (elastic limit) is the important factor that ascertains whether a blunt or penetrating injury is inflicted and its severity. Inaccuracy of rubber bullets and improper aiming and range of use resulted in severe injury and death in a substantial number of people. This ammunition should therefore not be considered a safe method of crowd control.	Technion Israel Inst Technol, Rambam Med Ctr, Dept Gen Surg, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Nazareth Hosp, Edembre Missionary Med Soc, Nazareth, Israel; Holy Family Hosp, Nazareth, Israel; El Haiat Clin, Umm El Faham, Israel; Israeli Police Force Headquarters, Jerusalem, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Krausz, MM (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Dept Gen Surg, POB 9602, IL-31096 Haifa, Israel.							BALOURIS CA, 1990, LANCET, V335, P415, DOI 10.1016/0140-6736(90)90252-Z; BARACH E, 1986, J TRAUMA, V26, P225, DOI 10.1097/00005373-198603000-00003; BELLAMY RF, 1990, CONVENTIONAL WARFARE, P107; COHEN MA, 1985, S AFR MED J, V68, P849; Feliciano DV, 1996, TRAUMA, P85; GUO W, 1993, INT J ARTIF ORGANS, V16, P276, DOI 10.1177/039139889301600508; HISS J, 1994, J FORENSIC SCI SOC, V34, P225, DOI 10.1016/S0015-7368(94)72924-8; Hiss J, 1997, MED SCI LAW, V37, P139, DOI 10.1177/002580249703700209; Jaouni ZM, 1997, EYE, V11, P392, DOI 10.1038/eye.1997.83; MENDELSON JA, 1991, J TRAUMA, V31, P1181, DOI 10.1097/00005373-199109000-00001; MILLAR R, 1975, BRIT J SURG, V62, P480, DOI 10.1002/bjs.1800620613; National Research Council Committee on Trauma Research, 1985, INJ AM CONT PUBL HLT, P48; ORDOG GJ, 1984, ANN EMERG MED, V13, P1113, DOI 10.1016/S0196-0644(84)80336-4; RITCHIE AJ, 1990, BRIT MED J, V301, P1332, DOI 10.1136/bmj.301.6764.1332; ROCKE L, 1983, LANCET, V1, P919; SCHNITZER JJ, 1993, SURG GYNECOL OBSTET, V176, P172; SHAW J, 1972, BRIT MED J, V4, P764, DOI 10.1136/bmj.4.5843.764; WHITLOCK RIH, 1978, INT J ORAL MAXILLOF, V7, P240, DOI 10.1016/S0300-9785(78)80087-8; YELLIN A, 1992, J THORAC CARDIOV SUR, V103, P381	19	48	52	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 25	2002	359	9320					1795	1800		10.1016/S0140-6736(02)08708-1	http://dx.doi.org/10.1016/S0140-6736(02)08708-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044373				2022-12-24	WOS:000175775500006
J	Cheng, MY; Bullock, CM; Li, CY; Lee, AG; Bermak, JC; Belluzzi, J; Weaver, DR; Leslie, FM; Zhou, QY				Cheng, MY; Bullock, CM; Li, CY; Lee, AG; Bermak, JC; Belluzzi, J; Weaver, DR; Leslie, FM; Zhou, QY			Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus	NATURE			English	Article							EFFERENT PROJECTIONS; CLOCK; GENE; LIGHT; EXPRESSION; MUTATION; MPER2; MICE; ORGANIZATION; TRANSPORT	The suprachiasmatic nucleus (SCN) controls the circadian rhythm of physiological and behavioural processes in mammals. Here we show that prokineticin 2 (PK2), a cysteine-rich secreted protein, functions as an output molecule from the SCN circadian clock. PK2 messenger RNA is rhythmically expressed in the SCN, and the phase of PK2 rhythm is responsive to light entrainment. Molecular and genetic studies have revealed that PK2 is a gene that is controlled by a circadian clock (clock-controlled). Receptor for PK2 (PKR2) is abundantly expressed in major target nuclei of the SCN output pathway. Inhibition of nocturnal locomotor activity in rats by intracerebroventricular delivery of recombinant PK2 during subjective night, when the endogenous PK2 mRNA level is low, further supports the hypothesis that PK2 is an output molecule that transmits behavioural circadian rhythm. The high expression of PKR2 mRNA within the SCN and the positive feedback of PK2 on its own transcription through activation of PKR2 suggest that PK2 may also function locally within the SCN to synchronize output.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA	University of California System; University of California Irvine; University of Massachusetts System; University of Massachusetts Worcester	Zhou, QY (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	qzhou@uci.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Cheng, Michelle/0000-0003-3241-5174; Weaver, David/0000-0001-7941-6719				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Boer GJ, 1999, NEUROSCIENCE, V89, P375, DOI 10.1016/S0306-4522(98)00300-5; Buijs RM, 1996, PROG BRAIN RES, V111, P229, DOI 10.1016/S0079-6123(08)60411-2; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; Hardin P.E., 2000, GENOME BIOL, V1; Hastings MH, 2000, NAT REV NEUROSCI, V1, P143, DOI 10.1038/35039080; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jilek A, 2000, GENE, V256, P189, DOI 10.1016/S0378-1119(00)00355-3; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kalsbeek A, 1996, J NEUROSCI, V16, P5555, DOI 10.1523/jneurosci.16-17-05555.1996; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Winzer-Serhan UH, 1999, BRAIN RES PROTOC, V3, P229, DOI 10.1016/S1385-299X(98)00043-9; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	50	529	555	2	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					405	410		10.1038/417405a	http://dx.doi.org/10.1038/417405a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024206				2022-12-24	WOS:000175730900030
J	Storz, G				Storz, G			An expanding universe of noncoding RNAs	SCIENCE			English	Editorial Material							SMALL NUCLEOLAR RNAS; ESCHERICHIA-COLI; GENES; IDENTIFICATION; RIBONUCLEOPROTEINS; EXPRESSION; DATABASE	Noncoding RNAs (ncRNAs) have been found to have roles in a great variety of processes, including transcriptional regulation, chromosome replication, RNA processing and modification, messenger RNA stability and translation, and even protein degradation and translocation. Recent studies indicate that ncRNAs are far more abundant and important than initially imagined. These findings raise several fundamental questions: How many ncRNAs are encoded by a genome? Given the absence of a diagnostic open reading frame, how can these genes be identified? How can all the functions of ncRNAs be elucidated?	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Storz, G (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	storz@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altuvia S, 2000, P NATL ACAD SCI USA, V97, P9824, DOI 10.1073/pnas.97.18.9824; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; CHEN S, IN PRESS BIOSYSTEMS; Chen XG, 2000, GENE DEV, V14, P777; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Erdmann VA, 2000, NUCLEIC ACIDS RES, V28, P197, DOI 10.1093/nar/28.1.197; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Grosshans H, 2002, J CELL BIOL, V156, P17, DOI 10.1083/jcb.200111033; Gu J, 1998, NUCLEIC ACIDS RES, V26, P160, DOI 10.1093/nar/26.1.160; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kable ML, 1997, TRENDS BIOCHEM SCI, V22, P162, DOI 10.1016/S0968-0004(97)01041-4; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KLEIN RJ, IN PRESS P NATL ACAD; Kuryshev VY, 2001, J MOL BIOL, V309, P1049, DOI 10.1006/jmbi.2001.4725; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Olivas WM, 1997, NUCLEIC ACIDS RES, V25, P4619, DOI 10.1093/nar/25.22.4619; Plant KE, 2001, MOL CELL BIOL, V21, P6507, DOI 10.1128/MCB.21.19.6507-6514.2001; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Samarsky DA, 1999, NUCLEIC ACIDS RES, V27, P161, DOI 10.1093/nar/27.1.161; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Souza AE, 1997, NUCLEIC ACIDS RES, V25, P104, DOI 10.1093/nar/25.1.104; TANG TH, IN PRESS P NATL ACAD; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	48	430	482	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1260	1263		10.1126/science.1072249	http://dx.doi.org/10.1126/science.1072249			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016301				2022-12-24	WOS:000175713000038
J	Innes, KE; Byers, TE; Marshall, JA; Baron, A; Orleans, M; Hamman, RF				Innes, KE; Byers, TE; Marshall, JA; Baron, A; Orleans, M; Hamman, RF			Association of a woman's own birth weight with subsequent risk for gestational diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; GLUCOSE-TOLERANCE; FETAL ORIGINS; INDIAN CHILDREN; ADULT DISEASE; SHORT STATURE; WOMEN; PREGNANCY; MELLITUS; GROWTH	Context Several studies have reported links between reduced fetal growth and subsequent risk for type 2 diabetes among older adults, but the association between indices of-fetal growth and gestational diabetes mellitus (GDM), a major complication of pregnancy and a strong predictor of type 2 diabetes, remains little explored. Objective To test the hypothesis that a woman's own fetal growth is inversely related to her later risk for GDM. Design and Setting Case-control study of linked hospital discharge and vital record data from the New York State Department of Health. Population Healthy women who completed their first pregnancies in New York State between 1994 and 1998 and who were also born in New York State, Records from each woman's first pregnancy were linked to those from her own birth (1970-1985). Cases were 440 women with a record of GDM. Controls were 22 955 remaining women with no indication of GDM. Main Outcome Measure A woman's own birth weight, alone and adjusted for gestational age. Results Birth weight showed a U-shaped relationship to a woman's risk of GDM in her first pregnancy, with the highest risks associated with low and high birth weights. Odds ratios (ORs) adjusted for gestational age were 2.16 (95% confidence interval [CI], 1.04-4.50) for birth weight of less than 2000 g and 1.53 (95% CI, 1.03-2.27) for a birth weight of 4000 g or more. Adjustment for potential confounding factors, particularly prepregnancy body mass index and maternal diabetes, increased the OR for low birth weight to 4.23 (95% CI, 1.55-11.51), but reduced the OR for high birth weight to 0.92 (95% CI, 0.54-1.57), leaving a strong inverse dose-response relationship between birth weight and risk of GDM (adjusted P for trend <.001). Conclusions In this large population-based study, a woman's own birth weight was strongly and inversely related to her risk of GDM, suggesting that early life factors may be important in the etiology of this disorder.	Univ Virginia, SE Rural Mental Hlth Ctr, Charlottesville, VA 22903 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA	University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Innes, KE (corresponding author), Univ Virginia, SE Rural Mental Hlth Ctr, McLeod Hall,202 15th St SW, Charlottesville, VA 22903 USA.	kei6n@virginia.edu			NHLBI NIH HHS [1R03HL59467-D] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AbuSayeed M, 1997, DIABETES RES CLIN PR, V34, P149, DOI 10.1016/S0168-8227(96)01337-X; Anastasiou E, 1998, DIABETOLOGIA, V41, P997, DOI 10.1007/s001250051022; Anastasiou E, 1998, DIABETES CARE, V21, P2111, DOI 10.2337/diacare.21.12.2111; [Anonymous], 1989, DIABETES CARE, V12, P365; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BARKER DJP, 1994, J ROY COLL PHYS LOND, V28, P544; BARKER DJP, 1995, FETUS NEONATE PHYSL, P255; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; BERKOWITZ GS, 1992, AM J EPIDEMIOL, V135, P965, DOI 10.1093/oxfordjournals.aje.a116408; Branchtein L, 2000, DIABETOLOGIA, V43, P848, DOI 10.1007/s001250051460; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P201; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P213; Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V47, P408; Clark CM, 1997, DIABETES CARE, V20, P867, DOI 10.2337/diacare.20.5.867; Clark PM, 1998, EUR J PEDIATR, V157, pS7, DOI 10.1007/PL00014289; Couch SC, 1998, J REPROD MED, V43, P816; Coustan DR, 1995, DIABETES AM, P703; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; DORNHORST A, 1990, BAILLIERE CLIN ENDOC, V4, P291, DOI 10.1016/S0950-351X(05)80052-7; Egeland GM, 2000, BMJ-BRIT MED J, V321, P546, DOI 10.1136/bmj.321.7260.546; Emery ES, 1997, PAEDIATR PERINAT EP, V11, P313; ENGELGAU MM, 1995, DIABETES CARE, V18, P1029, DOI 10.2337/diacare.18.7.1029; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1998, DIABETES CARE S1, V21, pS5; Fall CH, 2001, INT J DIABETES DEV C, V21, P3; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Hoet JJ, 2000, ENVIRON HEALTH PERSP, V108, P563, DOI 10.2307/3454547; Innes KE, 1999, ACTA OBSTET GYN SCAN, V78, P263, DOI 10.1034/j.1600-0412.1999.780401.x; Jang HC, 1998, DIABETOLOGIA, V41, P778, DOI 10.1007/s001250050987; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; KJOS SL, 1990, AM J OBSTET GYNECOL, V163, P93, DOI 10.1016/S0002-9378(11)90676-0; Kousta E, 2000, DIABETIC MED, V17, P792, DOI 10.1046/j.1464-5491.2000.00393.x; Kramer MS, 2000, AM J EPIDEMIOL, V152, P605, DOI 10.1093/aje/152.7.605; LAW C, 2001, PEDIATR RES, V50, pA59; Law CM, 1996, DIABETIC MED, V13, pS49; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MAGEE MS, 1993, JAMA-J AM MED ASSOC, V269, P609, DOI 10.1001/jama.269.5.609; MARRERO DG, 1992, DIABETES CARE, V15, P101, DOI 10.2337/diacare.15.1.101; McAllister AS, 1999, DIABETES CARE, V22, P2061, DOI 10.2337/diacare.22.12.2061; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; MOOY JM, 1995, DIABETES CARE, V18, P1270, DOI 10.2337/diacare.18.9.1270; Moses RG, 1999, DIABETES CARE, V22, P1059, DOI 10.2337/diacare.22.7.1059; Pan WH, 2001, CHINESE J PHYSIOL, V44, P44; Petry CJ, 2000, HUM REPROD UPDATE, V6, P578, DOI 10.1093/humupd/6.6.578; PETTITT DJ, 1991, DIABETES, V40, P126, DOI 10.2337/diab.40.2.S126; Phillips DIW, 1998, DIABETES CARE, V21, pB150; PUGNALONI A, 1995, GYNECOL OBSTET INVES, V39, P239, DOI 10.1159/000292418; Reece E A, 1994, Obstet Gynecol Surv, V49, P64, DOI 10.1097/00006254-199401000-00027; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; ROBINSON S, 1992, DIABETOLOGIA, V35, P444, DOI 10.1007/BF02342441; ROSEMAN JM, 1991, DIABETES METAB REV, V7, P93, DOI 10.1002/dmr.5610070203; Ryan EA, 1998, MED CLIN N AM, V82, P823, DOI 10.1016/S0025-7125(05)70026-2; Silverman BL, 1998, DIABETES CARE, V21, pB142; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Solomon CG, 1996, DIABETES CARE, V19, P12, DOI 10.2337/diacare.19.1.12; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Weintrob N, 1996, J DIABETES COMPLICAT, V10, P294, DOI 10.1016/1056-8727(95)00080-1; Whincup PH, 1997, DIABETOLOGIA, V40, P319, DOI 10.1007/s001250050681	61	115	121	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2534	2541		10.1001/jama.287.19.2534	http://dx.doi.org/10.1001/jama.287.19.2534			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020334				2022-12-24	WOS:000175566200022
J	Kasting, JF; Siefert, JL				Kasting, JF; Siefert, JL			Life and the evolution of Earth's atmosphere	SCIENCE			English	Article							METHANE	Harvesting tight to produce energy and oxygen (photosynthesis) is the signature of all land plants. This ability was co-opted from a precocious and ancient form of life known as cyanobacteria. Today these bacteria, as well as microscopic algae, supply oxygen to the atmosphere and chum out fixed nitrogen in Earth's vast oceans. Microorganisms may also have played a major role in atmosphere evolution before the rise of oxygen. Under the more dim light of a young sun cooler than today's, certain groups of anaerobic bacteria may have been pumping out Large amounts of methane, thereby keeping the early climate warm and inviting. The evolution of Earth's atmosphere is linked tightly to the evolution of its biota.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Rice Univ, Dept Stat, Houston, TX 77251 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Rice University	Kasting, JF (corresponding author), Penn State Univ, Dept Geosci, 443 Deike, University Pk, PA 16802 USA.	kasting@essc.psu.edu	Kasting, James/AAF-6851-2020					Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; COONEY CL, 1975, BIOTECHNOL BIOENG, V17, P1119, DOI 10.1002/bit.260170804; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Houghton JT, 1994, CLIMATE CHANGE 1994; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KASTING JF, 1980, J GEOPHYS RES-OCEANS, V85, P3255, DOI 10.1029/JC085iC06p03255; Kral TA, 1998, ORIGINS LIFE EVOL B, V28, P311, DOI 10.1023/A:1006552412928; KUMP LR, 1999, EARTH SYSTEM, P135; LEWIN RA, 1976, NATURE, V261, P697, DOI 10.1038/261697b0; LOVLEY DR, 1985, APPL ENVIRON MICROB, V49, P1530, DOI 10.1128/AEM.49.6.1530-1531.1985; MARGULIS L, 1993, SYMBIOSIS CELL EVOLU, P327; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Prasad N, 1996, CATENA, V27, P105, DOI 10.1016/0341-8162(96)00003-3; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; WALTER FM, 1991, SUN TIME, P633; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Zinder Stephen H., 1993, P128	23	267	295	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1066	1068		10.1126/science.1071184	http://dx.doi.org/10.1126/science.1071184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004117				2022-12-24	WOS:000175565000039
J	Ogawa, H; Ishiguro, K; Gaubatz, S; Livingston, DM; Nakatani, Y				Ogawa, H; Ishiguro, K; Gaubatz, S; Livingston, DM; Nakatani, Y			A complex with chromatin modifiers that occupies E2F-and Myc-responsive genes in G(0) cells	SCIENCE			English	Article							TRANSCRIPTION FACTOR; HISTONE H3; E2F FAMILY; LYSINE 9; PROTEINS; BINDING; DOMAIN; MEMBER; PRB; INTERACTS	E2F-6 contributes to gene silencing in a manner independent of retinoblastoma protein family members. To better elucidate the molecular mechanism of repression by E2F-6, we have purified the factor from cultured cells. E2F-6 is found in a multimeric protein complex that contains Mga and Max, and thus the complex can bind not only to the E2F-binding site but also to Myc- and Brachyury-binding sites. Moreover, the complex contains chromatin modifiers such as a novel histone methyltransferase that modifies lysine 9 of histone H3, Hp1gamma, and Polycomb group (PcG) proteins. The E2F-6 complex preferentially occupies target promoters in G(0) cells rather than in G(1) cells. These data suggest that these chromatin modifiers contribute to silencing of E2F- and Myc-responsive genes in quiescent cells.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Ishiguro, Kei-ichiro/K-3340-2019; Ogawa, Hidesato/M-3778-2019; Ogawa, Hidesato/A-2079-2016	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Ogawa, Hidesato/0000-0001-9740-9010; Gaubatz, Stefan/0000-0001-8751-4191				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brown SE, 2001, MAMM GENOME, V12, P916, DOI 10.1007/s00335-001-3029-3; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; *GENB, AY083210 GENB; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; OGAWA H, UNPUB; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takahashi Y, 2000, GENE DEV, V14, P804; Technau U, 2001, BIOESSAYS, V23, P788, DOI 10.1002/bies.1114; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698	21	610	636	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1132	1136		10.1126/science.1069861	http://dx.doi.org/10.1126/science.1069861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004135				2022-12-24	WOS:000175565000058
J	Bjerrum, CJ; Canfield, DE				Bjerrum, CJ; Canfield, DE			Ocean productivity before about 1.9 Gyr ago limited by phosphorus adsorption onto iron oxides	NATURE			English	Article							TRANSVAAL SUPERGROUP; FORMATION DEPOSITION; CARBON; SEDIMENTS; PHOSPHATE; OXYGEN; TRANSITION; LIMESTONE; CLIMATE; SULFUR	After the evolution of oxygen-producing cyanobacteria at some time before 2.7 billion years ago(1), oxygen production on Earth is thought to have depended on the availability of nutrients in the oceans, such as phosphorus (in the form of orthophosphate). In the modern oceans, a significant removal pathway for phosphorus occurs by way of its adsorption onto iron oxide deposits(2,3). Such deposits were thought to be more abundant in the past when, under low sulphate conditions, the formation of large amounts of iron oxides resulted in the deposition of banded iron formations(4,5). Under these circumstances, phosphorus removal by iron oxide adsorption could have been enhanced. Here we analyse the phosphorus and iron content of banded iron formations to show that ocean orthophosphate concentrations from 3.2 to 1.9 billion years ago (during the Archaean and early Proterozoic eras) were probably only similar to10-25% of present-day concentrations. We suggest therefore that low phosphorus availability should have significantly reduced rates of photosynthesis and carbon burial, thereby reducing the long-term oxygen production on the early Earth-as previously speculated(4)-and contributing to the low concentrations of atmospheric oxygen during the late Archaean and early Proterozoic.	Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, DK-5230 Odense, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, Danish Ctr Earth Syst Sci, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Niels Bohr Institute	Bjerrum, CJ (corresponding author), Univ Copenhagen, Inst Geol, Oster Voldgade 10, DK-1350 Copenhagen, Denmark.	cjb@geo.geol.ku.dk	Bjerrum, Christian/A-4247-2015; Canfield, Don/C-1735-2012; Bjerrum, Christian Jannik/AAZ-5488-2021	Bjerrum, Christian/0000-0002-7804-1633; Canfield, Don/0000-0001-7602-8366; Bjerrum, Christian Jannik/0000-0002-7804-1633				ANBAR AD, 1999, AM GEOPH UN FALL M; Anderson LD, 2001, GLOBAL BIOGEOCHEM CY, V15, P65, DOI 10.1029/2000GB001270; [Anonymous], 1981, AQUATIC CHEM INTRO E; BERNER EK, 1994, GLOBAL WATER CYCLE G; BERNER RA, 1973, EARTH PLANET SC LETT, V18, P77, DOI 10.1016/0012-821X(73)90037-X; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Compton J., 2000, SEPM SPECIAL PUBLICA, P21, DOI DOI 10.2110/PEC.00.66.0021; DeRonde CEJ, 1997, GEOCHIM COSMOCHIM AC, V61, P4025, DOI 10.1016/S0016-7037(97)00205-6; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; Feely RA, 1998, GEOPHYS RES LETT, V25, P2253, DOI 10.1029/98GL01546; Filippelli GM, 2001, MAR GEOL, V174, P307, DOI 10.1016/S0025-3227(00)00157-2; Fralick P., 1995, SEDIMENTARY FACIES A, P137, DOI [10.1002/9781444304091.ch6, DOI 10.1002/9781444304091.CH6]; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; KAUFMAN AJ, 1990, GEOCHIM COSMOCHIM AC, V54, P3461, DOI 10.1016/0016-7037(90)90298-Y; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P249, DOI 10.1029/1999GB900076; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; Schaller T, 2000, GEOCHIM COSMOCHIM AC, V64, P2243, DOI 10.1016/S0016-7037(99)00443-3; SHAFFER G, 1989, J GEOPHYS RES-OCEANS, V94, P1979, DOI 10.1029/JC094iC02p01979; Sleep NH, 2001, J GEOPHYS RES-PLANET, V106, P1373, DOI 10.1029/2000JE001247; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; WALKER JCG, 1984, NATURE, V309, P340, DOI 10.1038/309340a0; Wheat CG, 1996, GEOCHIM COSMOCHIM AC, V60, P3593, DOI 10.1016/0016-7037(96)00189-5	30	280	293	7	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					159	162		10.1038/417159a	http://dx.doi.org/10.1038/417159a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000956				2022-12-24	WOS:000175460200039
J	Thitamadee, S; Tuchihara, K; Hashimoto, T				Thitamadee, S; Tuchihara, K; Hashimoto, T			Microtubule basis for left-handed helical growth in Arabidopsis	NATURE			English	Article							CORTICAL MICROTUBULES; TUBULIN; MUTANT	Left-right asymmetry in plants can be found in helices of stalks, stems and tendrils, and in fan-like petal arrangements. The handedness in these asymmetric structures is often fixed in given species, indicating that genetic factors control asymmetric development(1). Here we show that dominant negative mutations at the tubulin intradimer interface of alpha-tubulins 4 and 6 cause left-handed helical growth and clockwise twisting in elongating organs of Arabidopsis thaliana. We demonstrate that the mutant tubulins incorporate into microtubule polymers, producing right-handed obliquely oriented cortical arrays, in the root epidermal cells. The cortical microtubules in the mutants had increased sensitivity to microtubule-specific drugs. These results suggest that reduced microtubule stability can produce left-handed helical growth in plants.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Nara Institute of Science & Technology	Hashimoto, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Takayama 8916-5, Ikoma 6300101, Japan.	hasimoto@bs.aist-nara.ac.jp						Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Burns Roy G., 1994, V13, P3; DOLAN L, 1993, DEVELOPMENT, V119, P71; Endress PK, 1999, INT J PLANT SCI, V160, pS3, DOI 10.1086/314211; Furutani I, 2000, DEVELOPMENT, V127, P4443; GARDNER M, 1990, NEW AMBIDEXTROUS UNI, P54; GRIDDINGS TH, 1991, CYTOSKELETAL BASIS P, P85; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Marinelli B, 1997, PLANTA, V202, P196, DOI 10.1007/s004250050119; Morejohn LC., 1991, CYTOSKELETAL BASIS P, P29; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Rutherford R, 1996, PLANT PHYSIOL, V111, P987, DOI 10.1104/pp.111.4.987; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Young DH, 2000, PLANT PHYSIOL, V124, P115, DOI 10.1104/pp.124.1.115	17	231	243	1	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					193	196		10.1038/417193a	http://dx.doi.org/10.1038/417193a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000963				2022-12-24	WOS:000175460200047
J	Huber, H; Hohn, MJ; Rachel, R; Fuchs, T; Wimmer, VC; Stetter, KO				Huber, H; Hohn, MJ; Rachel, R; Fuchs, T; Wimmer, VC; Stetter, KO			A new phylum of Archaea represented by a nanosized hyperthermophilic symbiont	NATURE			English	Article							RNA; VISUALIZATION; DIVERSITY; SEQUENCES; BACTERIA	According to small subunit ribosomal RNA (ss rRNA) sequence comparisons all known Archaea belong to the phyla Crenarchaeota, Euryarchaeota, and-indicated only by environmental DNA sequences-to the 'Korarchaeota'(1,2). Here we report the cultivation of a new nanosized hyperthermophilic archaeon from a submarine hot vent. This archaeon cannot be attached to one of these groups and therefore must represent an unknown phylum which we name 'Nanoarchaeota' and species, which we name 'Nanoarchaeum equitans'. Cells of 'N. equitans' are spherical, and only about 400 nm in diameter. They grow attached to the surface of a specific archaeal host, a new member of the genus Ignicoccus(3) . The distribution of the 'Nanoarchaeota' is so far unknown. Owing to their unusual ss rRNA sequence, members remained undetectable by commonly used ecological studies based on the polymerase chain reaction(4). 'N. equitans' harbours the smallest archaeal genome; it is only 0.5 megabases in size. This organism will provide insight into the evolution of thermophily, of tiny genomes and of interspecies communication.	Univ Regensburg, Lehrstuhl Mikrobiol & Archaeenzentrum, D-93053 Regensburg, Germany; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	University of Regensburg; Max Planck Society	Stetter, KO (corresponding author), Univ Regensburg, Lehrstuhl Mikrobiol & Archaeenzentrum, Univ Str 31, D-93053 Regensburg, Germany.			Wimmer, Verena/0000-0002-9931-8179				ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Baumann C, 1998, EXTREMOPHILES, V2, P101, DOI 10.1007/s007920050048; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; BURGGRAF S, 1994, APPL ENVIRON MICROB, V60, P3112, DOI 10.1128/AEM.60.9.3112-3119.1994; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; Burggraf S, 1997, NATURE, V385, P780, DOI 10.1038/385780a0; DeRijk P, 1997, NUCLEIC ACIDS RES, V25, P4679, DOI 10.1093/nar/25.22.4679; Eder W, 1999, ARCH MICROBIOL, V172, P213, DOI 10.1007/s002030050762; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; FRICKE H, 1989, MAR BIOL, V102, P425, DOI 10.1007/BF00428495; HUBER H, 1985, SYST APPL MICROBIOL, V6, P105, DOI 10.1016/S0723-2020(85)80021-7; Huber H, 2000, INT J SYST EVOL MICR, V50, P2093, DOI 10.1099/00207713-50-6-2093; HUBER R, 1995, NATURE, V376, P57, DOI 10.1038/376057a0; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; ROHOZINSKI J, 1989, VIROLOGY, V168, P363, DOI 10.1016/0042-6822(89)90277-8; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; STETTER KO, 1995, ASM NEWS, V61, P285; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; [No title captured]	26	490	544	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					63	67		10.1038/417063a	http://dx.doi.org/10.1038/417063a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986665				2022-12-24	WOS:000175307200037
J	Sharma, GK; Osti, B; Sharma, B				Sharma, GK; Osti, B; Sharma, B			Physicians persecuted for ethical practice in Nepal	LANCET			English	Editorial Material									Ctr Victims Torture, Kathmandu, Nepal		Sharma, B (corresponding author), Ctr Victims Torture, Nepal GPO Box 5839, Kathmandu, Nepal.							*AMN INT, 2002, URG APP BEH J MAH; Stevenson PC, 2001, LANCET, V358, P752, DOI 10.1016/S0140-6736(01)05844-5; 2001, RISING NEPAL    1201; 2001, KATHMANDU POST  1201	4	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 27	2002	359	9316					1519	1519		10.1016/S0140-6736(02)08422-2	http://dx.doi.org/10.1016/S0140-6736(02)08422-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	546NA	11988269				2022-12-24	WOS:000175279100032
J	Prati, D; Taioli, E; Zanella, A; Della Torre, E; Butelli, S; Del Vecchio, E; Vianello, L; Zanuso, F; Mozzi, F; Milani, S; Conte, D; Colombo, M; Sirchia, G				Prati, D; Taioli, E; Zanella, A; Della Torre, E; Butelli, S; Del Vecchio, E; Vianello, L; Zanuso, F; Mozzi, F; Milani, S; Conte, D; Colombo, M; Sirchia, G			Updated definitions of healthy ranges for serum alanine aminotransferase levels	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; BODY-MASS INDEX; BLOOD-DONORS; RISK-FACTORS; VIRUS-INFECTION; NONALCOHOLIC STEATOHEPATITIS; GENERAL-POPULATION; CRYPTOGENIC CIRRHOSIS; PREVALENCE	Background: Serum alanine aminotransferase (ALT) activity, the variable most commonly measured to assess hepatic disease, fails to identify many patients with hepatic injury. Current standards for "normal" ALT level were defined by using populations that included persons with subclinical liver disease. Objective: To update definitions of healthy ranges for serum ALT level. Design: Retrospective cohort study. Setting: A university hospital in Milan, Italy. Participants: 6835 persons who were first-time blood donors from 1995 through 1999, were negative for anti-hepatitis C virus (HCV), and had no contraindications to donation and 209 persons who attempted to donate blood from 1990 through 1999 but were found to have anti-HCV antibodies. Of the latter group, 131 had HCV viremia. Measurements: Univariate and multivariate analyses examined associations between clinical and laboratory factors and ALT levels. Healthy ranges for ALT were computed from the population at lowest risk for liver disease. Sensitivity and specificity of healthy ALT ranges were evaluated in the donors with HCV antibodies, of whom 133 had liver biopsy. Results: Serum ALT activity was independently related to body mass index and to laboratory indicators of abnormal lipid or carbohydrate metabolism. Updated upper limits (for men, 500 nkat/L [30 U/L]; for women, 317 nkat/L [19 U/L]) were lower than current limits (for men, 667 nkat/L [40 U/L]; for women, 500 nkat/L [30 U/L]) and, during 6-month follow-up, showed superior sensitivity in identifying participants with HCV viremia (sensitivity, 76.3% [95 % Cl, 69.1% to 83.6%] vs. 55% [Cl, 46.4% to 63.5%]). The related tradeoff in specificity was acceptable (88.5% [Cl, 79.2% to 94.6%] vs. 97.4% [91% to 99.7%]). The increased sensitivity targeted patients with minimal to mild histologic lesions. Conclusion: In patients with chronic HCV infection or nonalcoholic fatty liver disease, revision of normal limits for ALT level is advisable.	Osped Maggiore, Ctr Trasfus & Immunol Trapianti, IRCCS, Lab Epidemiol,Div Ematol, I-20122 Milan, Italy; Osped Maggiore, Ist Stat Med & Biometria, IRCCS, Cattedra Gastroenterol, I-20122 Milan, Italy; Osped Maggiore, Ist Med Interna, IRCCS, I-20122 Milan, Italy; Univ Milan, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Prati, D (corresponding author), Osped Maggiore, Ctr Trasfus & Immunol Trapianti, IRCCS, Lab Epidemiol,Div Ematol, Via F Sforza 35, I-20122 Milan, Italy.	dprati@yahoo.com	milani, silvano/I-7889-2012; Prati, Daniele/P-8215-2019	milani, silvano/0000-0002-5677-1758; Prati, Daniele/0000-0002-2281-7498				ALBERTI A, 1992, LANCET, V340, P697, DOI 10.1016/0140-6736(92)92234-7; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Bellentani S, 1999, GUT, V44, P874, DOI 10.1136/gut.44.6.874; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; BLAJCHMAN MA, 1995, LANCET, V345, P21, DOI 10.1016/S0140-6736(95)91153-7; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Craxi A, 1996, J HEPATOL, V25, P47; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; Darling GM, 1997, NEW ENGL J MED, V337, P595, DOI 10.1056/NEJM199708283370903; DEBAC C, 1994, HEPATOLOGY, V20, P1225; DESFORGES JF, 1995, JAMA-J AM MED ASSOC, V274, P1374; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; GUAZZOTTI L, 1983, SISTEMA SANGUE, P95; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401; LONARDO A, 1995, AM J GASTROENTEROL, V90, P2072; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McCullough AJ, 1999, HEPATOLOGY, V29, P1328, DOI 10.1002/hep.510290451; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; Prati D, 1997, TRANSFUSION, V37, P1200, DOI 10.1046/j.1537-2995.1997.37111298088052.x; Prati D, 2000, J VIRAL HEPATITIS, V7, P352; Prati D, 1997, HEPATOLOGY, V25, P702, DOI 10.1002/hep.510250335; Prati D, 1996, GASTROENTEROLOGY, V110, P178, DOI 10.1053/gast.1996.v110.pm8536854; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Puoti C, 1997, HEPATOLOGY, V26, P1393; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Silvani C, 2000, HAEMATOLOGICA, V85, P1055; WEJSTAL R, 1988, VOX SANG, V55, P152, DOI 10.1111/j.1423-0410.1988.tb05083.x; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; ZANELLA A, 1995, HEPATOLOGY, V21, P913, DOI 10.1016/0270-9139(95)90233-3	39	1044	1087	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2002	137	1					1	9		10.7326/0003-4819-137-1-200207020-00006	http://dx.doi.org/10.7326/0003-4819-137-1-200207020-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569VA	12093239				2022-12-24	WOS:000176622000001
J	Senn, DB; Hemond, HF				Senn, DB; Hemond, HF			Nitrate controls on iron and arsenic in an urban lake	SCIENCE			English	Article							OXIDATION; SPECIATION; REDUCTION; MANGANESE; GENERATION; ADSORPTION; WATERS; PH	Aquatic ecosystems are often contaminated by multiple substances. Nitrate, a common aquatic pollutant, strongly influenced the cycling of arsenic (As) under anoxic conditions in urban Upper Mystic Lake (Massachusetts, USA) by oxidizing ferrous iron [Fe(II)] to produce As-sorbing particulate hydrous ferric oxides and causing the more oxidized As(V), which is more particle-reactive than As(III) under these conditions, to dominate. This process is likely to be important in many natural waters.	MIT, Dept Civil & Environm Engn, Parsons Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Senn, DB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Sci & Engn, Bldg 1,Room G21,665 Huntington Ave, Boston, MA 02115 USA.	dbsenn@alum.mit.edu	张, 楠/B-1010-2010; Senn, David B/E-7813-2010	Senn, David/0000-0002-4869-3550	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004675] Funding Source: NIH RePORTER; NIEHS NIH HHS [5P42ES04675-06] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AGGETT J, 1988, WATER RES, V22, P407, DOI 10.1016/0043-1354(88)90034-6; Ahmann D, 1997, ENVIRON SCI TECHNOL, V31, P2923, DOI 10.1021/es970124k; AURILLO AC, 1994, ENVIRON SCI TECHNOL, V28, P577, DOI 10.1021/es00053a008; BALISTRIERI LS, 1992, LIMNOL OCEANOGR, V37, P510, DOI 10.4319/lo.1992.37.3.0510; Benz M, 1998, ARCH MICROBIOL, V169, P159, DOI 10.1007/s002030050555; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Cummings DE, 1999, ENVIRON SCI TECHNOL, V33, P723, DOI 10.1021/es980541c; DAVISON W, 1993, EARTH-SCI REV, V34, P119, DOI 10.1016/0012-8252(93)90029-7; DEVITRE RR, 1988, GEOCHIM COSMOCHIM AC, V52, P1601, DOI 10.1016/0016-7037(88)90229-3; Dzombak D.A., 1990, SURFACE COMPLEXATION; Gelda RK, 2000, WATER RES, V34, P1107, DOI 10.1016/S0043-1354(99)00265-1; Harrington JM, 1998, ENVIRON SCI TECHNOL, V32, P2425, DOI 10.1021/es971129k; Hoeft SE, 2002, GEOMICROBIOL J, V19, P23, DOI 10.1080/014904502317246147; LEWIS BL, 1991, DEEP-SEA RES, V38, pS773, DOI 10.1016/S0198-0149(10)80009-3; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; MASSCHELEYN PH, 1991, ENVIRON SCI TECHNOL, V25, P1414, DOI 10.1021/es00020a008; Mengis M, 1997, LIMNOL OCEANOGR, V42, P1530, DOI 10.4319/lo.1997.42.7.1530; MOORE JN, 1988, ENVIRON SCI TECHNOL, V22, P432, DOI 10.1021/es00169a011; MURRAY JW, 1995, ADV CHEM SER, V244, P157, DOI 10.1021/ba-1995-0244.ch007; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nickson RT, 2000, APPL GEOCHEM, V15, P403, DOI 10.1016/S0883-2927(99)00086-4; Nolan BT, 2000, ENVIRON SCI TECHNOL, V34, P1156, DOI 10.1021/es9907663; Ottley CJ, 1997, GEOCHIM COSMOCHIM AC, V61, P1819, DOI 10.1016/S0016-7037(97)00058-6; PIERCE ML, 1982, WATER RES, V16, P1247, DOI 10.1016/0043-1354(82)90143-9; POSTMA D, 1991, WATER RESOUR RES, V27, P2027, DOI 10.1029/91WR00989; Ratering S, 2001, ENVIRON MICROBIOL, V3, P100, DOI 10.1046/j.1462-2920.2001.00163.x; Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p; SCOTT MJ, 1995, ENVIRON SCI TECHNOL, V29, P1898, DOI 10.1021/es00008a006; SENN DB, 2001, THESIS MIT; SIGG L, 1991, MAR CHEM, V36, P9, DOI 10.1016/S0304-4203(09)90051-2; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Spliethoff HM, 1996, ENVIRON SCI TECHNOL, V30, P121, DOI 10.1021/es950169q; SPLIETHOFF HM, 1995, ENVIRON SCI TECHNOL, V29, P2157, DOI 10.1021/es00008a041; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; TROWBRIDGE PR, 1995, THESIS MIT; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weber KA, 2001, ENVIRON SCI TECHNOL, V35, P1644, DOI 10.1021/es0016598; Wetzel R.G., 1983, LIMNOLOGY, V2nd; Wilkie JA, 1998, ENVIRON SCI TECHNOL, V32, P657, DOI 10.1021/es970637r	40	152	169	8	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2373	2376		10.1126/science.1072402	http://dx.doi.org/10.1126/science.1072402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089437				2022-12-24	WOS:000176467200035
J	Wang, KC; Koprivica, V; Kim, JA; Sivasankaran, R; Guo, Y; Neve, RL; He, ZG				Wang, KC; Koprivica, V; Kim, JA; Sivasankaran, R; Guo, Y; Neve, RL; He, ZG			Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; SPINAL-CORD; IN-VIVO; IDENTIFICATION; GROWTH; PROTEINS; BRAIN; NEUROBIOLOGY; CONTAINS	The inhibitory activity associated with myelin is a major obstacle for successful axon regeneration in the adult mammalian central nervous system (CNS)(1,2). In addition to myelin-associated glycoprotein (MAG)(3,4) and Nogo-A(5-7), available evidence suggests the existence of additional inhibitors in CNS myelin(8). We show here that a glycosylphosphatidylinositol (GPI)-anchored CNS myelin protein, oligodendrocyte-myelin glycoprotein (OMgp), is a potent inhibitor of neurite outgrowth in cultured neurons. Like Nogo-A, OMgp contributes significantly to the inhibitory activity associated with CNS myelin. To further elucidate the mechanisms that mediate this inhibitory activity of OMgp, we screened an expression library and identified the Nogo receptor (NgR)(9) as a high-affinity OMgp-binding protein. Cleavage of NgR and other GPI-linked proteins from the cell surface renders axons of dorsal root ganglia insensitive to OMgp. Introduction of exogenous NgR confers OMgp responsiveness to otherwise insensitive neurons. Thus, OMgp is an important inhibitor of neurite outgrowth that acts through NgR and its associated receptor complex. Interfering with the OMgp/NgR pathway may allow lesioned axons to regenerate after injury in vivo.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Aventis Pharmaceut, Bridgewater, NJ 08807 USA; McLean Hosp, Belmont, MA 02478 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Sanofi-Aventis; Harvard University; McLean Hospital	He, ZG (corresponding author), Childrens Hosp, Div Neurosci, 320 Longwood Ave, Boston, MA 02115 USA.			Wang, Kevin/0000-0002-5305-6791				Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Habib AA, 1998, J NEUROCHEM, V70, P1704; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MIKOL DD, 1988, J CELL BIOL, V106, P1273, DOI 10.1083/jcb.106.4.1273; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Spillmann AA, 1998, J BIOL CHEM, V273, P19283, DOI 10.1074/jbc.273.30.19283; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tessier-Lavigne M, 2000, SCIENCE, V287, P813, DOI 10.1126/science.287.5454.813	23	736	838	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					941	944		10.1038/nature00867	http://dx.doi.org/10.1038/nature00867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12068310				2022-12-24	WOS:000176441200037
J	Vollmer, SV; Palumbi, SR				Vollmer, SV; Palumbi, SR			Hybridization and the evolution of reef coral diversity	SCIENCE			English	Article							GENUS ACROPORA; SCLERACTINIA; CNIDARIA; MITOCHONDRIAL; POPULATIONS; PATTERNS; HISTORY	Hundreds of coral species coexist sympatrically on reefs, reproducing in mass-spawning events where hybridization appears common. In the Caribbean, DNA sequence data from all three sympatric Acropora corals show that mass spawning does not erode species barriers. Species A. cervicornis and A. palmata are distinct at two nuclear loci or share ancestral alleles. Morphotypes historically given the name Acropora prolifera are entirety F-1 hybrids of these two species, showing morphologies that depend on which species provides the egg for hybridization. Although selection limits the evolutionary potential of hybrids, F-1 individuals can reproduce asexually and form long-lived, potentially immortal hybrids with unique morphologies.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Vollmer, SV (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	svollmer@oeb.harvard.edu						Arnold ML, 1997, NATURAL HYBRIDIZATIO; Avise John C., 1994, pi; BOWDENKERBY A, 1997, P 8 INT COR REEF S, V2, P2063; Budd A.F., 1997, P423; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; BURTON RS, 1990, EVOLUTION, V44, P1814, DOI 10.1111/j.1558-5646.1990.tb05252.x; Cairns SD, 1982, STONY CORALS CNIDARI; de Graaf M, 1999, B MAR SCI, V64, P189; GOLDMAN N, 1993, J MOL EVOL, V36; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; JEN Veron, 1995, CORALS SPACE TIME BI; NASON JD, 1992, AM J BOT, V79, P101, DOI 10.2307/2445203; Nielsen R, 2001, GENETICS, V158, P885; Odorico DM, 1997, MOL BIOL EVOL, V14, P465, DOI 10.1093/oxfordjournals.molbev.a025783; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SWOFFORD DL, 1996, PAUP STAR PHYLOGENET; TAKAHATA N, 1990, THEOR POPUL BIOL, V38, P331, DOI 10.1016/0040-5809(90)90018-Q; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron JE., 2000, CORALS WORLD, P404; VERON JEN, 1988, ASS AUST PALAEONTOL, V6, P1; VRIJENHOEK RC, 1984, POPULATION BIOL EVOL, P175; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; WALLACE CC, 2000, STAGHORN CORALS WORL; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242	30	206	215	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 14	2002	296	5575					2023	2025		10.1126/science.1069524	http://dx.doi.org/10.1126/science.1069524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065836				2022-12-24	WOS:000176273300052
J	van Hinsbergh, VWM				van Hinsbergh, VWM			Coagulation signals for intact blood vessels	LANCET			English	Editorial Material							ENDOTHELIAL-CELLS; THROMBIN RECEPTOR; MICE		TNO Prevent & Hlth, Gaubius Lab, NL-2301 CE Leiden, Netherlands; Vrije Univ Amsterdam, Inst Cardiovasc Res, Amsterdam, Netherlands	Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam	van Hinsbergh, VWM (corresponding author), TNO Prevent & Hlth, Gaubius Lab, NL-2301 CE Leiden, Netherlands.							Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4; Cines DB, 1998, BLOOD, V91, P3527; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457	9	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 8	2002	359	9322					1958	1960		10.1016/S0140-6736(02)08846-3	http://dx.doi.org/10.1016/S0140-6736(02)08846-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076547				2022-12-24	WOS:000176232500004
J	Huber, KE; Waldor, MK				Huber, KE; Waldor, MK			Filamentous phage integration requires the host recombinases XerC and XerD	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; VIBRIO-CHOLERAE; ESCHERICHIA-COLI; CTX-PHI; GENOME SEQUENCE; CHROMOSOME; DNA; PLASMIDS; DIF; INSERTION	Many bacteriophages and animal viruses integrate their genomes into the chromosomal DNA of their hosts as a method of promoting vertical transmission. Phages that integrate in a site-specific fashion encode an integrase enzyme that catalyses recombination between the phage and host genomes(1,2). CTXphi is a filamentous bacteriophage that contains the genes encoding cholera toxin, the principal virulence factor of the diarrhoea-causing Gram-negative bacterium Vibrio cholerae(3). CTXphi integrates into the V. cholerae genome in a site-specific manner(4,5); however, the similar to6.9-kilobase (kb) CTXphi genome does not encode any protein with significant homology to known recombinases. Here we report that XerC and XerD, two chromosome-encoded recombinases that ordinarily function to resolve chromosome dimers at the dif recombination site(6), are essential for CTXphi integration into the V. cholerae genome. The CTXphi integration site was found to overlap with the dif site of the larger of the two V. cholerae chromosomes. Examination of sequences of the integration sites of other filamentous phages indicates that the XerCD recombinases also mediate the integration of these phage genomes at dif-like sites in various bacterial species.	Tufts Univ New England Med Ctr, Div Geog Med Infect Dis, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA; Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Howard Hughes Medical Institute	Waldor, MK (corresponding author), Tufts Univ New England Med Ctr, Div Geog Med Infect Dis, 750 Washington St, Boston, MA 02111 USA.			Waldor, Matthew/0000-0003-1843-7000; Huber, Kathryn/0000-0001-8194-5871				BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; BUTTERTON JR, 1995, INFECT IMMUN, V63, P2689, DOI 10.1128/IAI.63.7.2689-2696.1995; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; DAI H, 1988, VIROLOGY, V167, P613, DOI 10.1016/0042-6822(88)90124-9; Davis BM, 1999, J BACTERIOL, V181, P6779, DOI 10.1128/JB.181.21.6779-6787.1999; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Davis BM, 2000, J BACTERIOL, V182, P6992, DOI 10.1128/JB.182.24.6992-6998.2000; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KUEMPEL PL, 1991, NEW BIOL, V3, P799; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; Lin NT, 2001, MOL GENET GENOMICS, V266, P425, DOI 10.1007/s004380100532; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Moyer KE, 2001, MOL MICROBIOL, V41, P311, DOI 10.1046/j.1365-2958.2001.02517.x; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; TECKLENBURG M, 1995, P NATL ACAD SCI USA, V92, P1352, DOI 10.1073/pnas.92.5.1352; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	22	138	153	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					656	659		10.1038/nature00782	http://dx.doi.org/10.1038/nature00782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050668				2022-12-24	WOS:000176001200050
J	Pui, CH; Gaynon, PS; Boyett, JM; Chessells, JM; Baruchel, A; Kamps, W; Silverman, LB; Biondi, A; Harms, DO; Vilmer, E; Schrappe, M; Camitta, B				Pui, CH; Gaynon, PS; Boyett, JM; Chessells, JM; Baruchel, A; Kamps, W; Silverman, LB; Biondi, A; Harms, DO; Vilmer, E; Schrappe, M; Camitta, B			Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region	LANCET			English	Article							ACUTE MYELOID-LEUKEMIA; MLL-GENE REARRANGEMENTS; CHILDRENS CANCER GROUP; INFANT ACUTE-LEUKEMIA; POOR-PROGNOSIS; CLINICAL CHARACTERISTICS; TRANSPLANTATION; CHEMOTHERAPY; FEATURES; AGE	Background The prognosis and optimum treatment of childhood acute lymphoblastic leukaemia (ALL) with abnormalities of chromosomal band 11q23 are controversial. We aimed to identify prognostic factors that might help in planning future therapy, and to assess the effectiveness of haemopoietic stem-cell transplantation in patients with the t(4;11) translocation, which is associated with a particularly poor outcome. Methods We reviewed data on 497 children and young adults who had ALL with various 11q23 abnormalities, including the translocations t(4;11), t(9;11), and t(11;19). All patients were treated with intensive chemotherapy, with or without haemopoietic stem-cell transplantation in first complete remission, by 11 study groups and single institutions from 1983 to 1995. Findings Age was the most important prognostic factor. In a Cox's proportional-hazard model stratified by 11q23 abnormalities, infants younger than 1 year fared significantly worse than patients 1 year of age or older (hazard ratio for event-free survival 1.84 [95% CI 1.38-2.47], p=0.0001). Among infants, any category of 11q23 abnormality conferred a dismal outcome, whereas in older patients, t(4;11) and t(9;11) were associated with a worse outcome than were other 11q23 changes. In the largest subgroup-256 patients with t(4;11)-any type of transplantation was associated with significantly worse disease-free survival (1.61 [1.10-2.35], p=0.014) and overall survival (1.76 [1.08-2.45], p=0.004) compared with chemotherapy only. Even transplantation with stem cells from HLA-matched related or HLA-matched unrelated donors tended to be associated with a worse outcome than chemotherapy alone. Interpretation The prognosis of acute lymphoblastic leukaemia with an 11q23 abnormality is particularly dismal in infants. Allogeneic transplantation with haemopoietic stem cells from an HLA-matched related donor does not seem to improve the clinical outcome in patients with t(4:11)-positive leukaemia.	St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN 38163 USA; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Univ So Calif, Los Angeles, CA USA; Inst Child Hlth, Mol Haematol Unit, London, England; Hop St Louis, Serv Pediat Hematol, Paris, France; Dutch Childhood Leukemia Study Grp, The Hague, Netherlands; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; Univ Milano Bicocca, Dept Pediat, Monza, Italy; Osped San Gerardo, Monza, Italy; Univ Hamburg, Dept Pediat Hematol & Oncol, Hamburg, Germany; Hop Robert Debre, Serv Hematoimmunol, F-75019 Paris, France; Hannover Med Sch, Dept Pediat Hematol Oncol, Childrens Univ Hosp, Hannover, Germany; Med Coll Wisconsin, Dept Pediat, Midwest Childrens Canc Ctr, Milwaukee, WI 53226 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Children's Hospital Los Angeles; University of Southern California; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Milano-Bicocca; San Gerardo Hospital; University of Hamburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical College of Wisconsin	Pui, CH (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Raimondi, Susana C/N-8166-2018; Schrappe, Martin/ABA-6144-2020; Schrappe, Martin/A-8109-2010; Pui, Ching-Hon/N-8076-2018; Biondi, Andrea/AAX-1865-2020; Biondi, Andrea/K-9997-2016	Pui, Ching-Hon/0000-0003-0303-5658; Biondi, Andrea/0000-0002-6757-6173; 	NCI NIH HHS [CA37379, CA29139, CA51001, CA 31566, CA21765, CA78224] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051001, R01CA078224, U10CA031566, U10CA029139, P30CA021765, R29CA051001, U10CA037379] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Behm FG, 1996, BLOOD, V87, P2870, DOI 10.1182/blood.V87.7.2870.bloodjournal8772870; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; BORDIGONI P, 1989, BRIT J HAEMATOL, V72, P293, DOI 10.1111/j.1365-2141.1989.tb07702.x; CHEN CS, 1993, BLOOD, V81, P2386; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Dreyer Z. E., 1998, P AN M AM SOC CLIN, V17, p529a; Forestier E, 2000, BRIT J HAEMATOL, V110, P147, DOI 10.1046/j.1365-2141.2000.02153.x; HEEREMA NA, 1994, BLOOD, V83, P2274, DOI 10.1182/blood.V83.8.2274.bloodjournal8382274; Heerema NA, 1999, LEUKEMIA, V13, P679, DOI 10.1038/sj.leu.2401413; Johansson B, 1998, LEUKEMIA, V12, P779, DOI 10.1038/sj.leu.2401012; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Kumagai MA, 1996, J CLIN INVEST, V97, P755, DOI 10.1172/JCI118474; LEWIS M, IN PRESS BLOOD; Ludwig WD, 1998, BLOOD, V92, P1898; Marco F, 2000, J CLIN ONCOL, V18, P3256, DOI 10.1200/JCO.2000.18.18.3256; MOOREMAN AV, 1988, LEUKEMIA, V12, P805; Nakano Y, 1999, BRIT J HAEMATOL, V104, P659, DOI 10.1046/j.1365-2141.1999.01256.x; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Pirich L, 1999, MED PEDIATR ONCOL, V32, P1, DOI 10.1002/(SICI)1096-911X(199901)32:1<1::AID-MPO2>3.0.CO;2-J; PUI CH, 1994, J CLIN ONCOL, V12, P909, DOI 10.1200/JCO.1994.12.5.909; Pui CH, 2000, LEUKEMIA, V14, P684, DOI 10.1038/sj.leu.2401725; PUI CH, 1991, BLOOD, V77, P440; RAIMONDI SC, 1995, BLOOD, V86, P1881, DOI 10.1182/blood.V86.5.1881.bloodjournal8651881; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RUBNITZ JE, 1994, BLOOD, V84, P570; Rubnitz JE, 1999, J CLIN ONCOL, V17, P191, DOI 10.1200/JCO.1999.17.1.191; Silverman LB, 1997, CANCER-AM CANCER SOC, V80, P2285; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Smith M, 1996, J CLIN ONCOL, V14, P680, DOI 10.1200/JCO.1996.14.2.680; Stram DO, 1996, BIOMETRICS, V52, P1079, DOI 10.2307/2533069; Taki T, 1996, LEUKEMIA, V10, P1303; UCKUN FM, 1995, BLOOD, V85, P873, DOI 10.1182/blood.V85.4.873.bloodjournal854873; VONBUELTZINGSLOEWEN A, 1995, BONE MARROW TRANSPL, V16, P521	35	272	293	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2002	359	9321					1909	1915		10.1016/S0140-6736(02)08782-2	http://dx.doi.org/10.1016/S0140-6736(02)08782-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057554				2022-12-24	WOS:000175975700011
J	Brembs, B; Lorenzetti, FD; Reyes, FD; Baxter, DA; Byrne, JH				Brembs, B; Lorenzetti, FD; Reyes, FD; Baxter, DA; Byrne, JH			Operant reward learning in Aplysia: Neuronal correlates and mechanisms	SCIENCE			English	Article							IN-VITRO ANALOG; CELLULAR MECHANISM; FUNCTIONAL DYNAMICS; REINFORCEMENT; IDENTIFICATION; MEMORY; FOOD	Operant conditioning is a form of associative learning through which an animal learns about the consequences of its behavior, Here, we report an appetitive operant conditioning procedure in Aplysia that induces long-term memory. Biophysical changes that accompanied the memory were found in an identified neuron (cell B51) that is considered critical for the expression of behavior that was rewarded. Similar cellular changes in B51 were produced by contingent reinforcement of B51 with dopamine in a single-cell analog of the operant procedure. These findings allow for the detailed analysis of the cellular and molecular processes underlying operant conditioning.	Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System	Byrne, JH (corresponding author), Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77030 USA.	john.h.byrne@uth.tmc.edu	Brembs, Björn/A-9970-2008	Brembs, Björn/0000-0001-7824-7650	NIMH NIH HHS [MH 58321] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Botzer D, 1998, LEARN MEMORY, V5, P204; COOK DG, 1989, J NEUROSCI, V9, P3115; Cropper EC, 1996, CURR OPIN NEUROBIOL, V6, P833, DOI 10.1016/S0959-4388(96)80035-3; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HOYLE G, 1979, TRENDS NEUROSCI, V2, P153, DOI 10.1016/0166-2236(79)90060-2; Kabotyanski EA, 1998, J NEUROPHYSIOL, V79, P605, DOI 10.1152/jn.1998.79.2.605; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; Lechner HA, 2000, J NEUROSCI, V20, P3377, DOI 10.1523/JNEUROSCI.20-09-03377.2000; Lechner HA, 2000, J NEUROSCI, V20, P3369, DOI 10.1523/JNEUROSCI.20-09-03369.2000; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; MOZZACHIODI R, 2001, 31 ANN M SOC NEUR SA; Nargeot R, 1999, J NEUROSCI, V19, P2261; Nargeot R, 1999, J NEUROSCI, V19, P2247; Nargeot R, 1999, J NEUROPHYSIOL, V81, P1983, DOI 10.1152/jn.1999.81.4.1983; Nargeot R, 1997, J NEUROSCI, V17, P8093; Pavlov I.P., 1927, CONDITIONED REFLEXES; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHWARZ M, 1986, J NEUROSCI, V6, P1528; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	25	183	187	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1706	1709		10.1126/science.1069434	http://dx.doi.org/10.1126/science.1069434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040200	Green Submitted			2022-12-24	WOS:000175976200065
J	Ishihara, T; Iino, Y; Mohri, A; Mori, I; Gengyo-Ando, K; Mitani, S; Katsura, I				Ishihara, T; Iino, Y; Mohri, A; Mori, I; Gengyo-Ando, K; Mitani, S; Katsura, I			HEN-1, a secretory protein with an LDL receptor motif, regulates sensory integration and learning in Caenorhabditis elegans	CELL			English	Article							C-ELEGANS; LIPOPROTEIN RECEPTORS; SYNAPTIC PLASTICITY; NERVOUS-SYSTEM; HEAVY-CHAIN; DROSOPHILA; GENE; MEMORY; NEURONS; THERMOTAXIS	Animals sense many environmental stimuli simultaneously and integrate various sensory signals within the nervous system both to generate proper behavioral responses and also to form relevant memories. HEN-1, a secretory protein with an LDL receptor motif, regulates such processes in Caenorhabditis elegans. The hen-1 mutants show defects in the integration of two sensory signals and in behavioral plasticity by paired stimuli, although their sensation capability seems to be identical to that of the wild-type. The HEN-1 protein is expressed in two pairs of neurons, but expression in other neurons is sufficient for wild-type behavior. In addition, expression of HEN-1 at the adult stage is sufficient. Thus, HEN-1 regulates sensory processing non-cell-autonomously in the mature neuronal circuit.	Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Tokyo Womens Med Univ, Sch Med, Japan Sci & Technol Corp, PRESTO, Tokyo 1628666, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Tokyo; Nagoya University; Japan Science & Technology Agency (JST); Tokyo Women's Medical University	Ishihara, T (corresponding author), Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan.	tishihar@lab.nig.ac.jp	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019; IINO, YUICHI/G-4962-2014					Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1985, J NEUROSCI, V5, P956; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LASITER PS, 1982, J COMP PHYSIOL PSYCH, V96, P376, DOI 10.1037/h0077894; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Morrison GE, 1999, BEHAV NEUROSCI, V113, P358, DOI 10.1037/0735-7044.113.2.358; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Rankin CH, 2000, BEHAV NEUROSCI, V114, P496, DOI 10.1037/0735-7044.114.3.496; Rosay P, 2001, NEURON, V30, P759, DOI 10.1016/S0896-6273(01)00323-3; Saeki S, 2001, J EXP BIOL, V204, P1757; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shioi G, 2001, GENETICS, V157, P1611; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; WILLIAMS BD, 1992, GENETICS, V131, P609; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	49	111	116	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2002	109	5					639	649		10.1016/S0092-8674(02)00748-1	http://dx.doi.org/10.1016/S0092-8674(02)00748-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062106	Bronze			2022-12-24	WOS:000175957900012
J	Lucht, W; Prentice, IC; Myneni, RB; Sitch, S; Friedlingstein, P; Cramer, W; Bousquet, P; Buermann, W; Smith, B				Lucht, W; Prentice, IC; Myneni, RB; Sitch, S; Friedlingstein, P; Cramer, W; Bousquet, P; Buermann, W; Smith, B			Climatic control of the high-latitude vegetation greening trend and Pinatubo effect	SCIENCE			English	Article							MOUNT-PINATUBO; LAND; INDEX; CO2	A biogeochemical model of vegetation using observed climate data predicts the high northern latitude greening trend over the past two decades observed by satellites and a marked setback in this trend after the Mount Pinatubo, volcano eruption in 1991. The observed trend toward earlier spring budburst and increased maximum leaf area is produced by the model as a consequence of biogeochemical vegetation responses mainly to changes in temperature. The post-Pinatubo decline in vegetation in 1992-1993 is apparent as the effect of temporary cooling caused by the eruption. High-latitude CO2 uptake during these years is predicted as a consequence of the differential response of heterotrophic respiration and net primary production.	Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; Max Planck Inst Biogeochem, D-07745 Jena, Germany; Boston Univ, Dept Geog, Boston, MA 02215 USA; Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden	Potsdam Institut fur Klimafolgenforschung; Max Planck Society; Boston University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Lund University	Lucht, W (corresponding author), Potsdam Inst Climate Impact Res, POB 601203, D-14412 Potsdam, Germany.	Wolfgang.Lucht@pik-potsdam.de	Friedlingstein, Pierre/H-2700-2014; Smith, Benjamin/I-1212-2016; Myneni, Ranga B/F-5129-2012; Sitch, Stephen A/F-8034-2015; Cramer, Wolfgang/B-8221-2008; Lucht, Wolfgang/G-2180-2011; Myneni, Ranga B./AAU-6088-2021	Friedlingstein, Pierre/0000-0003-3309-4739; Smith, Benjamin/0000-0002-6987-5337; Myneni, Ranga B/0000-0002-0234-6393; Sitch, Stephen A/0000-0003-1821-8561; Cramer, Wolfgang/0000-0002-9205-5812; Lucht, Wolfgang/0000-0002-3398-8575; Bousquet, Philippe/0000-0002-4444-2703				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Cihlar J, 1998, J GEOPHYS RES-ATMOS, V103, P23163, DOI 10.1029/98JD00050; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; GROISMAN PY, 1994, SCIENCE, V263, P198, DOI 10.1126/science.263.5144.198; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; SELF S, 1995, REV GEOPHYS, V33, P257, DOI 10.1029/95RG00556; SITCH S, UNPUB; SITCH S, 2000, THESIS LUND U SWEDEN; Stenchikov GL, 1998, J GEOPHYS RES-ATMOS, V103, P13837, DOI 10.1029/98JD00693; Timmreck C, 1999, J GEOPHYS RES-ATMOS, V104, P9337, DOI 10.1029/1999JD900088; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Yang FL, 2001, J GEOPHYS RES-ATMOS, V106, P14757, DOI 10.1029/2001JD900146; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	19	540	593	14	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1687	1689		10.1126/science.1071828	http://dx.doi.org/10.1126/science.1071828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040194				2022-12-24	WOS:000175976200058
J	Rebbeck, TR; Lynch, HT; Neuhausen, SL; Narod, SA; van't Veer, L; Garber, JE; Evans, G; Isaacs, C; Daly, MB; Matloff, E; Olopade, OI; Weber, BL				Rebbeck, TR; Lynch, HT; Neuhausen, SL; Narod, SA; van't Veer, L; Garber, JE; Evans, G; Isaacs, C; Daly, MB; Matloff, E; Olopade, OI; Weber, BL		Prevention Observation Surg End Po	Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY PERITONEAL CARCINOMA; PAPILLARY SEROUS CARCINOMA; BREAST-CANCER RISK; OVARIAN-CANCER; ORAL-CONTRACEPTIVES; WOMEN	Background: Data concerning the efficacy of bilateral prophylactic oophorectomy for reducing the risk of gynecologic cancer in women with BRCA1 or BRCA2 mutations are limited. We investigated whether this procedure reduces the risk of cancers of the coelomic epithelium and breast in women who carry such mutations. Methods: A total of 551 women with disease-associated germ-line BRCA1 or BRCA2 mutations were identified from registries and studied for the occurrence of ovarian and breast cancer. We determined the incidence of ovarian cancer in 259 women who had undergone bilateral prophylactic oophorectomy and in 292 matched controls who had not undergone the procedure. In a subgroup of 241 women with no history of breast cancer or prophylactic mastectomy, the incidence of breast cancer was determined in 99 women who had undergone bilateral prophylactic oophorectomy and in 142 matched controls. The length of postoperative follow-up for both groups was at least eight years. Results: Six women who underwent prophylactic oophorectomy (2.3 percent) received a diagnosis of stage I ovarian cancer at the time of the procedure; two women (0.8 percent) received a diagnosis of papillary serous peritoneal carcinoma 3.8 and 8.6 years after bilateral prophylactic oophorectomy. Among the controls, 58 women (19.9 percent) received a diagnosis of ovarian cancer, after a mean follow-up of 8.8 years. With the exclusion of the six women whose cancer was diagnosed at surgery, prophylactic oophorectomy significantly reduced the risk of coelomic epithelial cancer (hazard ratio, 0.04; 95 percent confidence interval, 0.01 to 0.16). Of 99 women who underwent bilateral prophylactic oophorectomy and who were studied to determine the risk of breast cancer, breast cancer developed in 21 (21.2 percent), as compared with 60 (42.3 percent) in the control group (hazard ratio, 0.47; 95 percent confidence interval, 0.29 to 0.77). Conclusions: Bilateral prophylactic oophorectomy reduces the risk of coelomic epithelial cancer and breast cancer in women with BRCA1 or BRCA2 mutations. (N Engl J Med 2002;346:1616-22.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Inst, Philadelphia, PA 19104 USA; Creighton Univ, Omaha, NE 68178 USA; Univ Utah, Div Genet Epidemiol, Salt Lake City, UT USA; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; Netherlands Canc Inst, Amsterdam, Netherlands; Dana Farber Canc Inst, Boston, MA 02115 USA; St Marys Hosp, Manchester M13 0JH, Lancs, England; Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Yale Univ, New Haven, CT USA; Univ Chicago, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Creighton University; Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; Womens College Hospital; Netherlands Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Manchester; Georgetown University; Fox Chase Cancer Center; Yale University; University of Chicago	Rebbeck, TR (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 904 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Rebbeck, Timothy/GLU-8348-2022; Narod, Steven A/AAA-6112-2022; Evans, D Gareth/AAB-4308-2022	Rebbeck, Timothy/0000-0002-4799-1900; Evans, D Gareth/0000-0002-8482-5784	NCI NIH HHS [N01-CN-6700, CA57601, R01-CA83855, CA74415] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057601, R01CA083855, R01CA074415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRINTON LA, 1988, CANCER INVEST, V6, P245, DOI 10.3109/07357908809080645; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; EASTON DF, 1994, LANCET, V344, P761, DOI 10.1016/S0140-6736(94)92256-X; Eltabbakh GH, 1998, ONCOLOGY-NY, V12, P813; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FROMM GL, 1990, OBSTET GYNECOL, V75, P89; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MEIJER WJ, 1992, EUR J OBSTET GYN R B, V47, P59, DOI 10.1016/0028-2243(92)90215-K; Modan B, 2001, NEW ENGL J MED, V345, P235, DOI 10.1056/NEJM200107263450401; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; Parazzini F, 1997, OBSTET GYNECOL, V90, P453, DOI 10.1016/S0029-7844(97)00295-0; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Prior JC, 1997, J BONE MINER RES, V12, P1851, DOI 10.1359/jbmr.1997.12.11.1851; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; ZHOU J, 1995, CANCER, V76, P429, DOI 10.1002/1097-0142(19950801)76:3<429::AID-CNCR2820760313>3.0.CO;2-8	20	1052	1083	0	44	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1616	1622		10.1056/NEJMoa012158	http://dx.doi.org/10.1056/NEJMoa012158			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023993				2022-12-24	WOS:000175728600003
J	Pathania, S; Jayaram, M; Harshey, RM				Pathania, S; Jayaram, M; Harshey, RM			Path of DNA within the Mu transpososome: Transposase interactions bridging two Mu ends and the enhancer trap five DNA supercoils	CELL			English	Article							PHAGE-MU; TOPOLOGICAL SELECTIVITY; STRAND EXCHANGE; SITE ALIGNMENT; RECOMBINATION; COMPLEX; SYNAPSIS; CONDENSATION; MECHANISM; BINDING	The phage Mu transpososome is assembled by interactions of transposase subunits with the left (L) and right (R) ends of Mu and an enhancer (E) located in between. A metastable three-site complex LER progresses into a more stable type 0 complex in which a tetrameric transposase is poised for DNA cleavage. "Difference topology" has revealed five trapped negative supercoils within type 0, three contributed by crossings of E with L and R, and two by crossings of L with R. This is the most complex DNA arrangement seen to date within a recombination synapse. Contrary to the prevailing notion, the enhancer appears not to be released immediately following type 0 assembly. Difference topology provides a simple method for determining the ordered sequestration of DNA segments within nucleoprotein assemblies.	Univ Texas, Sch Mol Genet & Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Cellular Biol & Pathol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Harshey, RM (corresponding author), Univ Texas, Sch Mol Genet & Microbiol, Austin, TX 78712 USA.	rasika@uts.cc.utexas.edu			NIGMS NIH HHS [GM35654, GM33247] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035654, R01GM033247] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON RG, 1992, J BIOL CHEM, V267, P19963; Chaconas George, 2002, P384; Chalmers R, 1998, CELL, V93, P897, DOI 10.1016/S0092-8674(00)81449-X; Colloms SD, 1997, CELL, V88, P855, DOI 10.1016/S0092-8674(00)81931-5; Grainge I, 2000, J MOL BIOL, V298, P749, DOI 10.1006/jmbi.2000.3679; GRINDLEY NDF, 1994, NUCLEIC ACIDS MOL BI, V8, P236; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; HEICHMAN KA, 1991, GENE DEV, V5, P1622, DOI 10.1101/gad.5.9.1622; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Jiang H, 2001, J BIOL CHEM, V276, P4373, DOI 10.1074/jbc.M008523200; Jiang H, 1999, EMBO J, V18, P3845, DOI 10.1093/emboj/18.13.3845; KANAAR R, 1990, CELL, V62, P353, DOI 10.1016/0092-8674(90)90372-L; Kilbride E, 1999, J MOL BIOL, V289, P1219, DOI 10.1006/jmbi.1999.2864; KIM K, 1995, J BIOL CHEM, V270, P1472, DOI 10.1074/jbc.270.3.1472; KLIPPEL A, 1993, EMBO J, V12, P1047, DOI 10.1002/j.1460-2075.1993.tb05746.x; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SURETTE MG, 1992, CELL, V68, P1101, DOI 10.1016/0092-8674(92)90081-M; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Wang ZG, 1996, J BIOL CHEM, V271, P9619, DOI 10.1074/jbc.271.16.9619; WASSERMAN SA, 1985, P NATL ACAD SCI USA, V82, P1079, DOI 10.1073/pnas.82.4.1079; Watson MA, 1996, CELL, V85, P435, DOI 10.1016/S0092-8674(00)81121-6; WHITE JH, 1984, P NATL ACAD SCI-BIOL, V81, P3322, DOI 10.1073/pnas.81.11.3322; YANG JY, 1995, GENE DEV, V9, P2545, DOI 10.1101/gad.9.20.2545; Zechiedrich EL, 1999, METH MOL B, V94, P99	33	53	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2002	109	4					425	436		10.1016/S0092-8674(02)00728-6	http://dx.doi.org/10.1016/S0092-8674(02)00728-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086600	Bronze			2022-12-24	WOS:000175696800005
J	Henikoff, S; Malik, HS				Henikoff, S; Malik, HS			Selfish drivers	NATURE			English	Article									Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave, Seattle, WA 98109 USA.		Malik, Harmit S/E-8519-2012	Henikoff, Steven/0000-0002-7621-8685				de Villena FPM, 2001, GENETICS, V159, P1179; HERIKOFF S, 2001, SCIENCE, V293, P1098; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Zwick ME, 1999, GENETICS, V152, P1605	4	102	102	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					227	227		10.1038/417227a	http://dx.doi.org/10.1038/417227a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015578	Bronze			2022-12-24	WOS:000175592100024
J	Weissman, IL				Weissman, IL			Stem cells - Scientific, medical, and political issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOUSE EMBRYOS		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; *CA ADV COMM HUM C, 2002, FIN REP CAL ADV COMM; *COMM BIOL BIOM AP, 2002, STEM CELLS FUT REG M; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.3.CO;2-K; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; *PAN SCI MED ASP H, 2002, SCI MED ASP HUM REPR; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Thomson JA, 1998, SCIENCE, V282, P1827; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	19	75	85	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1576	1579		10.1056/NEJMsb020693	http://dx.doi.org/10.1056/NEJMsb020693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	11994551				2022-12-24	WOS:000175563900012
J	Paton, NI; Aboulhab, J; Karim, F				Paton, NI; Aboulhab, J; Karim, F			Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MARKERS; CELLS	Most people who have HIV-1 and live in less-developed countries cannot afford standard combination antiretroviral therapy, and more economical approaches to treatment are therefore needed. We treated 22 patients who were Infected with HIV-1 (viral load <100 000 copies/mL and CD4 count >150 cells/muL) with hydroxychloroquine (200 mg), hydroxycarbamide (hydroxyurea) (500 mg), and didanosine (125-200 mg), taken twice daily. Treatment was well tolerated, with few serious adverse events. Viral load showed a sustained decrease of 1.3 log, and CD4 count was maintained (percentage increase; 2.9%) over 48 weeks in the 16 evaluable patients. This new combination of drugs could be suitable for countries that have restricted resources, but should first be further investigated.	Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore	Tan Tock Seng Hospital	Paton, NI (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore.							Boelaert JR, 1999, AIDS RES HUM RETROV, V15, P1241, DOI 10.1089/088922299310133; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; SPERBER K, 1993, AIDS RES HUM RETROV, V9, P91, DOI 10.1089/aid.1993.9.91; Sperber K, 1997, CLIN THER, V19, P913, DOI 10.1016/S0149-2918(97)80045-8	5	42	45	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1667	1668		10.1016/S0140-6736(02)08557-4	http://dx.doi.org/10.1016/S0140-6736(02)08557-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020529				2022-12-24	WOS:000175593300012
J	Lallena, MJ; Chalmers, KJ; Llamazares, S; Lamond, AI; Valcarcel, J				Lallena, MJ; Chalmers, KJ; Llamazares, S; Lamond, AI; Valcarcel, J			Splicing regulation at the second catalytic step by sex-lethal involves 3 ' splice site recognition by SPF45	CELL			English	Article							PRE-MESSENGER-RNA; MAMMALIAN INTRONS; FACTOR U2AF(35); MASS-SPECTROMETRY; FACTOR HSLU7; 2ND STEP; PROTEIN; 3'-SPLICE-SITE; DROSOPHILA; YEAST	The Drosophila protein Sex-lethal (SXL) promotes skipping of exon 3 from its own pre-mRNA. An unusual sequence arrangement of two AG dinucleotides and an intervening polypyrimidine (Py)-tract at the 3' end of intron 2 is important for Sxl autoregulation. Here we show that U2AF interacts with the Py-tract and downstream AG, whereas the spliceosomal protein SPF45 interacts with the upstream AG and activates it for the second catalytic step of the splicing reaction. SPF45 represents a new class of second step factors, and its interaction with SXL blocks splicing at the second step. These results are in contrast with other known mechanisms of splicing regulation, which target early events of spliceosome assembly. A similar role for SPF45 is demonstrated in the activation of a cryptic 3' ss generated by a mutation that causes human beta-thalassemia.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Dundee	Valcarcel, J (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Valcarcel, Juan/O-9814-2014	Valcarcel, Juan/0000-0001-5398-3571; Lamond, Angus/0000-0001-6204-6045; Llamazares, Salud/0000-0002-8771-2312				Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Brys A, 1996, RNA, V2, P707; Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; Chiara MD, 1997, EMBO J, V16, P4746, DOI 10.1093/emboj/16.15.4746; Chua K, 1999, NATURE, V402, P207, DOI 10.1038/46086; Chua K, 1999, GENE DEV, V13, P841, DOI 10.1101/gad.13.7.841; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Forch P, 2001, RNA, V7, P1185, DOI 10.1017/S1355838201010536; FRANK D, 1992, GENE DEV, V6, P2112, DOI 10.1101/gad.6.11.2112; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; GE H, 1990, P NATL ACAD SCI USA, V87, P3338, DOI 10.1073/pnas.87.9.3338; Gebauer F, 1998, RNA, V4, P142; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Granadino B, 1997, P NATL ACAD SCI USA, V94, P7343, DOI 10.1073/pnas.94.14.7343; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KRAINER AR, 1985, RA WELCH FDN C CHEM, V29, P353; LUUKKONEN BG, 1997, EMBO J, V17, P779; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Penalva LOF, 2001, MOL CELL BIOL, V21, P1986, DOI 10.1128/MCB.21.6.1986-1996.2001; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; RUSKIN B, 1986, P NATL ACAD SCI USA, V83, P2022, DOI 10.1073/pnas.83.7.2022; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; SAWA H, 1991, NUCLEIC ACIDS RES, V19, P3953, DOI 10.1093/nar/19.14.3953; Schutt C, 2000, DEVELOPMENT, V127, P667; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; UMEN JG, 1995, RNA, V1, P584; Umen JG, 1995, RNA, V1, P869; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Wu SP, 1997, EMBO J, V16, P4421, DOI 10.1093/emboj/16.14.4421; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZHUANG Y, 1990, GENE, V90, P263, DOI 10.1016/0378-1119(90)90189-X; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	57	121	123	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					285	296		10.1016/S0092-8674(02)00730-4	http://dx.doi.org/10.1016/S0092-8674(02)00730-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015979	Bronze			2022-12-24	WOS:000175412100005
J	Maslov, S; Sneppen, K				Maslov, S; Sneppen, K			Specificity and stability in topology of protein networks	SCIENCE			English	Article								Molecular networks guide the biochemistry of a living cell on multiple levels: Its metabolic and signaling pathways are shaped by the network of interacting proteins, whose production, in turn, is controlled by the genetic regulatory network. To address topological properties of these two networks, we quantified correlations between connectivities of interacting nodes and compared them to a null model of a network, in which all links were randomly rewired. We found that for both interaction and regulatory networks, links between highly connected proteins are systematically suppressed, whereas those between a highly connected and low-connected pairs of proteins are favored. This effect decreases the likelihood of cross talk between different functional modules of the cell and increases the overall robustness of a network by localizing effects of deleterious perturbations.	Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Norwegian Univ Sci & Technol, Dept Phys, N-7491 Trondheim, Norway	United States Department of Energy (DOE); Brookhaven National Laboratory; Norwegian University of Science & Technology (NTNU)	Maslov, S (corresponding author), Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA.	mastov@bnl.gov	Maslov, Sergei/C-2397-2009	Maslov, Sergei/0000-0002-3701-492X; Sneppen, Kim/0000-0001-9820-3567				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913	14	2112	2169	15	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2002	296	5569					910	913		10.1126/science.1065103	http://dx.doi.org/10.1126/science.1065103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988575	Green Submitted			2022-12-24	WOS:000175442500044
J	Sillaber, I; Rammes, G; Zimmermann, S; Mahal, B; Zieglgansberger, W; Wurst, W; Holsboer, F; Spanagel, R				Sillaber, I; Rammes, G; Zimmermann, S; Mahal, B; Zieglgansberger, W; Wurst, W; Holsboer, F; Spanagel, R			Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors	SCIENCE			English	Article							CORTICOTROPIN-RELEASING FACTOR; SUBUNIT EXPRESSION; BRAIN; HORMONE-RECEPTOR-1; CONSUMPTION; ETHANOL; PEPTIDE; SYSTEM; REWARD; UPDATE	There is a relation between stress and alcohol drinking. We show that the corticotropin-releasing hormone (CRH) system that mediates endocrine and behavioral responses to stress plays a role in the control of long-term alcohol drinking. In mice lacking a functional CRH1 receptor, stress leads to enhanced and progressively increasing alcohol intake. The effect of repeated stress on alcohol drinking behavior appeared with a delay and persisted throughout life. It was associated with an up-regulation of the N-methyl-D-aspartate receptor subunit NR2B. Alterations in the CRH1 receptor gene and adaptional changes in NR2B subunits may constitute a genetic risk factor for stress-induced alcohol drinking and alcoholism.	Max Planck Inst Psychiat, D-80804 Munich, Germany; Natl Res Ctr Environm & Hlth, Inst Mammalian Genet, D-85764 Munich, Germany; Univ Heidelberg, Cent Inst Mental Hlth, D-68159 Mannheim, Germany	Max Planck Society; University of Munich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Sillaber, I (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.			Wurst, Wolfgang/0000-0003-4422-7410				ABEL EL, 1994, PHYSIOL BEHAV, V56, P795, DOI 10.1016/0031-9384(94)90245-3; Allgaier C, 1999, BRIT J PHARMACOL, V126, P121, DOI 10.1038/sj.bjp.0702284; BARTANUSZ V, 1995, NEUROSCIENCE, V66, P247, DOI 10.1016/0306-4522(95)00084-V; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHU B, 1995, J NEUROCHEM, V65, P140; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; Heinrichs SC, 1995, ANN NY ACAD SCI, V771, P92, DOI 10.1111/j.1749-6632.1995.tb44673.x; KOOLHAAS JM, 1997, ACTA PHYSL SCAND S, V640, P69; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; Muller MB, 2000, ENDOCRINOLOGY, V141, P4262, DOI 10.1210/en.141.11.4262; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; POHORECKY LA, 1990, ALCOHOL ALCOHOLISM, V25, P263, DOI 10.1093/oxfordjournals.alcalc.a045000; POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x; Rammes G, 2001, NEUROPHARMACOLOGY, V40, P749, DOI 10.1016/S0028-3908(01)00008-9; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; SAUVAGE M, UNPUB; Schuckit MA, 1998, J STUD ALCOHOL, V59, P485, DOI 10.15288/jsa.1998.59.485; SCHUCKIT MA, 1985, JAMA-J AM MED ASSOC, V254, P2614, DOI 10.1001/jama.254.18.2614; SCHUMANN G, IN PRESS MOL PSYCHIA; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; SPANAGEL R, 2002, THERAPEUTIC POTENTIA, pCH12; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Wand GS, 2002, NEUROPSYCHOPHARMACOL, V26, P106, DOI 10.1016/S0893-133X(01)00294-9; Winkler A, 1999, MOL BRAIN RES, V72, P166, DOI 10.1016/S0169-328X(99)00218-1	28	175	180	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					931	933		10.1126/science.1069836	http://dx.doi.org/10.1126/science.1069836			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988580				2022-12-24	WOS:000175442500050
J	Kim, JH; Auerbach, JM; Rodriguez-Gomez, JA; Velasco, I; Gavin, D; Lumelsky, N; Lee, SH; Nguyen, J; Sanchez-Pernaute, R; Bankiewicz, K; McKay, R				Kim, JH; Auerbach, JM; Rodriguez-Gomez, JA; Velasco, I; Gavin, D; Lumelsky, N; Lee, SH; Nguyen, J; Sanchez-Pernaute, R; Bankiewicz, K; McKay, R			Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; NURR1-DEFICIENT MICE; ISTHMIC ORGANIZER; NEURAL PLATE; SPINAL-CORD; MUTANT MICE; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION	Parkinson's disease is a widespread condition caused by the loss of midbrain neurons that synthesize the neurotransmitter dopamine. Cells derived from the fetal midbrain can modify the course of the disease, but they are an inadequate source of dopamine-synthesizing neurons because their ability to generate these neurons is unstable. In contrast, embryonic stem (ES) cells proliferate extensively and can generate dopamine neurons. If ES cells are to become the basis for cell therapies, we must develop methods of enriching for the cell of interest and demonstrate that these cells show functions that will assist in treating the disease. Here we show that a highly enriched population of midbrain neural stem cells can be derived from mouse ES cells. The dopamine neurons generated by these stem cells show electrophysiological and behavioural properties expected of neurons from the midbrain. Our results encourage the use of ES cells in cell-replacement therapy for Parkinson's disease.	NINCDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McKay, R (corresponding author), NINCDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Velasco, Ivan/AAE-4249-2019; Rodríguez-Gómez, José A./C-8313-2015; Sanchez-Pernaute, Rosario/AAZ-9566-2021; Kim, Jong-Hoon/F-2504-2013; Velasco, Iván/D-3593-2014; Kim, Jong-Hoon/H-1476-2015; Sanchez-Pernaute, Rosario/ABD-8661-2021	Velasco, Ivan/0000-0002-8953-6578; Rodríguez-Gómez, José A./0000-0002-4107-7229; Sanchez-Pernaute, Rosario/0000-0003-1144-9025; Kim, Jong-Hoon/0000-0003-3419-0538; Velasco, Iván/0000-0002-8953-6578; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, Z01NS002981, Z01NS002881, ZIANS002881] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABROUS DN, 1993, NEUROSCIENCE, V53, P187, DOI 10.1016/0306-4522(93)90297-S; Auerbach JM, 2000, EUR J NEUROSCI, V12, P1696, DOI 10.1046/j.1460-9568.2000.00067.x; Bader A, 2000, CIRC RES, V86, P787, DOI 10.1161/01.RES.86.7.787; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; GERFEN CR, 1987, J NEUROSCI, V7, P3935; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; HUDSON JL, 1994, J NEUROSCI, V14, P283; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 1999, EXP NEUROL, V159, P451, DOI 10.1006/exnr.1999.7191; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; NIKKHAH G, 1993, NEUROSCIENCE, V56, P33, DOI 10.1016/0306-4522(93)90559-X; Offield MF, 1996, DEVELOPMENT, V122, P983; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; OLSSON M, 1995, J NEUROSCI, V15, P3863; REYPORT S, 1992, J NEUROSCI, V12, P4264; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rohrbacher J, 2000, NEUROSCIENCE, V97, P703, DOI 10.1016/S0306-4522(00)00046-4; Sanchez-Pernaute R, 2001, J NEUROSCI RES, V65, P284, DOI 10.1002/jnr.1152; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; WURST W, 1994, DEVELOPMENT, V120, P2065; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; ZUDDAS A, 1991, EUR J NEUROSCI, V3, P77	43	1235	1398	1	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					50	56		10.1038/nature00900	http://dx.doi.org/10.1038/nature00900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12077607				2022-12-24	WOS:000176599200034
J	Wentworth, P				Wentworth, P			Antibody design by man and nature	SCIENCE			English	Editorial Material							CATALYTIC ANTIBODIES; REACTIVE IMMUNIZATION; STRATEGY; HYDROLYSIS; BAIT		Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.							ARLAUD GJ, 1987, IMMUNOL TODAY, V8, P1076; Blackburn GM, 1998, ADV PHYS ORG CHEM, V31, P249; Gao CS, 1998, J AM CHEM SOC, V120, P2211, DOI 10.1021/ja9720220; HEIN MB, 1991, BIOTECHNOL PROGR, V7, P455, DOI 10.1021/bp00011a011; JANDA KD, 1990, J AM CHEM SOC, V112, P1274, DOI 10.1021/ja00159a074; JANDA KD, 1993, SCIENCE, V259, P490, DOI 10.1126/science.8424171; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P3; JONES LH, 2001, J AM CHEM SOC, V123; KLEBANOFF S, 1998, ENCY IMMUNOL, V3, P1713; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LI TY, 1994, SCIENCE, V264, P1289, DOI 10.1126/science.8191282; Lo CHL, 1997, J AM CHEM SOC, V119, P10251, DOI 10.1021/ja971442m; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; SIM RB, 1991, IMMUNOL TODAY, V12, P307, DOI 10.1016/0167-5699(91)90004-D; Toker JD, 2000, J AM CHEM SOC, V122, P3244, DOI 10.1021/ja994423g; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; WENTOWRTH P, 1999, COMPREHENSIVE ASYMME, V1, P1403; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 1998, P NATL ACAD SCI USA, V95, P5971, DOI 10.1073/pnas.95.11.5971; Wentworth P, 1998, CURR OPIN CHEM BIOL, V2, P138, DOI 10.1016/S1367-5931(98)80046-X; Wentworth P, 1997, J AM CHEM SOC, V119, P2315, DOI 10.1021/ja961625t; Wentworth P, 1996, P NATL ACAD SCI USA, V93, P799, DOI 10.1073/pnas.93.2.799; WIRSCHING P, 1995, SCIENCE, V270, P1775, DOI 10.1126/science.270.5243.1775	25	10	15	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2247	2249		10.1126/science.296.5576.2247	http://dx.doi.org/10.1126/science.296.5576.2247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077422				2022-12-24	WOS:000176379000066
J	Seidler, RD; Purushotham, A; Kim, SG; Ugurbil, K; Willingham, D; Ashe, J				Seidler, RD; Purushotham, A; Kim, SG; Ugurbil, K; Willingham, D; Ashe, J			Cerebellum activation associated with performance change but not motor learning	SCIENCE			English	Article							ARM MOVEMENTS; BRAIN; LESIONS; MEMORY; REFLEX; TIME; HAND	The issue of whether the cerebellum contributes to motor skill learning is controversial, principally because of the difficulty of separating the effects of motor learning from changes in performance. We performed a functional magnetic resonance imaging investigation during an implicit, motor sequence-learning task that was designed to separate these two processes. During the sequence-encoding phase, human participants performed a concurrent distractor task that served to suppress the performance changes associated with learning. Upon removal of the distractor, participants showed evidence of having learned. No cerebellar activation was associated with the learning phase, despite extensive involvement of other cortical and subcortical regions. There was, however, significant cerebellar activation during the expression of learning; thus, the cerebellum does not contribute to learning of the motor skill itself but is engaged primarily in the modification of performance.	Vet Affairs Med Ctr, Brain Sci Ctr 11B, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia	Ashe, J (corresponding author), Vet Affairs Med Ctr, Brain Sci Ctr 11B, Minneapolis, MN 55417 USA.	ashe@umn.edu	Kim, Seong-Gi/A-2691-2008; Ugurbil, Kamil/AAD-6058-2022	Seidler, Rachael/0000-0003-2452-9024	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040106] Funding Source: NIH RePORTER; NCRR NIH HHS [RR08079] Funding Source: Medline; NINDS NIH HHS [NS40106] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; BLOEDEL JR, 1995, BEHAV BRAIN RES, V68, P1, DOI 10.1016/0166-4328(94)00171-B; EVANS AC, 1994, NATO ADV SCI INST A, V264, P263; Friston K.J., 1994, HUMAN BRAIN MAPPING, V2, P211, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1992, P ROY SOC B-BIOL SCI, V248, P223, DOI 10.1098/rspb.1992.0065; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Grill SE, 1997, EXP BRAIN RES, V113, P33; HOLMES G, 1939, BRAIN, V63, P1; Horwitz B, 2000, NEUROIMAGE, V12, P434, DOI 10.1006/nimg.2000.0632; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; IVRY RB, 1989, J COGNITIVE NEUROSCI, V1, P134; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MEYERLOHMANN J, 1977, J NEUROPHYSIOL, V40, P1038, DOI 10.1152/jn.1977.40.5.1038; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Sakai K, 1998, J NEUROSCI, V18, P1827; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; STEINMETZ JE, 1992, J NEUROSCI, V12, P4403; Talairach J., 1988, COPLANAR STEREOTAXIC; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; TSUJIMOTO T, 1993, BRAIN RES, V629, P1, DOI 10.1016/0006-8993(93)90473-Z; van Mier H, 1998, J NEUROPHYSIOL, V80, P2177, DOI 10.1152/jn.1998.80.4.2177; Vaughan T., 2001, IEEE Antennas and Propagation Society International Symposium. 2001 Digest. Held in conjunction with: USNC/URSI National Radio Science Meeting (Cat. No.01CH37229), P378, DOI 10.1109/APS.2001.958871; WELSH JP, 1989, J NEUROSCI, V9, P299; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; YEO CH, 1984, BEHAV BRAIN RES, V13, P261, DOI 10.1016/0166-4328(84)90168-2	29	160	161	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 14	2002	296	5575					2043	2046		10.1126/science.1068524	http://dx.doi.org/10.1126/science.1068524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563UD	12065841				2022-12-24	WOS:000176273300058
J	van Leeuwen, F; Gafken, PR; Gottschling, DE				van Leeuwen, F; Gafken, PR; Gottschling, DE			Dot1p modulates silencing in yeast by methylation of the nucleosome core	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H3; CHROMATIN; PROTEIN; BINDING; METHYLTRANSFERASE; IDENTIFICATION; PROMOTER; HETEROCHROMATIN; PARTICLE	DOT1 was originally identified as a gene affecting telomeric silencing in S. cerevisiae. We now find that Dot1p methylates histone H3 on lysine 79, which maps to the top and bottom of the nucleosome core. Methylation occurs only when histone H3 is assembled in chromatin. In vivo, Dot1p is solely responsible for this methylation and methylates similar to90% of histone H3. In dot1Delta cells, silencing is compromised and silencing proteins become redistributed at the expense of normally silenced loci. We suggest that methylation of histone H3 lysine 79 limits silencing to discrete loci by preventing the binding of Sir proteins elsewhere along the genome. Because Dot1p and histone H3 are conserved, similar mechanisms are likely at work in other eukaryotes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Proteom Facil, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	dgottsch@fhcrc.org	van Leeuwen, Fred/A-7698-2010	van Leeuwen, Fred/0000-0002-7267-7251	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043893] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43893] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brachmann CB, 1998, YEAST, V14, P115; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Fajkus J, 2001, BIOCHEM BIOPH RES CO, V280, P961, DOI 10.1006/bbrc.2000.4208; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Georgel PT, 2001, P NATL ACAD SCI USA, V98, P8584, DOI 10.1073/pnas.151258798; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; Gottschling DE, 2000, CURR BIOL, V10, pR708, DOI 10.1016/S0960-9822(00)00714-4; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guyon JR, 1999, MOL CELL BIOL, V19, P2088; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Horn PJ, 2002, NAT STRUCT BIOL, V9, P167, DOI 10.1038/nsb762; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kelly TJ, 2000, MOL CELL BIOL, V20, P7051, DOI 10.1128/MCB.20.19.7051-7058.2000; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lebrun E, 2001, GENETICS, V158, P167; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; VANLEEUWEN F, 2002, IN PRESS METHODS ENZ, V350; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	45	639	657	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 14	2002	109	6					745	756		10.1016/S0092-8674(02)00759-6	http://dx.doi.org/10.1016/S0092-8674(02)00759-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086673	Bronze			2022-12-24	WOS:000176265600005
J	Borgdorff, AJ; Choquet, D				Borgdorff, AJ; Choquet, D			Regulation of AMPA receptor lateral movements	NATURE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC TRANSMISSION; HIPPOCAMPAL CULTURES; MOLECULAR MECHANISMS; NEURONS; ENDOCYTOSIS; PLASTICITY; EXPRESSION; SYNAPSES; LTD	An essential feature in the modulation of the efficacy of synaptic transmission is rapid changes in the number of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors at post-synaptic sites on neurons(1-4). Regulation of receptor endo- and exocytosis has been shown to be involved in this process(5-14). Whether regulated lateral diffusion of receptors in the plasma membrane also participates in receptor exchange to and from post-synaptic sites remains unknown. We analysed the lateral mobility of native AMPA receptors containing the glutamate receptor subunit GluR2 in rat cultured hippocampal neurons, using single-particle tracking and video microscopy. Here we show that AMPA receptors alternate within seconds between rapid diffusive and stationary behaviour. During maturation of neurons, stationary periods increase in frequency and length, often in spatial correlation with synaptic sites. Raising intracellular calcium, a central element in synaptic plasticity, triggers rapid receptor immobilization and local accumulation on the neuronal surface. We suggest that calcium influx prevents AMPA receptors from diffusing, and that lateral receptor diffusion to and from synaptic sites acts in the rapid and controlled regulation of receptor numbers at synapses.	Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Choquet, D (corresponding author), Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France.		Choquet, Daniel/E-4203-2013; Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763				Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hemar A, 1997, J NEUROSCI, V17, P9026; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Pickard L, 2000, J NEUROSCI, V20, P7922; SERGE A, IN PRESS J NEUROSCI; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Simson R, 1998, BIOPHYS J, V74, P297, DOI 10.1016/S0006-3495(98)77787-2; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	29	389	400	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					649	653		10.1038/nature00780	http://dx.doi.org/10.1038/nature00780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050666				2022-12-24	WOS:000176001200048
J	Pedley, TA; Hauser, WA				Pedley, TA; Hauser, WA			Sudden death in epilepsy: a wake-up call for management	LANCET			English	Editorial Material							UNEXPECTED DEATH; RISK-FACTORS; UNEXPLAINED DEATH; SUDEP; SEIZURES		Neurol Inst, New York, NY 10032 USA		Pedley, TA (corresponding author), Neurol Inst, 710 W 168th St, New York, NY 10032 USA.		Hauser, W Allen/AAB-5277-2020					Annegers JF, 1999, SEIZURE-EUR J EPILEP, V8, P347, DOI 10.1053/seiz.1999.0306; Donner EJ, 2001, NEUROLOGY, V57, P430, DOI 10.1212/WNL.57.3.430; EARNEST MP, 1992, EPILEPSIA, V33, P310, DOI 10.1111/j.1528-1157.1992.tb02321.x; Ficker DM, 2000, EPILEPSIA, V41, pS7, DOI 10.1111/j.1528-1157.2000.tb01519.x; Kloster R, 1999, J NEUROL NEUROSUR PS, V67, P439, DOI 10.1136/jnnp.67.4.439; Langan Y, 2000, SEIZURE-EUR J EPILEP, V9, P179, DOI 10.1053/seiz.2000.0388; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; LEESTMA JE, 1984, EPILEPSIA, V25, P84, DOI 10.1111/j.1528-1157.1984.tb04159.x; Nashef L, 1998, J NEUROL NEUROSUR PS, V64, P349, DOI 10.1136/jnnp.64.3.349; Nei M, 2000, EPILEPSIA, V41, P542, DOI 10.1111/j.1528-1157.2000.tb00207.x; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Opeskin K, 2000, J CLIN NEUROSCI, V7, P34, DOI 10.1054/jocn.1999.0137; Simon RP, 1997, EPILEPSIA, V38, pS35, DOI 10.1111/j.1528-1157.1997.tb06124.x; So EL, 2000, EPILEPSIA, V41, P1494, DOI 10.1111/j.1528-1157.2000.tb00128.x; TERRENCE CF, 1975, NEUROLOGY, V25, P594, DOI 10.1212/WNL.25.6.594; Timmings PL, 1998, SEIZURE-EUR J EPILEP, V7, P289, DOI 10.1016/S1059-1311(98)80020-4; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519	17	55	56	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 25	2002	359	9320					1790	1791		10.1016/S0140-6736(02)08726-3	http://dx.doi.org/10.1016/S0140-6736(02)08726-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044369				2022-12-24	WOS:000175775500002
J	Odze, R				Odze, R			Cytokeratin 7/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia?	LANCET			English	Editorial Material							GASTROESOPHAGEAL REFLUX DISEASE; ESOPHAGOGASTRIC JUNCTION; HELICOBACTER-PYLORI; ESOPHAGUS; INFLAMMATION; CARDIA; IMMUNOREACTIVITY; EXPRESSION; PATTERNS; SUBSETS		Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Odze, R (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	rodze@partners.org						Chandrasoma PT, 2000, AM J SURG PATHOL, V24, P344, DOI 10.1097/00000478-200003000-00002; Couvelard A, 2001, GUT, V49, P761, DOI 10.1136/gut.49.6.761; El-Zimaity HMT, 2001, AM J GASTROENTEROL, V96, P1378; Glickman JN, 2001, AM J SURG PATHOL, V25, P87, DOI 10.1097/00000478-200101000-00010; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Goldblum JR, 2000, DIGEST DIS, V18, P14, DOI 10.1159/000016929; Goldblum JR, 1998, GASTROENTEROLOGY, V114, P633, DOI 10.1016/S0016-5085(98)70576-1; Kirchner T, 2001, VIRCHOWS ARCH, V439, P512, DOI 10.1007/s004280100477; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nandurkar S, 1997, GUT, V40, P710, DOI 10.1136/gut.40.6.710; Oberg S, 1997, ANN SURG, V226, P522, DOI 10.1097/00000658-199710000-00013; Ormsby AH, 1999, HUM PATHOL, V30, P288, DOI 10.1016/S0046-8177(99)90007-2; Ormsby AH, 2000, GASTROENTEROLOGY, V119, P683, DOI 10.1053/gast.2000.16482; ORMSBY AH, 2000, MODERN PATHOL, V31, pA86; SARBIA M, 1993, PATHOL RES PRACT, V189, P530, DOI 10.1016/S0344-0338(11)80361-4; Shields HM, 2001, AM J GASTROENTEROL, V96, P3268; Trudgill NJ, 1997, GUT, V41, P585, DOI 10.1136/gut.41.5.585; Wallner B, 2001, SCAND J GASTROENTERO, V36, P910, DOI 10.1080/003655201750305404	18	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2002	359	9319					1711	1713		10.1016/S0140-6736(02)08661-0	http://dx.doi.org/10.1016/S0140-6736(02)08661-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554MV	12049855				2022-12-24	WOS:000175740500003
J	Burness, GP				Burness, GP			Ecology - Elephants, mice, and red herrings	SCIENCE			English	Editorial Material									Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Burness, GP (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.							Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Brown J., 2000, SCALING BIOL; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Hochachka PW, 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Weibel E.R., 2000, SYMMORPHOSIS FORM FU; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	7	7	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1245	+		10.1126/science.1072300	http://dx.doi.org/10.1126/science.1072300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016294				2022-12-24	WOS:000175713000030
J	Hauert, C; De Monte, S; Hofbauer, J; Sigmund, K				Hauert, C; De Monte, S; Hofbauer, J; Sigmund, K			Volunteering as Red Queen mechanism for cooperation in public goods games	SCIENCE			English	Article							SIZABLE GROUPS; EVOLUTION; RECIPROCITY; PUNISHMENT	The evolution of cooperation among nonrelated individuals is one of the fundamental problems in biology and social sciences. Reciprocal altruism fails to provide a solution if interactions are not repeated often enough or groups are too large. Punishment and reward can be very effective but require that defectors can be traced and identified. Here we present a simple but effective mechanism operating under full anonymity. Optional participation can foil exploiters and overcome the social dilemma. In voluntary public goods interactions, cooperators and defectors will coexist. We show that this result holds under very diverse assumptions on population structure and adaptation mechanisms, leading usually not to an equilibrium but to an unending cycle of adjustments (a Red Queen type of evolution). Thus, voluntary participation offers an escape hatch out of some social traps. Cooperation can subsist in sizable groups even if interactions are not repeated, defectors remain anonymous, players have no memory, and assortment is purely random.	Univ Vienna, Inst Math, A-1090 Vienna, Austria; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Danish Tech Univ, Dept Phys, DK-2800 Kgs Lyngby, Denmark; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	University of Vienna; University of British Columbia; Technical University of Denmark; International Institute for Applied Systems Analysis (IIASA)	Sigmund, K (corresponding author), Univ Vienna, Inst Math, Strudlhofgasse 4, A-1090 Vienna, Austria.		Hauert, Christoph/E-5369-2011	Hauert, Christoph/0000-0002-1239-281X; De Monte, Silvia/0000-0001-7953-5494				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Binmore K., 1994, PLAYING FAIR GAME TH; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Colman AM., 1995, GAME THEORY ITS APPL; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fudenberg D, 1998, THEORY LEARNING GAME; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H., 2000, GAME THEORY EVOLVING; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HAUERT C, IN PRESS J THEOR BIO; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Kagel JH, 1995, HDB EXPT EC; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; ORBELL JM, 1993, AM SOCIOL REV, V58, P787, DOI 10.2307/2095951; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Smith J. M., 1995, MAJOR TRANSITIONS EV; SOBER E, 1999, UNTO OTHERS EVOLUTIO; Sugden R, 1986, EC RIGHTS COOPERATIO; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	28	717	735	9	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1129	1132		10.1126/science.1070582	http://dx.doi.org/10.1126/science.1070582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551MG	12004134	Green Submitted			2022-12-24	WOS:000175565000057
J	Presley, JF; Ward, TH; Pfeifer, AC; Siggia, ED; Phair, RD; Lippincott-Schwartz, J				Presley, JF; Ward, TH; Pfeifer, AC; Siggia, ED; Phair, RD; Lippincott-Schwartz, J			Dissection of COPI and Arf1 dynamics in vivo and role in Golgi membrane transport	NATURE			English	Article							ADP-RIBOSYLATION FACTOR-1; ENDOPLASMIC-RETICULUM; LIVING CELLS; COATOMER BINDING; BREFELDIN-A; G-PROTEIN; EXCHANGE; VESICLES; MUTATION; CLATHRIN	Cytosolic coat proteins that bind reversibly to membranes have a central function in membrane transport within the secretory pathway(1,2). One well-studied example is COPI or coatomer, a heptameric protein complex that is recruited to membranes by the GTP-binding protein Arf1. Assembly into an electron-dense coat then helps in budding off membrane to be transported between the endoplasmic reticulum (ER) and Golgi apparatus 2. Here we propose and corroborate a simple model for coatomer and Arf1 activity based on results analysing the distribution and lifetime of fluorescently labelled coatomer and Arf1 on Golgi membranes of living cells. We find that activated Arf1 brings coatomer to membranes. However, once associated with membranes, Arf1 and coatomer have different residence times: coatomer remains on membranes after Arf1-GTP has been hydrolysed and dissociated. Rapid membrane binding and dissociation of coatomer and Arf1 occur stochastically, even without vesicle budding. We propose that this continuous activity of coatomer and Arf1 generates kinetically stable membrane domains that are connected to the formation of COPI-containing transport intermediates. This role for Arf1/coatomer might provide a model for investigating the behaviour of other coat protein systems within cells.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Ctr Studies & Phys Biol, New York, NY 10021 USA; BioInformat Serv, Rockville, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Rockefeller University	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.		Ward, Theresa H./E-9650-2013	Ward, Theresa H./0000-0002-9881-8649	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001609] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klumperman J, 1998, J CELL SCI, V111, P3411; LAHTINEN U, 1992, J CELL SCI, V103, P321; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Vasudevan C, 1998, J CELL SCI, V111, P1277; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	29	207	210	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					187	193		10.1038/417187a	http://dx.doi.org/10.1038/417187a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000962				2022-12-24	WOS:000175460200046
J	Setou, M; Seog, DH; Tanaka, Y; Kanai, Y; Takei, Y; Kawagishi, M; Hirokawa, N				Setou, M; Seog, DH; Tanaka, Y; Kanai, Y; Takei, Y; Kawagishi, M; Hirokawa, N			Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites	NATURE			English	Article							HEAVY-CHAIN; CONVENTIONAL KINESIN; HIPPOCAMPAL-NEURONS; BINDING PROTEIN; AMPA RECEPTORS; TRANSPORT; SUPPRESSION; DOMAIN	In cells, molecular motors operate in polarized sorting of molecules, although the steering mechanisms of motors remain elusive(1). In neurons, the kinesin motor(2) conducts vesicular transport such as the transport of synaptic vesicle components to axons(3) and of neurotransmitter receptors to dendrites(4), indicating that vesicles may have to drive the motor for the direction to be correct. Here we show that an AMPA (alpha-amino-3-hydroxy-5- methylisoxazole-4-propionate) receptor subunit-GluR2-interacting protein (GRIP1)-can directly interact and steer kinesin heavy chains to dendrites as a motor for AMPA receptors. As would be expected if this complex is functional, both gene targeting and dominant negative experiments of heavy chains of mouse kinesin showed abnormal localization of GRIP1. Moreover, expression of the kinesin-binding domain of GRIP1 resulted in accumulation of the endogenous kinesin predominantly in the somatodendritic area. This pattern was different from that generated by the overexpression of the kinesin-binding scaffold protein JSAP1 (JNK/SAPK-associated protein-1, also known as Mapk8ip3), which occurred predominantly in the somatoaxon area. These results indicate that directly binding proteins can determine the traffic direction of a motor protein.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Inje Univ, Coll Med, Dept Microbiol, Jingu 633165, Busan, South Korea	University of Tokyo; Inje University	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Takei, Yosuke/I-1828-2015; Kanai, Yoshimitsu/W-3486-2019	Takei, Yosuke/0000-0002-5026-8027; , Masahiko/0000-0001-7416-4938; Kanai, Yoshimitsu/0000-0002-0375-6853; Tanaka, Yosuke/0000-0001-5376-5726				BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rubio ME, 1999, J NEUROSCI, V19, P5549; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Severt WL, 1999, J CELL SCI, V112, P3691; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8	29	379	393	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					83	87		10.1038/nature743	http://dx.doi.org/10.1038/nature743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986669				2022-12-24	WOS:000175307200042
J	Talwar, SK; Xu, SH; Hawley, ES; Weiss, SA; Moxon, KA; Chapin, JK				Talwar, SK; Xu, SH; Hawley, ES; Weiss, SA; Moxon, KA; Chapin, JK			Behavioural neuroscience: Rat navigation guided by remote control - Free animals can be 'virtually' trained by microstimulating key areas of their brains.	NATURE			English	Article							SELF-STIMULATION		Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Drexel University	Talwar, SK (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.		Moxon, Karen/K-7407-2012	Moxon, Karen/0000-0002-5790-097X; Weiss, Shennan/0000-0003-0825-8439				DEUTSCH JA, 1963, J THEOR BIOL, V4, P193, DOI 10.1016/0022-5193(63)90028-6; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; FUKUDA M, 1992, J NEUROSCI METH, V44, P121, DOI 10.1016/0165-0270(92)90005-X; GALLISTEL CR, 1969, J COMP PHYSIOL PSYCH, V69, P713, DOI 10.1037/h0028232; HAWLEY ES, IN PRESS HIPPOCAMPUS; Loucks RB, 1933, J COMP PSYCHOL, V16, P439, DOI 10.1037/h0073424; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OLDS ME, 1981, ANNU REV PSYCHOL, V32, P523, DOI 10.1146/annurev.ps.32.020181.002515; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Skinner B.F., 1938, BEHAV ORG EXPT ANAL	10	236	281	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					37	38		10.1038/417037a	http://dx.doi.org/10.1038/417037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986657				2022-12-24	WOS:000175307200029
J	Nakazawa, K; Quirk, MC; Chitwood, RA; Watanabe, M; Yeckel, MF; Sun, LD; Kato, A; Carr, CA; Johnston, D; Wilson, MA; Tonegawa, S				Nakazawa, K; Quirk, MC; Chitwood, RA; Watanabe, M; Yeckel, MF; Sun, LD; Kato, A; Carr, CA; Johnston, D; Wilson, MA; Tonegawa, S			Requirement for hippocampal CA3 NMDA receptors in associative memory recall	SCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; ANIMAL-MODELS; PLACE CELLS; RAT; NEURONS; BRAIN; ORGANIZATION; RETRIEVAL	Pattern completion, the ability to retrieve complete memories on the basis of incomplete sets of cues, is a crucial function of biological memory systems. The extensive recurrent connectivity of the CA3 area of hippocampus has led to suggestions that it might provide this function. We have tested this hypothesis by generating and analyzing a genetically engineered mouse strain in which the N-methyl-D-asparate ( NMDA) receptor gene is ablated specifically in the CA3 pyramidal cells of adult mice. The mutant mice normally acquired and retrieved spatial reference memory in the Morris water maze, but they were impaired in retrieving this memory when presented with a fraction of the original cues. Similarly, hippocampal CA1 pyramidal cells in mutant mice displayed normal place- related activity in a full- cue environment but showed a reduction in activity upon partial cue removal. These results provide direct evidence for CA3 NMDA receptor involvement in associative memory recall.	MIT, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Hokkaido University	Tonegawa, S (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Watanabe, Masahiko/S-3614-2019; Nakazawa, Kazutoshi/J-6195-2015; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; Nakazawa, Kazutoshi/0000-0001-5699-9093; WATANABE, Masahiko/0000-0001-5037-7138; Chitwood, Raymond/0000-0002-2016-5238	NIMH NIH HHS [P50-MH58880, P50 MH058880, F32 MH011390-03, F32 MH067462, F32 MH011390] Funding Source: Medline; NINDS NIH HHS [R01 NS032925, R01-NS32925] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, F32MH067462, F32MH011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032925] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; BERGER TW, 1991, LONG TERM POTENTIATI, P327; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; CHATTARJI S, UNPUB; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; GARDNERMEDWIN AR, 1976, PROC R SOC SER B-BIO, V194, P375, DOI 10.1098/rspb.1976.0084; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Kadar T, 1998, J NEURAL TRANSM, V105, P987, DOI 10.1007/s007020050107; LeJeune H, 1996, NEUROSCIENCE, V74, P349; Liu Y, 1996, EXP BRAIN RES, V108, P389; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nakazawa K., UNPUB; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; ROLLS E, 1989, COMP NEUR S, P125; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; TUOKKO H, 1991, J CLIN EXP NEUROPSYC, V13, P871, DOI 10.1080/01688639108405104; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WATANABE M, UNPUB; WILLIAMS S, 1988, SCIENCE, V242, P84, DOI 10.1126/science.2845578; WISDEN W, 1993, J NEUROSCI, V13, P3582; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	49	762	796	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					211	218		10.1126/science.1071795	http://dx.doi.org/10.1126/science.1071795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12040087	Green Accepted			2022-12-24	WOS:000176738100031
J	Furmanski, L				Furmanski, L			Waiting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2002	288	2					142	142		10.1001/jama.288.2.142	http://dx.doi.org/10.1001/jama.288.2.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	571HC	12095365				2022-12-24	WOS:000176711100001
J	Crawford, LM				Crawford, LM			Meetings on drug applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2002	288	1					36	36		10.1001/jama.288.1.36	http://dx.doi.org/10.1001/jama.288.1.36			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	568YW	12090852				2022-12-24	WOS:000176573400008
J	Brun, VH; Otnaess, MK; Molden, S; Steffenach, HA; Witter, MP; Moser, MB; Moser, EI				Brun, VH; Otnaess, MK; Molden, S; Steffenach, HA; Witter, MP; Moser, MB; Moser, EI			Place cells and place recognition maintained by direct entorhinal-hippocampal circuitry	SCIENCE			English	Article							PYRAMIDAL CELLS; SPATIAL MEMORY; GOAL LOCATION; UNIT-ACTIVITY; RATS; CORTEX; FIELDS; MODEL; ACID; CA3	Place cells in hippocampal area CA1 may receive positional information from the intrahippocampal associative network in area CA3 or directly from the entorhinal cortex. To determine whether direct entorhinal connections support spatial ring and spatial memory, we removed all input from areas CA3 to CA1, thus isolating the CA1 area. Pyramidal cells in the isolated CA1 area developed sharp and stable place fields. Rats with an isolated CA1 area showed normal acquisition of an associative hippocampal-dependent spatial recognition task. Spatial recall was impaired. These results suggest that the hippocampus contains two functionally separable memory circuits: The direct entorhinal-CA1 system is sufficient for recollection-based recognition memory, but recall depends on intact CA3-CA1 connectivity.	Norwegian Univ Sci & Technol, Med Tech Res Ctr, Neurosci Unit, N-7489 Trondheim, Norway; Vrije Univ Amsterdam, Med Ctr, Dept Anat, Neurosci Res Inst, Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Neurosci Unit, N-7489 Trondheim, Norway.		Brun, Vegard Heimly/ADZ-5405-2022	Brun, Vegard Heimly/0000-0002-4136-3073				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; [Anonymous], 1998, NEURAL NETWORKS BRAI; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; HANDELMANN GE, 1981, BRAIN RES, V217, P41, DOI 10.1016/0006-8993(81)90183-9; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; Kali S, 2000, J NEUROSCI, V20, P7463; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; MULLER RU, 1987, J NEUROSCI, V7, P1935; NAKAZAWA K, IN PRESS SCIENCE; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; Witter MP, 2000, HIPPOCAMPUS, V10, P398; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	29	446	453	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2243	2246		10.1126/science.1071089	http://dx.doi.org/10.1126/science.1071089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077421				2022-12-24	WOS:000176379000065
J	Harnden, A; Alves, B; Sheikh, A				Harnden, A; Alves, B; Sheikh, A			Rising incidence of Kawasaki disease in England: analysis of hospital admission data	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England; Univ London Imperial Coll Sci Technol & Med, Dept Primary Hlth Care, London W2 1PG, England	University of Oxford; Imperial College London	Harnden, A (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England.		Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Curtis N, 1997, BRIT MED J, V315, P322; DHILLON R, 1993, ARCH DIS CHILD, V69, P631, DOI 10.1136/adc.69.6.631; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Royle JA, 1998, ARCH DIS CHILD, V78, P33, DOI 10.1136/adc.78.1.33; Yanagawa H, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e33	5	81	85	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2002	324	7351					1424	1425		10.1136/bmj.324.7351.1424	http://dx.doi.org/10.1136/bmj.324.7351.1424			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565CQ	12065266	Green Published, Bronze			2022-12-24	WOS:000176351400018
J	Mohr, S; Stryker, JM; Lambowitz, AM				Mohr, S; Stryker, JM; Lambowitz, AM			A DEAD-box protein functions as an ATP-dependent RNA chaperone in group I intron splicing	CELL			English	Article							LARGE RIBOSOMAL-RNA; NEUROSPORA MITOCHONDRIA; CATALYTIC CORE; TETRAHYMENA RIBOZYME; NUCLEAR MUTANTS; SYNTHETASE; VITRO; HELICASE	The Neurospora crassa CYT-18 protein, the mitochondrial tyrosyl-tRNA synthetase, functions in splicing group I introns by inducing formation of the catalytically active RNA structure. Here, we identified a DEAD-box protein (CYT-19) that functions in concert with CYT-18 to promote group I intron splicing in vivo and vitro. CYT-19 does not bind specifically to group I intron RNAs and instead functions as an ATP-dependent RNA chaperone to destabilize nonnative RNA structures that constitute kinetic traps in the CYT-18-assisted RNA-folding pathway. Our results demonstrate that a DExH/ D-box protein has a specific, physiologically relevant chaperone function in the folding of a natural RNA substrate.	Univ Texas, Inst Mol & Cellular Biol, Dept Chem & Biochem, Sect Mol Genet & Microbiol,Sch Biol Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Chem & Biochem, Sect Mol Genet & Microbiol,Sch Biol Sci, Austin, TX 78712 USA.				NIGMS NIH HHS [GM37951] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037951, R01GM037951] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; AKINS RA, 1985, MOL CELL BIOL, V5, P2272, DOI 10.1128/MCB.5.9.2272; BERTRAND H, 1982, CELL, V29, P517, DOI 10.1016/0092-8674(82)90168-4; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Clodi E, 1999, EMBO J, V18, P3776, DOI 10.1093/emboj/18.13.3776; COETZEE T, 1994, GENE DEV, V8, P1575, DOI 10.1101/gad.8.13.1575; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; GUO QB, 1991, J BIOL CHEM, V266, P1809; HENDERSON MF, 1981, THESIS ST LOUIS U ST; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; KARPEL RL, 1982, BIOCHEMISTRY-US, V21, P2102, DOI 10.1021/bi00538a019; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; MANNELLA CA, 1979, P NATL ACAD SCI USA, V76, P2635, DOI 10.1073/pnas.76.6.2635; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Myers CA, 2002, P NATL ACAD SCI USA, V99, P2630, DOI 10.1073/pnas.052596299; NIEMER I, 1995, NUCLEIC ACIDS RES, V23, P2966, DOI 10.1093/nar/23.15.2966; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; SALDANHA RJ, 1995, BIOCHEMISTRY-US, V34, P1275, DOI 10.1021/bi00004a022; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; TURCQ B, 1992, P NATL ACAD SCI USA, V89, P1676, DOI 10.1073/pnas.89.5.1676; Wagner JDO, 1998, EMBO J, V17, P2926, DOI 10.1093/emboj/17.10.2926; Wallweber GJ, 1997, RNA, V3, P114; Webb AE, 2001, J MOL BIOL, V309, P1087, DOI 10.1006/jmbi.2001.4714; WOLLENZIEN PL, 1983, CELL, V32, P397, DOI 10.1016/0092-8674(83)90459-2; Woodson SA, 2000, CELL MOL LIFE SCI, V57, P796, DOI 10.1007/s000180050042; ZHANG A, 1995, RNA, V1, P783	34	152	157	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 14	2002	109	6					769	779		10.1016/S0092-8674(02)00771-7	http://dx.doi.org/10.1016/S0092-8674(02)00771-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086675	Bronze			2022-12-24	WOS:000176265600007
J	Vassylyev, DG; Sekine, S; Laptenko, O; Lee, J; Vassylyeva, MN; Borukhov, S; Yokoyama, S				Vassylyev, DG; Sekine, S; Laptenko, O; Lee, J; Vassylyeva, MN; Borukhov, S; Yokoyama, S			Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 angstrom resolution	NATURE			English	Article							ESCHERICHIA-COLI SIGMA-70; SIGMA(70) SUBUNIT; PROMOTER RECOGNITION; MUTATIONAL ANALYSIS; CONSERVED REGIONS; TRANSCRIPTION; BINDING; DNA; ELONGATION; COMPLEX	In bacteria, the binding of a single protein, the initiation factor sigma, to a multi-subunit RNA polymerase core enzyme results in the formation of a holoenzyme, the active form of RNA polymerase essential for transcription initiation. Here we report the crystal structure of a bacterial RNA polymerase holoenzyme from Thermus thermophilus at 2.6 Angstrom resolution. In the structure, two amino-terminal domains of the sigma subunit form a V-shaped structure near the opening of the upstream DNA-binding channel of the active site cleft. The carboxy-terminal domain of sigma is near the outlet of the RNA-exit channel, about 57 Angstrom from the N-terminal domains. The extended linker domain forms a hairpin protruding into the active site cleft, then stretching through the RNA-exit channel to connect the N- and C-terminal domains. The holoenzyme structure provides insight into the structural organization of transcription intermediate complexes and into the mechanism of transcription initiation.	RIKEN, Spring 8, Harima Inst, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; RIKEN, Spring 8, Harima Inst, Structurome Res Grp, Sayo, Hyogo 6795148, Japan; SUNY Hlth Sci Ctr, Dept Microbiol, Brooklyn, NY 11203 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; RIKEN; University of Tokyo	Vassylyev, DG (corresponding author), RIKEN, Spring 8, Harima Inst, Cellular Signaling Lab, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@yumiyoshi.harima.riken.go.jp; serbor@asan.com; yokoyama@biochem.s.u-tokyo.ac.jp	Sekine, Shun-ichi/N-5450-2015; Borukhov, Sergei/AAF-3195-2019; Yokoyama, Shigeyuki/N-6911-2015; Vassylyev, Dmitry/A-9005-2008	Sekine, Shun-ichi/0000-0001-8174-8704; Borukhov, Sergei/0000-0002-3517-3003; Yokoyama, Shigeyuki/0000-0003-3133-7338; 				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang XJ, 1997, NUCLEIC ACIDS RES, V25, P2603, DOI 10.1093/nar/25.13.2603; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; VASSYLYEVA MN, UNPUB ACTA CRYSTALLO; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	48	611	635	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					712	719		10.1038/nature752	http://dx.doi.org/10.1038/nature752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12000971				2022-12-24	WOS:000176154700037
J	Kroll, L; Rothwell, J; Bradley, D; Shah, P; Bailey, S; Harrington, RC				Kroll, L; Rothwell, J; Bradley, D; Shah, P; Bailey, S; Harrington, RC			Mental health needs of boys in secure care for serious or persistent offending: a prospective, longitudinal study	LANCET			English	Article							JUVENILE-OFFENDERS; ADOLESCENTS	Background The mental health needs of children and adolescents in secure care are a matter of concern, but little systematic research has been done. Our aim was to assess the mental health, social, and educational needs of these young people in a prospective, longitudinal study. Methods We enrolled 97 boys aged 12-17 years who had been admitted to secure care. We assessed their needs (n=97) at the time of admission and 3 months later (n=90) with standardised interviews and psychometric tests. Results 26 (27%) boys had an intelligence quotient (IQ) of less than 70. The need for psychiatric help was high on admission to a secure unit, with the most frequent disorders being depression and anxiety. There were high rates of aggression, substance misuse, self harm, and social, family, and educational problems, and associated needs. The mean number of needs was 8.5 (SD 2.9) on admission and 2.9 (SD 2.4) after 3 months (mean difference 5.6, 95% CI 5.0-6.3). Areas in which needs were mostly met included education, substance misuse, self care, and diet. Areas where the frequency of need fell substantially, but remained high, were social and family problems, and aggressive behaviours. Psychological needs persisted, with new onsets of depression, anxiety problems, and post-traumatic-stress symptoms shortly after admission. The most frequently required interventions were psychological assessment and cognitive behavioural work. Interpretation Boys in secure care have many needs and a high rate of psychiatric morbidity. During the admission period, secure care units address some domains of need, but others remain unchanged or get worse. Psychological and psychiatric provision in secure units need to be improved.	Univ Manchester, Royal Manchester Childrens Hosp, Dept Child Psychiat, Manchester M27 4HA, Lancs, England; Manchester Childrens Trust, Manchester, Lancs, England; Salford Mental Hlth Trust, Manchester, Lancs, England	Royal Manchester Children's Hospital; University of Manchester	Harrington, RC (corresponding author), Univ Manchester, Royal Manchester Childrens Hosp, Dept Child Psychiat, Manchester M27 4HA, Lancs, England.		Lorente, Rosa/AAL-5850-2021					Bailey S, 1996, J ADOLESCENCE, V19, P19, DOI 10.1006/jado.1996.0003; Bailey S., 2000, YOUNG PEOPLE MENTAL, P91; BAILEY SM, 1994, J ADOLESCENCE, V17, P207, DOI 10.1006/jado.1994.1021; Boswell G., 2000, VIOLENT CHILDREN ADO; Bullock R, 1998, SECURE TREATMENT OUT; DITCHFILD J, 1992, JUVENILES SENTENCED; Goldstein, 1987, AGGRESSION REPLACEME; Goldstein A.P., 1994, PROSOCIAL GANG IMPLE; Harrington RC, 1999, EUR CHILD ADOLES PSY, V8, P1; Henggeler SW, 1996, J ADOLESCENCE, V19, P47, DOI 10.1006/jado.1996.0005; JAMESON EJ, 1989, J ADOLESCENT HEALTH, V10, P490, DOI 10.1016/0197-0070(89)90011-9; Kaufman J, 1996, SCHEDULE AFFECTIVE D; Kazdin AE, 1997, J CHILD PSYCHOL PSYC, V38, P161, DOI 10.1111/j.1469-7610.1997.tb01851.x; Kroll L, 1999, PSYCHOL MED, V29, P891, DOI 10.1017/S0033291799008752; KURTZ Z, 1997, STUDY DEMAND NEEDS F; LADER D, 2000, PSYCHIAT MORBIDITY Y; MILIN R, 1991, J AM ACAD CHILD PSY, V30, P569, DOI 10.1097/00004583-199107000-00007; *PSYCH CORP, 1992, WESCHL INT SCAL CHIL; TimmonsMitchell J, 1997, BEHAV SCI LAW, V15, P195, DOI 10.1002/(SICI)1099-0798(199721)15:2<195::AID-BSL269>3.0.CO;2-8	19	101	101	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 8	2002	359	9322					1975	1979		10.1016/S0140-6736(02)08829-3	http://dx.doi.org/10.1016/S0140-6736(02)08829-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563BA	12076552				2022-12-24	WOS:000176232500009
J	Mao, BY; Wu, W; Davidson, G; Marhold, J; Li, MF; Mechler, BM; Delius, H; Hoppe, D; Stannek, P; Walter, C; Glinka, A; Niehrs, C				Mao, BY; Wu, W; Davidson, G; Marhold, J; Li, MF; Mechler, BM; Delius, H; Hoppe, D; Stannek, P; Walter, C; Glinka, A; Niehrs, C			Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling	NATURE			English	Article							ENERGY-TRANSFER BRET; WNT; TRANSDUCTION; DROSOPHILA; MECHANISM; MEMBER; FAMILY	The Wnt family of secreted glycoproteins mediate cell-cell interactions during cell growth and differentiation in both embryos and adults(1,2). Canonical Wnt signalling by way of the beta-catenin pathway is transduced by two receptor families. Frizzled proteins and lipoprotein-receptor-related proteins 5 and 6 (LRP5/6) bind Wnts and transmit their signal by stabilizing intracellular beta-catenin(3-6). Wnt/beta-catenin signalling is inhibited by the secreted protein Dickkopf1 (Dkk1), a member of a multigene family, which induces head formation in amphibian embryos(7). Dkk1 has been shown to inhibit Wnt signalling by binding to and antagonizing LRP5/6(8-10). Here we show that the transmembrane proteins Kremen1 and Kremen2 are high-affinity Dkk1 receptors that functionally cooperate with Dkk1 to block Wnt/beta-catenin signalling. Kremen2 forms a ternary complex with Dkk1 and LRP6, and induces rapid endocytosis and removal of the Wnt receptor LRP6 from the plasma membrane. The results indicate that Kremen1 and Kremen2 are components of a membrane complex modulating canonical Wnt signalling through LRP6 in vertebrates.	Deutsch Krebsforschungszentrum, Mol Embryol Div, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, Dev Genet Div, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, Appl Tumor Virol Div, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Mol Embryol Div, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Mao, Bingyu/L-9955-2014; Davidson, Gary/AAA-7321-2021; Davidson, Gary/J-6059-2013	Davidson, Gary/0000-0002-2264-5518; Mao, Bingyu/0000-0002-7993-3158				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; COUSO JP, 1994, DEVELOPMENT, V120, P621; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Nakamura T, 2001, BBA-GENE STRUCT EXPR, V1518, P63, DOI 10.1016/S0167-4781(01)00168-3; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	19	815	879	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					664	667		10.1038/nature756	http://dx.doi.org/10.1038/nature756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050670				2022-12-24	WOS:000176001200052
J	Iijima, M; Devreotes, P				Iijima, M; Devreotes, P			Tumor suppressor PTEN mediates sensing of chemoattractant gradients	CELL			English	Article							DICTYOSTELIUM-DISCOIDEUM; SIGNAL-TRANSDUCTION; LIVING CELLS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; NEUTROPHIL MIGRATION; PHOSPHATASE-ACTIVITY; ADENYLYL-CYCLASE; CHEMOTAXIS; PROTEIN; ACTIVATION	Shallow gradients of chemoattractants, sensed by G protein-linked signaling pathways, elicit localized binding of PH domains specific for PI(3,4,5)P-3 at sites on the membrane where rearrangements of the cytoskeleton and pseudopod extension occur. Disruption of the PI 3-phosphatase, PTEN, in Dictyostelium discoideum dramatically prolonged and broadened the PH domain relocation and actin polymerization responses, causing the cells lacking PTEN to follow a circuitous route toward the attractant. Exogenously expressed PTEN-GFP localized to the surface membrane at the rear of the cell. Membrane localization required a putative PI(4,5)P-2 binding motif and was required for chemotaxis. These results suggest that specific phosphoinositides direct actin polymerization to the cell's leading edge and regulation of PTEN through a feedback loop plays a critical role in gradient sensing and directional migration.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Devreotes, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM57874, GM34933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034933, R01GM057874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1808, DOI 10.1006/bbrc.1994.2880; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Buczynski G, 1997, J CELL BIOL, V136, P1271, DOI 10.1083/jcb.136.6.1271; COCUCCI SM, 1970, J CELL BIOL, V45, P399, DOI 10.1083/jcb.45.2.399; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Kim CH, 1999, J CLIN INVEST, V104, P1751, DOI 10.1172/JCI7310; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; KONIJN TM, 1970, EXPERIENTIA, V26, P367, DOI 10.1007/BF01896891; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; THEIBERT A, 1986, J BIOL CHEM, V261, P5121; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; VANHAASTERT PJM, 1982, MOL CELL ENDOCRINOL, V26, P1, DOI 10.1016/0303-7207(82)90002-8; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wardlaw AJ, 2000, BRIT MED BULL, V56, P985, DOI 10.1258/0007142001903490; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu DQ, 2000, J CELL SCI, V113, P2935; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zhou KM, 1998, J CELL SCI, V111, P283	49	530	538	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 31	2002	109	5					599	610		10.1016/S0092-8674(02)00745-6	http://dx.doi.org/10.1016/S0092-8674(02)00745-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062103	Bronze			2022-12-24	WOS:000175957900009
J	Owen, PJ; Miles, DPB; Draper, GJ; Vincent, TJ				Owen, PJ; Miles, DPB; Draper, GJ; Vincent, TJ			Retrospective study of mortality incident at Lowermoor in north after a water pollution Cornwall	BRITISH MEDICAL JOURNAL			English	Article							ALUMINUM		Cornwall & Isles Scilly Hlth Author, St Austell PL25 4NQ, Cornwall, England; Univ Oxford, Dept Paediat, Childhood Canc Res Grp, Oxford OX2 6HJ, England	University of Oxford	Owen, PJ (corresponding author), Cornwall & Isles Scilly Hlth Author, St Austell PL25 4NQ, Cornwall, England.							*LOW INC HLTH ADV, 1989, WAT POLL LOW N CORNW; *LOW INC HLTH ADV, 1990, 2 LOW INC HLTH ADV G; OWEN PJ, 1995, J PUBLIC HEALTH MED, V17, P200, DOI 10.1093/oxfordjournals.pubmed.a043093; ROWLAND A, 1990, J ROY SOC HEALTH, V110, P166, DOI 10.1177/146642409011000507	4	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1189	1189		10.1136/bmj.324.7347.1189	http://dx.doi.org/10.1136/bmj.324.7347.1189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554XV	12016184	Bronze, Green Published			2022-12-24	WOS:000175763200019
J	Olsen, PE; Kent, DV; Sues, HD; Koeberl, C; Huber, H; Montanari, A; Rainforth, EC; Fowell, SJ; Szajna, MJ; Hartline, BW				Olsen, PE; Kent, DV; Sues, HD; Koeberl, C; Huber, H; Montanari, A; Rainforth, EC; Fowell, SJ; Szajna, MJ; Hartline, BW			Ascent of dinosaurs linked to an iridium anomaly at the Triassic-Jurassic boundary	SCIENCE			English	Article							NEWARK SUPERGROUP; EXTINCTION; SYSTEM; EVENT	Analysis of tetrapod footprints and skeletal material from more than 70 localities in eastern North America shows that large theropod dinosaurs appeared less than 10,000 years after the Triassic-Jurassic boundary and less than 30,000 years after the last Triassic taxa, synchronous with a terrestrial mass extinction. This extraordinary turnover is associated with an iridium anomaly (up to 285 parts per trillion, with an average maximum of 141 parts per trillion) and a fern spore spike, suggesting that a bolide impact was the cause. Eastern North American dinosaurian diversity reached a stable maximum less than 100,000 years after the boundary, marking the establishment of dinosaur-dominated communities that prevailed for the next 135 million years.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Royal Ontario Museum, Dept Paleobiol, Toronto, ON M5S 2C6, Canada; Univ Vienna, Inst Geochem, A-1090 Vienna, Austria; Osservatorio Geol Coldigiocom, I-62020 Frontale Di Apiro, Italy; Univ Alaska Fairbanks, Dept Geol & Geophys, Fairbanks, AK 99775 USA; Reading Publ Museum, Reading, PA 19611 USA	Columbia University; Rutgers State University New Brunswick; Royal Ontario Museum; University of Vienna; University of Alaska System; University of Alaska Fairbanks	Olsen, PE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.							BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; BICE DM, 1992, SCIENCE, V255, P443, DOI 10.1126/science.255.5043.443; CHARIG AJ, 1984, S ZOOL SOC LONDON, V52, P597; COHEN AS, 1993, PALEOBIOLOGY, V19, P433; Fowell S.J., 1994, GEOLOGICAL SOC AM SP, V288, P197, DOI [DOI 10.1130/SPE288-P197, 10.1130/SPE288-p197]; FRASER NC, 1994, IN THE SHADOW OF THE DINOSAURS, P398; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; Mossman DJ, 1998, CAN J EARTH SCI, V35, P101, DOI [10.1139/cjes-35-2-101, 10.1139/e97-101]; Olsen P.E., 1986, P61; Olsen P. E., 1996, MUSEUM NO ARIZONA B, V60, P11; Olsen PE, 1997, ANNU REV EARTH PL SC, V25, P337, DOI 10.1146/annurev.earth.25.1.337; Olsen PE, 1996, PALAEOGEOGR PALAEOCL, V122, P1, DOI 10.1016/0031-0182(95)00171-9; OLSEN PE, 1987, SCIENCE, V237, P1025, DOI 10.1126/science.3616622; OLSEN PE, 1977, SCIENCE, V197, P983, DOI 10.1126/science.197.4307.983; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; SMITH RC, 1988, PA GEOL, P8; Spray JG, 1998, NATURE, V392, P171, DOI 10.1038/32397; Sues HD, 2000, J VERTEBR PALEONTOL, V20, P275, DOI 10.1671/0272-4634(2000)020[0275:COOHFA]2.0.CO;2; SZAJNA MJ, GREAT RIFT VALLEYS P, V2; TSHUDY RH, 1984, SCIENCE, V225, P1090; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	25	276	295	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1305	1307		10.1126/science.1065522	http://dx.doi.org/10.1126/science.1065522			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016313	Green Submitted			2022-12-24	WOS:000175713000051
J	Wilkins, MR; Aldashev, A; Morrell, NW				Wilkins, MR; Aldashev, A; Morrell, NW			Nitric oxide, phosphodiesterase inhibition, and adaption to hypoxic conditions	LANCET			English	Editorial Material							PULMONARY-HYPERTENSION; HIGH-ALTITUDE; CIRCULATION; ADAPTATION; SILDENAFIL; SYNTHASE; CATTLE; RATS; YAK		Hammersmith Hosp, Imperial Coll Sch Med, Clin Pharmacol Sect, London W12 0NN, England	Imperial College London	Wilkins, MR (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Clin Pharmacol Sect, London W12 0NN, England.	m.wilkins@ic.ac.uk		ALDASHEV, Almaz/0000-0002-4793-2206; Morrell, Nicholas/0000-0001-5700-9792				ANAND IS, 1986, THORAX, V41, P696, DOI 10.1136/thx.41.9.696; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Budts W, 2000, CIRCULATION, V102, P2880; DURMOWICZ AG, 1993, J APPL PHYSIOL, V74, P2276, DOI 10.1152/jappl.1993.74.5.2276; Fagan KA, 2000, PHYSIOL RES, V49, P539; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hanasato N, 1999, AM J PHYSIOL-LUNG C, V277, pL225, DOI 10.1152/ajplung.1999.277.2.L225; HEATH D, 1989, THORAX, V44, P981, DOI 10.1136/thx.44.12.981; MacLean MR, 1997, J PHARMACOL EXP THER, V283, P619; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; STAMLER JS, 1994, CIRCULATION, V89, P2035, DOI 10.1161/01.CIR.89.5.2035; Steudel W, 1999, ANESTHESIOLOGY, V91, P1090, DOI 10.1097/00000542-199910000-00030; WEIR EK, 1974, CARDIOVASC RES, V8, P745, DOI 10.1093/cvr/8.6.745; WEST JB, 1995, EUR RESPIR J, V8, P523; Wilkens H, 2001, CIRCULATION, V104, P1218, DOI 10.1161/hc3601.096826; YUAN XJ, 1990, AM J PHYSIOL, V259, pH281, DOI 10.1152/ajpheart.1990.259.2.H281; Zhao L, 2001, CIRCULATION, V103, P442; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	19	20	20	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2002	359	9317					1539	1540		10.1016/S0140-6736(02)08528-8	http://dx.doi.org/10.1016/S0140-6736(02)08528-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047961				2022-12-24	WOS:000175460700005
J	Oster, G				Oster, G			Brownian ratchets: Darwin's motors	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Oster, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							Boyer PD, 1998, ANGEW CHEM INT EDIT, V37, P2297, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2296::AID-ANIE2296>3.0.CO;2-W; Huxley AF, 1998, CURR BIOL, V8, pR485, DOI 10.1016/S0960-9822(98)70313-6; Simmons RM, 2000, PHILOS T ROY SOC B, V355, P415, DOI 10.1098/rstb.2000.0582; WALKER J, 2000, BIOCHIM BIOPHYS ACTA, V1458, P231	4	61	64	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2002	417	6884					25	25		10.1038/417025a	http://dx.doi.org/10.1038/417025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986647	Bronze			2022-12-24	WOS:000175307200021
J	Feng, LX; Chen, YL; Dettin, L; Pera, RAR; Herr, JC; Goldberg, E; Dym, M				Feng, LX; Chen, YL; Dettin, L; Pera, RAR; Herr, JC; Goldberg, E; Dym, M			Generation and in vitro differentiation of a spermatogonial cell line	SCIENCE			English	Article							PRIMORDIAL GERM-CELLS; KIT RECEPTOR; STEM-CELLS; C-KIT; MOUSE; PROLIFERATION; TELOMERASE; EXPRESSION; GENE; RAT	Spermatogenesis is the process by which spermatogonial stem cells divide and differentiate to produce sperm. In vitro sperm production has been difficult to achieve because of the lack of culture system to maintain viable spermatogonia for long periods of time. Here we report the in vitro generation of spermatocytes and spermatids from telomerase-immortalized mouse type A spermatogonial cells in the presence of stem cell factor. This differentiation can occur in the absence of supportive cells. The immortalized spermatogonial cell line may serve as powerful tool in elucidating the molecular mechanisms of spermatogenesis. Furthermore, through genomic modi cation and transplantation techniques, this male germ cell line may be used to generate transgenic mice and to develop germ cell gene therapy.	Georgetown Univ, Med Ctr, Dept Cell Biol, Washington, DC 20007 USA; Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Georgetown University; University of California System; University of California San Francisco; University of Virginia; Northwestern University	Feng, LX (corresponding author), Georgetown Univ, Med Ctr, Dept Cell Biol, Washington, DC 20007 USA.			Reijo Pera, Renee/0000-0002-6487-1329	NICHD NIH HHS [HD-36483] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036483] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; DONOVAN PJ, 1986, CELL, V44, P831, DOI 10.1016/0092-8674(86)90005-X; DYM M, 1995, BIOL REPROD, V52, P8, DOI 10.1095/biolreprod52.1.8; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LIANG ZG, 1986, J EXP ZOOL, V240, P377, DOI 10.1002/jez.1402400312; MALI P, 1989, REPROD FERT DEVELOP, V1, P369, DOI 10.1071/RD9890369; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Meng XJ, 2001, CANCER RES, V61, P3267; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Ohta H, 2000, DEVELOPMENT, V127, P2125; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Ravindranath N, 1997, ENDOCRINOLOGY, V138, P4026, DOI 10.1210/en.138.9.4026; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Wolkowicz MJ, 1996, BIOL REPROD, V55, P923, DOI 10.1095/biolreprod55.4.923; Yeager TR, 1999, CURR OPIN BIOTECH, V10, P465, DOI 10.1016/S0958-1669(99)00011-7	28	186	227	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2002	297	5580					392	395		10.1126/science.1073162	http://dx.doi.org/10.1126/science.1073162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12077424				2022-12-24	WOS:000176892600049
J	Myllykallio, H; Lipowski, G; Leduc, D; Filee, J; Forterre, P; Liebl, U				Myllykallio, H; Lipowski, G; Leduc, D; Filee, J; Forterre, P; Liebl, U			An alternative flavin-dependent mechanism for thymidylate synthesis	SCIENCE			English	Article							GENERATION; SYNTHASE; DNA	Although deoxythymidylate cannot be provided directly by ribonucleotide reductase, the gene encoding thymidylate synthase ThyA is absent from the genomes of a large number of nonsymbiotic microbes. We show that ThyX (Thy1) proteins of previously unknown function form a large and distinct class of thymidylate synthases. ThyX has a wide but sporadic phylogenetic distribution, almost exclusively limited to microbial genomes lacking thyA. ThyX and ThyA use different reductive mechanisms, because ThyX activity is dependent on reduced flavin nucleotides. Our findings reveal complexity in the evolution of thymidine in present-day DNA. Because ThyX proteins are found in many pathogenic microbes, they present a previously uncharacterized target for antimicrobial compounds.	Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR 8621, Orsay, France; Ecole Polytech, ENSTA, Lab Opt & Biosci, INSERM,U451, Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris	Myllykallio, H (corresponding author), Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR 8621, Orsay, France.		Myllykallio, Hannu/Y-5462-2019; Filée, Jonathan/AAC-9035-2021	Myllykallio, Hannu/0000-0002-0541-1197; LIEBL, Ursula/0000-0003-0869-4388				Adachi J, 1996, MOL PHYLOGENET EVOL, V6, P72, DOI 10.1006/mpev.1996.0059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurora R, 1998, P NATL ACAD SCI USA, V95, P2818, DOI 10.1073/pnas.95.6.2818; Capo-chichi CD, 2000, AM J CLIN NUTR, V71, P978; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; DELK AS, 1980, J BIOL CHEM, V255, P4837; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; MYLLYKALLIO H, UNPUB; Neuhard J., 1996, ESCHERICHIA COLI SAL, V2nd, P580; Poole A, 2001, NAT REV MOL CELL BIO, V2, P147, DOI 10.1038/35052091; ROBERTS D, 1966, BIOCHEMISTRY-US, V5, P3546, DOI 10.1021/bi00875a022; WHITE RH, 1991, J BACTERIOL, V173, P1987, DOI 10.1128/jb.173.6.1987-1991.1991	16	211	212	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					105	107		10.1126/science.1072113	http://dx.doi.org/10.1126/science.1072113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12029065				2022-12-24	WOS:000176711000044
J	Sun, ZW; Allis, CD				Sun, ZW; Allis, CD			Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast	NATURE			English	Article							N-END RULE; SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; RAD6 PROTEIN; ACETYLATION; NUCLEOSOME; PARTICLE; DOMAINS; CODE	In eukaryotes, the DNA of the genome is packaged with histone proteins to form nucleosomal filaments, which are, in turn, folded into a series of less well understood chromatin structures(1). Post-translational modifications of histone tail domains modulate chromatin structure and gene expression(2-4). Of these, histone ubiquitination is poorly understood. Here we show that the ubiquitin-conjugating enzyme Rad6 (Ubc2) mediates methylation of histone H3 at lysine 4 (Lys 4) through ubiquitination of H2B at Lys 123 in yeast (Saccharomyces cerevisiae). Moreover, H3 (Lys 4) methylation is abolished in the H2B-K123R mutant, whereas H3-K4R retains H2B (Lys 123) ubiquitination. These data indicate a unidirectional regulatory pathway in which ubiquitination of H2B (Lys 123) is a prerequisite for H3 (Lys 4) methylation. We also show that an H2B-K123R mutation perturbs silencing at the telomere, providing functional links between Rad6-mediated H2B (Lys 123) ubiquitination, Set1-mediated H3 (Lys 4) methylation, and transcriptional silencing. Thus, these data reveal a pathway leading to gene regulation through concerted histone modifications on distinct histone tails. We refer to this as 'trans-tail' regulation of histone modification, a stated prediction of the histone code hypothesis(5,6)	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Allis, CD (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.							Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Huang HH, 1997, MOL CELL BIOL, V17, P6693, DOI 10.1128/MCB.17.11.6693; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; MADURA K, 1993, J BIOL CHEM, V268, P12046; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 1999, GENETICS, V152, P921; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner SD, 2002, MOL CELL BIOL, V22, P4011, DOI 10.1128/MCB.22.12.4011-4019.2002; Urnov FD, 2001, J MAMMARY GLAND BIOL, V6, P153, DOI 10.1023/A:1011304606604; VANHOLDE KE, 1989, CHROMATIN, P111; Varshavsky A, 1995, COLD SPRING HARB SYM, V60, P461, DOI 10.1101/SQB.1995.060.01.051; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	30	804	828	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					104	108		10.1038/nature00883	http://dx.doi.org/10.1038/nature00883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12077605				2022-12-24	WOS:000176599200048
J	Selan, L; Passariello, C; Rizzo, L; Varesi, P; Speziale, F; Renzini, G; Thaller, MC; Fiorani, P; Rossolini, GM				Selan, L; Passariello, C; Rizzo, L; Varesi, P; Speziale, F; Renzini, G; Thaller, MC; Fiorani, P; Rossolini, GM			Diagnosis of vascular graft infections with antibodies against staphylococcal slime antigens	LANCET			English	Article							EPIDERMIDIS	Late-onset Infections of synthetic vascular grafts (LO-SVGIs) are generally caused by staphylococcl that produce a slime polysaccharide and grow as a biofilm on the graft surface. We developed an ELISA to detect serum antibodies against staphylococcal slime polysaccharide antigens (SSPA). Patients with an ongoing staphylococcal LO-SVGI had greater titres of IgM antibodies against SSPA than did patients In other groups. Antibody titres of 0.40 ELISA units (EU) or more, or 0.35 EU or more detected 97% and 100% of staphylococcal LO-SVGIs, respectively, 0% and 2% titre/unit false-positive results. Our findings suggest that such an ELISA represents a sensitive, specific, and non-invasive diagnostic test for staphylococcal LO-SVGIs.	Univ Siena, Dipartimento Biol Mol, Sez Microbiol, Siena, Italy; Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Rome, Italy; Univ Roma La Sapienza, Dipartimento Chirurg Vasc, Rome, Italy	University of Siena; University of Rome Tor Vergata; Sapienza University Rome; Sapienza University Rome	Rossolini, GM (corresponding author), Univ Siena, Dipartimento Biol Mol, Sez Microbiol, Siena, Italy.			THALLER, MARIA CRISTINA/0000-0003-2788-3563; ROSSOLINI, Gian Maria/0000-0002-9386-0434; SPEZIALE, Francesco/0000-0001-8106-2083				CALLIGARO KD, 1991, SURGERY, V110, P805; Henke PK, 1998, AM SURGEON, V64, P39; HUSSAIN M, 1991, J MED MICROBIOL, V34, P143, DOI 10.1099/00222615-34-3-143; Karamanos NK, 1997, ARCH BIOCHEM BIOPHYS, V342, P389, DOI 10.1006/abbi.1997.0107; Lambert PA, 2000, FEMS IMMUNOL MED MIC, V29, P195, DOI 10.1111/j.1574-695X.2000.tb01523.x	5	25	31	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 22	2002	359	9324					2166	2168		10.1016/S0140-6736(02)09086-4	http://dx.doi.org/10.1016/S0140-6736(02)09086-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566RJ	12090985				2022-12-24	WOS:000176441800014
J	Dominguez, P; Jacobson, AG; Jefferies, RPS				Dominguez, P; Jacobson, AG; Jefferies, RPS			Paired gill slits in a fossil with a calcite skeleton	NATURE			English	Article							ICHNOLOGICAL EVIDENCE; BEHAVIOR; ECHINODERMS; MITRATE	The chordates, hemichordates (such as acorn worms) and echinoderms (such as starfish) comprise the group Deuterostomia, well established as monophyletic(1,2). Among extant deuterostomes, a skeleton in which each plate has the crystallographic structure of a single crystal of calcite is characteristic of echinoderms and is always associated with radial symmetry and never with gill slits. Among fossils, however, such a skeleton sometimes occurs without radial symmetry. This is true of Jaekelocarpus oklahomensis, from the Upper Carboniferous of Oklahoma, USA, which, being externally almost bilaterally symmetrical, is traditionally placed in the group Mitrata (Ordovician to Carboniferous periods, 530-280 million years ago), by contrast with the bizarrely asymmetrical Cornuta (Cambrian to Ordovician periods, 540 to 440 million years ago). Using computer X-ray microtomography, we describe the anatomy of Jaekelocarpus in greater detail than formerly possible, reveal evidence of paired gill slits internally and interpret its functional anatomy. On this basis we suggest its phylogenetic position within the deuterostomes.	Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Texas, MCDB, Patterson Labs, Austin, TX 78712 USA; Univ Complutense Madrid, Dept Palaeontol, E-28040 Madrid, Spain	Natural History Museum London; University of Texas System; University of Texas Austin; Complutense University of Madrid	Jefferies, RPS (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.		Domínguez Alonso, Patricio/C-2679-2013					Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; CRIPPS AP, 1989, ZOOL J LINN SOC-LOND, V96, P49, DOI 10.1111/j.1096-3642.1989.tb01821.x; David B, 2000, PALEOBIOLOGY, V26, P529, DOI 10.1666/0094-8373(2000)026<0529:AHEAAF>2.0.CO;2; Jefferies R.P.S., 1998, Integrative Biology, V1, P115, DOI 10.1002/(SICI)1520-6602(1998)1:4<115::AID-INBI2>3.0.CO;2-0; JEFFERIES R. P. S., 1967, SYMP ZOOL SOC LONDON, V20, P163; Jefferies RPS, 1997, LETHAIA, V30, P1; Jefferies RPS, 2001, LETHAIA, V34, P262, DOI 10.1080/002411601753292999; JEFFERIES RPS, 1986, ZOOL J LINN SOC; JEFFERIES RPS, 2000, MAJOR EVENTS VERTEBR, P20; JORGENSEN CB, 1989, COMP BIOCHEM PHYS A, V94, P383, DOI 10.1016/0300-9629(89)90562-8; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; KOLATA DR, 1991, J PALEONTOL, V65, P844, DOI 10.1017/S0022336000037811; KOTT P, 1990, Memoirs of the Queensland Museum, V29, P1; KOTT P, 1985, MEMOIRS QUEENSLAND M, V20, P1; Kott Patricia, 1992, Memoirs of the Queensland Museum, V32, P375; Lefebvre B, 2001, LETHAIA, V34, P260; MARTINUCCI GB, 1991, SELECTED S MONOGRAPH, P123; PARSLEY RL, 1988, ECHINODERM PHYLOGENY, P347; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; PHILIP GM, 1979, BIOL REV, V54, P439, DOI 10.1111/j.1469-185X.1979.tb00845.x; Ruta M, 1999, EVOL DEV, V1, P123, DOI 10.1046/j.1525-142x.1999.99008.x; Sutcliffe OE, 2000, LETHAIA, V33, P1; UBAGHS G, 1968, TREATISE INVERTEBR S, pS297; VANGEET, 2000, SEDIM GEOL, V132, P1	24	67	69	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					841	U6		10.1038/nature00805	http://dx.doi.org/10.1038/nature00805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075349				2022-12-24	WOS:000176285600044
J	Senior, K				Senior, K			Collated evidence confirms the value of atrial fibrillation prevention	LANCET			English	Article																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 15	2002	359	9323					2093	2093		10.1016/S0140-6736(02)08960-2	http://dx.doi.org/10.1016/S0140-6736(02)08960-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562JX	12086771				2022-12-24	WOS:000176194600019
J	Yao, LN; Arolfo, MP; Dohrman, DP; Jiang, Z; Fan, PD; Fuchs, S; Janak, PH; Gordon, AS; Diamond, I				Yao, LN; Arolfo, MP; Dohrman, DP; Jiang, Z; Fan, PD; Fuchs, S; Janak, PH; Gordon, AS; Diamond, I			beta gamma dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption	CELL			English	Article							DEPENDENT PROTEIN-KINASE; ADENYLYL-CYCLASE; NUCLEUS-ACCUMBENS; CAMP LEVELS; ACTIVATION; EXPRESSION; RAT; HIPPOCAMPUS; RELEASE; CELLS	Dopamine release is activated by ethanol and addicting drugs, but molecular mechanisms linking dopaminergic signaling to neuronal responses and drinking behavior are poorly understood. We report that dopamine-D2 receptors induce PKA Calpha translocation and increase CRE-regulated gene expression. Ethanol also activates PKA signaling. Subthreshold concentrations of the D2 agonist NPA and ethanol, without effect alone, together cause synergistic PKA translocation and CRE-mediated gene transcription. D2 or adenosine A2 receptor blockade, pertussis toxin, Rp-cAMPS, or overexpression of dominant-negative peptides that sequester betagamma dimers; prevent synergy. Importantly, overexpression of a betagamma inhibitor peptide in the nucleus accumbens strikingly reduces sustained alcohol consumption. We propose that synergy of D2 and A2 confers ethanol hypersensitivity and that betagamma dimers are required for voluntary drinking.	Univ Calif San Francisco, Ernest Gallo Clin, San Francisco, CA 94110 USA; Univ Calif San Francisco, Res Ctr, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94110 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA; Weizmann Inst Sci, Dept Immunol, Rehovot, Israel	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Weizmann Institute of Science	Diamond, I (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, San Francisco, CA 94110 USA.	diamond@itsa.ucsf.edu		Janak, Patricia/0000-0002-3333-9049	NIAAA NIH HHS [AA10039, AA10030] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010030, R01AA010039, R37AA010030] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Asai K, 1998, ALCOHOL CLIN EXP RES, V22, P163, DOI 10.1111/j.1530-0277.1998.tb03633.x; Asher O, 2002, J PHARMACOL EXP THER, V301, P66, DOI 10.1124/jpet.301.1.66; Baker LP, 1999, J NEUROSCI, V19, P180, DOI 10.1523/JNEUROSCI.19-01-00180.1999; Boyadjieva N, 1999, BRAIN RES, V824, P112, DOI 10.1016/S0006-8993(99)01170-1; Chakrabarti S, 1998, MOL PHARMACOL, V54, P655; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Constantinescu A, 1999, J BIOL CHEM, V274, P26985, DOI 10.1074/jbc.274.38.26985; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Dar MS, 2001, BRAIN RES BULL, V55, P513, DOI 10.1016/S0361-9230(01)00552-4; Dohrman DP, 2002, ALCOHOL CLIN EXP RES, V26, P407, DOI 10.1111/j.1530-0277.2002.tb02553.x; Dohrman DP, 1996, P NATL ACAD SCI USA, V93, P10217, DOI 10.1073/pnas.93.19.10217; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; GOLDSMITH SK, 1994, HIPPOCAMPUS, V4, P354, DOI 10.1002/hipo.450040318; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; Gordon AS, 2001, MOL PHARMACOL, V59, P153, DOI 10.1124/mol.59.1.153; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hodge CW, 1997, ALCOHOL CLIN EXP RES, V21, P1083, DOI 10.1111/j.1530-0277.1997.tb04257.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Klinker JF, 1996, NEUROSCI LETT, V213, P25, DOI 10.1016/0304-3940(96)12816-0; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lissin DV, 1999, J NEUROSCI, V19, P1263; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; O'Kane EM, 1998, EUR J PHARMACOL, V362, P17, DOI 10.1016/S0014-2999(98)00730-4; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; Pandey SC, 2001, J PHARMACOL EXP THER, V296, P857; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; Risinger FO, 2000, PSYCHOPHARMACOLOGY, V152, P343, DOI 10.1007/s002130000548; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; SAPRU MK, 1994, J PHARMACOL EXP THER, V271, P542; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Swanson TH, 1995, J COMP NEUROL, V363, P517, DOI 10.1002/cne.903630402; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Thibault C, 2000, MOL PHARMACOL, V58, P1593, DOI 10.1124/mol.58.6.1593; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; Wand G, 2001, J NEUROSCI, V21, P5297, DOI 10.1523/JNEUROSCI.21-14-05297.2001; Waszczak BL, 1998, P NATL ACAD SCI USA, V95, P11440, DOI 10.1073/pnas.95.19.11440; Watts VJ, 1996, MOL PHARMACOL, V50, P966; Watts VJ, 1997, MOL PHARMACOL, V52, P181, DOI 10.1124/mol.52.2.181; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Weng GZ, 1996, J BIOL CHEM, V271, P26445, DOI 10.1074/jbc.271.43.26445; Wise A, 1999, BIOCHEMISTRY-US, V38, P2272, DOI 10.1021/bi982054f; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Yan SZ, 1998, MOL PHARMACOL, V53, P182, DOI 10.1124/mol.53.2.182; Yoshimura M, 1999, ALCOHOL CLIN EXP RES, V23, P1457, DOI 10.1097/00000374-199909000-00006	58	107	110	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 14	2002	109	6					733	743		10.1016/S0092-8674(02)00763-8	http://dx.doi.org/10.1016/S0092-8674(02)00763-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086672	Bronze			2022-12-24	WOS:000176265600004
J	Crittenden, SL; Bernstein, DS; Bachorik, JL; Thompson, BE; Gallegos, M; Petcherski, AG; Moulder, G; Barstead, R; Wickens, M; Kimble, J				Crittenden, SL; Bernstein, DS; Bachorik, JL; Thompson, BE; Gallegos, M; Petcherski, AG; Moulder, G; Barstead, R; Wickens, M; Kimble, J			A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegans	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; IN-VIVO; GLD-1; PUMILIO; PATHWAY; GLP-1; NANOS; ROLES; LINE; FBF	Germline stem cells are defined by their unique ability to generate more of themselves as well as differentiated gametes(1). The molecular mechanisms controlling the decision between self-renewal and differentiation are central unsolved problems in developmental biology with potentially broad medical implications. In Caenorhabditis elegans, germline stem cells are controlled by the somatic distal tip cell(2,3). FBF-1 and FBF-2, two nearly identical proteins, which together are called FBF ('fem-3 mRNA binding factor'), were originally discovered as regulators of germline sex determination(4). Here we report that FBF also controls germline stem cells: in an fbf-1 fbf-2 double mutant, germline proliferation is initially normal, but stem cells are not maintained. We suggest that FBF controls germline stem cells, at least in part, by repressing gld-1, which itself promotes commitment to the meiotic cell cycle(5,6). FBF belongs to the PUF family ('Pumilio and FBF') of RNA-binding proteins(7). Pumilio controls germline stem cells in Drosophila females(8,9),and, in lower eukaryotes, PUF proteins promote continued mitoses(10,11). We suggest that regulation by PUF proteins may be an ancient and widespread mechanism for control of stem cells.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA; Oklahoma Med Res Fdn, Program Mol Biol, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oklahoma Medical Research Foundation	Kimble, J (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.			Thompson, Beth/0000-0002-5358-0796; Bernstein, David/0000-0002-4564-8578				Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Forbes A, 1998, DEVELOPMENT, V125, P679; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lin HF, 1997, DEVELOPMENT, V124, P2463; SCHEDL T, 1997, C ELEGANS, V2, P241; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Souza GM, 1999, DEVELOPMENT, V126, P3263; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Xu L, 2001, GENETICS, V159, P1007; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	26	322	334	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					660	663		10.1038/nature754	http://dx.doi.org/10.1038/nature754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050669				2022-12-24	WOS:000176001200051
J	Michelow, IC; Wendel, GD; Norgard, MV; Zeray, F; Leos, NK; Alsaadi, R; Sanchez, PJ				Michelow, IC; Wendel, GD; Norgard, MV; Zeray, F; Leos, NK; Alsaadi, R; Sanchez, PJ			Central nervous system infection in congenital syphilis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Joint Meeting of the Pediatric-Academic-Societies/American-Academy-of-Pediatrics	MAY 12-16, 2000	BOSTON, MA	Pediat Acad Soc, Amer Acad Pediat			BENZATHINE PENICILLIN-G; TREPONEMA-PALLIDUM ANTIGENS; POLYMERASE-CHAIN-REACTION; CEREBROSPINAL-FLUID; AMNIOTIC-FLUID; DIAGNOSIS; IGM; ANTIBODIES; FETAL; DNA	Background: Identification of infants with Treponema pallidum infection of the central nervous system remains challenging. Methods: We used rabbit-infectivity testing of the cerebrospinal fluid to detect T. pallidum infection of the central nervous system in infants born to mothers with syphilis. The results were compared with those of clinical, radiographic, and conventional laboratory evaluations; IgM immunoblotting of serum and cerebrospinal fluid; polymerase-chain-reaction (PCR) assay testing of serum or blood and cerebrospinal fluid; and rabbit-infectivity testing of serum or blood. Results: Spirochetes were detected in the cerebrospinal fluid of 19 of 148 infants by rabbit-infectivity testing. Exposure of the infant to antibiotics before cerebrospinal fluid was obtained for rabbit-infectivity testing was associated with a negative test result (P=0.001). Spirochetes were detected in the cerebrospinal fluid in 17 of 76 infants (22 percent) who had no prior antibiotic exposure. These 17 infants included 41 percent (16 of 39) of those with some abnormality on clinical, laboratory, or radiographic evaluation; 60 percent (15 of 25) of those with abnormal findings on physical examination that were consistent with congenital syphilis; and 41 percent (17 of 41) of those with a positive result on IgM immunoblotting or PCR testing of serum, blood, or cerebrospinal fluid, or a positive result on rabbit-infectivity testing of serum or blood. Only one infant who had normal findings on clinical evaluation had a positive cerebrospinal fluid rabbit-infectivity test. Overall, central nervous system infection was best predicted by IgM immunoblotting of serum or PCR assay of serum or blood. Conclusions: Most infants with T. pallidum infection of the central nervous system can be identified by physical examination, conventional laboratory tests, and radiographic studies. However, the identification of all such infants requires the use of additional tests, including IgM immunoblotting and PCR assay.	Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sanchez, PJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	pablo.sanchez@utsouthwestern.edu	Michelow, Ian C./AAH-2373-2020	Michelow, Ian C./0000-0002-8399-480X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034932] Funding Source: NIH RePORTER; NIAID NIH HHS [1R29 AI 34932-01] Funding Source: Medline; PHS HHS [C1000 689] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed A, 1996, PEDIATR INFECT DIS J, V15, P298, DOI 10.1097/00006454-199604000-00004; BECKSAGUE C, 1987, PEDIATR INFECT DIS J, V6, P1061, DOI 10.1097/00006454-198706110-00014; Beeram MR, 1996, J PEDIATR-US, V128, P125, DOI 10.1016/S0022-3476(96)70441-9; Benzick AE, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e4; BROMBERG K, 1993, J INFECT DIS, V168, P238, DOI 10.1093/infdis/168.1.238; BURSTAIN JM, 1991, J CLIN MICROBIOL, V29, P62, DOI 10.1128/JCM.29.1.62-69.1991; DOBSON SRM, 1988, J INFECT DIS, V157, P903, DOI 10.1093/infdis/157.5.903; Gomez E, 1998, PEDIATR INFECT DIS J, V17, P782, DOI 10.1097/00006454-199809000-00006; GRIMPREL E, 1991, J CLIN MICROBIOL, V29, P1711, DOI 10.1128/JCM.29.8.1711-1718.1991; Hall C, 1991, PRACTICAL STAT MED R, P404; HAY PE, 1990, GENITOURIN MED, V66, P428; HAY PE, 1990, FEMS MICROBIOL LETT, V68, P233, DOI 10.1111/j.1574-6968.1990.tb13943.x; INGALL D, 2000, INFECT DIS FETUS NEW, P643; KAPLAN JM, 1973, J PEDIATR-US, V82, P1069, DOI 10.1016/S0022-3476(73)80450-0; LEWIS LL, 1992, INFECT DIS CLIN N AM, V6, P31; LEWIS LL, 1990, J CLIN MICROBIOL, V28, P296, DOI 10.1128/JCM.28.2.296-302.1990; LUKEHART SA, 1988, ANN INTERN MED, V109, P855, DOI 10.7326/0003-4819-109-11-855; Magnuson Harold J., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V32, P1; MEYER MP, 1994, J CLIN MICROBIOL, V32, P629, DOI 10.1128/JCM.32.3.629-633.1994; MULLER F, 1984, J NEUROIMMUNOL, V7, P43, DOI 10.1016/S0165-5728(84)80005-3; NOORDHOEK GT, 1991, J CLIN MICROBIOL, V29, P1976, DOI 10.1128/JCM.29.9.1976-1984.1991; PARYANI SG, 1994, J PEDIATR-US, V125, P471, DOI 10.1016/S0022-3476(05)83300-1; PICKERING LK, 2000, 2000 RED BOOK REPORT, P547; PLATOU RV, 1949, ADV PEDIATR, V4, P39; Radcliffe M, 1997, S AFR MED J, V87, P62; SANCHEZ PJ, 1993, J INFECT DIS, V167, P148, DOI 10.1093/infdis/167.1.148; SANCHEZ PJ, 1992, AM J DIS CHILD, V146, P1171, DOI 10.1001/archpedi.1992.02160220057022; SANCHEZ PJ, 1989, J INFECT DIS, V159, P508, DOI 10.1093/infdis/159.3.508; SCHMITZ JL, 1994, CLIN DIAGN LAB IMMUN, V1, P32, DOI 10.1128/CDLI.1.1.32-37.1994; SPEER ME, 1977, J PEDIATR-US, V91, P996, DOI 10.1016/S0022-3476(77)80914-1; STOLL BJ, 1993, J INFECT DIS, V167, P1093, DOI 10.1093/infdis/167.5.1093; THORLEY JD, 1975, LANCET, V1, P651; TURNER TB, 1969, BRIT J VENER DIS, V45, P183; WENDEL GD, 1991, OBSTET GYNECOL, V78, P890; WICHER K, 1992, J CLIN MICROBIOL, V30, P497, DOI 10.1128/JCM.30.2.497-500.1992; WOOLF A, 1980, N C MED J, V41, P443; 1998, MMWR MORB MORTAL WKL, V47, P41	37	49	66	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2002	346	23					1792	1798		10.1056/NEJMoa012684	http://dx.doi.org/10.1056/NEJMoa012684			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559EK	12050339				2022-12-24	WOS:000176012500005
J	Gregson, S; Nyamukapa, CA; Garnett, GP; Mason, PR; Zhuwau, T; Carael, M; Chandiwana, SK; Anderson, RM				Gregson, S; Nyamukapa, CA; Garnett, GP; Mason, PR; Zhuwau, T; Carael, M; Chandiwana, SK; Anderson, RM			Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe	LANCET			English	Article							CONCURRENT PARTNERSHIPS; DEMOGRAPHIC-IMPACT; CONTACT PATTERNS; SPREAD; DYNAMICS; TRANSMISSION; POPULATION; EPIDEMIC; BEHAVIOR; HIV/AIDS	Background HIV-1 prevalence typically rises more rapidly at young ages in women than in men in sub-Saharan Africa. Greater susceptibility to infection on exposure in women is believed to be a contributory factor as is greater exposure to previously infected sexual partners of the opposite sex. We investigated the latter hypothesis using data from a field study in rural Manicaland, Zimbabwe. Methods Quantitative data on onset and degree of sexual activity, numbers of partners, concurrent partnerships, condom use, and partner characteristics were used in conjunction with epidemiological data on age and sex specific prevalence of HIV infection to do statistical analyses of association between key variables. Mathematical models and qualitative data were used to aid analysis and interpretation. Findings Older age of sexual partner was associated with increased risk of HIV-1 infection in men (odds ratio 1.13 [95% CI 1.02-1.25]) and women (1.04 [1.01-1.07]). Young women form partnerships with men 5-10 years older than themselves, whereas young men have relationships with women of a similar age or slightly younger. Greater number of lifetime partners is also associated with increased risk of HIV (1.03 [1.00-1.05]). Young men report more partners than do women but infrequent coital acts and greater use of condoms. These behaviour patterns are underpinned by cultural factors including the expectation that women should marry earlier than men. A strong gender effect remains after factors that affect exposure to infected partners are controlled for (6.04 [1.49-24.47]). Interpretation The substantial age difference between female and male sexual partners in Manicaland is the major behavioural determinant of the more rapid rise in HIV prevalence in young women than in men. Theoretical studies have suggested that this difference is an important determinant of observed epidemiological patterns but the study reported in this paper provides clear empirical evidence of association.	Univ London, Imperial Coll Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Biomed Res & Training Inst, Harare, Zimbabwe; UNAIDS, Geneva, Switzerland	Imperial College London; University of London; Biomedical Research Training Institute; UNAIDS	Gregson, S (corresponding author), Univ London, Imperial Coll Fac Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.		Garnett, Geoffrey P/A-9312-2008	Gregson, Simon/0000-0003-2707-0714; Anderson, Roy/0000-0002-9528-3175; Nyamukapa, Constance/0000-0001-6779-4069				ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; Aral SO, 1996, INT J STD AIDS, V7, P30, DOI 10.1258/0956462961917753; Bourdillon M.F.C., 1993, ARE ANCESTORS CHANGI; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Garnett G, 2000, MATH POPUL STUD, V8, P251, DOI DOI 10.1080/08898480009525485; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Garnett GP, 1999, PHILOS T R SOC B, V354, P787, DOI 10.1098/rstb.1999.0431; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gregson S, 1997, AIDS, V11, P1269, DOI 10.1097/00002030-199710000-00011; Gregson S, 1998, SOC SCI MED, V46, P321, DOI 10.1016/S0277-9536(97)00165-2; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Gregson S, 2000, AIDS, V14, pS85; GREGSON S, IN PRESS SEX TRANSM; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Mbizvo M. T., 1994, Central African Journal of Medicine, V40, P294; MORGAN DL, 1988, FOCUS GROUPS QUANTIT; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; NUNN AJ, 1994, AIDS, V8, P81, DOI 10.1097/00002030-199401000-00012; *PANOS I, 1989, WORLD AIDS, V6, P10; PETERMAN TA, 1988, JAMA-J AM MED ASSOC, V259, P55, DOI 10.1001/jama.259.1.55; Ray CS, 1997, TROP MED INT HEALTH, V2, P83, DOI 10.1046/j.1365-3156.1997.d01-125.x; Ray S., 1996, REPROD HEALTH MATTER, V4, P34, DOI [10.1016/S0968-8080(96)90004-X, DOI 10.1016/S0968-8080(96)90004-X]; RUNGANGA A, 1992, SOC SCI MED, V35, P1037, DOI 10.1016/0277-9536(92)90243-J; *US BUR CENS, 1993, CENS POP; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; WAWER MJ, 1991, BRIT MED J, V303, P1303, DOI 10.1136/bmj.303.6813.1303	28	398	404	1	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 1	2002	359	9321					1896	1903		10.1016/S0140-6736(02)08780-9	http://dx.doi.org/10.1016/S0140-6736(02)08780-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057552				2022-12-24	WOS:000175975700009
J	Ge, K; Guermah, M; Yuan, CX; Ito, M; Wallberg, AE; Spiegelman, BM; Roeder, RG				Ge, K; Guermah, M; Yuan, CX; Ito, M; Wallberg, AE; Spiegelman, BM; Roeder, RG			Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA; NUCLEAR RECEPTORS; COMPLEX; PROTEIN; MEDIATOR; DIFFERENTIATION; COMPONENT; TRAP/SMCC; REGULATOR	The TRAP (thyroid hormone receptor-associated proteins) transcription coactivator complex (also known as Mediator) was first isolated as a group of proteins that facilitate the function of the thyroid hormone receptor(1). This complex interacts physically with several nuclear receptors through the TRAP220 subunit, and with diverse activators through other subunits(2). TRAP220 has been reported to show ligand-enhanced interaction with peroxisome proliferator-activated receptor gamma(2) (PPARgamma2)(3,4),a nuclear receptor essential for adipogenesis(5-8). Here we show that Trap220(-/-) fibroblasts are refractory to PPARgamma(2-)stimulated adipogenesis, but not to MyoD-stimulated myogenesis, and do not express adipogenesis markers or PPARgamma2 target genes. These defects can be restored by expression of exogenous TRAP220. Further indicative of a direct role for TRAP220 in PPARgamma2 function via the TRAP complex, TRAP functions directly as a transcriptional coactivator for PPARgamma2 in a purified in vitro system and interacts with PPARgamma2 in a ligand- and TRAP220-dependent manner. These data indicate that TRAP220 acts, via the TRAP complex, as a PPARgamma2-selective coactivator and, accordingly, that it is specific for one fibroblast differentiation pathway (adipogenesis) relative to another (myogenesis).	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Ge, Kai/H-2810-2019	Ge, Kai/0000-0002-7442-5138				Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Glass CK, 2000, GENE DEV, V14, P121; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	30	262	279	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					563	567		10.1038/417563a	http://dx.doi.org/10.1038/417563a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037571				2022-12-24	WOS:000175860300046
J	Guet, CC; Elowitz, MB; Hsing, WH; Leibler, S				Guet, CC; Elowitz, MB; Hsing, WH; Leibler, S			Combinatorial synthesis of genetic networks	SCIENCE			English	Article							ESCHERICHIA-COLI; EVOLUTION; ELEMENTS; OPERATOR; PROTEIN; BIOLOGY	A central problem in biology is determining how genes interact as parts of functional networks. Creation and analysis of synthetic networks, composed of well-characterized genetic elements, provide a framework for theoretical modeling. Here, with the use of a combinatorial method, a library of networks with varying connectivity was generated in Escherichia coli. These networks were composed of genes encoding the transcriptional regulators Lacl, TetR, and lambda Cl, as well as the corresponding promoters. They displayed phenotypic behaviors resembling binary logical circuits, with two chemical "inputs" and a fluorescent protein "output." Within this simple system, diverse computational functions arose through changes in network connectivity. Combinatorial synthesis provides an alternative approach for studying biological networks, as well as an efficient method for producing diverse phenotypes in vivo.	Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Rockefeller University; Howard Hughes Medical Institute; Princeton University; Princeton University	Leibler, S (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.							BERGER SL, 1994, ANAL BIOCHEM, V222, P1, DOI 10.1006/abio.1994.1445; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; dAri R., 1990, BIOL FEEDBACK; Davidson E. H., 2001, DEV EVOLUTION; DHaese E, 1997, APPL ENVIRON MICROB, V63, P4116, DOI 10.1128/AEM.63.10.4116-4119.1997; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; MULLINAX RL, 1992, BIOTECHNIQUES, V12, P864; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a	18	392	420	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1466	1470		10.1126/science.1067407	http://dx.doi.org/10.1126/science.1067407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029133				2022-12-24	WOS:000175910300048
J	Rosenberg, MI; Parkhurst, SM				Rosenberg, MI; Parkhurst, SM			Drosophila Sir2 is required for heterochromatic silencing and by euchromatic Hairy/E(Spl) bHLH repressors in segmentation and sex determination	CELL			English	Article							PAN-NEURAL GENE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; DNA-BINDING; CHROMATIN STRUCTURE; PROTEIN SIR2; HAIRY; DOMAIN; YEAST	Yeast SIR2 is a NAD(+)-dependent histone deacetylase required for heterochromatic silencing at telomeres, rDNA, and mating-type loci. We find that the Drosophila homolog of Sir2 (dSir2) also encodes deacetylase activity and is required for heterochromatic silencing, but unlike ySir2, is not required for silencing at telomeres. We show that dSir2 interacts genetically and physically with members of the Hairy/Deadpan/E(Spl) family of bHLH euchromatic repressors, key regulators of Drosophila development. dSir2 is an essential gene whose loss of function results in both segmentation defects and skewed sex ratios, associated with reduced activities of the Hairy and Deadpan bHLH repressors. These results indicate that Sir2 in higher organisms plays an essential role in both euchromatic repression and heterochromatic silencing.	Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98195 USA; Univ Washington, Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Parkhurst, SM (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98195 USA.			Rosenberg, Miriam/0000-0001-5348-8247; Parkhurst, Susan/0000-0001-5806-9930	NIGMS NIH HHS [GM 47852, T32 GM07270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM047852, T32GM007270, R01GM047852] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cockell MM, 2000, GENETICS, V154, P1069; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Gottschling DE, 2000, CURR BIOL, V10, pR708, DOI 10.1016/S0960-9822(00)00714-4; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guarente L, 2000, GENE DEV, V14, P1021; HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cellbio.9.1.479; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; ISHHOROWICZ D, 1985, COLD SPRING HARB SYM, V50, P135, DOI 10.1101/SQB.1985.050.01.019; KADDURAHDAOUK R, 1987, GENE DEV, V1, P347, DOI 10.1101/gad.1.4.347; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magie CR, 1999, DEVELOPMENT, V126, P5353; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; MOZER B, 1985, MOL CELL BIOL, V5, P885, DOI 10.1128/MCB.5.4.885; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; PARKHURST SM, 1990, CELL, V63, P1179, DOI 10.1016/0092-8674(90)90414-A; PARKHURST SM, 1991, GENE DEV, V5, P341, DOI 10.1101/gad.5.3.341; PARKHURST SM, 1993, DEVELOPMENT, V117, P737; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; RINE J, 1987, GENETICS, V116, P9; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TOROK T, 1993, GENETICS, V135, P71; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wieschaus E., 1986, P199; YOUNGERSHEPHERD S, 1992, CELL, V70, P911, DOI 10.1016/0092-8674(92)90242-5	53	103	106	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 17	2002	109	4					447	458		10.1016/S0092-8674(02)00732-8	http://dx.doi.org/10.1016/S0092-8674(02)00732-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086602	Bronze			2022-12-24	WOS:000175696800007
J	Rubin, MA				Rubin, MA			Understanding disease cell by cell	SCIENCE			English	Article							REED-STERNBERG CELLS; GENE-EXPRESSION; CANCER; MUTATIONS		Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rubin, MA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.			Rubin, Mark/0000-0002-8321-9950				BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cossman J, 1999, BLOOD, V94, P411, DOI 10.1182/blood.V94.2.411; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.3.CO;2-F; Messineo C, 1998, BLOOD, V91, P2443, DOI 10.1182/blood.V91.7.2443.2443_2443_2451; Nuland Sherwin B., 1988, DOCTORS BIOGRAPHY ME; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Sgroi DC, 1999, CANCER RES, V59, P5656; Strausberg RL, 2001, J PATHOL, V195, P31, DOI 10.1002/1096-9896(200109)195:1<31::AID-PATH920>3.0.CO;2-W; TRUMPER LH, 1993, BLOOD, V81, P3097; Virchow R, 1858, CELLULARPATHOLOGIE I; Vocke CD, 1996, CANCER RES, V56, P2411; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	16	24	26	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1329	1330		10.1126/science.296.5571.1329	http://dx.doi.org/10.1126/science.296.5571.1329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016318				2022-12-24	WOS:000175713000058
J	Simpson, JL; Gray, R; Perez, A; Mena, P; Queenan, J; Barbato, M; Pardo, F; Kambic, R; Jennings, V				Simpson, JL; Gray, R; Perez, A; Mena, P; Queenan, J; Barbato, M; Pardo, F; Kambic, R; Jennings, V			Fertilisation involving ageing gametes, major birth defects, and Down's syndrome	LANCET			English	Article							RISK	For many years, ageing of gametes as a result of prolonged retention In the female reproductive tract before fertilisation has been circumstantially associated with major birth defects. To assess this association, we studied pregnant women who had recorded the timing, with regard to presumed ovulation, of the coital event leading to conception. We found major anomalies In 11 l of 400 Infants born to women with optimally timed conceptions (on the day of or 1 day before ovulation), compared with 14 (2.5%) of 538 Infants of women with non-optimally timed conceptions (odds ratio 0.94, 95% CI 0.43-2.06). The numbers of Infants with Down's syndrome were two l of 400, and four (0.7%) of 538, respectively (1.48, 0.27-8.06). There is no association between ageing gametes and major birth defects, Including Down's syndrome.	Baylor Coll Med, Houston, TX 77030 USA; Johns Hopkins Univ, Baltimore, MD USA; Pontificia Univ Catolica Chile, Santiago, Chile; Univ Los Andes, Santiago, Chile; Georgetown Univ, Inst Reprod Hlth, Washington, DC USA; Ctr Ambrosiano Metodi Nat, Milan, Italy; Univ Javeriana, Bogota, Colombia	Baylor College of Medicine; Johns Hopkins University; Pontificia Universidad Catolica de Chile; Universidad de los Andes - Chile; Georgetown University; Pontificia Universidad Javeriana	Simpson, JL (corresponding author), Baylor Coll Med, 6650 Fannin, Houston, TX 77030 USA.							CASTILLA EE, 1995, AM J MED GENET, V59, P525, DOI 10.1002/ajmg.1320590424; GRAY RH, 1995, AM J OBSTET GYNECOL, V172, P1567, DOI 10.1016/0002-9378(95)90498-0; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; SIMPSON J L, 1988, Advances in Contraception, V4, P247, DOI 10.1007/BF01849266; Yoon PW, 1996, AM J HUM GENET, V58, P628	5	1	1	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1670	1671		10.1016/S0140-6736(02)08559-8	http://dx.doi.org/10.1016/S0140-6736(02)08559-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020531				2022-12-24	WOS:000175593300014
J	Finlay, BJ				Finlay, BJ			Global dispersal of free-living microbial eukaryote species	SCIENCE			English	Article							GEOGRAPHIC-DISTRIBUTION; POPULATION-DENSITY; MOLECULAR EVIDENCE; BODY-SIZE; DIVERSITY; PROTOZOA; BIODIVERSITY; GYMNAMOEBAE; ABUNDANCES; CILIOPHORA	The abundance of individuals in microbial species is so large that dispersal is rarely (if ever) restricted by geographical barriers. This "ubiquitous" dispersal requires an alternative view of the scale and dynamics of biodiversity at the microbial Level, wherein global species number is relatively low and Local species richness is always sufficient to drive ecosystem functions.	Ctr Ecol & Hydrol Windermere, Ambleside LA22 0LP, Cumbria, England	UK Centre for Ecology & Hydrology (UKCEH)	Finlay, BJ (corresponding author), Ctr Ecol & Hydrol Windermere, Ferry House, Ambleside LA22 0LP, Cumbria, England.	bjf@ceh.ac.uk						Anderson OR, 1997, J EUKARYOT MICROBIOL, V44, P393, DOI 10.1111/j.1550-7408.1997.tb05714.x; ANDERSON S, 1994, Q REV BIOL, V69, P451, DOI 10.1086/418743; Atkins MS, 2000, J EUKARYOT MICROBIOL, V47, P400, DOI 10.1111/j.1550-7408.2000.tb00067.x; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BERNINGER UG, 1991, LIMNOL OCEANOGR, V36, P139, DOI 10.4319/lo.1991.36.1.0139; Bischoff PJ, 1998, ACTA PROTOZOOL, V37, P17; Bowers N, 1998, EUR J PROTISTOL, V34, P341, DOI 10.1016/S0932-4739(98)80001-1; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; CORLISS JO, 1999, NATURE HUMAN SOC QUE, P130; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darwin C., 1846, Q J GEOL SOC, V2, P26, DOI DOI 10.1144/GSL.JGS.1846.002.01-02.09; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Esteban GF, 2001, J ZOOL, V255, P139, DOI 10.1017/S0952836901001200; Esteban GF, 2000, J NAT HIST, V34, P159, DOI 10.1080/002229300299598; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; FENCHEL T, 1994, PHILOS T ROY SOC B, V343, P51, DOI 10.1098/rstb.1994.0007; Fenchel T., 1986, Progress in Protistology, V1, P65; FENCHEL T, 1993, OIKOS, V68, P375, DOI 10.2307/3544855; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; FENCHEL T, COMMUNICATION; FINLAY BB, UNPUB; Finlay BJ, 1999, PROTIST, V150, P229, DOI 10.1016/S1434-4610(99)70025-8; Finlay BJ, 1998, PROTIST, V149, P29, DOI 10.1016/S1434-4610(98)70007-0; Finlay BJ, 1996, Q REV BIOL, V71, P221, DOI 10.1086/419370; Finlay BJ, 1997, OIKOS, V80, P209, DOI 10.2307/3546587; Finlay BJ, 2001, PROTIST, V152, P355, DOI 10.1078/1434-4610-00073; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Finlay BJ, 1999, ECOGRAPHY, V22, P138, DOI 10.1111/j.1600-0587.1999.tb00461.x; Finlay Bland J., 2001, P901, DOI 10.1006/rwbd.1999.0285; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; HAPPEYWOOD CM, 1988, HYDROBIOLOGIA, V161, P99, DOI 10.1007/BF00044104; Hubbell S.P., 2001, MG POP BIOL, V32; KRISTIANSEN J, 2001, NOVA HEDWIGIA, V122, P23; Kusch J, 1998, PROTIST, V149, P147, DOI 10.1016/S1434-4610(98)70019-7; Lawton JH, 1998, OIKOS, V81, P3, DOI 10.2307/3546461; Maskell WM, 1887, T P NZ I, V20, P3; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Nanney DL, 1999, SPECIES, P93; Noland L. E, 1967, RES PROTOZOOL, V2; PATTERSON DJ, 2000, FLAGELLATES UNITY DI, P269; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Schmid PE, 2000, SCIENCE, V289, P1557, DOI 10.1126/science.289.5484.1557; Stoeck T, 1998, EUR J PROTISTOL, V34, P348, DOI 10.1016/S0932-4739(98)80002-3; VANNIEL CB, 1983, MW BEIJERINCK HIS LI	46	1246	1313	12	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1061	1063		10.1126/science.1070710	http://dx.doi.org/10.1126/science.1070710			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004115				2022-12-24	WOS:000175565000037
J	Rulifson, EJ; Kim, SK; Nusse, R				Rulifson, EJ; Kim, SK; Nusse, R			Ablation of insulin-producing neurons in flies: Growth and diabetic phenotypes	SCIENCE			English	Article							DROSOPHILA; RECEPTOR; GENE; PEPTIDE	In the fruit fly Drosophila, four insulin genes are coexpressed in small clusters of cells [insulin-producing cells (IPCs)] in the brain. Here, we show that ablation of these IPCs causes developmental delay, growth retardation, and elevated carbohydrate levels in larval hemolymph. All of the defects were reversed by ectopic expression of a Drosophila insulin transgene. On the basis of these functional data and the observation that IPCs release insulin into the circulatory system, we conclude that brain IPCs are the main systemic supply of insulin during larval growth. We propose that IPCs and pancreatic islet beta cells are functionally analogous and may have evolved from a common ancestral insulin-producing neuron. Interestingly, the phenotype of flies lacking IPCs includes certain features of diabetes mellitus.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr B300, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Rulifson, EJ (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.			Kim, Seung/0000-0001-6135-7810				Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; CLARKE DW, 1986, J NEUROCHEM, V47, P831; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Joslin E.P., 1994, JOSLINS DIABETES MEL; Kondo H, 1996, J MOL BIOL, V259, P926, DOI 10.1006/jmbi.1996.0370; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Nijhout H.F., 1994, INSECT HORMONES; NOYES BE, 1995, MOL CELL ENDOCRINOL, V109, P133, DOI 10.1016/0303-7207(95)03492-P; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; Vroemen SF, 1998, MOL CELL ENDOCRINOL, V141, P7, DOI 10.1016/S0303-7207(98)00079-3; WYATT GR, 1961, ANNU REV ENTOMOL, V6, P75, DOI 10.1146/annurev.en.06.010161.000451	15	793	818	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1118	1120		10.1126/science.1070058	http://dx.doi.org/10.1126/science.1070058			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004130				2022-12-24	WOS:000175565000053
J	Kaufman, J; Jing, J				Kaufman, J; Jing, J			AIDS - China and AIDS - The time to act is now	SCIENCE			English	Editorial Material									Harvard Univ, Radcliffe Inst Adv Studies, Cambridge, MA 02138 USA; Tsinghua Univ, Beijing 100084, Peoples R China	Harvard University; Tsinghua University	Kaufman, J (corresponding author), 50 Woodridge Rd, Wellesley, MA 02482 USA.	joankaufman@levineonline.com						[Anonymous], 1997, NIH Consens Statement, V15, P1; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; CHAN E, 2001, REUTERS         1115; *CHIN UN THEM GROU, 2001, HIV AIDS CHIN TIT PE; *CHIN UN THEM GROU, 1997, CHIN RESP AIDS HIV A; CHUAN Q, 2001, CHINA DAILY     1114; Cowhig D., 2000, LIANHE ZAOBAO   1002; HE A, 2000, REVEALING BLOOD WOUN; JING J, 2002, WORKSH CHANG HLTH NE; Kaufman J, 1999, STUD FAMILY PLANN, V30, P112, DOI 10.1111/j.1728-4465.1999.00112.x; LIU W, 2002, 12 INT AIDS C DURB S; *MIN HLTH BRAZ, HIV AIDS CONTR BRAZ; NANTULYA V, 2002, SEM HARV U CTR POP D; PAN S, 2001, UNPUB 1 CHIN C AIDS; Rosenthal E, 2008, NY TIMES        0820, pA1; Saich T, 2000, CHINA QUART, P124; *SHANGH I PLANN PA, 2000, P INT S REPR HLTH RE; *UNAIDS, 2001, UNAIDS0115E; *UNAIDS CHIN, 2000, WE CARE DO YOU; XIN Y, 2002, HIV AIDS RELATED MEN; ZHANG B, 2001, FRIENDS EXCHANGE APR; ZHANG B, 2000, UNPUB SURVEY HIV AID; 2000, CHINA HLTH NEWS 0726; 2002, CHINA DAILY     0412; 2000, CHINA HLTH NEWS 0828; 2000, SO WEEKEND      1130	26	97	109	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2339	2340		10.1126/science.1074479	http://dx.doi.org/10.1126/science.1074479			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089428				2022-12-24	WOS:000176467200022
J	Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; Teague, J; Woffendin, H; Garnett, MJ; Bottomley, W; Davis, N; Dicks, N; Ewing, R; Floyd, Y; Gray, K; Hall, S; Hawes, R; Hughes, J; Kosmidou, V; Menzies, A; Mould, C; Parker, A; Stevens, C; Watt, S; Hooper, S; Wilson, R; Jayatilake, H; Gusterson, BA; Cooper, C; Shipley, J; Hargrave, D; Pritchard-Jones, K; Maitland, N; Chenevix-Trench, G; Riggins, GJ; Bigner, DD; Palmieri, G; Cossu, A; Flanagan, A; Nicholson, A; Ho, JWC; Leung, SY; Yuen, ST; Weber, BL; Siegler, HF; Darrow, TL; Paterson, H; Marais, R; Marshall, CJ; Wooster, R; Stratton, MR; Futreal, PA				Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; Teague, J; Woffendin, H; Garnett, MJ; Bottomley, W; Davis, N; Dicks, N; Ewing, R; Floyd, Y; Gray, K; Hall, S; Hawes, R; Hughes, J; Kosmidou, V; Menzies, A; Mould, C; Parker, A; Stevens, C; Watt, S; Hooper, S; Wilson, R; Jayatilake, H; Gusterson, BA; Cooper, C; Shipley, J; Hargrave, D; Pritchard-Jones, K; Maitland, N; Chenevix-Trench, G; Riggins, GJ; Bigner, DD; Palmieri, G; Cossu, A; Flanagan, A; Nicholson, A; Ho, JWC; Leung, SY; Yuen, ST; Weber, BL; Siegler, HF; Darrow, TL; Paterson, H; Marais, R; Marshall, CJ; Wooster, R; Stratton, MR; Futreal, PA			Mutations of the BRAF gene in human cancer	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; TYROSINE KINASE; B-RAF; ACTIVATION; PATHWAY; PROLIFERATION; INHIBITOR	Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis signalling pathways in which at least one gene is mutated in human cancer. The RAS-RAF-MEK-ERK-MAP kinase pathway mediates cellular responses to growth signals(1). RAS is mutated to an oncogenic formin about 15% of human cancer. The three RAF genes code for cytoplasmic serine/threonine kinases that are regulated by binding RAS(1-3). Here we report BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers. All mutations are within the kinase domain, with a single substitution (V599E) accounting for 80%. Mutated BRAF proteins have elevated kinase activity and are transforming in NIH3T3 cells. Furthermore, RAS function is not required for the growth of cancer cell lines with the V599E mutation. As BRAF is a serine/threonine kinase that is commonly activated by somatic point mutation in human cancer, it may provide new therapeutic opportunities in malignant melanoma.	Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Inst Canc Res, Sect Mol Carcinogenesis, Sutton SM2 5NG, Surrey, England; Inst Canc Res, Paediat Sect, Sutton SM2 5NG, Surrey, England; Univ Glasgow, Western Infirm, Dept Pathol, Glasgow S11 6NT, Lanark, Scotland; Univ York, Dept Biol, YCR Canc Res Unit, York YO10 5YW, N Yorkshire, England; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; CNR, Inst Mol Genet, I-07040 Alghero, Italy; Univ Sassari, Dept Pathol, I-07100 Sassari, Italy; UCL Royal Free & Univ Coll Med Sch, London WC1E 6JJ, England; Royal Brompton Hosp, London SW3 6NP, England; Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Univ Penn, Ctr Canc, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Wellcome Trust Sanger Institute; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of Glasgow; University of York - UK; QIMR Berghofer Medical Research Institute; Duke University; Duke University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Sassari; University of London; University College London; UCL Medical School; Royal Brompton Hospital; University of Hong Kong; University of Hong Kong; University of Pennsylvania; Pennsylvania Medicine	Wooster, R (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	rw1@sanger.ac.uk	Chenevix-Trench, Georgia/AAV-2014-2020; Hargrave, Darren R/H-1066-2014; Palmieri, Giuseppe/AAX-2627-2021; Palmieri, G/K-6095-2016; Pritchard-Jones, Kathy/F-4286-2014; Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Cossu, Antonio/I-8836-2018; Toon, Christopher W/G-3610-2012; Leung, Suet Yi/T-9620-2019	Chenevix-Trench, Georgia/0000-0002-1878-2587; Hargrave, Darren R/0000-0001-8219-9807; Palmieri, G/0000-0002-4350-2276; Pritchard-Jones, Kathy/0000-0002-2384-9475; Cossu, Antonio/0000-0002-2390-2205; Gray, Kristian/0000-0002-7035-7107; Edkins, Sarah/0000-0003-0717-1972; Shipley, Janet/0000-0001-6748-8678; Maitland, Norman/0000-0003-1607-9035; Marais, Richard/0000-0001-7484-4183; Leung, Suet Yi/0000-0001-8614-4619; Hughes, Jaime/0000-0001-6045-4053				Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Caduff RF, 1999, AM J SURG PATHOL, V23, P323, DOI 10.1097/00000478-199903000-00012; COOKE M P, 1989, New Biologist, V1, P66; DAYAGROSJEAN L, 1995, J PHOTOCH PHOTOBIO B, V28, P115, DOI 10.1016/1011-1344(95)07130-T; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Grant BD, 1998, BIOCHEMISTRY-US, V37, P7708, DOI 10.1021/bi972987w; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; ODAWARA M, 1989, SCIENCE, V245, P66, DOI 10.1126/science.2544998; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Rozycka M, 2000, GENOMICS, V70, P34, DOI 10.1006/geno.2000.6354; STACEY DW, 1987, EXP CELL RES, V171, P232, DOI 10.1016/0014-4827(87)90266-7; VANTVEER LJ, 1989, MOL CELL BIOL, V9, P3114, DOI 10.1128/MCB.9.7.3114; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	24	7662	8010	23	805	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2002	417	6892					949	954		10.1038/nature00766	http://dx.doi.org/10.1038/nature00766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12068308	Green Accepted			2022-12-24	WOS:000176441200039
J	Brown, DA; Breit, SN; Buring, J; Fairlie, WD; Bauskin, AR; Liu, T; Ridker, PM				Brown, DA; Breit, SN; Buring, J; Fairlie, WD; Bauskin, AR; Liu, T; Ridker, PM			Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study	LANCET			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; C-REACTIVE PROTEIN; ATHEROSCLEROSIS; DISEASE; MEMBER; MIC-1; P53; INFLAMMATION; EXPRESSION	Background Macrophage inhibitory cytokine-1 (MIC-1) is part of the TGF-beta superfamily. Raised concentrations of MIC-1 in serum arise in several disease states, can be detected in normal individuals, and can partly be genetically determined. We aimed to investigate whether MIC-1 has a role in atherothrombosis. Methods We did a prospective, nested, case-control study in 27 628 initially healthy women. Of these women, we established baseline concentrations of MIC-1 in 257 who subsequently had myocardial infarction, stroke, or died from a cardiovascular event (cases) and in 257 matched for age and smoking status, who did not report cardiovascular disease during 4-year follow-up (controls). We also assessed polymorphisms in the MIC-1 gene (MIC-1 H and MIC-1 D) in all 514 women. Findings MIC-1 concentrations were higher at baseline in women who subsequently had cardiovascular events than in those who did not (618 vs 538 pg/mL, p=0.0002). Concentrations above the 90th percentile (>856 pg/mL) were associated with a 2.7-fold increase in risk (95% CI 1.6-4.9, p=0.001). This effect was independent of traditional cardiovascular risk factors and at least additive to that of C-reactive protein. There was no significant association between MIC-1 polymorphism and vascular events. Interpretation MIC-1 could be a novel target for cardiovascular disease prevention.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Leducq Ctr Cardiovasc Res, Boston, MA 02115 USA; St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia; Univ New S Wales, Sydney, NSW, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; St Vincents Hospital Sydney; University of New South Wales Sydney	Ridker, PM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02115 USA.	pridker@partners.org	Fairlie, Walter/M-8401-2015; Liu, Tao/A-3922-2015	Fairlie, Walter/0000-0002-2498-1160; Brown, David/0000-0003-1382-9419; Liu, Tao/0000-0001-6244-7316	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063293, R01HL058755] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-63293, HL-58755] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baoutina A, 2001, TRENDS CARDIOVAS MED, V11, P1, DOI 10.1016/S1050-1738(01)00075-5; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; BROWN DA, 2001, J LEUKOCYTE BIOL   S, V90, P311; BROWN DA, IN PRESS BIOTECHNIQU; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Fairlie WD, 2001, BIOCHEMISTRY-US, V40, P65, DOI 10.1021/bi001064p; Kannan K, 2000, FEBS LETT, V470, P77, DOI 10.1016/S0014-5793(00)01291-6; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Mayr M, 2001, EXP GERONTOL, V36, P969, DOI 10.1016/S0531-5565(01)00090-0; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Tegos TJ, 2001, ANGIOLOGY, V52, P89, DOI 10.1177/000331970105200201; VONDERTHUSEN TH, 2000, J SUBMICR CYTOL PATH, V32, P328	21	200	237	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2002	359	9324					2159	2163		10.1016/S0140-6736(02)09093-1	http://dx.doi.org/10.1016/S0140-6736(02)09093-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566RJ	12090982				2022-12-24	WOS:000176441800011
J	Freeman, BC; Yamamoto, KR				Freeman, BC; Yamamoto, KR			Disassembly of transcriptional regulatory complexes by molecular chaperones	SCIENCE			English	Article							GLUCOCORTICOID RECEPTOR; ORDERED RECRUITMENT; PROMOTER; CELLS; GENE; EXPRESSION; ACTIVATION; ENHANCER; BINDING; SITES	Many biological processes are initiated by cooperative assembly of large multicomponent complexes; however, mechanisms for modulating or terminating the actions of these complexes are not well understood. For example, hormone-bound intracellular receptors (IRs) nucleate formation of transcriptional regulatory complexes whose actions cease promptly upon hormone withdrawal. Here, we show that the p23 molecular chaperone localizes in vivo to genomic response elements in a hormone-dependent manner, disrupting receptor-mediated transcriptional activation in vivo and in vitro; Hsp90 weakly displayed similar activities. Indeed, p23 and Hsp90 also disrupted the activities of some non IR-containing transcriptional regulatory complexes. We suggest that molecular chaperones promote disassembly of transcriptional regulatory complexes, thus enabling regulatory machineries to detect and respond to signaling changes.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus, San Francisco, CA 94143 USA.							Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DANESCH U, 1987, EMBO J, V6, P625, DOI 10.1002/j.1460-2075.1987.tb04800.x; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; FREEMAN BC, UNPUB; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; NARDULLI AM, 1986, ENDOCRINOLOGY, V119, P2038, DOI 10.1210/endo-119-5-2038; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; ODDOS J, 1989, NUCLEIC ACIDS RES, V17, P8877, DOI 10.1093/nar/17.21.8877; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; RINGOLD GM, 1977, P NATL ACAD SCI USA, V74, P2879, DOI 10.1073/pnas.74.7.2879; ROUSSEAU GG, 1973, J MOL BIOL, V79, P539, DOI 10.1016/0022-2836(73)90405-1; UCKER DS, 1984, J BIOL CHEM, V259, P7416; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3	23	337	351	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2232	2235		10.1126/science.1073051	http://dx.doi.org/10.1126/science.1073051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077419				2022-12-24	WOS:000176379000062
J	Hughes, AL				Hughes, AL			Genetic markers: Strength in numbers	NATURE			English	Article									Univ S Carolina, Inst Biotechnol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hughes, AL (corresponding author), Univ S Carolina, Inst Biotechnol, Columbia, SC 29208 USA.								0	3	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					795	795		10.1038/417795a	http://dx.doi.org/10.1038/417795a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075328	Bronze			2022-12-24	WOS:000176285600025
J	Pasparakis, M; Courtois, G; Hafner, M; Schmidt-Supprian, M; Nenci, A; Toksoy, A; Krampert, M; Goebeler, M; Gillitzer, R; Israel, A; Krieg, T; Rajewsky, K; Haase, I				Pasparakis, M; Courtois, G; Hafner, M; Schmidt-Supprian, M; Nenci, A; Toksoy, A; Krampert, M; Goebeler, M; Gillitzer, R; Israel, A; Krieg, T; Rajewsky, K; Haase, I			TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2	NATURE			English	Article							NF-KAPPA-B; SEVERE LIVER DEGENERATION; GAMMA-DEFICIENT MICE; INCONTINENTIA PIGMENTI; ACTIVATION; ALPHA; LACKING; KINASE; EXPRESSION; RECEPTOR	The IkappaB kinase (IKK), consisting of the IKK1 and IKK2 catalytic subunits and the NEMO (also known as IKKgamma) regulatory subunit, phosphorylates IkappaB proteins, targeting them for degradation and thus inducing activation of NF-kappaB (reviewed in refs 1, 2). IKK2 and NEMO are necessary for NF-kappaB activation through pro-inflammatory signals(3-8). IKK1 seems to be dispensable for this function but controls epidermal differentiation independently of NF-kappaB(9-12). Previous studies suggested that NF-kappaB has a function in the growth regulation of epidermal keratinocytes(12-14). Mice lacking RelB or IkappaBalpha, as well as both mice and humans with heterozygous NEMO mutations, develop skin lesions(7,8,15-18). However, the function of NF-kappaB in the epidermis remains unclear(19). Here we used Cre/loxP-mediated gene targeting to investigate the function of IKK2 specifically in epidermal keratinocytes. IKK2 deficiency inhibits NF-kappaB activation, but does not lead to cell-autonomous hyperproliferation or impaired differentiation of keratinocytes. Mice with epidermis-specific deletion of IKK2 develop a severe inflammatory skin disease, which is caused by a tumour necrosis factor-mediated, alphabeta T-cell-independent inflammatory response that develops in the skin shortly after birth. Our results suggest that the critical function of IKK2-mediated NF-kappaB activity in epidermal keratinocytes is to regulate mechanisms that maintain the immune homeostasis of the skin.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; EMBL Mouse Biol Programme, I-00016 Monterotondo, Italy; Inst Pasteur, CNRS, URA 1773, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50924 Cologne, Germany; Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland	University of Cologne; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Cologne; University of Cologne; University of Wurzburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.	pasparakis@embl-monterotondo.it	Pasparakis, Manolis/H-9292-2017; Hafner, Martin/B-9040-2008; Goebeler, Matthias/F-7118-2013; Schmidt-Supprian, Marc/F-5893-2011; Goebeler, Matthias/P-3612-2019; Pasparakis, Manolis/N-4350-2019	Pasparakis, Manolis/0000-0002-9870-0966; Hafner, Martin/0000-0003-0769-1812; Schmidt-Supprian, Marc/0000-0002-8543-6166; Pasparakis, Manolis/0000-0002-9870-0966; COURTOIS, Gilles/0000-0003-3117-9595; Rajewsky, Klaus/0000-0002-6633-6370				Barton D, 2000, EUR J IMMUNOL, V30, P2323, DOI 10.1002/1521-4141(2000)30:8<2323::AID-IMMU2323>3.0.CO;2-H; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klement JF, 1996, MOL CELL BIOL, V16, P2341; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seitz CS, 2000, CANCER RES, V60, P4085; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Smahi A, 2000, NATURE, V405, P466; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	381	393	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					861	866		10.1038/nature00820	http://dx.doi.org/10.1038/nature00820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075355	Bronze			2022-12-24	WOS:000176285600050
J	Rosenwald, A; Wright, G; Chan, WC; Connors, JM; Campo, E; Fisher, RI; Gascoyne, RD; Muller-Hermelink, HK; Smeland, EB; Staudt, LM				Rosenwald, A; Wright, G; Chan, WC; Connors, JM; Campo, E; Fisher, RI; Gascoyne, RD; Muller-Hermelink, HK; Smeland, EB; Staudt, LM		Lymphoma Leukemia Mol Profiling Pr	The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-EXPRESSION; PROLIFERATION; THERAPY	Background: The survival of patients with diffuse large-B-cell lymphoma after chemotherapy is influenced by molecular features of the tumors. We used the gene-expression profiles of these lymphomas to develop a molecular predictor of survival. Methods: Biopsy samples of diffuse large-B-cell lymphoma from 240 patients were examined for gene expression with the use of DNA microarrays and analyzed for genomic abnormalities. Subgroups with distinctive gene-expression profiles were defined on the basis of hierarchical clustering. A molecular predictor of risk was constructed with the use of genes with expression patterns that were associated with survival in a preliminary group of 160 patients and was then tested in a validation group of 80 patients. The accuracy of this predictor was compared with that of the international prognostic index. Results: Three gene-expression subgroups -- germinal-center B-cell-like, activated B-cell-like, and type 3 diffuse large-B-cell lymphoma -- were identified. Two common oncogenic events in diffuse large-B-cell lymphoma, bcl-2 translocation and c-rel amplification, were detected only in the germinal-center B-cell-like subgroup. Patients in this subgroup had the highest five-year survival rate. To identify other molecular determinants of outcome, we searched for individual genes with expression patterns that correlated with survival in the preliminary group of patients. Most of these genes fell within four gene-expression signatures characteristic of germinal-center B cells, proliferating cells, reactive stromal and immune cells in the lymph node, or major-histocompatibility-complex class II complex. We used 17 genes to construct a predictor of overall survival after chemotherapy. This gene-based predictor and the international prognostic index were independent prognostic indicators. Conclusions: DNA microarrays can be used to formulate a molecular predictor of survival after chemotherapy for diffuse large-B-cell lymphoma.	NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; British Columbia Canc Ctr, Vancouver, BC, Canada; Univ Barcelona, Hosp Clin, Barcelona, Spain; Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA; Univ Rochester, Sch Med, SW Oncol Grp, Rochester, NY USA; Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany; Norwegian Radium Hosp, Dept Immunol, Oslo, Norway; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; NIA, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA; Univ Arizona, Ctr Canc, Tucson, AZ USA; SW Oncol Grp, Tucson, AZ USA; SW Oncol Grp, Seattle, WA USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Medical Center; British Columbia Cancer Agency; University of Barcelona; Hospital Clinic de Barcelona; University of Rochester; Southwest Oncology Group; University of Rochester; University of Wurzburg; University of Oslo; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Arizona; Southwest Oncology Group; Southwest Oncology Group; Fred Hutchinson Cancer Center	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bldg 10,Rm 4N114, Bethesda, MD 20892 USA.		Connors, Joseph/AAF-5284-2019; Wright, George W/M-1660-2017; Smeland, Erlend/AAO-3214-2020; Jaffe, Elaine S/G-8984-2014; Campo, Elias/AAC-5593-2019; Staudt, Louis/AAC-5324-2019	Connors, Joseph/0000-0002-1361-7531; Jaffe, Elaine S/0000-0003-4632-0301; Campo, Elias/0000-0001-9850-9793; Delabie, Jan/0000-0001-5023-0689	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260, Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA084967] Funding Source: NIH RePORTER; NCI NIH HHS [UO1-CA84967] Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Coiffier B, 2001, CURR OPIN ONCOL, V13, P325, DOI 10.1097/00001622-200109000-00003; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Goff LK, 2000, BRIT J HAEMATOL, V111, P618, DOI 10.1046/j.1365-2141.2000.02352.x; GROGAN TM, 1988, BLOOD, V71, P1157; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Huang JZ, 2002, BLOOD, V99, P2285, DOI 10.1182/blood.V99.7.2285; MILLER TP, 1988, J CLIN INVEST, V82, P370, DOI 10.1172/JCI113598; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shipp MA, 1999, J CLIN ONCOL, V17, P423, DOI 10.1200/JCO.1999.17.1.423; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; SILVESTRINI R, 1993, INT J CANCER, V54, P231, DOI 10.1002/ijc.2910540212; STETLERSTEVENSON M, 1988, BLOOD, V72, P1822	17	2804	2957	2	91	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2002	346	25					1937	1947		10.1056/NEJMoa012914	http://dx.doi.org/10.1056/NEJMoa012914			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563QC	12075054				2022-12-24	WOS:000176266200002
J	Yoshikawa, K; Okazaki, IM; Eto, T; Kinoshita, K; Muramatsu, M; Nagaoka, H; Honjo, T				Yoshikawa, K; Okazaki, IM; Eto, T; Kinoshita, K; Muramatsu, M; Nagaoka, H; Honjo, T			AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts	SCIENCE			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; SEQUENCES; MUTATION; MECHANISM; TARGETS	Activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme, is indispensable for somatic hypermutation (SHM), class switch recombination, and gene conversion of immunoglobulin genes, which indicates a common molecular mechanism for these phenomena. Here we show that ectopic expression of AID alone can induce hypermutation in an artificial GFP substrate in NIH 3T3 murine fibroblast cells. The frequency of mutations was closely correlated with the level of transcription of the target gene, and the distribution of mutations in NIH 3T3 cells was similar to those of SHM in B lymphocytes. These results indicate that AID is sufficient for the generation of SHIM in an actively transcribed gene in fibroblasts, as well as B cells, and that any of the required cofactors must be present in these fibroblasts.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Okazaki, Il-mi/0000-0001-8644-0100				Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Fugmann SD, 2002, SCIENCE, V295, P1244, DOI 10.1126/science.1070023; Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Smith DS, 1996, J IMMUNOL, V156, P2642; Spencer J, 1999, J IMMUNOL, V162, P6596; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; YOSHIKAWA K, UNPUB	28	303	322	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2033	2036		10.1126/science.1071556	http://dx.doi.org/10.1126/science.1071556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065838				2022-12-24	WOS:000176273300055
J	Armstrong, J; Reilly, JJ				Armstrong, J; Reilly, JJ		Child Hlth Information Team	Breastfeeding and lowering the risk of childhood obesity	LANCET			English	Article								Breastfeeding might confer protection against obesity later in life, but the evidence is inconclusive. We tested the hypothesis that breastfeeding is associated with a reduced risk of obesity in a population-based sample of 32 200 Scottish children studied at age 39-42 months in 1998 and 1999. Obesity was defined as body-mass index (BMI) at the 95th and 98th percentiles or higher. The prevalence of obesity was significantly lower in breastfed children, and the association persisted after adjustment for socioeconomic status, birthweight, and sex. The adjusted odds ratio for obesity (BMI greater than or equal to98th percentile) was 0.70 (95% CI 0.61-0.80). Our results suggest that breastfeeding Is associated with a reduction in childhood obesity risk.	Univ Glasgow, Royal Hosp Sick Children, Dept Human Nutr, Glasgow G3 8SJ, Lanark, Scotland; Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; Child Hlth Informat Team, Hosp & Community Informat Unit, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Glasgow; Glasgow Caledonian University	Reilly, JJ (corresponding author), Univ Glasgow, Royal Hosp Sick Children, Dept Human Nutr, Glasgow G3 8SJ, Lanark, Scotland.							CARSTAIRS V, 1991, DEPRIVATION HLTH SCO, P18; Dietz WH, 2001, JAMA-J AM MED ASSOC, V285, P2506, DOI 10.1001/jama.285.19.2506; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Reilly JJ, 1999, LANCET, V354, P1874, DOI 10.1016/S0140-6736(99)04555-9; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147	5	273	282	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 8	2002	359	9322					2003	2004		10.1016/S0140-6736(02)08837-2	http://dx.doi.org/10.1016/S0140-6736(02)08837-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076560				2022-12-24	WOS:000176232500017
J	Wikelski, M; Wong, V; Chevalier, B; Rattenborg, N; Snell, HL				Wikelski, M; Wong, V; Chevalier, B; Rattenborg, N; Snell, HL			Marine iguanas die from trace oil pollution	NATURE			English	Article							GALAPAGOS; SPILL		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI 53719 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Charles Darwin Res Stn, Galapagos, Ecuador	Princeton University; University of Wisconsin System; University of Wisconsin Madison; University of New Mexico	Wikelski, M (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.		Snell, Howard/N-2455-2015; /ABD-1334-2021	Snell, Howard/0000-0001-8770-7540; 				Fowler GS, 1995, AUK, V112, P382, DOI 10.2307/4088725; MACKIE RI, UNPUB PHYS BIOCH ZOO; Ormseth OA, 2000, J COMP PHYSIOL B, V170, P419, DOI 10.1007/s003600000119; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Prichard AK, 1997, CHEMOSPHERE, V35, P1531, DOI 10.1016/S0045-6535(97)00223-3; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; van Tamelen PG, 1997, MAR ECOL PROG SER, V160, P265, DOI 10.3354/meps160265; WIKELSKI M, 1993, OECOLOGIA, V94, P373, DOI 10.1007/BF00317112; Wikelski M, 2001, SCIENCE, V292, P437; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; 2001, SEA TECHNOL, V42, P74	11	69	71	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					607	608		10.1038/417607a	http://dx.doi.org/10.1038/417607a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050651				2022-12-24	WOS:000176001200033
J	Connor, J; Norton, R; Ameratunga, S; Robinson, E; Civil, I; Dunn, R; Bailey, J; Jackson, R				Connor, J; Norton, R; Ameratunga, S; Robinson, E; Civil, I; Dunn, R; Bailey, J; Jackson, R			Driver sleepiness and risk of serious injury to car occupants: population based case control study	BRITISH MEDICAL JOURNAL			English	Article							ATTRIBUTABLE RISK; WORK HOURS; ACCIDENTS; CRASHES; DEPRIVATION	Objectives To estimate the contribution of driver sleepiness to the causes of car crash injuries. Design Population based case control study. Setting Auckland region of New Zealand, April 1998 to July 1999. Participants 571 car drivers involved in crashes where at least one occupant was admitted to hospital or killed ("injury crash"); 588 car drivers recruited while driving on public roads (controls), representative of all time spent driving in the study region during the study period. Main outcome measures Relative risk for injury crash associated with driver characteristics related to sleep, and the population attributable risk for driver sleepiness. Results There was a strong association between measures of acute sleepiness and the risk of an injury crash. After adjustment for major confounders significantly increased risk was associated with drivers who identified themselves as sleepy (Stanford sleepiness score 4-7 v 1-3; odds ratio 8.2, 95% confidence interval 3.4 to 19.7); with drivers who reported five hours or less of sleep in the previous 24 hours compared with more than five hours (2.7, 1.4 to 5.4); and with driving between 2 am and 5 am compared with other times of day (5.6, 1.4 to 22.7 No increase in risk was associated with measures of chronic sleepiness. The population attributable risk for driving with one or more of the acute sleepiness risk factors was 19% (15% to 25%). Conclusions Acute sleepiness in car drivers significantly increases the risk of a crash in which a car occupant is injured or killed. Reductions in road traffic injuries may be achieved if fewer people drive when they are sleepy or have been deprived of sleep or drive between 2 am and 5 am.	Univ Auckland, Div Community Hlth, Auckland 1, New Zealand; Univ Sydney, Inst Int Hlth, Newtown, NSW, Australia; Auckland Hosp, Dept Surg, Auckland, New Zealand; Univ Auckland, Dept Civil & Environm Engn, Auckland 1, New Zealand; Bailey Partnership, Porirua 6006, New Zealand	University of Auckland; University of Sydney; Auckland City Hospital; University of Auckland	Connor, J (corresponding author), Univ Auckland, Div Community Hlth, Private Bag 92019, Auckland 1, New Zealand.			Civil, Ian/0000-0002-1371-1114; Connor, Jennie/0000-0002-3209-8693; Ameratunga, Shanthi/0000-0001-8042-2251; Jackson, Rod/0000-0001-5914-6934				Akerstedt T, 1995, J SLEEP RES, V4, P1, DOI 10.1111/j.1365-2869.1995.tb00219.x; Akerstedt T, 1995, J SLEEP RES, V4, P15, DOI 10.1111/j.1365-2869.1995.tb00221.x; BENICHOU J, 1991, STAT MED, V10, P1753, DOI 10.1002/sim.4780101113; BONNET MH, 2000, PRINCIPLES PRACTICE; CHERVIN R, 2000, PRINCIPLES PRACTICE; Connor J, 2001, SLEEP, V24, P688, DOI 10.1093/sleep/24.6.688; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; COUGHLIN SS, 1994, EPIDEMIOL REV, V16, P51, DOI 10.1093/oxfordjournals.epirev.a036144; Cummings P, 2001, Inj Prev, V7, P194, DOI 10.1136/ip.7.3.194; DINGES DF, 1991, SLEEP SLEEPINESS PER, P98; *EXP PAN DRIV FAT, 1997, DROWES DRIV AUT CRAS; *EXP PAN DRIV FAT, 1997, DROWS DRIV AUT CRASH; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JOHNS M, 1991, SLEEP, V14, P54; *LAND TRANSP SAF A, 1998, ACC INV SYST AIS 199; LEGER D, 1994, SLEEP, V17, P84, DOI 10.1093/sleep/17.1.84; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; MAYCOCK G, 1995, DRIVER SLEEPINESS FA, P39; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Pierce RJ, 1999, AUST NZ J MED, V29, P658, DOI 10.1111/j.1445-5994.1999.tb01613.x; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; ROEHRS T, 2000, PRINCIPLES PRACTICE; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104	25	460	479	0	39	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1125	1128A		10.1136/bmj.324.7346.1125	http://dx.doi.org/10.1136/bmj.324.7346.1125			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003884	Bronze, Green Published			2022-12-24	WOS:000175622800018
J	Neutel, AM; Heesterbeek, JAP; de Ruiter, PC				Neutel, AM; Heesterbeek, JAP; de Ruiter, PC			Stability in real food webs: Weak links in long loops	SCIENCE			English	Article							ECOLOGY; FIELD	Increasing evidence that the strengths of interactions among populations in biological communities form patterns that are crucial for system stability requires clarification of the precise form of these patterns, how they come about, and why they influence stability. We show that in real food webs, interaction strengths are organized in trophic loops in such a way that long loops contain relatively many weak links. We show and explain mathematically that this patterning enhances stability, because it reduces maximum "loop weight" and thus reduces the amount of intraspecific interaction needed for matrix stability. The patterns are brought about by biomass pyramids, a feature common to most ecosystems. Incorporation of biomass pyramids in 104 food-web descriptions reveals that the tow weight of the tong loops stabilizes complex food webs. Loop-weight analysis could be a useful toot for exploring the structure and organization of complex communities.	Univ Utrecht, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands; Univ Utrecht, Fac Vet Med, Quantitat Vet Epidemiol Grp, NL-3508 TD Utrecht, Netherlands	Utrecht University; Utrecht University	Neutel, AM (corresponding author), Univ Utrecht, Dept Environm Sci, POB 80115, NL-3508 TC Utrecht, Netherlands.	a.neutel@geog.uu.nl						Cohen JE, 1990, COMMUNITY FOOD WEBS; de Ruiter PC, 1998, APPL SOIL ECOL, V10, P217, DOI 10.1016/S0929-1393(98)00121-8; DERUITER PC, 1993, PLANT SOIL, V157, P263, DOI 10.1007/BF00011055; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Hall S. J., 1993, V24, P187; HOFBAUER J, 1988, THEORY EVOLUTION DYN, P193; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; KRASNOSELSKIJ J, 1989, POSITIVE LINEAR SYST, P169; LAWTON JH, 1992, NATURE, V355, P19, DOI 10.1038/355019a0; Levins R, 1977, LECT NOTES BIOMATH, V18, P153; LOGOFET DO, 1993, MATRICES GRAPHS STAB, P128; May R. M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Moore JC, 1996, ECOLOGY, V77, P694, DOI 10.2307/2265494; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; ODUM E P, 1971, P574; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1994, AUST J ECOL, V19, P121; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0; Yodzis P., 1989, INTRO THEORETICAL EC	23	509	527	3	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1120	1123		10.1126/science.1068326	http://dx.doi.org/10.1126/science.1068326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004131	Green Submitted			2022-12-24	WOS:000175565000054
J	Lelouard, H; Gatti, E; Cappello, F; Gresser, O; Camosseto, V; Pierre, P				Lelouard, H; Gatti, E; Cappello, F; Gresser, O; Camosseto, V; Pierre, P			Transient aggregation of ubiquitinated proteins during dendritic cell maturation	NATURE			English	Article							NEWLY SYNTHESIZED PROTEINS; PEPTIDE LIGANDS; IN-VIVO; PROTEASOME; ANTIGEN; DEGRADATION; AGGRESOMES; BIOLOGY	Dendritic cells (DCs) are antigen-presenting cells with the unique capacity to initiate primary immune responses(1). Dendritic cells have a remarkable pattern of differentiation (maturation) that exhibits highly specific mechanisms to control antigen presentation restricted by major histocompatibility complex (MHC)(2). MHC class I molecules present to CD8(+) cytotoxic T cells peptides that are derived mostly from cytosolic proteins, which are ubiquitinated and then degraded by the proteasome(3,4). Here we show that on inflammatory stimulation, DCs accumulate newly synthesized ubiquitinated proteins in large cytosolic structures. These structures are similar to, but distinct from, aggresomes and inclusion bodies observed in many amyloid diseases(5,6). Notably, these dendritic cell aggresome-like induced structures (DALIS) are transient, require continuous protein synthesis and do not affect the ubiquitin-proteasome pathway. Our observations suggest the existence of an organized prioritization of protein degradation in stimulated DCs, which is probably important for regulating MHC class I presentation during maturation.	Univ Med, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pierre, P (corresponding author), Univ Med, CNRS, INSERM, Ctr Immunol Marseille Luminy, Campus Luminy,Case 906, F-13288 Marseille 09, France.		Gatti, Evelina/B-7941-2012; Lelouard, Hugues/R-7985-2019	Gatti, Evelina/0000-0002-0667-0799; Lelouard, Hugues/0000-0002-9205-5011; pierre, philippe/0000-0003-0863-8255				Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bogyo M, 1998, CHEM BIOL, V5, P307, DOI 10.1016/S1074-5521(98)90169-7; BRODSKY FM, 1982, J IMMUNOL, V128, P129; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gatti E, 2000, J IMMUNOL, V164, P3600, DOI 10.4049/jimmunol.164.7.3600; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; STAUFENBIEL M, 1984, J CELL BIOL, V98, P1886, DOI 10.1083/jcb.98.5.1886; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Yewdell JW, 2001, CURR OPIN IMMUNOL, V13, P13, DOI 10.1016/S0952-7915(00)00175-8; Yewdell JW, 2001, J CELL SCI, V114, P845	29	148	152	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					177	182		10.1038/417177a	http://dx.doi.org/10.1038/417177a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000969				2022-12-24	WOS:000175460200044
J	Klironomos, JN				Klironomos, JN			Feedback with soil biota contributes to plant rarity and invasiveness in communities	NATURE			English	Article							DIVERSITY; PATHOGENS; VEGETATION; ECOSYSTEM; MOSAICS	Understanding the relative abundance of species in plant communities is an unsolved problem(1-10). Mechanisms such as competition, resource partitioning(5), dispersal ability(10) and predation tolerance(6-9) do not adequately explain relative abundance under field conditions(11,12). Recent work suggests that interactions between plants and soil microbes is important(13-21). Here I show that such interaction explains a significant proportion of the variance in the relative abundance of species in plant communities. Rare plants exhibited a relative decrease in growth on 'home' soil in which pathogens had had a chance to accumulate, whereas invasive plants benefited from interactions with mycorrhizal fungi. Some plant species accumulate pathogens quickly and maintain low densities as a result of the accumulation of species-specific pathogens, whereas others accumulate species-specific pathogens more slowly and do not experience negative feedback until plant densities reach high levels(13,15,21). These results indicate that plants have different abilities to influence their abundance by changing the structure of their soil communities, and that this is an important regulator of plant community structure.	Univ Guelph, Dept Bot, Guelph, ON N1G 2W1, Canada	University of Guelph	Klironomos, JN (corresponding author), Univ Guelph, Dept Bot, Guelph, ON N1G 2W1, Canada.							Anderson TH., 1980, COMPENDIUM SOIL FUNG, V1; [Anonymous], 1994, RARITY; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Blomqvist MM, 2000, OIKOS, V90, P582, DOI 10.1034/j.1600-0706.2000.900316.x; BRAGULAT MR, 1991, APPL ENVIRON MICROB, V57, P2777, DOI 10.1128/AEM.57.9.2777-2780.1991; BURDON JJ, 1987, CAMBRIDGE STUDIES EC; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Huston, 1994, BIOL DIVERSITY COEXI; KLIRONOMOS JN, 1993, CAN J BOT, V71, P1472, DOI 10.1139/b93-178; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Milton WEJ, 1940, J ECOL, V28, P326, DOI 10.2307/2256233; Olff H, 2000, OECOLOGIA, V125, P45, DOI 10.1007/PL00008890; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; PYSEK P, 1995, PLANT INVASIONS GEN; RABINOWITZ D, 1989, AM NAT, V134, P525, DOI 10.1086/284995; Reader RJ, 1998, PLANT ECOL, V134, P43, DOI 10.1023/A:1009700100343; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; TILMAN D, 1994, BIODIVERSITY ECOSYST, P327; Tokeshi M, 1999, SPECIES COEXISTENCE; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Putten WH, 2000, NATURE, V404, P232, DOI 10.1038/35005188; VANDERPUTTEN WH, 1993, NATURE, V362, P53; [No title captured]	27	1248	1335	34	883	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					67	70		10.1038/417067a	http://dx.doi.org/10.1038/417067a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986666				2022-12-24	WOS:000175307200038
J	Ben-Yehuda, S; Losick, R				Ben-Yehuda, S; Losick, R			Asymmetric cell division in B-subtilis involves a spiral-like intermediate of the cytokinetic protein FtsZ	CELL			English	Article							ESCHERICHIA-COLI-CELLS; BACILLUS-SUBTILIS; SPORULATION; TRANSCRIPTION; SPOIIE; LOCALIZATION; ACTIVATION; SEPTATION; MUTANTS; RING	A fundamental feature of development in the spore-forming bacterium Bacillus subtilis is the switch from medial to asymmetric division. The switch is brought about by a change in the location of the cytokinetic Z ring, which is composed of the tubulin-like protein FtsZ, from the cell middle to the poles during sporulation. We report that the medial Z ring is replaced by a spiral-like filament of FtsZ that grows along the long axis of the cell. We propose that the filament mediates the switch by redeploying FtsZ to the poles. Spiral formation and the switch to polar Z rings are largely caused by a sporulation-specific increase in transcription of the gene for FtsZ and activation of the gene for the FtsZ-assoclated protein SpollE.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 18568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Barak I, 1996, J BACTERIOL, V178, P4984, DOI 10.1128/jb.178.16.4984-4989.1996; Barak I, 1998, J BACTERIOL, V180, P5327; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; DUNN G, 1976, J BACTERIOL, V125, P776, DOI 10.1128/JB.125.3.776-779.1976; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Erickson HP, 2000, J CELL BIOL, V148, P1103, DOI 10.1083/jcb.148.6.1103; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Flardh K, 2000, MOL MICROBIOL, V38, P737, DOI 10.1046/j.1365-2958.2000.02177.x; GHOLAMHOSEINIAN A, 1992, J BACTERIOL, V174, P4647, DOI 10.1128/JB.174.14.4647-4656.1992; GONZYTREBOUL G, 1992, J MOL BIOL, V224, P967, DOI 10.1016/0022-2836(92)90463-T; Harwood C. R., 1990, MOL BIOL METHODS BAC; Hatt JK, 1998, J BACTERIOL, V180, P3584, DOI 10.1128/JB.180.14.3584-3591.1998; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Khvorova A, 1998, J BACTERIOL, V180, P1256, DOI 10.1128/JB.180.5.1256-1260.1998; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Kwak J, 2001, J BACTERIOL, V183, P5092, DOI 10.1128/JB.183.17.5092-5101.2001; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; LEWIS PJ, 1994, P NATL ACAD SCI USA, V91, P3849, DOI 10.1073/pnas.91.9.3849; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Ma XL, 1997, J BACTERIOL, V179, P6788, DOI 10.1128/jb.179.21.6788-6797.1997; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Parker GF, 1996, MICROBIOL-UK, V142, P3445, DOI 10.1099/13500872-142-12-3445; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schwedock J, 1997, MOL MICROBIOL, V25, P847, DOI 10.1111/j.1365-2958.1997.mmi507.x; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	47	249	257	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					257	266		10.1016/S0092-8674(02)00698-0	http://dx.doi.org/10.1016/S0092-8674(02)00698-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007411	Bronze			2022-12-24	WOS:000175082600014
J	Phillips, BL				Phillips, BL			Skydiving	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2002	288	1					16	16		10.1001/jama.288.1.16	http://dx.doi.org/10.1001/jama.288.1.16			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	568YW	12090848				2022-12-24	WOS:000176573400001
J	Wood, RA; Grotzinger, JP; Dickson, JAD				Wood, RA; Grotzinger, JP; Dickson, JAD			Proterozoic modular biomineralized metazoan from the Nama Group, Namibia	SCIENCE			English	Article							SHELLY FOSSILS; EVOLUTION; ORIGINS; CORALS; SPONGES; AFRICA; FAUNA	We describe a Proterozoic, fully biomineralized metazoan from the Omkyk Member (similar to million years before the present) of the northern Nama Group, Namibia. Namapoikia rietoogensis gen. et sp. nov. is up to 1 meter in diameter and bears a complex and robust biomineralized skeleton; it probably represents a cnidarian or poriferan. Namapoikia encrusts perpendicular to the walls of vertical synsedimentary fissures in microbial reefs. This finding implies that large, modular metazoans with biologically controlled mineralization appeared some 15 million years earlier than previously documented.	Schlumberger Cambridge Res Ltd, Cambridge CB2 OEL, England; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Schlumberger; University of Cambridge; Massachusetts Institute of Technology (MIT)	Wood, RA (corresponding author), Schlumberger Cambridge Res Ltd, High Cross,Madingley Rd, Cambridge CB2 OEL, England.							Bengtson S., 1992, TOP GEOBIOL, V20, P447; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; Brasier M, 1997, GEOLOGY, V25, P303, DOI 10.1130/0091-7613(1997)025<0303:ESSCFS>2.3.CO;2; BRASIER MD, 1989, PRECAMBRIAN CAMBRIAN, P117; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; GRANT SWF, 1990, AM J SCI, V290A, P261; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; GROTZINGER JP, IN PRESS COMMUN GEOL; Hofmann HJ, 2001, GEOLOGY, V29, P1091, DOI 10.1130/0091-7613(2001)029<1091:NCAINM>2.0.CO;2; Jensen S, 2000, GEOLOGY, V28, P143, DOI 10.1130/0091-7613(2000)028<0143:CTFFTT>2.3.CO;2; KOBLUK DR, 1984, J PALEONTOL, V58, P703; KOBLUK DR, 1979, CAN J EARTH SCI, V16, P2040, DOI 10.1139/e79-189; Narbonne GM, 1997, J PALEONTOL, V71, P953, DOI 10.1017/S0022336000035940; Reitner Joachim, 1992, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V1, P1; Romano SL, 2000, B MAR SCI, V67, P1043; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; Scrutton C.T., 1979, ORIGIN MAJOR INVERTE, V12, P161; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Watters WA, 2001, PALEOBIOLOGY, V27, P159, DOI 10.1666/0094-8373(2001)027<0159:DROCEM>2.0.CO;2; WOOD R, 1990, AM SCI, V78, P224; Wood R., 1999, REEF EVOLUTION; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; ZHURAVLEV AY, 1999, PALEONTOL J, V33, P502	27	138	142	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2383	2386		10.1126/science.1071599	http://dx.doi.org/10.1126/science.1071599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089440				2022-12-24	WOS:000176467200038
J	Lee, SB; Mitchell, DT; Trofin, L; Nevanen, TK; Soderlund, H; Martin, CR				Lee, SB; Mitchell, DT; Trofin, L; Nevanen, TK; Soderlund, H; Martin, CR			Antibody-based bio-nanotube membranes for enantiomeric drug separations	SCIENCE			English	Article							IMMUNOAFFINITY CHROMATOGRAPHY; FACILITATED TRANSPORT; OPTICAL RESOLUTION; AMINO-ACIDS; POLYMERIC MEMBRANES; SERUM-ALBUMIN; AFFINITY; MUTAGENESIS; SELECTIVITY; SITE	Synthetic bio-nanotube membranes were developed and used to separate two enantiomers of a chiral drug. These membranes are based on alumina films that have cylindrical pores with monodisperse nanoscopic diameters (for example, 20 nanometers). Silica nanotubes were chemically synthesized within the pores of these films, and an antibody that selectively binds one of the enantiomers of the drug was attached to the inner walls of the silica nanotubes. These membranes selectively transport the enantiomer that specifically binds to the antibody, relative to the enantiomer that has lower affinity for the antibody. The solvent dimethyl sulfoxide was used to tune the antibody binding affinity. The enantiomeric selectivity coefficient increases as the inside diameter of the silica nanotubes decreases.	Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Ctr Res BioNano Interface, Gainesville, FL 32611 USA; VTT Biotechnol, FIN-02044 Espoo, Finland	State University System of Florida; University of Florida; State University System of Florida; University of Florida; VTT Technical Research Center Finland	Martin, CR (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.		Lee, Sang Bok/B-4421-2009; Martin, Charles/AAA-1040-2019	Lee, Sang Bok/0000-0003-1375-7099; Nevanen, Tarja/0000-0001-8964-1012				Aoki T, 1997, POLYMER, V38, P235, DOI 10.1016/S0032-3861(96)00630-1; Bayley H, 2000, CHEM REV, V100, P2575, DOI 10.1021/cr980099g; Brinker C.J., 1990, SOL GEL SCI, DOI [10.1016/B978-0-08-057103-4.50013-1, DOI 10.1016/C2009-0-22386-5]; BRUNING C, 1995, CHEM COMMUN, P2323; CHASE HA, 1984, CHEM ENG SCI, V39, P1099; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; CROSBY J, 1991, TETRAHEDRON, V47, P4789, DOI 10.1016/S0040-4020(01)80950-9; FOSS CA, 1994, J PHYS CHEM-US, V98, P2963, DOI 10.1021/j100062a037; HARLOW E, 1988, ANTIBODIES, P8; Hemminki A, 1998, IMMUNOTECHNOLOGY, V4, P59, DOI 10.1016/S1380-2933(98)00002-5; Hemminki A, 1998, PROTEIN ENG, V11, P311, DOI 10.1093/protein/11.4.311; HIGUCHI A, 1994, J MEMBRANE SCI, V93, P157, DOI 10.1016/0376-7388(94)80004-9; Hulteen JC, 1998, J AM CHEM SOC, V120, P6603, DOI 10.1021/ja980045o; Javaid A, 2001, J MEMBRANE SCI, V187, P141, DOI 10.1016/S0376-7388(01)00341-6; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Kim CK, 2001, J PHYS CHEM A, V105, P9024, DOI 10.1021/jp011338y; Kojima K, 2001, J BIOCHEM BIOPH METH, V49, P241, DOI 10.1016/S0165-022X(01)00201-9; Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2001, ANAL CHEM, V73, P768, DOI 10.1021/ac0008901; Lee SB, 2001, CHEM MATER, V13, P3236, DOI 10.1021/cm0101071; LIU C, 1991, NATURE, V352, P50, DOI 10.1038/352050a0; Masuda H, 1996, JPN J APPL PHYS 2, V35, pL126, DOI 10.1143/JJAP.35.L126; MATHEWS CK, 1996, BIOCHEMISTRY-US, P247; Miller SA, 2001, J AM CHEM SOC, V123, P12335, DOI 10.1021/ja011926p; NACHMAN M, 1992, J CHROMATOGR, V597, P167, DOI 10.1016/0021-9673(92)80106-5; Nakamura M, 1998, J CHROMATOGR A, V822, P53, DOI 10.1016/S0021-9673(98)00501-9; Nevanen TK, 2001, J CHROMATOGR A, V925, P89, DOI 10.1016/S0021-9673(01)01021-4; NISHIZAWA M, 1995, SCIENCE, V268, P700, DOI 10.1126/science.268.5211.700; NOBLE RD, 1992, J MEMBRANE SCI, V75, P121, DOI 10.1016/0376-7388(92)80011-8; OVERDEVEST PEM, 1999, SURFACTANT BASED SEP, pCH9; Park YS, 2000, LANGMUIR, V16, P9662, DOI 10.1021/la000466v; Paugam MF, 1996, J AM CHEM SOC, V118, P9820, DOI 10.1021/ja9615076; STUBBINGS D, 1993, ANAL BIOCHEM, V210, P159, DOI 10.1006/abio.1993.1167; Tone S, 1996, J MEMBRANE SCI, V118, P31, DOI 10.1016/0376-7388(96)00071-3; Ward TJ, 2000, ANAL CHEM, V72, P4521, DOI 10.1021/ac000841o; Westmark PR, 1996, J AM CHEM SOC, V118, P11093, DOI 10.1021/ja961264h; Wolpert S, 1997, J MEMBRANE SCI, V132, P23, DOI 10.1016/S0376-7388(97)00011-2; Yang JP, 2000, CHEM MATER, V12, P2693, DOI 10.1021/cm0010506; YELTON DE, 1995, J IMMUNOL, V155, P1994; Yoshikawa M, 1996, MACROMOLECULES, V29, P8197, DOI 10.1021/ma951716v; Yu SF, 2001, NANO LETT, V1, P495, DOI 10.1021/nl010044l	42	592	620	6	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2198	2200		10.1126/science.1071396	http://dx.doi.org/10.1126/science.1071396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077410				2022-12-24	WOS:000176379000051
J	Le Masson, G; Renaud-Le Masson, S; Debay, D; Bal, T				Le Masson, G; Renaud-Le Masson, S; Debay, D; Bal, T			Feedback inhibition controls spike transfer in hybrid thalamic circuits	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; THALAMOCORTICAL OSCILLATIONS; NEURONS; CAT; MECHANISMS; CONDUCTANCES; DYNAMICS; AROUSAL; CELLS; MODEL	Sensory information reaches the cerebral cortex through the thalamus, which differentially relays this input depending on the state of arousal(1-5). Such 'gating' involves inhibition of the thalamocortical relay neurons by the reticular nucleus of the thalamus(6-8), but the underlying mechanisms are poorly understood. We reconstructed the thalamocortical circuit as an artificial and biological hybrid network in vitro. With visual input simulated as retinal cell activity, we show here that when the gain in the thalamic inhibitory feedback loop is greater than a critical value, the circuit tends towards oscillations-and thus imposes a temporal decorrelation of retinal cell input and thalamic relay output. This results in the functional disconnection of the cortex from the sensory drive, a feature typical of sleep states. Conversely, low gain in the feedback inhibition and the action of noradrenaline, a known modulator of arousal(4,9,10), converge to increase input-output correlation in relay neurons. Combining gain control of feedback inhibition and modulation of membrane excitability thus enables thalamic circuits to finely tune the gating of spike transmission from sensory organs to the cortex.	Inst Neurobiol Alfred Fessard, CNRS, UPR 2191, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France; Univ Bordeaux 2, Inst Francois Magendie, Lab Physiopathol Reseaux Neuronaux Medullaires, INSERM,EPI 9914, F-33077 Bordeaux, France; Univ Bordeaux 1, ENSEIRB, CNRS, UMR 5818,Lab IXL, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Bal, T (corresponding author), Inst Neurobiol Alfred Fessard, CNRS, UPR 2191, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France.	thierry.bal@iaf.cnrs-gif.fr		Renaud, Sylvie/0000-0001-5632-7991				AHLSEN G, 1985, EXP BRAIN RES, V58, P134; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; Bal T, 2000, J NEUROSCI, V20, P7478; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; FUNKE K, 1993, J PHYSIOL-LONDON, V463, P169, DOI 10.1113/jphysiol.1993.sp019590; Kim U, 1998, J NEUROSCI, V18, P9500; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Le Masson S, 1999, IEEE T BIO-MED ENG, V46, P638, DOI 10.1109/10.764940; Lee CC, 1996, AM J NEURORADIOL, V17, P321; LeMasson G, 1995, PROG BIOPHYS MOL BIO, V64, P201, DOI 10.1016/S0079-6107(96)00004-1; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SNEAD OC, 1995, ANN NEUROL, V37, P146, DOI 10.1002/ana.410370204; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1997, THALAMUS ORG FUNCTIO, P533; TROY JB, 1992, VISUAL NEUROSCI, V9, P535, DOI 10.1017/S0952523800001784; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Williams SR, 2000, J NEUROSCI, V20, P1307; Yingling C.D., 1977, PROG CLIN NEUROPHYS, V1, P70	30	153	155	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2002	417	6891					854	858		10.1038/nature00825	http://dx.doi.org/10.1038/nature00825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075353				2022-12-24	WOS:000176285600048
J	Panting, JR; Gatehouse, PD; Yang, GZ; Grothues, F; Firmin, DN; Collins, P; Pennell, DJ				Panting, JR; Gatehouse, PD; Yang, GZ; Grothues, F; Firmin, DN; Collins, P; Pennell, DJ			Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NORMAL CORONARY ARTERIOGRAMS; LEFT-VENTRICULAR FUNCTION; MYOCARDIAL BLOOD-FLOW; ANGINA-PECTORIS; CHEST-PAIN; ARTERY-DISEASE; VASODILATOR RESERVE; LACTATE PRODUCTION; ISCHEMIA; DYSFUNCTION	Background: In cardiac syndrome X (a syndrome characterized by typical angina, abnormal exercise-test results, and normal coronary arteries), conventional investigations have not found that chest pain is due to myocardial ischemia. Magnetic resonance techniques have higher resolution and therefore may be more sensitive. Methods: We performed myocardial-perfusion cardiovascular magnetic resonance imaging in 20 patients with syndrome X and 10 matched controls, both at rest and during an infusion of adenosine. Quantitative perfusion analysis was performed by using the normalized upslope of myocardial signal enhancement to derive the myocardial perfusion index and the myocardial-perfusion reserve index (defined as the ratio of the myocardial perfusion index during stress to the index at rest). Results: In the controls, the myocardial perfusion index increased in both myocardial layers with adenosine (in the subendocardium, from a mean [+/-SD] of 0.12+/-0.03 to 0.16+/-0.03 [P=0.02]; in the subepicardium, from 0.11+/-0.02 to 0.17+/-0.05 [P=0.002]); in patients with syndrome X, the myocardial perfusion index did not change significantly in the subendocardium (0.13+/-0.02 vs. 0.14+/-0.03, P=0.11; P=0.09 as compared with controls) but increased in the subepicardium (from 0.11+/-0.02 to 0.20+/-0.04, P<0.001; P=0.11 for the comparison with controls). Adenosine provoked chest pain in 95 percent of patients with syndrome X and 40 percent of controls (P<0.001). Conclusions: In patients with syndrome X, cardiovascular magnetic resonance imaging demonstrates subendocardial hypoperfusion during the intravenous administration of adenosine, which is associated with intense chest pain. These data support the notion that the chest pain may have an ischemic cause.	Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England; Royal Brompton Hosp, Dept Cardiovasc Med, London SW3 6NP, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London; Imperial College London	Pennell, DJ (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Sydney St, London SW3 6NP, England.			Pennell, Dudley/0000-0001-5523-1314; Firmin, David/0000-0003-3894-7489; Gatehouse, Peter/0000-0002-0260-4719				Al-Saadi N, 2000, CIRCULATION, V101, P1379, DOI 10.1161/01.CIR.101.12.1379; ARBOGAST R, 1973, AM J CARDIOL, V32, P257, DOI 10.1016/S0002-9149(73)80130-4; Bellamy MF, 1998, CARDIOVASC RES, V40, P410, DOI 10.1016/S0008-6363(98)00184-9; BOUDOULAS H, 1974, AM J CARDIOL, V34, P501, DOI 10.1016/0002-9149(74)90118-0; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Buffon A, 2000, AM J PHYSIOL-HEART C, V279, pH2627, DOI 10.1152/ajpheart.2000.279.6.H2627; CAMICI PG, 1992, CIRCULATION, V86, P179, DOI 10.1161/01.CIR.86.1.179; CAMICI PG, 1991, J AM COLL CARDIOL, V17, P1461, DOI 10.1016/0735-1097(91)90632-J; CANNON RO, 1985, CIRCULATION, V71, P218, DOI 10.1161/01.CIR.71.2.218; CANNON RO, 1983, J AM COLL CARDIOL, V1, P1359, DOI 10.1016/S0735-1097(83)80037-0; CANNON RO, 1988, AM J CARDIOL, V61, P1338, DOI 10.1016/0002-9149(88)91180-0; CANTY JM, 1985, CIRCULATION, V71, P370, DOI 10.1161/01.CIR.71.2.370; Cullen JHS, 1999, J AM COLL CARDIOL, V33, P1386, DOI 10.1016/S0735-1097(99)00004-2; EMDIN M, 1989, J AM COLL CARDIOL, V14, P1450, DOI 10.1016/0735-1097(89)90380-X; GALASSI AR, 1993, AM J CARDIOL, V72, P134, DOI 10.1016/0002-9149(93)90148-6; GREENBERG MA, 1987, J AM COLL CARDIOL, V9, P743, DOI 10.1016/S0735-1097(87)80227-9; KASKI JC, 1995, J AM COLL CARDIOL, V25, P807, DOI 10.1016/0735-1097(94)00507-M; KASKI JC, 1991, J AM COLL CARDIOL, V18, P50, DOI 10.1016/S0735-1097(10)80216-5; Keijer JT, 2000, J CARDIOV MAGN RESON, V2, P189, DOI 10.3109/10976640009146567; KEMP HG, 1986, J AM COLL CARDIOL, V7, P479, DOI 10.1016/S0735-1097(86)80456-9; KEMP HG, 1973, AM J CARDIOL, V32, P375, DOI 10.1016/S0002-9149(73)80150-X; Lanza GA, 1997, CIRCULATION, V96, P821; Lauerma K, 1997, CIRCULATION, V96, P2859, DOI 10.1161/01.CIR.96.9.2859; LEGRAND V, 1985, J AM COLL CARDIOL, V6, P1245, DOI 10.1016/S0735-1097(85)80209-6; MASERI A, 1991, J AM COLL CARDIOL, V17, P499, DOI 10.1016/S0735-1097(10)80122-6; Meeder JG, 1995, EUR HEART J, V16, P1571, DOI 10.1093/oxfordjournals.eurheartj.a060780; NIHOYANNOPOULOS P, 1991, J AM COLL CARDIOL, V18, P1463, DOI 10.1016/0735-1097(91)90676-Z; OPHERK D, 1981, CIRCULATION, V63, P817, DOI 10.1161/01.CIR.63.4.817; OPHERK D, 1989, CIRCULATION, V80, P1610, DOI 10.1161/01.CIR.80.6.1610; ROSEN SD, 1994, CIRCULATION, V90, P50, DOI 10.1161/01.CIR.90.1.50; Schwitter J, 2001, CIRCULATION, V103, P2230; TWEDDEL AC, 1992, BRIT HEART J, V68, P48; WILKE N, 1993, MAGNET RESON MED, V29, P485, DOI 10.1002/mrm.1910290410; Wood D, 1998, HEART, V80, pS1	34	543	567	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2002	346	25					1948	1953		10.1056/NEJMoa012369	http://dx.doi.org/10.1056/NEJMoa012369			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563QC	12075055				2022-12-24	WOS:000176266200003
J	Macian, F; Garcia-Cozar, F; Im, SH; Horton, HF; Byrne, MC; Rao, A				Macian, F; Garcia-Cozar, F; Im, SH; Horton, HF; Byrne, MC; Rao, A			Transcriptional mechanisms underlying lymphocyte tolerance	CELL			English	Article							T-CELL ANERGY; NEGATIVE REGULATION; GENE-EXPRESSION; SELF-TOLERANCE; ACTIVATION; RECEPTOR; PROTEIN; NFAT; CLEAVAGE; IL-2	In lymphocytes, integration of Call and other signaling pathways results in productive activation, while unopposed Call signaling leads to tolerance or anergy. We show that the Ca2+-regulated transcription factor NFAT has an integral role in both aspects of lymphocyte function. Ca2+/calcineurin signaling induces a limited set of anergy-associated genes, distinct from genes induced in the productive immune response; these genes are upregulated in vivo in tolerant T cells and are largely NFAT dependent. T cells lacking NFAT1 are resistant to anergy induction; conversely, NFAT1 induces T cell anergy if prevented from interacting with its transcriptional partner AP-1 (Fos/Jun). Thus, in the absence of AP-1, NFAT imposes a genetic program of lymphocyte anergy that counters the program of productive activation mediated by the cooperative NFAT:AP-1 complex.	Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Garcia-Cozar, Francisco/A-6212-2013; Im, Sin-Hyeog/E-6811-2013; Im, Sin-Hyeog/AAM-9586-2021	Garcia-Cozar, Francisco/0000-0003-3720-259X; Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Macian, Fernando/0000-0003-2666-035X	NCI NIH HHS [CA42471] Funding Source: Medline; NIAID NIH HHS [AI48213] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Garside P, 2001, SEMIN IMMUNOL, V13, P177, DOI 10.1006/smim.2001.0310; Gastman BR, 1999, CANCER RES, V59, P1422; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074/jbc.273.39.25185; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hofmann TG, 2000, ONCOGENE, V19, P1153, DOI 10.1038/sj.onc.1203406; JAIN JN, 1993, J IMMUNOL, V151, P837; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Li XC, 2000, CURR OPIN IMMUNOL, V12, P522, DOI 10.1016/S0952-7915(00)00133-3; Li YS, 1998, TRANSPLANTATION, V66, P1387, DOI 10.1097/00007890-199811270-00021; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.0.CO;2-1; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SloanLancaster J, 1996, J EXP MED, V184, P1525, DOI 10.1084/jem.184.4.1525; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Telander DG, 1999, J IMMUNOL, V162, P1460; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yankee TM, 2001, P NATL ACAD SCI USA, V98, P6789, DOI 10.1073/pnas.111158598	61	528	561	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 14	2002	109	6					719	731		10.1016/S0092-8674(02)00767-5	http://dx.doi.org/10.1016/S0092-8674(02)00767-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086671	Bronze			2022-12-24	WOS:000176265600003
J	Merrell, DS; Butler, SM; Qadri, F; Dolganov, NA; Alam, A; Cohen, MB; Calderwood, SB; Schoolnik, GK; Camilli, A				Merrell, DS; Butler, SM; Qadri, F; Dolganov, NA; Alam, A; Cohen, MB; Calderwood, SB; Schoolnik, GK; Camilli, A			Host-induced epidemic spread of the cholera bacterium	NATURE			English	Article							VIBRIO-CHOLERAE; GENE-EXPRESSION; DNA MICROARRAY; TOXR REGULON; VIRULENCE; INFECTION; MOTILITY	The factors that enhance the transmission of pathogens during epidemic spread are ill defined. Water-borne spread of the diarrhoeal disease cholera occurs rapidly in nature, whereas infection of human volunteers with bacteria grown in vitro is difficult in the absence of stomach acid buffering(1). It is unclear, however, whether stomach acidity is a principal factor contributing to epidemic spread(2). Here we report that characterization of Vibrio cholerae from human stools supports a model whereby human colonization creates a hyperinfectious bacterial state that is maintained after dissemination and that may contribute to epidemic spread of cholera. Transcriptional profiling of V. cholerae from stool samples revealed a unique physiological and behavioural state characterized by high expression levels of genes required for nutrient acquisition and motility, and low expression levels of genes required for bacterial chemotaxis.	Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; Int Ctr Diarrhoeal Dis Res, Dhaka 1212, Bangladesh; Stanford Univ, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Tufts University; International Centre for Diarrhoeal Disease Research (ICDDR); Stanford University; Cincinnati Children's Hospital Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Camilli, A (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	Andrew.Camilli@Tufts.edu	Al, Mamun M./AAF-5850-2019; Qadri, Firdausi/AAF-4583-2019	Cohen, Mitchell/0000-0002-4412-350X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI045746-02, R01 AI045746] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045746] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; Carroll PA, 1997, MOL MICROBIOL, V25, P1099, DOI 10.1046/j.1365-2958.1997.5371901.x; CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; FRETER R, 1961, J INFECT DIS, V109, P35, DOI 10.1093/infdis/109.1.35; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GITELSON S, 1971, ISRAEL J MED SCI, V7, P663; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Lee SH, 2001, P NATL ACAD SCI USA, V98, P6889, DOI 10.1073/pnas.111581598; Merrell DS, 1999, MOL MICROBIOL, V34, P836, DOI 10.1046/j.1365-2958.1999.01650.x; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MILLER VL, 1984, P NATL ACAD SCI-BIOL, V81, P3471, DOI 10.1073/pnas.81.11.3471; RICHARDSON K, 1991, INFECT IMMUN, V59, P2727, DOI 10.1128/IAI.59.8.2727-2736.1991; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schoolnik GK, 2001, METHOD ENZYMOL, V336, P3, DOI 10.1016/S0076-6879(01)36573-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	18	368	397	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2002	417	6889					642	645		10.1038/nature00778	http://dx.doi.org/10.1038/nature00778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050664	Green Accepted, Bronze			2022-12-24	WOS:000176001200046
J	Jernvall, J; Fortelius, M				Jernvall, J; Fortelius, M			Common mammals drive the evolutionary increase of hypsodonty in the Neogene	NATURE			English	Article							DIVERSIFICATION; ECOLOGY	During the past 20 million years, herbivorous mammals of numerous lineages have evolved hypsodont, or high-crowned, cheek teeth. Hypsodonty is informative ecologically because it is well developed in mammals eating fibrous and abrasive foods that are most abundant in open and generally or seasonally dry environments(1-5). Here we report that in the Neogene of Europe mammals with the greatest locality coverages showed an increase in hypsodonty. We used a data set of 209 localities to measure whether large mammals occurring in many fossil localities show a similar increase in hypsodonty to mammals occurring in single or few localities. Taxonomic and morphological groupings show a low average hypsodonty in the early Miocene epoch. From the middle Miocene onwards, only the hypsodonty of commonly found mammals shows a marked increase. Therefore, in the drying Europe of the late Miocene, only increasingly hypsodont mammals may have been able to expand their share of habitats and food resources. These results suggest that the relatively small number of species known from multiple localities are palaeoecologically informative by themselves, irrespective of the rest of the known species.	Univ Helsinki, Inst Biotechnol, Dev Biol Programme, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Systemat & Ecol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Geol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Jernvall, J (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Programme, POB 56, FIN-00014 Helsinki, Finland.	mikael.fortelius@helsinki.fi	Self, Casey J/B-6871-2011					Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; ALROY J, 1998, HIST GEOL, V38, P243; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Broccoli A.J., 1997, TECTONIC UPLIFT CLIM, P89; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; Fortelius M., 1996, P414; FORTELIUS M, 2001, PHYLOGENY NEOGNE HOM; Garces M, 1997, GEOLOGY, V25, P19, DOI 10.1130/0091-7613(1997)025<0019:OWFADO>2.3.CO;2; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; JANIS CM, 1982, BIOL REV, V57, P216; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Jernvall Jukka, 1995, Acta Zoologica Fennica, V198, P1; MacFadden Bruce J., 2000, P223, DOI 10.1017/CBO9780511549717.009; Manly B. F. J, 1997, RANDOMIZATION BOOTST; MEIN P, 1989, NATO ADV SCI I A-LIF, V180, P73; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Perez-Barberia FJ, 2001, EVOL ECOL RES, V3, P221; Ruddiman W. F., 1997, TECTONIC UPLIFT CLIM; Simpson G.G., 1951, HORSES; Steininger F. F, 1996, EVOLUTION W EURASIAN, P7; VANVALEN L, 1960, EVOLUTION, V14, P531	24	127	135	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					538	540		10.1038/417538a	http://dx.doi.org/10.1038/417538a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037565				2022-12-24	WOS:000175860300039
J	Srinivasan, G; James, CM; Krzycki, JA				Srinivasan, G; James, CM; Krzycki, JA			Pyrrolysine encoded by UAG in Archaea: Charging of a UAG-decoding specialized tRNA	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASES; METHANOSARCINA-BARKERI; SEQUENCE; GENES; MONOMETHYLAMINE; RECOGNITION; DATABASE; BINDING; DOMAIN	Pyrrolysine is a lysine derivative encoded by the UAG codon in methylamine methyltransferase genes of Methanosarcina barkeri. Near a methyltransferase gene cluster is the pylT gene, which encodes an unusual transfer RNA (tRNA) with a CUA anticodon. The adjacent pylS gene encodes a class II aminoacyl-tRNA synthetase that charges the pylT-derived tRNA with lysine but is not closely related to known lysyl-tRNA synthetases. Homologs of pylS and pylT are found in a Gram-positive bacterium. Charging a tRNA(CUA) with lysine is a likely first step in translating UAG amber codons as pyrrolysine in certain methanogens. Our results indicate that pyrrolysine is the 22nd genetically encoded natural amino acid.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.							Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERGUSON T, UNPUB; FREIST W, 1995, BIOL CHEM HOPPESEYLE, V276, P451; GALE AJ, 1995, BIOCHEMISTRY-US, V34, P8896, DOI 10.1021/bi00027a042; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; SRINIVASAN G, UNPUB; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000	26	420	446	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1459	1462		10.1126/science.1069588	http://dx.doi.org/10.1126/science.1069588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029131				2022-12-24	WOS:000175910300046
J	Zhuang, XW; Kim, H; Pereira, MJB; Babcock, HP; Walter, NG; Chu, S				Zhuang, XW; Kim, H; Pereira, MJB; Babcock, HP; Walter, NG; Chu, S			Correlating structural dynamics and function in single ribozyme molecules	SCIENCE			English	Article							HAIRPIN RIBOZYME; CLEAVAGE MECHANISM; TERTIARY STRUCTURE; RNA; CATALYSIS; DOMAIN; LOOP	We have studied the correlation between structural dynamics and function of the hairpin ribozyme. The enzyme-substrate complex exists in either docked (active) or undocked (inactive) conformations. Using single-molecule fluorescence methods, we found complex structural dynamics with four docked states of distinct stabilities and a strong memory effect where each molecule rarely switches between different docked states. We also found substrate cleavage to be rate-Limited by a combination of conformational transitions and reversible chemistry equilibrium. The complex structural dynamics quantitatively explain the heterogeneous cleavage kinetics common to many catalytic RNAs. The intimate coupling of structural dynamics and function is likely a general phenomenon for RNA.	Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Stanford University	Walter, NG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.		Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275; Babcock, Hazen/0000-0003-4835-3692	NIGMS NIH HHS [GM62357] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062357] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins J.F, 1999, RNA WORLD; Butcher SE, 1999, NAT STRUCT BIOL, V6, P212; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Earnshaw DJ, 1997, J MOL BIOL, V274, P197, DOI 10.1006/jmbi.1997.1405; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Esteban JA, 1998, P NATL ACAD SCI USA, V95, P6091, DOI 10.1073/pnas.95.11.6091; Esteban JA, 1997, J BIOL CHEM, V272, P13629, DOI 10.1074/jbc.272.21.13629; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Nesbitt SM, 1999, J MOL BIOL, V286, P1009, DOI 10.1006/jmbi.1999.2543; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; Pinard R, 2001, J MOL BIOL, V307, P51, DOI 10.1006/jmbi.2000.4472; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SANTALUCIA J, 1992, SCIENCE, V256, P217, DOI 10.1126/science.1373521; Schutz GJ, 1998, BIOPHYS J, V74, P2223, DOI 10.1016/S0006-3495(98)77931-7; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Walter NG, 1998, CURR OPIN CHEM BIOL, V2, P24, DOI 10.1016/S1367-5931(98)80032-X; Walter NG, 1998, EMBO J, V17, P2378, DOI 10.1093/emboj/17.8.2378; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	29	413	430	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1473	1476		10.1126/science.1069013	http://dx.doi.org/10.1126/science.1069013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029135				2022-12-24	WOS:000175910300050
J	Zimmers, TA; Davies, MV; Koniaris, LG; Haynes, P; Esquela, AF; Tomkinson, KN; McPherron, AC; Wolfman, NM; Lee, SJ				Zimmers, TA; Davies, MV; Koniaris, LG; Haynes, P; Esquela, AF; Tomkinson, KN; McPherron, AC; Wolfman, NM; Lee, SJ			Induction of cachexia in mice by systemically administered myostatin	SCIENCE			English	Article							GROWTH-FACTOR-BETA; MOLECULAR-WEIGHT COMPLEX; INHIBIN-DEFICIENT MICE; SUPERFAMILY MEMBER; BINDING-PROTEIN; HUMAN-PLATELETS; MUSCLE GROWTH; CATTLE; GENE; MUTATIONS	Mice and cattle with genetic deficiencies in myostatin exhibit dramatic increases in skeletal muscle mass, suggesting that myostatin normally suppresses muscle growth. Whether this increased muscling results from prenatal or postnatal lack of myostatin activity is unknown. Here we show that myostatin circulates in the blood of adult mice in a latent form that can be activated by acid treatment Systemic overexpression of myostatin in adult mice was found to induce profound muscle and fat loss analogous to that seen in human cachexia syndromes. These data indicate that myostatin acts systemically in adult animals and may be a useful pharmacologic target in clinical settings such as cachexia, where muscle growth is desired.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Wyeth Pharmaceut Inc, Wyeth Res Div, Cambridge, MA 02140 USA	Johns Hopkins University; Pfizer	Lee, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	sjlee@jhmi.edu	Zimmers, Teresa/AAD-5461-2019	Zimmers, Teresa/0000-0001-7872-0540; Haynes, Paul/0000-0003-1472-8249	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009139, R01CA088866] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA88866, 5 T32 CA09139] Funding Source: Medline; NICHD NIH HHS [R01 HD35887] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLACK K, 1991, ENDOCRINOLOGY, V128, P2657, DOI 10.1210/endo-128-5-2657; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; BULLOUGH WS, 1962, BIOL REV, V37, P307, DOI 10.1111/j.1469-185X.1962.tb01615.x; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; COSTA G, 1981, CANCER TREAT REP, V65, P3; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; GROSVENOR M, 1989, CANCER, V63, P330, DOI 10.1002/1097-0142(19890115)63:2<330::AID-CNCR2820630221>3.0.CO;2-U; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Sakuma K, 2000, BBA-MOL CELL RES, V1497, P77, DOI 10.1016/S0167-4889(00)00044-6; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tisdale MJ, 1999, J NUTR, V129, p243S, DOI 10.1093/jn/129.1.243S; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; ZIMMERS T, UNPUB	30	681	783	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1486	1488		10.1126/science.1069525	http://dx.doi.org/10.1126/science.1069525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029139				2022-12-24	WOS:000175910300054
J	Berglund, GI; Carlsson, GH; Smith, AT; Szoke, H; Henriksen, A; Hajdu, J				Berglund, GI; Carlsson, GH; Smith, AT; Szoke, H; Henriksen, A; Hajdu, J			The catalytic pathway of horseradish peroxidase at high resolution	NATURE			English	Article							X-RAY; RADIATION-DAMAGE; ATOMIC-RESOLUTION; CRYSTAL-STRUCTURE; SYNCHROTRON-RADIATION; ANGSTROM RESOLUTION; PROTEIN CRYSTALS; ACTIVATION; REDUCTASE; ELECTRON	A molecular description of oxygen and peroxide activation in biological systems is difficult, because electrons liberated during X-ray data collection reduce the active centres of redox enzymes catalysing these reactions(1-5). Here we describe an effective strategy to obtain crystal structures for high-valency redox intermediates and present a three-dimensional movie of the X-ray-driven catalytic reduction of a bound dioxygen species in horseradish peroxidase (HRP). We also describe separate experiments in which high-resolution structures could be obtained for all five oxidation states of HRP, showing such structures with preserved redox states for the first time.	Univ Uppsala, Ctr Biomed, Dept Biochem, S-75123 Uppsala, Sweden; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Copenhagen, Dept Chem, Prot Struct Grp, DK-2100 Copenhagen, Denmark	Uppsala University; University of Sussex; University of Copenhagen	Hajdu, J (corresponding author), Univ Uppsala, Ctr Biomed, Dept Biochem, Box 576, S-75123 Uppsala, Sweden.			Smith, Andrew/0000-0002-0926-1878; Henriksen, Anette/0000-0003-4051-5079				[Anonymous], MEM IST GEOL MIN U P; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; CHANCE B, 1984, ARCH BIOCHEM BIOPHYS, V235, P596, DOI 10.1016/0003-9861(84)90234-0; CHANCE B, 1980, FEBS LETT, V112, P178, DOI 10.1016/0014-5793(80)80174-8; Cravens TE, 1997, GEOPHYS RES LETT, V24, P105, DOI 10.1029/96GL03780; Dunford H. B., 1999, HEME PEROXIDASES; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GONZALEZ A, 1994, ACTA CRYSTALLOGR D, V50, P874, DOI 10.1107/S0907444994006311; Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leiros HKS, 2001, ACTA CRYSTALLOGR D, V57, P488, DOI 10.1107/S0907444901000646; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; NAKAJIMA R, 1987, J BIOL CHEM, V262, P2576; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Persson P, 2001, PROTEIN SCI, V10, P2480, DOI 10.1110/ps.ps.26201; Planche L. A., 1810, B PHARM, V<bold>2</bold>, P578; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sjogren T, 2001, J BIOL CHEM, V276, P13072, DOI 10.1074/jbc.M011312200; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Szoke A, 1998, ACTA CRYSTALLOGR A, V54, P543, DOI 10.1107/S0108767397019235; VANWART HE, 1985, J BIOL CHEM, V260, P8372; Veitch NC, 2001, ADV INORG CHEM, V51, P107; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Ziaja B, 2001, PHYS REV B, V64, DOI [10.1103/PhysRevLett.87.214104, 10.1103/PhysRevB.64.214104]	30	707	729	9	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					463	468		10.1038/417463a	http://dx.doi.org/10.1038/417463a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024218				2022-12-24	WOS:000175730900044
J	Gill, RA; Polley, HW; Johnson, HB; Anderson, LJ; Maherali, H; Jackson, RB				Gill, RA; Polley, HW; Johnson, HB; Anderson, LJ; Maherali, H; Jackson, RB			Nonlinear grassland responses to past and future atmospheric CO2	NATURE			English	Article							ELEVATED CO2; CARBON-DIOXIDE; WATER-USE; SOIL; NITROGEN; BIOMASS; DECOMPOSITION; FEEDBACK; LITTER	Carbon sequestration in soil organic matter may moderate increases in atmospheric CO2 concentrations (C-a) as C-a increases to more than 500 mumol mol(-1) this century from interglacial levels of less than 200 mumol mol(-1) (refs 1- 6). However, such carbon storage depends on feedbacks between plant responses to Ca and nutrient availability(7,8). Here we present evidence that soil carbon storage and nitrogen cycling in a grassland ecosystem are much more responsive to increases in past Ca than to those forecast for the coming century. Along a continuous gradient of 200 to 550 mumol mol(-1) (refs 9, 10), increased C-a promoted higher photosynthetic rates and altered plant tissue chemistry. Soil carbon was lost at subambient C-a, but was unchanged at elevated C-a where losses of old soil carbon offset increases in new carbon. Along the experimental gradient in C-a there was a nonlinear, threefold decrease in nitrogen availability. The differences in sensitivity of carbon storage to historical and future C-a and increased nutrient limitation suggest that the passive sequestration of carbon in soils may have been important historically, but the ability of soils to continue as sinks is limited.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; ARS, USDA, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; Univ Texas, Dept Bot, Austin, TX 78713 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University; United States Department of Agriculture (USDA); University of Texas System; University of Texas Austin; Duke University	Gill, RA (corresponding author), Washington State Univ, Program Environm Sci & Reg Planning, Pullman, WA 99164 USA.	rgill@wsu.edu	Gill, Richard/AAC-8137-2021	Gill, Richard/0000-0001-8981-0621; Polley, Herbert/0000-0002-1197-8800; Jackson, Robert/0000-0001-8846-7147				Anderson LJ, 2001, GLOBAL CHANGE BIOL, V7, P693, DOI 10.1046/j.1354-1013.2001.00438.x; Canadell JG, 1996, PLANT SOIL, V187, P391, DOI 10.1007/BF00017102; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; CHICHESTER FW, 1992, SOIL SCI, V153, P237, DOI 10.1097/00010694-199203000-00007; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Follett RF, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P401; Hattenschwiler S, 1996, OECOLOGIA, V106, P172, DOI 10.1007/BF00328596; HOOK PB, 1995, SOIL SCI SOC AM J, V59, P831, DOI 10.2136/sssaj1995.03615995005900030028x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; JACKSON RB, 1994, OECOLOGIA, V98, P257, DOI 10.1007/BF00324212; Johnson HB, 2000, FUNCT ECOL, V14, P388, DOI 10.1046/j.1365-2435.2000.00435.x; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; KORNER C, 1992, SCIENCE, V257, P1672, DOI 10.1126/science.257.5077.1672; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Morgan JA, 2001, GLOBAL CHANGE BIOL, V7, P451, DOI 10.1046/j.1365-2486.2001.00415.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; POLLEY HW, 1993, NATURE, V361, P61, DOI 10.1038/361061a0; Sage RF, 1999, CARBON DIOXIDE ENV S, P289; SCHINDEWOLF U, 1991, J PHYS IV, V1, P77, DOI 10.1051/jp4:1991509; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Tans PP, 1998, SCIENCE, V281, P183, DOI 10.1126/science.281.5374.183; Van Kessel C, 2000, GLOBAL CHANGE BIOL, V6, P123, DOI 10.1046/j.1365-2486.2000.00287.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zak DR, 2000, ECOL APPL, V10, P34, DOI 10.1890/1051-0761(2000)010[0034:ACSNAA]2.0.CO;2	29	252	287	5	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					279	282		10.1038/417279a	http://dx.doi.org/10.1038/417279a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015601				2022-12-24	WOS:000175592100045
J	Hoerger, TJ; Bethke, AD; Richter, A; Sorensen, SW; Engelgau, M; Thompson, T; Narayan, KMV; Williamson, DF; Gregg, E; Zhang, P; Eastman, RC; Fuller, J; Gibbons, CB; Haffner, S; Herman, WH; Howard, B; Ratner, R; Orchard, T				Hoerger, TJ; Bethke, AD; Richter, A; Sorensen, SW; Engelgau, M; Thompson, T; Narayan, KMV; Williamson, DF; Gregg, E; Zhang, P; Eastman, RC; Fuller, J; Gibbons, CB; Haffner, S; Herman, WH; Howard, B; Ratner, R; Orchard, T		CDC Diabet Cost-Effectiveness Grp	Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DIRECT MEDICAL COSTS; SECULAR TRENDS; COMPLICATIONS; MORTALITY; GLUCOSE; STROKE; HEALTH; PRAVASTATIN; MANAGEMENT	Context Several treatment interventions can reduce complications of type 2 diabetes, but their relative cost-effectiveness is not known. Objective To estimate the incremental cost-effectiveness of intensive glycemic control (relative to conventional control), intensified hypertension control, and reduction in serum cholesterol level for patients with type 2 diabetes. Design, Setting, and Patients Cost-effectiveness analysis of a hypothetical cohort of individuals living in the United States, aged 25 years or older, who were newly diagnosed as having type 2 diabetes. The results of the United Kingdom Prospective Diabetes Study (UKPDS) and other studies were used to create a model of disease progression and treatment patterns. Costs were based on those used in community practices in the United States. Interventions Insulin or sulfonylurea therapy for intensive glycemic control; angiotensin-converting enzyme inhibitor or beta-blocker for intensified hypertension control; and pravastatin for reduction of serum cholesterol level. Main Outcome Measures Cost per quality-adjusted life-year (QALY) gained, Costs (in 1997 US dollars) and QALYs were discounted at a 3% annual rate. Results The incremental cost-effectiveness ratio for intensive glycemic control is $41384 per QALY; this ratio increased with age at diagnosis from $9614 per QALY for patients aged 25 to 34 years to $2.1 million for patients aged 85 to 94 years. For intensified hypertension control the cost-effectiveness ratio is -$1959 per QALY. The cost-effectiveness ratio for reduction in serum cholesterol level is $51889 per QALY; this ratio varied by age at diagnosis and is lowest for patients diagnosed between the ages of 45 and 84 years. Conclusions Intensified hypertension control reduces costs and improves health outcomes relative to moderate hypertension control. Intensive glycemic control and reduction in serum cholesterol level increase costs and improve health outcomes. The cost-effectiveness ratios for these 2 interventions are comparable with those of several other frequently adopted health care interventions.	Res Triangle Inst, Res Triangle Pk, NC 27709 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; Cygnus Inc, Redwood City, CA 94063 USA; UCL, London, England; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Univ Texas, Ctr Hlth, San Antonio, TX USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; MedStar Res Inst, Washington, DC USA; Univ Pittsburgh, Pittsburgh, PA USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoerger, TJ (corresponding author), Res Triangle Inst, 3040 Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.		Narayan, K.M. Venkat/J-9819-2012; Richter, Anke/I-9050-2012	Narayan, K.M. Venkat/0000-0001-8621-5405; Hoerger, Thomas/0000-0003-4154-7806; orchard, trevor/0000-0001-9552-3215; Gregg, Edward/0000-0003-2381-6822				ALBERTI KGM, 1995, INT TXB DIABETES MEL; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 1997, Am J Cardiol, V79, P756; [Anonymous], 1995, DIABETES AM; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; *CDCP, 1997, DIAB SURV; *CDCP, 1997, NAT DIAB FACT SHEET; Chapman RH, 2000, MED DECIS MAKING, V20, P451, DOI 10.1177/0272989X0002000409; Cowie CC, 1995, NIH PUBLICATION, V95-1468, P117; DONG F, 1997, EC EVALUATION APPROA; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; ECKMAN MH, 1995, JAMA-J AM MED ASSOC, V273, P712, DOI 10.1001/jama.273.9.712; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Gold MR, 1996, COST EFFECTIVENESS H; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; *HLTH CAR FIN ADM, 2002, DUR MED EQ REG CARR; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kuller LH, 1995, NIH PUBLICATION, P449; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; *MED EC CO, 1997, RED BOOK; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; O'Brien JA, 1998, DIABETES CARE, V21, P1122, DOI 10.2337/diacare.21.7.1122; Ray NF, 1998, DIABETES CARE, V21, P296; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shin AY, 1997, STROKE, V28, P2395, DOI 10.1161/01.STR.28.12.2395; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; TURNER R, 1998, EUR ASS STUD DIAB M; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US BUR CENS, 2002, NAT POP EST 1990; *US DEP HHS, 1994, DHHS PUBL 1; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wingard DL., 1995, DIABETES AM, P429; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001	46	387	392	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2542	2551						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020335				2022-12-24	WOS:000175566200023
J	Lill, JT; Marquis, RJ; Ricklefs, RE				Lill, JT; Marquis, RJ; Ricklefs, RE			Host plants influence parasitism of forest caterpillars	NATURE			English	Article							PHYTOPHAGOUS INSECTS; SPECIES RICHNESS; HERBIVORES; SPECIALIZATION; BUTTERFLIES; EVOLUTION; LARVAE	Patterns of association between herbivores and host plants have been thought to reflect the quality of plants as food resources(1,2) as influenced by plant nutrient composition(3), defences(4,5),and phenology(6). Host-plant-specific enemies, that is, the third trophic level, might also influence the distribution of herbivores across plant species(7-10). However, studies of the evolution of herbivore host range(11-15) have generally not examined the third trophic level, leaving unclear the importance of this factor in the evolution of plant-insect herbivore interactions(16). Analysis of parasitoid rearings by the Canadian Forest Insect Survey shows that parasitism of particular Lepidoptera species is strongly host-plant-dependent, that the pattern of host-plant dependence varies among species of caterpillars, and that some parasitoid species are themselves specialized with respect to tree species. Host-plant-dependent parasitism suggests the possibility of top-down influence on host plant use. Differences in parasitism among particular caterpillar-host plant combinations could select for specialization of host plant ranges within caterpillar communities. Such specialization would ultimately promote the species diversification of Lepidoptera in temperate forests with respect to escape from enemies.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Lill, JT (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.		Lill, John/A-7935-2009					Barbosa P, 2001, ECOLOGY, V82, P698, DOI 10.1890/0012-9658(2001)082[0698:DPOMHO]2.0.CO;2; Barbosa Pedro, 1998, P55, DOI 10.1016/B978-012078147-8/50050-5; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; BROWER LP, 1958, AM NAT, V864, P886; BUSH GL, 1975, ANNU REV ECOL SYST, V6, P339, DOI 10.1146/annurev.es.06.110175.002011; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; COURTNEY SP, 1981, OECOLOGIA, V51, P91, DOI 10.1007/BF00344658; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ELZEN GW, 1983, ENVIRON ENTOMOL, V12, P1873; ENGELS W, 1988, STAT TESTS CATEGORIC; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; GOULD F, 1979, EVOLUTION, V33, P791, DOI [10.1111/j.1558-5646.1979.tb04735.x, 10.2307/2407646]; GREENBLATT JA, 1981, J APPL ECOL, V18, P1, DOI 10.2307/2402474; GROSS P, 1988, ECOLOGY, V69, P1506, DOI 10.2307/1941648; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janzen D.H., 1985, Illinois Natural History Survey Bulletin, V33, P141; KARBAN R, 1983, ECOLOGY, V64, P636, DOI 10.2307/1937182; Le Corff J, 2000, ENVIRON ENTOMOL, V29, P181, DOI 10.1603/0046-225X(2000)029[0181:TASVIA]2.0.CO;2; MCGUGAN BM, 1958, P 10 INT C ENT, V4, P219; MUELLER TF, 1983, ENTOMOL EXP APPL, V34, P78, DOI 10.1007/BF00300903; OHSAKI N, 1994, ECOLOGY, V75, P59, DOI 10.2307/1939382; RAUSHER MD, 1985, J INSECT PHYSIOL, V31, P873, DOI 10.1016/0022-1910(85)90105-2; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; Weseloh Ronald M., 1993, P203; WOOD TK, 1990, EVOLUTION, V44, P619, DOI 10.1111/j.1558-5646.1990.tb05942.x	30	148	161	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					170	173		10.1038/417170a	http://dx.doi.org/10.1038/417170a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000959				2022-12-24	WOS:000175460200042
J	McLellan, JS; Marcos, S; Prieto, PM; Burns, SA				McLellan, JS; Marcos, S; Prieto, PM; Burns, SA			Imperfect optics may be the eye's defence against chromatic blur	NATURE			English	Article							ABERRATION	The optics of the eye cause different wavelengths of light to be differentially focused at the retina. This phenomenon is due to longitudinal chromatic aberration, a wavelength-dependent change in refractive power(1). Retinal image quality may consequently vary for the different classes of cone photoreceptors, cells tuned to absorb bands of different wavelengths. For instance, it has been assumed that when the eye is focused for mid-spectral wavelengths near the peak sensitivities of long- (L) and middle( M) wavelength-sensitive cones, short-wavelength (bluish) light is so blurred that it cannot contribute to and may even impair spatial vision(2,3). These optical effects have been proposed to explain the function of the macular pigment(4), which selectively absorbs short-wavelength light, and the sparsity of short-wavelength-sensitive (S) cones(5). However, such explanations have ignored the effect of monochromatic wave aberrations present in real eyes. Here we show that, when these effects are taken into account, short wavelengths are not as blurred as previously thought, that the potential image quality for S cones is comparable to that for L and M cones, and that macular pigment has no significant function in improving the retinal image.	Schepens Eye Res Inst, Boston, MA 02114 USA; CSIC, Inst Opt, E-28006 Madrid, Spain; Univ Murcia, Lab Opt, E-30071 Murcia, Spain	Harvard University; Schepens Eye Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes); University of Murcia	McLellan, JS (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	mclellan@vision.eri.harvard.edu	Burns, Stephen/AAN-3044-2021; Burns, Stephen A/D-9259-2011; Prieto, Pedro M/A-7346-2008; Marcos, Susana/A-7765-2008	Burns, Stephen A/0000-0001-5348-035X; Prieto, Pedro M/0000-0001-6192-4053; Marcos, Susana/0000-0001-5511-1697	NEI NIH HHS [R01 EY004395, R01 EY004395-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004395] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BEDFORD RE, 1957, J OPT SOC AM, V47, P564; Boynton R. M., 1979, HUMAN COLOR VISION; HAEGERSTROMPORTNOY G, 1988, J OPT SOC AM A, V5, P2140, DOI 10.1364/JOSAA.5.002140; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Marcos S, 1999, VISION RES, V39, P4309, DOI 10.1016/S0042-6989(99)00145-5; Marcos S, 2001, VISION RES, V41, P3861, DOI 10.1016/S0042-6989(01)00133-X; McLellan JS, 2001, INVEST OPHTH VIS SCI, V42, P1390; MOLLON JD, 1989, J EXP BIOL, V146, P21; Mollon JD, 1982, DOC OPHTHALMOL P SER, V33, P87; Porter J, 2001, J OPT SOC AM A, V18, P1793, DOI 10.1364/JOSAA.18.001793; READING VM, 1974, J OPT SOC AM, V64, P231, DOI 10.1364/JOSA.64.000231; RYNDERS M, 1995, J OPT SOC AM A, V12, P2348, DOI 10.1364/JOSAA.12.002348; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P548, DOI 10.1097/00006324-199707000-00024; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; WYSECKI G, 1982, COLOR SCI CONCEPTS M	17	113	122	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					174	176		10.1038/417174a	http://dx.doi.org/10.1038/417174a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000960				2022-12-24	WOS:000175460200043
J	Launay, P; Fleig, A; Perraud, AL; Scharenberg, AM; Penner, R; Kinet, JP				Launay, P; Fleig, A; Perraud, AL; Scharenberg, AM; Penner, R; Kinet, JP			TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization	CELL			English	Article							COLLECTING DUCT CELLS; APICAL MEMBRANE; CALCIUM; ACTIVATION; PROTEIN; INFLUX; SYSTEM; LTRPC2; ENTRY; CA2+	Calcium-activated nonselective (CAN) cation channels are expressed in various excitable and nonexcitable cells supporting important cellular responses such as neuronal bursting activity, fluid secretion, and cardiac rhythmicity. We have cloned and characterized a second form of TRPM4, TRPM4b, a member of the TRP channel family, as a molecular candidate of a CAN channel. TRPM4b encodes a cation channel of 25 pS unitary conductance that is directly activated by [Ca2+]i with an apparent K-D of similar to400 nM. It conducts monovalent cations such as Na+ and K+ without significant permeation of Ca2+. TRPM4b is activated following receptor-mediated Ca2+ mobilization, representing a regulatory mechanism that controls the magnitude of Call influx by modulating the membrane potential and, with it, the driving force for Ca2+ entry through other Ca2+-permeable pathways.	Univ Hawaii, John A Burns Sch Med, Queens Med Ctr, Ctr Biomed Res,Lab Cell & Mol Signalling, Honolulu, HI 96813 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA	The Queen's Medical Center; University of Hawaii System; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle	Penner, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Queens Med Ctr, Ctr Biomed Res,Lab Cell & Mol Signalling, Honolulu, HI 96813 USA.		Launay, Pierre/AAH-7076-2019	Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050200, R01AI046734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI46734, R01 AI50200] Funding Source: Medline; NIGMS NIH HHS [R01 GM64091] Funding Source: Medline; NINDS NIH HHS [R01 NS40927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Chiba T, 2000, J MEMBRANE BIOL, V174, P167, DOI 10.1007/s002320001041; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; EHARA T, 1988, J PHYSIOL-LONDON, V403, P117, DOI 10.1113/jphysiol.1988.sp017242; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Floto RA, 1997, J BIOL CHEM, V272, P4753, DOI 10.1074/jbc.272.8.4753; Gao ZH, 1999, J BIOL CHEM, V274, P5972, DOI 10.1074/jbc.274.9.5972; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; MARUYAMA Y, 1982, NATURE, V299, P159, DOI 10.1038/299159a0; MCKEMY DD, 2002, IN PRESS NATURE; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NONAKA T, 1995, BBA-BIOMEMBRANES, V1233, P163, DOI 10.1016/0005-2736(94)00241-G; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARTRIDGE LD, 1994, BRAIN RES REV, V19, P319, DOI 10.1016/0165-0173(94)90017-5; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; RAZANIBOROUJERDI S, 1993, BRAIN RES, V623, P195, DOI 10.1016/0006-8993(93)91427-T; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Siemen D, 1993, EXS, V66, P3; Thorn P, 1993, EXS, V66, P185; VANDENABBEELE T, 1994, PFLUG ARCH EUR J PHY, V427, P56, DOI 10.1007/BF00585942; WANG Q, 1993, PFLUG ARCH EUR J PHY, V423, P28, DOI 10.1007/BF00374957; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0	30	512	559	3	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					397	407		10.1016/S0092-8674(02)00719-5	http://dx.doi.org/10.1016/S0092-8674(02)00719-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015988	Bronze			2022-12-24	WOS:000175412100014
J	Marin, EC; Jefferis, GSXE; Komiyama, T; Zhu, HT; Luo, LQ				Marin, EC; Jefferis, GSXE; Komiyama, T; Zhu, HT; Luo, LQ			Representation of the glomerular olfactory map in the Drosophila brain	CELL			English	Article							RECEPTOR GENE-EXPRESSION; ANTENNAL LOBE; ODORANT RECEPTORS; SENSORY MAP; MELANOGASTER; BULB; ORGANIZATION; NEURONS; COMBINATORIAL; INFORMATION	We explored how the odor map in the Drosophila antennal lobe is represented in higher olfactory centers, the mushroom body and lateral horn. Systematic single-cell tracing of projection neurons (PNs) that send dendrites to specific glomeruli in the antennal lobe revealed their stereotypical axon branching patterns and terminal fields in the lateral horn. PNs with similar axon terminal fields tend to receive input from neighboring glomeruli. The glomerular classes of individual PNs could be accurately predicted based solely on their axon projection patterns. The sum of these patterns defines an "axon map" in higher olfactory centers reflecting which olfactory receptors provide input. This map is characterized by spatial convergence and divergence of PN axons, allowing integration of olfactory information.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Jefferis, GSXE (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jefferis@stanford.edu; lluo@stanford.edu	Jefferis, Gregory/C-6386-2012	Komiyama, Takaki/0000-0001-9609-4600; Jefferis, Gregory/0000-0002-0587-9355; Luo, Liqun/0000-0001-5467-9264				AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MALUN D, 1993, J COMP NEUROL, V329, P143, DOI 10.1002/cne.903290202; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Penfield W., 1950, CEREBRAL CORTEX MAN, DOI DOI 10.1001/JAMA.1950.02920160086033; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Venables W.N., 2013, MODERN APPL STAT S; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	45	347	350	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					243	255		10.1016/S0092-8674(02)00700-6	http://dx.doi.org/10.1016/S0092-8674(02)00700-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007410	Bronze			2022-12-24	WOS:000175082600013
J	Stracke, S; Kistner, C; Yoshida, S; Mulder, L; Sato, S; Kaneko, T; Tabata, S; Sandal, N; Stougaard, J; Szczyglowski, K; Parniske, M				Stracke, S; Kistner, C; Yoshida, S; Mulder, L; Sato, S; Kaneko, T; Tabata, S; Sandal, N; Stougaard, J; Szczyglowski, K; Parniske, M			A plant receptor-like kinase required for both bacterial and fungal symbiosis	NATURE			English	Article							PEA PISUM-SATIVUM; LOTUS-JAPONICUS; CALCIUM SPIKING; MEDICAGO-TRUNCATULA; NITROGEN-FIXATION; NOD FACTORS; NODULATION; MUTANTS; CELLS; GENE	Most higher plant species can enter a root symbiosis with arbuscular mycorrhizal fungi, in which plant carbon is traded for fungal phosphate(1,2). This is an ancient symbiosis, which has been detected in fossils of early land plants(3). In contrast, the nitrogen-fixing root nodule symbioses of plants with bacteria evolved more recently, and are phylogenetically restricted to the rosid I clade of plants(4). Both symbioses rely on partially overlapping genetic programmes(5,6). We have identified the molecular basis for this convergence by cloning orthologous SYMRK ('symbiosis receptor-like kinase') genes from Lotus and pea, which are required for both fungal and bacterial recognition. SYMRK is predicted to have a signal peptide, an extracellular domain comprising leucine-rich repeats, a transmembrane and an intracellular protein kinase domain. Lotus SYMRK is required for a symbiotic signal transduction pathway leading from the perception of microbial signal molecules to rapid symbiosis-related gene activation. The perception of symbiotic fungi and bacteria is mediated by at least one common signalling component, which could have been recruited during the evolution of root nodule symbioses from the already existing arbuscular mycorrhiza symbiosis.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Kazusa DNA Res Inst, Chiba 2920812, Japan; Aarhus Univ, IMSB, Gene Express Lab, DK-8000 Aarhus, Denmark; Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON N5V 4T3, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Kazusa DNA Research Institute; Aarhus University; Agriculture & Agri Food Canada	Parniske, M (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.		Parniske, Martin/M-3781-2019; poinssot, benoit/B-2569-2009; Yoshida, Satoko/G-5003-2010; Yoshida, Satoko/AAZ-4757-2021; Parniske, Martin/F-2202-2011; Sato, Shusei/A-3616-2015; yoshida, satoko/AAO-4892-2020	Parniske, Martin/0000-0001-8561-747X; poinssot, benoit/0000-0001-5890-4318; Yoshida, Satoko/0000-0002-9999-7861; Parniske, Martin/0000-0001-8561-747X; Sato, Shusei/0000-0002-0293-5366; yoshida, satoko/0000-0002-9999-7861; Stougaard, Jens/0000-0002-9312-2685				Bonfante P, 2000, MOL PLANT MICROBE IN, V13, P1109, DOI 10.1094/MPMI.2000.13.10.1109; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Cullimore JV, 2001, TRENDS PLANT SCI, V6, P24, DOI 10.1016/S1360-1385(00)01810-0; Downie JA, 1999, CURR OPIN PLANT BIOL, V2, P483, DOI 10.1016/S1369-5266(99)00018-7; DUC G, 1989, PLANT SCI, V60, P215, DOI 10.1016/0168-9452(89)90169-6; DUC G, 1989, PLANT SCI, V60, P207, DOI 10.1016/0168-9452(89)90168-4; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; FIRMIN JL, 1993, MOL MICROBIOL, V10, P351, DOI 10.1111/j.1365-2958.1993.tb01961.x; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Heidstra R, 1997, MOL PLANT MICROBE IN, V10, P215, DOI 10.1094/MPMI.1997.10.2.215; Jones DA, 1997, ADV BOT RES, V24, P89; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Sato S, 2001, DNA RES, V8, P311, DOI 10.1093/dnares/8.6.311; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schneider A, 1999, MOL GEN GENET, V262, P1, DOI 10.1007/s004380051053; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; TURNER SR, 1993, MOL GEN GENET, V236, P402, DOI 10.1007/BF00277140; van Spronsen PC, 2001, MOL PLANT MICROBE IN, V14, P839, DOI 10.1094/MPMI.2001.14.7.839; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Wegel E, 1998, MOL PLANT MICROBE IN, V11, P933, DOI 10.1094/MPMI.1998.11.9.933	25	617	667	24	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					959	962		10.1038/nature00841	http://dx.doi.org/10.1038/nature00841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087405				2022-12-24	WOS:000176441200041
J	Morris, MC; Evans, DA; Bienias, JL; Tangney, CC; Bennett, DA; Aggarwal, N; Wilson, RS; Scherr, PA				Morris, MC; Evans, DA; Bienias, JL; Tangney, CC; Bennett, DA; Aggarwal, N; Wilson, RS; Scherr, PA			Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease on a biracial community study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED OXIDATIVE STRESS; E PREVENTS APOPTOSIS; C SUPPLEMENT USE; VITAMIN-E; LIPID-PEROXIDATION; ALPHA-TOCOPHEROL; RAT-BRAIN; COGNITIVE FUNCTION; CORTICAL-NEURONS; APOLIPOPROTEIN-E	Context Oxidative processes have been suggested as elements in the development of Alzheimer disease (AD), but whether dietary intake of vitamin E and other antioxidant nutrients prevents its development is unknown. Objective To examine whether intake of antioxidant nutrients, vitamin E, vitamin C, and beta carotene is associated with incident AD. Design, Setting, and Participants Prospective study, conducted from 1993 to 2000, of individuals selected in a stratified random sample of community-dwelling residents. The 815 residents 65 years and older were free of AD at baseline and were followed up for a mean of 3.9 years. They completed food frequency questionnaires an average of 1.7 years after baseline. Main Outcome Measure Incident AD diagnosed in clinical evaluations with standardized criteria. Results Increasing vitamin E intake from foods was associated with decreased risk of developing AD after adjustment for age, education, sex, race, APOE epsilon4, and length of follow-up. Relative risks (95% confidence intervals [CIs]) from lowest to highest quintiles of intake were 1.00, 0.71 (0.24-2.07), 0.62 (0.26-1.45), 0.71 (0.27-1.88), and 0.30 (0.10-0.92) (P for trend =.05). The protective association of vitamin E was observed only among persons who were APOE epsilon4 negative, Adjustment for other dietary factors reduced the protective association. After adjustment for baseline memory score, the risk was 0.36 (95% CI, 0.11-1.17). Intake of vitamin C, beta carotene, and vitamin E from supplements was not significantly associated with risk of AD. Conclusion This study suggests that vitamin E from food, but not other antioxidants, may be associated with a reduced risk of AD. Unexpectedly, this association was observed only among individuals without the APOE epsilon4 allele.	Rush Presbyterian St Lukes Med Ctr, Rush Inst Hlth Aging, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Clin Nutr, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Psychol, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University; Rush University; Rush University; Rush University	Morris, MC (corresponding author), Rush Presbyterian St Lukes Med Ctr, Rush Inst Hlth Aging, 1645 W Jackson,Suite 675, Chicago, IL 60612 USA.	mmorris@rush.edu			NIA NIH HHS [AG13170, AG11101] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011101, R01AG013170] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahlemeyer B, 2000, NEUROCHEM INT, V36, P1, DOI 10.1016/S0197-0186(99)00101-1; ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7; BERTONIFREDDARI C, 1995, SCANNING MICROSCOPY, V9, P289; BIENIAS JL, 2001, P 14 ANN M NE SAS US; Cardoso SM, 1998, BIOCHEM BIOPH RES CO, V246, P703, DOI 10.1006/bbrc.1998.8563; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; El-Fattah AAA, 1998, BIOCHEM MOL BIOL INT, V46, P1175; Escames G, 1997, NEUROSCI LETT, V230, P147, DOI 10.1016/S0304-3940(97)00498-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giray B, 2001, TOXICOL LETT, V118, P139, DOI 10.1016/S0378-4274(00)00277-0; Guerrero AL, 1999, NEUROREPORT, V10, P1689, DOI 10.1097/00001756-199906030-00012; HIXSON JE, 1990, J LIPID RES, V31, P545; Huang HM, 2000, LIFE SCI, V66, P1879, DOI 10.1016/S0024-3205(00)00511-7; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; LEE ES, 1989, ANAL COMPLEX SURVEY; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Masaki KH, 2000, NEUROLOGY, V54, P1265, DOI 10.1212/WNL.54.6.1265; Mason RP, 1999, J NEUROCHEM, V72, P1448, DOI 10.1046/j.1471-4159.1999.721448.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris MC, 1998, ANN EPIDEMIOL, V8, P342, DOI 10.1016/S1047-2797(97)00236-6; Morris MC, 1998, ALZ DIS ASSOC DIS, V12, P121, DOI 10.1097/00002093-199809000-00001; Morris MC, 2000, J GERONTOL A-BIOL, V55, pM130, DOI 10.1093/gerona/55.3.M130; MORRIS MC, IN PRESS ARCH NEUROL; O'Donnell E, 1998, NEUROBIOL AGING, V19, P461, DOI 10.1016/S0197-4580(98)00082-7; Post A, 1998, J NEUROSCI, V18, P8236; Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200; Rose G, 1982, CARDIOVASCULAR SURVE; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SCHERR PA, 1988, AM J EPIDEMIOL, V128, P1084; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; Smith A., 1984, SYMBOL DIGIT MODALIT; Sopher BL, 1996, MOL CHEM NEUROPATHOL, V29, P153, DOI 10.1007/BF02814999; Subramaniam R, 1998, NEUROCHEM RES, V23, P1403, DOI 10.1023/A:1020754807671; Tagami M, 1998, LAB INVEST, V78, P1415; Tagami M, 1999, LAB INVEST, V79, P609; Urano S, 1997, EUR J BIOCHEM, V245, P64, DOI 10.1111/j.1432-1033.1997.00064.x; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.11; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; Yallampalli S, 1998, NEUROSCI LETT, V251, P105, DOI 10.1016/S0304-3940(98)00515-1; Zhang P, 2000, TOXICOLOGY, V146, P37, DOI 10.1016/S0300-483X(00)00160-8	42	498	529	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2002	287	24					3230	3237		10.1001/jama.287.24.3230	http://dx.doi.org/10.1001/jama.287.24.3230			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566FF	12076219				2022-12-24	WOS:000176415800027
J	Croll, DA; Clark, CW; Acevedo, A; Tershy, B; Flores, S; Gedamke, J; Urban, J				Croll, DA; Clark, CW; Acevedo, A; Tershy, B; Flores, S; Gedamke, J; Urban, J			Bioacoustics: Only male fin whales sing loud songs - These mammals need to call long-distance when it comes to attracting females.	NATURE			English	Editorial Material							BLUE		Univ Calif Santa Cruz, Ctr Ocean Hlth, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; Cornell Lab Ornithol, Bioacoust Res Program, Ithaca, NY 14850 USA; Calif Acad Sci, San Francisco, CA 94118 USA; Univ Autonoma Baja Calif Sur, La Paz, BCS, Mexico	University of California System; University of California Santa Cruz; Cornell University; California Academy of Sciences; Universidad Autonoma de Baja California	Croll, DA (corresponding author), Univ Calif Santa Cruz, Ctr Ocean Hlth, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	croll@biology.ucsc.edu	R., Jorge Urbán/J-8126-2019	R., Jorge Urbán/0000-0003-1423-8573; Acevedo-Gutierrez, Alejandro/0000-0002-9128-826X				Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Aroyan JL, 2000, SPR HDB AUD, V12, P409; Berube M, 1996, MOL ECOL, V5, P283; Charif RA, 2002, MAR MAMMAL SCI, V18, P81, DOI 10.1111/j.1748-7692.2002.tb01020.x; Clapham PJ, 1996, MAMMAL REV, V26, P27, DOI 10.1111/j.1365-2907.1996.tb00145.x; CLARK CW, IN PRESS ECHOLOCATIO; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Popper Arthur N., 1997, Bioacoustics, V8, P163; Richardson W.J., 1995, MARINE MAMMALS NOISE; SCHEVILL WE, 1964, MARINE BIOACOUSTICS, P147; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685	13	161	171	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2002	417	6891					809	809		10.1038/417809a	http://dx.doi.org/10.1038/417809a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075339				2022-12-24	WOS:000176285600034
J	Terray, A; Oakey, J; Marr, DWM				Terray, A; Oakey, J; Marr, DWM			Microfluidic control using colloidal devices	SCIENCE			English	Article							LIQUID FLOW; SYSTEMS; MANIPULATION; POLY(DIMETHYLSILOXANE); MICROMACHINES; SEPARATIONS; DRIVEN; LIGHT; PUMPS	By manipulating colloidal microspheres within customized channels, we have created micrometer-scale fluid pumps and particulate valves. We describe two positive-displacement designs, a gear and a peristaltic pump, both of which are about the size of a human red blood cell. Two colloidal valve designs,are also demonstrated, one actuated and one passive, for the direction of cells or small particles. The use of colloids as both valves and pumps wit[ allow device integration at a density far beyond what is currently achievable by other approaches and may provide a link between fluid manipulation at the macro- and nanoscale.	Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	Colorado School of Mines	Oakey, J (corresponding author), Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA.	joakey@mines.edu; dmarr@mines.edu						BART SF, 1990, SENSOR ACTUAT A-PHYS, V21, P193, DOI 10.1016/0924-4247(90)85037-5; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; EFFENHAUSER CS, 1993, ANAL CHEM, V65, P2637, DOI 10.1021/ac00067a015; Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258; Gauthier RC, 2001, APPL OPTICS, V40, P930, DOI 10.1364/AO.40.000930; Hatch A, 2001, J MICROELECTROMECH S, V10, P215, DOI 10.1109/84.925748; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Jager EWH, 2000, SCIENCE, V288, P2335, DOI 10.1126/science.288.5475.2335; Kamholz AE, 1999, ANAL CHEM, V71, P5340, DOI 10.1021/ac990504j; Kataoka DE, 1999, NATURE, V402, P794, DOI 10.1038/45521; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Kuebler SM, 2000, PROC SPIE, V3937, P97, DOI 10.1117/12.382799; MANZ A, 1994, J MICROMECH MICROENG, V4, P257, DOI 10.1088/0960-1317/4/4/010; Maruo S, 2001, PROC IEEE MICR ELECT, P594, DOI 10.1109/MEMSYS.2001.906611; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mio C, 2000, ADV MATER, V12, P917, DOI 10.1002/1521-4095(200006)12:12<917::AID-ADMA917>3.0.CO;2-K; Mio C, 2000, REV SCI INSTRUM, V71, P2196, DOI 10.1063/1.1150605; Service RF, 1998, SCIENCE, V282, P400, DOI 10.1126/science.282.5388.400; SHOJI S, 1994, J MICROMECH MICROENG, V4, P157, DOI 10.1088/0960-1317/4/4/001; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; VANDENBERG A, 2000, MICRO TOTAL ANAL SYS; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; WILDING P, 1994, CLIN CHEM, V40, P1815; Yu Q, 2001, APPL PHYS LETT, V78, P2589, DOI 10.1063/1.1367010; Zhao B, 2001, SCIENCE, V291, P1023, DOI 10.1126/science.291.5506.1023	28	331	379	0	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1841	1844		10.1126/science.1072133	http://dx.doi.org/10.1126/science.1072133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052952				2022-12-24	WOS:000176054300040
J	Swales, J				Swales, J			The dangers of conformity	LANCET			English	Editorial Material									Univ Leicester, Fac Med, Leicester LE2 7LX, Leics, England	University of Leicester	Swales, J (corresponding author), Univ Leicester, Fac Med, Leicester LE2 7LX, Leics, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 1	2002	359	9321					1936	1936		10.1016/S0140-6736(05)71111-9	http://dx.doi.org/10.1016/S0140-6736(05)71111-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057559				2022-12-24	WOS:000175975700026
J	Ishii, K; Arib, G; Lin, C; Van Houwe, G; Laemmli, UK				Ishii, K; Arib, G; Lin, C; Van Houwe, G; Laemmli, UK			Chromatin boundaries in budding yeast: The nuclear pore connection	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL DOMAINS; BINDING-PROTEINS; GENE-EXPRESSION; LIVING CELLS; TRANSFER-RNA; COMPLEX; EXPORT; DNA; HETEROCHROMATIN	Chromatin boundary activities (BAs) were identified in Saccharomyces cerevisiae by genetic screening. Such BAs bound to sites flanking a reporter gene establish a nonsilenced domain within the silent mating-type locus HML. Interestingly, various proteins involved in nuclear-cytoplasmic traffic, such as exportins Cse1p, Mex67p, and Los1p, exhibit a robust BA. Genetic studies, immunolocalization, live imaging, and chromatin immunoprecipitation experiments show that these transport proteins block spreading of heterochromatin by physical tethering of the HML locus to the Nup2p receptor of the nuclear pore complex. Genetic deletion of NUP2 abolishes the BA of all transport proteins, while direct targeting of Nup2p to the bracketing DNA elements restores activity. The data demonstrate that physical tethering of genomic loci to the NPC can dramatically alter their epigenetic activity.	Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Laemmli, UK (corresponding author), Univ Geneva, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.		Ishii, Kojiro/L-5102-2017	Galora De Mora, Raul Pavlov/0000-0001-8342-9782				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Cheng TH, 2000, GENE DEV, V14, P452; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DELATOUR EB, 1988, CELL, V55, P937, DOI 10.1016/0092-8674(88)90239-5; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; Hart CM, 1998, CURR OPIN GENET DEV, V8, P519, DOI 10.1016/S0959-437X(98)80005-1; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; HOLDRIDGE C, 1991, MOL CELL BIOL, V11, P1894, DOI 10.1128/MCB.11.4.1894; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Hood JK, 2000, J CELL SCI, V113, P1471; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LOEB JDJ, 1993, MOL BIOL CELL, V4, P209, DOI 10.1091/mbc.4.2.209; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	48	286	291	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 31	2002	109	5					551	562		10.1016/S0092-8674(02)00756-0	http://dx.doi.org/10.1016/S0092-8674(02)00756-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062099	Bronze			2022-12-24	WOS:000175957900005
J	Saitoh, S; Chabes, A; McDonald, WH; Thelander, L; Yates, JR; Russell, P				Saitoh, S; Chabes, A; McDonald, WH; Thelander, L; Yates, JR; Russell, P			Cid13 is a cytoplasmic poly(A) polymerase that regulates ribonucleotide reductase mRNA	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; PROTEIN IDENTIFICATION TECHNOLOGY; S-M CHECKPOINT; FISSION YEAST; DNA-REPLICATION; MESSENGER-RNA; CELL-CYCLE; POLY(A)-BINDING PROTEIN; SPISULA OOCYTES; POLYADENYLATION	Fission yeast Cid13 and budding yeast Trf4/5 are members of a newly identified nucleotidyltransferase family conserved from yeast to man. Trf4/5 are thought to be essential DNA polymerases. We report that Cid13 is a poly(A) polymerase. Unlike conventional poly(A) polymerases, which act in the nucleus and indiscriminately polyadenylate, all mRNA, Cid13 is a cytoplasmic enzyme that specifically targets suc22 mRNA that encodes a subunit of ribonucleotide reductase (RNR). cid13 mutants have reduced dNTP pools and are sensitive to hydroxyurea, an RNR inhibitor. We propose that Cid13 defines a cytoplasmic form of poly(A) polymerase important for DNA replication and genome maintenance.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Scripps Research Institute; Scripps Research Institute; Umea University	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	prussell@scripps.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X; Chabes, Andrei/0000-0003-1708-8259; Saitoh, Shigeaki/0000-0001-5408-296X	NCI NIH HHS [CA81665] Funding Source: Medline; NCRR NIH HHS [RR11823] Funding Source: Medline; NEI NIH HHS [R01 EY1328801] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA081665] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013288] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; BALLANTYNE S, 1995, RNA, V1, P64; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Burgers PMJ, 1998, CHROMOSOMA, V107, P218, DOI 10.1007/s004120050300; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Carson DR, 2001, P NATL ACAD SCI USA, V98, P8270, DOI 10.1073/pnas.131022798; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Chapon C, 1997, RNA, V3, P1337; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; GEBAUER F, 1995, MOL CELL BIOL, V15, P1422; HAGAN IM, 1988, J CELL SCI, V89, P343; Harris P, 1996, MOL GEN GENET, V252, P284; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCDONALD WH, 2002, IN PRESS INT J MASS; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; REYMOND A, 1992, MOL GEN GENET, V234, P449, DOI 10.1007/BF00538705; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; ROSENTHAL ET, 1983, J MOL BIOL, V166, P309, DOI 10.1016/S0022-2836(83)80087-4; ROSENTHAL ET, 1987, DEV BIOL, V121, P237, DOI 10.1016/0012-1606(87)90155-2; Sambrook J., 2001, MOL CLONING; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; STANDART NM, 1985, J CELL BIOL, V100, P1968, DOI 10.1083/jcb.100.6.1968; SWENSON KI, 1987, DEV BIOL, V123, P10, DOI 10.1016/0012-1606(87)90421-0; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uhlmann F, 2000, CURR BIOL, V10, pR698, DOI 10.1016/S0960-9822(00)00709-0; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang SW, 1999, J CELL SCI, V112, P927; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544	57	113	120	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2002	109	5					563	573		10.1016/S0092-8674(02)00753-5	http://dx.doi.org/10.1016/S0092-8674(02)00753-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062100	Bronze			2022-12-24	WOS:000175957900006
J	Shidara, M; Richmond, BJ				Shidara, M; Richmond, BJ			Anterior cingulate: Single neuronal signals related to degree of reward expectancy	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; RHESUS-MONKEY; SYMPTOM PROVOCATION; MOTOR AREAS; HUMAN BRAIN; CORTEX; ACTIVATION; BEHAVIOR; SELECTION; TOMOGRAPHY	As monkeys perform schedules containing several trials with a visual cue indicating reward proximity, their error rates decrease as the number of remaining trials decreases, suggesting that their motivation and/or reward expectancy increases as the reward approaches. About one-third of single neurons recorded in the anterior cingulate cortex of monkeys during these reward schedules had responses that progressively changed strength with reward expectancy, an effect that disappeared when the cue was random. Alterations of this progression could be the basis for the changes from normal that are reported in anterior cingulate population activity for obsessive-compulsive disorder and drug abuse, conditions characterized by disturbances in reward expectancy.	Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Shidara, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	m.shidara@aist.go.jp			NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002619, Z01MH002032, ZIAMH002032, Z01MH002619] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adinoff R, 2001, AM J PSYCHIAT, V158, P390, DOI 10.1176/appi.ajp.158.3.390; Adler CM, 2000, J PSYCHIATR RES, V34, P317, DOI 10.1016/S0022-3956(00)00022-4; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexandrov YI, 2001, ACTA PHYSIOL SCAND, V171, P87, DOI 10.1046/j.1365-201x.2001.171001087.x; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Busatto GF, 2000, PSYCHIAT RES-NEUROIM, V99, P15, DOI 10.1016/S0925-4927(00)00050-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Drexler K, 2000, AM J ADDICTION, V9, P331; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Ingvar M, 1998, J STUD ALCOHOL, V59, P258, DOI 10.15288/jsa.1998.59.258; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MIALLEF J, 2001, CLIN NEUROPHARMACOL, V24, P191; MORECRAFT RJ, 1993, J COMP NEUROL, V337, P669, DOI 10.1002/cne.903370411; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Nimchinsky EA, 1996, J COMP NEUROL, V374, P136; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; SAUNDERS RC, 1990, EXP BRAIN RES, V81, P443; Shidara M, 1998, J NEUROSCI, V18, P2613; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; Takenouchi K, 1999, NEUROSCIENCE, V93, P1271, DOI 10.1016/S0306-4522(99)00216-X; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208	39	385	391	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1709	1711		10.1126/science.1069504	http://dx.doi.org/10.1126/science.1069504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040201				2022-12-24	WOS:000175976200066
J	Urizar, NL; Liverman, AB; Dodds, DT; Silva, FV; Ordentlich, P; Yan, YZ; Gonzalez, FJ; Heyman, RA; Mangelsdorf, DJ; Moore, DD				Urizar, NL; Liverman, AB; Dodds, DT; Silva, FV; Ordentlich, P; Yan, YZ; Gonzalez, FJ; Heyman, RA; Mangelsdorf, DJ; Moore, DD			A natural product that lowers cholesterol as an antagonist ligand for FXR	SCIENCE			English	Article							ST JOHNS WORT; NUCLEAR RECEPTOR; BILE-ACID; COMMIPHORA-MUKUL; TARGETED DISRUPTION; ENZYME-INDUCTION; PROTEIN GENE; IDENTIFICATION; ACTIVATION; MICE	Extracts of the resin of the guggul tree (Commiphora mukul) tower LDL (low-density lipoprotein) cholesterol levels in humans. The plant sterol guggul-sterone [4,17(20)-pregnadiene-3,16-dione] is the active agent in this extract. We show that guggulsterone is a highly efficacious antagonist of the farnesoid X receptor (FXR), a nuclear hormone receptor that is activated by bile acids. Guggulsterone treatment decreases hepatic cholesterol in wild-type mice fed a high-cholesterol diet but is not effective in FXR-null mice. Thus, we propose that inhibition of FXR activation is the basis for the cholesterol-lowering activity of guggulsterone. Other natural products with specific biologic effects may modulate the activity of FXR or other relatively promiscuous nuclear hormone receptors.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; X Ceptor Therapeut Inc, San Diego, CA 92121 USA; NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA	Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	moore@bcm.tmc.edu		Mangelsdorf, David/0000-0002-4355-0796; Valentin, Frank/0000-0003-3502-7097				ALLAIN CC, 1974, CLIN CHEM, V20, P470; BACHS L, 1992, GASTROENTEROLOGY, V102, P2077, DOI 10.1016/0016-5085(92)90335-V; CARLSON SE, 1977, CLIN CHIM ACTA, V79, P575, DOI 10.1016/0009-8981(77)90178-4; Chander R, 1996, PHYTOTHER RES, V10, P508, DOI 10.1002/(SICI)1099-1573(199609)10:6&lt;508::AID-PTR895&gt;3.0.CO;2-P; Cheema SK, 2000, J BIOL CHEM, V275, P12530, DOI 10.1074/jbc.275.17.12530; Crestani M, 1996, BIOCHEM BIOPH RES CO, V225, P585, DOI 10.1006/bbrc.1996.1215; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Dev S, 1999, ENVIRON HEALTH PERSP, V107, P783, DOI 10.2307/3454574; ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411; FEELY J, 1983, BRIT J CLIN PHARMACO, V16, P195, DOI 10.1111/j.1365-2125.1983.tb04986.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Howard WR, 2000, TOXICOL APPL PHARM, V163, P195, DOI 10.1006/taap.1999.8869; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Nityanand S, 1989, J Assoc Physicians India, V37, P323; OHNHAUS EE, 1979, CLIN PHARMACOL THER, V25, P591; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; SATYAVATI GV, 1988, INDIAN J MED RES, V87, P327; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SINGH RB, 1994, CARDIOVASC DRUG THER, V8, P659, DOI 10.1007/BF00877420; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; VONBERGMANN K, 1981, ANTIMICROB AGENTS CH, V19, P342, DOI 10.1128/AAC.19.2.342; Wang DP, 1996, J LIPID RES, V37, P1831; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wentworth JM, 2000, J ENDOCRINOL, V166, pR11, DOI 10.1677/joe.0.166R011; WILLIAMS GM, 1982, MUTAT RES, V97, P359, DOI 10.1016/0165-1161(82)90003-6; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; Zavacki AM, 1997, P NATL ACAD SCI USA, V94, P7909, DOI 10.1073/pnas.94.15.7909	39	384	440	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1703	1706		10.1126/science.1072891	http://dx.doi.org/10.1126/science.1072891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	11988537				2022-12-24	WOS:000175976200064
J	Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R				Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R			Crystal structure and mechanism of a calcium-gated potassium channel	NATURE			English	Article							CA-2+-ACTIVATED K+ CHANNELS; MAMMALIAN SKELETAL-MUSCLE; ION CHANNELS; BACTERIAL TRANSPORT; BINDING-PROTEIN; LIGAND-BINDING; BK CHANNEL; COMPLEX; CRYSTALLOGRAPHY; CHARYBDOTOXIN		Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cohen SL, 2001, ANNU REV BIOPH BIOM, V30, P67, DOI 10.1146/annurev.biophys.30.1.67; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549	41	1133	1184	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					515	522		10.1038/417515a	http://dx.doi.org/10.1038/417515a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037559				2022-12-24	WOS:000175860300033
J	Ming, GL; Wong, ST; Henley, J; Yuan, XB; Song, HJ; Spitzer, NC; Poo, MM				Ming, GL; Wong, ST; Henley, J; Yuan, XB; Song, HJ; Spitzer, NC; Poo, MM			Adaptation in the chemotactic guidance of nerve growth cones	NATURE			English	Article							PROTEIN-SYNTHESIS; SIGNAL-TRANSDUCTION; DNA FRAGMENTATION; MESSENGER-RNA; AXONS; NEUROTROPHINS; GRADIENTS; PROLIFERATION; INHIBITION; MECHANISM	Pathfinding by growing axons in the developing nervous system may be guided by gradients of extracellular guidance factors. Analogous to the process of chemotaxis in microorganisms, we found that axonal growth cones of cultured Xenopus spinal neurons exhibit adaptation during chemotactic migration, undergoing consecutive phases of desensitization and resensitization in the presence of increasing basal concentrations of the guidance factor netrin-1 or brain-derived neurotrophic factor. The desensitization is specific to the guidance factor and is accompanied by a reduction of Ca2+ signalling, whereas resensitization requires activation of mitogen-associated protein kinase and local protein synthesis. Such adaptive behaviour allows the growth cone to re-adjust its sensitivity over a wide range of concentrations of the guidance factor, an essential feature for long-range chemotaxis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California San Diego; Salk Institute	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	gming@biomail.ucsd.edu	Henley, John/D-7171-2011; Ming, Guo-li/J-7880-2013	Spitzer, Nicholas/0000-0002-3523-1103; Henley, John/0000-0003-1846-5941; Yuan, Xiaobing/0000-0002-1632-8460; Ming, Guo-li/0000-0002-2517-6075				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; CAJAL SRY, 1995, HISTOLOGY NERVOUS SY, V1, P532; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; DeSilva DR, 1998, J IMMUNOL, V160, P4175; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; KOCHI SK, 1993, EXP CELL RES, V208, P296, DOI 10.1006/excr.1993.1249; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 1997, J NEUROSCI, V17, P7860; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MITTLEMAN B, 1983, J MOL BIOL, V165, P461, DOI 10.1016/S0022-2836(83)80213-7; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; PIERCEALL WE, 1994, DEV BIOL, V166, P654, DOI 10.1006/dbio.1994.1345; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; SEGER R, 1994, J BIOL CHEM, V269, P25699; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang YW, 1998, J CELL SCI, V111, P373; WARING P, 1990, J BIOL CHEM, V265, P14476; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	50	327	337	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					411	418		10.1038/nature745	http://dx.doi.org/10.1038/nature745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	11986620				2022-12-24	WOS:000175730900031
J	Duman-Scheel, M; Weng, L; Xin, SJ; Du, W				Duman-Scheel, M; Weng, L; Xin, SJ; Du, W			Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E	NATURE			English	Article							DEPENDENT KINASE INHIBITOR; DROSOPHILA EMBRYOGENESIS; S-PHASE; PROGRESSION; PROTEINS; SIZE; WINGLESS; TARGETS; DACAPO; ARREST	Although mutations that activate the Hedgehog (Hh) signalling pathway have been linked to several types of cancer(1), the molecular and cellular basis of Hh's ability to induce tumour formation is not well understood. We identified a mutation in patched (ptc), an inhibitor of Hh signalling, in a genetic screen for regulators of the Retinoblastoma (Rb) pathway in Drosophila. Here we show that Hh signalling promotes transcription of Cyclin E and Cyclin D, two inhibitors of Rb-2, and principal regulators of the cell cycle during development in Drosophila. Upregulation of Cyclin E expression, accomplished through binding of Cubitus interruptus (Ci) to the Cyclin E promoter, mediates the ability of Hh to induce DNA replication. Upregulation of Cyclin D expression by Hh mediates the distinct ability of Hh to promote cellular growth. The discovery of a direct connection between Hh signalling and principal cell-cycle regulators provides insight into the mechanism by which deregulated Hh signalling promotes tumour formation.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Ctr Mol Oncol, Chicago, IL 60637 USA; Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Du, W (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.				NCI NIH HHS [R01 CA080871] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080871] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; BOSCH T, 1995, OPT REV, V2, P289, DOI 10.1007/s10043-995-0289-2; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Huang Z, 1998, DEVELOPMENT, V125, P3753; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Jones L, 2000, DEVELOPMENT, V127, P4619; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PATEL N, 1996, IN SITU HYBRIDIZATIO, P357; Secombe J, 1998, GENETICS, V149, P1867; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wolff Tanya, 1993, P1277; Xin SJ, 2002, DEVELOPMENT, V129, P1345; XU T, 1993, DEVELOPMENT, V117, P1223; ZARKOWER D, 1993, NUCLEIC ACIDS RES, V21, P3691, DOI 10.1093/nar/21.16.3691	30	336	361	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					299	304		10.1038/417299a	http://dx.doi.org/10.1038/417299a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015606				2022-12-24	WOS:000175592100050
J	Bentley, SD; Chater, KF; Cerdeno-Tarraga, AM; Challis, GL; Thomson, NR; James, KD; Harris, DE; Quail, MA; Kieser, H; Harper, D; Bateman, A; Brown, S; Chandra, G; Chen, CW; Collins, M; Cronin, A; Fraser, A; Goble, A; Hidalgo, J; Hornsby, T; Howarth, S; Huang, CH; Kieser, T; Larke, L; Murphy, L; Oliver, K; O'Neil, S; Rabbinowitsch, E; Rajandream, MA; Rutherford, K; Rutter, S; Seeger, K; Saunders, D; Sharp, S; Squares, R; Squares, S; Taylor, K; Warren, T; Wietzorrek, A; Woodward, J; Barrell, BG; Parkhill, J; Hopwood, DA				Bentley, SD; Chater, KF; Cerdeno-Tarraga, AM; Challis, GL; Thomson, NR; James, KD; Harris, DE; Quail, MA; Kieser, H; Harper, D; Bateman, A; Brown, S; Chandra, G; Chen, CW; Collins, M; Cronin, A; Fraser, A; Goble, A; Hidalgo, J; Hornsby, T; Howarth, S; Huang, CH; Kieser, T; Larke, L; Murphy, L; Oliver, K; O'Neil, S; Rabbinowitsch, E; Rajandream, MA; Rutherford, K; Rutter, S; Seeger, K; Saunders, D; Sharp, S; Squares, R; Squares, S; Taylor, K; Warren, T; Wietzorrek, A; Woodward, J; Barrell, BG; Parkhill, J; Hopwood, DA			Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; CHROMOSOME; IDENTIFICATION; BIOSYNTHESIS; METABOLISM; ALIGNMENT; STRESS; MAP	Streptomyces coelicolor is a representative of the group of soil-dwelling, filamentous bacteria responsible for producing most natural antibiotics used in human and veterinary medicine. Here we report the 8,667, 507 base pair linear chromosome of this organism, containing the largest number of genes so far discovered in a bacterium. The 7,825 predicted genes include more than 20 clusters coding for known or predicted secondary metabolites. The genome contains an unprecedented proportion of regulatory genes, predominantly those likely to be involved in responses to external stimuli and stresses, and many duplicated gene sets that may represent 'tissue-specific' isoforms operating in different phases of colonial development, a unique situation for a bacterium. An ancient synteny was revealed between the central 'core' of the chromosome and the whole chromosome of pathogens Mycobacterium tuberculosis and Corynebacterium diphtheriae. The genome sequence will greatly increase our understanding of microbial life in the soil as well as aiding the generation of new drug candidates by genetic engineering.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Warwick; National Yang Ming Chiao Tung University	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	david.hopwood@bbsrc.ac.uk	Bateman, Alex/H-2861-2019; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Rutherford, Kim/Y-7995-2018; Bateman, Alex/E-6518-2011; Thomson, Nicholas/P-5988-2014	Bateman, Alex/0000-0002-6982-4660; Parkhill, Julian/0000-0002-7069-5958; Rutherford, Kim/0000-0001-6277-726X; Harper, David/0000-0002-8313-3516; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Chandra, Govind/0000-0002-7882-6676; Challis, Gregory/0000-0001-5976-3545; Thomson, Nicholas/0000-0002-4432-8505; Murphy, Lee/0000-0001-6467-7449				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bao K, 2001, GENE DEV, V15, P1518, DOI 10.1101/gad.896201; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Challis GL, 2000, FEMS MICROBIOL LETT, V187, P111, DOI 10.1111/j.1574-6968.2000.tb09145.x; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chater K. F., 1997, BACTERIA MULTICELLUL, P149; Chong PP, 1998, MICROBIOL-UK, V144, P193, DOI 10.1099/00221287-144-1-193; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAVIS NK, 1990, MOL MICROBIOL, V4, P1679, DOI 10.1111/j.1365-2958.1990.tb00545.x; Eisen JA, 2000, GENOME BIOL, V1; FRIEND EJ, 1971, J GEN MICROBIOL, V68, P187, DOI 10.1099/00221287-68-2-187; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Harris DE, 2001, METH MOL B, V175, P217; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hopwood D A, 1995, Biotechnology, V28, P65; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; IMBERT M, 1995, CURR MICROBIOL, V31, P129, DOI 10.1007/BF00294289; Jacobs C, 1999, P NATL ACAD SCI USA, V96, P5891, DOI 10.1073/pnas.96.11.5891; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Krugel H, 1999, BBA-MOL CELL BIOL L, V1439, P57, DOI 10.1016/S1388-1981(99)00075-X; Kwak J, 2001, J BACTERIOL, V183, P5092, DOI 10.1128/JB.183.17.5092-5101.2001; Li N, 1998, J BACTERIOL, V180, P2450, DOI 10.1128/JB.180.9.2450-2458.1998; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; MAZODIER P, 1990, MOL GEN GENET, V222, P431, DOI 10.1007/BF00633850; Messer W, 1997, MOL MICROBIOL, V24, P1, DOI 10.1046/j.1365-2958.1997.3171678.x; Offner S, 2000, J BACTERIOL, V182, P4328, DOI 10.1128/JB.182.15.4328-4336.2000; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; PAGET MSB, 2002, CONTROL BACTERIAL GE, P105; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Poralla K, 2000, FEMS MICROBIOL LETT, V189, P93, DOI 10.1111/j.1574-6968.2000.tb09212.x; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Revill WP, 2001, J BACTERIOL, V183, P3526, DOI 10.1128/JB.183.11.3526-3530.2001; Rodriguez E, 2001, CURR OPIN MICROBIOL, V4, P526, DOI 10.1016/S1369-5274(00)00246-0; Sezonov G, 1998, J BACTERIOL, V180, P3056, DOI 10.1128/JB.180.12.3056-3061.1998; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takeyama H, 1997, MICROBIOL-UK, V143, P2725, DOI 10.1099/00221287-143-8-2725; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000; Volff JN, 1998, MOL MICROBIOL, V27, P239, DOI 10.1046/j.1365-2958.1998.00652.x; Zakrzewska-Czerwinska J, 2000, ANTON LEEUW INT J G, V78, P211, DOI 10.1023/A:1010202411244	50	2450	3463	17	494	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					141	147		10.1038/417141a	http://dx.doi.org/10.1038/417141a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000953	Bronze			2022-12-24	WOS:000175460200034
J	Giraud, E; Fardoux, L; Fourrier, N; Hannibal, L; Genty, B; Bouyer, P; Dreyfus, B; Vermeglio, A				Giraud, E; Fardoux, L; Fourrier, N; Hannibal, L; Genty, B; Bouyer, P; Dreyfus, B; Vermeglio, A			Bacteriophytochrome controls photosystem synthesis in anoxygenic bacteria	NATURE			English	Article							PHYTOCHROME; CHROMOPHORE; LIGHT; PHOTOSYNTHESIS; EXPRESSION; SIMILARITY; PERCEPTION; SENSORS; OXYGEN; REDOX	Plants use a set of light sensors to control their growth and development in response to changes in ambient light. In particular, phytochromes exert their regulatory activity by switching between a biologically inactive red-light-absorbing form (Pr) and an active far-red-light absorbing form (Pfr)(1,2). Recently, biochemical and genetic studies have demonstrated the occurrence of phytochrome-like proteins in photosynthetic and non-photosynthetic bacteria(3-7)-but little is known about their functions. Here we report the discovery of a bacteriophytochrome located downstream from the photosynthesis gene cluster in a Bradyrhizobium strain symbiont of Aeschynomene. The synthesis of the complete photosynthetic apparatus is totally under the control of this bacteriophytochrome. A similar behaviour is observed for the closely related species Rhodopseudomonas palustris, but not for the more distant anoxygenic photosynthetic bacteria of the genus Rhodobacter, Rubrivivax or Rhodospirillum. Unlike other (bacterio) phytochromes, the carboxy-terminal domain of this bacteriophytochrome contains no histidine kinase features. This suggests a light signalling pathway involving direct protein-protein interaction with no phosphorelay cascade. This specific mechanism of regulation may represent an important ecological adaptation to optimize the plant-bacteria interaction.	Univ Mediterranee CEA1000, CEA Cadarache, DEVM Lab Bioenerget Cellulaire, CEA,CNRS,UMR 163, F-13108 St Paul Les Durance, France; CEA, DEVM Lab Ecophysiol Photosynth, CEA Cadarache, CEA,CNRS,UMR 163, F-13108 St Paul Les Durance, France; ENSAM, INRA, CIRAD,IRD,Lab Symbioses Trop & Mediterraneennes, LSTM TA 10,UMR 113, F-34398 Montpellier, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Arts et Metiers Institute of Technology; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Vermeglio, A (corresponding author), Univ Mediterranee CEA1000, CEA Cadarache, DEVM Lab Bioenerget Cellulaire, CEA,CNRS,UMR 163, F-13108 St Paul Les Durance, France.		Giraud, Eric/GLS-1036-2022					Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; BOIVIN C, 1990, PLANT CELL, V2, P1157, DOI 10.1105/tpc.2.12.1157; CLAYTON RK, 1960, BIOCHIM BIOPHYS ACTA, V37, P503, DOI 10.1016/0006-3002(60)90507-2; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Fleischman D, 1998, BBA-BIOENERGETICS, V1364, P17, DOI 10.1016/S0005-2728(98)00011-5; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; LI LM, 1992, J BIOL CHEM, V267, P19204; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PONNAMPALAM SN, 1995, J BACTERIOL, V177, P2990, DOI 10.1128/jb.177.11.2990-2997.1995; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Yurkov V, 1998, PHOTOSYNTH RES, V57, P117, DOI 10.1023/A:1006097120530; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	22	167	180	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					202	205		10.1038/417202a	http://dx.doi.org/10.1038/417202a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000965				2022-12-24	WOS:000175460200049
J	Haffty, BG; Harrold, E; Khan, AJ; Pathare, P; Smith, TE; Turner, BC; Glazer, PM; Ward, B; Carter, D; Matloff, E; Bale, AE; Alvarez-Franco, M				Haffty, BG; Harrold, E; Khan, AJ; Pathare, P; Smith, TE; Turner, BC; Glazer, PM; Ward, B; Carter, D; Matloff, E; Bale, AE; Alvarez-Franco, M			Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status	LANCET			English	Article							GERMLINE MUTATIONS; PROPHYLACTIC MASTECTOMY; JEWISH WOMEN; THERAPY; RISK; OOPHORECTOMY; RADIOTHERAPY; CARCINOMAS; PROGNOSIS; SURVIVAL	Background Management of early-stage breast cancer in young women with mutations in BRCA1 or BRCA2 remains controversial. This study assessed the long-term risks of ipsilateral and contralateral breast cancer in a cohort of young women who underwent breast-conserving surgery followed by radiotherapy. Methods Between 1975 and 1998, 290 women with breast cancer diagnosed at age 42 years or younger underwent lumpectomy followed by radiotherapy at our hospital. We recruited 127 of these women for complete sequencing of BRCA1 and BRCA2. Demographic, clinical, pathological, and outcome data were recorded. The primary endpoints were rates of ipsilateral and contralateral breast cancer, in relation to germline BRCA1/2 status. Findings 105 women were classified as having sporadic disease (94 with wild-type or known polymorphisms and 11 with variants of unclear significance) and 22 as having genetic predisposition (deleterious mutations in BRCA1 [15] or BRCA2 [seven]). At 12 years of follow-up, the genetic group had significantly higher rates of ipsilateral (49% vs 21%, p=0.007) and contralateral events (42% vs 9%, p=0.001) than the sporadic group. The majority of events were classified as second primary tumours. No patient in the genetic group had undergone oophorectomy or was taking prophylactic agents such as tamoxifen. Interpretation Patients with germline mutations in BRCA1 or BRCA2 have a high risk of developing late ipsilateral and contralateral second primary tumours. With breast-conserving therapy, chemoprophylaxis or other interventions to reduce the rate of second cancers may be valuable. Alternatively, bilateral mastectomy may be considered, to minimise the risk of second tumours in the breasts.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Haffty, BG (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	bruce.haffty@yale.edu	Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560; Khan, Atif/0000-0001-8640-8530; Ratchford, Elizabeth/0000-0002-2244-5604				Blackwood MA, 1998, J CLIN ONCOL, V16, P1969, DOI 10.1200/JCO.1998.16.5.1969; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; FISHER B, 1989, NEW ENGL J MED, V320, P822, DOI 10.1056/NEJM198903303201302; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Formenti SC, 2000, J CLIN ONCOL, V18, P1159, DOI 10.1200/JCO.2000.18.5.1159; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; *NAT HUM GEN RES I, 2002, OP ACC ON LIN BREAST; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Phillips KA, 1999, J CLIN ONCOL, V17, P3653, DOI 10.1200/JCO.1999.17.11.3653; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Robson M, 1999, JNCI-J NATL CANCER I, V91, P2112, DOI 10.1093/jnci/91.24.2112; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; SEYNAEVE C, 1998, P AN M AM SOC CLIN, V17, pA119; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Turner BC, 1999, J CLIN ONCOL, V17, P3017, DOI 10.1200/JCO.1999.17.10.3017; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Walker RA, 1996, BRIT J CANCER, V74, P1796, DOI 10.1038/bjc.1996.632; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	31	208	217	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2002	359	9316					1471	1477		10.1016/S0140-6736(02)08434-9	http://dx.doi.org/10.1016/S0140-6736(02)08434-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546NA	11988246				2022-12-24	WOS:000175279100010
J	Klappacher, GW; Lunyak, VV; Sykes, DB; Sawka-Verhelle, D; Sage, J; Brard, G; Ngo, SD; Gangadharan, D; Jacks, T; Kamps, MP; Rose, DW; Rosenfeld, MG; Glass, CK				Klappacher, GW; Lunyak, VV; Sykes, DB; Sawka-Verhelle, D; Sage, J; Brard, G; Ngo, SD; Gangadharan, D; Jacks, T; Kamps, MP; Rose, DW; Rosenfeld, MG; Glass, CK			An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation	CELL			English	Article							DEAD BOX PROTEIN; DNA-BINDING DOMAIN; TRANSCRIPTION FACTORS; COMBINATORIAL INTERACTIONS; INTERSTITIAL COLLAGENASE; TARGETED DISRUPTION; SIGNALING PATHWAYS; RAS; EXPRESSION; ACTIVATION	Defining the molecular mechanisms that coordinately regulate proliferation and differentiation is a central issue in development. Here, we describe a mechanism in which induction of the Ets repressor METS/PE1 links terminal differentiation to cell cycle arrest. Using macrophages as a model, we provide evidence that METS/PE1 blocks Ras-dependent proliferation without inhibiting Ras-dependent expression of cell type-specific genes by selectively replacing Ets activators on the promoters of cell cycle control genes. Antiproliferative effects of METS require its interaction with DP103, a DEAD box-containing protein that assembles a novel corepressor complex. Functional interactions between the METS/DP103 complex and E2F/pRB family proteins are also necessary for inhibition of cellular proliferation, suggesting a combinatorial code that directs permanent cell cycle exit during terminal differentiation.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021; lunyak, victoria/R-3765-2017	Glass, Christopher/0000-0003-4344-3592; lunyak, victoria/0000-0001-9093-2714	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; BORLES JC, 1995, NATURE, V377, P635; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Grundhoff AT, 1999, J BIOL CHEM, V274, P19136, DOI 10.1074/jbc.274.27.19136; Guidez F, 1998, MOL CELL BIOL, V18, P3851, DOI 10.1128/MCB.18.7.3851; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; JIN DI, 1995, MOL CELL BIOL, V15, P693; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Kolch W, 1996, ONCOGENE, V13, P1305; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Olson MF, 2000, SEMIN IMMUNOL, V12, P63, DOI 10.1006/smim.2000.0208; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ou QL, 2001, MOL ENDOCRINOL, V15, P69, DOI 10.1210/me.15.1.69; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; REDDY MA, 1992, MOL ENDOCRINOL, V6, P1051, DOI 10.1210/me.6.7.1051; ROSE DW, 1999, NUCL RECEPTORS PRACT, P199; ROUSSEL MF, 1994, ONCOGENE, V9, P405; SAARIALHOKERE UK, 1993, J BIOL CHEM, V268, P17354; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; STACEY DW, 1988, COLD SPRING HARB SYM, V53, P871, DOI 10.1101/SQB.1988.053.01.100; STACEY KJ, 1995, MOL CELL BIOL, V15, P3430; Sullivan J, 1997, J BIOL CHEM, V272, P1943, DOI 10.1074/jbc.272.3.1943; Sykes DB, 2001, BLOOD, V98, P2308, DOI 10.1182/blood.V98.8.2308; Takahashi Y, 2000, GENE DEV, V14, P804; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	50	77	85	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					169	180		10.1016/S0092-8674(02)00714-6	http://dx.doi.org/10.1016/S0092-8674(02)00714-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007404	Bronze			2022-12-24	WOS:000175082600007
J	Pruyne, D; Evangelista, M; Yang, CS; Bi, EF; Zigmond, S; Bretscher, A; Boone, C				Pruyne, D; Evangelista, M; Yang, CS; Bi, EF; Zigmond, S; Bretscher, A; Boone, C			Role of formins in actin assembly: Nucleation and barbed-end association	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ARP2/3 COMPLEX; BUDDING YEAST; CELL-CYCLE; PROTEINS; BNI1P; CYTOSKELETON; CYTOKINESIS; INHERITANCE; DROSOPHILA	Nucleation of branched actin laments by the Arp2/3 complex is a conserved process in eukaryotic cells, yet the source of unbranched actin laments has remained obscure. In yeast, formins stimulate assembly of actin cables independently of Arp2/3. Here, the conserved core of formin homology domains 1 and 2 of Bni1p (Bni1pFH1FH2) was found to nucleate unbranched actin laments in vitro. Bni1pFH2 provided the minimal region sufficient for nucleation. Unique among actin nucleators, Bni1pFH1FH2 remained associated with the growing barbed ends of laments. This combination of properties suggests a direct role for formins in regulating nucleation and polarization of unbranched filamentous actin structures.	Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L6, Canada	Queens University - Canada; Cornell University; University of Pennsylvania; University of Pennsylvania; University of Toronto; University of Toronto	Bretscher, A (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.				NIAID NIH HHS [AI19883] Funding Source: Medline; NIGMS NIH HHS [GM59216] Funding Source: Medline; CGH CDC HHS [GH39066] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019883, R01AI019883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059216] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CGH CDC HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; COOPER JA, 1987, J CELL BIOL, V104, P491, DOI 10.1083/jcb.104.3.491; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; LIN DC, 1980, ANAL BIOCHEM, V103, P316; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Ridley AJ, 1999, NAT CELL BIOL, V1, pE64, DOI 10.1038/11034; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schott DH, 2002, J CELL BIOL, V156, P35, DOI 10.1083/jcb.200110086; TELLAM R, 1982, BIOCHEMISTRY-US, V21, P3207, DOI 10.1021/bi00256a027; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zeller R, 1999, CELL TISSUE RES, V296, P85, DOI 10.1007/s004410051269	32	548	560	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					612	615		10.1126/science.1072309	http://dx.doi.org/10.1126/science.1072309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12052901				2022-12-24	WOS:000177054200054
J	Canli, T; Sivers, H; Whitfield, SL; Gotlib, IH; Gabrieli, JDE				Canli, T; Sivers, H; Whitfield, SL; Gotlib, IH; Gabrieli, JDE			Amygdala response to happy faces as a function of extraversion	SCIENCE			English	Article							FACIAL EXPRESSIONS		Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Canli, T (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.		Canli, Turhan/F-9274-2019; Gabrieli, John/AAJ-2869-2020	Canli, Turhan/0000-0003-3646-239X; 	NIMH NIH HHS [MH59259] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059259] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; COSTA PT, 1991, NEO 5 FACTOR INVENTO; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Pervin L., 1999, HDB PERSONALITY THEO, V2nd; Whalen PJ, 1998, J NEUROSCI, V18, P411	8	372	382	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2191	2191		10.1126/science.1068749	http://dx.doi.org/10.1126/science.1068749			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077407				2022-12-24	WOS:000176379000048
J	Hoitsma, E; Marziniak, M; Faber, CG; Reulen, JPH; Sommer, C; De Baets, M; Drent, M				Hoitsma, E; Marziniak, M; Faber, CG; Reulen, JPH; Sommer, C; De Baets, M; Drent, M			Small fibre neuropathy in sarcoidosis	LANCET			English	Article								Some patients with sarcoidosis have unexplained pain and dysaesthesia. We did quantitative sensory testing in 31 sarcoidosis patients with pain or autonomic dysfunction. 25 patients had reduced warmth sensitivity, cold sensitivity, or both. Intraepidermal nerve fibre density (IENFD) was measured in punch biopsy skin samples in seven consecutive patients. All seven patients had reduced IENFD compared with controls, which confirmed the presence of small fibre neuropathy in these patients. Some patients with sarcoidosis may have small fibre neuropathy with autonomic involvement.	Univ Hosp, Dept Neurol, Maastricht, Netherlands; Univ Hosp, Dept Clin Neurophysiol, Maastricht, Netherlands; Univ Hosp, Dept Pulmonol, Maastricht, Netherlands; Sarcoidosis Management Ctr, Maastricht, Netherlands; Univ Hosp Wuerzburg, Dept Neurol, Wurzburg, Germany	Maastricht University; Maastricht University; Maastricht University; University of Wurzburg	Hoitsma, E (corresponding author), POB 5800, NL-6202 AZ Maastricht, Netherlands.		Sommer, Claudia/A-9820-2010; Drent, Marjolein/ABA-9526-2020	Sommer, Claudia/0000-0002-7064-5002; Drent, Marjolein/0000-0003-1586-0110; Faber, Catharina G./0000-0002-2467-067X				Hunninghake GW, 1999, SARCOIDOSIS VASC DIF, V16, P149; Kennedy WR, 1999, NEUROLOGY, V53, P1614, DOI 10.1212/WNL.53.8.1614; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Sharma OP, 1999, EUR RESPIR J, V13, P713, DOI 10.1034/j.1399-3003.1999.13d01.x; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9	5	136	140	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 15	2002	359	9323					2085	2086		10.1016/S0140-6736(02)08912-2	http://dx.doi.org/10.1016/S0140-6736(02)08912-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562JX	12086764				2022-12-24	WOS:000176194600012
J	Baxter-Burrell, A; Yang, ZB; Springer, PS; Bailey-Serres, J				Baxter-Burrell, A; Yang, ZB; Springer, PS; Bailey-Serres, J			RopGAP4-dependent Rop GTPase rheostat control of Arabidopsis oxygen deprivation tolerance	SCIENCE			English	Article							GENE-EXPRESSION; BINDING PROTEIN; TIP GROWTH; CALCIUM; POLLEN; SWITCH; RAC; INVOLVEMENT; METABOLISM; MOTIF	Transient soil flooding limits cellular oxygen to roots and reduces crop yield. Plant response to oxygen deprivation involves increased expression of the alcohol dehydrogenase gene (ADH) and ethanolic fermentation. Disruption of the Arabidopsis gene that encodes Rop (RHO-like small G protein of plants) guanosine triphosphatase (GTPase) activating protein 4 (ROPGAP4), a Rop deactivator, elevates ADH expression in response to oxygen deprivation but decreases tolerance to stress. Rop-dependent production of hydrogen peroxide via a diphenylene iodonium chloride-sensitive calcium-dependent reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is necessary for induction of both ADH and RopGAP4 expression. Tolerance to oxygen deprivation requires Rop activation and RopGAP4-dependent negative feedback regulation. This Rop signal transduction rheostat balances the ability to increase ethanolic fermentation with survival.	Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bailey-Serres, J (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	serres@mail.ucr.edu	Bailey-Serres, Julia/A-2470-2010	Bailey-Serres, Julia/0000-0002-8568-7125				BAXTERBURRELL A, IN PRESS ANN BOT, V90; Chung HJ, 1999, PLANT PHYSIOL, V121, P429, DOI 10.1104/pp.121.2.429; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; JACOBS M, 1988, BIOCHEM GENET, V26, P105, DOI 10.1007/BF00555492; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Kost B, 1999, CURR OPIN PLANT BIOL, V2, P462, DOI 10.1016/S1369-5266(99)00024-2; Lemichez E, 2001, GENE DEV, V15, P1808, DOI 10.1101/gad.900401; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Li H, 1998, PLANT PHYSIOL, V118, P407, DOI 10.1104/pp.118.2.407; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Park J, 2000, PLANT PHYSIOL, V124, P725, DOI 10.1104/pp.124.2.725; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Sedbrook JC, 1996, PLANT PHYSIOL, V111, P243, DOI 10.1104/pp.111.1.243; SUBBAIAH CC, 1994, PLANT PHYSIOL, V105, P369, DOI 10.1104/pp.105.1.369; SUBBAIAH CC, 1994, PLANT CELL, V6, P1747, DOI 10.1105/tpc.6.12.1747; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Zheng ZL, 2000, TRENDS PLANT SCI, V5, P298, DOI 10.1016/S1360-1385(00)01654-X; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948	27	266	299	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2026	2028		10.1126/science.1071505	http://dx.doi.org/10.1126/science.1071505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065837				2022-12-24	WOS:000176273300053
J	McGill, GG; Horstmann, M; Widlund, HR; Du, JY; Motyckova, G; Nishimura, EK; Lin, YL; Ramaswamy, S; Avery, W; Ding, HF; Jordan, SA; Jackson, IJ; Korsmeyer, SJ; Golub, TR; Fisher, DE				McGill, GG; Horstmann, M; Widlund, HR; Du, JY; Motyckova, G; Nishimura, EK; Lin, YL; Ramaswamy, S; Avery, W; Ding, HF; Jordan, SA; Jackson, IJ; Korsmeyer, SJ; Golub, TR; Fisher, DE			Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability	CELL			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; ELEMENT-BINDING PROTEIN; MALIGNANT-MELANOMA; GROWTH-FACTOR; BCL-2-DEFICIENT MICE; POLYCYSTIC KIDNEY; FAMILY MEMBERS; NEURAL CREST; EXPRESSION; GENE	Kit/SCF signaling and Mitf-dependent transcription are both essential for melanocyte development and pigmentation. To identify Mitf-dependent Kit transcriptional targets in primary melanocytes, microarray studies were undertaken. Among identified targets was BCL2, whose germline deletion produces melanocyte loss and which exhibited phenotypic synergy with Mitf in mice. BCL2's regulation by Mitf was verified in melanocytes and melanoma cells and by chromatin immunoprecipitation of the BCL2 promoter. Mitf also regulates BCL2 in osteoclasts, and both Mitf(mi/mi) and Bcl2(-/-) mice exhibit severe osteopetrosis. Disruption of Mitf in melanocytes or melanoma triggered profound apoptosis susceptible to rescue by BCL2 overexpression. Clinically, primary human melanoma expression microarrays revealed tight nearest neighbor linkage for MITF and BCL2. This linkage helps explain the vital roles of both Mitf and Bcl2 in the melanocyte lineage and the well-known treatment resistance of melanoma.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; University of Edinburgh	Fisher, DE (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.			Ding, Han-Fei/0000-0001-5702-3439; Jackson, Ian/0000-0001-6526-0688; Widlund, Hans/0000-0002-7506-2447	NCI NIH HHS [CA50239] Funding Source: Medline; NIAMS NIH HHS [AR43369, AR45662] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050239, R37CA050239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045662, R01AR043369] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Banerjee D, 2001, Curr Opin Investig Drugs, V2, P574; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Bullock ED, 1996, J BIOL CHEM, V271, P27500, DOI 10.1074/jbc.271.44.27500; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; CARSON WE, 1994, P NATL ACAD SCI USA, V91, P7553, DOI 10.1073/pnas.91.16.7553; CERRONI L, 1995, AM J DERMATOPATH, V17, P7, DOI 10.1097/00000372-199502000-00002; Chang KL, 2001, ADV ANAT PATHOL, V8, P273, DOI 10.1097/00125480-200109000-00004; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; Dorvault CC, 2001, CANCER CYTOPATHOL, V93, P337, DOI 10.1002/cncr.9049; EISINGER M, 1982, P NATL ACAD SCI-BIOL, V79, P2018, DOI 10.1073/pnas.79.6.2018; Goding CR, 2000, GENE DEV, V14, P1712; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grover R, 1996, EUR J SURG ONCOL, V22, P347, DOI 10.1016/S0748-7983(96)90176-6; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509; Ito A, 2001, BLOOD, V97, P2075, DOI 10.1182/blood.V97.7.2075; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; KAMADA S, 1995, CANCER RES, V55, P354; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; King R, 2001, AM J SURG PATHOL, V25, P51, DOI 10.1097/00000478-200101000-00005; Koch MB, 2001, AM J SURG PATHOL, V25, P58, DOI 10.1097/00000478-200101000-00006; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Mekori YA, 2001, J CLIN IMMUNOL, V21, P171, DOI 10.1023/A:1011083031272; Miettinen M, 2001, AM J SURG PATHOL, V25, P205, DOI 10.1097/00000478-200102000-00008; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAMSAY JA, 1995, MODERN PATHOL, V8, P150; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Weilbaecher KN, 1998, J EXP MED, V187, P775, DOI 10.1084/jem.187.5.775; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Yamamura K, 1996, CANCER RES, V56, P3546	57	558	580	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 14	2002	109	6					707	718		10.1016/S0092-8674(02)00762-6	http://dx.doi.org/10.1016/S0092-8674(02)00762-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086670	Bronze			2022-12-24	WOS:000176265600002
J	Foster, G				Foster, G			Supporting community efforts to assist orphans in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHILDREN; FAMILY; AIDS; CARE		Mutare Prov Hosp, Mutare, Zimbabwe		Foster, G (corresponding author), Mutare Prov Hosp, Mutare, Zimbabwe.							*AG INT DEV, 2001, PRINC GUID PROGR ORP; ANKRAH EM, 1993, AIDS CARE, V5, P5, DOI 10.1080/09540129308258580; Caldwell J. C., 1997, HLTH T REV S2, V7, P169; Drew RS, 1998, AIDS CARE, V10, pS9, DOI 10.1080/09540129850124325; Foster C, 2000, AIDS, V14, pS275; Foster G, 1996, AIDS CARE, V8, P389, DOI 10.1080/09540129650125597; Foster G, 1998, AIDS CARE, V10, pS17, DOI 10.1080/09540129850124334; FOSTER G, 1995, AIDS CARE, V7, P3, DOI 10.1080/09540129550126911; Foster G., 1997, HLTH T REV S2, V7, P155; FOSTER G, 2002, 14 INT C AIDS BARC S; FOSTER G, IN PRESS HIV DEV; Foster G., 2000, PSYCHOL HEALTH MED, V5, P55, DOI DOI 10.1080/135485000106007; FOSTER G, IN PRESS AIDS AFRICA; Hunter S, 2000, CHILDREN BRINK EXECU; HUNTER S, 1998, CHIDLREN BRINK STRAT; LEE T, 1999, FOCUS EVALUATION REP; LEVINE C, 1994, ORPHANS HIV EPIDEMIC; Makame V, 2002, ACTA PAEDIATR, V91, P459, DOI 10.1080/080352502317371724; Ntozi J P, 1997, Health Transit Rev, V7 Suppl, P1; PHIRI SN, 2001, EXPANDING STRENGTHEN; *SYN PROJ, 2001, USAID PROJ PROF CHIL; *UNAIDS, 1999, REV HOUS COMM RESP H; *UNAIDS, 2001, CAR OUR CHILDR PROM; *UNICEF, 2001, SIT AN ORPH CHILDR N; VERHOEF HS, 2002, PROMOTING POSITIVE C, V3; WOODS E, 2002, REALITY US RHETORIC	26	51	52	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2002	346	24					1907	1910		10.1056/NEJMsb020718	http://dx.doi.org/10.1056/NEJMsb020718			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561NA	12063378				2022-12-24	WOS:000176146100012
J	Thompson, JN; Cunningham, BM				Thompson, JN; Cunningham, BM			Geographic structure and dynamics of coevolutionary selection	NATURE			English	Article							YUCCA MOTH LINEAGE; LODGEPOLE PINE; GENE FLOW; MUTUALISM; PLANT; CROSSBILLS; GRADIENTS; EVOLUTION; VIRULENCE; PARASITES	Coevolution of species is one of the major processes organizing the Earth's biodiversity. Recent coevolutionary theory has indicated that the geographic structure of species has the potential to impose powerful and continuing effects on coevolutionary dynamics, if that structure creates selection mosaics and coevolutionary hotspots across landscapes(1-7). Here we confirm that current coevolutionary selection in interspecific interactions can be highly divergent across both narrow and broad geographic scales, thereby fuelling continuing coevolution of taxa. Study of a widespread plant-insect interaction across a broad range of habitats for several years showed that an insect functioning both as a pollinator and a floral parasite can be strongly mutualistic in some habitats but commensal or antagonistic in neighbouring habitats. The results for one of the habitats span seven years, demonstrating that the local structure of coevolutionary selection can remain stable across multiple generations. Conservation of the evolutionary processes maintaining long-term biological diversity may require preservation of the conditions that allow a long-term shifting geographic mosaic of coevolutionary hotspots and coldspots.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; Washington State Univ, Sch Life Sci, Pullman, WA 99164 USA	University of California System; University of California Santa Cruz; Washington State University	Thompson, JN (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Earth & Marine Sci Bldg, Santa Cruz, CA 95064 USA.		Thompson, Jessica/GXW-0323-2022					Benkman CW, 1999, AM NAT, V153, pS75, DOI 10.1086/303213; Benkman CW, 2001, EVOLUTION, V55, P282, DOI 10.1111/j.0014-3820.2001.tb01293.x; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; Brodie ED, 1999, EVOLUTION, V53, P626, DOI 10.1111/j.1558-5646.1999.tb03798.x; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; CAICCO SL, 1995, CONSERV BIOL, V9, P498, DOI 10.1046/j.1523-1739.1995.09030498.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; de Jong PW, 2001, MOL ECOL, V10, P1323, DOI 10.1046/j.1365-294X.2001.01268.x; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Hochberg ME, 1998, AM NAT, V152, P620, DOI 10.1086/286194; Hochberg ME, 2000, J EVOLUTION BIOL, V13, P213, DOI 10.1046/j.1420-9101.2000.00157.x; Holland JN, 1999, OECOLOGIA, V121, P405, DOI 10.1007/s004420050945; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Nuismer SL, 1999, P ROY SOC B-BIOL SCI, V266, P605, DOI 10.1098/rspb.1999.0679; Nuismer SL, 2000, EVOLUTION, V54, P1102; Parker MA, 1999, AM NAT, V153, pS48, DOI 10.1086/303211; PELLMYR O, 1992, P NATL ACAD SCI USA, V89, P2927, DOI 10.1073/pnas.89.7.2927; Pellmyr O, 1996, AM NAT, V148, P827, DOI 10.1086/285958; Pellmyr O, 1996, OECOLOGIA, V107, P595, DOI 10.1007/BF00333953; Radtkey RR, 1997, P NATL ACAD SCI USA, V94, P9740, DOI 10.1073/pnas.94.18.9740; Ricketts T.H., 1999, TERRESTRIAL ECOREGIO; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; THOMPSON JN, 1992, ECOLOGY, V73, P1780, DOI 10.2307/1940029	24	346	355	6	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2002	417	6890					735	738		10.1038/nature00810	http://dx.doi.org/10.1038/nature00810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066183				2022-12-24	WOS:000176154700043
J	Douglas, SA; Tayara, L; Ohlstein, EH; Halawa, N; Giaid, A				Douglas, SA; Tayara, L; Ohlstein, EH; Halawa, N; Giaid, A			Congestive heart failure and expression of myocardial urotensin II	LANCET			English	Article							CARDIOVASCULAR ACTIONS; CONFOCAL MICROSCOPY; ENDOTHELIUM; ARTERIES	Background Human urotensin II has several cardiovascular actions, including potent vasoactive, and cardiac inotropic and hypertropic properties. Our aim was to ascertain degree of expression of urotensin II and its receptor GPR14 (now known as UT receptor) in the myocardium of patients with congestive heart failure (CHF). Methods We obtained specimens of myocardium from the hearts of 19 patients with end-stage CHF (12 ischaemic heart disease, seven dilated cardiomyopathy), five patients with early-stage CHF, and eight healthy controls. We used immunohistochemistry, in-situ hybridisation, reverse transcriptase-PCR (RT-PCR), and fluorescein isothiocyanate (FITC)-conjugated urotensin II to ascertain degree of myocardial expression of urotensin II and binding urotensin receptor. Findings Our results showed strong expression of urotensin II in the cardiomyocytes, and to a lesser extent in the vascular smooth muscle cells, endothelial cells, and inflammatory cells of patients with end-stage CHF. There was significantly less urotensin II expression in the myocardium of patients with early-stage CHF (p<0.0001). Also, there was little to no urotensin II expression in the myocardium of healthy controls. Myocardial expression of urotensin II correlated significantly with left ventricular end-diastolic dimension (p=0.0092), and inversely with election fraction (p=0.0002). RT-PCR showed increased concentrations of urotensin II and presence of urotensin receptor mRNA in the myocardium of patients with CHF. The confocal microscopy results showed a significant increase in the binding sites for urotensin in the myocardium of patients with end-stage CHF (P<0.0001). Interpretation Our findings suggest a possible role for urotensin II in the cardiac dysfunction and remodelling characteristic of CHF.	McGill Univ, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA USA	McGill University; GlaxoSmithKline	Giaid, A (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada.	adel.giaid@mcgill.ca						Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; AMES RS, 1998, P NATL ACAD SCI USA, V22, P5803; Beaudet A, 1998, BRAZ J MED BIOL RES, V31, P1479, DOI 10.1590/S0100-879X1998001100017; BELL JR, 1974, AM J MED SCI, V268, P2, DOI 10.1097/00000441-197407000-00001; Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; Bottrill FE, 2000, BRIT J PHARMACOL, V130, P1865, DOI 10.1038/sj.bjp.0703513; Camarda V, 2002, N-S ARCH PHARMACOL, V365, P141, DOI 10.1007/s00210-001-0503-0; Douglas SA, 2000, CIRCULATION, V102, P113; Douglas SA, 2000, J CARDIOVASC PHARM, V36, pS163, DOI 10.1097/00005344-200036051-00051; DOUGLAS SA, 2000, IUPHAR COMPENDIUM RE, P365; Fukuchi M, 1998, CIRCULATION, V98, P132, DOI 10.1161/01.CIR.98.2.132; GONZALEZ GC, 1992, PEPTIDES, V13, P695, DOI 10.1016/0196-9781(92)90175-3; HAZON N, 1993, AM J PHYSIOL, V265, pR573, DOI 10.1152/ajpregu.1993.265.3.R573; Hillier C, 2001, CIRCULATION, V103, P1378, DOI 10.1161/01.CIR.103.10.1378; LeMevel JC, 1996, AM J PHYSIOL-REG I, V271, pR1335, DOI 10.1152/ajpregu.1996.271.5.R1335; Leslie SJ, 2000, CIRCULATION, V102, P113; LIMA JAC, 1993, J AM COLL CARDIOL, V21, P1741, DOI 10.1016/0735-1097(93)90397-J; Maguire JJ, 2000, BRIT J PHARMACOL, V131, P441, DOI 10.1038/sj.bjp.0703601; Opgaard OS, 2000, EUR J PHARMACOL, V406, P265, DOI 10.1016/S0014-2999(00)00672-5; PERKINS TDJ, 1990, BIOCHEM SOC T, V18, P918, DOI 10.1042/bst0180918; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; SABBAH HN, 1981, AM J PHYSIOL, V240, pH920, DOI 10.1152/ajpheart.1981.240.6.H920; Tzanidis A, 2000, EUR HEART J, V21, P72; Wilkinson IB, 2002, CARDIOVASC RES, V53, P341, DOI 10.1016/S0008-6363(01)00485-0; YANO K, 1995, GEN COMP ENDOCR, V97, P103, DOI 10.1006/gcen.1995.1010	26	225	256	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2002	359	9322					1990	1997		10.1016/S0140-6736(02)08831-1	http://dx.doi.org/10.1016/S0140-6736(02)08831-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076554				2022-12-24	WOS:000176232500011
J	Paxinos, EE; James, HF; Olson, SL; Ballou, JD; Leonard, JA; Fleischer, RC				Paxinos, EE; James, HF; Olson, SL; Ballou, JD; Leonard, JA; Fleischer, RC			Prehistoric decline of genetic diversity in the nene	SCIENCE			English	Article							POPULATIONS		Smithsonian Inst, Conservat & Res Ctr, Washington, DC 20008 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Systemat Biol, Washington, DC 20560 USA; Univ Calif Los Angeles, Dept Ecol Evolut & Organismal Biol, Los Angeles, CA 90095 USA	Smithsonian Institution; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California Los Angeles	Fleischer, RC (corresponding author), Smithsonian Inst, Conservat & Res Ctr, 3001 Connecticut Ave NW, Washington, DC 20008 USA.		Paxinos, Ellen/AAG-2907-2019; Leonard, Jennifer/A-7894-2010	Paxinos, Ellen/0000-0002-1710-8064; James, Helen/0000-0002-2495-6133; Leonard, Jennifer/0000-0003-0291-7819				Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; JAMES HF, UNPUB; Kirch P.V., 1985, FEATHERED GODS FISHH; Olson SL, 1991, ORNITHOL MONOGR, V45, P1, DOI DOI 10.2307/40166794; Paxinos EE, 2002, P NATL ACAD SCI USA, V99, P1399, DOI 10.1073/pnas.032166399; RAVE EH, 1994, CONSERV BIOL, V8, P744, DOI 10.1046/j.1523-1739.1994.08030744.x; [No title captured]	7	50	51	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1827	1827		10.1126/science.296.5574.1827	http://dx.doi.org/10.1126/science.296.5574.1827			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052947	Green Submitted			2022-12-24	WOS:000176054300035
J	Bernheim-Groswasser, A; Wiesner, S; Golsteyn, RM; Carlier, MF; Sykes, C				Bernheim-Groswasser, A; Wiesner, S; Golsteyn, RM; Carlier, MF; Sykes, C			The dynamics of actin-based motility depend on surface parameters	NATURE			English	Article							ARP2/3 COMPLEX; DENDRITIC ORGANIZATION; LISTERIA-MONOCYTOGENES; PROTEIN; POLYMERIZATION; FILAMENTS; NETWORKS; WASP; NUCLEATION; PROPULSION	In cells, actin polymerization at the plasma membrane is induced by the recruitment of proteins such as the Arp2/3 complex, and the zyxin/VASP complex(1-3). The physical mechanism of force generation by actin polymerization has been described theoretically using various approaches(4-6), but lacks support from experimental data. By the use of reconstituted motility medium 7,we find that the Wiskott-Aldrich syndrome protein(8,9) (WASP) subdomain, known as VCA, is sufficient to induce actin polymerization and movement when grafted on microspheres. Changes in the surface density of VCA protein or in the microsphere diameter markedly affect the velocity regime, shifting from a continuous to a jerky movement resembling that of the mutated 'hopping' Listeria(10). These results highlight how simple physical parameters such as surface geometry and protein density directly affect spatially controlled actin polymerization, and play a fundamental role in actin-dependent movement.	Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, F-75231 Paris 05, France; Lab Enzymol & Biochim Struct, CNRS, UPR A 9063, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sykes, C (corresponding author), Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, 11 Rue Pierre & Marie Curie, F-75231 Paris 05, France.	carlier@lebs.caps-gif.fr; cecile.sykes@curie.fr	Sykes, Cécile/B-1271-2016; Bernheim, Anne/AAM-5969-2020	Sykes, Cécile/0000-0003-3057-2600; Bernheim-Groswasser, Anne/0000-0003-3999-6098				Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Carlsson AE, 2001, BIOPHYS J, V81, P1907, DOI 10.1016/S0006-3495(01)75842-0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Gerbal F, 2000, BIOPHYS J, V79, P2259, DOI 10.1016/S0006-3495(00)76473-3; Gerbal F, 1999, PRAMANA-J PHYS, V53, P155, DOI 10.1007/s12043-999-0147-z; Giardini PA, 2001, BIOPHYS J, V81, P3193, DOI 10.1016/S0006-3495(01)75955-3; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Lasa I, 1997, EMBO J, V16, P1531, DOI 10.1093/emboj/16.7.1531; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Noireaux V, 2000, BIOPHYS J, V78, P1643, DOI 10.1016/S0006-3495(00)76716-6; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Rutenberg AD, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021904; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takenawa T, 2001, J CELL SCI, V114, P1801; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4	29	186	190	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					308	311		10.1038/417308a	http://dx.doi.org/10.1038/417308a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015607				2022-12-24	WOS:000175592100052
J	Soares, D				Soares, D			An ancient sensory organ in crocodilians - Waiting alligators can detect silent ripples in the water even in total darkness.	NATURE			English	Article									Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Soares, D (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.							Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; GREGORY JE, 1987, NATURE, V326, P386, DOI 10.1038/326386a0; Jackson K, 1996, J MORPHOL, V229, P315, DOI 10.1002/(SICI)1097-4687(199609)229:3<315::AID-JMOR6>3.0.CO;2-X; MOLENAAR GJ, 1974, BRAIN RES, V78, P340, DOI 10.1016/0006-8993(74)90560-5; von During M., 1973, Zeitschrift Anat Entwickl-Gesch, V143, P81	6	85	87	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					241	242		10.1038/417241a	http://dx.doi.org/10.1038/417241a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015589				2022-12-24	WOS:000175592100033
J	Aono, N; Sutani, T; Tomonaga, T; Mochida, S; Yanagida, M				Aono, N; Sutani, T; Tomonaga, T; Mochida, S; Yanagida, M			Cnd2 has dual roles in mitotic condensation and interphase	NATURE			English	Article							CHROMOSOME CONDENSATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; CDC2 PHOSPHORYLATION; TOPOISOMERASE-II; PROTEIN-KINASE; CHECKPOINT; MITOSIS; GENE	Chromosome condensation requires condensin(1-4), which comprises five subunits(5,6). Two of these subunits-both being structural maintenance of chromosome (SMC) proteins-are coiled-coils with globular terminal domains that interact with ATP and DNA. The remaining three, non-SMC subunits also have essential, albeit undefined, roles in condensation. Here we report that Cnd2 (ref. 6), a non-SMC subunit of fission yeast similar to Drosophila Barren 7 and the budding yeast protein Brn1 (refs 8, 9), is required for both interphase and mitotic condensation. In cnd2-1 mutants, ultraviolet-induced DNA damage is not repaired, and cells arrested by hydroxyurea do not recover. A definitive defect of interphase is abolishment of Cds1 (a checkpoint kinase) activation in the presence of hydroxyurea in both cnd2-1 mutant cells and in cells where other condensin subunits have been genetically disrupted. In the absence of hydroxyurea, a G2 checkpoint delay occurred in cnd2-1 mutants in a manner dependent on Cds1 and ATM-like Rad3, but not Chk1 (refs 10-13), before the mitotic condensation defect. Furthermore, cnd2-1 was synthetic-lethal with mutations of excision repair, RecQ helicase and DNA replication enzymes. These interphase and mitotic defects provide insight into the mechanistic role of non-SMC subunits that interact with the globular SMC domains in the heteropentameric holocomplex(14).	Kyoto Univ, Dept Gene Mech, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068582, Japan	Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Dept Gene Mech, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068582, Japan.			Sutani, Takashi/0000-0002-9959-9513				Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; CARR AM, 1993, NUCLEIC ACIDS RES, V21, P1345, DOI 10.1093/nar/21.6.1345; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Hutchins JRA, 2000, FEBS LETT, V466, P91, DOI 10.1016/S0014-5793(99)01763-9; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1997, NATURE, V388, P798, DOI 10.1038/42062; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; YAJIMA H, 1995, EMBO J, V14, P2393, DOI 10.1002/j.1460-2075.1995.tb07234.x; Yamashita YM, 1999, GENES CELLS, V4, P445, DOI 10.1046/j.1365-2443.1999.00274.x; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	30	118	122	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					197	202		10.1038/417197a	http://dx.doi.org/10.1038/417197a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000964				2022-12-24	WOS:000175460200048
J	Biellik, R; Madema, S; Taole, A; Kutsulukuta, A; Allies, E; Eggers, R; Ngcobo, N; Nxumalo, M; Shearley, A; Mabuzane, E; Kufa, E; Okwo-Bele, JM				Biellik, R; Madema, S; Taole, A; Kutsulukuta, A; Allies, E; Eggers, R; Ngcobo, N; Nxumalo, M; Shearley, A; Mabuzane, E; Kufa, E; Okwo-Bele, JM			First 5 years of measles elimination in southern Africa: 1996-2000	LANCET			English	Article							AMERICA	Background Measles is the leading cause of vaccine-preventable death in Africa. Regional measles elimination is considered feasible using current vaccines and a series of WHO-recommended strategies. We aimed to interrupt transmission of measles, and to use case-based surveillance to show the effect of such interruption. Methods In southern Africa from 1996, seven countries with a total population of approximately 70 million and with relatively high routine vaccination coverage implemented measles elimination strategies. In addition to routine measles immunisation at 9 months of age, these included nationwide catch-up campaigns among children aged 9 months to 14 years, then follow-up campaigns every 3-4 years among children aged 9-59 months, and the establishment of case-based measles surveillance with serological diagnostic confirmation. Results Nearly 24 million children aged 9 months to 14 years were vaccinated, with overall vaccination coverage of 91%. Reported clinical measles cases declined from 60 000 in 1996 to 117 laboratory-confirmed measles cases in 2000. Reported measles deaths declined from 166 in 1996 to zero in 2000. No increase in adverse events was noted after the measles vaccination campaign. Conclusion A reduction in measles mortality and morbidity can be achieved in very low-income countries, in countries that split their vaccination campaigns by geographical area or by age-group of the target population, and where initial routine measles vaccination coverage among infants was <90%, even when prevalance of HIV/AIDS was extremely high. Continued high-level national commitment will be crucial to implementation and maintenance of proven strategies in southern Africa.	WHO, Harare, Zimbabwe; Minist Hlth, Gaborone, Botswana; Minist Hlth & Social Serv, Maseru, Lesotho; Minist Hlth & Populat, Lilongwe, Malawi; Minist Hlth, Windhoek, Namibia; Dept Hlth, Pretoria, South Africa; Minist Hlth, Mbabane, Eswatini; Minist Hlth & Child Welf, Harare, Zimbabwe	World Health Organization	Biellik, R (corresponding author), WHO, POB 5160, Harare, Zimbabwe.	biellikr@who.co.zw						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P429; BABAD HR, 1995, EPIDEMIOL INFECT, V114, P319, DOI 10.1017/S0950268800057976; BIELLIK RJ, 1995, INT VIR C JOH JUL 14; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; CHRISTOPHER JL, 1996, GLOBAL BURDEN DIS CO, P17; CUTTS FT, 1995, BIOLOGICALS, V23, P95; De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; Hersh BS, 2000, LANCET, V355, P1943, DOI 10.1016/S0140-6736(00)02325-4; MARSHALL T, IN PRESS NOSOCOMIAL; *UNICEF, 1990, PLAN ACT IMPL WORLD; UZICANIN A, IN PRESS IMPACT 1996; VANDENHEEVER J, 1999, SO AFR MEASL EL M HA; *WHO, 2001, WHOVB0113; *WORLD HLTH ASS, 1989, WHA4232	18	98	102	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2002	359	9317					1564	1568		10.1016/S0140-6736(02)08517-3	http://dx.doi.org/10.1016/S0140-6736(02)08517-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047966				2022-12-24	WOS:000175460700010
J	Ruitenberg, M; Kannt, A; Bamberg, E; Fendler, K; Michel, H				Ruitenberg, M; Kannt, A; Bamberg, E; Fendler, K; Michel, H			Reduction of cytochrome c oxidase by a second electron leads to proton translocation	NATURE			English	Article							BO UBIQUINOL OXIDASE; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; SUBUNIT-I; SITE; STATE	Cytochrome c oxidase, the terminal enzyme of cellular respiration in mitochondria and many bacteria, reduces O-2 to water. This four-electron reduction process is coupled to translocation (pumping) of four protons across the mitochondrial or bacterial membrane(1); however, proton pumping is poorly understood. Proton pumping was thought to be linked exclusively to the oxidative phase, that is, to the transfer of the third and fourth electron(2). Upon re-evaluation of these data, however, this proposal has been questioned(3,4), and a transport mechanism including proton pumping in the reductive phase-that is, during the transfer of the first two electrons-was suggested. Subsequently, additional studies reported that proton pumping during the reductive phase can occur, but only when it is immediately preceded by an oxidative phase(5). To help clarify the issue we have measured the generation of the electric potential across the membrane, starting from a defined one-electron reduced state. Here we show that a second electron transfer into the enzyme leads to charge translocation corresponding to pumping of one proton without necessity for a preceding turnover.	Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60528 Frankfurt, Germany; Max Planck Inst Biophys, Dept Biophys Chem, D-60596 Frankfurt, Germany	Max Planck Society; Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Heinrich Hoffmann Str 7, D-60528 Frankfurt, Germany.	fendler@mpibp-frankfurt.mpg.de; michel@mpibp-frankfurt.mpg.de	Kannt, Aimo/AAZ-6898-2020	Kannt, Aimo/0000-0002-5197-2286; Fendler, Klaus/0000-0002-5699-7060				BRZEZINSKI P, 1985, FEBS LETT, V187, P111, DOI 10.1016/0014-5793(85)81224-2; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; GREENWOOD C, 1974, BIOCHEM J, V137, P205, DOI 10.1042/bj1370205; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 1999, BIOCHEMISTRY-US, V38, P2697, DOI 10.1021/bi982275l; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; MOODY AJ, 1991, BIOCHEM SOC T, V19, P617, DOI 10.1042/bst0190617; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; OLIVEBERG M, 1991, BIOCHEMISTRY-US, V30, P7053, DOI 10.1021/bi00243a003; Ruitenberg M, 2000, P NATL ACAD SCI USA, V97, P4632, DOI 10.1073/pnas.080079097; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P11173, DOI 10.1021/bi00092a029; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Verkhovsky MI, 2001, BIOCHEMISTRY-US, V40, P7077, DOI 10.1021/bi010030u; VYGODINA TV, 1988, ANN NY ACAD SCI, V550, P124, DOI 10.1111/j.1749-6632.1988.tb35329.x; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; WITT SN, 1987, J BIOL CHEM, V262, P1446	22	98	100	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2002	417	6884					99	102		10.1038/417099a	http://dx.doi.org/10.1038/417099a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986672				2022-12-24	WOS:000175307200046
J	Buffon, A; Biasucci, LM; Liuzzo, G; D'Onofrio, G; Crea, F; Maseri, A				Buffon, A; Biasucci, LM; Liuzzo, G; D'Onofrio, G; Crea, F; Maseri, A			Widespread coronary inflammation in unstable angina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART-DISEASE; C-REACTIVE PROTEIN; ATHEROSCLEROTIC PLAQUES; IN-VIVO; ADHESION MOLECULES; ELEVATED LEVELS; BLOOD-FLOW; NEUTROPHIL; RUPTURE	Background: Inflammation within vulnerable coronary plaques may cause unstable angina by promoting rupture and erosion. In unstable angina, activated leukocytes may be found in peripheral and coronary-sinus blood, but it is unclear whether they are selectively activated in the vascular bed of the culprit stenosis. Methods: We measured the content neutrophil myeloperoxidase content in the cardiac and femoral circulations in five groups of patients: two groups with unstable angina and stenosis in either the left anterior descending coronary artery (24 patients) or the right coronary artery (9 patients); 13 with chronic stable angina; 13 with variant angina and recurrent ischemia; and 6 controls. Blood samples were taken from the aorta, the femoral vein, and the great cardiac vein, which selectively drains blood from the left but not the right coronary artery. Results: The neutrophil myeloperoxidase content of aortic blood was similar in both groups of patients with unstable angina (-3.9 and -5.5, with negative values representing depletion of the enzyme due to neutrophil activation) and significantly lower than in the other three groups (P<0.05). Independently of the site of the stenosis, the neutrophil myeloperoxidase content in blood from the great cardiac vein was significantly decreased in both groups of patients with unstable angina (-6.4 in those with a left coronary lesion and -6.6 in those with a right coronary lesion), but not in patients with stable angina and multiple stenoses, patients with variant angina and recurrent ischemia, or controls. There was also a significant transcoronary reduction in myeloperoxidase content in both groups with unstable angina. Conclusions: The widespread activation of neutrophils across the coronary vascular bed in patients with unstable angina, regardless of the location of the culprit stenosis, challenges the concept of a single vulnerable plaque in unstable coronary syndromes.	Univ Vita & Salute, Cardiothorac & Vasc Dept, I-20132 Milan, Italy; Catholic Univ, Inst Cardiol, Rome, Italy; Catholic Univ, Inst Hematol, Rome, Italy	Vita-Salute San Raffaele University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maseri, A (corresponding author), Univ Vita & Salute, Hosp San Raffaele, Cardiothorac & Vasc Dept, Via Olgettina 60, I-20132 Milan, Italy.	maseri.attilio@hsr.it	LIUZZO, GIOVANNA/J-8090-2018	LIUZZO, GIOVANNA/0000-0002-5714-0907; biasucci, luigi m/0000-0002-6921-6497; Buffon, Antonino/0000-0001-8144-6597				ARAUJO L I, 1988, Cardiovascular Drugs and Therapy, V2, P41; ARBUSTINI E, 1991, AM J CARDIOL, V68, pB36, DOI 10.1016/0002-9149(91)90383-V; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Biasucci LM, 1996, J AM COLL CARDIOL, V27, P611, DOI 10.1016/0735-1097(95)00524-2; BOGATY P, 1993, CIRCULATION, V87, P1938, DOI 10.1161/01.CIR.87.6.1938; Casscells W, 1996, LANCET, V347, P1447, DOI 10.1016/S0140-6736(96)91684-0; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; deServi S, 1996, AM J CARDIOL, V78, P564, DOI 10.1016/S0002-9149(96)00367-0; DINERMAN JL, 1990, J AM COLL CARDIOL, V15, P1559, DOI 10.1016/0735-1097(90)92826-N; DISCIASCIO G, 1994, AM HEART J, V128, P419, DOI 10.1016/0002-8703(94)90612-2; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fayad ZA, 2000, CIRCULATION, V102, P506; GANZ W, 1971, CIRCULATION, V44, P181, DOI 10.1161/01.CIR.44.2.181; Gibson CM, 1999, J AM COLL CARDIOL, V34, P974, DOI 10.1016/S0735-1097(99)00335-6; GLANTZ SA, 1987, PRIMER BIOSTATISTICS, P287; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Libby P, 2000, AM J CARDIOL, V86, p3J; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Liuzzo G, 1999, J AM COLL CARDIOL, V34, P1696, DOI 10.1016/S0735-1097(99)00432-5; MAZZONE A, 1993, CIRCULATION, V88, P358, DOI 10.1161/01.CIR.88.2.358; MEHTA J, 1989, CIRCULATION, V79, P549, DOI 10.1161/01.CIR.79.3.549; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Rabbani R, 1999, CARDIOVASC RES, V41, P402, DOI 10.1016/S0008-6363(98)00279-X; SHAH PK, 1995, CIRCULATION, V92, P1565; Stefanadis C, 1999, CIRCULATION, V99, P1965, DOI 10.1161/01.CIR.99.15.1965; UREN NG, 1994, NEW ENGL J MED, V331, P222, DOI 10.1056/NEJM199407283310402; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; WALLSH E, 1986, TEX HEART I J, V13, P105	33	708	763	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2002	347	1					5	12		10.1056/NEJMoa012295	http://dx.doi.org/10.1056/NEJMoa012295			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569HA	12097534				2022-12-24	WOS:000176594500002
J	Demers, LM; Ginger, DS; Park, SJ; Li, Z; Chung, SW; Mirkin, CA				Demers, LM; Ginger, DS; Park, SJ; Li, Z; Chung, SW; Mirkin, CA			Direct patterning of modified oligonucleotides on metals and insulators by dip-pen nanolithography	SCIENCE			English	Article							DNA; INK; GOLD	The use of direct-write dip-pen nanolithography (DPN) to generate covalently anchored, nanoscale patterns of oligonucleotides on both metallic and insulating substrates is described. Modification of DNA with hexanethiol groups allowed patterning on gold, and oligonucleotides bearing 5'-terminal acrylamide groups could be patterned on derivatized silica. Feature sizes ranging from many micrometers to less than 100 nanometers were achieved, and the resulting patterns exhibited the sequence-specific binding properties of the DNA from which they were composed. The patterns can be used to direct the assembly of individual oligonucleotide-modified particles on a surface, and the deposition of multiple DNA sequences in a single array is demonstrated.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Ctr Nanofabricat & Mol Self Assembly, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	camirkin@chem.nwu.edu	Chung, Sungwook/ABH-7052-2020; Chung, Sungwook/H-6248-2012; Park, So-Jung/F-9471-2017; Ginger, David S/C-4866-2011; Mirkin, Chad A/E-3911-2010	Chung, Sungwook/0000-0001-7479-8025; Ginger, David S/0000-0002-9759-5447; Mirkin, Chad/0000-0002-6634-7627	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG002463] Funding Source: NIH RePORTER; NHGRI NIH HHS [1 F32 HG02463] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Demers LM, 2001, ANGEW CHEM INT EDIT, V40, P3071, DOI 10.1002/1521-3773(20010817)40:16<3071::AID-ANIE3071>3.0.CO;2-S; Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523; Ivanisevic A, 2001, J AM CHEM SOC, V123, P7887, DOI 10.1021/ja010671c; Jang JY, 2001, J CHEM PHYS, V115, P2721, DOI 10.1063/1.1384550; Kenney M, 1998, BIOTECHNIQUES, V25, P516, DOI 10.2144/98253pf01; KURTH DG, 1993, LANGMUIR, V9, P2965, DOI 10.1021/la00035a039; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Levicky R, 1998, J AM CHEM SOC, V120, P9787, DOI 10.1021/ja981897r; Maynor BW, 2001, LANGMUIR, V17, P2575, DOI 10.1021/la001755m; Mirkin CA, 2000, INORG CHEM, V39, P2258, DOI 10.1021/ic991123r; Mirkin CA, 2000, MRS BULL, V25, P43, DOI 10.1557/S0883769400065015; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Noy A, 2002, NANO LETT, V2, P109, DOI 10.1021/nl010081c; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Piner RD, 1999, LANGMUIR, V15, P5457, DOI 10.1021/la990408d; Schwartz PV, 2001, LANGMUIR, V17, P5971, DOI 10.1021/la001625d; Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p; Weinberger DA, 2000, ADV MATER, V12, P1600, DOI 10.1002/1521-4095(200011)12:21<1600::AID-ADMA1600>3.0.CO;2-6; Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198	24	610	643	2	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2002	296	5574					1836	1838		10.1126/science.1071480	http://dx.doi.org/10.1126/science.1071480			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052950				2022-12-24	WOS:000176054300038
J	Denker, JA; Zuckerman, DM; Maroney, PA; Nilsen, TW				Denker, JA; Zuckerman, DM; Maroney, PA; Nilsen, TW			New components of the spliced leader RNP required for nematode trans-splicing	NATURE			English	Article							FACTOR SF1; TRI-SNRNP; SM	Pre-messenger-RNA maturation in nematodes and in several other lower eukaryotic phyla involves spliced leader (SL) addition trans-splicing(1,2). In this unusual RNA processing reaction, a short common 5' exon, the SL, is affixed to the 5'-most exon of multiple pre-mRNAs. The nematode SL is derived from a trans-splicing-specific similar to100-nucleotide RNA (SL RNA) that bears striking similarities to the cis-spliceosomal U small nuclear RNAs U1, U2, U4 and U5 (refs 3, 4); for example, the SL RNA functions only if it is assembled into an Sm small nuclear ribonucleoprotein (snRNP)(5). Here we have purified and characterized the SL RNP and show that it contains two proteins (relative molecular masses 175,000 and 30,000 (M-r 175K and 30K)) in addition to core Sm proteins. Immunodepletion and reconstitution with recombinant proteins demonstrates that both proteins are essential for SL trans-splicing; however, neither protein is required either for conventional cis-splicing or for bimolecular (trans-) splicing of fragmented cis constructs. The M-r 175K and 30K SL RNP proteins are the first factors identified that are involved uniquely in SL trans- splicing. Several lines of evidence indicate that the SL RNP proteins function by participating in a trans- splicing specific network of protein-protein interactions analogous to the U1 snRNP-SF1/BBP-U2AF complex that comprises the cross-intron bridge in cis-splicing.	Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Nilsen, TW (corresponding author), Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.							Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; BLUMENTHAL T, 1997, C ELEGANS, V2, P117; BRUZIK JP, 1988, NATURE, V335, P559, DOI 10.1038/335559a0; BRUZIK JP, 1995, P NATL ACAD SCI USA, V92, P7056, DOI 10.1073/pnas.92.15.7056; CHIARA MD, 1995, NATURE, V375, P510, DOI 10.1038/375510a0; Davis RE, 1996, PARASITOL TODAY, V12, P33, DOI 10.1016/0169-4758(96)80643-0; Denker JA, 1996, RNA, V2, P746; HANNON GJ, 1991, J BIOL CHEM, V266, P22792; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; MARONEY PA, 1990, EMBO J, V9, P3667, DOI 10.1002/j.1460-2075.1990.tb07578.x; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Mazroui R, 1999, RNA, V5, P1615, DOI 10.1017/S1355838299991872; Nilsen TW, 2001, TRENDS GENET, V17, P678, DOI 10.1016/S0168-9525(01)02499-4; NILSEN TW, 1997, FRONTIERS MOL BIOL E, P310; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Stover NA, 2001, P NATL ACAD SCI USA, V98, P5693, DOI 10.1073/pnas.101049998; THOMAS JD, 1988, CELL, V54, P533, DOI 10.1016/0092-8674(88)90075-X	17	41	41	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					667	670		10.1038/nature00783	http://dx.doi.org/10.1038/nature00783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050671				2022-12-24	WOS:000176001200053
J	Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF				Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF			Results of screening colonoscopy among persons 40 to 49 years of age.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COST-EFFECTIVENESS; COLORECTAL-CANCER; ASYMPTOMATIC ADULTS; COLONIC NEOPLASIA; LARGE-BOWEL; POLYPS; ADENOMAS; SIZE; RISK	Background: The prevalence of colorectal lesions in persons 40 to 49 years of age, as identified on colonoscopy, has not been determined. Methods: We reviewed the procedure and pathology reports for 906 consecutive persons 40 to 49 years of age who voluntarily participated in an employer-based screening-colonoscopy program. The histologic features of lesions that were identified and removed on endoscopy were categorized according to those of the most advanced lesion removed proximally (up to the junction of the splenic flexure and the descending colon) and the most advanced lesion removed distally. An advanced lesion was defined as an adenoma at least 1 cm in diameter, a polyp with villous histologic features or severe dysplasia, or a cancer. Results: Among those who underwent colonoscopic screening, 78.9 percent had no detected lesions, 10.0 percent had hyperplastic polyps, 8.7 percent had tubular adenomas, and 3.5 percent had advanced neoplasms, none of which were cancerous (95 percent confidence interval for cancer, 0 to 0.4 percent). Eighteen of 33 advanced neoplasms (55 percent) were located distally and were potentially within reach of a sigmoidoscope. If these results are applicable to the general population, at least 250 persons, and perhaps 1000 or more, would need to be screened to detect one cancer in this age group. Conclusions: Colonoscopic detection of colorectal cancer is uncommon in asymptomatic persons 40 to 49 years of age. The noncancerous lesions are equally distributed proximally and distally. The low yield of screening colonoscopy in this age group is consistent with current recommendations about the age at which to begin screening in persons at average risk.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA; Indiana Univ, Sch Med, Div Gen Internal Med, Indianapolis, IN USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Indianapolis Gastroenterol Res Fdn, Indianapolis, IN USA; Eli Lilly & Co, Indianapolis, IN 46285 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Eli Lilly	Imperiale, TF (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER; NIDDK NIH HHS [1 K24 DK 02756] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gopalswamy N, 1997, GASTROINTEST ENDOSC, V46, P497, DOI 10.1016/S0016-5107(97)70003-8; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; MARBLE K, 1992, J SURG ONCOL, V51, P179, DOI 10.1002/jso.2930510311; MILLER BA, 1993, NIH PUBLICATION; Ness RM, 2000, AM J GASTROENTEROL, V95, P1800; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P524, DOI 10.1016/S0016-5107(00)70283-5; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; RIES LAG, 1997, NIH PUBLICATION; Schoen RE, 1997, GASTROINTEST ENDOSC, V46, P492, DOI 10.1016/S0016-5107(97)70002-6; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625	23	271	283	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2002	346	23					1781	1785		10.1056/NEJM200206063462304	http://dx.doi.org/10.1056/NEJM200206063462304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559EK	12050337				2022-12-24	WOS:000176012500003
J	Fedo, CM; Whitehouse, MJ				Fedo, CM; Whitehouse, MJ			Metasomatic origin of quartz-pyroxene rock, Akilia, Greenland, and implications for Earth's earliest life	SCIENCE			English	Article							FISCHER-TROPSCH SYNTHESIS; COMBINED ION-MICROPROBE; EARLY ARCHEAN ROCKS; PB ZIRCON DATA; WEST GREENLAND; CRUSTAL EVOLUTION; SEDIMENTARY-ROCKS; AGE SIGNIFICANCE; ELEMENTS; FRACTIONATION	A quartz-pyroxene rock interpreted as a banded iron formation (BIF) from the island of Akilia, southwest Greenland, contains C-13-depleted graphite that has been claimed as evidence for the oldest (>3850 million years ago) life on Earth. Field relationships on Akilia document multiple intense deformation events that have resulted in parallel transposition of Early Archean rocks and significant boudinage, the tails of which commonly form the banding in the quartz-pyroxene rock. Geochemical data possess distinct characteristics consistent with an ultramafic igneous, not BIF, protolith for this lithology and the adjacent schists. Later metasomatic silica and iron introduction have merely resulted in a rock that superficially resembles a BIF. An ultramafic igneous origin invalidates claims that the carbon isotopic composition of graphite inclusions represents evidence for life at the time of crystallization.	George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA; Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden	George Washington University; Swedish Museum of Natural History	Fedo, CM (corresponding author), George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA.	cfedo@gwu.edu	Whitehouse, Martin J/E-1425-2013	Whitehouse, Martin J/0000-0003-2227-577X				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Arrhenius G, 2000, CHEM GEOL, V169, P69, DOI 10.1016/S0009-2541(00)00333-8; Bau M, 1996, PRECAMBRIAN RES, V79, P37, DOI 10.1016/0301-9268(95)00087-9; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; CHYBA CF, 1993, GEOCHIM COSMOCHIM AC, V57, P3351, DOI 10.1016/0016-7037(93)90543-6; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; Eiler JM, 1997, NATURE, V386, P665, DOI 10.1038/386665a0; GRIFFIN WL, 1980, EARTH PLANET SC LETT, V50, P59, DOI 10.1016/0012-821X(80)90119-3; Hobbs BE., 1976, OUTLINE STRUCTURAL G; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Kamber BS, 1998, CHEM GEOL, V150, P19, DOI 10.1016/S0009-2541(98)00059-X; Kamber BS, 2001, GEOCHIM COSMOCHIM AC, V65, P2509, DOI 10.1016/S0016-7037(01)00613-5; Klein C., 1992, PROTEROZOIC BIOSPHER, P139, DOI DOI 10.1017/CB09780511601064; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; LEPLAND A, 2001, EOS, V82; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MCGREGOR VR, 1977, AM MINERAL, V62, P887; MCLENNAN SM, 1989, REV MINERAL, V21, P169; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mojzsis SJ, 1999, NATURE, V400, P127, DOI 10.1038/22035; Mojzsis SJ, 2000, GSA TODAY, V10, P1; Myers JS, 2001, PRECAMBRIAN RES, V105, P129, DOI 10.1016/S0301-9268(00)00108-X; Myers JS, 2000, PRECAMBRIAN RES, V103, P101, DOI 10.1016/S0301-9268(00)00089-9; Nutman A.P., 1986, GRONLANDS GEOLOGISKE, V154, P80, DOI DOI 10.34194/BULLGGU.V154.6696; Nutman AP, 1997, GEOCHIM COSMOCHIM AC, V61, P2475, DOI 10.1016/S0016-7037(97)00097-5; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; PERRY EC, 1977, EARTH PLANET SC LETT, V36, P280, DOI 10.1016/0012-821X(77)90210-2; Rose NM, 1996, AM J SCI, V296, P1004, DOI 10.2475/ajs.296.9.1004; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; Sano Y, 1999, NATURE, V400, P127, DOI 10.1038/22032; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; SZATMARI P, 1989, AAPG BULL, V73, P989; VENNEMANN TW, 1999, AM SPEC PAP, V329, P133; Whitehouse MJ, 1999, CHEM GEOL, V160, P201, DOI 10.1016/S0009-2541(99)00066-2; Whitehouse MJ, 2001, CHEM GEOL, V175, P201, DOI 10.1016/S0009-2541(00)00301-6	38	139	144	5	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1448	1452		10.1126/science.1070336	http://dx.doi.org/10.1126/science.1070336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029129				2022-12-24	WOS:000175910300043
J	Fares, MA; Ruiz-Gonzalez, MX; Moya, A; Elena, SF; Barrio, E				Fares, MA; Ruiz-Gonzalez, MX; Moya, A; Elena, SF; Barrio, E			Endosymbiotic bacteria - GroEL buffers against deleterious mutations	NATURE			English	Article							ESCHERICHIA-COLI; EVOLUTION; EXPRESSION; SYMBIONT		Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46071, Spain; Univ Valencia, Dept Genet, Valencia 46071, Spain	University of Valencia; University of Valencia	Barrio, E (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, POB 22085, Valencia 46071, Spain.		Barrio, Eladio/G-8969-2015; Elena, Santiago F./A-4191-2011; Moya, Andrés/A-8190-2008; Fares, Mario/L-7100-2016; Ruiz-González, Mario X./B-4009-2017; Ruiz-González, Mario X./M-4450-2019	Barrio, Eladio/0000-0003-1024-954X; Elena, Santiago F./0000-0001-8249-5593; Moya, Andrés/0000-0002-2867-1119; Fares, Mario/0000-0002-4345-3013; Ruiz-González, Mario X./0000-0003-3654-773X; 				AKSOY S, 1995, INSECT MOL BIOL, V4, P2; Charles H, 1997, BIOCHEM BIOPH RES CO, V239, P769, DOI 10.1006/bbrc.1997.7552; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Funk DJ, 2001, GENETICS, V157, P477; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sato S, 1997, J BACTERIOL, V179, P2300, DOI 10.1128/jb.179.7.2300-2304.1997; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; ZYSKIND J, 1989, RECOMBINANT DNA LAB	13	194	196	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					398	398		10.1038/417398a	http://dx.doi.org/10.1038/417398a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024205	Bronze			2022-12-24	WOS:000175730900028
J	Nitabach, MN; Blau, J; Holmes, TC				Nitabach, MN; Blau, J; Holmes, TC			Electrical silencing of Drosophila pacemaker neurons stops the free-running circadian clock	CELL			English	Article							AMYOTROPHIC LATERAL SCLEROSIS; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; NERVOUS-SYSTEM; SYNAPTIC TRANSMISSION; BEHAVIORAL RHYTHMS; CALCIUM REGULATION; AXONAL SWELLINGS; K+ CHANNEL; PERIOD	Electrical silencing of Drosophila circadian pacemaker neurons through targeted expression of K+ channels causes severe deficits in free-running circadian locomotor rhythmicity in complete darkness. Pacemaker electrical silencing also stops the free-running oscillation of PERIOD (PER) and TIMELESS (TIM) proteins that constitutes the core of the cell-autonomous molecular clock. In contrast, electrical silencing fails to abolish PER and TIM oscillation in light-dark cycles, although it does impair rhythmic behavior. On the basis of these findings, we propose that electrical activity is an essential element of the free-running molecular clock of pacemaker neurons along with the transcription factors and regulatory enzymes that have been previously identified as required for clock function.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Holmes, TC (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.			Holmes, Todd/0000-0001-8152-8832	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Barish ME, 1998, J NEUROBIOL, V37, P146, DOI 10.1002/(SICI)1097-4695(199810)37:1<146::AID-NEU11>3.3.CO;2-K; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Colwell CS, 2001, EUR J NEUROSCI, V13, P1420, DOI 10.1046/j.0953-816x.2001.01517.x; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; GOLD BG, 1987, TOXICOLOGY, V46, P125, DOI 10.1016/0300-483X(87)90123-5; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Johns DC, 1999, J NEUROSCI, V19, P1691; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 2000, J BIOL RHYTHM, V15, P13, DOI 10.1177/074873040001500103; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Michel S, 1999, J BIOL RHYTHM, V14, P141, DOI 10.1177/074873099129000533; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Ramon y, 1928, DEGENERATION REGENER; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2000, J BIOL RHYTHM, V15, P357, DOI 10.1177/074873000129001459; Ruppersberg JP, 2000, PFLUG ARCH EUR J PHY, V441, P1, DOI 10.1007/s004240000380; SOKALOVE G, 1978, J THEOR BIOL, V72, P131; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; YAO KM, 1994, J NEUROCHEM, V63, P41; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721	49	340	344	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 17	2002	109	4					485	495		10.1016/S0092-8674(02)00737-7	http://dx.doi.org/10.1016/S0092-8674(02)00737-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086605	Bronze			2022-12-24	WOS:000175696800010
J	Mortensen, EL; Michaelsen, KF; Sanders, SA; Reinisch, JM				Mortensen, EL; Michaelsen, KF; Sanders, SA; Reinisch, JM			The association between duration of breastfeeding and adult intelligence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; COGNITIVE-DEVELOPMENT; PRETERM INFANTS; METAANALYSIS; TRIAL	Context A number of studies suggest a positive association between breastfeeding and cognitive development in early and middle childhood. However, the only previous study that investigated the relationship between breastfeeding and intelligence in adults had several methodological shortcomings. Objective To determine the association between duration of infant breastfeeding and intelligence in young adulthood. Design, Setting, and Participants Prospective longitudinal birth cohort study conducted in a sample of 973 men and women and a sample of 2280 men, all of whom were born in Copenhagen, Denmark, between October 1959 and December 1961, The samples were divided into 5 categories based on duration of breastfeeding, as assessed by physician interview with mothers at a 1-year examination. Main Outcome Measures Intelligence, assessed using the Wechsler Adult Intelligence Scale (WAIS) at a mean age of 27.2 years in the mixed-sex sample and the Borge Priens Prove (BPP) test at a mean age of 18.7 years in the all-male sample. Thirteen potential confounders were included as covariates: parental social status and education; single mother status; mother's height, age, and weight gain during pregnancy and cigarette consumption during the third trimester; number of pregnancies; estimated gestational age; birth weight; birth length; and indexes of pregnancy and delivery complications. Results Duration of breastfeeding was associated with significantly higher scores on the Verbal, Performance, and Full Scale WAIS IQs. With regression adjustment for potential confounding factors, the mean Full Scale WAIS IQs were 99.4, 101.7, 102.3, 106.0, and 104.0 for breastfeeding durations of less than 1 month, 2 to 3 months, 4 to 6 months, 7 to 9 months, and more than 9 months, respectively (P=.003 for overall F test). The corresponding mean scores on the BPP were 38.0, 39.2, 39.9, 40.1, and 40.1 (P=.01 for overall F test). Conclusion Independent of a wide range of possible confounding factors, a significant positive association between duration of breastfeeding and intelligence was observed in 2 independent samples of young adults, assessed with 2 different intelligence tests.	Copenhagen Univ Hosp, Inst Prevent Med, Danish Epidemiol Sci Ctr, Copenhagen, Denmark; Univ Copenhagen, Inst Publ Hlth, Dept Hlth Psychol, DK-1168 Copenhagen, Denmark; Royal Vet & Agr Univ, Res Dept Human Nutr, Frederiksberg, Denmark; Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Bloomington, IN USA	Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; Indiana University System; Indiana University Bloomington	Mortensen, EL (corresponding author), Kommune Hosp Copenhagen, Inst Prevent Med, DK-1399 Copenhagen K, Denmark.	e.l.mortensen@pubhealth.ku.dk; rosenbl@downstate.edu		Michaelsen, Kim F/0000-0003-0449-0839; Mortensen, Erik Lykke/0000-0002-6985-451X	NICHD NIH HHS [HD20263, HD17655] Funding Source: Medline; NIDA NIH HHS [DA05056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020263, R01HD017655] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Angelsen NK, 2001, ARCH DIS CHILD, V85, P183, DOI 10.1136/adc.85.3.183; BAKER RL, 1984, INFLUENCES DEV LONGI, P3; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Cohen J., 1983, APPL MULTIPLE REGRES; Feldman W, 1996, LANCET, V347, P1057, DOI 10.1016/S0140-6736(96)90270-6; FERGUSSON DM, 1982, SOC SCI MED, V16, P1705, DOI 10.1016/0277-9536(82)90096-X; Gale CR, 1996, LANCET, V347, P1072, DOI 10.1016/S0140-6736(96)90278-0; Golding J, 1997, EARLY HUM DEV, V49, pS175, DOI 10.1016/S0378-3782(97)00062-5; Horwood LJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e9; JACOBSON SW, 1992, LANCET, V339, P926, DOI 10.1016/0140-6736(92)90962-3; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; LUCAS A, 1994, ARCH DIS CHILD-FETAL, V70, pF141, DOI 10.1136/fn.70.2.F141; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; McGue M, 1993, NATURE NURTURE PSYCH, P59, DOI DOI 10.1037/10131-003; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Mortensen EL, 2001, NEUROLOGY, V57, P89, DOI 10.1212/WNL.57.1.89; REINISCH JM, 1995, JAMA-J AM MED ASSOC, V274, P1518, DOI 10.1001/jama.274.19.1518; REINISCH JM, 1993, ACTA PSYCHIAT SCAND, V87, P54, DOI 10.1111/j.1600-0447.1993.tb05361.x; RODGERS B, 1978, DEV MED CHILD NEUROL, V20, P421, DOI 10.1111/j.1469-8749.1978.tb15242.x; Rogers IS, 1997, EARLY HUM DEV, V49, pS45, DOI 10.1016/S0378-3782(97)00053-4; Rogers IS, 1997, EARLY HUM DEV, V49, pS157, DOI 10.1016/S0378-3782(97)00061-3; SanGiovanni JP, 2000, PEDIATRICS, V105, P1292, DOI 10.1542/peds.105.6.1292; SCHUERGER JM, 1989, J CLIN PSYCHOL, V45, P294, DOI 10.1002/1097-4679(198903)45:2<294::AID-JCLP2270450218>3.0.CO;2-N; TEASDALE TW, 1987, NATURE, V325, P119, DOI 10.1038/325119a0; Wechsler D, 1958, MEASUREMENT APPRAISA; ZACHAUCHRISTIAN.B, 1975, BABIES HUMAN DEV 1 Y	27	268	281	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2002	287	18					2365	2371		10.1001/jama.287.18.2365	http://dx.doi.org/10.1001/jama.287.18.2365			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548PF	11988057	Bronze			2022-12-24	WOS:000175397000025
J	Iben, S; Tschochner, H; Bier, M; Hoogstraten, D; Hozak, P; Egly, JM; Grummt, I				Iben, S; Tschochner, H; Bier, M; Hoogstraten, D; Hozak, P; Egly, JM; Grummt, I			TFIIH plays an essential role in RNA polymerase I transcription	CELL			English	Article							TERMINAL DOMAIN KINASE; TATA-BINDING PROTEIN; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; MULTIPROTEIN COMPLEX; GENE-TRANSCRIPTION; COILED BODIES; RIBOSOMAL-RNA; FACTOR-IIH; INITIATION	TFIIH is a multisubunit protein complex that plays an essential role in nucleotide excision repair and transcription of protein-coding genes. Here, we report that TFIIH is also required for ribosomal RNA synthesis in vivo and in vitro. In yeast, pre-rRNA synthesis is impaired in TFIIH ts strains. In a mouse, part of cellular TFIIH is localized within the nucleolus and is associated with subpopulations of both RNA polymerase I and the basal factor TIF-IB. Transcription systems lacking TFIIH are inactive and exogenous TFIIH restores transcriptional activity. TFIIH is required for productive but not abortive rDNA transcription, implying a postinitiation role in transcription. The results provide a molecular link between RNA polymerase I transcription and transcription-coupled repair of active ribosomal RNA genes.	German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany; Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 Rotterdam, Netherlands; Acad Sci Czech Republ, Inst Expt Med, Dept Cell Ultrastruct & Mol Biol, Prague 14220 4, Czech Republic; Charles Univ Prague, Fac Med 3, Dept Cell & Mol Biol, Prague 10034, Czech Republic; Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Erasmus University Rotterdam; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grummt, I (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany.	j.grummt@dkfz-heidelberg.de	Hozak, Pavel/AAB-5359-2021; Hozak, Pavel/J-4182-2014	Hozak, Pavel/0000-0003-1901-1394; Hozak, Pavel/0000-0003-1901-1394				Albert AC, 1999, MOL CELL BIOL, V19, P796; Balajee AS, 1999, NUCLEIC ACIDS RES, V27, P2511, DOI 10.1093/nar/27.12.2511; BOHMANN K, 1995, J CELL BIOL, V131, P817, DOI 10.1083/jcb.131.4.817; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Conconi A, 2002, P NATL ACAD SCI USA, V99, P649, DOI 10.1073/pnas.022373099; Dvir A, 1996, J BIOL CHEM, V271, P23352, DOI 10.1074/jbc.271.38.23352; Dvir A, 1997, J BIOL CHEM, V272, P28175, DOI 10.1074/jbc.272.45.28175; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Grande MA, 1997, J CELL SCI, V110, P1781; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; Hannan RD, 1999, NUCLEIC ACIDS RES, V27, P3720, DOI 10.1093/nar/27.18.3720; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; HOZAK P, 1994, J CELL SCI, V107, P639; JIANG Y, 1995, J BIOL CHEM, V270, P1277, DOI 10.1074/jbc.270.3.1277; Jordan P, 1997, MOL BIOL CELL, V8, P1207, DOI 10.1091/mbc.8.7.1207; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LOFQUIST AK, 1993, NUCLEIC ACIDS RES, V21, P3233; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Lyon CE, 1997, EXP CELL RES, V230, P84, DOI 10.1006/excr.1996.3380; MALATESTA M, 1994, EXP CELL RES, V211, P415, DOI 10.1006/excr.1994.1106; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; MEIER UT, 1992, CELL, V70, P127; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; RASKA I, 1990, J STRUCT BIOL, V104, P120, DOI 10.1016/1047-8477(90)90066-L; SaezVasquez J, 1997, P NATL ACAD SCI USA, V94, P11869, DOI 10.1073/pnas.94.22.11869; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Schnapp A, 1996, METHOD ENZYMOL, V273, P233; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; SCHNAPP G, 1994, EMBO J, V13, P4028, DOI 10.1002/j.1460-2075.1994.tb06719.x; Seither P, 1998, J MOL BIOL, V275, P43, DOI 10.1006/jmbi.1997.1434; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133	47	117	122	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2002	109	3					297	306		10.1016/S0092-8674(02)00729-8	http://dx.doi.org/10.1016/S0092-8674(02)00729-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015980	Bronze			2022-12-24	WOS:000175412100006
J	Marrosu, MG; Cocco, E; Lai, M; Spinicci, G; Pischedda, MP; Contu, P				Marrosu, MG; Cocco, E; Lai, M; Spinicci, G; Pischedda, MP; Contu, P			Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study	LANCET			English	Article							AUTOIMMUNE-DISEASES; PATIENTS TARGET; SUSCEPTIBILITY; PREDISPOSITION; ENCEPHALITIS; ASSOCIATION; POPULATION; HAPLOTYPES; PREVALENCE; RELATIVES	Background Individuals from Sardinia, Italy, are at high risk of developing multiple sclerosis and type 1 diabetes mellitus. We attempted to assess the prevalence in this region of type 1 diabetes mellitus in individuals with multiple sclerosis, and to ascertain disease risk factors. Methods We did a cohort study to assess prevalence of type I diabetes in 1090 people with multiple sclerosis, and in their parents (n=2180) and siblings (n=3300), all born and living in Sardinia, All participants were patients at the multiple sclerosis clinic in Cagliari, and were judged representative of the total Sardinian outpatients and inpatients. We asked patients whether their parents or siblings had multiple sclerosis or diabetes, confirming replies by examining clinical records. We identified risk factors for diabetes with univariate and multivariate logistic regression analyses. Findings Diabetes prevalence in people with multiple sclerosis was, respectively, about three-fold and five-fold that in their healthy siblings (p=0.001) and in the general population (p<0.0001). Presence of other relatives with multiple sclerosis conferred increased risk of type 1 diabetes to healthy siblings of individuals with multiple sclerosis (odds ratio=3.41, p=0.0019). Diabetes risk was six-fold higher in patients with relatives having multiple sclerosis than in healthy siblings of multiple sclerosis patients without other relatives with the disease (p=0.0001). Interpretation In Sardinian families with genetic inheritance of multiple sclerosis type I diabetes is prevalent, both in multiple sclerosis patients and in healthy siblings. This finding indicates that common genes contribute to susceptibility to both diseases in this population.	Osped Binaghi, Ctr Sclerosi Multipla, Dipartimento Neurosci, I-09126 Cagliari, Italy; Univ Cagliari, Dipartimento Salute Pubbl, Cagliari, Italy	University of Cagliari	Marrosu, MG (corresponding author), Osped Binaghi, Ctr Sclerosi Multipla, Dipartimento Neurosci, Via Is Guadazzonis 2, I-09126 Cagliari, Italy.	gmarrosu@unica.it	Cocco, Eleonora/G-5064-2012; Contu, Paolo/I-2409-2019	Cocco, Eleonora/0000-0002-3878-8820; Contu, Paolo/0000-0002-5511-0923; Marrosu, Maria Giovanna/0000-0003-2334-2081				Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; CLAYTON D, 1996, STAT MODELS EPIDEMIO, P227; CONGIA M, 1994, NATO ADV SCI INST SE, V270, P173; Coraddu F, 2001, EUR J HUM GENET, V9, P621, DOI 10.1038/sj.ejhg.5200680; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; CUCCA F, 1996, HLA MHC GENES MOL FU, P383; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; *EXP COMM DIAGN CL, 1997, DIABETES CARE, V20, P1193; Frongia O, 1997, ACTA DIABETOL, V34, P199, DOI 10.1007/s005920050074; GERSTEIN HC, 1994, DIABETES CARE, V17, P13, DOI 10.2337/diacare.17.1.13; Granieri E, 2000, NEUROLOGY, V55, P842, DOI 10.1212/WNL.55.6.842; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; Lampis R, 2000, HUM MOL GENET, V9, P2959, DOI 10.1093/hmg/9.20.2959; Lauer K, 1997, NEUROLOGY, V49, pS55, DOI 10.1212/WNL.49.2_Suppl_2.S55; Marrosu MG, 1997, AM J HUM GENET, V61, P454; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; Merriman TR, 2001, DIABETES, V50, P184, DOI 10.2337/diabetes.50.1.184; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; OLMOS P, 1988, DIABETOLOGIA, V31, P747, DOI 10.1007/BF00274777; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; SADOVNICK AD, 1993, CAN J NEUROL SCI, V20, P17, DOI 10.1017/S0317167100047351; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2001, J IMMUNOL, V166, P4751, DOI 10.4049/jimmunol.166.7.4751; WITHAKER JN, 1997, MULTIPLE SCLEROSIS C, P3	30	96	97	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2002	359	9316					1461	1465		10.1016/S0140-6736(02)08431-3	http://dx.doi.org/10.1016/S0140-6736(02)08431-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546NA	11988243				2022-12-24	WOS:000175279100007
J	Feldman, WC; Boynton, WV; Tokar, RL; Prettyman, TH; Gasnault, O; Squyres, SW; Elphic, RC; Lawrence, DJ; Lawson, SL; Maurice, S; McKinney, GW; Moore, KR; Reedy, RC				Feldman, WC; Boynton, WV; Tokar, RL; Prettyman, TH; Gasnault, O; Squyres, SW; Elphic, RC; Lawrence, DJ; Lawson, SL; Maurice, S; McKinney, GW; Moore, KR; Reedy, RC			Global distribution of neutrons from Mars: Results from Mars Odyssey	SCIENCE			English	Article							GROUND ICE; EPITHERMAL NEUTRONS; LUNAR PROSPECTOR; TEMPERATURES; STABILITY; SURFACE; MOON	Global distributions of thermal, epithermal, and fast neutron fluxes have been mapped during late southern summer/northern winter using the Mars Odyssey Neutron Spectrometer. These fluxes are selectively sensitive to the vertical and lateral spatial distributions of H and CO2 in the uppermost meter of the martian surface. Poleward of +/-60degrees latitude is terrain rich in hydrogen, probably H2O ice buried beneath tens of centimeter-thick hydrogen-poor soil. The central portion of the north polar cap is covered by a thick CO2 layer, as is the residual south polar cap. Portions of the low to middle latitudes indicate subsurface deposits of chemically and/or physically bound H2O and/or OH.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Arizona, Lunar Planetary Lab, Tucson, AZ 85721 USA; Observ Midi Pyrenees, F-31400 Toulouse, France	United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University; University of Arizona; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Feldman, WC (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.		Gasnault, Olivier/F-4327-2010; Lawrence, David J/E-7463-2015	Gasnault, Olivier/0000-0002-6979-9012; Lawrence, David J/0000-0002-7696-6667; Prettyman, Thomas/0000-0003-0072-2831; Reedy, Robert/0000-0002-2189-1303				Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; BOYNTON WV, UNPUB SPACE SCI REV; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; Feldman WC, 1998, SCIENCE, V281, P1489, DOI 10.1126/science.281.5382.1489; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; FELDMAN WC, 1986, NUCL INSTRUM METH A, V245, P182, DOI 10.1016/0168-9002(86)90274-3; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P20347, DOI 10.1029/1999JE001183; FELDMAN WC, IN PRESS J GEOPHYS R; Gasnault O, 2001, GEOPHYS RES LETT, V28, P3797, DOI 10.1029/2001GL013072; GENETAY I, UNPUB PLANET SPACE S; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; JAMES PB, 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LINGENFELTER R, 1961, J GEOPHYS RES, V66, P2665, DOI 10.1029/JZ066i009p02665; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; NEUGEBAUER G, 1971, ASTRON J, V76, P719, DOI 10.1086/111189; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; SODERBLOM L. A., 1992, MARS, P557; Thomas P., 1992, MARS, P767	23	412	420	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					75	78		10.1126/science.1073541	http://dx.doi.org/10.1126/science.1073541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040088				2022-12-24	WOS:000176711000034
J	Sebire, NJ; Foskett, M; Paradinas, FJ; Fisher, RA; Francis, RJ; Short, D; Newlands, ES; Seckl, MJ				Sebire, NJ; Foskett, M; Paradinas, FJ; Fisher, RA; Francis, RJ; Short, D; Newlands, ES; Seckl, MJ			Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin	LANCET			English	Article								We assessed 77 twin pregnancies, comprising complete hydatidiform mole (CHM) and healthy co-twin, to ascertain the risks to the mother and baby of continuing the pregnancy, versus termination. 24 women with histologically confirmed CHM and healthy co-twin pregnancies decided to have a termination. 53 women continued with their pregnancies, though two had to have terminations because of severe pre-eclampsia, and 23 spontaneously aborted (<24 weeks' gestation). 28 pregnancies lasted 24 weeks or more, resulting in 20 livebirths. Chemotherapy to eliminate persistent gestational trophoblastic disease (pGTD) was required in three of 19 women (16%; 95% CI 3-39) who terminated their pregnancies in the first trimester, and in 12 of 58 (21%; 95% CI 11-33%) who continued their pregnancies. CHM and healthy co-twin pregnancies have a high risk of spontaneous abortion, but about 40% result in livebirths, without significantly increasing the risk of pGTD.	Charing Cross Hosp, Imperial Coll Sch Med, Dept Histopathol, Trophoblast Dis Unit, London W6 8RF, England; Charing Cross Hosp, Imperial Coll Sch Med, Dept Canc Med, London W6 8RF, England	Imperial College London; Imperial College London	Seckl, MJ (corresponding author), Charing Cross Hosp, Imperial Coll Sch Med, Dept Histopathol, Trophoblast Dis Unit, London W6 8RF, England.		sebire, neil J/C-4960-2008	Sebire, Neil/0000-0001-5348-9063; Fisher, Rosemary/0000-0002-2721-8726				GOLDSTEIN DP, 1994, J REPROD MED, V39, P139; Matsui H, 2000, HUM REPROD, V15, P608, DOI 10.1093/humrep/15.3.608; Newlands E.S., 1997, GESTATIONAL TROPHOBL; Paradinas FJ, 1994, CURR DIAGN PATHOL, V1, P24; Seckl MJ, 2000, LANCET, V356, P36, DOI 10.1016/S0140-6736(00)02432-6	5	152	179	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 22	2002	359	9324					2165	2166		10.1016/S0140-6736(02)09085-2	http://dx.doi.org/10.1016/S0140-6736(02)09085-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566RJ	12090984				2022-12-24	WOS:000176441800013
J	Dunah, AW; Jeong, H; Griffin, A; Kim, YM; Standaert, DG; Hersch, SM; Mouradian, MM; Young, AB; Tanese, N; Krainc, D				Dunah, AW; Jeong, H; Griffin, A; Kim, YM; Standaert, DG; Hersch, SM; Mouradian, MM; Young, AB; Tanese, N; Krainc, D			Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease	SCIENCE			English	Article							MEDIATED TRANSCRIPTION; GLUTAMINE REPEATS; GENE-EXPRESSION; TRANSGENIC MICE; MAMMALIAN-CELLS; BINDING PROTEIN; NERVOUS-SYSTEM; RECEPTOR GENE; TFIID SUBUNIT; HUMAN BRAIN	Huntington's disease (HD) is an inherited neurodegenerative disease caused by expansion of a polyglutamine tract in the huntingtin protein. Transcriptional dysregulation has been implicated in HD pathogenesis. Here, we report that huntingtin interacts with the transcriptional activator Sp1 and coactivator TAFII130. Coexpression of Sp1 and TAFII130 in cultured striatal cells from wild-type and HD transgenic mice reverses the transcriptional inhibition of the dopamine D2 receptor gene caused by mutant huntingtin, as well as protects neurons from huntingtin-induced cellular toxicity. Furthermore, soluble mutant huntingtin inhibits Sp1 binding to DNA in postmortem brain tissues of both presymptomatic and affected HD patients. Understanding these early molecular events in HD may provide an opportunity to interfere with the effects of mutant huntingtin before the development of disease symptoms.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Ctr Aging Genet & Neurodegenerat, Charlestown, MA 02129 USA; NINCDS, Genet Pharmacol Unit, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA; NYU, Sch Med, Dept Microbiol MSB258, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); New York University	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Ctr Aging Genet & Neurodegenerat, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu	Young, Anne/AAF-4283-2020	Mouradian, M. Maral/0000-0002-9937-412X; Standaert, David/0000-0003-2921-8348; Tanese, Naoko/0000-0002-1946-3211	NCCIH NIH HHS [AT00613] Funding Source: Medline; NIA NIH HHS [5R37AG13617] Funding Source: Medline; NINDS NIH HHS [NS35255, NS02174, NS34361] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000613] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [U01AT000613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034361, Z01NS002826, R01NS034361, R01NS035255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013617] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; DUNAH AW, UNPUB; Furukawa T, 2000, J BIOL CHEM, V275, P29847, DOI 10.1074/jbc.M002989200; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; HUANG CC, 1998, SOMAT CELL MOLEC GEN, V24, P971; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; KRAINC D, UNPUB; Lahiri DK, 2000, BRAIN RES PROTOC, V5, P257, DOI 10.1016/S1385-299X(00)00021-0; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; LI SH, 2002, MOL CELL BIOL, V22, P1722; Lunkes A, 1998, ESSAYS BIOCHEM, V33, P149, DOI 10.1042/bse0330149; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Metsis M, 2001, EXP CELL RES, V269, P214, DOI 10.1006/excr.2001.5307; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Rojo-Niersbach E, 1999, J BIOL CHEM, V274, P33778, DOI 10.1074/jbc.274.47.33778; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Weeks RA, 1996, ANN NEUROL, V40, P49, DOI 10.1002/ana.410400110; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yajima S, 1998, DNA CELL BIOL, V17, P471, DOI 10.1089/dna.1998.17.471; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	42	545	567	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2002	296	5576					2238	2243		10.1126/science.1072613	http://dx.doi.org/10.1126/science.1072613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	11988536				2022-12-24	WOS:000176379000064
J	Alencar, AM; Arold, SP; Buldyrev, SV; Majumdar, A; Stamenovic, D; Stanley, HE; Suki, B				Alencar, AM; Arold, SP; Buldyrev, SV; Majumdar, A; Stamenovic, D; Stanley, HE; Suki, B			Physiology - Dynamic instabilities in the inflating lung	NATURE			English	Editorial Material							AIRWAY		Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Alencar, AM (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.		Majumdar, Arnab/A-8096-2008; Alencar, Adriano M/L-5071-2013; Buldyrev, Sergey V/I-3933-2015	Alencar, Adriano M/0000-0001-9324-2698; Stanley, H./0000-0003-2800-4495; Buldyrev, Sergey/0000-0002-3008-1070				CLEMENTS JA, 1961, J APPL PHYSIOL, V16, P444, DOI 10.1152/jappl.1961.16.3.444; FUKAYA H, 1968, J APPL PHYSIOL, V25, P689, DOI 10.1152/jappl.1968.25.6.689; GAVER DP, 1990, J APPL PHYSIOL, V69, P74, DOI 10.1152/jappl.1990.69.1.74; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; MEAD J, 1967, J APPL PHYSIOL, V22, P95, DOI 10.1152/jappl.1967.22.1.95; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; PATTLE RE, 1962, LANCET, V2, P469; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; SHLESINGER MF, 1991, PHYS REV LETT, V67, P2106, DOI 10.1103/PhysRevLett.67.2106; STAMENOVIC D, 1992, J APPL PHYSIOL, V73, P596, DOI 10.1152/jappl.1992.73.2.596; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Tobin MJ, 2002, AM J RESP CRIT CARE, V165, P598, DOI 10.1164/ajrccm.165.5.2201062	12	44	47	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					809	811		10.1038/417809b	http://dx.doi.org/10.1038/417809b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075340				2022-12-24	WOS:000176285600035
J	Crackower, MA; Sarao, R; Oudit, GY; Yagil, C; Kozieradzki, I; Scanga, SE; Oliveira-dos-Santos, AJ; da Costa, J; Zhang, LY; Pei, Y; Scholey, J; Ferrario, CM; Manoukian, AS; Chappell, MC; Backx, PH; Yagil, Y; Penninger, JM				Crackower, MA; Sarao, R; Oudit, GY; Yagil, C; Kozieradzki, I; Scanga, SE; Oliveira-dos-Santos, AJ; da Costa, J; Zhang, LY; Pei, Y; Scholey, J; Ferrario, CM; Manoukian, AS; Chappell, MC; Backx, PH; Yagil, Y; Penninger, JM			Angiotensin-converting enzyme 2 is an essential regulator of heart function	NATURE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASES; DEFICIENT MICE; RISK-FACTORS; MOUSE HEART; PART I; DROSOPHILA; EXPRESSION; RAT; HYPERTENSION	Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.	Univ Toronto, Ontario Canc Inst, Amgen Res Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med, Toronto, ON M5G 2M9, Canada; Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Div Cellular & Mol Biol, Toronto, ON M5G 2M9, Canada; Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Ben Gurion Univ Negev, Barzilai Med Ctr, Fac Hlth Sci, Dept Nephrol & Hypertens,Lab Mol Med, IL-78306 Ashqelon, Israel; Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27157 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Ben Gurion University; Barzilai Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Penninger, JM (corresponding author), Univ Toronto, Ontario Canc Inst, Amgen Res Inst, Univ Ave, Toronto, ON M5G 2M9, Canada.		Penninger, Josef M/I-6860-2013; Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020	Penninger, Josef M/0000-0002-8194-3777; Ferrario, Carlos/0000-0003-0792-6239				Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF636, DOI 10.1152/ajprenal.2000.279.4.F636; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; CHAPPELL MC, 1991, J HYPERTENS, V9, P751, DOI 10.1097/00004872-199108000-00008; CORNEL MJ, 1995, J BIOL CHEM, V270, P13613, DOI 10.1074/jbc.270.23.13613; CORVOL P, 1998, HDB PROTEOLYTIC ENZY, P1066; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Elkind MS, 1998, SEMIN NEUROL, V18, P429, DOI 10.1055/s-2008-1040896; Enseleit F, 2001, J CARDIOVASC PHARM, V37, pS21, DOI 10.1097/00005344-200109011-00004; Esther CR, 1996, LAB INVEST, V74, P953; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Heusch G, 1998, PHYSIOL REV, V78, P1055, DOI 10.1152/physrev.1998.78.4.1055; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; Hollenberg N K, 1988, Curr Opin Cardiol, V3, pS19, DOI 10.1097/00001573-198801001-00003; Jacob HJ, 1999, CLIN EXP PHARMACOL P, V26, P530, DOI 10.1046/j.1440-1681.1999.03078.x; Kietzmann T, 1999, BLOOD, V94, P4177, DOI 10.1182/blood.V94.12.4177.424k14_4177_4185; Kloner RA, 1998, CIRCULATION, V97, P1848, DOI 10.1161/01.CIR.97.18.1848; Kloting I, 1998, LIFE SCI, V62, P973, DOI 10.1016/S0024-3205(98)00017-4; KOIKE G, 1995, HYPERTENSION, V26, P998, DOI 10.1161/01.HYP.26.6.998; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; LARAGH JH, 1986, J HYPERTENS, V4, pS79; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Skeggs L T, 1980, Adv Exp Med Biol, V130, P1; Sowter HM, 2001, CANCER RES, V61, P6669; Spradling AC, 1999, GENETICS, V153, P135; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Taylor CAM, 1996, GENE, V181, P191, DOI 10.1016/S0378-1119(96)00503-3; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Wickenden AD, 1999, CIRC RES, V85, P1067; Wuyts B, 1997, ACTA CLIN BELG, V52, P338, DOI 10.1080/17843286.1997.11718599; Yagil C, 1999, HYPERTENSION, V33, P261, DOI 10.1161/01.HYP.33.1.261; YAGIL C, 1996, J HYPERTENS, V14, P175; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; ZHIZHANG Y, 1998, DEV GENET, V22, P187; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	42	1415	1576	8	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					822	828		10.1038/nature00786	http://dx.doi.org/10.1038/nature00786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075344				2022-12-24	WOS:000176285600039
J	McCaig, LF; Besser, RE; Hughes, JM				McCaig, LF; Besser, RE; Hughes, JM			Trends in antimicrobial prescribing rates for children and adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-TRACT INFECTIONS; ANTIBIOTIC USE; OTITIS-MEDIA; RISK-FACTORS; PHYSICIANS; AGENTS; ADULTS; INTERVENTION; PRINCIPLES	Context Annual rates of antimicrobial prescribing for children by office-based physicians increased from 1980 through 1992. The development of antimicrobial resistance, which increased for many organisms during the 1990s, is associated with antimicrobial use. To combat development of antimicrobial resistance, professional and public health organizations undertook efforts to promote appropriate antimicrobial prescribing. Objective To assess changes in antimicrobial prescribing rates overall and for respiratory tract infections for children and adolescents younger than 15 years. Design, Setting, and Participants National Ambulatory Medical Care Survey data provided by 2500 to 3500 office-based physicians for 6500 to 13 600 pediatric visits during 2-year periods from 1989-1990 through 1999-2000. Main Outcome Measures Population- and visit-based antimicrobial prescribing rates overall and for respiratory tract infections (otitis media, pharyngitis, bronchitis, sinusitis, and upper respiratory tract infection) among children and adolescents younger than 15 years. Results The average population-based annual rate of overall antimicrobial prescriptions per 1000 children and adolescents younger than 15 years decreased from 838 (95% confidence interval [CI], 711-966) in 1989-1990 to 503 (95% CI, 419-588) in 1999-2000 (P for slope <.001). The visit-based rate decreased from 330 antimicrobial prescriptions per 1000 off ice visits (95% CI, 305-355) to 234 (95% CI, 210-257; P for slope <.001). For the 5 respiratory tract infections, the population-based prescribing rate decreased from 674 (95% CI, 568-781) to 379 (95% CI, 311-447; P for slope <.001) and the visit-based prescribing rate decreased from 715 (95% CI, 682748) to 613 (95% CI, 570-657; P for slope <.001). Both population- and visit-based prescribing rates decreased for pharyngitis and upper respiratory tract infection; however, for otitis media and bronchitis, declines were only observed in the population-based rate. Prescribing rates for sinusitis remained stable. Conclusion The rate of antimicrobial prescribing overall and for respiratory tract infections by office-based physicians for children and adolescents younger than 15 years decreased significantly between 1989-1990 and 1999-2000.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Ambulatory Care Stat Branch, Div Hlth Care Stat, Natl Ctr Hlth Stat, Hyattsville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	McCaig, LF (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,MS C23, Atlanta, GA 30333 USA.	lfm1@cdc.gov; rbesser@cdc.gov						Barden LS, 1998, CLIN PEDIATR, V37, P665, DOI 10.1177/000992289803701104; Bauchner H, 1999, PEDIATRICS, V103, P395, DOI 10.1542/peds.103.2.395; Belongia EA, 2001, PEDIATRICS, V108, P575, DOI 10.1542/peds.108.3.575; Bergman DA, 1999, PEDIATRICS, V103, P843; Besser RE, 2001, ROY SOC MED INT CONG, V247, P151; BILLUPS NF, 1989, AM DRUG IND; BLOCK SL, 1995, PEDIATR INFECT DIS J, V14, P751, DOI 10.1097/00006454-199509000-00005; BRYANT E, 1988, VITAL HLTH STAT 2, V108, P1; Burke JP, 1998, JAMA-J AM MED ASSOC, V280, P1270, DOI 10.1001/jama.280.14.1270; *CDCP, 2002, PREV EM INF DIS ADDR; Dowell SF, 1998, PEDIATRICS, V101, P163; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; Forum on Emerging Infections Institute of Medicine, 1998, ANT RES ISS OPT; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Institute of Medicine, 1992, EM INF MICR THREATS; Jernigan DB, 1996, JAMA-J AM MED ASSOC, V275, P206, DOI 10.1001/jama.275.3.206; KOCH H, 1982, VITAL HLTH STAT 2, V90, P1; Levy SB, 1998, NEW ENGL J MED, V338, P1376, DOI 10.1056/NEJM199805073381909; Low DE, 1998, JAMA-J AM MED ASSOC, V279, P394, DOI 10.1001/jama.279.5.394; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MCCAIG LF, 2001, ADV DATA VITAL HLTH, V320; MCEVOY CK, 1996, AM HOSP FORMULARY SE; MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033; *MED EC CO INC, 1989, PHYS DESK REF; *MED EC CO INC, 1996, PHYS DESK REF; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; PALLARES R, 1987, NEW ENGL J MED, V317, P18, DOI 10.1056/NEJM198707023170104; PARADISE JL, 1995, PEDIATRICS, V96, P712; *PHS US DEP HLTH H, 1988, INT CLASS DIS 9 REV; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; SAAH AJ, 1980, JAMA-J AM MED ASSOC, V243, P1824, DOI 10.1001/jama.1980.03300440026020; Schwartz B, 1997, JAMA-J AM MED ASSOC, V278, P944, DOI 10.1001/jama.278.11.944; SHAH BV, 1991, SUDAAN USERS MANUAL; SIRKEN MG, 1990, MANUAL STANDARDS PRO; Swartz MN, 1997, NEW ENGL J MED, V337, P491, DOI 10.1056/NEJM199708143370709; *US BUR CENS, 2002, POP CENS; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; *WOLT KLUW CO, 1999, DRUG FACTS COMP	45	368	383	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2002	287	23					3096	3102		10.1001/jama.287.23.3096	http://dx.doi.org/10.1001/jama.287.23.3096			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563NK	12069672	Bronze			2022-12-24	WOS:000176262300024
J	Bousso, P; Bhakta, NR; Lewis, RS; Robey, E				Bousso, P; Bhakta, NR; Lewis, RS; Robey, E			Dynamics of thymocyte-stromal cell interactions visualized by two-photon microscopy	SCIENCE			English	Article							T-CELLS; ANTIGEN PRESENTATION; POSITIVE SELECTION; ACTIVATION	Thymocytes are selected to mature according to their ability to interact with self major histocompatibility complex (MHC)-peptide complexes displayed on the thymic stroma. Using two-photon microscopy, we performed real-time analysis of the cellular contacts made by developing thymocytes undergoing positive selection in a three-dimensional thymic organ culture. A large fraction of thymocytes within these cultures were highly motile. MHC recognition was found to increase the duration of thymocyte-stromal cell interactions and occurred as both long-lived cellular associations displaying stable cell-cell contacts and as shorter, highly dynamic contacts. Our results identify the diversity and dynamics of thymocyte interactions during positive selection.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Robey, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X; Lewis, Richard/0000-0002-6010-7403	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042033, R01AI032985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374, R37GM045374] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42033, AI32985] Funding Source: Medline; NIGMS NIH HHS [R01 GM045374, GM45374] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON G, 1994, J IMMUNOL, V153, P1915; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; BOUSSO P, UNPUB; Brelinska R, 1997, MICROSC RES TECHNIQ, V38, P250; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pezzano M, 2001, MICROBIOL MOL BIOL R, V65, P390, DOI 10.1128/MMBR.65.3.390-403.2001; Tanaka Y, 1997, INT IMMUNOL, V9, P381, DOI 10.1093/intimm/9.3.381; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909	16	222	231	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1876	1880		10.1126/science.1070945	http://dx.doi.org/10.1126/science.1070945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052962				2022-12-24	WOS:000176054300051
J	Riewald, M; Petrovan, RJ; Donner, A; Mueller, BM; Ruf, W				Riewald, M; Petrovan, RJ; Donner, A; Mueller, BM; Ruf, W			Activation of endothelial cell protease activated receptor 1 by the protein C pathway	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; COLI SEPTIC SHOCK; ESCHERICHIA-COLI; TISSUE FACTOR; FACTOR VIIA; RESPONSES; SEPSIS; COAGULATION; MECHANISMS; EXPRESSION	The coagulant and inflammatory exacerbation in sepsis is counterbalanced by the protective protein C (PC) pathway. Activated PC (APC) was shown to use the endothelial cell PC receptor (EPCR) as a coreceptor for cleavage of protease activated receptor 1 (PAR1) on endothelial cells. Gene profiling demonstrated that PAR1 signaling could account for all APC-induced protective genes, including the immunomodulatory monocyte chemoattractant protein-1 (MCP-1), which was selectively induced by activation of PAR1, but not PAR2. Thus, the prototypical thrombin receptor is the target for EPCR-dependent APC signaling, suggesting a role for this receptor cascade in protection from sepsis.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Mol Med, Div Canc Biol, San Diego, CA 92121 USA	Scripps Research Institute	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol, C204,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ruf@scripps.edu			NHLBI NIH HHS [P01-HL16411] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bone-Larson CL, 2000, AM J PATHOL, V157, P1177, DOI 10.1016/S0002-9440(10)64633-0; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; Esmon CT, 1999, THROMB HAEMOSTASIS, V82, P251; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; GREY ST, 1994, J IMMUNOL, V153, P3664; Grinnell BW, 1996, AM J PHYSIOL-HEART C, V270, pH603, DOI 10.1152/ajpheart.1996.270.2.H603; HANSON SR, 1993, J CLIN INVEST, V92, P2003, DOI 10.1172/JCI116795; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Shu F, 2000, FEBS LETT, V477, P208, DOI 10.1016/S0014-5793(00)01740-3; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Taylor FB, 1998, BLOOD, V91, P1609, DOI 10.1182/blood.V91.5.1609.1609_1609_1615; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; TAYLOR FB, 1994, BACTERIAL ENDOTOXINS; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475	26	697	736	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1880	1882		10.1126/science.1071699	http://dx.doi.org/10.1126/science.1071699			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052963				2022-12-24	WOS:000176054300052
J	Lowe, L; Murray, CS; Custovic, A; Simpson, BM; Kissen, PM; Woodcock, A				Lowe, L; Murray, CS; Custovic, A; Simpson, BM; Kissen, PM; Woodcock, A		NAC Manchester Asthma Allergy Stud	Specific airway resistance in 3-year-old children: a prospective cohort study	LANCET			English	Article							PASSIVE RESPIRATORY MECHANICS; LUNG-FUNCTION; EARLY-LIFE; BRONCHIAL RESPONSIVENESS; PULMONARY-FUNCTION; MANCHESTER ASTHMA; YOUNG-CHILDREN; FAMILY HISTORY; INFANTS; PREGNANCY	Background The development of a method to assess lung function in young children may provide new insight into asthma development. Plethysmographic measurement of specific airway resistance (sR(aw)) is feasible in this age group. We aimed to identify risk factors associated with low lung function in early childhood in a prospective birth cohort. Methods Children were prenatally assigned to risk group according to parental atopic status (high risk, both parents atopic; medium risk, one parent atopic; low risk, neither parent atopic) and followed prospectively until age 3 years. We measured sR(aw) in 503 symptom-free children using whole-body plethysmography during tidal breathing. Findings 803 of 868 children attended the clinic, of whom 503 obtained satisfactory sR(aw) readings, 200 who wheezed at least once during first 3 years of life had significantly higher sR(aw) than the 303 who had never wheezed (mean difference 5.8%, 95% CI 2.2-9.3, p=0.002). For children who had never wheezed there were significant differences in sR(aw) between risk groups (p<0.001). Children at high risk (n=87) had a higher sR(aw) (geometric mean 1.17 kPa/s, 1.12-1.22) than children at medium risk (n=162; 1.02 kPa/s, 1.00-1.05) and at low risk (54; 1.04 kPa/s, 0.99-1.11). Atopic children (n=62) had significantly higher sR(aw) (1.15 kPa/s, 1.09-1.21) than those who were not atopic (232; 1.05 kPa/s, 1.02-1.07, p=0.002). For non-atopic children, those at high risk (58) had higher sR(aw) (1.13 kPa/s, 1.07-1.18) than those at medium risk (125, 1.01 kPa/s, 0.98-1.05) or at low risk (49, 1.04 kPa/s, 0.97-1.10, p=0.003). We showed a significant interaction between history of maternal asthma and child's atopic status (p=0.006). Interpretation Even in the absence of respiratory symptoms, children of atopic parents and those with personal atopy have impaired lung function in early life.	Wythenshawe Hosp, N W Lung Ctr, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Woodcock, A (corresponding author), Wythenshawe Hosp, N W Lung Ctr, Southmoor Rd, Manchester M23 9LT, Lancs, England.	awoodcock@fs1.with.man.ac.uk	Custovic, Adnan/A-2435-2012	Custovic, Adnan/0000-0001-5218-7071; Murray, Clare/0000-0002-8961-8055; Woodcock, Ashley/0000-0002-5428-8578				Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Bisgaard H, 1995, EUR RESPIR J, V8, P2067, DOI 10.1183/09031936.95.08122067; CLARKE JR, 1995, AM J RESP CRIT CARE, V151, P1434, DOI 10.1164/ajrccm.151.5.7735597; *COMM PROF STAND C, 1995, AM J RESP CRIT CARE, V152, P1107, DOI DOI 10.1164/AJRCCM; Custovic A, 2001, LANCET, V358, P188, DOI 10.1016/S0140-6736(01)05406-X; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; DAB I, 1978, PEDIATR RES, V12, P878, DOI 10.1203/00006450-197808000-00016; DAB I, 1976, PEDIATR RES, V10, P996, DOI 10.1203/00006450-197612000-00009; Dezateux C, 1997, BRIT MED BULL, V53, P40; Gappa M, 2001, EUR RESPIR J, V17, P141, DOI 10.1183/09031936.01.17101410; Goetz I, 2001, EUR RESPIR J, V17, P449, DOI 10.1183/09031936.01.17304490; Holgate ST, 2000, AM J RESP CRIT CARE, V162, pS113, DOI 10.1164/ajrccm.162.supplement_2.ras-12; Klug B, 1998, PEDIATR PULM, V25, P322, DOI 10.1002/(SICI)1099-0496(199805)25:5<322::AID-PPUL6>3.0.CO;2-K; Klug B, 1997, EUR RESPIR J, V10, P1599, DOI 10.1183/09031936.97.10071599; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; Morris MG, 2001, EUR RESPIR J, V17, P529, DOI 10.1183/09031936.01.17305290; Nielsen KG, 2001, AM J RESP CRIT CARE, V164, P554, DOI 10.1164/ajrccm.164.4.2006119; Phagoo SB, 1996, EUR RESPIR J, V9, P1374, DOI 10.1183/09031936.96.09071374; POHUNEK P, 1997, EUR RESP J S25, V12, pS160; REID L, 1977, PEDIATR RES, V11, P210; SILVERMAN M, 1998, LUNG FUNCTION TESTS, P170; Simpson BM, 2001, CLIN EXP ALLERGY, V31, P391, DOI 10.1046/j.1365-2222.2001.01050.x; Sly PD, 2000, EUR RESPIR J, V16, P741, DOI 10.1034/j.1399-3003.2000.16d29.x; Stick SM, 1996, LANCET, V348, P1060, DOI 10.1016/S0140-6736(96)04446-7; Stocks J, 2001, EUR RESPIR J, V17, P302, DOI 10.1183/09031936.01.17203020; Stocks J, 1996, INFANT RESP FUNCTION; Ulrik CS, 1999, AM J RESP CRIT CARE, V160, P40, DOI 10.1164/ajrccm.160.1.9806059; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	29	110	114	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2002	359	9321					1904	1908		10.1016/S0140-6736(02)08781-0	http://dx.doi.org/10.1016/S0140-6736(02)08781-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057553				2022-12-24	WOS:000175975700010
J	Nosil, P; Crespi, BJ; Sandoval, CP				Nosil, P; Crespi, BJ; Sandoval, CP			Host-plant adaptation drives the parallel evolution of reproductive isolation	NATURE			English	Article							NATURAL-SELECTION; PHYLOGENETIC INFERENCE; SEXUAL ISOLATION; SPECIATION; FREQUENCIES	Parallel evolution of similar traits in independent populations that inhabit ecologically similar environments strongly implicates natural selection as the cause of evolution(1). Parallel speciation is a special form of parallel evolution where traits that determine reproductive isolation evolve repeatedly, in closely related populations, as by-products of adaptation to ecological conditions(1,2). The outcome of such parallel evolution is that ecologically divergent pairs of populations exhibit greater levels of reproductive isolation than ecologically similar pairs of populations of a similar or younger age(2-4). The parallel evolution of reproductive isolation provides strong evidence for natural selection in the process of speciation(1), but only one conclusive example from nature is known(2). Populations of the walking-stick insect Timema cristinae that use different host-plant species have diverged in body size and shape, host preference, behaviour and the relative frequency of two highly cryptic colour-pattern morphs(5,6). Here we report that divergent selection for host adaptation, and not genetic drift, has promoted the parallel evolution of sexual isolation in this species. Our findings represent a clear demonstration that host-plant adaptation can play a crucial and repeatable role in the early stages of speciation.	Simon Fraser Univ, Dept Biosci, Behav Ecol Res Grp, Burnaby, BC V5A 1S6, Canada; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93206 USA	Simon Fraser University; University of California System; University of California Santa Barbara	Nosil, P (corresponding author), Simon Fraser Univ, Dept Biosci, Behav Ecol Res Grp, Burnaby, BC V5A 1S6, Canada.							Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.1111/j.1558-5646.1998.tb02254.x, 10.2307/2411347]; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Manly B. F. J, 1997, RANDOMIZATION BOOTST; McPeek MA, 1998, LIMNOL OCEANOGR, V43, P1162, DOI 10.4319/lo.1998.43.6.1162; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rolan-Alvarez E, 2000, EVOLUTION, V54, P30, DOI 10.1554/0014-3820(2000)054[0030:ESSASI]2.0.CO;2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; SANDOVAL CP, 1994, BIOL J LINN SOC, V52, P341; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x; Sandoval CP, 1993, THESIS U CALIFORNIA; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SWOFFORD DL, 2001, PAUP STAR PHYLOGENET; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x	16	346	360	1	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					440	443		10.1038/417440a	http://dx.doi.org/10.1038/417440a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024213				2022-12-24	WOS:000175730900038
J	Bear, JE; Svitkina, TM; Krause, M; Schafer, DA; Loureiro, JJ; Strasser, GA; Maly, IV; Chaga, OY; Cooper, JA; Borisy, GG; Gertler, FB				Bear, JE; Svitkina, TM; Krause, M; Schafer, DA; Loureiro, JJ; Strasser, GA; Maly, IV; Chaga, OY; Cooper, JA; Borisy, GG; Gertler, FB			Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility	CELL			English	Article							LISTERIA-MONOCYTOGENES; CULTURED-CELLS; PHOSPHOPROTEIN VASP; ARP2/3 COMPLEX; EVH1 DOMAIN; DYNAMICS; CYTOSKELETON; POLYMERIZATION; ORGANIZATION; LAMELLIPODIA	Cell motility requires lamellipodial protrusion, a process driven by actin polymerization. Ena/VASP proteins accumulate in protruding lamellipodia and promote the rapid actin-driven motility of the pathogen Listeria. In contrast, Ena/VASP negatively regulate cell translocation. To resolve this paradox, we analyzed the function of Ena/VASP during lamellipodial protrusion. Ena/VASP-deficient lamellipodia protruded slower but more persistently, consistent with their increased cell translocation rates. Actin networks in Ena/VASP-deficient lamellipodia contained shorter, more highly branched filaments compared to controls. Lamellipodia with excess Ena/VASP contained longer, less branched filaments. In vitro, Ena/VASP promoted actin filament elongation by interacting with barbed ends, shielding them from capping protein. We conclude that Ena/VASP regulates cell motility by controlling the geometry of actin filament networks within lamellipodia.	MIT, Dept Biol, Cambridge, MA 02139 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Massachusetts Institute of Technology (MIT); Northwestern University; Washington University (WUSTL)	Gertler, FB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Krause, Matthias/D-9814-2013; Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Krause, Matthias/0000-0002-3200-3199; Cooper, John/0000-0002-0933-4571; Borisy, Gary/0000-0002-0266-8018	NIGMS NIH HHS [R01 GM038542, GM38542, IU54 GM63126, R01 GM038542-13, GM62431, GM58801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062431, R01GM038542, R01GM058801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Lasa I, 1997, EMBO J, V16, P1531, DOI 10.1093/emboj/16.7.1531; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Nakagawa H, 2001, J CELL SCI, V114, P1555; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; SMALHEISER NR, 1991, DEV BRAIN RES, V62, P81, DOI 10.1016/0165-3806(91)90192-L; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; SVITKINA TM, 1986, J CELL SCI, V82, P235	37	642	659	0	41	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 17	2002	109	4					509	521		10.1016/S0092-8674(02)00731-6	http://dx.doi.org/10.1016/S0092-8674(02)00731-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086607	Bronze, Green Published			2022-12-24	WOS:000175696800012
J	Harmar, AJ; Marston, HM; Shen, SB; Spratt, C; West, KM; Sheward, WJ; Morrison, CF; Dorin, JR; Piggins, HD; Reubi, JC; Kelly, JS; Maywood, ES; Hastings, MH				Harmar, AJ; Marston, HM; Shen, SB; Spratt, C; West, KM; Sheward, WJ; Morrison, CF; Dorin, JR; Piggins, HD; Reubi, JC; Kelly, JS; Maywood, ES; Hastings, MH			The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei	CELL			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; PHOTIC INDUCTION; GENE-EXPRESSION; PHASE-SHIFTS; MICE LACKING; PERIOD GENE; CLOCK GENE; PEPTIDE; MPER1; LIGHT	The neuropeptides pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are implicated in the photic entrainment of circadian rhythms in the suprachiasmatic nuclei (SON). We now report that mice carrying a null mutation of the VPAC(2) receptor for VIP and PACAP(Vipr2(-/-)) are incapable of sustaining normal circadian rhythms of rest/activity behavior. These mice also fail to exhibit circadian expression of the core clock genes mPer1, mPer2, and mCry1 and the clock-controlled gene arginine vasopressin (AVP) in the SON. Moreover, the mutants fail to show acute induction of mPer1 and mPer2 by nocturnal illumination. This study highlights the role of intercellular neuropeptidergic signaling in maintenance of circadian function within the SCN.	Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Fujisawa Inst Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Manchester; University of Bern; MRC Laboratory Molecular Biology	Harmar, AJ (corresponding author), Univ Edinburgh, Dept Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	tony.harmar@ed.ac.uk	Shen, Sanbing/E-3750-2015; Marston, Hugh M/G-8555-2011	Marston, Hugh M/0000-0002-7460-0581; Hastings, Michael Harvey/0000-0001-8576-6651; Harmar, Anthony/0000-0002-3838-9264; Shen, Sanbing/0000-0002-8217-9811; Piggins, Hugh/0000-0003-2555-9858				Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Clark AJ, 1997, NUCLEIC ACIDS RES, V25, P1009, DOI 10.1093/nar/25.5.1009; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Fukuhara C, 1997, NEUROSCI LETT, V229, P49, DOI 10.1016/S0304-3940(97)00415-1; Gourlet P, 1997, PEPTIDES, V18, P403, DOI 10.1016/S0196-9781(96)00322-1; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hastings M H, 1999, J Neurosci, V19, pRC11; Hastings MH, 2000, NAT REV NEUROSCI, V1, P143, DOI 10.1038/35039080; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; Laemle LK, 1999, PHYSIOL BEHAV, V66, P461, DOI 10.1016/S0031-9384(98)00318-7; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mackay M, 1996, GENOMICS, V37, P345, DOI 10.1006/geno.1996.0569; Masubuchi S, 2001, EUR J NEUROSCI, V14, P1177, DOI 10.1046/j.0953-816x.2001.01749.x; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Piggins HD, 2001, NEUROSCI LETT, V305, P25, DOI 10.1016/S0304-3940(01)01796-7; Pinnock SB, 2001, EUR J NEUROSCI, V13, P576, DOI 10.1046/j.0953-816x.2000.01406.x; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; REPPERT SM, 1989, RES PERINATAL MED, V9, P25; Reubi JC, 2000, CANCER RES, V60, P3105; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shearman LP, 1999, NEUROREPORT, V10, P613, DOI 10.1097/00001756-199902250-00031; Shen SB, 2000, P NATL ACAD SCI USA, V97, P11575, DOI 10.1073/pnas.97.21.11575; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	50	408	418	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2002	109	4					497	508		10.1016/S0092-8674(02)00736-5	http://dx.doi.org/10.1016/S0092-8674(02)00736-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086606	Bronze			2022-12-24	WOS:000175696800011
J	Budd, GE				Budd, GE			A palaeontological solution to the arthropod head problem	NATURE			English	Article							BURGESS SHALE; MORPHOLOGY; CHELICERATE; EXPRESSION; CRUSTACEA; EVOLUTION; POSITION; BEARING; ORIGIN	The composition of the arthropod head has been one of the most controversial topics in zoology, with a large number of theories being proposed to account for it over the last century(1). Although fossils have been recognized as being of potential importance in resolving the issue(2,3), a lack of consensus over their systematics(4,5) has obscured their contribution. Here, I show that a group of previously problematic Cambrian arthropods from the Burgess Shale and Chengjiang faunas form a clade close to crown- group euarthropods, the group containing myriapods, chelicerates, insects and crustaceans(6). They are characterized by modified or even absent endopods, and two pre- oral appendages. Comparison with reconstructions of the crown- group euarthropod ground plan(6) and recent investigations into onychophorans(7,8) demonstrates that these two appendages are the first antenna (of extant crustaceans) and a more anterior appendage associated with an ocular segment. The latter appendage has been reduced in all crown- group euarthropods. Its most likely relic is as a component of the labrum(9). These fossils thus tie together results from disparate living groups (onychophorans and euarthropods).	Uppsala Univ, Dept Earth Sci Hist Geol & Paleontol, SE-75236 Uppsala, Sweden	Uppsala University	Budd, GE (corresponding author), Uppsala Univ, Dept Earth Sci Hist Geol & Paleontol, Norbyvagen 22, SE-75236 Uppsala, Sweden.	graham.budd@pal.uu.se		Budd, Graham/0000-0001-9007-4369				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Bousfield E.L., 1995, Amphipacifica, V2, P3; BRIGGS DEG, 1978, PHILOS T ROY SOC B, V281, P439, DOI 10.1098/rstb.1978.0005; BRIGGS DEG, 1988, PALAEONTOLOGY, V31, P779; BRUTON DL, 1983, PHILOS T R SOC B, V300, P553, DOI 10.1098/rstb.1983.0020; Budd G. E., 1997, ARTHROPOD RELATIONSH, V55, P125; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Dewel R. A., 1997, ARTHROPOD RELATIONSH, V55, P109; Dewel RA, 1999, ZOOL ANZ, V238, P191; Edgecombe GD, 1999, J PALEONTOL, V73, P263, DOI 10.1017/S0022336000027761; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; ERIKSSON BJ, IN PRESS J MORPHOL; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Haas MS, 2001, DEV GENES EVOL, V211, P89, DOI 10.1007/s004270000128; Hou XG, 1999, J PALEONTOL, V73, P102; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou Xianguang, 1997, Fossils and Strata, V45, P1; REMPEL J G, 1975, Quaestiones Entomologicae, V11, P7; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Scholtz G, 2001, ZOOL-ANAL COMPLEX SY, V103, P99; SIMONETTA AM, 1991, EARLY EVOLUTION META, P189; Swofford D., 1998, PAUP PHYLOGENETIC AN; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Walossek Dieter, 1999, P3; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Whittington HB., 1979, ORIGIN MAJOR INVERTE, P253; Wills Matthew A., 1995, Verhandlungen der Deutschen Zoologischen Gesellschaft, V88, P203; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27	31	195	199	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					271	275		10.1038/417271a	http://dx.doi.org/10.1038/417271a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015599				2022-12-24	WOS:000175592100043
J	Rosenkranz, JA; Grace, AA				Rosenkranz, JA; Grace, AA			Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning	NATURE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; LATERAL AMYGDALA; FEAR; INHIBITION; ANESTHESIA; RESPONSES; NEURONS	Pavlovian conditioning results when an innocuous stimulus, such as an odour, is paired with a behaviourally relevant stimulus, such as a foot-shock, so that eventually the former stimulus alone will elicit the behavioural response of the latter. The lateral nucleus of the amygdala (LAT) is necessary for the emotional memory formation in this paradigm(1-4). Enhanced neuronal firing in LAT to conditioned stimuli emerge in parallel with the behavioural changes(5-11) and are dependent on local dopamine(12-15). To study the changes in neuronal excitability and synaptic drive that contribute to the pavlovian conditioning process, here we used in vivo intracellular recordings to examine LAT neurons during pavlovian conditioning in rats. We found that repeated pairings of an odour with a foot-shock resulted in enhanced post-synaptic potential (PSP) responses to the odour and increased neuronal excitability. However, a non-paired odour displayed PSP decrement. The dopamine antagonist haloperidol blocked the PSP enhancement and associated increased neuronal excitability, without reversing previous conditioning. These results demonstrate that conditioning and habituation processes produce opposite effects on LAT neurons and that dopamine is important in these events, consistent with its role in emotional memory formation.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosenkranz, JA (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	rosenk@bns.pitt.edu		Grace, Anthony/0000-0003-1864-5504				ANDREASEN NC, 1994, ACTA PSYCHIAT SCAND, V90, P51, DOI 10.1111/j.1600-0447.1994.tb05891.x; BENARI Y, 1972, ELECTROEN CLIN NEURO, V32, P667, DOI 10.1016/0013-4694(72)90103-4; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Dutton RC, 2001, ANESTHESIOLOGY, V94, P514, DOI 10.1097/00000542-200103000-00024; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Ghoneim MM, 1997, ANESTHESIOLOGY, V87, P387, DOI 10.1097/00000542-199708000-00027; GOLD PE, 1985, BEHAV NEUROSCI, V99, P1019, DOI 10.1037/0735-7044.99.5.1019; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Grossberg S, 2000, BIOL PSYCHIAT, V48, P81, DOI 10.1016/S0006-3223(00)00903-3; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; McGough JJ, 2000, CURR OPIN PEDIATR, V12, P319, DOI 10.1097/00008480-200008000-00006; MORRISON RL, 1988, SCHIZOPHRENIA BULL, V14, P67, DOI 10.1093/schbul/14.1.67; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Nishijo H, 1998, J NEUROPHYSIOL, V79, P21, DOI 10.1152/jn.1998.79.1.21; Pare D, 2000, J NEUROSCI, V20, P2701; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RESCORLA RA, 1967, PSYCHOL REV, V74, P71, DOI 10.1037/h0024109; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Sacchetti B, 1999, J NEUROSCI, V19, P9570; WEINBERGER NM, 1984, SCIENCE, V223, P605, DOI 10.1126/science.6695173	27	272	275	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					282	287		10.1038/417282a	http://dx.doi.org/10.1038/417282a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551YT	12015602				2022-12-24	WOS:000175592100046
J	Karter, AJ; Ferrara, A; Liu, JY; Moffet, HH; Ackerson, LM; Selby, JV				Karter, AJ; Ferrara, A; Liu, JY; Moffet, HH; Ackerson, LM; Selby, JV			Ethnic disparities in diabetic complications in an insured population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; LOWER-EXTREMITY AMPUTATION; MANAGED CARE POPULATION; RISK-FACTORS; SOCIOECONOMIC-STATUS; MEDICAL-CARE; MEXICAN-AMERICANS; GLYCEMIC CONTROL; RACIAL-DIFFERENCES	Context Higher rates of microvascular complications have been reported for minorities. Disparate access to quality health care is a common explanation for ethnic disparities in diabetic complication rates in the US population. Examining an ethnically diverse population with uniform health care coverage may be useful. Objective To assess ethnic disparities in the incidence of diabetic complications within a nonprofit prepaid health care organization. Design and Setting Longitudinal observational study conducted January 1, 1995, through December 31, 1998, at Kaiser Permanente Medical Care Program in northern California. Participants A total of 62432 diabetic patients including Asians (12%), blacks (14%), Latinos (10%), and whites (64%). Main Outcome Measures Incident myocardial infarction (MI), stroke, congestive heart failure (CHF), and nontraumatic lower extremity amputation (LEA), defined by primary hospitalization discharge diagnosis, procedures, or underlying cause of death; and end-stage renal disease (ESRD), defined as renal insufficiency requiring renal replacement therapy or transplantation for survival or by underlying cause of death. Results Patterns of ethnic differences were not consistent across complications and frequently persisted despite adjustment for a wide range of demographic, socioeconomic, behavioral, and clinical factors. Adjusted hazard ratios (relative to that of whites) were 0.56, 0.68, and 0.68 for blacks, Asians, and Latinos, respectively (P<.001), for MI; 0.76 and 0.72 for Asians and Latinos, respectively (P<.01), for stroke; 0.70 and 0.61 for Asians and Latinos, respectively (P<.01), for CHF; 0.40 for Asians (P<.001) for LEA and 2.03, 1.85, and 1.46 for blacks, Asians, and Latinos, respectively (P<.01), for ESRD. There were no statistically significant black-white differences for stroke, CHF, or LEA and no Latino-white differences for LEA. Conclusions This study confirms previous reports of elevated incidence of ESRD among ethnic minorities, despite uniform medical care coverage, and provides new evidence that rates of other complications are similar or lower relative to those of whites. The persistence of ethnic disparities after adjustment suggests a possible genetic origin, the contribution of unmeasured environmental factors, or a combination of these factors.	Kaiser Permanente, Div Res, Oakland, CA 94612 USA	Kaiser Permanente	Karter, AJ (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.			Ferrara, Assiamira/0000-0002-7505-4826				Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; AYANIAN JZ, 1994, JAMA-J AM MED ASSOC, V271, P1207, DOI 10.1001/jama.271.15.1207; Backlund E, 1999, SOC SCI MED, V49, P1373, DOI 10.1016/S0277-9536(99)00209-9; Bruno G, 1999, J CLIN EPIDEMIOL, V52, P413, DOI 10.1016/S0895-4356(99)00002-5; BURDEN AC, 1992, DIABETIC MED, V9, P641, DOI 10.1111/j.1464-5491.1992.tb01860.x; Burge MR, 2000, DIABETES OBES METAB, V2, P351, DOI 10.1046/j.1463-1326.2000.00105.x; *CDCP, 1997, DIAB SURV 1997; Chaturvedi N, 1996, DIABETES CARE, V19, P423, DOI 10.2337/diacare.19.5.423; Chaturvedi N, 1998, BMJ-BRIT MED J, V316, P100; Christen WG, 1999, AM J EPIDEMIOL, V150, P1142; Conigliaro J, 2000, ARCH INTERN MED, V160, P1329, DOI 10.1001/archinte.160.9.1329; Connolly VM, 1996, DIABETES CARE, V19, P419, DOI 10.2337/diacare.19.5.419; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Curb JD, 2002, DIABETES CARE, V25, P386; Destefano Frank, 1993, Ethnicity and Disease, V3, P145; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; Ferrara A, 2001, DIABETES CARE, V24, P1144, DOI 10.2337/diacare.24.7.1144; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P710, DOI 10.1016/0272-6386(95)90546-4; Freeman HP, 2000, NEW ENGL J MED, V342, P1045, DOI 10.1056/NEJM200004063421411; Gordon N P, 1991, Adv Health Econ Health Serv Res, V12, P19; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; GUJRAL JS, 1993, DIABETIC MED, V10, P271, DOI 10.1111/j.1464-5491.1993.tb00057.x; HAFFNER SM, 1991, DIABETES CARE, V14, P665, DOI 10.2337/diacare.14.7.665; Harris MI, 1999, DIABETES CARE, V22, P1679, DOI 10.2337/diacare.22.10.1679; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HIATT RA, 1982, AM J PUBLIC HEALTH, V72, P829, DOI 10.2105/AJPH.72.8.829; Iribarren C, 2001, CIRCULATION, V103, P2668; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Karter AJ, 1999, DIABETES CARE, V22, P938, DOI 10.2337/diacare.22.6.938; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Karter AJ, 1998, J REGISTRY MANAGEMEN, V25, P7; Krieger N, 1998, AM J PUBLIC HEALTH, V88, P1308, DOI 10.2105/AJPH.88.9.1308; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lavery LA, 1996, DIABETES CARE, V19, P48, DOI 10.2337/diacare.19.1.48; Leggetter S, 2002, ARCH INTERN MED, V162, P73, DOI 10.1001/archinte.162.1.73; MARTIN TL, 1995, DIABETES CARE, V18, P1124, DOI 10.2337/diacare.18.8.1124; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Miller A D, 1985, J Med Soc N J, V82, P723; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; MOST RS, 1983, DIABETES CARE, V6, P87, DOI 10.2337/diacare.6.1.87; National Diabetes Data Group (U.S.) National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) National Institutes of Health (U.S.). Diabetes in America, 1995, DIAB AM; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; PISUNYER X, 1998, CLIN GUIDELINES IDEN; PUGH JA, 1995, DIABETES, V44, P1375, DOI 10.2337/diabetes.44.12.1375; PUGH JA, 1988, AM J EPIDEMIOL, V127, P135, DOI 10.1093/oxfordjournals.aje.a114773; Pugh Jacqueline A., 1992, Journal of Diabetes and its Complications, V6, P236, DOI 10.1016/1056-8727(92)90058-S; REIBER GE, 1992, ANN INTERN MED, V117, P97, DOI 10.7326/0003-4819-117-2-97; REWERS M, 1992, AM J EPIDEMIOL, V135, P1321, DOI 10.1093/oxfordjournals.aje.a116243; RISCH N, IN PRESS GENOME BIOL; Robbins JM, 2000, J EPIDEMIOL COMMUN H, V54, P839, DOI 10.1136/jech.54.11.839; ROSEN AB, 2002, SOC GEN INT MED MAY; ROSTAND SG, 1982, NEW ENGL J MED, V306, P1276, DOI 10.1056/NEJM198205273062106; Schneeweiss S, 2001, HEALTH POLICY, V55, P97, DOI 10.1016/S0168-8510(00)00120-2; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; Selby JV, 1997, ANN INTERN MED, V127, P719, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00056; Selby JV, 1999, DIABETES CARE, V22, P38, DOI 10.2337/diacare.22.1.38; SELBY JV, 1995, DIABETES CARE, V18, P509, DOI 10.2337/diacare.18.4.509; SLOAN NR, 1963, JAMA-J AM MED ASSOC, V183, P419, DOI 10.1001/jama.1963.03700060061008; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; *US DEP HHS, 2002, PRES RAC HLTH DISP I; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; 1992, MMWR MORB MORTAL WKL, V41, P845; [No title captured]	75	654	659	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2519	2527		10.1001/jama.287.19.2519	http://dx.doi.org/10.1001/jama.287.19.2519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551MV	12020332	Bronze			2022-12-24	WOS:000175566200020
J	Hugel, T; Holland, NB; Cattani, A; Moroder, L; Seitz, M; Gaub, HE				Hugel, T; Holland, NB; Cattani, A; Moroder, L; Seitz, M; Gaub, HE			Single-molecule optomechanical cycle	SCIENCE			English	Article							FORCE SPECTROSCOPY; PHOTOMODULATION; PHOTOISOMERIZATION; PHOTOREGULATION; ISOMERIZATION; PEPTIDES	Light-powered molecular machines are conjectured to be essential constituents of future nanoscale devices. As a model for such systems, we have synthesized a polymer of bistable photosensitive azobenzenes. Individual polymers were investigated by single-molecule force spectroscopy in combination with optical excitation in total internal reflection. We were able to optically lengthen and contract individual polymers by switching the azo groups between their trans and cis configurations. The polymer was found to contract against an external force acting along the polymer backbone, thus delivering mechanical work. As a proof of principle, the polymer was operated in a periodic mode, demonstrating for the first time optomechanical energy conversion in a single-molecule device.	Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; Univ Munich, Ctr Nanosci, D-80799 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Munich; University of Munich; Max Planck Society	Gaub, HE (corresponding author), Univ Munich, Lehrstuhl Angew Phys, Amalienstr 54, D-80799 Munich, Germany.		Cattani-Scholz, Anna/G-5150-2016; Holland, Nolan B./F-6933-2011	Holland, Nolan B./0000-0002-0752-6887; Moroder, Luis/0000-0001-9570-5713; Hugel, Thorsten/0000-0003-3292-4569				Archut A, 1998, J AM CHEM SOC, V120, P12187, DOI 10.1021/ja9822409; Asanuma H, 1999, ANGEW CHEM INT EDIT, V38, P2393, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2393::AID-ANIE2393>3.0.CO;2-7; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Behrendt R, 1999, ANGEW CHEM INT EDIT, V38, P2771, DOI 10.1002/(SICI)1521-3773(19990917)38:18<2771::AID-ANIE2771>3.0.CO;2-W; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BLAIR HS, 1980, POLYMER, V21, P1195, DOI 10.1016/0032-3861(80)90087-7; Clausen-Schaumann H, 1998, ADV MATER, V10, P949, DOI 10.1002/(SICI)1521-4095(199808)10:12<949::AID-ADMA949>3.3.CO;2-S; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Collin JP, 1998, EUR J INORG CHEM, P1; EISENBACH CD, 1980, POLYMER, V21, P1175, DOI 10.1016/0032-3861(80)90083-X; Feringa BL, 2000, CHEM REV, V100, P1789, DOI 10.1021/cr9900228; FERINGA BL, 1993, TETRAHEDRON, V49, P8267, DOI 10.1016/S0040-4020(01)81913-X; Finkelmann H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015501; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Hartley GS, 1937, NATURE, V140, P281, DOI 10.1038/140281a0; Hugel T, 2001, MACROMOL RAPID COMM, V22, P989, DOI 10.1002/1521-3927(20010901)22:13<989::AID-MARC989>3.0.CO;2-D; IRIE M, 1981, MACROMOLECULES, V14, P262, DOI 10.1021/ma50003a007; IRIE M, 1990, ADV POLYM SCI, V94, P27; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; KUMAR GS, 1989, CHEM REV, V89, P1915, DOI 10.1021/cr00098a012; Labarthet FL, 2000, PHYS CHEM CHEM PHYS, V2, P5154; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; MONTI S, 1982, CHEM PHYS, V71, P87, DOI 10.1016/0301-0104(82)87008-0; MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4; Nagele T, 1997, CHEM PHYS LETT, V272, P489, DOI 10.1016/S0009-2614(97)00531-9; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; RAU H, 1984, J PHOTOCHEM, V26, P221, DOI 10.1016/0047-2670(84)80041-6; Rau H, 1990, PHOTOCHROMISM MOL SY; Renner C, 2000, BIOPOLYMERS, V54, P501, DOI 10.1002/1097-0282(200012)54:7<501::AID-BIP30>3.0.CO;2-8; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Robertson JM, 1939, J CHEM SOC, P232, DOI 10.1039/jr9390000232; SHINKAI S, 1984, TOP CURR CHEM, V121, P67; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; STRZEGOWSKI LA, 1994, J AM CHEM SOC, V116, P813, DOI 10.1021/ja00081a070; Tamai N, 2000, CHEM REV, V100, P1875, DOI 10.1021/cr9800816; ULYSSE L, 1995, J AM CHEM SOC, V117, P8466, DOI 10.1021/ja00137a023; VOGTLE F, 1991, SUPRAMOLECULAR CHEM; Willner I, 1997, ACCOUNTS CHEM RES, V30, P347, DOI 10.1021/ar9700062; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; WURTHNER F, 1995, J CHEM SOC PERK T 2, P1727, DOI 10.1039/p29950001727	44	689	713	7	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1103	1106		10.1126/science.1069856	http://dx.doi.org/10.1126/science.1069856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004125				2022-12-24	WOS:000175565000048
J	Bose, HS; Lingappa, VR; Miller, WL				Bose, HS; Lingappa, VR; Miller, WL			Rapid regulation of steroidogenesis by mitochondrial protein import	NATURE			English	Article							CHAIN CLEAVAGE ENZYME; STAR; MECHANISM; EXPRESSION; MEMBRANE; SEQUENCE; BINDING; CLONING	Most mitochondrial proteins are synthesized on cytoplasmic ribosomes and imported into mitochondria(1-3). The imported proteins are directed to one of four submitochondrial compartments-the outer mitochondrial membrane, the inner mitochondrial membrane, the intramembraneous space, or the matrix-where the protein then functions. Here we show that the steroidogenic acute regulatory protein (StAR), a mitochondrial protein required for stress responses, reproduction, and sexual differentiation of male fetuses(4-7), exerts its activity transiently at the outer mitochondrial membrane rather than at its final resting place in the matrix. We also show that its residence time at this outer membrane and its activity are regulated by its speed of mitochondrial import. This may be the first example of a mitochondrial protein exerting its biological activity in a compartment other than that to which it is finally targeted. This system enables steroidogenic cells to initiate and terminate massive levels of steroidogenesis within a few minutes, permitting the rapid regulation of serum steroid hormone concentrations.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Miller, Walter L/J-3696-2012	Lingappa, Vishwanath R./0000-0003-0962-6571				Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; Bauer MF, 2001, J INHERIT METAB DIS, V24, P166, DOI 10.1023/A:1010314900814; Bose HS, 2000, BIOCHEMISTRY-US, V39, P11722, DOI 10.1021/bi000911l; Bose HS, 1998, BIOCHEMISTRY-US, V37, P9768, DOI 10.1021/bi980588a; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Christensen K, 2001, J BIOL CHEM, V276, P17044, DOI 10.1074/jbc.M100903200; CHUCK SL, 1992, NATURE, V356, P115, DOI 10.1038/356115b0; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; JEFCOATE CR, 1974, EUR J BIOCHEM, V42, P539, DOI 10.1111/j.1432-1033.1974.tb03369.x; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Luciano P, 2001, EMBO J, V20, P4099, DOI 10.1093/emboj/20.15.4099; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Miller WL, 1999, J STEROID BIOCHEM, V69, P131, DOI 10.1016/S0960-0760(98)00153-8; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Song MS, 2001, BIOCHEM J, V356, P151, DOI 10.1042/0264-6021:3560151; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; TOAFF ME, 1982, ENDOCRINOLOGY, V111, P1785, DOI 10.1210/endo-111-6-1785; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408	30	267	274	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2002	417	6884					87	91		10.1038/417087a	http://dx.doi.org/10.1038/417087a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	11986670				2022-12-24	WOS:000175307200043
J	Gitlin, L; Karelsky, S; Andino, R				Gitlin, L; Karelsky, S; Andino, R			Short interfering RNA confers intracellular antiviral immunity in human cells	NATURE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; MESSENGER-RNA; POLIOVIRUS; PLANTS; COSUPPRESSION; IMMUNIZATION; INHIBITION; EXPRESSION	Gene silencing mediated by double-stranded RNA (dsRNA) is a sequence-specific, highly conserved mechanism in eukaryotes. In plants, it serves as an antiviral defence mechanism(1-3). Animal cells also possess this machinery but its specific function is unclear(4-10). Here we demonstrate that dsRNA can effectively protect human cells against infection by a rapidly replicating and highly cytolytic RNA virus. Pre-treatment of human and mouse cells with double-stranded, short interfering RNAs (siRNAs) to the poliovirus genome markedly reduces the titre of virus progeny and promotes clearance of the virus from most of the infected cells. The antiviral effect is sequence-specific and is not attributable to either classical antisense mechanisms or to interferon and the interferon response effectors protein kinase R (PKR) and RNaseL. Protection is the result of direct targeting of the viral genome by siRNA, as sequence analysis of escape virus (resistant to siRNAs) reveals one nucleotide substitution in the middle of the targeted sequence. Thus, siRNAs elicit specific intracellular antiviral resistance that may provide a therapeutic strategy against human viruses.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Box 0414, San Francisco, CA 94143 USA.							Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bahramian MB, 1999, MOL CELL BIOL, V19, P274; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Crotty S, 1999, J VIROL, V73, P9485, DOI 10.1128/JVI.73.11.9485-9495.1999; DEBENEDETTI A, 1984, NATURE, V311, P79, DOI 10.1038/311079a0; Dernburg AF, 2000, GENE DEV, V14, P1578; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Svoboda P, 2000, DEVELOPMENT, V127, P4147; TOLSKAYA EA, 1995, J VIROL, V69, P1181, DOI 10.1128/JVI.69.2.1181-1189.1995; TORRENCE PF, 1993, P NATL ACAD SCI USA, V90, P1300, DOI 10.1073/pnas.90.4.1300; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	26	466	561	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					430	434		10.1038/nature00873	http://dx.doi.org/10.1038/nature00873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12087357				2022-12-24	WOS:000177009700041
J	Nordstrom, DK				Nordstrom, DK			Public health - Worldwide occurrences of arsenic in ground water	SCIENCE			English	Editorial Material									US Geol Survey, Div Water Resources, Boulder, CO 80303 USA	United States Department of the Interior; United States Geological Survey	Nordstrom, DK (corresponding author), US Geol Survey, Div Water Resources, Boulder, CO 80303 USA.	dkn@usgs.gov	张, 楠/B-1010-2010					ALAERTS K, UNPUB; Bagla P, 1996, SCIENCE, V274, P174, DOI 10.1126/science.274.5285.174; Farago M., 1997, ARSENIC EXPOSURE HLT, P210; Gleick Peter H., 1998, WORLDS WATER 1998 19; Gooch F.A., 1888, US GEOL SURVEY B, V47; HERNANDEZ M, THESIS COMPLUTENSE U; Hsu KH., 1997, ARSENIC EXPOSURE HLT, P190, DOI DOI 10.1007/978-94-011-5864-0_16; KOLKER A, US GEOL SURV WORKSH; Kumar S, 1997, LANCET, V349, P1378, DOI 10.1016/S0140-6736(05)63226-6; Matschullat J, 2000, APPL GEOCHEM, V15, P181, DOI 10.1016/S0883-2927(99)00039-6; MUELLER S, 2001, FS11101 USGS; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Schreiber ME, 2000, HYDROGEOL J, V8, P161; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; WEBSTER J, IN PRESS ARSENIC GRO; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x	17	1171	1262	12	378	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2002	296	5576					2143	2145		10.1126/science.1072375	http://dx.doi.org/10.1126/science.1072375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077387				2022-12-24	WOS:000176379000026
J	Worm, B; Lotze, HK; Hillebrand, H; Sommer, U				Worm, B; Lotze, HK; Hillebrand, H; Sommer, U			Consumer versus resource control of species diversity and ecosystem functioning	NATURE			English	Article							BOTTOM-UP; PRODUCTIVITY; DISTURBANCE; COMPETITION; CONSEQUENCES; PREDATION; RICHNESS	A key question in ecology is which factors control species diversity in a community(1-3). Two largely separate groups of ecologists have emphasized the importance of productivity or resource supply, and consumers or physical disturbance, respectively. These variables show unimodal relationships with diversity when manipulated in isolation(4-8). Recent multivariate models(9-10), however, predict that these factors interact, such that the disturbance-diversity relationship depends on productivity, and vice versa. We tested these models in marine food webs, using field manipulations of nutrient resources and consumer pressure on rocky shores of contrasting productivity. Here we show that the effects of consumers and nutrients on diversity consistently depend on each other, and that the direction of their effects and peak diversity shift between sites of low and high productivity. Factorial meta-analysis of published experiments confirms these results across widely varying aquatic communities. Furthermore, our experiments demonstrate that these patterns extend to important ecosystem functions such as carbon storage and nitrogen retention. This suggests that human impacts on nutrient supply(11) and food-web structure(12,13) have strong and interdependent effects on species diversity and ecosystem functioning, and must therefore be managed together.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Kiel, Inst Marine Sci, Sect Marine Ecol, D-24105 Kiel, Germany; Uppsala Univ, Dept Limnol, Erken Lab, S-76173 Norrtalje, Sweden	Dalhousie University; University of Kiel; Uppsala University	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	bworm@is.dal.ca	Hillebrand, Helmut/I-1717-2014	Hillebrand, Helmut/0000-0001-7449-1613; Worm, Boris/0000-0002-5742-8716; Lotze, Heike/0000-0001-6258-1304				Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Floder S, 1999, LIMNOL OCEANOGR, V44, P1114; Gough L, 1998, ECOLOGY, V79, P1586, DOI 10.1890/0012-9658(1998)079[1586:HEOPSD]2.0.CO;2; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Hillebrand H, 2000, MAR ECOL PROG SER, V204, P27, DOI 10.3354/meps204027; Hillebrand H, 2001, LIMNOL OCEANOGR, V46, P1881, DOI 10.4319/lo.2001.46.8.1881; Huston M.A., 1994, BIOL DIVERSITY; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Lotze HK, 2001, LIMNOL OCEANOGR, V46, P749, DOI 10.4319/lo.2001.46.4.0749; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Nielsen KJ, 2001, ECOL MONOGR, V71, P187, DOI 10.1890/0012-9615(2001)071[0187:BUATDF]2.0.CO;2; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Proulx M, 1996, OIKOS, V76, P191, DOI 10.2307/3545761; SOMMER U, 2002, CONNETITION COEXISTE; Sorokin Y. I., 1995, CORAL REEF ECOLOGY; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D., 1982, Monographs in Population Biology, pi; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Worm B, 2000, LIMNOL OCEANOGR, V45, P339, DOI 10.4319/lo.2000.45.2.0339	30	363	371	6	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2002	417	6891					848	851		10.1038/nature00830	http://dx.doi.org/10.1038/nature00830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075351				2022-12-24	WOS:000176285600046
J	Harris, KD; Henze, DA; Hirase, H; Leinekugel, X; Dragoi, G; Czurko, A; Buzsaki, G				Harris, KD; Henze, DA; Hirase, H; Leinekugel, X; Dragoi, G; Czurko, A; Buzsaki, G			Spike train dynamics predicts theta-related phase precession in hippocampal pyramidal cells	NATURE			English	Article							BEHAVING RAT; IN-VIVO; NEURONS; SYNCHRONIZATION; EVENTS; CORTEX	According to the temporal coding hypothesis(1), neurons encode information by the exact timing of spikes. An example of temporal coding is the hippocampal phase precession phenomenon, in which the timing of pyramidal cell spikes relative to the theta rhythm shows a unidirectional forward precession during spatial behaviour(2,3). Here we show that phase precession occurs in both spatial and non-spatial behaviours. We found that spike phase correlated with instantaneous discharge rate, and precessed unidirectionally at high rates, regardless of behaviour. The spatial phase precession phenomenon is therefore a manifestation of a more fundamental principle governing the timing of pyramidal cell discharge. We suggest that intrinsic properties of pyramidal cells have a key role in determining spike times, and that the interplay between the magnitude of dendritic excitation and rhythmic inhibition of the somatic region is responsible for the phase assignment of spikes(4,5)	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.		Hirase, Hajime/A-3709-2012; Harris, Kenneth/B-3469-2009; Czurkó, András/H-5500-2019; Leinekugel, Xavier/ABD-8347-2021; Leinekugel, Xavier/F-4034-2014	Hirase, Hajime/0000-0003-3806-6905; Leinekugel, Xavier/0000-0003-2878-3791; Harris, Kenneth/0000-0002-5930-6456; Czurko, Andras/0000-0002-1985-7296; Buzsaki, Gyorgy/0000-0002-3100-4800				Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Fisher NI, 1993, STAT ANAL CIRCULAR D; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0	23	272	278	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2002	417	6890					738	741		10.1038/nature00808	http://dx.doi.org/10.1038/nature00808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066184				2022-12-24	WOS:000176154700044
J	Kennedy, TA; Naeem, S; Howe, KM; Knops, JMH; Tilman, D; Reich, P				Kennedy, TA; Naeem, S; Howe, KM; Knops, JMH; Tilman, D; Reich, P			Biodiversity as a barrier to ecological invasion	NATURE			English	Article							PLANT DIVERSITY; BIOLOGICAL INVASIONS; SPECIES-DIVERSITY; INVASIBILITY; RESISTANCE; INTERFERENCE; COMMUNITIES; ECOSYSTEM; RICHNESS; PATTERN	Biological invasions are a pervasive and costly environmental problem(1,2) that has been the focus of intense management and research activities over the past half century. Yet accurate predictions of community susceptibility to invasion remain elusive. The diversity resistance hypothesis, which argues that diverse communities are highly competitive and readily resist invasion(3-5), is supported by both theory(6) and experimental studies(7-14) conducted at small spatial scales. However, there is also convincing evidence that the relationship between the diversity of native and invading species is positive when measured at regional scales(3,11,15,16). Although this latter relationship may arise from extrinsic factors, such as resource heterogeneity, that covary with diversity of native and invading species at large scales, the mechanisms conferring greater invasion resistance to diverse communities at local scales remain unknown. Using neighbourhood analyses, a technique from plant competition studies(17-19), we show here that species diversity in small experimental grassland plots enhances invasion resistance by increasing crowding and species richness in localized plant neighbourhoods. Both the establishment (number of invaders) and success (proportion of invaders that are large) of invading plants are reduced. These results suggest that local biodiversity represents an important line of defence against the spread of invaders.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Washington, Dept Zool, Seattle, WA 98195 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Lincoln; University of Minnesota System; University of Minnesota Twin Cities	Kennedy, TA (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.		Knops, Johannes/AAA-8546-2020; Tilman, David/ABD-5309-2021	Reich, Peter/0000-0003-4424-662X; Kennedy, Theodore/0000-0003-3477-3629				CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Drake, 1986, ECOLOGY BIOL INVASIO; Dukes JS, 2001, OECOLOGIA, V126, P563, DOI 10.1007/s004420000549; Elton C. S., 1958, ECOLOGY INVASIONS; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; MACK RN, 1977, J ECOL, V65, P345, DOI 10.2307/2259487; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; PACALA SW, 1987, OIKOS, V48, P217, DOI 10.2307/3565858; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; REJMANEK M, 1989, RM185 USDA, P97; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vitousek PM, 1996, AM SCI, V84, P468; Wardle DA, 2001, OIKOS, V95, P161, DOI 10.1034/j.1600-0706.2001.950119.x	22	789	877	10	528	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					636	638		10.1038/nature00776	http://dx.doi.org/10.1038/nature00776			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050662	Green Published			2022-12-24	WOS:000176001200044
J	Letinic, K; Zoncu, R; Rakic, P				Letinic, K; Zoncu, R; Rakic, P			Origin of GABAergic neurons in the human neocortex	NATURE			English	Article							LOCAL CIRCUIT NEURONS; CELL-MIGRATION; GANGLIONIC EMINENCE; CEREBRAL-CORTEX; FOREBRAIN; INTERNEURONS; PROGENITORS; DIVERSITY; DYNAMICS; MONKEY	The mammalian neocortex contains two major classes of neurons, projection and local circuit neurons(1-4). Projection neurons contain the excitatory neurotransmitter glutamate, while local circuit neurons are inhibitory, containing GABA(2,4). The complex function of neocortical circuitry depends on the number and diversity of GABAergic (gamma-aminobutyric-acid-releasing) local circuit neurons(1-3). Using retroviral labelling in organotypic slice cultures of the embryonic human forebrain, we demonstrate the existence of two distinct lineages of neocortical GABAergic neurons. One lineage expresses Dlx1/2 and Mash1 transcription factors, represents 65% of neocortical GABAergic neurons in humans, and originates from Mash1-expressing progenitors of the neocortical ventricular and subventricular zone of the dorsal forebrain. The second lineage, characterized by the expression of Dlx1/2 but not Mash1, forms around 35% of the GABAergic neurons and originates from the ganglionic eminence of the ventral forebrain. We suggest that modifications in the expression pattern of transcription factors in the forebrain may underlie species-specific programmes for the generation of neocortical local circuit neurons(5-11) and that distinct lineages of cortical interneurons may be differentially affected in genetic and acquired diseases of the human brain.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Rakic, P (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA.	pasko.rakic@yale.edu						Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; CAJAL SRY, 1911, HIST SYSTEME NERVEUX; Casarosa S, 1999, DEVELOPMENT, V126, P525; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Fairen A., 1984, CEREB CORTEX, V1, P201; Fode C, 2000, GENE DEV, V14, P67; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; HENDRY SHC, 1993, VISUAL NEUROSCI, V10, P1109, DOI 10.1017/S095252380001021X; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2001, NAT NEUROSCI, V4, P931, DOI 10.1038/nn0901-931; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Neyt C, 1997, J NEUROSCI, V17, P9194; ORourke NA, 1997, DEVELOPMENT, V124, P997; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Preuss TM, 2000, BRAIN BEHAV EVOLUT, V55, P287, DOI 10.1159/000006664; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1975, NEUROSCI RES PROGR B, V13, P1; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636	32	509	522	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2002	417	6889					645	649		10.1038/nature00779	http://dx.doi.org/10.1038/nature00779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050665				2022-12-24	WOS:000176001200047
J	Clark, P; Twaddle, S; Walker, ID; Scott, L; Greer, IA				Clark, P; Twaddle, S; Walker, ID; Scott, L; Greer, IA			Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women	LANCET			English	Article								The factor V Leiden (FVL) mutation Is associated with vascular complications In pregnancy, and routine screening of all pregnant women has been suggested. We did a prospective, unselected study In 967 pregnant women to evaluate the cost-effectiveness of screening all women, or only those with a personal or family history of venous thrombosis (n=113). When anticoagulant prophylaxis was assumed to effect a 50% reduction In vascular complications, we recorded an additional management cost of UKpound3768 with selective screening and pound39 841 with universal screening. This additional cost would result In prevention of less than one and three vascular events, respectively. Our findings, therefore, suggest that screening of pregnant women for the FVL mutation Is not cost-effective.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Transfus Med, Dundee DD1 9SY, Scotland; Royal Infirm, Dept Haematol, Glasgow G31 2ER, Lanark, Scotland; Univ Glasgow, Royal Infirm, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland; Stobhill Gen Hosp, Dept Res & Dev, Glasgow G21 3UW, Lanark, Scotland	University of Dundee; Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; University of Glasgow	Clark, P (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Transfus Med, Dundee DD1 9SY, Scotland.							Clark P, 1999, BLOOD REV, V13, P127, DOI 10.1054/blre.1999.0114; Clark P, 2001, THROMB HAEMOSTASIS, V85, P30; Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253	4	54	54	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 1	2002	359	9321					1919	1920		10.1016/S0140-6736(02)08740-8	http://dx.doi.org/10.1016/S0140-6736(02)08740-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057557				2022-12-24	WOS:000175975700014
J	Macleod, J; Smith, GD; Heslop, PF; Metcalfe, C; Carroll, D; Hart, C				Macleod, J; Smith, GD; Heslop, PF; Metcalfe, C; Carroll, D; Hart, C			Psychological stress and cardiovascular disease: empirical demonstration of bias in a prospective observational study of Scottish men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PSYCHOSOCIAL FACTORS; RISK-FACTORS; FRAMINGHAM; MORTALITY; HEALTH; EDUCATION; PROGNOSIS; EVENTS; WORK	Objectives To examine the association between self perceived psychological stress mid cardiovascular disease in a population where stress was not associated with social disadvantage. Design Prospective observational study with follow up of 21 years and repeat screening of half the cohort 5 years from baseline. Measures included perceived psychological stress, coronary risk factors, self reported angina, and ischaemia detected by electrocardiography. Setting 27 workplaces in Scotland. Participants 5606 men (mean age 48 years) at first screening and 2623 men at second screening with complete data on all measures. Main outcome measures Prevalence of angina and ischaemia at baseline, odds ratio for incident angina and ischaemia at second screening, rate ratios for cause specific hospital admission, and hazard ratios for cause specific mortality, Results Both prevalence and incidence of angina increased with increasing perceived stress (fully adjusted odds ratio for incident angina high versus low stress 2.66, 95% confidence interval 1.61 to 4.41; P for trend < 0.001). Prevalence mid incidence of ischaemia showed weak trends in tire opposite direction. High stress was associated with a higher rate of admissions to hospital generally and for admissions related to cardiovascular disease and psychiatric disorders (fully adjusted rate ratios for any general hospital admission 1.13, 1.01 to 1.27, cardiovascular disease 1.20, 1.00 to 1.45, and psychiatric disorders 2.34, 1.41 to 3.91). High stress was not associated with increased admission for coronary heart disease (1.00, 0.76-1.32) and showed an inverse relation with all cause mortality, mortality from cardiovascular disease, and mortality from coronary heart disease, that was attenuated by adjustment for occupational class (fully, adjusted hazard ratio for all cause mortality 0.94, 0.81 to 1.11, cardiovascular mortality 0.91, 0.78 to 1.06, and mortality from coronary heart disease 0.98, 0.75 to 1.27). Conclusions The relation between higher stress, angina, and some categories of hospital admissions probably resulted from the tendency of participants reporting higher stress to also report more symptoms. The lack of a corresponding relation with objective indices of heart disease suggests that these symptoms did not reflect physical disease. The data suggest that associations between psychosocial measures and disease outcomes reported from some other studies may be spurious.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Birmingham; University of Bristol; University of Birmingham; University of Glasgow	Macleod, J (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	j.a.macleod@bham.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Metcalfe, Chris/0000-0001-8318-8907; Macleod, John/0000-0001-8202-1144	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; CHAPMAN JM, 1966, AM J EPIDEMIOL, V83, P537, DOI 10.1093/oxfordjournals.aje.a120605; DAVEYSMITH G, 1997, LANCET, V350, P1369; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Greenwood DC, 1996, J PUBLIC HEALTH MED, V18, P221, DOI 10.1093/oxfordjournals.pubmed.a024483; HAGMAN M, 1987, J CHRON DIS, V40, P265, DOI 10.1016/0021-9681(87)90163-9; Haines H, 2001, HEART, V85, P385, DOI 10.1136/heart.85.4.385; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P362, DOI 10.1093/oxfordjournals.aje.a112556; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P384, DOI 10.1093/oxfordjournals.aje.a112557; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Heslop P, 2001, BRIT J HEALTH PSYCH, V6, P167, DOI 10.1348/135910701169133; HOLLIS JF, 1990, J BEHAV MED, V13, P263, DOI 10.1007/BF00846834; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Macleod J., 2002, Journal of Epidemiology and Community Health, V56, P76, DOI 10.1136/jech.56.1.76; MACLEOD J, 2002, J EPIDEMIOL COMMUNIT, V56, P75; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008; REEDER LG, 1973, SOC SCI MED, V7, P573, DOI 10.1016/0037-7856(73)90026-7; Reeder LG., 1968, P EXCERPTA MED INT C, V182, P226, DOI 10.1093/oxfordjournals.aje.a120605; Rose G, 1982, CARDIOVASCULAR SURVE; ROSENGREN A, 1991, AM J CARDIOL, V68, P1171, DOI 10.1016/0002-9149(91)90189-R; SACKETT DL, 1978, CLIN INVEST MED, V1, P37; SCHACHTER S, 1977, J EXP PSYCHOL GEN, V106, P24, DOI 10.1037/0096-3445.106.1.24; Smith GD, 1997, LANCET, V350, P1369, DOI 10.1016/S0140-6736(05)65141-0; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Wainwright D, 2000, EUR J PUBLIC HEALTH, V10, P231, DOI 10.1093/eurpub/10.3.231; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465	29	205	206	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2002	324	7348					1247	1251		10.1136/bmj.324.7348.1247	http://dx.doi.org/10.1136/bmj.324.7348.1247			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	557EJ	12028978	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000175894900018
J	Ostrowsky, BE; Whitener, C; Bredenberg, HK; Carson, LA; Holt, S; Hutwagner, L; Arduino, MJ; Jarvis, WR				Ostrowsky, BE; Whitener, C; Bredenberg, HK; Carson, LA; Holt, S; Hutwagner, L; Arduino, MJ; Jarvis, WR			Serratia marcescens bacteremia traced to an infused narcotic	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; FENTANYL; OUTBREAK; EPIDEMIC; RISK	Background: From June 30, 1998, through March 21, 1999, several patients in the surgical intensive care unit of a hospital acquired Serratia marcescens bacteremia. We investigated this outbreak. Methods: A case was defined as the occurrence of S. marcescens bacteremia in any patient in the surgical intensive care unit during the period of the epidemic. To identify risk factors, we compared patients with S. marcescens bacteremia with randomly selected controls. Isolates from patients and from medications were evaluated by pulsed-field gel electrophoresis. The hair of one employee was tested for fentanyl. Results: Twenty-six patients with S. marcescens bacteremia were identified; eight (31 percent) had polymicrobial bacteremia, and seven of these had Enterobacter cloacae and S. marcescens in the same culture. According to univariate analysis, patients with S. marcescens bacteremia stayed in the surgical intensive care unit longer than controls (13.5 vs. 4.0 days, P<0.001), were more likely to have received fentanyl in the surgical intensive care unit (odds ratio, 31; P<0.001), and were more likely to have been exposed to two particular respiratory therapists (odds ratios, 13.1 and 5.1; P<0.001 for both comparisons). In a multivariate analysis, receipt of fentanyl and exposure to the two respiratory therapists (adjusted odds ratio for one therapist, 6.7; P=0.002; adjusted odds ratio for the other therapist, 9.5; P=0.02) remained significant. One respiratory therapist had been reported for tampering with fentanyl; his hair sample tested positive for fentanyl. Cultures of fentanyl infusions from two case patients yielded S. marcescens and E. cloacae. The isolates from the case patients and from the fentanyl infusions had similar patterns on pulsed-field gel electrophoresis. After removal of the implicated respiratory therapist, no further cases occurred. Conclusions: An outbreak of S. marcescens and E. cloacae bacteremia in a surgical intensive care unit was traced to extrinsic contamination of the parenteral narcotic fentanyl by a health care worker. Our findings underscore the risk of complications in patients that is associated with illicit narcotic use by health care workers.	Ctr Dis Control & Prevent, Epidemiol Program Off, Natl Ctr Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Div Appl Publ Hlth Training, Epidem Intelligence Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Div Publ Hlth Surveillance & Informat, Atlanta, GA USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ostrowsky, BE (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Epidemiol & Infect Control, POB 980019, Richmond, VA 23298 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X				American Public Health Association, 1998, STAND METH EX WAT WA; Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; Archibald LK, 1997, INFECT CONT HOSP EP, V18, P704; Berens AIL, 1996, LANCET, V347, P1334, DOI 10.1016/S0140-6736(96)90981-2; CLEARY TJ, 1981, AM J INFECT CONTROL, V9, P107, DOI 10.1016/S0196-6553(81)80090-9; DONOWITZ LG, 1979, JAMA-J AM MED ASSOC, V242, P1749, DOI 10.1001/jama.242.16.1749; EHRENKRANZ NJ, 1980, LANCET, V2, P1289; GOLDSTEIN A, 2000, WASHINGTON POST 0414, pB1; GOLDSTEIN A, 2000, WASHINGTON POST 0301, pB4; HAYS LR, 1992, ANESTHESIOLOGY, V77, P819, DOI 10.1097/00000542-199210000-00029; HIBBS J, 1991, JAMA-J AM MED ASSOC, V265, P1011, DOI 10.1001/jama.265.8.1011; HOFFMAN JP, 1996, DHHS SMA PUBLICATION; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LAI E, 1989, BIOTECHNIQUES, V7, P34; MAKI DG, 1991, JAMA-J AM MED ASSOC, V265, P981, DOI 10.1001/jama.265.8.981; MIECZKOWSKI T, 1995, HAIR ANAL DRUG DETEC, P1; Passaro DJ, 1997, J INFECT DIS, V175, P992, DOI 10.1086/514008; PETERSEN NJ, 1973, HEALTH LAB SCI, V10, P18; Sachs H, 1998, J CHROMATOGR B, V713, P147, DOI 10.1016/S0378-4347(98)00168-6; SMIALEK JE, 1994, J FORENSIC SCI, V39, P159; STANLEY TH, 1989, ANESTH ANALG, V69, P21; VILLARINO ME, 1989, J CLIN MICROBIOL, V27, P2433, DOI 10.1128/JCM.27.11.2433-2436.1989; WARD CF, 1983, JAMA-J AM MED ASSOC, V250, P922, DOI 10.1001/jama.250.7.922; WEBB SF, 1975, CHEST, V68, P703, DOI 10.1378/chest.68.5.703; YU VL, 1979, NEW ENGL J MED, V300, P887, DOI 10.1056/NEJM197904193001604	25	51	52	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1529	1537		10.1056/NEJMoa012370	http://dx.doi.org/10.1056/NEJMoa012370			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015392	Green Published			2022-12-24	WOS:000175563900004
J	Palmer, SM; Driscoll, CT				Palmer, SM; Driscoll, CT			Acidic deposition - Decline in mobilization of toxic aluminium	NATURE			English	Article							BROOK EXPERIMENTAL FOREST; HUBBARD-BROOK; NEW-HAMPSHIRE; CHEMISTRY; RECOVERY; CALCIUM; RAIN		Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA	Syracuse University	Palmer, SM (corresponding author), Syracuse Univ, Dept Civil & Environm Engn, 220 Hinds Hall, Syracuse, NY 13244 USA.		Driscoll, Charles/F-9832-2014	Driscoll, Charles/0000-0003-2692-2890				BULGER AJ, 1993, CAN J FISH AQUAT SCI, V50, P575, DOI 10.1139/f93-066; CRONAN CS, 1995, J ENVIRON QUAL, V24, P209, DOI 10.2134/jeq1995.00472425002400020002x; DRISCOLL CT, 1985, SOIL SCI SOC AM J, V49, P437, DOI 10.2136/sssaj1985.03615995004900020033x; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Driscoll CT., 1996, ENV CHEM ALUMINUM, P363; JOHNSON NM, 1981, GEOCHIM COSMOCHIM AC, V45, P1421, DOI 10.1016/0016-7037(81)90276-3; LAWRENCE GB, 1986, BIOGEOCHEMISTRY, V2, P115, DOI 10.1007/BF02180190; Likens GE, 1998, BIOGEOCHEMISTRY, V41, P89, DOI 10.1023/A:1005984620681; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114	10	26	28	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					242	243		10.1038/417242a	http://dx.doi.org/10.1038/417242a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015590				2022-12-24	WOS:000175592100034
J	Percec, I; Plenge, RM; Nadeau, JH; Bartolomei, MS; Willard, HF				Percec, I; Plenge, RM; Nadeau, JH; Bartolomei, MS; Willard, HF			Autosomal, dominant mutations affecting X inactivation choice in the mouse	SCIENCE			English	Article							CHROMOSOME INACTIVATION; CONTROLLING ELEMENTS; EMBRYOS; GENE; DIFFERENTIATION; TRANSLOCATION; METHYLATION; REGION; TSIX	X chromosome inactivation is the silencing mechanism eutherian mammals use to equalize the expression of X-linked genes between mates and females early in embryonic development In the mouse, genetic control of inactivation requires elements within the X inactivation center (Xic) on the X chromosome that influence the choice of which X chromosome is to be inactivated in individual cells. It has long been posited that unidentified autosomal factors are essential to the process. We have used chemical mutagenesis in the mouse to identify specific factors involved in X inactivation and report two genetically distinct autosomal mutations with dominant effects on X chromosome choice early in embryogenesis.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University Hospitals of Cleveland; University Hospitals of Cleveland	Bartolomei, MS (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	bartolom@mail.med.upenn.edu; willard@uhri.org			NIGMS NIH HHS [GM45441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; CATTANACH BM, 1981, HEREDITAS, V94, P5; CATTANACH BM, 1972, GENET RES, V19, P229, DOI 10.1017/S001667230001449X; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; Cattanach BM, 1994, MOUSE GENOME, V92, P114; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; NESBITT MN, 1971, DEV BIOL, V26, P252, DOI 10.1016/0012-1606(71)90125-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Percec I, 2002, SCIENCE, V295, P287, DOI 10.1126/science.1068663; PERCEC I, UNPUB; Plenge RM, 2000, MAMM GENOME, V11, P405, DOI 10.1007/s003350010077; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; Russell L B, 1978, Basic Life Sci, V12, P393; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S	32	53	54	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1136	1139		10.1126/science.1070087	http://dx.doi.org/10.1126/science.1070087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004136				2022-12-24	WOS:000175565000059
J	Price, SR; Garcia, NVD; Ranscht, B; Jessell, TM				Price, SR; Garcia, NVD; Ranscht, B; Jessell, TM			Regulation of motor neuron pool sorting by differential expression of type II cadherins	CELL			English	Article							N-CADHERIN; CLASSIC CADHERINS; SUBTYPE IDENTITY; CELL ADHESION; ORGANIZATION; IDENTIFICATION; CONNECTIONS; DISRUPTION; PATTERNS; REGIONS	During spinal cord development, motor neurons with common targets and afferent inputs cluster into discrete nuclei, termed motor pools. Motor pools can be delineated by transcription factor expression, but cell surface proteins that distinguish motor pools in a systematic manner have not been identified. We show that the developmentally regulated expression of type II cadherins defines specific motor pools. Expression of one type II cadherin, MN-cadherin, regulates the segregation of motor pools that are normally distinguished by expression of this protein. Type II cadherins are also expressed by proprioceptive sensory neurons, raising the possibility that cadherins regulate additional steps in the development of sensory-motor circuits.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA	Columbia University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu		Price, Stephen/0000-0001-7804-9849	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 25938] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arndt K, 1998, MOL CELL NEUROSCI, V10, P211, DOI 10.1006/mcne.1998.0665; BRENOWITZ GL, 1983, BRAIN RES, V274, P371, DOI 10.1016/0006-8993(83)90721-7; CAJAL SRY, 1911, HISTOLOGIE SYSTEM NE, V1; CAJAL SRY, 1911, HISTOLOGIE SYSTEM NE, V2; Chang Q, 2000, BRAIN RES REV, V32, P242, DOI 10.1016/S0165-0173(99)00085-5; DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; ECCLES J. C., 1930, PROC ROY SOC [LONDON] B, V106, P326, DOI 10.1098/rspb.1930.0032; Elliott HC, 1942, AM J ANAT, V70, P95, DOI 10.1002/aja.1000700105; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Frank E, 1988, MESSAGE MIND, P180; FREDETTE BJ, 1994, J NEUROSCI, V14, P7331; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Inoue T, 2001, DEVELOPMENT, V128, P561; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; LEE MT, 1988, J NEUROSCI, V8, P2530; LEVINE E, 1994, DEVELOPMENT, V120, P901; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Luo Y, 2001, DEVELOPMENT, V128, P459; Milner LD, 1999, J NEUROSCI, V19, P3007; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Rafuse VF, 1996, J NEUROSCI, V16, P6864; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramon y Cajal S, 1894, P R SOC LOND, V55, P444, DOI DOI 10.1098/RSPL.1894.0063; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Ritter A, 1999, J NEUROSCI, V19, P3457; ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93; ROMANES GJ, 1942, J ANAT, V76, P112; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Yoon MS, 2000, J COMP NEUROL, V421, P461, DOI 10.1002/(SICI)1096-9861(20000612)421:4<461::AID-CNE2>3.0.CO;2-M	52	235	238	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					205	216		10.1016/S0092-8674(02)00695-5	http://dx.doi.org/10.1016/S0092-8674(02)00695-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007407	Bronze			2022-12-24	WOS:000175082600010
J	Howlett, NG; Taniguchi, T; Olson, S; Cox, B; Waisfisz, Q; de Die-Smulders, C; Persky, N; Grompe, M; Joenje, H; Pals, G; Ikeda, H; Fox, EA; D'Andrea, AD				Howlett, NG; Taniguchi, T; Olson, S; Cox, B; Waisfisz, Q; de Die-Smulders, C; Persky, N; Grompe, M; Joenje, H; Pals, G; Ikeda, H; Fox, EA; D'Andrea, AD			Biallelic inactivation of BRCA2 in Fanconi anemia	SCIENCE			English	Article							MITOMYCIN-C RESISTANCE; DNA-REPAIR; CANCER SUSCEPTIBILITY; GENE; MICE; MUTATIONS; RECOMBINATION; DEFICIENCY; FREQUENCY; PROTEINS	Fanconi anemia ( FA) is a rare autosomal recessive cancer susceptibility disorder characterized by cellular hypersensitivity to mitomycin C (MMC). Six FA genes have been cloned, but the gene or genes corresponding to FA subtypes B and D1 remain unidentified. Here we show that cell lines derived from FA-B and FA-D1 patients have biallelic mutations in BRCA2 and express truncated BRCA2 proteins. Functional complementation of FA-D1 fibroblasts with wild-type BRCA2 complementary DNA restores MMC resistance. Our results link the six cloned FA genes with BRCA1 and BRCA2 in a common pathway. Germ-line mutation of genes in this pathway may result in cancer risks similar to those observed in families with BRCA1 or BRCA2 mutations.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; Free Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Univ Limburg, Acad Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands; Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido 0608557, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Oregon Health & Science University; Oregon Health & Science University; Vrije Universiteit Amsterdam; Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Sapporo Medical University	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Pals, Gerard/A-5198-2011; Taniguchi, Toshiyasu/ADD-8489-2022	Waisfisz, Quinten/0000-0002-7384-9182; Grompe, Markus/0000-0002-6616-4345; Pals, Gerard/0000-0003-4091-7115	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054785, R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL52725, P01HL54785] Funding Source: Medline; NIDDK NIH HHS [R01DK43889] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; BUCHWALD M, 1987, MUTAT RES, V184, P153, DOI 10.1016/0167-8817(87)90072-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Goggins M, 1996, CANCER RES, V56, P5360; Grompe M, 2001, HUM MOL GENET, V10, P2253, DOI 10.1093/hmg/10.20.2253; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; McAllister KA, 2002, CANCER RES, V62, P990; Moynahan ME, 2001, CANCER RES, V61, P4842; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; SWIFT M, 1980, J NATL CANCER I, V65, P863; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; TANIGUCHI T, 2002, BLOOD; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498	31	884	909	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					606	609		10.1126/science.1073834	http://dx.doi.org/10.1126/science.1073834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12065746				2022-12-24	WOS:000177054200052
J	Jacque, JM; Triques, K; Stevenson, M				Jacque, JM; Triques, K; Stevenson, M			Modulation of HIV-1 replication by RNA interference	NATURE			English	Article							DOUBLE-STRANDED-RNA; HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; DROSOPHILA; CELLS; COMPETENT; TISSUE	RNA interference (RNAi) is the process by which double-stranded RNA (dsRNA) directs sequence-specific degradation of messenger RNA in animal and plant cells(1,2). In mammalian cells, RNAi can be triggered by 21-nucleotide duplexes of small interfering RNA (siRNA)(3). Here we describe inhibition of early and late steps of HIV-1 replication in human cell lines and primary lymphocytes by siRNAs targeted to various regions of the HIV-1 genome. We demonstrate that synthetic siRNA duplexes or plasmid-derived siRNAs inhibit HIV-1 infection by specifically degrading genomic HIV-1 RNA, thereby preventing formation of viral complementary-DNA intermediates. These results demonstrate the utility of RNAi for modulating the HIV replication cycle and provide evidence that genomic HIV-1 RNA, as it exists within a nucleoprotein reverse-transcription complex, is amenable to siRNA-mediated degradation.	Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	mario.stevenson@umassmed.edu	Jacque, Jean-Marc/B-6875-2008		NIAID NIH HHS [R01 AI032890, R33 AI088595, R01 AI037475] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; Brichacek B, 1997, METHODS, V12, P294, DOI 10.1006/meth.1997.0482; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Dornburg R, 2000, Adv Pharmacol, V49, P229; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Moore JP, 2000, NAT REV MOL CELL BIO, V1, P40, DOI 10.1038/35036060; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Tabara H, 1999, DEVELOPMENT, V126, P1; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; Wang MB, 2000, PLANT MOL BIOL, V43, P67, DOI 10.1023/A:1006490331303; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	28	680	883	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					435	438		10.1038/nature00896	http://dx.doi.org/10.1038/nature00896			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12087358	Green Accepted			2022-12-24	WOS:000177009700042
J	Weston, CR; Lambright, DG; Davis, RJ				Weston, CR; Lambright, DG; Davis, RJ			Signal transduction: MAP kinase signaling specificity	SCIENCE			English	Editorial Material							ANTHRAX LETHAL FACTOR		Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Weston, CR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.							Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740	10	105	117	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2345	2347		10.1126/science.1073344	http://dx.doi.org/10.1126/science.1073344			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089430				2022-12-24	WOS:000176467200026
J	Dragon, F; Gallagher, JEG; Compagnone-Post, PA; Mitchell, BM; Porwancher, KA; Wehner, KA; Wormsley, S; Settlage, RE; Shabanowitz, J; Osheim, Y; Beyer, AL; Hunt, DF; Baserga, SJ				Dragon, F; Gallagher, JEG; Compagnone-Post, PA; Mitchell, BM; Porwancher, KA; Wehner, KA; Wormsley, S; Settlage, RE; Shabanowitz, J; Osheim, Y; Beyer, AL; Hunt, DF; Baserga, SJ			A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN; YEAST; DISRUPTION; COMPONENT; COMPLEXES; SNORNP; RCL1P; SNRNP	Although the U3 small nucleolar RNA (snoRNA), a member of the box C/D class of snoRNAs, was identified with the spliceosomal small nuclear RNAs (snRNAs) over 30 years ago(1,2), its function and its associated protein components have remained more elusive. The U3 snoRNA is ubiquitous in eukaryotes and is required for nucleolar processing of pre-18S ribosomal RNA in all organisms where it has been tested(3,4). Biochemical and genetic analyses suggest that U3-pre-rRNAbase-pairing interactions mediate endonucleolytic pre-rRNA cleavages(3). Here we have purified a large ribonucleoprotein (RNP) complex from Saccharomyces cerevisiae that contains the U3 snoRNA and 28 proteins. Seventeen new proteins (Utp1-17) and Rrp5 were present, as were ten known components. The Utp proteins are nucleolar and specifically associated with the U3 snoRNA. Depletion of the Utp proteins impedes production of the 18S rRNA, indicating that they are part of the active pre-rRNA processing complex. On the basis of its large size (80S; calculated relative molecular mass of at least 2,200,000) and function, this complex may correspond to the terminal knobs present at the 5' ends of nascent pre-rRNAs. We have termed this large RNP the small subunit (SSU) processome.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; ProteoMS LLC, Charlottesville, VA 22903 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22904 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA	Yale University; Yale University; Yale University; University of Virginia; University of Virginia; University of Virginia	Baserga, SJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	susan.baserga@yale.edu	Bernstein, Kara Anne/S-4943-2016; Hunt, Donald F/I-6936-2012; Dragon, François/K-7094-2019	Bernstein, Kara Anne/0000-0003-2247-6459; Hunt, Donald F/0000-0003-2815-6368; Gallagher, Jennifer/0000-0002-6163-3181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020905] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM020905] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Dunbar DA, 2000, P NATL ACAD SCI USA, V97, P13027, DOI 10.1073/pnas.97.24.13027; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; FOURNIER MJ, 1993, TRENDS BIOCHEM SCI, V18, P131, DOI 10.1016/0968-0004(93)90020-N; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Kamakaka RT, 1998, GENETICS, V149, P903; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee SJ, 1997, P NATL ACAD SCI USA, V94, P13536, DOI 10.1073/pnas.94.25.13536; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; LUBBEN B, 1993, NUCLEIC ACIDS RES, V21, P5377, DOI 10.1093/nar/21.23.5377; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MOUGEY EB, 1993, GENE DEV, V7, P1609, DOI 10.1101/gad.7.8.1609; NAKAMURA T, 1968, J BIOL CHEM, V243, P1368; OSHEIM YN, 1989, METHOD ENZYMOL, V180, P481; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Samarsky DA, 1998, MOL CELL BIOL, V18, P3431, DOI 10.1128/MCB.18.6.3431; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Venema J, 1995, YEAST, V11, P1629, DOI 10.1002/yea.320111607; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; Wiederkehr T, 1998, RNA, V4, P1357, DOI 10.1017/S1355838298980955	30	540	584	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2002	417	6892					967	970		10.1038/nature00769	http://dx.doi.org/10.1038/nature00769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12068309				2022-12-24	WOS:000176441200043
J	Gabriel, SB; Schaffner, SF; Nguyen, H; Moore, JM; Roy, J; Blumenstiel, B; Higgins, J; DeFelice, M; Lochner, A; Faggart, M; Liu-Cordero, SN; Rotimi, C; Adeyemo, A; Cooper, R; Ward, R; Lander, ES; Daly, MJ; Altshuler, D				Gabriel, SB; Schaffner, SF; Nguyen, H; Moore, JM; Roy, J; Blumenstiel, B; Higgins, J; DeFelice, M; Lochner, A; Faggart, M; Liu-Cordero, SN; Rotimi, C; Adeyemo, A; Cooper, R; Ward, R; Lander, ES; Daly, MJ; Altshuler, D			The structure of haplotype blocks in the human genome	SCIENCE			English	Article							HUMAN LIPOPROTEIN-LIPASE; MODERN HUMAN ORIGINS; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; CROHNS-DISEASE; GENE; SUSCEPTIBILITY; COMPLEX; IDENTIFICATION; MUTATION	Haplotype-based methods offer a powerful approach to disease gene mapping, based on the association between causal mutations and the ancestral haplotypes on which they arose. As part of The SNP Consortium Allele Frequency Projects, we characterized haplotype patterns across 51 autosomal regions (spanning 13 megabases of the human genome) in samples from Africa, Europe, and Asia. We show that the human genome can be parsed objectively into haplotype blocks: sizable regions over which there is little evidence for historical recombination and within which only a few common haplotypes are observed. The boundaries of blocks and specific haplotypes they contain are highly correlated across populations. We demonstrate that such haplotype frameworks provide substantial statistical power in association studies of common genetic variation across each region. Our results provide a foundation for the construction of a haplotype map of the human genome, facilitating comprehensive genetic association studies of human disease.	Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Ibadan, Coll Med, Dept Pediat, Ibadan, Nigeria; Loyola Univ, Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60143 USA; Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard University; University of Ibadan; Loyola University Chicago; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA.		ravegnini, gloria/K-1330-2016; Ganesh, Dunna Sai/AGX-5170-2022; Schaffner, Stephen F/D-1189-2011; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017	ravegnini, gloria/0000-0002-7774-402X; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Schaffner, Stephen/0000-0001-6699-3568; Adeyemo, Adebowale/0000-0002-3105-3231				Boehnke M, 2000, NAT GENET, V25, P246, DOI 10.1038/76980; CANN RL, 1984, GENETICS, V106, P479; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEWONTIN RC, 1964, GENETICS, V49, P49; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	32	4489	4676	4	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2225	2229		10.1126/science.1069424	http://dx.doi.org/10.1126/science.1069424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12029063				2022-12-24	WOS:000176379000060
J	Lynn, A; Koehler, KE; Judis, L; Chan, ER; Cherry, JP; Schwartz, S; Seftel, A; Hunt, PA; Hassold, TJ				Lynn, A; Koehler, KE; Judis, L; Chan, ER; Cherry, JP; Schwartz, S; Seftel, A; Hunt, PA; Hassold, TJ			Covariation of synaptonemal complex length and mammalian meiotic exchange rates	SCIENCE			English	Article							CROSSING-OVER; CROSSOVER INTERFERENCE; DNA-SEQUENCE; HUMAN MALES; RECOMBINATION; PROTEIN; MLH1; MICE	Analysis of recombination between loci (linkage analysis) has been a cornerstone of human genetic research, enabling investigators to localize and, ultimately, identify genetic loci. However, despite these efforts little is known about patterns of meiotic exchange in human germ cells or the mechanisms that control these patterns. Using recently developed immuno fluorescence methodology to examine exchanges in human spermatocytes, we have identified remarkable variation in the rate of recombination within and among individuals. Subsequent analyses indicate that, in humans and mice, this variation is linked to differences in the length of the synaptonemal complex. Thus, at least in mammals, a physical structure, the synaptonemal complex, reflects genetic rather than physical distance.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; Cleveland VA Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Hassold, TJ (corresponding author), Case Western Reserve Univ, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.			Chan, Ernest/0000-0001-9277-5329	NICHD NIH HHS [HD21341, HD07518, HD37502] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037502, R01HD021341] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carpenter ATC, 1988, GENETIC RECOMBINATIO, P529, DOI [10.1038/ng1287, DOI 10.1038/NG1287]; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; HALDANE J. B. S., 1931, CYTOLOGIA, V3, P54; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HAWLEY RS, 1993, TRENDS GENET, V9, P310; KOEHLER KM, UNPUB; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LYNN A, UNPUB; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MANLY BFJ, 1997, RADNOMIZATION BOOTST; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Reeves A, 2000, MICROMEASURE WINDOWS; SOLARI AJ, 1980, CHROMOSOMA, V81, P315, DOI 10.1007/BF00368145; STACK SM, 1984, J CELL SCI, V71, P159; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; TEASE C, IN PRESS AM J HUM GE; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yu J, 1996, AM J HUM GENET, V59, P1186	25	208	229	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2222	2225		10.1126/science.1071220	http://dx.doi.org/10.1126/science.1071220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12052900				2022-12-24	WOS:000176379000059
J	Woloshin, S; Schwartz, LM; Welch, HG				Woloshin, S; Schwartz, LM; Welch, HG			Tobacco money: up in smoke?	LANCET			English	Editorial Material							COMPUTED-TOMOGRAPHY SCANNER; MAYO LUNG PROJECT; CANCER; RATES; CARCINOMA; SURVIVAL; NECROPSY; CT		Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Dartmouth Coll Sch Med, Dept Med, Hanover, NH USA; Dartmouth Coll Sch Med, Dept Community & Family Med, Hanover, NH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Dartmouth College; Dartmouth College	Woloshin, S (corresponding author), Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, 111B 215 N Main St, White River Jct, VT 05009 USA.				NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER; NCI NIH HHS [R18 CA91052-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoki T, 2000, AM J ROENTGENOL, V174, P763, DOI 10.2214/ajr.174.3.1740763; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; CHAN CK, 1989, CHEST, V96, P291, DOI 10.1378/chest.96.2.291; Devita V., 1989, CANC PRINCIPLES PRAC, V3rd; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; GRADY D, 1999, NY TIMES        0925, pA8; GRADY D, 1999, NY TIMES        0709, pA1; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Kramer BS, 2000, HEMATOL ONCOL CLIN N, V14, P831, DOI 10.1016/S0889-8588(05)70314-2; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; MCFARLANE MJ, 1987, JAMA-J AM MED ASSOC, V258, P331, DOI 10.1001/jama.258.3.331; Merrill RM, 1999, CHEST, V116, P697, DOI 10.1378/chest.116.3.697; *OFF MAYOR, 2001, NEW YORK CIT COMM BI; Pigula FA, 1996, ANN THORAC SURG, V61, P174, DOI 10.1016/0003-4975(95)00828-4; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Sone S, 2000, BRIT J RADIOL, V73, P137, DOI 10.1259/bjr.73.866.10884725; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Spratt JS, 1996, J SURG ONCOL, V61, P68, DOI 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014	21	13	13	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 15	2002	359	9323					2108	2111		10.1016/S0140-6736(02)08939-0	http://dx.doi.org/10.1016/S0140-6736(02)08939-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562JX	12086781				2022-12-24	WOS:000176194600028
J	Mukouyama, Y; Shin, D; Britsch, S; Taniguchi, M; Anderson, DJ				Mukouyama, Y; Shin, D; Britsch, S; Taniguchi, M; Anderson, DJ			Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR SMOOTH-MUSCLE; GLIAL-CELL DEVELOPMENT; CARDIOVASCULAR DEVELOPMENT; VENOUS DIFFERENTIATION; PERIPHERAL-NERVE; RECEPTOR; GENE; MICE; EXPRESSION	Nerves and blood vessels are branched structures, but whether their branching patterns are established independently or coordinately is not clear. Here we show that arteries, but not veins, are specifically aligned with peripheral nerves in embryonic mouse limb skin. Mutations that eliminate peripheral sensory nerves or Schwann cells prevent proper arteriogenesis, while those that disorganize the nerves maintain the alignment of arteries with misrouted axons. In vitro, sensory neurons or Schwann cells can induce arterial marker expression in isolated embryonic endothelial cells, and VEGF(164/120) is necessary and sufficient to mediate this induction. These data suggest that peripheral nerves provide a template that determines the organotypic pattern of blood vessel branching and arterial differentiation in the skin, via local secretion of VEGF.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Tokyo	Mukouyama, Y (corresponding author), CALTECH, Div Biol 216 76, 1201 E Calif Blvd, Pasadena, CA 91125 USA.		Shin, Donghun/A-2092-2012	Mukouyama, Yoh-suke/0000-0002-9084-4922; Shin, Donghun/0000-0002-7975-9014	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066221] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66221] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; BALUK P, 1997, J INVEST DERMATOL S, V2, P76; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BURNSTOCK G, 1994, BRIT J PLAST SURG, V47, P527, DOI 10.1016/0007-1226(94)90136-8; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2000, RECENT PROG HORM RES, V55, P15; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; MARTIN P, 1989, International Journal of Developmental Biology, V33, P379; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Moyon D, 2001, DEVELOPMENT, V128, P3359; Murphy P, 1996, DEVELOPMENT, V122, P2847; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shima DT, 2000, CURR OPIN GENET DEV, V10, P536, DOI 10.1016/S0959-437X(00)00124-6; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Studer L, 2000, J NEUROSCI, V20, P7377; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Thurston G, 2001, NATURE, V414, P163, DOI 10.1038/35102664; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; van Kempen MJA, 1999, HISTOCHEM CELL BIOL, V112, P479, DOI 10.1007/s004180050432; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; ZUKOWSKAGROJEC Z, 1993, PEPTIDES, V14, P263, DOI 10.1016/0196-9781(93)90040-N	44	491	511	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 14	2002	109	6					693	705		10.1016/S0092-8674(02)00757-2	http://dx.doi.org/10.1016/S0092-8674(02)00757-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086669	Bronze			2022-12-24	WOS:000176265600001
J	Brattebo, G; Hofoss, D; Flaatten, H; Muri, AK; Gjerde, S; Plsek, PE				Brattebo, G; Hofoss, D; Flaatten, H; Muri, AK; Gjerde, S; Plsek, PE			Quality improvement report - Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Need for improved sedation strategy for adults receiving ventilator support. Design Observational study of effect of introduction of guidelines to improve the doctors' and nurses' Performance. The project was a prospective improvement and was part of a national quality improvement collaborative. Background and setting A general mixed surgical. intensive care unit in a university hospital; all doctors and nurses in the unit; all adult patients (> 18 years) treated by intermittent positive pressure ventilation for more than 24 hours. Key measures for improvement Reduction in patients' mean time on a ventilator and length of stay in intensive care over a period of 11 months; anonymous reporting of critical incidents; staff perceptions of ease and of consequences of changes. Strategies for change Multiple measures (protocol development, educational presentations, written guidelines, posters, flyers, emails, personal discussions, and continuous feedback) were tested, rapidly assessed, and adopted if beneficial. Effects of change Mean ventilator time decreased by 9.1 days (95% confidence interval 0.7 to 3.6 days) from 7.4 days before intervention to 5.3 days after. Mean stay decreased by 1.0 day (-0.9 to 2.9 days) from 9.3 days to 8.3 days. No accidental extubations or other incidents were identified. Lessons learnt Relatively simple changes in sedation practice had significant effects on length of ventilator support. The change process was well received by e staff and increased their interest in identifying other areas for improvement,	Haukeland Hosp, Dept Anaesthesia & Intens Care, N-5021 Bergen, Norway; HELTEF, Fdn Hlth Serv Res, N-1474 Nordbyhagen, Norway; Paul E Plsek & Associates, Roswell, GA 30075 USA	University of Bergen; Haukeland University Hospital	Brattebo, G (corresponding author), Haukeland Hosp, Dept Anaesthesia & Intens Care, N-5021 Bergen, Norway.	gbra@haukeland.no	Flaatten, Hans/AAG-7030-2020	Flaatten, Hans/0000-0001-9186-3482; Brattebo, Guttorm/0000-0002-7124-5641				BARR J, 1995, CRIT CARE CLIN, V11, P827, DOI 10.1016/S0749-0704(18)30041-1; Brock WA, 1998, NEW HORIZ-SCI PRACT, V6, P61; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Carey RG, 1995, MEASURING QUALITY IM; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; Devlin JW, 1999, CRIT CARE MED, V27, P1271, DOI 10.1097/00003246-199907000-00008; Flaatten Hans, 1997, Acta Anaesthesiologica Scandinavica, V41, P193; Flaatten Hans, 1997, Acta Anaesthesiologica Scandinavica, V41, P175; Kollef MH, 1998, NEW HORIZ-SCI PRACT, V6, P52; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Marx WH, 1999, J TRAUMA, V46, P625, DOI 10.1097/00005373-199904000-00011; Plsek P E, 1999, Pediatrics, V103, P203; RAINEY TG, 1998, BREAKTHROUGH SERIES	15	144	152	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2002	324	7350					1386	1389		10.1136/bmj.324.7350.1386	http://dx.doi.org/10.1136/bmj.324.7350.1386			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052813	Green Published			2022-12-24	WOS:000176234100028
J	LiPuma, JJ; Spilker, T; Coenye, T; Gonzalez, CF				LiPuma, JJ; Spilker, T; Coenye, T; Gonzalez, CF			An epidemic Burkholderia cepacia complex strain identified in soil	LANCET			English	Article							ENDEMICITY	Life threatening infection with species of the Burkholderia cepacia complex frequently occurs as a result of cross Infection among Individuals with cystic fibrosis. Stringent infection control measures have decreased but not eliminated such infection in this vulnerable population, implying that non-patient reservoirs contribute to ongoing acquisition. However, strains common to both the natural environment and patients with cystic fibrosis have not yet been described. By use of various genotyping methods, we have identified from agricultural soil the B cepacia genomovar III strain that is most frequently recovered from cystic fibrosis patients in the mid-Atlantic region of the USA. This finding indicates that human pathogenic strains are not necessarily distinct from environmental strains, and might help explain ongoing human acquisition despite strict infection control measures.	Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	University of Michigan System; University of Michigan; Texas A&M University System; Texas A&M University College Station	LiPuma, JJ (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, 8323 MSRB III,Box 0646, Ann Arbor, MI 48109 USA.	jlipuma@umich.edu	Meis, Jacques F/A-9241-2010; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014	Meis, Jacques F/0000-0003-3253-6080; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601				Chen JS, 2001, J PEDIATR-US, V139, P643, DOI 10.1067/mpd.2001.118430; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Holmes A, 1999, J INFECT DIS, V179, P1197, DOI 10.1086/314699; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225	5	133	134	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2002	359	9322					2002	2003		10.1016/S0140-6736(02)08836-0	http://dx.doi.org/10.1016/S0140-6736(02)08836-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BA	12076559				2022-12-24	WOS:000176232500016
J	Taylor, DM; Tillery, SIH; Schwartz, AB				Taylor, DM; Tillery, SIH; Schwartz, AB			Direct cortical control of 3D neuroprosthetic devices	SCIENCE			English	Article							COMPUTER; NEURONS	Three-dimensional (3D) movement of neuroprosthetic devices can be controlled by the activity of cortical neurons when appropriate algorithms are used to decode intended movement in real time. Previous studies assumed that neurons maintain fixed tuning properties, and the studies used subjects who were unaware of the movements predicted by their recorded units. In this study, subjects had real-time visual feedback of their brain-controlled trajectories. Cell tuning properties changed when used for brain-controlled movements. By using control algorithms that track these changes, subjects made long sequences of 3D movements using far fewer cortical units than expected. Daily practice improved movement accuracy and the directional tuning of these units.	Arizona State Univ, Dept Bioengn, Tempe, AZ 85287 USA; Inst Neurosci, San Diego, CA 92121 USA	Arizona State University; Arizona State University-Tempe	Schwartz, AB (corresponding author), Arizona State Univ, Dept Bioengn, Tempe, AZ 85287 USA.		Taylor, Dawn/J-2447-2015	Taylor, Dawn/0000-0002-9878-0054	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS062347, N01NS092321] Funding Source: NIH RePORTER; NINDS NIH HHS [N01-NS-6-2347, N01-NS-9-2321] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Craggs M D, 1975, Adv Neurol, V10, P91; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2931; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Shoham S, 2001, NATURE, V413, P793, DOI 10.1038/35101651; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807	8	1232	1296	7	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1829	1832		10.1126/science.1070291	http://dx.doi.org/10.1126/science.1070291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052948				2022-12-24	WOS:000176054300036
J	Funamoto, S; Meili, R; Lee, S; Parry, L; Firtel, RA				Funamoto, S; Meili, R; Lee, S; Parry, L; Firtel, RA			Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis	CELL			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; DICTYOSTELIUM-DISCOIDEUM; CHEMOATTRACTANT RECEPTOR; MEMBRANE LOCALIZATION; GENE-EXPRESSION; CELL-MIGRATION; LIVING CELLS; PROTEIN; KINASE; PI3K-GAMMA	We have investigated the mechanisms of leading edge formation in chemotaxing Dictyostelium cells. We demonstrate that while phosphatidylinositol 3-kinase (PI3K) transiently translocates to the plasma membrane in response to chemoattractant stimulation and to the leading edge in chemotaxing cells, PTEN, a negative regulator of PI3K pathways, exhibits a reciprocal pattern of localization. By uniformly localizing PI3K along the plasma membrane, we show that chemotaxis pathways are activated along the lateral sides of cells and PI3K can initiate pseudopod formation, providing evidence for a direct instructional role of PI3K in leading edge formation. These findings provide evidence that differential subcellular localization and activation of PI3K and PTEN is required for proper chemotaxis.	Univ Calif San Diego, Ctr Mol Genet, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Firtel, RA (corresponding author), Univ Calif San Diego, Ctr Mol Genet, Div Biol, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rafirtel@ucsd.edu						Blaauw M, 2000, GENE, V252, P71, DOI 10.1016/S0378-1119(00)00227-4; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Katanaev VL, 2001, BIOCHEMISTRY-MOSCOW+, V66, P351, DOI 10.1023/A:1010293809553; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Meili R, 2000, CURR BIOL, V10, P708, DOI 10.1016/S0960-9822(00)00536-4; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Tuxworth RI, 1997, J CELL BIOL, V138, P605, DOI 10.1083/jcb.138.3.605; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Wessels D, 1998, TECH MOD B, P101; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; ZHOU KM, 1995, MOL CELL BIOL, V15, P5645	36	598	604	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2002	109	5					611	623		10.1016/S0092-8674(02)00755-9	http://dx.doi.org/10.1016/S0092-8674(02)00755-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062104	Bronze			2022-12-24	WOS:000175957900010
J	Heissig, B; Hattori, K; Dias, S; Friedrich, M; Ferris, B; Hackett, NR; Crystal, RG; Besmer, P; Lyden, D; Moore, MAS; Werb, Z; Rafii, S				Heissig, B; Hattori, K; Dias, S; Friedrich, M; Ferris, B; Hackett, NR; Crystal, RG; Besmer, P; Lyden, D; Moore, MAS; Werb, Z; Rafii, S			Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; HEMATOPOIETIC PROGENITOR; FACTOR-I; MATRIX METALLOPROTEINASES; GELATINASE-B; MOBILIZATION; MATRIX-METALLOPROTEINASE-9; EXPRESSION; VIVO	Stem cells within the bone marrow (BM) exist in a quiescent state or are instructed to differentiate and mobilize to circulation following specific signals. Matrix metalloproteinase-9 (MMP-9), induced in BM cells, releases soluble Kit-ligand (sKitL), permitting the transfer of endothelial and hematopoietic stem cells (HSCs) from the quiescent to proliferative niche. BM ablation induces SDF-1, which upregulates MMP-9 expression, and causes shedding of sKitL and recruitment of c-Kit(+) stem/progenitors. In MMP-9(-/-) mice, release of sKitL and HSC motility are impaired, resulting in failure of hematopoietic recovery and increased mortality, while exogenous sKitL restores hematopoiesis and survival after BM ablation. Release of sKitL by MMP-9 enables BM repopulating cells to translocate to a permissive vascular niche favoring differentiation and reconstitution of the stem/progenitor cell pool.	Cornell Univ, Coll Med, Dept Hematol Oncol, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, New York, NY 10021 USA; Cornell Univ, Coll Med, Div Med Genet, New York, NY 10021 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Francisco	Rafii, S (corresponding author), Cornell Univ, Coll Med, Dept Hematol Oncol, 1300 York Ave,Room D601, New York, NY 10021 USA.		Heissig, Beate/AAF-6771-2021; Dias, Sergio/L-1250-2014	Heissig, Beate/0000-0002-0348-5934; Dias, Sergio/0000-0002-7603-4616	NCI NIH HHS [P01 CA072006-07, CA 75072, R01 CA075072-03, P01 CA072006, CA 72006] Funding Source: Medline; NHLBI NIH HHS [R01 HL061849, HL-58707, HL-66592, HL-67839, HL-61849, P01 HL067839] Funding Source: Medline; NIAMS NIH HHS [R01 AR046238-06A2, R01 AR046238, AR 46238] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072006, R01CA075072] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067839, R01HL061849, R01HL058707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046238] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; HEINRICH MC, 1993, BLOOD, V82, P771, DOI 10.1182/blood.V82.3.771.bloodjournal823771; HUANG CY, 1992, NAT PROD LETT, V1, P3; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lane WJ, 2000, BLOOD, V96, P4152; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; LONG MW, 1992, J CLIN INVEST, V90, P251, DOI 10.1172/JCI115844; Longley BJ, 1997, P NATL ACAD SCI USA, V94, P9017, DOI 10.1073/pnas.94.17.9017; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marquez-Curtis LA, 2001, BRIT J HAEMATOL, V115, P595, DOI 10.1046/j.1365-2141.2001.03160.x; Masure S, 1997, EUR J BIOCHEM, V244, P21, DOI 10.1111/j.1432-1033.1997.00021.x; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; Ohta H, 2000, DEVELOPMENT, V127, P2125; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Tajima Y, 1998, P NATL ACAD SCI USA, V95, P11903, DOI 10.1073/pnas.95.20.11903; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	35	1378	1507	1	98	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 31	2002	109	5					625	637		10.1016/S0092-8674(02)00754-7	http://dx.doi.org/10.1016/S0092-8674(02)00754-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	558GL	12062105	Bronze, Green Accepted			2022-12-24	WOS:000175957900011
J	Ray, LB; Gough, NR				Ray, LB; Gough, NR			Orienteering strategies for a signaling maze - Introduction	SCIENCE			English	Editorial Material													Gough, Nancy R./M-1360-2019	Gough, Nancy R./0000-0001-5179-8890					0	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1632	1633		10.1126/science.296.5573.1632	http://dx.doi.org/10.1126/science.296.5573.1632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040172				2022-12-24	WOS:000175976200035
J	Moore, CB; John, M; James, IR; Christiansen, FT; Witt, CS; Mallal, SA				Moore, CB; John, M; James, IR; Christiansen, FT; Witt, CS; Mallal, SA			Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level	SCIENCE			English	Article							CYTOTOXIC T-LYMPHOCYTES; HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE; INFECTION; SUSCEPTIBILITY; PROSTITUTES; INDIVIDUALS; NAIROBI; EPITOPE; SELECT	Antigen-specific T cell immunity is HLA-restricted. Human immunodeficiency virus-type 1 (HIV-1) mutations that allow escape from host immune responses may therefore be HLA allele-specific. We analyzed HIV-1 reverse transcriptase sequences from a large HLA-diverse population of HIV-1-infected individuals. Polymorphisms in HIV-1 were most evident at sites of least functional or structural constraint and frequently were associated with particular host HLA class I alleles. Absence of polymorphism was also HLA allele-specific. At a population Level, the degree of HLA-associated selection in viral sequence was predictive of viral load. These results support a fundamental role for HLA-restricted immune responses in driving and shaping HIV-1 evolution in vivo.	Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Royal Perth Hosp, Perth, WA 6000, Australia; Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA, Australia; Univ Western Australia, Dept Pathol, Nedlands, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Mallal, SA (corresponding author), Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Level 2 N Block,Wellington St, Perth, WA 6000, Australia.	mallal@prodigal.murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309				Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; CAMPOSLIMA P, 1993, SCIENCE, V260, P98; deCamposLima PO, 1997, J EXP MED, V186, P83, DOI 10.1084/jem.186.1.83; DeGroot AS, 1997, AIDS RES HUM RETROV, V13, P529, DOI 10.1089/aid.1997.13.529; DEL VM, 1991, CELL, V66, P1145; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; FABIO G, 1992, CLIN EXP IMMUNOL, V87, P20, DOI 10.1111/j.1365-2249.1992.tb06407.x; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Hay CM, 1999, J VIROL, V73, P5509, DOI 10.1128/JVI.73.7.5509-5519.1999; HOSMALIN A, 1990, P NATL ACAD SCI USA, V87, P2344, DOI 10.1073/pnas.87.6.2344; Korber B, 1999, HIV MOL IMMUNOLOGY D; Kuttler C, 2000, J MOL BIOL, V298, P417, DOI 10.1006/jmbi.2000.3683; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; MALLAL SA, 1998, AIDS HUM RETROVIROL, V17, pS23; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; RAMSEY FL, 1997, STAT SLEUTH COURSE M, P10; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Rowland-Jones SL, 1999, IMMUNOL LETT, V66, P9, DOI 10.1016/S0165-2478(98)00179-5; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Schmitt M, 2000, AIDS, V14, P653, DOI 10.1097/00002030-200004140-00004; Shankar P, 1998, J ACQ IMMUN DEF SYND, V19, P111, DOI 10.1097/00042560-199810010-00002; Sipsas NV, 1997, J CLIN INVEST, V99, P752, DOI 10.1172/JCI119221; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER BD, 1988, SCIENCE, V240, P64, DOI 10.1126/science.2451288; Wrobel JA, 1998, P NATL ACAD SCI USA, V95, P638, DOI 10.1073/pnas.95.2.638	30	601	625	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1439	1443		10.1126/science.1069660	http://dx.doi.org/10.1126/science.1069660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029127	Green Submitted			2022-12-24	WOS:000175910300040
J	Grant, RM; Hecht, FM; Warmerdam, M; Liu, L; Liegler, T; Petropoulos, CJ; Hellmann, NS; Chesney, M; Busch, MP; Kahn, JO				Grant, RM; Hecht, FM; Warmerdam, M; Liu, L; Liegler, T; Petropoulos, CJ; Hellmann, NS; Chesney, M; Busch, MP; Kahn, JO			Time trends in primary HIV-1 drug resistance among recently infected persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; HETEROSEXUAL TRANSMISSION; VIROLOGICAL FAILURE; PROTEASE INHIBITORS; ZIDOVUDINE; VARIANTS; SUSCEPTIBILITY; INDIVIDUALS	Context Transmission of multiclass drug-resistant human immunodeficiency virus type 1 (HIV-1) may increase with wider use of antiretroviral therapy. Objective To determine trends in prevalence of HIV-1 drug resistance among recently infected individuals in a geographic area with a high penetration of antiviral treatment. Design, Setting, and Patients Consecutive case series of 225 patients referred to a San Francisco, Calif, hospital with recent HIV-1 infection from June 1996 through June 2001. Main Outcome Measure Time trends in the prevalence of genotypic and phenotypic primary drug resistance. Results Mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) steadily increased from 0% in 1996-1997 to 12 (13.2%) in 20002001 (P=.01). There was 1 mutation associated with protease inhibitor resistance in 19961997 (2.5%) and there were 7 (7.7%) in 2000-2001 (P=.25). Genotypic resistance to nucleoside reverse transcriptase inhibitors (NRTIs) initially decreased and then returned to prior levels (P=.007 for test of homogeneity). Genotypic resistance to 2 or more classes of drugs increased from 1 (2.5%) to 12 (13.2%) (P=.004), but only 1 infection (1.2%) in the latter period was resistant to all 3 classes of agents (P=.58). Primary phenotypic resistance decreased for NRTIs from 21% to 6.2% (P=.03) and increased for NNRTIs from 0 to 8 (9.9%) (P=.02). Phenotypic resistance increased for protease inhibitors from 2.6% to 6.2% (P=32). Median time to virologic suppression (<500 copies/mL) during therapy was 12 weeks for patients with genotypic evidence of resistance compared with 5 weeks for patients with drug-sensitive infections (P=.02). Conclusions The frequency of primary resistance to NNRTIs is increasing, although resistance to all available classes of antiretroviral therapy remains rare. Genotypic resistance testing in recently infected persons predicts time to viral suppression during therapy.	Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA 94110 USA; Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Blood Ctr Pacific, San Francisco, CA USA; ViroLogic, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Grant, RM (corresponding author), Gladstone Inst Virol & Immunol, POB 914100, San Francisco, CA 94141 USA.		Liu, Li/K-1936-2012	Liu, Li/0000-0002-5054-2372; Hecht, Frederick/0000-0002-5782-1171; Grant, Robert/0000-0002-0851-7085	NIAID NIH HHS [AI 41531] Funding Source: Medline; NIMH NIH HHS [MH64384-01, P30 MH59037] Funding Source: Medline; ODCDC CDC HHS [U64/CCU913941] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH064384, P30MH059037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ODCDC CDC HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANGARANO G, 1994, AIDS, V8, P1013, DOI 10.1097/00002030-199407000-00023; BACHELER L, 2000, 4 INT WORKSH HIV DRU; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blower SM, 2001, NAT MED, V7, P1016, DOI 10.1038/nm0901-1016; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; BODEN D, 1999, ANTIVIR THER S, V4, P85; CONLON CP, 1994, J INFECT DIS, V169, P411, DOI 10.1093/infdis/169.2.411; DAQUILA RT, 2001, HIV MED, V9, P31; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Deeks SG, 2002, J INFECT DIS, V185, P315, DOI 10.1086/338467; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; FAUCI AS, 2002, GUIDELINES USE ANTIR; Goudsmit J, 2001, AIDS, V15, P2293, DOI 10.1097/00002030-200111230-00011; Harrigan PR, 2001, AIDS, V15, P1671, DOI 10.1097/00002030-200109070-00010; HARRIGAN PR, 2000, 4 INT WORKSH HIV DRU; HAUBRICH R, 2001, 5 INT WORKSH HIV DRU; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Imrie A, 1997, J INFECT DIS, V175, P1502, DOI 10.1086/516487; IPPOLITO G, 1994, JAMA-J AM MED ASSOC, V272, P433, DOI 10.1001/jama.272.6.433; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; KEMPF D, 2000, 4 INT WORKSH HIV DRU; LANIER ER, 2001, 8 C RETR OPP INF FEB; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; MCFARLAND W, 1998, SAN FRANCISCO HIV EP; Miller V, 2001, AIDS, V15, P309, DOI 10.1097/00002030-200102160-00003; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Roland ME, 2001, J INFECT DIS, V184, P1608, DOI 10.1086/324580; SAAG MS, 1993, NEW ENGL J MED, V329, P1065, DOI 10.1056/NEJM199310073291502; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Stoddart CA, 2001, NAT MED, V7, P712, DOI 10.1038/89090; VEENSTRA J, 1995, CLIN INFECT DIS, V21, P556, DOI 10.1093/clinids/21.3.556; Winters MA, 1998, J VIROL, V72, P5303, DOI 10.1128/JVI.72.6.5303-5306.1998; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Yerly S, 1998, J VIROL, V72, P3520, DOI 10.1128/JVI.72.5.3520-3523.1998	44	381	392	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2002	288	2					181	188		10.1001/jama.288.2.181	http://dx.doi.org/10.1001/jama.288.2.181			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	571HC	12095382	Bronze			2022-12-24	WOS:000176711100018
J	Vervoort, VS; Beachem, MA; Edwards, PS; Ladd, S; Miller, KE; de Mollerat, X; Clarkson, K; DuPont, B; Schwartz, CE; Stevenson, RE; Boyd, E; Srivastava, AK				Vervoort, VS; Beachem, MA; Edwards, PS; Ladd, S; Miller, KE; de Mollerat, X; Clarkson, K; DuPont, B; Schwartz, CE; Stevenson, RE; Boyd, E; Srivastava, AK			AGTR2 mutations in X-linked mental retardation	SCIENCE			English	Article							TYPE-2 RECEPTOR GENE; MICE LACKING; ANGIOTENSIN; TRANSCRIPTION; BEHAVIOR; AT2; MB	Two angiotensin II (Ang II) specific receptors, AGTR1 and AGTR2, are expressed in the mammalian brain. Ang II actions on blood pressure regulation, water electrolyte balance, and hormone secretion are primarily mediated by AGTR1. The function of AGTR2 remains unclear. Here, we show that expression of the AGTR2 gene was absent in a female patient with mental retardation (MR) who had a balanced X;7 chromosomal translocation. Additionally, 8 of 590 unrelated male patients with MR were found to have sequence changes in the AGTR2 gene, including one frameshift and three missense mutations. These findings indicate a role for AGTR2 in brain development and cognitive function.	Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; Fullerton Genet Ctr, Asheville, NC 28803 USA	Greenwood Genetic Center; Clemson University	Srivastava, AK (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, 1 Gregor Mendel Circle, Greenwood, SC 29646 USA.	anand@ggc.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH057840] Funding Source: NIH RePORTER; NICHD NIH HHS [R01-HD39331] Funding Source: Medline; NIMH NIH HHS [R24 MH57840] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chung O, 1996, Blood Press Suppl, V2, P47; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; GALLINAT S, 2001, AM J PHYSIOL-ENDOC M, V278, P357; Ge JA, 1996, EUR J PHARMACOL, V297, P299, DOI 10.1016/0014-2999(95)00762-8; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Knowle D, 2000, REGUL PEPTIDES, V87, P73, DOI 10.1016/S0167-0115(99)00111-1; LAZARD D, 1994, RECEPTOR CHANNEL, V2, P271; MACGREGOR DP, 1995, BRAIN RES, V675, P231, DOI 10.1016/0006-8993(95)00076-3; Nagaraja R, 1998, GENOMICS, V52, P247, DOI 10.1006/geno.1998.5438; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Nuyt AM, 1999, J COMP NEUROL, V407, P193; Okuyama S, 1999, BRAIN RES, V821, P150, DOI 10.1016/S0006-8993(99)01098-7; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Saavedra JM, 1999, REGUL PEPTIDES, V85, P31, DOI 10.1016/S0167-0115(99)00081-6; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; Steingruber HE, 1999, GENOME RES, V9, P751; STEVENSON RE, 2000, XLINKED MENTAL RETAR; Warnecke C, 1999, BIOCHEM J, V340, P17, DOI 10.1042/0264-6021:3400017; Zhu MY, 2000, J NEUROPHYSIOL, V84, P2494, DOI 10.1152/jn.2000.84.5.2494	23	116	123	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2401	2403						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089445				2022-12-24	WOS:000176467200044
J	Gerber, HP; Malik, AK; Solar, GP; Sherman, D; Liang, XH; Meng, G; Hong, K; Marsters, JC; Ferrara, N				Gerber, HP; Malik, AK; Solar, GP; Sherman, D; Liang, XH; Meng, G; Hong, K; Marsters, JC; Ferrara, N			VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEMATOPOIETIC PROGENITOR CELLS; ACUTE MYELOID-LEUKEMIA; KINASE INHIBITORS; EXPRESSION; GENE; MICE; PROLIFERATION; INACTIVATION; PRECURSORS	Vascular endothelial growth factor (VEGF) is a principal regulator of blood vessel formation and haematopoiesis(1,2), but the mechanisms by which VEGF differentially regulates these processes have been elusive. Here we describe a regulatory loop by which VEGF controls survival of haematopoietic stem cells (HSCs). We observed a reduction in survival, colony formation and in vivo repopulation rates of HSCs after ablation of the VEGF gene in mice. Intracellularly acting small-molecule inhibitors of VEGF receptor (VEGFR) tyrosine kinase dramatically reduced colony formation of HSCs, thus mimicking deletion of the VEGF gene. However, blocking VEGF by administering a soluble VEGFR-1, which acts extracellularly, induced only minor effects. These findings support the involvement in HSC survival of a VEGF-dependent internal autocrine loop mechanism (that is, the mechanism is resistant to inhibitors that fail to penetrate the intracellular compartment). Not only ligands selective for VEGF and VEGFR-2 but also VEGFR-1 agonists rescued survival and repopulation of VEGF-deficient HSCs, revealing a function for VEGFR-1 signalling during haematopoiesis.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Assay Dev, San Francisco, CA 94080 USA; Genentech Inc, Dept Organ Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Gerber, HP (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.			MALIK, AJAY/0000-0002-4831-3597				Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bautz F, 2000, EXP HEMATOL, V28, P700, DOI 10.1016/S0301-472X(00)00168-5; Behringer D, 1997, BRIT J HAEMATOL, V97, P9, DOI 10.1046/j.1365-2141.1997.d01-2143.x; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; BROWDER TM, 1989, MOL CELL BIOL, V9, P204, DOI 10.1128/MCB.9.1.204; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fiedler W, 1997, BLOOD, V89, P1870, DOI 10.1182/blood.V89.6.1870; Gerber HP, 2000, CANCER RES, V60, P6253; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; GILLE H, 2000, J BIOL CHEM, V10, P3222; Hennequin LF, 1999, J MED CHEM, V42, P5369, DOI 10.1021/jm990345w; Janowska-Wieczorek A, 2001, STEM CELLS, V19, P99, DOI 10.1634/stemcells.19-2-99; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; PARK JE, 1994, J BIOL CHEM, V269, P25646; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Sun L, 1999, J MED CHEM, V42, P5120, DOI 10.1021/jm9904295; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Wedge SR, 2000, CANCER RES, V60, P970; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	30	540	578	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					954	958		10.1038/nature00821	http://dx.doi.org/10.1038/nature00821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087404				2022-12-24	WOS:000176441200040
J	Callaway, RM; Brooker, RW; Choler, P; Kikvidze, Z; Lortie, CJ; Michalet, R; Paolini, L; Pugnaire, FI; Newingham, B; Aschehoug, ET; Armas, C; Kikodze, D; Cook, BJ				Callaway, RM; Brooker, RW; Choler, P; Kikvidze, Z; Lortie, CJ; Michalet, R; Paolini, L; Pugnaire, FI; Newingham, B; Aschehoug, ET; Armas, C; Kikodze, D; Cook, BJ			Positive interactions among alpine plants increase with stress	NATURE			English	Article							COMPETITION; GRADIENTS; BALANCE; MODEL	Plants can have positive effects on each other(1). For example, the accumulation of nutrients, provision of shade, amelioration of disturbance, or protection from herbivores by some species can enhance the performance of neighbouring species. Thus the notion that the distributions and abundances of plant species are independent of other species may be inadequate as a theoretical underpinning for understanding species coexistence and diversity(2). But there have been no large-scale experiments designed to examine the generality of positive interactions in plant communities and their importance relative to competition. Here we show that the biomass, growth and reproduction of alpine plant species are higher when other plants are nearby. In an experiment conducted in subalpine and alpine plant communities with 115 species in 11 different mountain ranges, we find that competition generally, but not exclusively, dominates interactions at lower elevations where conditions are less physically stressful. In contrast, at high elevations where abiotic stress is high the interactions among plants are predominantly positive. Furthermore, across all high and low sites positive interactions are more important at sites with low temperatures in the early summer, but competition prevails at warmer sites.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; CEH Banchory Res Stn, Ctr Ecol & Hydrol, Banchory AB31 4BY, Kincardine, Scotland; Univ Grenoble 1, CNRS, UMR 5553, Stn Alpine Lautaret, F-38041 Grenoble, France; Univ Grenoble 1, CNRS, UMR 5553, Lab Biol Populat Altitude, F-38041 Grenoble, France; Georgian Acad Sci, Inst Bot, GE-380007 Tbilisi, Georgia; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; UNT, Lab Invest Ecol Yungas, Yerba Buena, Tucuman, Argentina; CSIC, Estac Expt Zonas Aridas, Almeria 04001, Spain	University of Montana System; University of Montana; UK Centre for Ecology & Hydrology (UKCEH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; National Academy of Sciences of Georgia; University of British Columbia; Universidad Nacional de Tucuman; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Callaway, RM (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	callaway@selway.umt.edu	Kikvidze, Zaal/ABC-7252-2021; lortie, christopher j/F-6241-2014; Armas, Cristina/A-1128-2012; Brooker, Rob W/F-9569-2012; Choler, Philippe/A-7270-2008; Pugnaire, Francisco I./A-7150-2008	Kikvidze, Zaal/0000-0002-5007-4484; lortie, christopher j/0000-0002-4291-7023; Armas, Cristina/0000-0003-0356-8075; Brooker, Rob W/0000-0002-7014-0071; Choler, Philippe/0000-0002-9062-2721; Pugnaire, Francisco I./0000-0002-1227-6827; Paolini, Leonardo/0000-0001-8556-2712; Newingham, Beth A./0000-0002-3324-500X				[Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], 1975, COMMUNITIES ECOSYSTE; Archibold O. W, 1995, ECOLOGY WORLD VEGETA, P280; AUSTIN MP, 1985, ANNU REV ECOL SYST, V16, P39, DOI 10.1146/annurev.es.16.110185.000351; BEGON M, 1990, ECOLOGY, P626; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Callaway RM, 1998, OIKOS, V82, P202, DOI 10.2307/3546931; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Curtis J.T., 1959, VEGETATION WISCONSIN; Dodds WK, 1997, OIKOS, V78, P377, DOI 10.2307/3546305; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; JOHNSON HB, 1992, J RANGE MANAGE, V45, P322, DOI 10.2307/4003077; Markham JH, 1996, FUNCT ECOL, V10, P548; MILLER TE, 1994, AM NAT, V143, P1007, DOI 10.1086/285646; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; *SAS I INC, 2000, JIMPIN 4 0 2; Shaver GR, 1999, POLAR RES, V18, P245, DOI 10.1111/j.1751-8369.1999.tb00300.x; WHITTAKER RH, 1953, ECOL MONOGR, V23, P41, DOI 10.2307/1943519; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	25	1392	1506	24	727	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2002	417	6891					844	848		10.1038/nature00812	http://dx.doi.org/10.1038/nature00812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075350				2022-12-24	WOS:000176285600045
J	Adachi, JA; Mathewson, JJ; Jiang, ZD; Ericsson, CD; DuPont, HL				Adachi, JA; Mathewson, JJ; Jiang, ZD; Ericsson, CD; DuPont, HL			Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas	ANNALS OF INTERNAL MEDICINE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; TRAVELERS DIARRHEA; FOOD-CONSUMPTION; LOCATION	Background: The transmission of traveler's diarrhea is primarily foodborne. Objective: To examine the level of microbial contamination of tabletop sauces found in Mexican-style restaurants. Design: Cross-sectional study of Mexican sauces. Setting: Mexican restaurants in Guadalajara, Mexico, and Houston, Texas, during the summer of 1998. Measurements: 71 sauces from Guadalajara and 25 sauces from Houston were examined. The number of sauces contaminated with Escherichia coli, the median number of E. coli colonies per gram of sauce, and enteropathogens were identified. Results: 47 of 71 sauces from Guadalajara were contaminated with E. coli versus 10 of 25 sauces from Houston (P = 0.03); the median number of E. coli colonies per gram of sauce was 1000 In the Guadalajara sauces versus 0.0 in the Houston sauces (P = 0.007). Among sauces from Guadalajara tested for diarrheogenic E. coli, 4 of 43 sauces contained enterotoxigenic E. coli and 14 of 32 contained enteroaggregative E. coli. Conclusions: contamination with E. coli was common In samples of Mexican tabletop sauces from Guadalajara restaurants. These sauces commonly contained enteric pathogens.	Univ Texas, St Lukes Episcopal Hosp, Internal Med Serv, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA	Saint Lukes Episcopal Hospital; University of Texas System; Baylor College of Medicine	DuPont, HL (corresponding author), Univ Texas, St Lukes Episcopal Hosp, Internal Med Serv, 6720 Bertner Ave,MC 1-164, Houston, TX 77030 USA.	hdupont@sleh.com	DuPont, Herbert/AAH-6776-2021					Adachi JA, 2001, CLIN INFECT DIS, V32, P1706, DOI 10.1086/320756; ADACHI JA, 2002, IN PRESS J INFECT DI; Bower CK, 1999, INT J FOOD MICROBIOL, V50, P33, DOI 10.1016/S0168-1605(99)00075-6; Brudzinski L, 1998, J FOOD PROTECT, V61, P542, DOI 10.4315/0362-028X-61.5.542; DUPONT HL, 1992, JAMA-J AM MED ASSOC, V267, P1932, DOI 10.1001/jama.267.14.1932; ERICSSON CD, 1980, GASTROENTEROLOGY, V79, P812; FENG PCS, 1982, APPL ENVIRON MICROB, V43, P1320, DOI 10.1128/AEM.43.6.1320-1329.1982; FRAMPTON EW, 1993, J APPL BACTERIOL, V74, P223, DOI 10.1111/j.1365-2672.1993.tb03019.x; Jiang ZD, 2002, J INFECT DIS, V185, P497, DOI 10.1086/338834; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; TJOA WS, 1977, AM J EPIDEMIOL, V106, P61, DOI 10.1093/oxfordjournals.aje.a112433; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; WOOD LV, 1983, APPL ENVIRON MICROB, V46, P328, DOI 10.1128/AEM.46.2.328-332.1983	14	55	56	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2002	136	12					884	887		10.7326/0003-4819-136-12-200206180-00009	http://dx.doi.org/10.7326/0003-4819-136-12-200206180-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563JL	12069562				2022-12-24	WOS:000176252500005
J	Hainzl, T; Huang, SH; Sauer-Eriksson, AE				Hainzl, T; Huang, SH; Sauer-Eriksson, AE			Structure of the SRP19-RNA complex and implications for signal recognition particle assembly	NATURE			English	Article							CRYSTAL-STRUCTURE; RNA; DOMAIN	The signal recognition particle (SRP) is a phylogenetically conserved ribonucleoprotein. It associates with ribosomes to mediate co-translational targeting of membrane and secretory proteins to biological membranes. In mammalian cells, the SRP consists of a 7S RNA and six protein components. The S domain of SRP comprises the 7S. S part of RNA bound to SRP19, SRP54 and the SRP68/72 heterodimer; SRP54 has the main role in recognizing signal sequences of nascent polypeptide chains and docking SRP to its receptor(1-3). During assembly of the SRP, binding of SRP19 precedes and promotes the association of SRP54 (refs 4, 5). Here we report the crystal structure at 2.3 Angstrom resolution of the complex formed between 7S. S RNA and SRP19 in the archaeon Methanococcus jannaschii. SRP19 bridges the tips of helices 6 and 8 of 7S. S RNA by forming an extensive network of direct protein-RNA interactions. Helices 6 and 8 pack side by side; tertiary RNA interactions, which also involve the strictly conserved tetraloop bases, stabilize helix 8 in a conformation competent for SRP54 binding. The structure explains the role of SRP19 and provides a molecular framework for SRP54 binding and SRP assembly in Eukarya and Archaea.	Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden	Umea University	Hainzl, T (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden.	tobias.hainzl@ucmp.umu.se		Sauer-Eriksson, Elisabeth/0000-0003-0124-0199				ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bhuiyan SH, 2000, NUCLEIC ACIDS RES, V28, P1365, DOI 10.1093/nar/28.6.1365; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Diener JL, 2000, BIOCHEMISTRY-US, V39, P12862, DOI 10.1021/bi001180s; Gorodkin J, 2001, NUCLEIC ACIDS RES, V29, P169, DOI 10.1093/nar/29.1.169; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jovine L, 2000, STRUCTURE, V8, P527, DOI 10.1016/S0969-2126(00)00137-4; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; UHLENBECK OC, 1990, NATURE, V346, P613, DOI 10.1038/346613a0; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; Weichenrieder O, 2000, NATURE, V408, P167, DOI 10.1038/35041507; Wild K, 1999, STRUCTURE, V7, P1345, DOI 10.1016/S0969-2126(00)80024-6; Wild K, 2002, CURR OPIN STRUC BIOL, V12, P72, DOI 10.1016/S0959-440X(02)00292-0; Wild K, 2001, SCIENCE, V294, P598, DOI 10.1126/science.1063839; ZWIEB C, 1994, EUR J BIOCHEM, V222, P885, DOI 10.1111/j.1432-1033.1994.tb18936.x; ZWIEB C, 1992, J BIOL CHEM, V267, P15650	29	86	89	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					767	771		10.1038/nature00768	http://dx.doi.org/10.1038/nature00768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12050674				2022-12-24	WOS:000176154700051
J	Shankar, N; Baghdayan, AS; Gilmore, MS				Shankar, N; Baghdayan, AS; Gilmore, MS			Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis	NATURE			English	Article							VARIANT ESP GENE; AGGREGATION SUBSTANCE; SURFACE PROTEIN; NUCLEOTIDE-SEQUENCE; INFECTION; IDENTIFICATION; EXPRESSION; GENTAMICIN; FAECIUM	Enterococci are members of the healthy human intestinal flora, but are also leading causes of highly antibiotic-resistant, hospital-acquired infection(1). We examined the genomes of a strain of Enterococcus faecalis that caused an infectious outbreak in a hospital ward in the mid-1980s (ref. 2), and a strain that was identified as the first vancomycin-resistant isolate in the United States(3), and found that virulence determinants were clustered on a large pathogenicity island, a genetic element previously unknown in this genus. The pathogenicity island, which varies only subtly between strains, is approximately 150 kilobases in size, has a lower G + C content than the rest of the genome, and is flanked by terminal repeats. Here we show that subtle variations within the structure of the pathogenicity island enable strains harbouring the element to modulate virulence, and that these variations occur at high frequency. Moreover, the enterococcal pathogenicity island, in addition to coding for most known auxiliary traits that enhance virulence of the organism, includes a number of additional, previously unstudied genes that are rare in non-infection-derived isolates, identifying a class of new targets associated with disease which are not essential for the commensal behaviour of the organism.	Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Shankar, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, POB 26901, Oklahoma City, OK 73190 USA.	nathan-shankar@ouhsc.edu						ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; Baldassarri L, 2001, LANCET, V357, P1802, DOI 10.1016/S0140-6736(00)04919-9; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; DODD HM, 1994, J BACTERIOL, V176, P3393, DOI 10.1128/jb.176.11.3393-3396.1994; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; GALLI D, 1991, J BACTERIOL, V173, P3029, DOI 10.1128/JB.173.9.3029-3033.1991; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; GOLD OG, 1975, ARCH ORAL BIOL, V20, P473, DOI 10.1016/0003-9969(75)90236-8; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Huang CC, 1999, GENE, V239, P361, DOI 10.1016/S0378-1119(99)00388-1; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Novick RP, 2001, MICROBES INFECT, V3, P585, DOI 10.1016/S1286-4579(01)01414-9; Rakita RM, 1999, INFECT IMMUN, V67, P6067, DOI 10.1128/IAI.67.11.6067-6075.1999; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; ROUCH DA, 1987, J GEN MICROBIOL, V133, P3039; Rozdzinski E, 2001, MICROB PATHOGENESIS, V30, P211, DOI 10.1006/mpat.2000.0429; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Willems RJL, 2001, LANCET, V357, P853, DOI 10.1016/S0140-6736(00)04205-7; Woodford N, 2001, LANCET, V358, P584, DOI 10.1016/S0140-6736(01)05726-9	29	274	302	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					746	750		10.1038/nature00802	http://dx.doi.org/10.1038/nature00802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066186				2022-12-24	WOS:000176154700046
J	Contractor, A; Rogers, C; Maron, C; Henkemeyer, M; Swanson, GT; Heinemann, SF				Contractor, A; Rogers, C; Maron, C; Henkemeyer, M; Swanson, GT; Heinemann, SF			Trans-synaptic Eph receptor-ephrin signaling in hippocampal mossy fiber LTP	SCIENCE			English	Article							LONG-TERM POTENTIATION; TRANSMEMBRANE LIGANDS; KAINATE RECEPTORS; AMPA RECEPTORS; SYNAPSES; PROTEIN; PHOSPHORYLATION; NEURONS; PLASTICITY; RESPONSES	The site of induction of long-term potentiation (LTP) at mossy fiber-CA3 synapses in the hippocampus is unresolved, with data supporting both pre- and postsynaptic mechanisms. Here we report that mossy fiber LTP was reduced by perfusion of postsynaptic neurons with peptides and antibodies that interfere with binding of EphB receptor tyrosine kinases (EphRs) to the PDZ protein GRIP. Mossy fiber LTP was also reduced by extracellular application of soluble forms of B-ephrins, which are normally membrane-anchored presynaptic ligands for the EphB receptors. The application of soluble ligands for presynaptic ephrins increased basal excitatory transmission and occluded both tetanus and forskolin-induced synaptic potentiation. These findings suggest that PDZ interactions in the postsynaptic neuron and trans-synaptic interactions between postsynaptic EphB receptors and presynaptic B-ephrins are necessary for the induction of mossy fiber LTP.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75235 USA; Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	Salk Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston	Contractor, A (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Henkemeyer, Mark/0000-0002-7525-1061; Contractor, Anis/0000-0002-5131-2536	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Chung HJ, 2000, J NEUROSCI, V20, P7258; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	32	199	212	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1864	1869		10.1126/science.1069081	http://dx.doi.org/10.1126/science.1069081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052960				2022-12-24	WOS:000176054300048
J	Daulton, TL; Bernatowicz, TJ; Lewis, RS; Messenger, S; Stadermann, FJ; Amari, S				Daulton, TL; Bernatowicz, TJ; Lewis, RS; Messenger, S; Stadermann, FJ; Amari, S			Polytype distribution in circumsteller silicon carbide	SCIENCE			English	Article							ISOTOPIC COMPOSITIONS; CARBON; GROWTH; GRAINS; ENVELOPES; METEORITE; NITROGEN; ORIGIN	The inferred crystallographic class of circumstellar silicon carbide based on astronomical infrared spectra is controversial. We have directly determined the polytype distribution of circumstellar SiC from transmission electron microscopy of presolar silicon carbide from the Murchison carbonaceous meteorite. Only two polytypes (of a possible several hundred) were observed: cubic 3C and hexagonal 2H silicon carbide and their intergrowths. We conclude that this structural simplicity is a direct consequence of the low pressures in circumstellar outflows and the corresponding low silicon carbide condensation temperatures.	USN, Marine Geosci Div, Res Lab, Stennis Space Ctr, MS 39529 USA; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Washington University (WUSTL); University of Chicago	Daulton, TL (corresponding author), USN, Marine Geosci Div, Res Lab, Stennis Space Ctr, MS 39529 USA.	tdaulton@nrlssc.navy.mil						AMARI S, 1994, GEOCHIM COSMOCHIM AC, V58, P459, DOI 10.1016/0016-7037(94)90477-4; Andersen AC, 1999, ASTRON ASTROPHYS, V343, P933; BERNATOWICZ T, 1987, NATURE, V330, P728, DOI 10.1038/330728a0; Bernatowicz TJ, 1997, PHYS TODAY, V50, P26, DOI 10.1063/1.882049; BLANCO A, 1994, ASTRON ASTROPHYS, V283, P561; Blanco A, 1998, ASTRON ASTROPHYS, V330, P505; BOOTSMA GA, 1971, J CRYST GROWTH, V8, P341, DOI 10.1016/0022-0248(71)90263-6; GROENEWEGEN MAT, 1995, ASTRON ASTROPHYS, V293, P463; Henning T, 2001, SPECTROCHIM ACTA A, V57, P815, DOI 10.1016/S1386-1425(00)00446-7; HOPPE P, 1994, ASTROPHYS J, V430, P870, DOI 10.1086/174458; Hoppe P, 1998, METEORIT PLANET SCI, V33, pA71; Hoppe P, 1997, AIP CONF PROC, P27, DOI 10.1063/1.53314; Hoppe P, 1996, GEOCHIM COSMOCHIM AC, V60, P883, DOI 10.1016/0016-7037(95)00435-1; HUSS GR, 1995, GEOCHIM COSMOCHIM AC, V59, P115, DOI 10.1016/0016-7037(94)00376-W; Huss GR, 1997, AIP CONF PROC, P721, DOI 10.1063/1.53338; KRISHNA P, 1971, J CRYST GROWTH, V9, P319, DOI 10.1016/0022-0248(71)90249-1; KRISHNA P, 1971, J CRYST GROWTH, V8, P129, DOI 10.1016/0022-0248(71)90033-9; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LODDERS K, 1995, METEORITICS, V30, P661, DOI 10.1111/j.1945-5100.1995.tb01164.x; MATSUNAMI H, 1993, PHYSICA B, V185, P65, DOI 10.1016/0921-4526(93)90215-R; Mendybaev RA, 2002, GEOCHIM COSMOCHIM AC, V66, P661, DOI 10.1016/S0016-7037(01)00802-X; Mutschke H, 1999, ASTRON ASTROPHYS, V345, P187; Papoular R, 1998, ASTRON ASTROPHYS, V329, P1035; PATRICK L, 1966, PHYS REV, V143, P526, DOI 10.1103/PhysRev.143.526; RAMSDELL LS, 1947, AM MINERAL, V32, P64; SHARP CM, 1995, GEOCHIM COSMOCHIM AC, V59, P1633, DOI 10.1016/0016-7037(95)00069-C; Speck AK, 1999, ASTROPHYS J, V513, pL87, DOI 10.1086/311891; Speck AK, 1997, MON NOT R ASTRON SOC, V288, P431, DOI 10.1093/mnras/288.2.431; STAN MA, 1994, APPL PHYS LETT, V64, P2667, DOI 10.1063/1.111486; Treffers R., 1974, Astrophysical Journal, V188, P545, DOI 10.1086/152746; Zinner E, 2001, METEORIT PLANET SCI, V36, pA8, DOI 10.1111/j.1945-5100.2001.tb01533.x	31	59	61	5	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2002	296	5574					1852	1855		10.1126/science.1071136	http://dx.doi.org/10.1126/science.1071136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12052956				2022-12-24	WOS:000176054300044
J	Berger, A				Berger, A			Science commentary: Why is it important to reduce the need for blood transfusion, and how can it be done?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; PARKER MJ, 2001, COCHRANE DATABASE SY, V4; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Wiliamson L, 2000, VOX SANG, V78, P291	4	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1302	1303		10.1136/bmj.324.7349.1302	http://dx.doi.org/10.1136/bmj.324.7349.1302			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039821	Green Published, Bronze			2022-12-24	WOS:000176041500014
J	Thomas, JA; Knapp, JJ; Akino, T; Gerty, S; Wakamura, S; Simcox, DJ; Wardlaw, JC; Elmes, GW				Thomas, JA; Knapp, JJ; Akino, T; Gerty, S; Wakamura, S; Simcox, DJ; Wardlaw, JC; Elmes, GW			Insect communication: Parasitoid secretions provoke ant warfare - Subterfuge used by a rare wasp may be the key to an alternative type of pest control.	NATURE			English	Article							BUTTERFLY MACULINEA-REBELI; CHEMICAL MIMICRY; HOST-SPECIFICITY; SOCIAL PARASITE		Winfrith Technol Ctr, NERC, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Southampton; National Institute of Agrobiological Sciences - Japan	Thomas, JA (corresponding author), Winfrith Technol Ctr, NERC, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England.	jat@ceh.ac.uk	Thomas, Jeremy/A-9619-2013					Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; BILLEN I, 1998, PHEROMONE COMMUNICAT, P3; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Elmes GW, 1999, P ROY SOC B-BIOL SCI, V266, P447, DOI 10.1098/rspb.1999.0658; Godfray H.C.J, 1994, PARASITOIDS; Holldobler B., 1990, pi; Klotz JH, 1997, J AGR ENTOMOL, V14, P249; Lawton JH, 2001, ECOL ENTOMOL, V26, P225, DOI 10.1046/j.1365-2311.2001.00351.x; Sledge MF, 2000, J INSECT PHYSIOL, V46, P753, DOI 10.1016/S0022-1910(99)00164-X; THOMAS JA, 1993, ANIM BEHAV, V45, P593, DOI 10.1006/anbe.1993.1069; WILSON EO, 1963, RECENT PROG HORM RES, V19, P673	11	38	41	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					505	506		10.1038/417505a	http://dx.doi.org/10.1038/417505a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037556				2022-12-24	WOS:000175860300030
J	Hubbert, C; Guardiola, A; Shao, R; Kawaguchi, Y; Ito, A; Nixon, A; Yoshida, M; Wang, XF; Yao, TP				Hubbert, C; Guardiola, A; Shao, R; Kawaguchi, Y; Ito, A; Nixon, A; Yoshida, M; Wang, XF; Yao, TP			HDAC6 is a microtubule-associated deacetylase	NATURE			English	Article							HISTONE-DEACETYLASE; ALPHA-TUBULIN; ACETYLATION; MUSCLE; CELLS; PROTEINS; DYNAMICS; GROWTH	Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function(1). The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts(1,2). However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.	Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Japan Sci & Technol Corp, CREST Res Project, Saitama 3320012, Japan	Duke University; University of Tokyo; Japan Science & Technology Agency (JST)	Yao, TP (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.		Nixon, Andrew/AAJ-4712-2020; Ito, Akihiro/A-6100-2015; Yoshida, Minoru/C-8049-2014	Nixon, Andrew/0000-0003-3971-2964; Yoshida, Minoru/0000-0002-4376-5674				Barlow AL, 2001, EXP CELL RES, V265, P90, DOI 10.1006/excr.2001.5162; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; ROBSON SJ, 1989, CELL MOTIL CYTOSKEL, V12, P273, DOI 10.1002/cm.970120408; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8	21	1702	1773	4	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					455	458		10.1038/417455a	http://dx.doi.org/10.1038/417455a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024216				2022-12-24	WOS:000175730900042
J	Nowak, AP; Breedveld, V; Pakstis, L; Ozbas, B; Pine, DJ; Pochan, D; Deming, TJ				Nowak, AP; Breedveld, V; Pakstis, L; Ozbas, B; Pine, DJ; Pochan, D; Deming, TJ			Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles	NATURE			English	Article							BLOCK; MICELLES	Protein-based hydrogels are used for many applications, ranging from food and cosmetic thickeners to support matrices for drug delivery and tissue replacement(1-3). These materials are usually prepared using proteins extracted from natural sources, which can give rise to inconsistent properties unsuitable for medical applications(4). Recent developments have utilized recombinant DNA methods to prepare artificial protein hydrogels with specific association mechanisms and responsiveness to various stimuli(5,6). Here we synthesize diblock copolypeptide amphiphiles containing charged and hydrophobic segments. Dilute solutions of these copolypeptides would be expected to form micelles; instead, they form hydrogels that retain their mechanical strength up to temperatures of about 90 degreesC and recover rapidly after stress. The use of synthetic materials permits adjustment of copolymer chain length and composition, which we varied to study their effect on hydrogel formation and properties. We find that gelation depends not only on the amphiphilic nature of the polypeptides, but also on chain conformations-alpha-helix, beta-strand or random coil. Indeed, shape-specific supramolecular assembly is integral to the gelation process, and provides a new class of peptide-based hydrogels with potential for applications in biotechnology.	Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA; Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Delaware; University of Delaware	Deming, TJ (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	tdeming@mrl.ucsb.edu	Breedveld, Victor/A-6822-2009; Pine, David J/B-7740-2016; Breedveld, Victor/AAJ-5123-2020; Deming, Timothy/I-5411-2013	Pine, David J/0000-0002-3304-6684; Deming, Timothy/0000-0002-0594-5025				Adler A J, 1973, Methods Enzymol, V27, P675; Buitenhuis J, 1997, J CHEM PHYS, V107, P262, DOI 10.1063/1.474346; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; CLARK AH, 1987, ADV POLYM SCI, V83, P57; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; DAGANI R, 1997, CHEM ENG NEWS, V23, P26; Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899; Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084; Falini G, 2000, J CHEM SOC DALTON, P3983, DOI 10.1039/b003334k; Guenoun P, 2000, LANGMUIR, V16, P4436, DOI 10.1021/la991036b; Hamley IW, 2000, LANGMUIR, V16, P2508, DOI 10.1021/la991035j; Hoffmann H, 1996, CURR OPIN COLLOID IN, V1, P726, DOI 10.1016/S1359-0294(96)80074-4; KATCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243, DOI 10.1016/S0065-3233(08)60600-2; Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6; KLEIN HF, 1975, CHEM BER-RECL, V108, P944, DOI 10.1002/cber.19751080327; KUBOTA S, 1974, J AM CHEM SOC, V96, P4684, DOI 10.1021/ja00821a060; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Liu L, 1999, NATURE, V397, P141, DOI 10.1038/16426; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Moffitt M, 1996, ACCOUNTS CHEM RES, V29, P95, DOI 10.1021/ar940080+; Okano T, 1998, BIORELATED POLYM GEL; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Tsitsilianis C, 2000, MACROMOLECULES, V33, P2936, DOI 10.1021/ma991410e; Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092; Ward A. G., 1977, SCI TECHNOLOGY GELAT; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Yu M, 1999, J AM CHEM SOC, V121, P12210, DOI 10.1021/ja993637v	28	704	737	15	717	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					424	428		10.1038/417424a	http://dx.doi.org/10.1038/417424a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024209				2022-12-24	WOS:000175730900034
J	Hampe, J; Grebe, J; Nikolaus, S; Solberg, C; Croucher, PJP; Mascheretti, S; Jahnsen, J; Moum, B; Klump, B; Krawczak, M; Mirza, MM; Foelsch, UR; Vatn, M; Schreiber, S				Hampe, J; Grebe, J; Nikolaus, S; Solberg, C; Croucher, PJP; Mascheretti, S; Jahnsen, J; Moum, B; Klump, B; Krawczak, M; Mirza, MM; Foelsch, UR; Vatn, M; Schreiber, S			Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; SOUTHEASTERN NORWAY; ULCERATIVE-COLITIS; 4 COUNTIES; POPULATION; CLASSIFICATION; SUSCEPTIBILITY; CHROMOSOME-16; LINKAGE; DIAGNOSIS	Background Crohn's disease is a heterogeneous disorder for which NOD2 (CARD 15) has been identified as a susceptibility gene. We investigate the relation between NOD2 genotype and phenotypic characteristics of patients with Crohn's disease. Methods Hypotheses about the relation between NOD2 genotype and Crohn's disease phenotype were generated retrospectively from a group of 446 German patients with this disorder. Positive findings (p<0.10) were verified in prospectively established cohorts of 106 German and 55 Norwegian patients with Crohn's disease. All patients were genotyped for the main coding mutations in NOD2, denoted SNP8, SNP12, and SNP13, with Taqman technology. Findings In the retrospective cohort, six clinical characteristics showed noteworthy haplotype association: fistulising, ileal, left colonic and right colonic disease, stenosis, and resection. In the German prospective cohort, these haplotype associations could be replicated for ileal (p=0.006) and right colonic disease (p <= 0.001). A similar trend was noted in the Norwegian patients. Interpretation We recorded a distinct relation between NOD2 genotype and phenotype of Crohn's disease. Test strategies with NOD2 variations to predict the clinical course of Crohn's disease could lead to the development of new therapeutic paradigms.	Univ Kiel, Dept Gen Internal Med, D-24105 Kiel, Germany; Univ Tubingen, Tubingen, Germany; Univ Oslo, Rikshosp, N-0027 Oslo, Norway; Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England	University of Kiel; Eberhard Karls University of Tubingen; University of Oslo; National Hospital Norway; Cardiff University; University of London; King's College London	Schreiber, S (corresponding author), Univ Kiel, Dept Gen Internal Med, Schittenhelmstr 12, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Jahnsen, Jorgen/GRO-3253-2022; Krawczak, Michael/A-8964-2010; Hampe, Jochen/A-2555-2010	Jahnsen, Jorgen/0000-0002-0419-2914; Krawczak, Michael/0000-0003-2603-1502; Hampe, Jochen/0000-0002-2421-6127				Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; GREENSTEIN RJ, 1995, MOL MED TODAY, V1, P343, DOI 10.1016/S1357-4310(95)80034-4; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Moum B, 1996, SCAND J GASTROENTERO, V31, P355, DOI 10.3109/00365529609006410; Moum B, 1996, SCAND J GASTROENTERO, V31, P362, DOI 10.3109/00365529609006411; Moum B, 1997, GUT, V40, P328, DOI 10.1136/gut.40.3.328; *NCBI, 2002, SINGL NUCL POL; Nikolaus S, 2000, LANCET, V356, P1475, DOI 10.1016/S0140-6736(00)02871-3; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Steinhart AH, 1998, INFLAMM BOWEL DIS, V4, P228; Thompson NP, 1996, BRIT MED J, V312, P95; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Williams CN, 1999, CAN J GASTROENTEROL, V13, P799	24	334	346	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1661	1665		10.1016/S0140-6736(02)08590-2	http://dx.doi.org/10.1016/S0140-6736(02)08590-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020527				2022-12-24	WOS:000175593300010
J	Patrakka, J; Martin, P; Salonen, R; Kestila, M; Ruotsalainen, V; Mannikko, M; Ryynanen, M; Rapola, J; Holmberg, C; Tryggvason, K; Jalanko, H				Patrakka, J; Martin, P; Salonen, R; Kestila, M; Ruotsalainen, V; Mannikko, M; Ryynanen, M; Rapola, J; Holmberg, C; Tryggvason, K; Jalanko, H			Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations	LANCET			English	Article							NPHS1	High concentrations of alpha-fetoprotein (AFP) are used for prenatal diagnosis of the Finnish type of congenital nephrotic syndrome (NPHS1). We investigated the validity of this test. We retrospectively established fetal NPHS1 genotype and assessed renal pathology in 21 pregnancies that had been terminated because of raised concentrations of AFP in amniotic fluid. 12 fetuses were homozygous and nine were heterozygous (carriers) for NPHS1 mutations. Raised concentrations of AFP and similar proteinuric features in fetal kidneys were seen in both groups, Indicating that these signs are unreliable for prenatal diagnosis of congenital nephrosis. We strongly recommend the use of mutation analysis of the NPHS1 gene to confirm the AFP results In prenatal diagnosis of NPHS1.	Univ Helsinki, Hosp Children & Adolescents, FIN-00290 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, FIN-00290 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Oulu, Bioctr, Oulu, Finland; Univ Oulu, Dept Biochem, Oulu, Finland; Univ Oulu, Dept Obstet & Gynecol, SF-90220 Oulu, Finland; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Karolinska Institutet	Patrakka, J (corresponding author), Univ Helsinki, Hosp Children & Adolescents, FIN-00290 Helsinki, Finland.		Patrakka, Jaakko/AAG-8796-2019; Mannikko, Minna/C-5877-2008	Mannikko, Minna/0000-0002-6857-6423	NIDDK NIH HHS [DK 54724] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054724] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beltcheva O, 2001, HUM MUTAT, V17, P368, DOI 10.1002/humu.1111; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; LIU L, HUMAN MOL GENET, V10, P2637; Mannikko M, 1997, KIDNEY INT, V51, P868, DOI 10.1038/ki.1997.122; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x	5	42	48	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 4	2002	359	9317					1575	1577		10.1016/S0140-6736(02)08504-5	http://dx.doi.org/10.1016/S0140-6736(02)08504-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047969				2022-12-24	WOS:000175460700013
J	Fee, MS; Shraiman, B; Pesaran, B; Mitra, PP				Fee, MS; Shraiman, B; Pesaran, B; Mitra, PP			The role of nonlinear dynamics of the syrinx in the vocalizations of a songbird	NATURE			English	Article							ZEBRA FINCH SONG; BIRD SONG; MODEL; CANARY	Birdsong is characterized by the modulation of sound properties over a wide range of timescales'. Understanding the mechanisms by which the brain organizes this complex temporal behaviour is a central motivation in the study of the song control and learning system(2-8). Here we present evidence that, in addition to central neural control, a further level of temporal organization is provided by nonlinear oscillatory dynamics that are intrinsic to the avian vocal organ. A detailed temporal and spectral examination of song of the zebra finch (Taeniopygia guttata) reveals a class of rapid song modulations that are consistent with transitions in the dynamical state of the syrinx. Furthermore, in vitro experiments show that the syrinx can produce a sequence of oscillatory states that are both spectrally and temporally complex in response to the slow variation of respiratory or syringeal parameters. As a consequence, simple variations in a small number of neural signals can result in a complex acoustic sequence.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; CALTECH, Dept Phys, Pasadena, CA 91125 USA	Alcatel-Lucent; Lucent Technologies; AT&T; California Institute of Technology	Fee, MS (corresponding author), Lucent Technol, Bell Labs, 600 Mt Ave, Murray Hill, NJ 07974 USA.			Mitra, Partha/0000-0001-8818-6804; Fee, Michale/0000-0001-7539-1745				BERRY DA, 1994, J ACOUST SOC AM, V95, P3595, DOI 10.1121/1.409875; BERTRAM CD, 1982, J BIOMECH, V15, P39, DOI 10.1016/0021-9290(82)90033-1; FLETCHER NH, 1978, J ACOUST SOC AM, V64, P1566, DOI 10.1121/1.382139; FLETCHER NH, 1988, J THEOR BIOL, V135, P455, DOI 10.1016/S0022-5193(88)80270-4; Goller F, 1997, P NATL ACAD SCI USA, V94, P14787, DOI 10.1073/pnas.94.26.14787; GOLLER F, 1995, NATURE, V373, P63, DOI 10.1038/373063a0; GREENEWALT CH, 1968, BRID SONG ACOUSTICS; HARTLEY RS, 1989, J COMP PHYSIOL A, V165, P15, DOI 10.1007/BF00613795; HERZEL H, 1994, J SPEECH HEAR RES, V37, P1008, DOI 10.1044/jshr.3705.1008; Immelmann K., 1969, P61; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Jackson E., 1992, PERSPECTIVES NONLINE; Konishi Masakazu, 1994, Current Opinion in Neurobiology, V4, P827, DOI 10.1016/0959-4388(94)90130-9; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, P207; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; SCHARFF C, 1991, J NEUROSCI, V11, P2896; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; VU ET, 1994, J NEUROSCI, V14, P6924; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	21	190	194	0	31	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 3	1998	395	6697					67	71		10.1038/25725	http://dx.doi.org/10.1038/25725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116JY	12071206				2022-12-24	WOS:000075722200047
J	De Cock, KM; Janssen, RS				De Cock, KM; Janssen, RS			An unequal epidemic in an unequal world	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MATERNAL MORTALITY; HIV; TUBERCULOSIS; HIV/AIDS; SPREAD; AIDS; MEN; SEX		CDC Kenya, Nairobi, Kenya; CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Nat Ctr HIV STD & TB Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	De Cock, KM (corresponding author), Unit 64112, APO, AE 09831 USA.	kdecock@nairobi.mimcom.net						Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; *CDCP, 2001, HIV AIDS SURVEILLANC, V13, P1; *CENTR BUR STAT OF, 1999, KEN DEM HLTH SURV 19; *CENTR INT AG, 2002, GLOB INF DIS THREAT; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; *EUR, 2001, HIV AIDS SURV EUR, V65, P1; *GLOB FUND FIGHT A, 2002, TUB MAL; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; International Rescue Committee, 2001, MORT E DEM REP CONG; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; McElroy PD, 2001, AM J TROP MED HYG, V64, P18, DOI 10.4269/ajtmh.2001.64.18; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; Rosenberg PS, 1998, JAMA-J AM MED ASSOC, V279, P1894, DOI 10.1001/jama.279.23.1894; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Stall RD, 2000, AIDS, V14, pS101; *UNAIDS, 2002, EP FACT SHEETS COUNT; *UNAIDS WHO, 2001, AIDS EP UPD DEC 2001; *US BUR CENS, 2001, REC HIV SER LEV COUN; Van Nieuwenhove S, 2001, TROP MED INT HEALTH, V6, P335, DOI 10.1046/j.1365-3156.2001.00731.x; Weidle PJ, 2002, LANCET, V359, P2261, DOI 10.1016/S0140-6736(02)09297-8; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; World Bank, 1993, WORLD DEV REP 1993 I; World Health Organization, 2001, MACR HLTH INV HLTH E; ZABA B, 2000, REP GLOB HIV AIDS EP, P26	32	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2002	288	2					236	238		10.1001/jama.288.2.236	http://dx.doi.org/10.1001/jama.288.2.236			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	571HC	12095388	Green Accepted			2022-12-24	WOS:000176711100024
J	Hoen, B; Alla, F; Selton-Suty, C; Beguinot, I; Bouvet, A; Briancon, S; Casalta, JP; Danchin, N; Delahaye, F; Etienne, J; Le Moing, V; Leport, C; Mainardi, JL; Ruimy, R; Vandenesch, F				Hoen, B; Alla, F; Selton-Suty, C; Beguinot, I; Bouvet, A; Briancon, S; Casalta, JP; Danchin, N; Delahaye, F; Etienne, J; Le Moing, V; Leport, C; Mainardi, JL; Ruimy, R; Vandenesch, F		Assoc Etud Prevention Endocardite	Changing profile of infective endocarditis - Results of a 1-year survey in France	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL SPECTRUM	Context Since the first modern clinical description of infective endocarditis (IE) at the end of the 19th century, the profile of the disease has evolved continuously, as highlighted in epidemiological studies including a French survey performed in 1991. Objective To update information gained from the 1991 study on the epidemiology of IE in France. Design and Setting Population-based survey conducted from January through December 1999 in all hospitals in 6 French regions representing 26% of the population (16 million inhabitants). Patients Three hundred ninety adult inpatients diagnosed with IE according to Duke criteria. Main Outcome Measures Incidence of IE; proportion of patients with underlying heart disease; clinical characteristics; causative microorganisms; surgical and mortality outcomes. Results The annual age- and sex-standardized incidence was 31 (95% confidence interval [Cl], 28-35) cases per million, not including the region of New Caledonia, which had 161 (95% Cl, 117-216) cases per million. There was no previously known heart disease in 47% of the cases. The proportion of prosthetic-valve IE was 16%. Causative microorganisms were: streptococci, 48% (group D streptococci, 25%; oral streptococci, 17%, pyogenic streptococci, 6%); enterococci, 8%; Abiotrophia species, 2%; staphylococci, 29%; and other or multiple pathogens, 8%. Blood cultures were negative in 9% and no microorganism was identified in 5% of the cases. Early valve surgery was performed in 49% of the patients. In-hospital mortality was 16%. Compared with 1991, this study showed a decreased incidence of IE in patients with previously known underlying heart disease (20.6 cases per million vs 15.1 cases per million; P<.001); a smaller incidence of oral streptococcal IE (7.8 cases per million vs 5.1 cases per million; P<001), compensated by a larger proportion of IE due to group D streptococci (5.3 cases per million vs 6.2 cases per million; P=.67) and staphylococci (4.9 cases per million vs 5.7 cases per million; P=.97); an increased rate of early valve surgery (31.2% vs 49.7%; P<.001); and a decreased in-hospital mortality rate (21.6% vs 16.6%; P=.08). Conclusion Although the incidence of IE has not changed, important changes in disease characteristics, treatment, and outcomes were noted.	CHU Besancon, F-25030 Besancon, France; CHU Nancy, Nancy, France; CHU Reims, Reims, France; Univ Paris 07, Hotel Dieu, Ctr Natl Reference Streptocoques, F-75221 Paris 05, France; Ctr Natl Reference Rickettsies, Marseille, France; Hop Europeen Georges Pompidou, Paris, France; Hop Louis Pradel, Lyon, France; Ctr Natl Reference Staphylocoques, Lyon, France; CHU Bichat Claude Bernard, Paris, France	Universite de Franche-Comte; CHU Besancon; CHU de Nancy; CHU de Reims; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Hoen, B (corresponding author), Univ Besancon, Med Ctr, Serv Malad Infect & Trop, F-25030 Besancon, France.		ETIENNE, Jerome/C-5471-2014; MAINARDI, Jean-Luc/E-2714-2014; Vandenesch, Francois/C-7209-2014; alla, francois/D-2295-2014; Ruimy, Raymond/P-6068-2016; Danchin, Nicolas/AAN-8291-2020	ETIENNE, Jerome/0000-0002-3348-3315; MAINARDI, Jean-Luc/0000-0002-4159-0129; Vandenesch, Francois/0000-0001-9412-7106; alla, francois/0000-0002-5793-7190; Le Moing, Vincent/0000-0002-9529-2792; Selton-Suty, Christine/0000-0003-4129-5784				AHMEDMICHAUX P, 1997, IMAGES POPULATION NO; BAYER AS, 1993, CLIN INFECT DIS, V17, P313, DOI 10.1093/clinids/17.3.313; BERLIN JA, 1995, AM J CARDIOL, V76, P933, DOI 10.1016/S0002-9149(99)80264-1; BOUVET A, 1994, IN VITRO SUSCEPTIBIL, P72; DELAHAYE F, 1995, EUR HEART J, V16, P394, DOI 10.1093/oxfordjournals.eurheartj.a060923; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Esteve J., 1994, IARC SCI PUBLICATION, V128; Fay MP, 1997, STAT MED, V16, P791; FERNANDEZGUERRERO ML, 1995, CLIN INFECT DIS, V20, P16, DOI 10.1093/clinids/20.1.16; GARRAUD O, 1986, PRESSE MED, V15, P2047; GARVEY GJ, 1978, MEDICINE, V57, P105, DOI 10.1097/00005792-197803000-00001; GOULET V, 1986, PRESSE MED, V15, P1855; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; *INSEE, 1994, POP FRANC REC GEN PO; KING JW, 1988, AM J MED SCI, V295, P517, DOI 10.1097/00000441-198806000-00005; Kupferwasser I, 1998, HEART, V80, P276, DOI 10.1136/hrt.80.3.276; Kurland S, 1999, SCAND J INFECT DIS, V31, P87, DOI 10.1080/00365549950161952; Lamas CC, 1998, HEART, V79, P442, DOI 10.1136/hrt.79.5.442; MAINARDI JL, 1995, B SOC FR MICROBIOL, V10, P12; Mondejar PL, 1997, REV CLIN ESP, V197, P814; Nair B, 1996, AUST NZ J MED, V26, P363, DOI 10.1111/j.1445-5994.1996.tb01923.x; NUNLEY DL, 1993, POSTGRAD MED, V93, P235; Olaison L, 1996, QJM-MON J ASSOC PHYS, V89, P267; Osler W, 1885, Br Med J, V1, P577; Osler W., 1885, BMJ-BRIT MED J, P577; Osler W, 1885, BRIT MED J, V1, P577; Roder BL, 1999, ARCH INTERN MED, V159, P462, DOI 10.1001/archinte.159.5.462; STECKELBERG JM, 1990, AM J MED, V88, P582, DOI 10.1016/0002-9343(90)90521-E; Tornos MP, 1995, EUR HEART J, V16, P1686, DOI 10.1093/oxfordjournals.eurheartj.a060795; VANDERMEER JT, 1868, ARCH INTERN MED, V152, P1863; 2002, RECENSEMENT POPULATI; 2002, 1999 FRENCH NATL DAT	32	660	705	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2002	288	1					75	81		10.1001/jama.288.1.75	http://dx.doi.org/10.1001/jama.288.1.75			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	568YW	12090865	Bronze			2022-12-24	WOS:000176573400022
J	Scott, BA; Avidan, MS; Crowder, CM				Scott, BA; Avidan, MS; Crowder, CM			Regulation of hypoxic death in C-elegans by the insulin/IGF receptor homolog DAF-2	SCIENCE			English	Article							AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; CELL-DEATH; LONGEVITY; DIAPAUSE; GENE; FAMILY	To identify genetic determinants of hypoxic cell death, we screened for hypoxia-resistant (Hyp) mutants in Caenorhabditis elegans and found that specific reduction-of-function (rf) mutants of daf-2, an insulin/insulinlike growth factor (IGF) receptor (INR) homolog gene, were profoundly Hyp. The hypoxia resistance was acutely inducible just before hypoxic exposure and was mediated through an AKT-1/PDK-1/forkhead transcription factor pathway overlapping with but distinct from signaling pathways regulating life-span and stress resistance. Selective neuronal and muscle expression of daf-2(+) restored hypoxic death, and daf-2(rf) prevented hypoxia-induced muscle and neuronal cell death, which demonstrates a potential for INR modulation in prophylaxis against hypoxic injury of neurons and myocytes.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crowder, CM (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.			Avidan, Michael/0000-0001-6248-044X	NINDS NIH HHS [R01 NS045905] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Crowder CM, 1996, ANESTHESIOLOGY, V85, P901, DOI 10.1097/00000542-199610000-00027; Crowder CM, 2001, J BIOL CHEM, V276, P44369, DOI 10.1074/jbc.C100535200; DORMAN JB, 1995, GENETICS, V141, P1399; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gems D, 1998, GENETICS, V150, P129; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Hobert O, 1998, J NEUROSCI, V18, P2084; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murakami S, 2001, CURR BIOL, V11, P1517, DOI 10.1016/S0960-9822(01)00453-5; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; O'Connor R, 2000, BIOCHEM SOC T, V28, P47, DOI 10.1042/bst0280047; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; SCOTT B, UNPUB; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Wolkow Catherine A., 2000, Science (Washington D C), V290, P147, DOI 10.1126/science.290.5489.147	27	195	213	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2388	2391		10.1126/science.1072302	http://dx.doi.org/10.1126/science.1072302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12065745				2022-12-24	WOS:000176467200040
J	Park, JS; Marr, MT; Roberts, JW				Park, JS; Marr, MT; Roberts, JW			E-coli transcription repair coupling factor (Mfd protein) rescues arrested complexes by promoting forward translocation	CELL			English	Article							RNA-POLYMERASE-II; MUTATION FREQUENCY DECLINE; CLEAVAGE FACTORS GREA; ESCHERICHIA-COLI; ELONGATION COMPLEX; COCKAYNE-SYNDROME; SIGMA-70 SUBUNIT; STRUCTURAL BASIS; DNA; GENE	Transcription and DNA repair are coupled in E. coli by the Mfd protein, which dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. We show that Mfd influences the elongation state of RNA polymerase (RNAP); transcription complexes that have reverse translocated into the backtracked position, a potentially important intermediate in RNA proofreading and repair, are restored to the forward position by the activity of Mfd, and arrested complexes are rescued into productive elongation. Mfd may act through a translocase activity that rewinds upstream DNA, leading either to translocation or to release of RNA polymerase when the enzyme active site cannot continue elongation.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Roberts, JW (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Biotechnol Bldg, Ithaca, NY 14853 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021941, R01GM021941] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 21941] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borukhov S, 1996, METHOD ENZYMOL, V274, P315; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; KIM YC, 1990, SCIENCE, V249, P1307, DOI 10.1126/science.2399465; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; RAINJC, 2001, NATURE, V409, P211; REINES D, 1989, J BIOL CHEM, V264, P10799; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; RYDER AM, 2002, THESIS CORNELL U ITH; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; WITKIN EM, 1994, BIOESSAYS, V16, P437, DOI 10.1002/bies.950160613; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; Xie Z, 1997, J BIOL CHEM, V272, P31902, DOI 10.1074/jbc.272.50.31902; YARNELL WS, 1992, CELL, V69, P1181, DOI 10.1016/0092-8674(92)90639-T; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zakharova N, 1998, J BIOL CHEM, V273, P19371, DOI 10.1074/jbc.273.31.19371; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	42	221	226	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 14	2002	109	6					757	767		10.1016/S0092-8674(02)00769-9	http://dx.doi.org/10.1016/S0092-8674(02)00769-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086674	Bronze			2022-12-24	WOS:000176265600006
J	Roosild, TP; Miller, S; Booth, IR; Choe, S				Roosild, TP; Miller, S; Booth, IR; Choe, S			A mechanism of regulating transmembrane potassium flux through a ligand-mediated conformational switch	CELL			English	Article							ESCHERICHIA-COLI; K+-CHANNEL; EFFLUX SYSTEM; PROTEIN TRKA; TRANSPORT; GLUTATHIONE; ACTIVATION; DOMAIN; REPLACEMENT; COMPLEX	The regulation of cation content is critical for cell growth. However, the molecular mechanisms that gate the systems that control K+ movements remain unclear. KTN is a highly conserved cytoplasmic domain present ubiquitously in a variety of prokaryotic and eukaryotic K+ channels and transporters. Here we report crystal structures for two representative KTN domains that reveal a dimeric hinged assembly. Alternative ligands NAD(+) and NADH block or vacate, respectively, the hinge region affecting the dimer's conformational flexibility. Conserved, surface-exposed hydrophobic patches that become coplanar upon hinge closure provide an assembly interface for KTN tetramerization. Mutational analysis using the KefC system demonstrates that this domain directly interacts with its respective transmembrane constituent, coupling ligand-mediated KTN conformational changes to the permease's activity.	Univ Calif San Diego, Salk Inst, Struct Biol Lab, San Diego, CA 92037 USA; Univ Calif San Diego, Div Biol, San Diego, CA 92037 USA; Univ Aberdeen, Inst Med Sci, Dept Mol & Cell Biol, Aberdeen AB25 2ZD, Scotland	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Aberdeen	Choe, S (corresponding author), Univ Calif San Diego, Salk Inst, Struct Biol Lab, San Diego, CA 92037 USA.	choe@salk.edu	Miller, Samantha/A-4799-2010	Miller, Samantha/0000-0002-8223-9693	NCI NIH HHS [CA64041] Funding Source: Medline; NIGMS NIH HHS [GM6241, GM56653] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA064041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMUNDSEN S, 1997, POVRAY PERSISTENCE V; ANDERSEN KB, 1977, J BIOL CHEM, V252, P4151; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Booth I. R., 1996, HDB BIOL PHYS, V2, P693; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dauter Z, 2001, ACTA CRYSTALLOGR D, V57, P239, DOI 10.1107/S0907444900015249; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Derst C, 1998, J EXP BIOL, V201, P2791; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; ELMORE MJ, 1990, MOL MICROBIOL, V4, P405, DOI 10.1111/j.1365-2958.1990.tb00607.x; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; FERGUSON GP, 1993, MOL MICROBIOL, V9, P1297, DOI 10.1111/j.1365-2958.1993.tb01259.x; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MEURY J, 1982, EMBO J, V1, P339, DOI 10.1002/j.1460-2075.1982.tb01171.x; MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510; Miller S, 1997, J BIOL CHEM, V272, P24942, DOI 10.1074/jbc.272.40.24942; Miller S, 2000, J BACTERIOL, V182, P6536, DOI 10.1128/JB.182.22.6536-6540.2000; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARRALOPEZ C, 1994, EMBO J, V13, P3964, DOI 10.1002/j.1460-2075.1994.tb06712.x; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RHOADS DB, 1977, J BIOL CHEM, V252, P1394; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; STEWART LMD, 1985, J GEN MICROBIOL, V131, P77; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	41	104	111	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 14	2002	109	6					781	791		10.1016/S0092-8674(02)00768-7	http://dx.doi.org/10.1016/S0092-8674(02)00768-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	563PW	12086676	Bronze			2022-12-24	WOS:000176265600008
J	Scoular, A; Norrie, J; Gillespie, G; Mir, N; Carman, WF				Scoular, A; Norrie, J; Gillespie, G; Mir, N; Carman, WF			Longitudinal stud of genital infection by herpes simplex virus type 1 in western Scotland over 15 years	BRITISH MEDICAL JOURNAL			English	Article									Sandyford Initiat, Dept Genitourinary Med, Glasgow G3 7NB, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow G12 0XN, Lanark, Scotland; Russell Inst, Dept Genitourinary Med, Paisley PA1 1UR, Renfrew, Scotland	University of Glasgow; Gartnavel Royal Hospital	Scoular, A (corresponding author), Sandyford Initiat, Dept Genitourinary Med, Glasgow G3 7NB, Lanark, Scotland.							JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; LAFFERTY WE, 1987, NEW ENGL J MED, V316, P1444, DOI 10.1056/NEJM198706043162304; LAMEY PJ, 1999, HERPES, V6, P20; Scoular A, 2002, SEX TRANSM INFECT, V78, P21, DOI 10.1136/sti.78.1.21; Vyse AJ, 2000, SEX TRANSM INFECT, V76, P183, DOI 10.1136/sti.76.3.183	5	53	55	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2002	324	7350					1366	1367		10.1136/bmj.324.7350.1366	http://dx.doi.org/10.1136/bmj.324.7350.1366			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563BQ	12052804	Green Published, Bronze			2022-12-24	WOS:000176234100019
J	Miller, MJ; Wei, SH; Parker, I; Cahalan, MD				Miller, MJ; Wei, SH; Parker, I; Cahalan, MD			Two-photon imaging of lymphocyte motility and antigen response in intact lymph node	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; T-CELLS; IN-VIVO; MIGRATION; ACTIVATION; INDUCTION	Lymphocyte motility is vital for trafficking within lymphoid organs and for initiating contact with antigen-presenting cells. Visualization of these processes has previously been, limited to in vitro systems. We describe the use of two-photon laser microscopy to image the dynamic behavior of individual living lymphocytes deep within intact lymph nodes. in their native environment, T cells achieved peak velocities of more than 25 micrometers per minute, displaying a motility coefficient that is five to six times that of B cells. Antigenic challenge changed T cell trajectories from random walks to "swarms" and stable clusters. Real-time two-photon imaging reveals lymphocyte behaviors that are fundamental to the initiation of the immune response.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.			Miller, Mark/0000-0001-5676-389X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R01GM048071, R37GM048071] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-48071, GM-41514] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; ELENSTROMMAGNUSSON C, 1995, INT IMMUNOL, V7, P567, DOI 10.1093/intimm/7.4.567; FRIEDL P, 1994, IMMUNOLOGY, V82, P617; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163	14	945	965	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1869	1873		10.1126/science.1070051	http://dx.doi.org/10.1126/science.1070051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12016203	Green Submitted			2022-12-24	WOS:000176054300049
J	Fitter, AH; Fitter, RSR				Fitter, AH; Fitter, RSR			Rapid changes in flowering time in British plants	SCIENCE			English	Article							CLIMATE-CHANGE; TEMPERATURE; PHENOLOGY; BUTTERFLIES; RESPONSES; EARLIER; TRENDS; FLORA; UK	The average first flowering date of 385 British plant species has advanced by 4.5 days during the past decade compared with the previous four decades: 16% of species flowered significantly earlier in the 1990s than previously, with an average advancement of 15 days in a decade. Ten species (3%) flowered significantly later in the 1990s than previously. These data reveal the strongest biological signal yet of climatic change. Flowering is especially sensitive to the temperature in the previous month, and spring-flowering species are most responsive. However, large interspecific differences in this response will affect both the structure of plant communities and gene flow between species as climate warms. Annuals are more likely to flower early than congeneric perennials, and insect-pollinated species more than wind-pollinated ones.	Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; Danewood, Cambridge CB2 5AQ, England	University of York - UK	Fitter, AH (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.							Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Beaubien EG, 2000, INT J BIOMETEOROL, V44, P53, DOI 10.1007/s004840000050; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Bentham G, 1858, HDB BRIT FLORA; BONNIER G, 1925, BRIT FLORA; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Clapham AR, 1981, FLORA BRIT ISLES, V3rd; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; MCCLINTOCK D, 1956, POCKET GUIDE WILD FL; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Osborne CP, 2000, PLANT CELL ENVIRON, V23, P701, DOI 10.1046/j.1365-3040.2000.00584.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Post E, 2001, P ROY SOC B-BIOL SCI, V268, P15, DOI 10.1098/rspb.2000.1324; Rodwell, 1992, BRIT PLANT COMMUNITI, V3; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Santandreu M, 1999, CAN J BOT, V77, P734, DOI 10.1139/b99-015; Sparks TH, 1997, ECOGRAPHY, V20, P368, DOI 10.1111/j.1600-0587.1997.tb00381.x; SPARKS TH, 1995, J ECOL, V83, P321, DOI 10.2307/2261570; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Stace C., 1997, NEW FLORA BRIT ISLES; VERESOGLOU DS, 1984, J ECOL, V72, P259, DOI 10.2307/2260018; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	28	973	1072	14	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1689	1691		10.1126/science.1071617	http://dx.doi.org/10.1126/science.1071617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040195				2022-12-24	WOS:000175976200059
J	Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R				Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R			The open pore conformation of potassium channels	NATURE			English	Article							GATED K+ CHANNEL; SODIUM CHANNEL; ION CHANNELS; INACTIVATION; ACTIVATION; SITE	Living cells regulate the activity of their ion channels through a process known as gating. To open the pore, protein conformational changes must occur within a channel's membrane-spanning ion pathway. KcsA and MthK, closed and opened K+ channels, respectively, reveal how such gating transitions occur. Pore-lining 'inner' helices contain a 'gating hinge' that bends by approximately 30degrees. In a straight conformation four inner helices form a bundle, closing the pore near its intracellular surface. In a bent configuration the inner helices splay open creating a wide (12 Angstrom) entryway. Amino-acid sequence conservation suggests a common structural basis for gating in a wide range of K+ channels, both ligand- and voltage-gated. The open conformation favours high conduction by compressing the membrane field to the selectivity filter, and also permits large organic cations and inactivation peptides to enter the pore from the intracellular solution.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1974, Q REV BIOPHYS, V7, P179, DOI 10.1017/S0033583500001402; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	30	1012	1040	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					523	526		10.1038/417523a	http://dx.doi.org/10.1038/417523a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037560				2022-12-24	WOS:000175860300034
J	Hao, B; Gong, WM; Ferguson, TK; James, CM; Krzycki, JA; Chan, MK				Hao, B; Gong, WM; Ferguson, TK; James, CM; Krzycki, JA; Chan, MK			A new UAG-encoded residue in the structure of a methanogen methyltransferase	SCIENCE			English	Article							M METHYL TRANSFER; X-RAY STRUCTURE; METHANOSARCINA-BARKERI; CORRINOID PROTEIN; CRYSTAL-STRUCTURE; COENZYME B-12; AMINO-ACID; PROGRAM; MONOMETHYLAMINE; RECONSTITUTION	Genes encoding methanogenic methylamine methyltransferases all contain an in-frame amber (UAG) codon that is read through during translation. We have identified the UAG-encoded residue in a 1.55 angstrom resolution structure of the Methanosarcina barkeri monomethylamine methyltransferase (MtmB). This structure reveals a homohexamer comprised of individual subunits with a TIM barrel fold. The electron density for the UAG-encoded residue is distinct from any of the 21 natural amino acids. Instead it appears consistent with a lysine in amide-linkage to (4R,SR)-4-substituted-pyrroline-5-carboxylate. We suggest that this amino acid be named L-pyrrolysine.	Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chan, MK (corresponding author), Ohio State Univ, Dept Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.		Ferguson, Thomas A/O-3444-2014	Ferguson, Thomas A/0000-0001-5822-3731	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043268] Funding Source: NIH RePORTER; NCRR NIH HHS [RR07707] Funding Source: Medline; NIGMS NIH HHS [GM43268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins J.F., 1999, RNA WORLD NATURE MOD, P637; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Taylor JA, 1996, RAPID COMMUN MASS SP, V10, P679, DOI 10.1002/(SICI)1097-0231(199604)10:6<679::AID-RCM528>3.0.CO;2-Q; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377	22	295	314	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1462	1466		10.1126/science.1069556	http://dx.doi.org/10.1126/science.1069556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029132				2022-12-24	WOS:000175910300047
J	Harer, WB				Harer, WB			Vaginal birth after cesarean delivery - current status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LABOR; SECTION; WOMEN; RISK		Riverside Cty Reg Med Ctr, Dept Womens Hlth Care, Moreno Valley, CA 92555 USA		Harer, WB (corresponding author), Riverside Cty Reg Med Ctr, Dept Womens Hlth Care, 26520 Cactus Ave, Moreno Valley, CA 92555 USA.	bharer@co.riverside.ca.us						*AM COLL OBST GYN, 2000, TASK FORC CES DEL RA; *AM COLL OBST GYN, 1999, ACOG PRACT B, V5; *AM COLL OBST GYN, 1995, ACOG PRACT PATT 1 VA; American College of Obstetricians and Gynecologists, 1984, ACOG COMM OP 17 GUID; Ananth CV, 1997, AM J OBSTET GYNECOL, V177, P1071, DOI 10.1016/S0002-9378(97)70017-6; BEDOYA C, 1992, INT J GYNECOL OBSTET, V39, P285, DOI 10.1016/0020-7292(92)90259-L; Bernstein S., 1998, LOS ANGELES TIM 1203, p[A1, A26]; BERNSTEIN S, 1998, LOS ANGELES TIM 0125, pA26; *CDCP, 2002, BIRTHS FIN DAT 1999; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1073; Cragin E.B, 1916, NY MED; Davila GW, 2001, INT UROGYNECOL J, V12, P289; Faltin DL, 2000, OBSTET GYNECOL, V95, P643, DOI 10.1016/S0029-7844(99)00631-6; *FED INT GYN OBST, 2000, COMM ETH ASP HUM REP, P36; GRIFFIN LP, 1998, ACOG CLIN REV, V3, P1; GRIFFIN LP, 1998, ACOG CLIN REV, V3, P13; Harer WB, 2002, OBSTET GYNECOL SURV, V57, P61; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; MILLER DA, 1994, OBSTET GYNECOL, V84, P255; NOTZON FC, 1994, AM J OBSTET GYNECOL, V170, P495, DOI 10.1016/S0002-9378(94)70217-9; PINOTTI JA, 1994, J SOC OBSTET GYNECOL, V16, P2167; ROSS MG, 2001, LETT COLLEAGUES REGA; Schenker JG, 1999, INT J GYNECOL OBSTET, V64, P317; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; *US DEP HHS, 1981, NIH PUBL, P351	26	21	22	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2627	2630		10.1001/jama.287.20.2627	http://dx.doi.org/10.1001/jama.287.20.2627			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020285				2022-12-24	WOS:000175732400002
J	Collins, BM; McCoy, AJ; Kent, HM; Evans, PR; Owen, DJ				Collins, BM; McCoy, AJ; Kent, HM; Evans, PR; Owen, DJ			Molecular architecture and functional model of the endocytic AP2 complex	CELL			English	Article							CLATHRIN-COATED VESICLES; SORTING SIGNALS; CRYSTAL-STRUCTURE; ASSEMBLY POLYPEPTIDES; ADAPTER COMPLEXES; APPENDAGE DOMAIN; AP-2 COMPLEXES; PROTEIN AP-2; MU-2 SUBUNIT; IN-VITRO	AP2 is the best-characterized member of the family of heterotetrameric clathrin adaptor complexes that play pivotal roles in many vesicle trafficking pathways within the cell. AP2 functions in clathrin-mediated endocytosis, the process whereby cargo enters the endosomal system from the plasma membrane. We describe the structure of the 200 kDa AP2 "core" (alpha trunk, beta2 trunk, mu2, and sigma2) complexed with the polyphosphatidylinositol headgroup mimic inositolhexakisphosphate at 2.6 Angstrom resolution. Two potential polyphosphatidylinositide binding sites are observed, one on alpha and one on mu2. The binding site for Yxxphi endocytic motifs is buried, indicating that a conformational change, probably triggered by phosphorylation in the disordered mu2 linker, is necessary to allow Yxxphi motif binding. A model for AP2 recruitment and activation is proposed.	Univ Cambridge, Wellcome Med Res Inst, Dept Clin Biochem, Cambridge CB2 2XY, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Wellcome Med Res Inst, Dept Clin Biochem, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.		Collins, Brett/J-1563-2014	Collins, Brett/0000-0002-6070-3774				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BECK KA, 1991, J BIOL CHEM, V266, P4442; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Fingerhut A, 2001, J BIOL CHEM, V276, P5476, DOI 10.1074/jbc.M009516200; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Owen DJ, 2001, TRAFFIC, V2, P105, DOI 10.1034/j.1600-0854.2001.020205.x; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; PAULOIN A, 1993, BIOCHEM J, V296, P409, DOI 10.1042/bj2960409; PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Traub LM, 1997, TRENDS CELL BIOL, V7, P43, DOI 10.1016/S0962-8924(96)20042-X; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; ZAREMBA S, 1985, J CELL BIOCHEM, V28, P47, DOI 10.1002/jcb.240280108	60	423	436	0	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 17	2002	109	4					523	535		10.1016/S0092-8674(02)00735-3	http://dx.doi.org/10.1016/S0092-8674(02)00735-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086608	Bronze			2022-12-24	WOS:000175696800013
J	Robyr, D; Suka, Y; Xenarios, I; Kurdistani, SK; Wang, A; Suka, N; Grunstein, M				Robyr, D; Suka, Y; Xenarios, I; Kurdistani, SK; Wang, A; Suka, N; Grunstein, M			Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RPD3; REPLICATION; HETEROCHROMATIN; ACETYLATION; EXPRESSION; REPRESSION; COMPLEX; SIR2; SITE	Yeast contains a family of five related histone deacetylases (HDACs) whose functions are known at few genes. Therefore, we used chromatin immunoprecipitation and intergenic microarrays to generate genome-wide HDAC enzyme activity maps. Rpd3 and Hda1 deacetylate mainly distinct promoters and gene classes where they are recruited largely by novel mechanisms. Hda1 also deacetylates subtelomeric domains containing normally repressed genes that are used instead for gluconeogenesis, growth on carbon sources other than glucose, and adverse growth conditions. These domains have certain features of heterochromatin but are distinct from subtelomeric heterochromatin repressed by the deacetylase Sir2. Finally, Hos1/Hos3 and Hos2 preferentially affect ribosomal DNA and ribosomal protein genes, respectively. Thus, acetylation microarrays uncover the "division of labor" for yeast histone deacetylases.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, US DOE, Lab Struct Biol & Mol Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Grunstein, M (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Boyer Hall, Los Angeles, CA 90095 USA.		Xenarios, Ioannis/ABD-5045-2021	Xenarios, Ioannis/0000-0002-3413-6841; Kurdistani, Siavash/0000-0003-3295-3511	NIGMS NIH HHS [GM23674, GM42421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042421, R01GM023674, R37GM023674] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1111/j.1574-6976.1997.tb00346.x; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DeRubertis F, 1996, NATURE, V384, P589; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; KURDISTANI SK, 2002, IN PRESS NAT GENET, V31; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; LUCCHINI R, 1994, MOL CELL BIOL, V14, P318, DOI 10.1128/MCB.14.1.318; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Vannier D, 1996, GENETICS, V144, P1343; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	36	363	371	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 17	2002	109	4					437	446		10.1016/S0092-8674(02)00746-8	http://dx.doi.org/10.1016/S0092-8674(02)00746-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086601	Bronze			2022-12-24	WOS:000175696800006
J	Pepys, MB; Herbert, J; Hutchinson, WL; Tennent, GA; Lachmann, HJ; Gallimore, JR; Lovat, LB; Bartfai, T; Alanine, A; Hertel, C; Hoffmann, T; Jakob-Roetne, R; Norcross, RD; Kemp, JA; Yamamura, K; Suzuki, M; Taylor, GW; Murray, S; Thompson, D; Purvis, A; Kolstoe, S; Wood, SP; Hawkins, PN				Pepys, MB; Herbert, J; Hutchinson, WL; Tennent, GA; Lachmann, HJ; Gallimore, JR; Lovat, LB; Bartfai, T; Alanine, A; Hertel, C; Hoffmann, T; Jakob-Roetne, R; Norcross, RD; Kemp, JA; Yamamura, K; Suzuki, M; Taylor, GW; Murray, S; Thompson, D; Purvis, A; Kolstoe, S; Wood, SP; Hawkins, PN			Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis	NATURE			English	Article							SYSTEMIC AMYLOIDOSIS; ALZHEIMER-DISEASE; LIVER-TRANSPLANTATION; AA AMYLOIDOSIS; IN-VIVO; X-RAY; MOUSE; DEPOSITS; PROGRAM; PROTEIN	The normal plasma protein serum amyloid P component (SAP) binds to fibrils in all types of amyloid deposits, and contributes to the pathogenesis of amyloidosis. In order to intervene in this process we have developed a drug, R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine-2-carboxylic acid, that is a competitive inhibitor of SAP binding to amyloid fibrils. This palindromic compound also crosslinks and dimerizes SAP molecules, leading to their very rapid clearance by the liver, and thus produces a marked depletion of circulating human SAP. This mechanism of drug action potently removes SAP from human amyloid deposits in the tissues and may provide a new therapeutic approach to both systemic amyloidosis and diseases associated with local amyloid, including Alzheimer's disease and type 2 diabetes.	UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; F Hoffmann La Roche & Co Ltd, Preclin CNS Res, Div Pharmaceut, CH-4070 Basel, Switzerland; Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 860, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 860, Japan; Imperial Coll Sch Med, Div Med, London W12 0NN, England; Univ Southampton, Sch Biol Sci, Div Biochem & Mol Biol, Southampton SO16 7PX, Hants, England	University of London; University College London; UCL Medical School; Roche Holding; Kumamoto University; Kumamoto University; Imperial College London; University of Southampton	Pepys, MB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England.	m.pepys@rfc.ucl.ac.uk	Kolstoe, Simon/O-4996-2019; Hawkins, Philip N/C-5573-2008; Wood, Stephen P/B-1438-2009; Taylor, Graham Walter/R-4811-2019; Lovat, Laurence/C-1986-2009	Kolstoe, Simon/0000-0003-1472-3966; Taylor, Graham Walter/0000-0002-9672-8463; Lovat, Laurence/0000-0003-4542-3915; Lachmann, Helen/0000-0001-8378-2498				Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gillmore JD, 1997, BRIT J HAEMATOL, V99, P245, DOI 10.1046/j.1365-2141.1997.303194.x; Gillmore JD, 2000, QJM-INT J MED, V93, P269, DOI 10.1093/qjmed/93.5.269; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; HAWKINS PN, 1988, LANCET, V1, P1413; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HERTEL C, 2001, Patent No. 6262089; HIND CRK, 1984, LANCET, V2, P376; Hohenester E, 1997, J MOL BIOL, V269, P570, DOI 10.1006/jmbi.1997.1075; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; HUTCHINSON WL, 1994, J CLIN INVEST, V94, P1390, DOI 10.1172/JCI117474; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; IWANAGA T, 1989, DEV GENET, V10, P365, DOI 10.1002/dvg.1020100504; Jager PL, 1998, J NUCL MED, V39, P699; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEPYS MB, 1979, IMMUNOLOGY, V37, P637; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; PEPYS MB, 2001, SAMTERS IMMUNOLOGIC, P401; PEPYS MB, 2000, Patent No. 6126918; PEPYS MB, 2001, Patent No. 01193705; PEPYS MB, 1997, INT J EXP CLIN INVES, V4, P274; Rydh A, 1998, EUR J NUCL MED, V25, P709; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	40	387	438	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					254	259		10.1038/417254a	http://dx.doi.org/10.1038/417254a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015594				2022-12-24	WOS:000175592100038
J	Popp, W; Mentfewitz, J; Gotz, R; Voshaar, T				Popp, W; Mentfewitz, J; Gotz, R; Voshaar, T			Phosphine poisoning in a German office	LANCET			English	Article									Univ Med Ctr, D-45122 Essen, Germany; N Rhine Westphalia State Environm Agcy, Essen, Germany; Bethanien Hosp, Div Gastroenterol Hepatol & Metab Dis, D-47441 Moers, Germany; Bethanien Hosp, Med Clin 3, D-47441 Moers, Germany	University of Duisburg Essen	Popp, W (corresponding author), Univ Med Ctr, Hufelandstr 55, D-45122 Essen, Germany.							American Conference of Governmental Industrial Hygienists (ACGIH), 2000, TLVS BEIS; *DFG, 2001, LIST MAK BAT VAL 200; MISRA UK, 1988, TOXICOL LETT, V42, P257, DOI 10.1016/0378-4274(88)90110-5; Stokinger H.E., 1981, PATTYS IND HYGIENE T, V2A, P1807; WILSON R, 1980, JAMA-J AM MED ASSOC, V244, P148, DOI 10.1001/jama.244.2.148	5	17	18	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 4	2002	359	9317					1574	1574		10.1016/S0140-6736(02)08518-5	http://dx.doi.org/10.1016/S0140-6736(02)08518-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047968				2022-12-24	WOS:000175460700012
J	Roy, S; Knox, K; Segal, S; Griffiths, D; Moore, CE; Welsh, KI; Smarason, A; Day, NP; McPheat, WL; Crook, DW; Hill, AVS				Roy, S; Knox, K; Segal, S; Griffiths, D; Moore, CE; Welsh, KI; Smarason, A; Day, NP; McPheat, WL; Crook, DW; Hill, AVS		Oxford Pneumococcal Surveillance	MBL genotype and risk of invasive pneumococcal disease: a case-control study	LANCET			English	Article							MANNOSE-BINDING-PROTEIN; LECTIN MBL; GENE; INFECTION; ASSOCIATION; SUSCEPTIBILITY; MUTATIONS; VARIANTS; ALLELES; PATHOGENS	Background Streptococcus pneumoniae is a major cause of morbidity and mortality in developed and developing countries. No common genetic determinants of susceptibility have been defined. Mannose-binding lectin (MBL) is a key mediator of innate host immunity that activates the complement pathway and directly opsonises some infectious pathogens. Mutations in three codons in the MBL gene have been identified, and individuals homozygous for a mutant genotype have very little or no serum MBL. We did a case-control study in the UK to assess whether these mutant genotypes were associated with invasive pneumococcal disease. Methods The frequencies of genotypes defined by the three mutations in codons 52, 54, and 57, and a functional promoter polymorphism at -221, were compared in a two-stage study of 337 patients with invasive pneumococcal disease and 1032 controls. All individuals were recruited from an ethnically homogeneous white population in Oxfordshire, UK. Patients had S pneumoniae isolated from a normally sterile site. Findings In our initial set of participants, 28 (12%) of 229 patients and 18 (5%) of 353 controls were homozygotes for MBL codon variants (odds ratio 2.59 [95% CI 1.39-4.83], p=0.002). Neither heterozygosity for these codon variants nor the promoter polymorphism was associated with susceptibility. In a confirmatory study, 11 (10%) of 108 patients were MBL homozygotes compared with 36 (5%) of 679 controls (p=0.046). Interpretation Homozygotes for MBL codon variants, who represent about 5% of north Europeans and north Americans and larger proportions of populations in many developing countries, could be at substantially increased risk of invasive pneumococcal disease.	John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England; John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; Churchill Hosp, Dept Surg, Oxford OX3 7LJ, England; AstraZeneca, Macclesfield, Cheshire, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Oxford; AstraZeneca	Hill, AVS (corresponding author), John Radcliffe Hosp, Dept Microbiol, Room 7501, Oxford OX3 9DU, England.	adrian.hill@well.ox.ac.uk	HILL, Adrian V>S>/C-1306-2008; Moore, Catrin/K-1980-2017	Moore, Catrin/0000-0002-8639-9846				Bellamy R, 1998, QJM-INT J MED, V91, P13, DOI 10.1093/qjmed/91.1.13; Colman G, 1998, J MED MICROBIOL, V47, P17, DOI 10.1099/00222615-47-1-17; Davies J, 2000, LANCET, V355, P1885, DOI 10.1016/S0140-6736(00)02297-2; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; FINLAND M, 1982, BACTERIAL INFECT HUM; GABOLDE M, 1999, ASS VARIANT ALLELES, P1166; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; GARRED P, 1995, LANCET, V346, P941, DOI 10.1016/S0140-6736(95)91559-1; GARRED P, 1993, SCAND J IMMUNOL, V37, P468, DOI 10.1111/j.1365-3083.1993.tb03320.x; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Homoe P, 1999, SCAND J INFECT DIS, V31, P363, DOI 10.1080/00365549950163798; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LINDBERG B, 1977, CARBOHYD RES, V58, P177, DOI 10.1016/S0008-6215(00)83413-8; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Matsushita M, 1998, IMMUNOBIOLOGY, V199, P340, DOI 10.1016/S0171-2985(98)80038-7; Mead R, 1997, LANCET, V349, P1669, DOI 10.1016/S0140-6736(05)62635-9; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Sumiya M, 1996, QJM-MON J ASSOC PHYS, V89, P723, DOI 10.1093/qjmed/89.10.723; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; Tang C, 1999, LANCET, V354, P336, DOI 10.1016/S0140-6736(05)75240-5; Turner MW, 1998, IMMUNOBIOLOGY, V199, P327, DOI 10.1016/S0171-2985(98)80037-5; Valdimarsson H, 1998, SCAND J IMMUNOL, V48, P116; VANEMMERIK LC, 1994, CLIN EXP IMMUNOL, V97, P411; *WHO, 1998, WHO VACC RES DEV STE	35	237	250	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2002	359	9317					1569	1573		10.1016/S0140-6736(02)08516-1	http://dx.doi.org/10.1016/S0140-6736(02)08516-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047967				2022-12-24	WOS:000175460700011
J	Rambukkana, A; Zanazzi, G; Tapinos, N; Salzer, JL				Rambukkana, A; Zanazzi, G; Tapinos, N; Salzer, JL			Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells	SCIENCE			English	Article							PERIPHERAL-NERVE PREDILECTION; LEPROUS NEUROPATHY; DAMAGE	Demyelination results in severe disability in many neurodegenerative diseases and nervous system infections, and it is typically mediated by inflammatory responses. Mycobacterium leprae, the causative organism of leprosy, induced rapid demyelination by a contact-dependent mechanism in the absence of immune cells in an in vitro nerve tissue culture model and in Rag1-knockout (Rag1(-/-)) mice, which tack mature B and T lymphocytes. Myelinated Schwann cells were resistant to M. leprae invasion but undergo demyelination upon bacterial attachment, whereas nonmyelinated Schwann cells harbor intracellular M. leprae in large numbers. During M. leprae-induced demyelination, Schwann cells proliferate significantly both in vitro and in vivo and generate a more nonmyelinated phenotype, thereby securing the intracellular niche for M. leprae.	Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA; NYU, Med Ctr, Dept Neurol, New York, NY 10016 USA	Rockefeller University; New York University; New York University	Rambukkana, A (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.			rambukkana, anura/0000-0002-6286-9145; Salzer, James/0000-0001-9126-7197				BRENNAN PJ, 1989, REV INFECT DIS, V11, P420; Cajal RS., 1928, DEGENERATION REGENER; Curtiss R, 2001, LEPROSY REV, V72, P8; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981; JACOBS JM, 1987, J NEUROL SCI, V79, P301, DOI 10.1016/0022-510X(87)90237-1; JOB CK, 1989, INT J LEPROSY, V57, P532; JOHNSON PC, 1997, TXB NEUROPATHOLOGY, P1233; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; PLEASURE DE, 1972, ARCH NEUROL-CHICAGO, V26, P289, DOI 10.1001/archneur.1972.00490100019001; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rambukkana A, 2001, CURR OPIN MICROBIOL, V4, P21, DOI 10.1016/S1369-5274(00)00159-4; RAMBUKKANA A, UNPUB; Scherer S.S., 1996, GLIAL CELL DEV, P165; Schmid CD, 2000, J NEUROSCI, V20, P729, DOI 10.1523/JNEUROSCI.20-02-00729.2000; Shetty V P, 1980, Lepr India, V52, P5; SHETTY VP, 1988, J NEUROL SCI, V88, P115, DOI 10.1016/0022-510X(88)90210-9; SHETTY VP, 1994, ACTA NEUROPATHOL, V88, P300; SHETTY VP, 1993, INT J LEPROSY, V61, P70; STONER GL, 1979, LANCET, V10, P994; Waxman SG, 1998, NEW ENGL J MED, V338, P323, DOI 10.1056/NEJM199801293380510; Wingerchuk DM, 2001, LAB INVEST, V81, P263, DOI 10.1038/labinvest.3780235	23	135	138	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					927	931		10.1126/science.1067631	http://dx.doi.org/10.1126/science.1067631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988579				2022-12-24	WOS:000175442500049
J	Hollingsworth, RG; Armstrong, JW; Campbell, E				Hollingsworth, RG; Armstrong, JW; Campbell, E			Pest control: Caffeine as a repellent for slugs and snails	NATURE			English	Article							CALCIUM; NEURONS		ARS, US Pacific Basin Agr Res Ctr, USDA, Hilo, HI 96720 USA; USDA, APHIS, WS, Natl Wildlife Res Ctr, Hilo, HI 96721 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Hollingsworth, RG (corresponding author), ARS, US Pacific Basin Agr Res Ctr, USDA, POB 4459, Hilo, HI 96720 USA.							Ahmed IA, 1997, GEN PHARMACOL, V28, P245, DOI 10.1016/S0306-3623(96)00233-9; AHMED IA, 1993, COMP BIOCHEM PHYS C, V105, P363, DOI 10.1016/0742-8413(93)90072-S; COOK BJ, 1980, COMP BIOCHEM PHYS C, V67, P115, DOI 10.1016/0306-4492(80)90005-2; FAHIM MA, 1983, J NEUROBIOL, V14, P391, DOI 10.1002/neu.480140507; MARTIN A, 1991, OUTLOOK AGR, V20, P167, DOI 10.1177/003072709102000307; MOFFETT DF, 1983, COMP BIOCHEM PHYS C, V75, P305, DOI 10.1016/0742-8413(83)90196-2; NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592; *SAS I, 1988, SAS STAT US GUID 6 0; Steel RGD, 1980, PRINCIPLES PROCEDURE; WILKINS RM, 1995, PESTIC SCI, V43, P321, DOI 10.1002/ps.2780430412; WINDHOLZ M, 1976, MERCK INDEX	11	91	102	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					915	916		10.1038/417915a	http://dx.doi.org/10.1038/417915a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087394	Green Published			2022-12-24	WOS:000176441200028
J	Irwin, RP; Maxwell, TA; Howard, AD; Craddock, RA; Leverington, DW				Irwin, RP; Maxwell, TA; Howard, AD; Craddock, RA; Leverington, DW			A large paleolake basin at the head of Ma'adim Vallis, Mars	SCIENCE			English	Article							MARGARITIFER SINUS; CRATER; EVOLUTION; DRAINAGE; MODELS	At 8 to 15 kilometers wide, Ma'adim Vallis is one of the largest valleys in the martian highlands. Although a groundwater source was previously suggested, the channel originates at a spillway in the divide of a similar to3,000,000-square-kilometer closed drainage basin. The interior morphology of this source basin, including likely shoreline features following topographic contours, suggests that Ma'adim Vallis was created through catastrophic overflow of a similar to1,100,000-square-kilometer highland lake. The size, constant levels, and interior morphology of three regional paleolake basins require a warmer paleoclimate and a long-term, recharged, stable highland water table more than similar to3.5 billion years ago.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	Smithsonian Institution; University of Virginia	Irwin, RP (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.		Craddock, Robert/B-3884-2013	Howard, Alan/0000-0002-5423-1600				[Anonymous], 1993, 274 GEOL SOC AM; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Cabrol NA, 1997, ICARUS, V125, P455, DOI 10.1006/icar.1996.5625; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Carr M.H, 1996, WATER MARS; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; CARTER BL, 2001, LUNAR LANET SCI C, V32, P2042; Craddock RA, 1997, J GEOPHYS RES-PLANET, V102, P13321, DOI 10.1029/97JE01084; Forsythe RD, 1998, J GEOPHYS RES-PLANET, V103, P31421, DOI 10.1029/98JE01966; FREY HV, 2001, 2001 GSA ANN M BOST; Grant JA, 2000, GEOLOGY, V28, P223, DOI 10.1130/0091-7613(2000)028<0223:VFIMSM>2.3.CO;2; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; HOWARD AD, 2000, EOS S, V81; IRWIN RP, IN PRESS J GEOPHYS R; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MANENT LS, 1986, EARTH MOON PLANETS, V34, P149, DOI 10.1007/BF00055132; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 2000, LUNAR PLANET SCI, V31, P2033; SHARP RP, 1975, GEOL SOC AM BULL, V86, P593, DOI 10.1130/0016-7606(1975)86<593:COM>2.0.CO;2; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; THORNHILL GD, 1993, J GEOPHYS RES-PLANET, V98, P23581, DOI 10.1029/93JE03153; [No title captured]	27	115	115	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2209	2212		10.1126/science.1071143	http://dx.doi.org/10.1126/science.1071143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12077414				2022-12-24	WOS:000176379000055
J	Higashi, Y; Sasaki, S; Nakagawa, K; Matsuura, H; Oshima, T; Chayama, K				Higashi, Y; Sasaki, S; Nakagawa, K; Matsuura, H; Oshima, T; Chayama, K			Endothelial function and oxidative stress in renovascular hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT VASCULAR RELAXATION; LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE; REACTIVE HYPEREMIA; ANGIOTENSIN-II; RELAXING FACTOR; IN-VIVO; DYSFUNCTION; VASODILATION; ACTIVATION	Background: It has been reported that renovascular hypertension activates the renin-angiotensin system, leading to an increase in oxidative stress. We sought to determine whether renal-artery angioplasty improves endothelial dysfunction in patients with renovascular hypertension through a reduction in oxidative stress. Methods: We evaluated the response of forearm blood flow to acetylcholine, an endothelium-dependent vasodilator, and isosorbide dinitrate, an endothelium-independent vasodilator, before and after renal-artery angioplasty in 15 subjects with renovascular hypertension and 15 controls without hypertension who were matched for age and sex. Forearm blood flow was measured with the use of a mercury-filled Silastic strain-gauge plethysmograph. Results: The forearm blood flow in response to acetylcholine was less in subjects with renovascular hypertension than in controls, although the forearm blood flow in response to isosorbide dinitrate was similar in the two groups. Angioplasty decreased systolic and diastolic blood pressures, forearm vascular resistance, and urinary excretion of 8-hydroxy-2'-deoxyguanosine and serum malondialdehyde-modified low-density lipoprotein (LDL), indexes of oxidative stress. After angioplasty, the mean (+/-SD) forearm blood flow in response to acetylcholine was increased in the patients with renovascular hypertension (19.3+/-6.8 vs. 29.6+/-7.1 ml per minute per 100 ml, P=0.002). The increase in the maximal forearm blood flow in response to acetylcholine correlated significantly with the decrease in urinary excretion of 8-hydroxy-2'-deoxyguanosine (r=-0.51, P=0.004) and serum malondialdehyde-modified LDL (r=-0.39, P=0.02). Coinfusion of ascorbic acid (vitamin C) augmented the response of forearm blood flow to acetylcholine before angioplasty (P<0.001) but not after angioplasty. Conclusions: These findings suggest that excessive oxidative stress is involved, at least in part, in impaired endothelium-dependent vasodilatation in patients with renovascular hypertension.	Hiroshima Univ, Fac Med, Dept Internal Med 1, Div Hypertens & Cardiol,Minami Ku, Hiroshima 7348551, Japan; Hiroshima Univ, Fac Med, Dept Clin Lab Med, Hiroshima 7348551, Japan	Hiroshima University; Hiroshima University	Higashi, Y (corresponding author), Hiroshima Univ, Fac Med, Dept Internal Med 1, Div Hypertens & Cardiol,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yhigashi@hiroshima-u.ac.jp	Chayama, Kazuaki/B-2493-2016; Higashi, Yukihito/G-5343-2019	Chayama, Kazuaki/0000-0002-5530-5341				Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; CREAGER MA, 1994, HYPERTENSION, V24, P499, DOI 10.1161/01.HYP.24.4.499; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Dijkhorst-Oei LT, 1999, J CARDIOVASC PHARM, V33, P420, DOI 10.1097/00005344-199903000-00012; DOHI Y, 1990, HYPERTENSION, V16, P170, DOI 10.1161/01.HYP.16.2.170; Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; GREENBERG SS, 1990, AM J HYPERTENS, V3, P211, DOI 10.1093/ajh/3.3.211; Hegde LG, 1998, CLIN EXP HYPERTENS, V20, P885, DOI 10.3109/10641969809053253; Higashi Y, 1999, CIRCULATION, V100, P1194, DOI 10.1161/01.CIR.100.11.1194; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Higashi Y, 2001, J AM COLL CARDIOL, V37, P863, DOI 10.1016/S0735-1097(00)01177-3; Iwatsubo H, 1997, HYPERTENSION, V29, P286, DOI 10.1161/01.HYP.29.1.286; Leinonen J, 1997, FEBS LETT, V417, P150, DOI 10.1016/S0014-5793(97)01273-8; Lerman LO, 2001, HYPERTENSION, V37, P541, DOI 10.1161/01.HYP.37.2.541; MAGGI E, 1995, J HYPERTENS, V13, P129; Nakae D, 1997, CANCER RES, V57, P1281; OHYANAGI M, 1992, CIRC RES, V71, P188, DOI 10.1161/01.RES.71.1.188; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rizzoni D, 1998, HYPERTENSION, V31, P335, DOI 10.1161/01.HYP.31.1.335; Romero JC, 1999, HYPERTENSION, V34, P943, DOI 10.1161/01.HYP.34.4.943; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P699, DOI 10.1161/01.HYP.25.4.699; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; TADDEI S, 1993, HYPERTENSION, V21, P929, DOI 10.1161/01.HYP.21.6.929	28	396	413	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2002	346	25					1954	1962		10.1056/NEJMoa013591	http://dx.doi.org/10.1056/NEJMoa013591			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563QC	12075056				2022-12-24	WOS:000176266200004
J	Badri, M; Wilson, D; Wood, R				Badri, M; Wilson, D; Wood, R			Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; HIV-INFECTION; PULMONARY TUBERCULOSIS; MORTALITY; ADULTS; IMMUNODEFICIENCY; PREVALENCE; PREVENTION; ILLNESSES; IMPACT	Background Studies of the effect of highly active antiretroviral therapy (HAART) on the risk of HIV-1-associated tuberculosis have had variable results, We set out to determine the effect of HAART on the risk of tuberculosis in South Africa. Methods We compared the risk of tuberculosis in 264 patients who received HAART in phase III clinical trials and a prospective cohort of 770 non-HAART patients who were attending Somerset Hospital adult HIV clinic, University of Cape Town, between 1992 and 2001. Poisson regression models were fitted to determine risk of tuberculosis; patients were stratified by CD4 count, WHO clinical stage, and socioeconomic status. Findings HAART was associated with a lower incidence of tuberculosis (2.4 vs 9.7 cases per 100 patient-years, adjusted rate ratio 0.19 [95% Cl 0.09-0.38]; p<0.0001). This finding was apparent across all strata of socioeconomic status, baseline WHO stage, and CD4 count, except in patients with CD4 counts of more than 350 cells/&mu;L. The number of tuberculosis cases averted by HAART was greatest in patients with WHO stage 3 or 4 (18.8 averted cases per 100 patient-years, adjusted rate ratio 0.22 [0.09-0.41]; p=0.03) and in those with CD4 counts of less than 200 cells/&mu;L (14.2 averted cases per 100 patient-years, adjusted rate ratio 0.18 [0.07-0.47]; P<0.0001). Interpretation HAART reduced the incidence of HIV-1-associated tuberculosis by more than 80% (95% Cl 62-91) in an area endemic with tuberculosis and HIV-1. The protective effect of HAART was greatest in symptomatic patients and those with advanced immune suppression.	Univ Cape Town, Somerset Hosp, HIV Clin Res Unit, ZA-8005 Cape Town, South Africa	University of Cape Town	Wood, R (corresponding author), Univ Cape Town, Somerset Hosp, HIV Clin Res Unit, ZA-8005 Cape Town, South Africa.		Wood, Robin/G-8509-2011; Badri, Motasim/E-1141-2013	Badri, Motasim/0000-0002-5268-6492				ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Badri M, 2002, INT J TUBERC LUNG D, V6, P231; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; *CAP METR COUNC, 1997, LEV LIV CAP METR AR; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; LANGE JMA, 1993, AIDS, V7, P1675, DOI 10.1097/00002030-199312000-00021; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; LEROY V, 1997, AM J EPIDEMIOL, V145, P295; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; NAIDO P, 2001, 11 JOINT C STD ID SO; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; UNAIDS, 2000, AIDS EP UPD DEC 2000; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; *WHO, 2000, 1 M GLOB WORK GROUP; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; World Health Organization, 2002, SCAL ANT THER RES LT	26	430	433	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 15	2002	359	9323					2059	2064		10.1016/S0140-6736(02)08904-3	http://dx.doi.org/10.1016/S0140-6736(02)08904-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562JX	12086758				2022-12-24	WOS:000176194600006
J	Leinekugel, X; Khazipov, R; Cannon, R; Hirase, H; Ben-Ari, Y; Buzsaki, G				Leinekugel, X; Khazipov, R; Cannon, R; Hirase, H; Ben-Ari, Y; Buzsaki, G			Correlated bursts of activity in the neonatal hippocampus in vivo	SCIENCE			English	Article							LONG-TERM POTENTIATION; VISUAL-CORTEX; NETWORK; RAT; NEURONS; GABA(A); NMDA; OSCILLATIONS; MECHANISMS; PLASTICITY	The behavior of immature cortical networks in vivo remains largely unknown. Using multisite extracellular and patch-clamp recordings, we observed recurrent bursts of synchronized neuronal activity lasting 0.5 to 3 seconds that occurred spontaneously in the hippocampus of freely moving and anesthetized rat pups. The influence of slow rhythms (0.33 and 0.1 hertz) and the contribution of both gamma-aminobutyric acid A-mediated and glutamate receptor-mediated synaptic signals in the generation of hippocampal bursts was reminiscent of giant depolarizing potentials observed in vitro. This earliest pattern, which diversifies during the second postnatal week, could provide correlated activity for immature neurons and may underlie activity-dependent maturation of the hippocampal network.	INSERM, U29, INMED, F-13273 Marseille 09, France; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Paris 06, Fac Med Pitie Salpetriere, INSERM, EMI 0224, F-75013 Paris, France; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Rutgers State University Newark; Rutgers State University New Brunswick; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Boston Children's Hospital; Harvard Medical School	Leinekugel, X (corresponding author), INSERM, U29, INMED, Ave Luminy,Boite Postale 13, F-13273 Marseille 09, France.	xlkg@noos.fr	Leinekugel, Xavier/ABD-8347-2021; Hirase, Hajime/A-3709-2012; Khazipov, Roustem/M-1834-2016; Leinekugel, Xavier/F-4034-2014	Hirase, Hajime/0000-0003-3806-6905; Khazipov, Roustem/0000-0002-6763-2841; Leinekugel, Xavier/0000-0003-2878-3791; Ben-Ari, Yehezkel/0000-0001-6208-8480; Buzsaki, Gyorgy/0000-0002-3100-4800	FIC NIH HHS [FO6 TW02290] Funding Source: Medline; NCRR NIH HHS [RR09754] Funding Source: Medline; NINDS NIH HHS [NS 43157, NS 34994] Funding Source: Medline; PHS HHS [N0T 43994] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW002290] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS043157] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Aguilo A, 1999, J NEUROSCI, V19, P10856, DOI 10.1523/JNEUROSCI.19-24-10856.1999; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1989, EXP NEUROL, V105, P10, DOI 10.1016/0014-4886(89)90167-2; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; de la Prida LM, 1998, EUR J NEUROSCI, V10, P899, DOI 10.1046/j.1460-9568.1998.00097.x; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; LEBLANC MO, 1979, EXP NEUROL, V66, P220, DOI 10.1016/0014-4886(79)90076-1; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; REITER HO, 1986, EXP BRAIN RES, V65, P182; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; YLINEN A, 1995, J NEUROSCI, V15, P30; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	30	242	246	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2049	2052		10.1126/science.1071111	http://dx.doi.org/10.1126/science.1071111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065842				2022-12-24	WOS:000176273300060
J	Klar, AJS				Klar, AJS			Fibonacci's flowers	NATURE			English	Editorial Material							INHERITANCE; PATTERN		NCI, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klar, AJS (corresponding author), NCI, Ctr Canc Res, NIH, Frederick, MD 21702 USA.							GREEN PB, 1987, AM ZOOL, V27, P657; KLAR AJS, 1990, EMBO J, V9, P1407, DOI 10.1002/j.1460-2075.1990.tb08256.x; SUSSEX IM, 1989, CELL, V56, P225, DOI 10.1016/0092-8674(89)90895-7; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	4	21	21	5	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					595	595		10.1038/417595a	http://dx.doi.org/10.1038/417595a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050641	Bronze			2022-12-24	WOS:000176001200025
J	van der Linden, PD; Sturkenboom, MCJM; Herings, RMC; Leufkens, HGM; Stricker, BHC				van der Linden, PD; Sturkenboom, MCJM; Herings, RMC; Leufkens, HGM; Stricker, BHC			Fluoroquinolones and risk of Achilles tendon disorders: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTICS; TENDINITIS; RUPTURE		Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat & Internal Med, Pharmacoepidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University	Stricker, BHC (corresponding author), Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat & Internal Med, Pharmacoepidemiol Unit, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Herings, Ron/AAE-4096-2021	Herings, Ron/0000-0002-2561-8734				HUSTON KA, 1994, NEW ENGL J MED, V331, P748, DOI 10.1056/NEJM199409153311116; MCEWAN SR, 1988, LANCET, V2, P900; McGarvey WC, 1996, FOOT ANKLE INT, V17, P496, DOI 10.1177/107110079601700811; SZARFMAN A, 1995, NEW ENGL J MED, V332, P193; van der Linden PD, 1999, BRIT J CLIN PHARMACO, V48, P433	5	130	131	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1306	1307		10.1136/bmj.324.7349.1306	http://dx.doi.org/10.1136/bmj.324.7349.1306			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039823	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000176041500016
J	Sommer, MA; Wurtz, RH				Sommer, MA; Wurtz, RH			A pathway in primate brain for internal monitoring of movements	SCIENCE			English	Article							FRONTAL EYE FIELD; COROLLARY DISCHARGE; SUPERIOR COLLICULUS; EFFERENCE COPY; POSITION; RESPONSES; SACCADES; MUSCLES; NEURONS; SYSTEM	It is essential to keep track of the movements we make, and one way to do that is to monitor correlates, or corollary discharges, of neuronal movement commands. We hypothesized that a previously identified pathway from brainstem to frontal cortex might carry corollary discharge signals. We found that neuronal activity in this pathway encodes upcoming eye movements and that inactivating the pathway impairs sequential eye movements consistent with loss of corollary discharge without affecting single eye movements. These results identify a pathway in the brain of the primate Macaca mulatta that conveys corollary discharge signals.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sommer, MA (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA.			Sommer, Marc/0000-0001-5061-763X	NATIONAL EYE INSTITUTE [ZIAEY000109, Z01EY000109] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; BELL CC, 1984, COMP PHYSL SENSORY S, P637; BRIDGEMAN B, 1995, ANN BIOMED ENG, V23, P409, DOI 10.1007/BF02584441; Donaldson IML, 2000, PHILOS T R SOC B, V355, P1685, DOI 10.1098/rstb.2000.0732; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; GAYMARD B, 1994, EXP BRAIN RES, V102, P1; GNADT JW, 1991, VISION RES, V31, P693, DOI 10.1016/0042-6989(91)90010-3; GRANTYN R, 1989, REV OCULOMOTOR RES N, V2, pCH8; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HEIDE W, 1995, ANN NEUROL, V38, P739, DOI 10.1002/ana.410380508; KOWLER E, 1990, REV OCULOMOTOR RES E, V4, pCH1; Lewis RF, 2001, EXP BRAIN RES, V141, P349; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MCCLOSKEY DI, 1981, HDB PHYSL NERVOUS 2, V2, pCH32; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SKAVENSKI AA, 1990, REV OCULOMOTOR RES E, V4, pCH5; SPARKS DL, 1989, REV OCULOMOTOR RES N, V3, pCH5; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; TEUBER HL, 1966, INT J NEUROL, V5, P282; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; von Holst E., 1973, BEHAV PHYSL ANIMALS, V1, P139; VONHELMHOLTZ H, 2000, HELMHOLTZS TREATISE, V3, P242; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	29	399	402	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1480	1482		10.1126/science.1069590	http://dx.doi.org/10.1126/science.1069590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029137	Green Submitted			2022-12-24	WOS:000175910300052
J	Murakami, KS; Masuda, S; Campbell, EA; Muzzin, O; Darst, SA				Murakami, KS; Masuda, S; Campbell, EA; Muzzin, O; Darst, SA			Structural basis of transcription initiation: An RNA polymerase holoenzyme-DNA complex	SCIENCE			English	Article							ALPHA-SUBUNIT; PROMOTER INTERACTIONS; SIGMA FACTORS; BINDING; RECOGNITION; ROLES	The crystal structure of Thermus aquaticus RNA polymerase holoenzyme (alpha(2)betabeta'omegasigma-(A)) complexed with a fork-junction promoter DNA fragment has been determined by fitting high-resolution x-ray structures of individual components into a 6.5-angstrom resolution map. The DNA Lies across one face of the holoenzyme, completely outside the RNA polymerase active site channel. All sequence-specific contacts with core promoter elements are mediated by the a subunit. A universally conserved tryptophan is ideally positioned to stack on the exposed face of the base pair at the upstream edge of the transcription bubble. Universally conserved basic residues of the a subunit provide critical contacts with the DNA phosphate backbone and play a role in directing the melted DNA template strand into the RNA polymerase active site. The structure explains how holoenzyme recognizes promoters containing variably spaced -10 and -35 elements and provides the basis for models of the closed and open promoter complexes.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu		Murakami, Katsuhiko/0000-0003-2244-0501; Campbell, Elizabeth/0000-0002-1332-128X	NIGMS NIH HHS [GM61898, GM53759, GM20470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759, R01GM061898] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Buckle M, 1999, J MOL BIOL, V285, P955, DOI 10.1006/jmbi.1998.2391; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CASANPASTOR N, 1991, J AM CHEM SOC, V113, P5658, DOI 10.1021/ja00015a020; COWING DW, 1989, J MOL BIOL, V210, P521, DOI 10.1016/0022-2836(89)90128-9; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; DARST SA, 1997, NUCL ACIDS MOL BIOL, V11, P27; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 1997, J BACTERIOL, V179, P1734, DOI 10.1128/jb.179.5.1734-1747.1997; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Huang XJ, 1997, NUCLEIC ACIDS RES, V25, P2603, DOI 10.1093/nar/25.13.2603; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Jeon YH, 1997, J MOL BIOL, V267, P953, DOI 10.1006/jmbi.1997.0902; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEILTY S, 1987, J BIOL CHEM, V262, P6389; KOVACIC RT, 1987, J BIOL CHEM, V262, P13654; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; MECSAS J, 1991, J MOL BIOL, V220, P585, DOI 10.1016/0022-2836(91)90102-C; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SCHICKOR P, 1990, EMBO J, V9, P2215, DOI 10.1002/j.1460-2075.1990.tb07391.x; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; WESTON SA, 1992, J MOL BIOL, V226, P1237, DOI 10.1016/0022-2836(92)91064-V; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	39	519	534	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1285	1290		10.1126/science.1069595	http://dx.doi.org/10.1126/science.1069595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016307				2022-12-24	WOS:000175713000045
J	Brochier, C; Philippe, H				Brochier, C; Philippe, H			Phylogeny - A non-hyperthermophilic ancestor for bacteria	NATURE			English	Article							ARCHAEA; LIFE		Univ Paris 06, CNRS, UMR 7622, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Brochier, C (corresponding author), Univ Paris 06, CNRS, UMR 7622, 9 Quai St Bernard, F-75005 Paris, France.		Brochier-Armanet, Celine/B-7898-2011	Brochier-Armanet, Celine/0000-0003-4669-3589				Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Brochier C, 2002, TRENDS GENET, V18, P1, DOI 10.1016/S0168-9525(01)02522-7; Daubin V, 2001, Genome Inform, V12, P155; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J, 2001, J MOL EVOL, V53, P447, DOI 10.1007/s002390010234; Forterre P, 2000, TRENDS GENET, V16, P152, DOI 10.1016/S0168-9525(00)01980-6; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Philippe H, 2000, CURR OPIN GENET DEV, V10, P596, DOI 10.1016/S0959-437X(00)00137-4; Stetter KO, 1996, CIBA F SYMP, V202, P1	12	184	195	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					244	244		10.1038/417244a	http://dx.doi.org/10.1038/417244a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015592				2022-12-24	WOS:000175592100036
J	Evers, K				Evers, K			European perspectives on therapeutic cloning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Int Council Sci Standing Comm Responsibil & Eth S, N-0105 Oslo, Norway		Evers, K (corresponding author), Int Council Sci Standing Comm Responsibil & Eth S, N-0105 Oslo, Norway.							*COM CONS NAT ETH, 2001, 67 COM CONS NAT ETH; *CONC EUR, 2002, CONV PROT HUM RIGHTS; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Nationaler Ethikrat, 2002, STELL IMP MENSCHL EM STELL IMP MENSCHL EM; PETITNICOLAS C, 2002, ENJEUX CLONAGE THERA; Scheper-Hughes N, 2000, CURR ANTHROPOL, V41, P191, DOI 10.1086/300123; *SWED RES COUNC, 2002, SWED RES COUNC GUID; 2002, BIOETHIQUE      0213; 2001, N ENGL J MED, V345, P146	9	16	18	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1579	1582		10.1056/NEJMsb020527	http://dx.doi.org/10.1056/NEJMsb020527			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	11994550				2022-12-24	WOS:000175563900013
J	Rewers, A; Chase, HP; Mackenzie, T; Walravens, P; Roback, M; Rewers, M; Hamman, RF; Klingensmith, G				Rewers, A; Chase, HP; Mackenzie, T; Walravens, P; Roback, M; Rewers, M; Hamman, RF; Klingensmith, G			Predictors of acute complications in children with type 1 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVED GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; METABOLIC-CONTROL; CEREBRAL EDEMA; RISK-FACTORS; ADOLESCENTS; KETOACIDOSIS; INSULIN; MELLITUS; POPULATION	Context Diabetic ketoacidosis and severe hypoglycemia are acute complications of type 1 diabetes that are related, respectively, to insufficient or excessive insulin treatment. However, little is known about additional modifiable risk factors. Objective To examine the incidence of ketoacidosis and severe hypoglycemia in children with diabetes and to determine the factors that predict these complications. Design, Setting, and Participants A cohort of 1243 children from infancy to age 19 years with type I diabetes who resided in the Denver, Colo, metropolitan area were followed up prospectively for 3994 person-years from January 1, 1996, through December 31, 2000. Main Outcome Measures Incidence of ketoacidosis leading to hospital admission or emergency department visit and severe hypoglycemia (loss of consciousness, seizure, or hospital admission or emergency department visit). Results The incidence of ketoacidosis was 8 per 100 person-years and increased with age in girls (4 per 100 person-years in <7 8 in 7-12; and 12 in :13 years; P<.001 for trend). In multivariate analyses, sex-adjusted and stratified by age (<13 vs >= 13 years), the risk of ketoacidosis in younger children increased with higher hemoglobin A(1c) (HbA(1c)) (relative risk [RR], 1.68 per 1% increase; 95% confidence interval [CI], 1.45-1.94) and higher reported insulin dose (RR, 1.40 per 0.2 U/kg per day; 95% CI, 1.20-1.64). In older children, the risk of ketoacidosis increased with higher HbA(1c) (RR, 1.43; 95% CI, 1.30-1.58), higher reported insulin dose (RR, 1.13; 95% CI, 1.02-1.25), underinsurance (RR, 2.18; 95% CI, 1.65-2.95), and presence of psychiatric disorders (for boys, RR, 1.59; 95% CI, 0.96-2.65; for girls, RR, 3.22; 95 % CI, 2.25-4.61). The incidence of severe hypoglycemia was 19 per 100 person-years (P<.001 for trend) and decreased with age in girls (24 per 100 patient-years in <7, 19 in 7-12, and 14 in >= 13 years). In younger children, the risk of severe hypoglycemia increased with diabetes duration (RR, 1.39 per 5 years; 95% CI, 1.16-1.69) and underinsurance (RR, 1.33; 95% CI, 1.08-1.65). In older children, the risk of severe hypoglycemia increased with duration (RR, 1.34; 95% CI, 1.25-1.51), underinsurance (RR, 1.42; 95% CI, 1.11-1.81), lower HbA(1c) (RR, 1,22; 95% CI, 1.12-1.32), and presence of psychiatric disorders (RR, 1.56; 95% CI, 1.23-1.98). Eighty percent of episodes occurred among the 20% of children who had recurrent events. Conclusions Some children with diabetes remain at high risk for ketoacidosis and severe hypoglycemia. Age- and sex-specific incidence patterns suggest that ketoacidosis is a challenge in adolescent girls while severe hypoglycemia continues to affect disproportionally the youngest patients and boys of all ages. The pattern of modifiable risk factors indicates that underinsured children and those with psychiatric disorders or at the extremes of the HbA(1c) distribution should be targeted for specific interventions.	Univ Colorado, Sch Med, Childrens Hosp, Dept Pediat, Denver, CO 80218 USA; Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Denver, CO 80218 USA; Univ Colorado, Sch Med, Dept Prevent Med & Biometr, Denver, CO 80218 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Rewers, A (corresponding author), Univ Colorado, Sch Med, Childrens Hosp, Dept Pediat, B251,1056 E 19th Ave, Denver, CO 80218 USA.	rewers.arleta@tchden.org	Rewers, Arleta/AAE-2484-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00069] Funding Source: Medline; NIDDK NIH HHS [P30 DK-57516] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen C, 2001, DIABETES CARE, V24, P1878, DOI 10.2337/diacare.24.11.1878; Alvi NS, 2001, ARCH DIS CHILD, V85, P60, DOI 10.1136/adc.85.1.60; [Anonymous], 1995, DIAB AM; Barkai L, 1998, DIABETOLOGIA, V41, P898, DOI 10.1007/s001250051005; BERGADA I, 1989, DIABETES CARE, V12, P239, DOI 10.2337/diacare.12.4.239; BHATIA V, 1991, PEDIATRICS, V88, P1187; Chase HP, 2001, DIABETES CARE, V24, P430, DOI 10.2337/diacare.24.3.430; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; Danne T, 2001, DIABETES CARE, V24, P1342, DOI 10.2337/diacare.24.8.1342; Davis EA, 1998, ARCH DIS CHILD, V78, P111, DOI 10.1136/adc.78.2.111; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; DELAMATER AM, 1991, DIABETES CARE, V14, P20, DOI 10.2337/diacare.14.1.20; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; DUMONT RH, 1995, DIABETIC MED, V12, P612, DOI 10.1111/j.1464-5491.1995.tb00551.x; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; Edge JA, 2001, ARCH DIS CHILD, V85, P16, DOI 10.1136/adc.85.1.16; FAICH GA, 1983, AM J EPIDEMIOL, V117, P551, DOI 10.1093/oxfordjournals.aje.a113577; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; HEPBURN DA, 1990, DIABETIC MED, V7, P711, DOI 10.1111/j.1464-5491.1990.tb01475.x; Javor KA, 1997, DIABETES CARE, V20, P349, DOI 10.2337/diacare.20.3.349; JOHNSON DD, 1980, MAYO CLIN PROC, V55, P83; Levine BS, 2001, J PEDIATR-US, V139, P197, DOI 10.1067/mpd.2001.116283; Lteif AN, 1999, MAYO CLIN PROC, V74, P211, DOI 10.4065/74.3.211; Meltzer LJ, 2001, DIABETES CARE, V24, P678, DOI 10.2337/diacare.24.4.678; Menzin J, 2001, DIABETES CARE, V24, P51, DOI 10.2337/diacare.24.1.51; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Nordfeldt S, 1999, ACTA PAEDIATR, V88, P1184, DOI 10.1080/080352599750030275; Nordfeldt S, 1997, DIABETES CARE, V20, P497, DOI 10.2337/diacare.20.4.497; Nordfeldt S, 2001, ACTA PAEDIATR, V90, P137; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Roberts M D, 2001, Pediatr Diabetes, V2, P109, DOI 10.1034/j.1399-5448.2001.002003109.x; Rosilio M, 1998, DIABETES CARE, V21, P1146, DOI 10.2337/diacare.21.7.1146; Smith CP, 1998, ACTA PAEDIATR, V87, P537, DOI 10.1080/08035259850158245; SNORGAARD O, 1989, J INTERN MED, V226, P223, DOI 10.1111/j.1365-2796.1989.tb01384.x; Thomsett MJ, 1999, J PAEDIATR CHILD H, V35, P479, DOI 10.1046/j.1440-1754.1999.355424.x; Tupola S, 1998, DIABETIC MED, V15, P695, DOI 10.1002/(SICI)1096-9136(199808)15:8<695::AID-DIA651>3.0.CO;2-C; WILSON BE, 1995, J COMMUN HEALTH, V20, P249, DOI 10.1007/BF02260408	38	303	315	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2511	2518		10.1001/jama.287.19.2511	http://dx.doi.org/10.1001/jama.287.19.2511			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020331				2022-12-24	WOS:000175566200019
J	Neumann, HPH; Bausch, B; McWhinney, SR; Bender, BU; Gimm, O; Franke, G; Schipper, J; Klisch, J; Altehoefer, C; Zerres, K; Januszewicz, A; Smith, WM; Munk, R; Manz, T; Glaesker, S; Apel, TW; Treier, M; Reineke, M; Walz, MK; Hoang-Vu, C; Brauckhoff, M; Klein-Franke, A; Klose, P; Schmidt, H; Maier-Woelfle, M; Peczkowska, M; Szmigielski, C; Eng, C				Neumann, HPH; Bausch, B; McWhinney, SR; Bender, BU; Gimm, O; Franke, G; Schipper, J; Klisch, J; Altehoefer, C; Zerres, K; Januszewicz, A; Smith, WM; Munk, R; Manz, T; Glaesker, S; Apel, TW; Treier, M; Reineke, M; Walz, MK; Hoang-Vu, C; Brauckhoff, M; Klein-Franke, A; Klose, P; Schmidt, H; Maier-Woelfle, M; Peczkowska, M; Szmigielski, C; Eng, C		Freiburg-Warsaw-Columbus Pheochrom	Germ-line mutations in nonsyndromic pheochromocytoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOCRINE NEOPLASIA TYPE-2; HIPPEL-LINDAU DISEASE; TUMOR-SUPPRESSOR GENE; COMPLEX-II GENE; RET PROTOONCOGENE; HEREDITARY PARAGANGLIOMAS; FAMILIES; SDHD; SUSCEPTIBILITY	Background: The group of susceptibility genes for pheochromocytoma that included the proto-oncogene RET (associated with multiple endocrine neoplasia type 2 [MEN-2]) and the tumor-suppressor gene VHL (associated with von Hippel-Lindau disease) now also encompasses the newly identified genes for succinate dehydrogenase subunit D (SDHD) and succinate dehydrogenase subunit B (SDHB), which predispose carriers to pheochromocytomas and glomus tumors. We used molecular tools to classify a large cohort of patients with pheochromocytoma with respect to the presence or absence of mutations of one of these four genes and to investigate the relevance of genetic analyses to clinical practice. Methods: Peripheral blood from unrelated, consenting registry patients with pheochromocytoma was tested for mutations of RET, VHL, SDHD, and SDHB. Clinical data at first presentation and follow-up were evaluated. Results: Among 271 patients who presented with nonsyndromic pheochromocytoma and without a family history of the disease, 66 (24 percent) were found to have mutations (mean age, 25 years; 32 men and 34 women). Of these 66, 30 had mutations of VHL, 13 of RET, 11 of SDHD, and 12 of SDHB. Younger age, multifocal tumors, and extraadrenal tumors were significantly associated with the presence of a mutation. However, among the 66 patients who were positive for mutations, only 21 had multifocal pheochromocytoma. Twenty-three (35 percent) presented after the age of 30 years, and 17 (8 percent) after the age of 40. Sixty-one (92 percent) of the patients with mutations were identified solely by molecular testing of VHL, RET, SDHD, and SDHB; these patients had no associated signs and symptoms at presentation. Conclusions: Almost one fourth of patients with apparently sporadic pheochromocytoma may be carriers of mutations; routine analysis for mutations of RET, VHL, SDHD, and SDHB is indicated to identify pheochromocytoma-associated syndromes that would otherwise be missed.	Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany; Univ Freiburg, Dept Otolaryngol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Neuroradiol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Radiol, D-79106 Freiburg, Germany; Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Univ Aachen, Inst Human Genet, D-5100 Aachen, Germany; Inst Cardiol, Dept Hypertens, Warsaw, Poland; Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge, England; Clin Albert Ludwigs Univ, Dept Nephrol, Freiburg, Germany; Clin Albert Ludwigs Univ, Dept Otolaryngol, Freiburg, Germany; Clin Albert Ludwigs Univ, Dept Gastroenterol & Endocrinol, Freiburg, Germany; Klinikum Essen Mitte, Dept Surg, Essen, Germany; Univ Halle, Dept Surg, Halle An Der Saale, Germany; Univ Gottingen, Dept Pediat, D-3400 Gottingen, Germany; City Hosp, Dept Pediat, Munich, Germany; Univ Munich, Dept Pediat, Munich, Germany; Kantonsspital, Dept Internal Med, St Gallen, Switzerland; Inst Cardiol, Dept Hypertens, Warsaw, Poland; Med Univ, Warsaw, Poland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; RWTH Aachen University; Institute of Cardiology - Poland; CRUK Cambridge Institute; University of Cambridge; Kliniken Essen-Mitte; Martin Luther University Halle Wittenberg; University of Gottingen; University of Munich; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Institute of Cardiology - Poland	Neumann, HPH (corresponding author), Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany.	neumann@mm41.ukl.uni-freiburg.de	Walz, Martin/AHE-7790-2022; Gläsker, Sven/AAB-9362-2022	Eng, Charis/0000-0002-3693-5145; Szmigielski, Cezary/0000-0002-0837-6323	NCI NIH HHS [P30CA16058] Funding Source: Medline; NICHD NIH HHS [R01HD39058] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguiar RCT, 2001, J CLIN ENDOCR METAB, V86, P2890, DOI 10.1210/jc.86.6.2890; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bender BU, 2001, J MED GENET, V38, P508, DOI 10.1136/jmg.38.8.508; BOLINO A, 1995, ONCOGENE, V10, P2415; Brenner B, 1995, HYPERTENSION PATHOPH, V2, P2225; Eng C, 1996, NEW ENGL J MED, V335, P943, DOI 10.1056/NEJM199609263351307; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; ENG C, 1995, ONCOGENE, V10, P509; ENG C, 1994, HUM MOL GENET, V3, P686; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Eng C, 1999, MULTIPLE PRIMARY CANCERS, P165; Gimm O, 2000, CANCER RES, V60, P6822; Glavac D, 1996, HUM GENET, V98, P271, DOI 10.1007/s004390050206; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Heutink Peter, 1994, European Journal of Human Genetics, V2, P148; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Nakamura K, 1996, J BIOL CHEM, V271, P521, DOI 10.1074/jbc.271.1.521; NEUMANN HPH, 1993, NEW ENGL J MED, V329, P1531, DOI 10.1056/NEJM199311183292103; NEUMANN HPH, 1994, NEW ENGL J MED, V331, P1535; NEUMANN HPH, 1987, VASA-J VASCULAR DIS, V16, P220; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; PONDER BAJ, 1988, LANCET, V1, P397; Walther MM, 1999, J UROLOGY, V162, P659, DOI 10.1097/00005392-199909010-00004; Woodward ER, 1997, HUM MOL GENET, V6, P1051, DOI 10.1093/hmg/6.7.1051; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	28	961	1008	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1459	1466		10.1056/NEJMoa020152	http://dx.doi.org/10.1056/NEJMoa020152			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000816				2022-12-24	WOS:000175433200005
J	Blumenthal, T; Evans, D; Link, CD; Guffanti, A; Lawson, D; Thierry-Mieg, J; Thierry-Mieg, D; Chiu, WL; Duke, K; Kiraly, M; Kim, SK				Blumenthal, T; Evans, D; Link, CD; Guffanti, A; Lawson, D; Thierry-Mieg, J; Thierry-Mieg, D; Chiu, WL; Duke, K; Kiraly, M; Kim, SK			A global analysis of Caenorhabditis elegans operons	NATURE			English	Article							C-ELEGANS; GENE-EXPRESSION; LIN-15; GENOME; SL2	The nematode worm Caenorhabditis elegans and its relatives are unique among animals in having operons(1). Operons are regulated multigene transcription units, in which polycistronic premessenger RNA (pre-mRNA coding for multiple peptides) is processed to monocistronic mRNAs. This occurs by 3' end formation and trans-splicing using the specialized SL2 small nuclear ribonucleoprotein particle(2) for downstream mRNAs(1). Previously, the correlation between downstream location in an operon and SL2 trans-splicing has been strong, but anecdotal(3). Although only 28 operons have been reported, the complete sequence of the C. elegans genome reveals numerous gene clusters(4). To determine how many of these clusters represent operons, we probed full-genome microarrays for SL2-containing mRNAs. We found significant enrichment for about 1,200 genes, including most of a group of several hundred genes represented by complementary DNAs that contain SL2 sequence. Analysis of their genomic arrangements indicates that >90% are downstream genes, falling in 790 distinct operons. Our evidence indicates that the genome contains at least 1,000 operons, 2-8 genes long, that contain about 15% of all C. elegans genes. Numerous examples of co-transcription of genes encoding functionally related proteins are evident. Inspection of the operon list should reveal previously unknown functional relationships.	Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Sanger Ctr, Cambridge CB10 1SA, England; Natl Inst Genet, Gene Network Lab, Mishima, Shizuoka 411, Japan; Natl Ctr Biotechnol Informat, Bethesda, MD USA; Pfizer Global Res & Dev, Dept Mol Sci & Technol, Ann Arbor, MI 48105 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Boulder; Wellcome Trust Sanger Institute; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Pfizer; Stanford University; Stanford University	Blumenthal, T (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Box B121,4200 E 9th Ave, Denver, CO 80262 USA.		THIERRY-MIEG, Jean/F-1975-2017	THIERRY-MIEG, Jean/0000-0002-0396-6789; Thierry-Mieg, Danielle/0000-0001-9568-4211; Lawson, Daniel/0000-0001-7765-983X				BLUMENTHAL T, 1997, C ELEGANS, V2, P117; CLARK SG, 1994, GENETICS, V137, P987; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Evans D, 1997, P NATL ACAD SCI USA, V94, P9751, DOI 10.1073/pnas.94.18.9751; Furst J, 2002, J BIOL CHEM, V277, P4435, DOI 10.1074/jbc.M107372200; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Mazroui R, 1999, RNA, V5, P1615, DOI 10.1017/S1355838299991872; Page AP, 1997, DNA CELL BIOL, V16, P1335, DOI 10.1089/dna.1997.16.1335; RABOUL J, 2000, NAT GENET, V27, P332; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; Williams C, 1999, MOL CELL BIOL, V19, P376; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	19	269	273	6	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					851	854		10.1038/nature00831	http://dx.doi.org/10.1038/nature00831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075352				2022-12-24	WOS:000176285600047
J	Aguado, E; Richelme, S; Nunez-Cruz, S; Miazek, A; Mura, AM; Richelme, M; Guo, XJ; Sainty, D; He, HT; Malissen, B; Malissen, M				Aguado, E; Richelme, S; Nunez-Cruz, S; Miazek, A; Mura, AM; Richelme, M; Guo, XJ; Sainty, D; He, HT; Malissen, B; Malissen, M			Induction of T helper type 2 immunity by a point mutation in the LAT adaptor	SCIENCE			English	Article							CELL DEVELOPMENT; TYROSINE RESIDUES; ACTIVATION; MICE; LYMPHOCYTES; RECEPTOR; LINKER; HOMEOSTASIS; EXPRESSION; CD5	The transmembrane protein LAT (tinker for activation of T cells) couples the T cell receptor (TCR) to downstream signaling effectors. Mice homozygous for a mutation of a single LAT tyrosine residue showed impeded T cell development. However, later they accumulated polyclonal helper T (T-H) cells that chronically produced type 2 cytokines in large amounts. This exaggerated T(H)2 differentiation caused tissue eosinophilia and massive maturation of plasma cells secreting to immunoglobulins of the E and G1 isotypes. This paradoxical phenotype establishes an unanticipated inhibitory function for LAT that is critical for the differentiation and homeostasis of T-H cells.	Ctr Immunol Marseille Luminy, INSERM, F-13288 Marseille 9, France; Univ Mediterranee, CNRS, F-13288 Marseille 9, France; Inst J Paoli I Calmettes, Dept Biol, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Malissen, B (corresponding author), Ctr Immunol Marseille Luminy, INSERM, Parc Sci Luminy, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr	Guo, Xiao-Jun/M-9454-2016; Aguado, Enrique/L-4908-2014; HE, Hai-Tao/O-6551-2016; Malissen, Bernard/AAK-4659-2020	Aguado, Enrique/0000-0002-7232-2661; HE, Hai-Tao/0000-0002-6594-290X; Malissen, Bernard/0000-0003-1340-9342; Miazek, Arkadiusz/0000-0002-7210-2706; Malissen, Marie/0000-0003-2331-1445				Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Emson CL, 1998, J EXP MED, V188, P399, DOI 10.1084/jem.188.2.399; Erb KJ, 1997, J EXP MED, V185, P329, DOI 10.1084/jem.185.2.329; Foote LC, 1998, J EXP MED, V187, P847, DOI 10.1084/jem.187.6.847; Goldman M, 2001, TRENDS IMMUNOL, V22, P247, DOI 10.1016/S1471-4906(01)01893-2; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MALISSEN M, UNPUB; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Van Parijs L, 1998, SCIENCE, V280, P243; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	21	216	225	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2036	2040		10.1126/science.1069057	http://dx.doi.org/10.1126/science.1069057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065839				2022-12-24	WOS:000176273300056
J	O'Neill, BC; Oppenheimer, M				O'Neill, BC; Oppenheimer, M			Climate change - Dangerous climate impacts and the Kyoto protocol	SCIENCE			English	Article							CO2; STABILITY		Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Brown University; Brown University; Princeton University; Princeton University	O'Neill, BC (corresponding author), Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA.	bconeill@brown.edu; omichael@princeton.edu	O'Neill, Brian C./E-6531-2013	O'Neill, Brian C./0000-0001-7505-8897; Oppenheimer, Michael/0000-0002-9708-5914				Azar C, 1997, SCIENCE, V276, P1818, DOI 10.1126/science.276.5320.1818; Azar C, 1998, INT J ENVIRON POLLUT, V10, P508, DOI 10.1504/IJEP.1998.002246; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; HaDuong M, 1997, NATURE, V390, P270, DOI 10.1038/36825; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; JAIN AK, 1995, GLOBAL BIOGEOCHEM CY, V9, P153, DOI 10.1029/94GB02394; Mastrandrea MD, 2001, CLIM POLICY, V1, P433, DOI 10.3763/cpol.2001.0146; Nakicenovic N., 2000, IPCC SPECIAL REPORT; NORDHAUS J, 2000, WARMING WORLD; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Rijsberman FR, 1990, TARGETS INDICATORS C; SEAGER R, IN PRESS Q J R METEO; SMITH JB, 2001, CLIMATE CHANGE; Smith JB, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P913; Stocker TF, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P417; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wigley TML, 1998, GEOPHYS RES LETT, V25, P2285, DOI 10.1029/98GL01855; WIGLEY TML, COMMUNICATION	22	205	212	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					1971	1972		10.1126/science.1071238	http://dx.doi.org/10.1126/science.1071238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065820				2022-12-24	WOS:000176273300030
J	Ogunkolade, BW; Boucher, BJ; Fairclough, PD; Hitman, GA; Dorudi, S; Jenkins, PJ; Bustin, SA				Ogunkolade, BW; Boucher, BJ; Fairclough, PD; Hitman, GA; Dorudi, S; Jenkins, PJ; Bustin, SA			Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer	LANCET			English	Article							VITAMIN-D; MUCOSA	Vitamin D prevents proliferation, promotes differentiation, and induces apoptosis of colon cells, and reduced intake or insufficiency of the vitamin in the body are associated with increased risk of colorectal cancer. Results of previous studies have suggested that mRNA that codes for 25-hydroxyvitamin D-1-alpha-hydroxylase (1alphaOHase), which converts 25-hydroxyvitamin D to its active metabolite, might be up regulated in human colon carcinomas. We used real-time reverse transcription PCR assays to measure absolute 1alphaOHase mRNA concentrations in the colonic mucosa of 44 individuals without cancer, and in paired healthy colon and cancerous colon samples taken from 27 individuals with the disease, to ascertain whether or not such up regulation takes place. Our results suggest that concentrations of 1alphaOHase mRNA in tumour samples and In healthy colon samples from individuals without cancer are similar, but that concentrations are significantly lower in the paired, phenotypically healthy mucosa of individuals with cancer.	Univ London, Queen Marys Sch Med & Dent, Barts & London, Acad Dept Surg, London E1 1BB, England; Univ London, Queen Marys Sch Med & Dent, Barts & London, Dept Diabet & Metab Med, London E1 1BB, England; Univ London, Queen Marys Sch Med & Dent, Barts & London, Dept Endocrinol, London E1 1BB, England; Univ London, Queen Marys Sch Med & Dent, Barts & London, Dept Gastroenterol, London E1 1BB, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Bustin, SA (corresponding author), Univ London, Queen Marys Sch Med & Dent, Barts & London, Acad Dept Surg, London E1 1BB, England.		Bustin, Stephen/HHT-0617-2022; Bustin, Stephen/H-3086-2013	Bustin, Stephen/0000-0003-1870-6098; Bustin, Stephen/0000-0003-1870-6098; Boucher, Barbara J/0000-0003-1206-7555				Bareis P, 2001, BIOCHEM BIOPH RES CO, V285, P1012, DOI 10.1006/bbrc.2001.5289; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cross HS, 2001, STEROIDS, V66, P287, DOI 10.1016/S0039-128X(00)00153-7; Tangpricha V, 2001, LANCET, V357, P1673, DOI 10.1016/S0140-6736(00)04831-5; THOMAS MG, 1992, GUT, V33, P1660, DOI 10.1136/gut.33.12.1660	5	42	46	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 25	2002	359	9320					1831	1832		10.1016/S0140-6736(02)08680-4	http://dx.doi.org/10.1016/S0140-6736(02)08680-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555CK	12044381				2022-12-24	WOS:000175775500014
J	Groisman, I; Jung, MY; Sarkissian, M; Cao, QP; Richter, JD				Groisman, I; Jung, MY; Sarkissian, M; Cao, QP; Richter, JD			Translational control of the embryonic cell cycle	CELL			English	Article							XENOPUS OOCYTE MATURATION; CAP-DEPENDENT TRANSLATION; CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; C-MOS; POLY(A) POLYMERASE; SPECIFICITY FACTOR; PROTEIN-SYNTHESIS; FROG OOCYTES; CPEB	The synthesis and destruction of cyclin B drives mitosis in eukaryotic cells. Cell cycle progression is also regulated at the level of cyclin B translation. In cycling extracts from Xenopus embryos, progression into M phase requires the polyadenylation-induced translation of cyclin B1 mRNA. Polyadenylation is mediated by the phosphorylation of CPEB by Aurora, a kinase whose activity oscillates with the cell cycle. Exit from M phase seems to require deadenylation and subsequent translational silencing of cyclin B1 mRNA by Maskin, a CPEB and eIF4E binding factor, whose expression is cell cycle regulated. These observations suggest that regulated cyclin B1 mRNA translation is essential for the embryonic cell cycle. Mammalian cells also display a cell cycle-dependent cytoplasmic polyadenylation, suggesting that translational control by polyadenylation might be a general feature of mitosis in animal cells.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu		Groisman, Irina/0000-0001-8909-678X; Groisman, Sonia/0000-0003-1153-3841				Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; BALLANTYNE S, 1995, RNA, V1, P64; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; FOX CA, 1990, GENE DEV, V4, P2287, DOI 10.1101/gad.4.12b.2287; GEBAUER F, 1995, MOL CELL BIOL, V15, P3460; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Hinchcliffe EH, 2001, METHOD CELL BIOL, V67, P269; Hodgman R, 2001, DEVELOPMENT, V128, P2815; HUANG YS, 2002, IN PRESS EMBO J; HUNT T, 1992, J CELL BIOL, V116, P707, DOI 10.1083/jcb.116.3.707; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; SHEETS MD, 1995, NATURE, V374, P511, DOI 10.1038/374511a0; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; VARNUM SM, 1990, GENE DEV, V4, P2278, DOI 10.1101/gad.4.12b.2278; Wakiyama M, 2000, CURR BIOL, V10, P1147, DOI 10.1016/S0960-9822(00)00701-6; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zhao WQ, 1996, MOL CELL BIOL, V16, P2378	49	153	157	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2002	109	4					473	483		10.1016/S0092-8674(02)00733-X	http://dx.doi.org/10.1016/S0092-8674(02)00733-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	553VM	12086604	Bronze			2022-12-24	WOS:000175696800009
J	Zamore, PD				Zamore, PD			Ancient pathways programmed by small RNAs	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; GERM-LINE DEVELOPMENT; C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; FUNCTIONAL-ANATOMY; GENE-EXPRESSION; DNA METHYLATION; INTERFERENCE; DROSOPHILA	Double-stranded RNA can now be used in a wide variety of eukaryotes to suppress the expression of virtually any gene, allowing the rapid analysis of that gene's function, a technique known as RNA interference. But how cells use the information in double-stranded RNA to suppress gene expression and why they contain the machinery to do so remain the subjects of intense scrutiny. Current evidence suggests that RNA interference and other "RNA silencing" phenomena reflect an elaborate cellular apparatus that eliminates abundant but defective messenger RNAs and defends against molecular parasites such as transposons and viruses.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Lazare Res Bldg,Room 825,364 Plantat St, Worcester, MA 01605 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; CELOTTO AM, IN PRESS RNA; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dernburg AF, 2000, GENE DEV, V14, P1578; DUDLEY NR, 2002, P NATL ACAD SCI US; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han YH, 2002, PLANT J, V29, P509, DOI 10.1046/j.1365-313x.2002.01236.x; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; LI H, IN PRESS SCIENCE; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; PADDISON PJ, GENES DEV, V16; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Parrish S, 2001, RNA, V7, P1397; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; SCHWARZ DS, IN PRESS GENES DEV; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; SMITH CJS, 1990, MOL GEN GENET, V224, P447; SUI G, IN PRESS P NATL ACAD; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; TABARA H, UNPUB; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	60	260	386	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1265	1269		10.1126/science.1072457	http://dx.doi.org/10.1126/science.1072457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016303				2022-12-24	WOS:000175713000040
J	Kim, JJ; Wright, TC; Goldie, SJ				Kim, JJ; Wright, TC; Goldie, SJ			Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; GENITAL HUMAN-PAPILLOMAVIRUS; THINPREP PAP TEST; NATURAL-HISTORY; PAPANICOLAOU SMEAR; CYTOLOGIC ABNORMALITIES; RISK-FACTORS; YOUNG-WOMEN; GYNECOLOGIC CYTOLOGY	Context Every year approximately 2 million US women are diagnosed as having a cervical cytological result of atypical squamous cells of undetermined significance (ASC-US). Objective To determine the most efficient and cost-effective management strategy for women in the United States diagnosed as having ASC-US. Design and Setting Cost-effectiveness analysis of data from clinical trials, prospective studies, and other published literature. A computer-based model was used to compare 4 management strategies for a cytological result of ASC-US: immediate colposcopy; human papillomavirus (HPV) triage, which includes colposcopy if high-risk HPV types are detected; repeat cytology, which includes follow-up cytology at 6 and 12 months and referral for colposcopy if a repeat abnormal result occurs; and reclassifying ASC-US as normal in which a cytological result of ASC-US is ignored. Reflex HPV DNA testing uses either residual liquid-based cytological specimens or samples co-collected at the time of the initial screening for conventional cytology. Another method, referred to as the 2-visit HPV DNA triage, requires a woman with an ASC-US result to return within 1 month to provide another speciman sample. Main Outcome Measures Years of life saved (YLS), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results The least costly strategy for biennial screening was to reclassify ASC-US as normal, resulting in a reduction in total cancer incidence of 75% for conventional cytology and 84% for liquid-based cytology compared with no screening. The next least costly strategy was HPV DNA testing resulting in a reduction in total cancer incidence of 86% for conventional cytology and 90% for liquid-based cytology, followed by immediate colposcopy with a reduction of 87% and 91%, respectively. Compared with reflex HPV DNA testing, a strategy of repeat cervical cytology or delayed HPV testing costs more but is less effective. When all strategies were compared simultaneously, varying frequency and type of cytological test, biennial (vs every 3 years) liquid-based cytology with reflex HPV testing had a cost of $174200 per YLS. In a similar comparison, liquid-based cytology with reflex HPV testing conducted every 3 years (vs every 5 years) had a cost of $59 600 per YLS and was more effective and less costly than a strategy of conventional cytology incorporating repeat cytology or immediate colposcopy conducted biennially. Conclusion Reflex HPV DNA testing provides the same or greater life expectancy benefits and is more cost-effective than other management strategies for women diagnosed as having ASC-US.	Harvard Univ, Ctr Risk Anal, Dept Hlth Policy & Management, Sch Publ Hlth, Boston, MA 02115 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Goldie, SJ (corresponding author), Harvard Univ, Ctr Risk Anal, Dept Hlth Policy & Management, Sch Publ Hlth, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.							Ashfaq R, 1999, ACTA CYTOL, V43, P81, DOI 10.1159/000330872; Bai HW, 2000, DIAGN CYTOPATHOL, V23, P19, DOI 10.1002/1097-0339(200007)23:1<19::AID-DC4>3.0.CO;2-K; Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; BAUER HM, 1993, SEX TRANSM DIS, V20, P274, DOI 10.1097/00007435-199309000-00007; Bergeron C, 2000, OBSTET GYNECOL, V95, P821, DOI 10.1016/S0029-7844(00)00795-X; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Burk RD, 1996, J INFECT DIS, V174, P679, DOI 10.1093/infdis/174.4.679; Burk RD, 1996, SEX TRANSM DIS, V23, P333, DOI 10.1097/00007435-199607000-00013; COX JT, 2000, J LOW GENIT TRACT DI, V4, P99; CUZICK J, 1999, HEALTH TECHNOL ASSES, V3, P14; Diaz-Rosario LA, 1999, ARCH PATHOL LAB MED, V123, P817; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Fahs MC, 1996, PHARMACOECONOMICS, V9, P211, DOI 10.2165/00019053-199609030-00004; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Ferris DG, 1998, J FAM PRACTICE, V46, P125; Ferris DG, 1998, J FAM PRACTICE, V46, P136; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Franco EL, 1999, AM J OBSTET GYNECOL, V181, P382, DOI 10.1016/S0002-9378(99)70586-7; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Goldie SJ, 2001, AM J MED, V111, P140, DOI 10.1016/S0002-9343(01)00780-X; GOLDIE SJ, 2001, MED DECIS MAKING, V20, P529; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; GUSTAFSSON L, 1992, CANCER CAUSE CONTROL, V3, P125, DOI 10.1007/BF00051652; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Helms LJ, 1999, MED CARE, V37, P652, DOI 10.1097/00005650-199907000-00005; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Ho GYF, 1998, INT J CANCER, V78, P281, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;281::AID-IJC3&gt;3.0.CO;2-R; Hopman EH, 2000, BRIT J OBSTET GYNAEC, V107, P600, DOI 10.1111/j.1471-0528.2000.tb13299.x; Hutchinson ML, 1999, CANCER CYTOPATHOL, V87, P48, DOI 10.1002/(SICI)1097-0142(19990425)87:2&lt;48::AID-CNCR2&gt;3.0.CO;2-D; Jones BA, 2000, ARCH PATHOL LAB MED, V124, P672; Jones BA, 2000, ARCH PATHOL LAB MED, V124, P665; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kotloff KL, 1998, SEX TRANSM DIS, V25, P243, DOI 10.1097/00007435-199805000-00005; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Koutsky LA, 1999, SEXUALLY TRANSMITTED, P347; KUNTZ KM, 2000, MED DECIS MAKING, V20, P484; KURMAN RJ, 1994, JAMA-J AM MED ASSOC, V271, P1866, DOI 10.1001/jama.271.23.1866; Lawson HW, 1998, OBSTET GYNECOL, V92, P745, DOI 10.1016/S0029-7844(98)00257-9; Lin CT, 2000, J REPROD MED, V45, P345; LIU TP, 1995, CANCER EPIDEM BIOMAR, V4, P373; Londesborough P, 1996, INT J CANCER, V69, P364; Lonky NM, 1999, AM J OBSTET GYNECOL, V181, P560, DOI 10.1016/S0002-9378(99)70493-X; Malik SN, 1999, ACTA CYTOL, V43, P376, DOI 10.1159/000331084; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; MCCRORY DC, 1999, AHCPR PUBLICATION; MELKERT PWJ, 1993, INT J CANCER, V53, P919, DOI 10.1002/ijc.2910530609; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Moscicki AB, 1999, PEDIATR CLIN N AM, V46, P783, DOI 10.1016/S0031-3955(05)70152-8; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Mount SL, 1999, PEDIATRICS, V103, P539, DOI 10.1542/peds.103.3.539; MULLER C, 1990, COSTS EFFECTIVENESS; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *NAT CTR HLTH STAT, 2001, STAT ABSTR US; *NCI, 1997, SURV EP END RES SEER; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; PETTERSSON F, 1985, INT J EPIDEMIOL, V14, P521, DOI 10.1093/ije/14.4.521; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; Quddus MR, 2001, CANCER CYTOPATHOL, V93, P16, DOI 10.1002/1097-0142(20010225)93:1<16::AID-CNCR9002>3.0.CO;2-A; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Sawaya GF, 2000, OBSTET GYNECOL, V96, P219, DOI 10.1016/S0029-7844(00)00882-6; SCHIFFMAN MH, 1995, J NATL CANCER I, V87, P1345, DOI 10.1093/jnci/87.18.1345; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Sellors JW, 1999, CAN FAM PHYSICIAN, V45, P245; SELLORS JW, 1999, CAN FAM PHYSICIAN, V45, P252; SherlawJohnson C, 1997, INT J CANCER, V72, P210, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;210::AID-IJC2&gt;3.0.CO;2-U; Sherman ME, 1999, MODERN PATHOL, V12, P335; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; Shlay JC, 2000, OBSTET GYNECOL, V96, P410, DOI 10.1016/S0029-7844(00)00907-8; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; SOLOMON D, 2001, TERMINOLOGY REPORTIN; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; *US BUR LAB STAT, 2001, PUBL US BUR LAB STAT; *US CENS BUR, 2001, POP EST PROGR; Weinstein MC, 1999, ANN INTERN MED, V130, P857, DOI 10.7326/0003-4819-130-10-199905180-00021; Wright TC, 1998, AM J OBSTET GYNECOL, V178, P962, DOI 10.1016/S0002-9378(98)70531-9; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120; WRIGHT TC, 1995, OBSTET GYNECOL, V85, P202, DOI 10.1016/0029-7844(94)00373-L; Wright TC, 1994, BLAUSTEINS PATHOLOGY, P229; 2001, NATL PHYSICIAN FEE S; 1994, MMWR MORB MORTAL WKL, V43, P530; 2001, 2001 CLIN DIAGNOSTIC	93	205	215	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2002	287	18					2382	2390		10.1001/jama.287.18.2382	http://dx.doi.org/10.1001/jama.287.18.2382			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548PF	11988059	Bronze			2022-12-24	WOS:000175397000027
J	Gibbons, RJ				Gibbons, RJ			Abnormal heart-rate recovery after exercise	LANCET			English	Editorial Material							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; TREADMILL EXERCISE; MORTALITY; PREDICTORS		Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Gibbons, RJ (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.							Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Desai MY, 2001, AM J CARDIOL, V87, P1164, DOI 10.1016/S0002-9149(01)01487-4; Diaz LA, 2001, J AM COLL CARDIOL, V37, P1558, DOI 10.1016/S0735-1097(01)01205-0; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Krone RJ, 2001, J AM COLL CARDIOL, V38, P136, DOI 10.1016/S0735-1097(01)01312-2; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	11	47	51	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 4	2002	359	9317					1536	1537		10.1016/S0140-6736(02)08525-2	http://dx.doi.org/10.1016/S0140-6736(02)08525-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047958				2022-12-24	WOS:000175460700002
J	Smith, GD; Gunthorpe, J; Kelsell, RE; Hayes, PD; Reilly, P; Facer, P; Wright, JE; Jerman, JC; Walhin, JP; Ooi, L; Egerton, J; Charles, KJ; Smart, D; Randall, AD; Anand, P; Davis, JB				Smith, GD; Gunthorpe, J; Kelsell, RE; Hayes, PD; Reilly, P; Facer, P; Wright, JE; Jerman, JC; Walhin, JP; Ooi, L; Egerton, J; Charles, KJ; Smart, D; Randall, AD; Anand, P; Davis, JB			TRPV3 is a temperature-sensitive vanilloid receptor-like protein	NATURE			English	Article							CAPSAICIN-RECEPTOR; SENSORY NEURONS; NOXIOUS HEAT; CHANNELS; GENE; IDENTIFICATION; EXPRESSION; RESPONSES; SUBUNITS; AGONIST	Vanilloid receptor-1 (VR1, also known as TRPV1) is a thermosensitive, nonselective cation channel that is expressed by capsaicin-sensitive sensory afferents and is activated by noxious heat, acidic pH and the alkaloid irritant capsaicin(1). Although VR1 gene disruption results in a loss of capsaicin responses, it has minimal effects on thermal nociception(2,3). This and other experiments-such as those showing the existence of capsaicin-insensitive heat sensors in sensory neurons(4)-suggest the existence of thermosensitive receptors distinct from VR1. Here we identify a member of the vanilloid receptor/TRP gene family, vanilloid receptor-like protein 3 (VRL3, also known as TRPV3), which is heat-sensitive but capsaicin-insensitive. VRL3 is coded for by a 2,370-base-pair open reading frame, transcribed from a gene adjacent to VR1, and is structurally homologous to VR1. VRL3 responds to noxious heat with a threshold of about 39 degreesC and is co-expressed in dorsal root ganglion neurons with VR1. Furthermore, when heterologously expressed, VRL3 is able to associate with VR1 and may modulate its responses. Hence, not only is VRL3 a thermosensitive ion channel but it may represent an additional vanilloid receptor subunit involved in the formation of heteromeric vanilloid receptor channels.	GlaxoSmithKline, Neurol CEDD, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Genet Res, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Discovery Res, Harlow CM19 5AW, Essex, England; Hammersmith Hosp, Imperial Coll, Peripheral Neuropathy Unit, London W12 0NN, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Imperial College London	Davis, JB (corresponding author), GlaxoSmithKline, Neurol CEDD, 3rd ave, Harlow CM19 5AW, Essex, England.			Ooi, Lezanne/0000-0001-9241-8268; Randall, Andrew/0000-0001-8852-3671				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Coward K, 2000, PAIN, V85, P41, DOI 10.1016/S0304-3959(99)00251-1; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Dempster J., 1993, COMPUTER ANAL ELECTR; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu M, 2001, J PHARMACOL EXP THER, V296, P1043; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Muller D, 2000, GENOMICS, V67, P48, DOI 10.1006/geno.2000.6203; Muller D, 2000, BIOCHEM BIOPH RES CO, V275, P47, DOI 10.1006/bbrc.2000.3227; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 2001, GENOMICS, V76, P99, DOI 10.1006/geno.2001.6606; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; [No title captured]	28	589	639	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					186	190		10.1038/nature00894	http://dx.doi.org/10.1038/nature00894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12077606				2022-12-24	WOS:000176710400041
J	Amornwichet, P; Teeraratkul, A; Simonds, RJ; Naiwatanakul, T; Chantharojwong, N; Culnane, M; Tappero, JW; Kanshana, S				Amornwichet, P; Teeraratkul, A; Simonds, RJ; Naiwatanakul, T; Chantharojwong, N; Culnane, M; Tappero, JW; Kanshana, S			Preventing mother-to-child HIV transmission - The first year of Thailand's national program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHORT-COURSE ZIDOVUDINE; TRIAL; REGIMENS	Context Each year in Thailand, about 10000 children are born at risk for mother-to-child human immunodeficiency virus (HIV) transmission. In 2000, Thailand implemented a national program to prevent mother-to-child HIV transmission. Objective To describe the results of implementation of the program. Design Monthly collection of summary data from hospitals. Setting Public health hospitals (n=822) in all 12 regions of Thailand, representing .75 provinces, excluding Bangkok. Participants Women giving birth from October 2000 through September 2001, including HIV-seropositive women and their neonates. Main Outcome Measures Percentages of women giving birth who were tested for HIV, HIV-seropositive women giving birth who received antenatal prophylactic antiretroviral drugs, and HIV-exposed neonates who received prophylactic antiretroviral drugs and infant formula. Results Among 573 655 women (range, 27344-77806 by region) giving birth, 554 912 (96.7%) received antenatal care (range, 91.9%-98.8% by region). Of 554912 women giving birth who had antenatal care, 517488 (93.3%) were tested for HIV (range, 87.7%-99.4% by region) before giving birth; of 18743 women giving birth who did not have antenatal care, 13314 (71.0%) were tested for HIV (range, 21.7%-92.9% by region). Of 6646 HIV-seropositive women giving birth, 4659 (70.1%) received prophylactic antiretroviral drugs before delivery (range, 55.3%-81.2% by region). Of 6475 neonates of HIV-seropositive women, 5741 (88.7%) received prophylactic antireiroviral, drugs (range, 67.4%-96.9% by region) and 5386 (83.2%) received infant formula (range, 65.3%-100% by-region). Conclusions Major program components of Thailand's national program for preventing mother-to-child HIV transmission were implemented. Thailand's experience may encourage other developing countries to implement or expand similar national programs.	Minist Publ Hlth, Dept Hlth, Nonthaburi 11000, Thailand; Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Nonthaburi, Thailand; Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Amornwichet, P (corresponding author), Minist Publ Hlth, Dept Hlth, Tivanon Rd, Nonthaburi 11000, Thailand.			Culnane, Mary/0000-0003-2070-4454				[Anonymous], PROJ HIV AIDS THAIL; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P599; Dean AG, 1995, EPI INFO VERSION 6; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Kanshana S, 2000, AIDS, V14, P1617, DOI 10.1097/00002030-200007280-00018; Kanshana S, 2002, AIDS, V16, P953, DOI 10.1097/00002030-200205030-00001; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; *MIN PUBL HLTH THA, 2000, NAT GUID CLIN MAN HI; NOLAN M, 2001, 3 C GLOB STRAT PREV; ROONGPISUTHIPON.A, 2001, 3 C GLOB STRAT PREV; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; TANGCHAROENSATH.V, 2001, 8 NAT AIDS SEM JUL 1; THAINEUA V, 2000, 13 INT AIDS C JUL 9; Thaineua Vallop, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P429; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; *WHO MIN PUBL HLTH, 2001, EV VOL COUNS TEST NA	16	34	42	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2002	288	2					245	248		10.1001/jama.288.2.245	http://dx.doi.org/10.1001/jama.288.2.245			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	571HC	12095391				2022-12-24	WOS:000176711100027
J	Miller, KD; Masur, H; Jones, EC; Joe, GO; Rick, ME; Kelly, GG; Mican, JM; Liu, SY; Gerber, LH; Blackwelder, WC; Falloon, J; Davey, RT; Polis, MA; Walker, RE; Lane, HC; Kovacs, JA				Miller, KD; Masur, H; Jones, EC; Joe, GO; Rick, ME; Kelly, GG; Mican, JM; Liu, SY; Gerber, LH; Blackwelder, WC; Falloon, J; Davey, RT; Polis, MA; Walker, RE; Lane, HC; Kovacs, JA			High prevalence of osteonecrosis of the femoral head in HIV-infected adults	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AVASCULAR NECROSIS; VENOUS THROMBOSIS; ANTIPHOSPHOLIPID ANTIBODIES; RENAL-TRANSPLANTATION; ARTERIAL-DISEASE; RISK-FACTORS; BONE	Background: osteonecrosis has been reported to occur occasionally among HIV-infected patients. The diagnosis of symptomatic osteonecrosis of the hip in two of the authors' patients, together with reports from community physicians, raised a concern that the prevalence of osteonecrosis is increasing. Objective: To determine the prevalence of osteonecrosis of the hip in asymptomatic HIV-infected patients and to identify potential risk factors associated with osteonecrosis. Design: Survey and comparison study. Setting: The Clinical Center of the U.S. National Institutes of Health. Participants: 339 asymptomatic HIV-infected adults (of 364 asked to participate) and 118 age- and sex-matched HIV-negative volunteers enrolled between 1 June and 15 December 1999. Measurements: Osteonecrosis of the hip, as documented by magnetic resonance imaging. Data from clinic records and a patient questionnaire administered before magnetic resonance imaging were used in an analysis of risk factors. A subset of patients was evaluated for hypercoagulable state. Results: Fifteen (4.4% [95% Cl, 2.5% to 7.2%]) of 339 HIV-infected participants had osteonecrosis lesions on magnetic resonance imaging, and no HIV-negative participants had similar lesions. Among HIV-infected participants, osteonecrosis occurred more frequently in those who used systemic corticosteroids, lipid-lowering agents, or testosterone; those who exercised routinely by bodybuilding; and those who had detectable levels of anticardiolipin antibodies. Conclusions: Patients infected with HIV have an unexpectedly high occurrence of osteonecrosis of the hip. Although screening a-symptomatic patients is not warranted, HIV-infected patients with persistent groin or hip pain should be evaluated for this debilitating complication.	NIH, Ctr Clin, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kovacs, JA (corresponding author), NIH, Ctr Clin, Bldg 10,room 7D43,MSC1662, Bethesda, MD 20892 USA.	jkovacs@niaid.nih.gov	Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880; Polis, Michael/0000-0002-9151-2268; Gerber, Lynn/0000-0001-7525-680X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000865, ZIAAI000390, Z01AI000636, Z01AI000866, ZIAAI000636, ZIAAI000865, Z01AI000390] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL001159, Z01CL001159] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER		Arruda VR, 1997, THROMB HAEMOSTASIS, V78, P1430; Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818; BELMONTE MA, 1993, J RHEUMATOL, V20, P1425; Blacksin MF, 1999, CLIN IMAG, V23, P314, DOI 10.1016/S0899-7071(99)00151-5; Blangy H, 2000, AIDS, V14, P2214, DOI 10.1097/00002030-200009290-00025; Bonfanti P, 2001, ORTHOPEDICS, V24, P271; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; CHANG CC, 1993, SEMIN ARTHRITIS RHEU, V23, P47, DOI 10.1016/S0049-0172(05)80026-5; CHEVALIER X, 1993, J BONE JOINT SURG BR, V75, P160, DOI 10.1302/0301-620X.75B1.8421018; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; Colwell CW, 1996, ORTHOPEDICS, V19, P941; CONE LA, 1996, 3 C RETR OPP INF 28; DETRUCHIS P, 1996, 11 INT C AIDS VANC B; Finazzi G, 1996, AM J MED, V100, P530, DOI 10.1016/S0002-9343(96)00060-5; Fink B, 1997, ARCH ORTHOP TRAUM SU, V116, P151, DOI 10.1007/BF00426064; FORDYCE MJF, 1993, J BONE JOINT SURG BR, V75, P365, DOI 10.1302/0301-620X.75B3.8496201; GALLANT JE, 1999, AIDS READ, V9, P602; GART JJ, 1988, BIOMETRICS, V44, P323, DOI 10.2307/2531848; GERSTER JC, 1991, J RHEUMATOL, V18, P300; Glueck CJ, 1997, CLIN ORTHOP RELAT R, P43; GONZALEZ LM, 1994, AN MED INTERNA, V11, P601; GOORNEY BP, 1990, GENITOURIN MED, V66, P451; GUERRA JJ, 1995, J BONE JOINT SURG AM, V77A, P616, DOI 10.2106/00004623-199504000-00017; Johns DG, 1999, AIDS, V13, P1997, DOI 10.1097/00002030-199910010-00036; Koeger AC, 1999, J RHEUMATOL, V26, P752; Koeger Anne Claude, 1995, Arthritis and Rheumatism, V38, pS199; Koller E, 2000, AIDS PATIENT CARE ST, V14, P405, DOI 10.1089/108729100416614; LAFFORGUE P, 1993, RADIOLOGY, V187, P199, DOI 10.1148/radiology.187.1.8451413; Llauger J, 1998, AM J ROENTGENOL, V171, P987, DOI 10.2214/ajr.171.4.9762981; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; MARTINCRESPO R, 1992, 8 INT AIDS C AMST NE; MEHTA C, 1999, STATXACT 4 WINDOWS U; Meyer D, 1999, AIDS, V13, P1147, DOI 10.1097/00002030-199906180-00025; Mirzai R, 1999, J ASTHMA, V36, P77, DOI 10.3109/02770909909065152; Mirzai Ray, 1998, Comprehensive Therapy, V24, P251; MITCHELL DG, 1987, RADIOLOGY, V162, P709, DOI 10.1148/radiology.162.3.3809484; Monier P, 2000, CLIN INFECT DIS, V31, P1488, DOI 10.1086/317503; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mont MA, 1997, J RHEUMATOL, V24, P654; Olive A, 1998, J RHEUMATOL, V25, P1243; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PATTON PR, 1988, SURGERY, V103, P63; Rademaker J, 1997, J RHEUMATOL, V24, P601; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; Roudiere L, 2000, AIDS, V14, P2056, DOI 10.1097/00002030-200009080-00026; Sakamoto M, 1997, J BONE JOINT SURG BR, V79B, P213, DOI 10.1302/0301-620X.79B2.7179; Scribner AN, 2000, J ACQ IMMUN DEF SYND, V25, P19, DOI 10.1097/00126334-200009010-00003; Sighinolfi L, 2000, INFECTION, V28, P254, DOI 10.1007/s150100070049; SOLOMON G, 1991, RHEUM DIS CLIN N AM, V17, P43; Stovall D Jr, 1995, Am J Orthop (Belle Mead NJ), V24, P71; SUGANO N, 1994, CLIN ORTHOP RELAT R, P190; Sugano N, 1999, J BONE JOINT SURG BR, V81B, P590, DOI 10.1302/0301-620X.81B4.9393; TERVONEN O, 1992, RADIOLOGY, V182, P845, DOI 10.1148/radiology.182.3.1535906; TIMPONE J, 1999, 6 C RETR OPP INF CHI; Vande Berg B C, 1997, J Belge Radiol, V80, P243; Varis T, 2000, CLIN PHARMACOL THER, V68, P487, DOI 10.1067/mcp.2000.110772; YOUNG JL, 1996, PHYSICAL MED REHABIL, P783	58	138	151	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2002	137	1					17	24		10.7326/0003-4819-137-1-200207020-00008	http://dx.doi.org/10.7326/0003-4819-137-1-200207020-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569VA	12093241				2022-12-24	WOS:000176622000003
J	Constancia, M; Hemberger, M; Hughes, J; Dean, W; Ferguson-Smith, A; Fundele, R; Stewart, F; Kelsey, G; Fowden, A; Sibley, C; Reik, W				Constancia, M; Hemberger, M; Hughes, J; Dean, W; Ferguson-Smith, A; Fundele, R; Stewart, F; Kelsey, G; Fowden, A; Sibley, C; Reik, W			Placental-specific IGF-II is a major modulator of placental and fetal growth	NATURE			English	Article							MAMMALIAN DEVELOPMENT; MATERNAL-BEHAVIOR; POSTNATAL-GROWTH; MOUSE; GENE; H19; TRANSLATION; GESTATION; DELETION; REGION	Imprinted genes in mammals are expressed from only one of the parental chromosomes, and are crucial for placental development and fetal growth(1-4). The insulin-like growth factor II gene (Igf2) is paternally expressed in the fetus and placenta(5). Here we show that deletion from the Igf2 gene of a transcript (P0)(6,7) specifically expressed in the labyrinthine trophoblast of the placenta leads to reduced growth of the placenta, followed several days later by fetal growth restriction. The fetal to placental weight ratio is thus increased in the absence of the P0 transcript. We show that passive permeability for nutrients of the mutant placenta is decreased, but that secondary active placental amino acid transport is initially upregulated, compensating for the decrease in passive permeability. Later the compensation fails and fetal growth restriction ensues. Our study provides experimental evidence for imprinted gene action in the placenta that directly controls the supply of maternal nutrients to the fetus, and supports the genetic conflict theory of imprinting(8). We propose that the Igf2 gene, and perhaps other imprinted genes, control both the placental supply of, and the genetic demand for, maternal nutrients to the mammalian fetus.	Babraham Inst, Dev Genet Programme, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Calgary; University of Cambridge; Max Planck Society	Constancia, M (corresponding author), Babraham Inst, Dev Genet Programme, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England.		Reik, Wolf/I-6794-2012; Constancia, Miguel/F-6654-2013; Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894; Reik, Wolf/0000-0003-0216-9881; Hemberger, Myriam/0000-0003-3332-6958; Kelsey, Gavin/0000-0002-9762-5634; Constancia, Miguel/0000-0002-8976-1679; Dean, Wendy/0000-0001-9441-5044				Adam GIR, 1996, DEVELOPMENT, V122, P839; ATKINSON DE, 1991, AM J PHYSIOL, V261, pR1461, DOI 10.1152/ajpregu.1991.261.6.R1461; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Burns JL, 2001, DEVELOPMENT, V128, P3819; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Cramer S, 2002, AM J PHYSIOL-CELL PH, V282, pC153, DOI 10.1152/ajpcell.2002.282.1.C153; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Gardner RL, 1999, BIOL REPROD, V60, P190, DOI 10.1095/biolreprod60.1.190; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; Godfrey K M, 2001, Public Health Nutr, V4, P611; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HILL DJ, 1990, EARLY HUM DEV, V21, P49, DOI 10.1016/0378-3782(90)90110-5; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; NEWELL S, 1994, MOL REPROD DEV, V39, P249, DOI 10.1002/mrd.1080390302; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NOVART FDN SYMP, V237, P19, DOI 10.1002/0470846666.ch3; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0	30	756	796	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2002	417	6892					945	948		10.1038/nature00819	http://dx.doi.org/10.1038/nature00819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087403				2022-12-24	WOS:000176441200038
J	Malliri, A; van der Kammen, RA; Clark, K; van der Valk, M; Michiels, F; Collard, JG				Malliri, A; van der Kammen, RA; Clark, K; van der Valk, M; Michiels, F; Collard, JG			Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours	NATURE			English	Article							CELL-CELL ADHESION; RHO GTPASES; MOUSE SKIN; EPITHELIAL-CELLS; IN-VIVO; INVASION; CARCINOGENESIS; PROGRESSION; CARCINOMA; PROTEINS	Proteins of the Rho family control signalling pathways that regulate the actin cytoskeleton and gene transcription(1,2). In vitro studies have implicated Rho-like GTP-hydrolysing enzymes (GTPases) in cell migration(3-5), cell-cycle progression(6,7), and Ras-induced focus formation 8,9, suggesting a role for these GTPases in the formation and progression of tumours in vivo. To study this, we have generated mice lacking the Rac-specific activator Tiam1(10-12), a T-lymphoma invasion and metastasis inducing protein. Here we show that such Tiam1(-/-) mice are resistant to the development of Ras-induced skin tumours initiated with 7,12-dimethylbenzanthracene and promoted with 12-O-tetradecanoylphorbol-13-acetate. Moreover, the few tumours produced in Tiam1(-/-) mice grew much slower than did tumours in wild-type mice. Tiam1-deficient primary embryonic fibroblasts were also resistant to Ras(V12)-induced focus formation. Analysis of Tiam1 heterozygotes indicated that both tumour initiation and promotion were dependent on the Tiam1 gene dose. Tiam1 deficiency was associated with increased apoptosis during initiation, and with impeded proliferation during promotion. Although the number of tumours in Tiam1(-/-) mice was small, a greater proportion progressed to malignancy, suggesting that Tiam1 deficiency promotes malignant conversion. Our studies identify the Rac activator Tiam1 as a critical regulator of different aspects of Ras-induced tumour formation.	Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Collard, JG (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.collard@nki.nl		Malliri, Angeliki/0000-0001-6848-090X				Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; BUCHMANN A, 1991, CANCER RES, V51, P4097; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Frame S, 2000, CURR OPIN GENET DEV, V10, P106, DOI 10.1016/S0959-437X(99)00052-0; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	29	285	307	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					867	871		10.1038/nature00848	http://dx.doi.org/10.1038/nature00848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12075356				2022-12-24	WOS:000176285600051
J	Parkinson, GN; Lee, MPH; Neidle, S				Parkinson, GN; Lee, MPH; Neidle, S			Crystal structure of parallel quadruplexes from human telomeric DNA	NATURE			English	Article							ANGSTROM RESOLUTION; G-QUARTETS; OLIGONUCLEOTIDES; DERIVATIVES; MECHANISMS; INHIBITION; TETRAPLEX; COMPLEX; TARGET; DESIGN	Telomeric ends of chromosomes, which comprise noncoding repeat sequences of guanine-rich DNA, are fundamental in protecting the cell from recombination and degradation(1). Disruption of telomere maintenance leads to eventual cell death, which can be exploited for therapeutic intervention in cancer. Telomeric DNA sequences can form four-stranded (quadruplex) structures(2-4), which may be involved in the structure of telomere ends(5). Here we describe the crystal structure of a quadruplex formed from four consecutive human telomeric DNA repeats and grown at a K+ concentration that approximates its intracellular concentration. K+ ions are observed in the structure. The folding and appearance of the DNA in this intramolecular quadruplex is fundamentally different from the published Na+-containing quadruplex structures(2,4,6). All four DNA strands are parallel, with the three linking trinucleotide loops positioned on the exterior of the quadruplex core, in a propeller-like arrangement. The adenine in each TTA linking trinucleotide loop is swung back so that it intercalates between the two thymines. This DNA structure suggests a straightforward path for telomere folding and unfolding, as well as ways in which it can recognize telomere-associated proteins.	Inst Canc Res, Chester Beatty Labs, Canc Res UK Biomol Struct Unit, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Neidle, S (corresponding author), Inst Canc Res, Chester Beatty Labs, Canc Res UK Biomol Struct Unit, 237 Fulham Rd, London SW3 6JB, England.							BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Bearss DJ, 2000, ONCOGENE, V19, P6632, DOI 10.1038/sj.onc.1204092; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175; Fedoroff OY, 1998, BIOCHEMISTRY-US, V37, P12367, DOI 10.1021/bi981330n; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Han HY, 1999, BIOCHEMISTRY-US, V38, P6981, DOI 10.1021/bi9905922; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Harrison RJ, 1999, BIOORG MED CHEM LETT, V9, P2463, DOI 10.1016/S0960-894X(99)00394-7; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Koeppel F, 2001, NUCLEIC ACIDS RES, V29, P1087, DOI 10.1093/nar/29.5.1087; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292; Read M, 2001, P NATL ACAD SCI USA, V98, P4844, DOI 10.1073/pnas.081560598; Read MA, 1999, J MED CHEM, V42, P4538, DOI 10.1021/jm990287e; Read MA, 2000, BIOCHEMISTRY-US, V39, P13422, DOI 10.1021/bi001584k; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; SMITH FW, 1995, STRUCTURE, V3, P997, DOI 10.1016/S0969-2126(01)00236-2; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; WANG Y, 1992, BIOCHEMISTRY-US, V31, P8112, DOI 10.1021/bi00150a002; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801	29	1667	1693	6	355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2002	417	6891					876	880		10.1038/nature755	http://dx.doi.org/10.1038/nature755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563YM	12050675				2022-12-24	WOS:000176285600053
J	Adam, A; Cugno, M; Molinaro, G; Perez, M; Lepage, Y; Agostoni, A				Adam, A; Cugno, M; Molinaro, G; Perez, M; Lepage, Y; Agostoni, A			Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors	LANCET			English	Article							CONVERTING ENZYME-INHIBITOR; BRADYKININ; PLASMA	Anglo-oedema Is a rare but potentially life threatening side-effect of angiotensin-converting-enzyme (ACE) inhibitor treatment. Identification of individuals at risk of this adverse effect is not possible. Anglo-oedema is associated with raised concentrations of bradykinin, which is mainly inactivated by ACE. We assessed the plasma activity of two other enzymes that catabolise bradykinin (aminopeptidase P and carboxypeptidase N) in 39 hypertensive patients with a history of angio-oedema during ACE inhibitor treatment and In 39 hypertensive patients who had never had ACE inhibitor associated side-effects. Patients with previous angio-oedema had a lower plasma activity of aminopeptidase P than did those who never presented with angio-oedema (p=0.003). Our data suggest that low plasma concentrations of aminopeptidase P could be a predisposing factor for development of angio-oedema in patients treated with ACE inhibitors.	Univ Montreal, Dept Math & Stat, Fac Pharm, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Math & Stat, Fac Arts & Sci, Montreal, PQ H3C 3J7, Canada; Univ Milan, Dept Internal Med, Milan, Italy	Universite de Montreal; Universite de Montreal; University of Milan	Adam, A (corresponding author), Univ Montreal, Dept Math & Stat, Fac Pharm, Montreal, PQ H3C 3J7, Canada.		Cugno, Massimo/K-8106-2016	Cugno, Massimo/0000-0002-9918-0763				Agostoni A, 2001, DRUG SAFETY, V24, P599, DOI 10.2165/00002018-200124080-00004; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Kim KS, 2000, J PHARMACOL EXP THER, V292, P295; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; Sigler C, 1997, ARCH DERMATOL, V133, P972, DOI 10.1001/archderm.133.8.972	5	138	142	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 15	2002	359	9323					2088	2089		10.1016/S0140-6736(02)08914-6	http://dx.doi.org/10.1016/S0140-6736(02)08914-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562JX	12086766				2022-12-24	WOS:000176194600014
J	Blum, JD; Klaue, A; Nezat, CA; Driscoll, CT; Johnson, CE; Siccama, TG; Eagar, C; Fahey, TJ; Likens, GE				Blum, JD; Klaue, A; Nezat, CA; Driscoll, CT; Johnson, CE; Siccama, TG; Eagar, C; Fahey, TJ; Likens, GE			Mycorrhizal weathering of apatite as an important calcium source in base-poor forest ecosystems	NATURE			English	Article							UNITED-STATES; SR-87/SR-86 RATIOS; ACIDIC DEPOSITION; SUGAR MAPLE; STRONTIUM; DEPLETION; INPUTS; RATES	The depletion of calcium in forest ecosystems of the northeastern USA(1-3) is thought to be a consequence of acidic deposition and to be at present restricting the recovery of forest and aquatic systems(4-7) now that acidic deposition itself is declining. This depletion of calcium has been inferred from studies(1-3) showing that sources of calcium in forest ecosystems-namely, atmospheric deposition and mineral weathering of silicate rocks such as plagioclase, a calcium-sodium silicate-do not match calcium outputs observed in forest streams. It is therefore thought that calcium is being lost from exchangeable and organically bound calcium in forest soils. Here we investigate the sources of calcium in the Hubbard Brook experimental forest, through analysis of calcium and strontium abundances and strontium isotope ratios within various soil, vegetation and hydrological pools. We show that the dissolution of apatite (calcium phosphate) represents a source of calcium that is comparable in size to known inputs from atmospheric sources and silicate weathering. Moreover, apatite-derived calcium was utilized largely by ectomycorrhizal tree species, suggesting that mycorrhizae may weather apatite and absorb the released ions directly, without the ions entering the exchangeable soil pool. Therefore, it seems that apatite weathering can compensate for some of the calcium lost from base-poor ecosystems, and should be considered when estimating soil acidification impacts and calcium cycling.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; US Forest Serv, NE Res Stn, USDA, Durham, NH 03824 USA; Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA	University of Michigan System; University of Michigan; Syracuse University; Yale University; United States Department of Agriculture (USDA); United States Forest Service; Cornell University; Cary Institute of Ecosystem Studies	Blum, JD (corresponding author), Univ Michigan, Dept Geol Sci, 425 E Univ Ave, Ann Arbor, MI 48109 USA.	jdblum@umich.edu	Driscoll, Charles/F-9832-2014; Johnson, Chris E/A-6979-2011	Driscoll, Charles/0000-0003-2692-2890; Johnson, Chris E/0000-0001-9079-813X; Nezat, Carmen/0000-0002-0432-4163				ABERG G, 1989, J HYDROL, V109, P65, DOI 10.1016/0022-1694(89)90007-3; Bailey SW, 1996, WATER RESOUR RES, V32, P707, DOI 10.1029/95WR03642; BAILEY SW, UNPUB ECOLOGY; BLUM AE, 1995, CHEM WEATHERING RATE, V31, P291; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; BRANTLEY SL, 1995, CHEM WEATHERING RATE, P119; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; CREASER RA, 1992, GEOCHIM COSMOCHIM AC, V56, P2789, DOI 10.1016/0016-7037(92)90359-Q; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; FEDERER CA, 1989, ENVIRON MANAGE, V13, P593, DOI 10.1007/BF01874965; Hogan JF, 2000, WATER RESOUR RES, V36, P3701, DOI 10.1029/2000WR900233; Huntington TG, 2000, GLOBAL BIOGEOCHEM CY, V14, P623, DOI 10.1029/1999GB001193; Johnson CE, 1998, SOIL SCI SOC AM J, V62, P782, DOI 10.2136/sssaj1998.03615995006200030035x; Johnson CE, 2000, ECOSYSTEMS, V3, P159, DOI 10.1007/s100210000017; Jones E. V., 1998, CHEM GEOL, V15, P215; KISTLER RW, 1986, CONTRIB MINERAL PETR, V94, P205, DOI 10.1007/BF00592937; Lawrence GB, 1999, ECOL APPL, V9, P1059, DOI 10.1890/1051-0761(1999)009[1059:SCSATR]2.0.CO;2; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; Likens GE, 1998, BIOGEOCHEMISTRY, V41, P89, DOI 10.1023/A:1005984620681; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Long RP, 1997, CAN J FOREST RES, V27, P1560, DOI 10.1139/cjfr-27-10-1560; MILLER EK, 1993, NATURE, V362, P438, DOI 10.1038/362438a0; Poszwa A, 2000, PLANT SOIL, V225, P299, DOI 10.1023/A:1026570812307; RUNIA LT, 1987, J ARCHAEOL SCI, V14, P599, DOI 10.1016/0305-4403(87)90078-1; van Breemen N, 2000, BIOGEOCHEMISTRY, V49, P53, DOI 10.1023/A:1006256231670; Vitousek PM, 1999, OECOLOGIA, V121, P255, DOI 10.1007/s004420050927; Wallander H, 2000, PLANT SOIL, V218, P249, DOI 10.1023/A:1014936217105; WALLANDER H, 2002, FEMS MICROBIOL ECOL, V1320, P1; YANAI RD, 1992, BIOGEOCHEMISTRY, V17, P1, DOI 10.1007/BF00002757; YAWNEY WJ, 1990, NEW PHYTOL, V114, P47, DOI 10.1111/j.1469-8137.1990.tb00372.x	30	287	295	5	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					729	731		10.1038/nature00793	http://dx.doi.org/10.1038/nature00793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066181	Green Published			2022-12-24	WOS:000176154700041
J	Skalen, K; Gustafsson, M; Rydberg, EK; Hulten, LM; Wiklund, O; Innerarity, TL; Boren, J				Skalen, K; Gustafsson, M; Rydberg, EK; Hulten, LM; Wiklund, O; Innerarity, TL; Boren, J			Subendothelial retention of atherogenic lipoproteins in early atherosclerosis	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; ARTERIAL PROTEOGLYCANS; RECEPTOR-BINDING; APOLIPOPROTEIN-B; CELL BIOLOGY; IDENTIFICATION; MACROPHAGES; MICE; OXIDATION; APO-B100	Complications of atherosclerosis are the most common cause of death in Western societies(1). Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors(2). However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis(3). The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins(4). The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans(5). Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.	Gothenburg Univ, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden; Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA	University of Gothenburg; University of California System; University of California San Francisco; The J David Gladstone Institutes	Boren, J (corresponding author), Gothenburg Univ, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden.							BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; BRISSETTE L, 1986, J BIOL CHEM, V261, P1631; CAMEJO G, 1988, ARTERIOSCLEROSIS, V8, P368, DOI 10.1161/01.ATV.8.4.368; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDMAN MH, 1998, ADV TISSUE BANKING, V2, P273; HIROSE N, 1987, BIOCHEMISTRY-US, V26, P5505, DOI 10.1021/bi00391a044; HURTCAMEJO E, 1992, ARTERIOSCLER THROMB, V12, P569, DOI 10.1161/01.ATV.12.5.569; Ji ZS, 1998, J BIOL CHEM, V273, P13452, DOI 10.1074/jbc.273.22.13452; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; PUHL H, 1994, METHOD ENZYMOL, V233, P425; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Schwenke DC, 1997, ARTERIOSCL THROM VAS, V17, P2150, DOI 10.1161/01.ATV.17.10.2150; SIMIONESCU M, 1991, CELL BIOL REV, V25, P5; SRINIVASAN SR, 1986, ATHEROSCLEROSIS, V62, P201, DOI 10.1016/0021-9150(86)90094-8; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; YAO ZM, 1992, J BIOL CHEM, V267, P1175	28	649	698	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2002	417	6890					750	754		10.1038/nature00804	http://dx.doi.org/10.1038/nature00804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066187				2022-12-24	WOS:000176154700047
J	O'Dowd, CD; Jimenez, JL; Bahreini, R; Flagan, RC; Seinfeld, JH; Hameri, K; Pirjola, L; Kulmala, M; Jennings, SG; Hoffmann, T				O'Dowd, CD; Jimenez, JL; Bahreini, R; Flagan, RC; Seinfeld, JH; Hameri, K; Pirjola, L; Kulmala, M; Jennings, SG; Hoffmann, T			Marine aerosol formation from biogenic iodine emissions	NATURE			English	Article							BOUNDARY-LAYER; ATMOSPHERIC PARTICLES; SIZE; MACROALGAE; NUCLEATION; CHEMISTRY; CLIMATE; RELEASE; BROMINE	The formation of marine aerosols and cloud condensation nuclei-from which marine clouds originate-depends ultimately on the availability of new, nanometre-scale particles in the marine boundary layer. Because marine aerosols and clouds scatter incoming radiation and contribute a cooling effect to the Earth's radiation budget(1), new particle production is important in climate regulation. It has been suggested that sulphuric acid-derived from the oxidation of dimethyl sulphide-is responsible for the production of marine aerosols and cloud condensation nuclei. It was accordingly proposed that algae producing dimethyl sulphide play a role in climate regulation 2, but this has been difficult to prove and, consequently, the processes controlling marine particle formation remains largely undetermined(3,4). Here, using smog chamber experiments under coastal atmospheric conditions, we demonstrate that new particles can form from condensable iodine-containing vapours, which are the photolysis products of biogenic iodocarbons emitted from marine algae. Moreover, we illustrate, using aerosol formation models, that concentrations of condensable iodine-containing vapours over the open ocean are sufficient to influence marine particle formation. We suggest therefore that marine iodocarbon emissions have a potentially significant effect on global radiative forcing.	Natl Univ Ireland Univ Coll Galway, Dept Phys, Galway, Ireland; Univ Helsinki, Dept Phys Sci, Div Atmospher Sci, FIN-00014 Helsinki, Finland; CALTECH, Dept Environm Sci & Engn, Pasadena, CA 91125 USA; CALTECH, Dept Chem Engn, Pasadena, CA 91125 USA; Finnish Inst Occupat Hlth, FIN-00250 Helsinki, Finland; Helsinki Polytech Technol, PL 4020, FIN-00099 Helsinki, Finland; Inst Spectrochem & Appl Spect, D-44139 Dortmund, Germany	Ollscoil na Gaillimhe-University of Galway; University of Helsinki; California Institute of Technology; California Institute of Technology; Finnish Institute of Occupational Health	O'Dowd, CD (corresponding author), Natl Univ Ireland Univ Coll Galway, Dept Phys, Galway, Ireland.	colin.odowd@cmas.demon.co.uk	O'Dowd, Colin D/K-8904-2012; Jimenez, Jose L/A-5294-2008; Kulmala, Markku T/I-7671-2016; Hoffmann, Thorsten/A-7490-2012	O'Dowd, Colin D/0000-0002-3068-2212; Jimenez, Jose L/0000-0001-6203-1847; Kulmala, Markku T/0000-0003-3464-7825; Hameri, Kaarle/0000-0003-2667-2174; Hoffmann, Thorsten/0000-0003-0939-271X				Allan BJ, 2001, GEOPHYS RES LETT, V28, P1945, DOI 10.1029/2000GL012468; ANACHE S, 2001, APPL ENVIRON MICROB, V67, P2718; Baker AR, 2000, ATMOS ENVIRON, V34, P4331, DOI 10.1016/S1352-2310(00)00208-9; BERRESHEIM H, IN PRESS J GEOPHYS R; Bloss WJ, 2001, J PHYS CHEM A, V105, P7840, DOI 10.1021/jp0044936; Capaldo KP, 1999, J GEOPHYS RES-ATMOS, V104, P3483, DOI 10.1029/1998JD100080; Carpenter LJ, 1999, J GEOPHYS RES-ATMOS, V104, P1679, DOI 10.1029/98JD02746; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cocker DR, 2001, ENVIRON SCI TECHNOL, V35, P2594, DOI 10.1021/es0019169; DALMASO M, IN PRESS J GEOPHYS R; GABLER HE, 1993, INT J ENVIRON AN CH, V50, P129, DOI 10.1080/03067319308027591; Giese B, 1999, ENVIRON SCI TECHNOL, V33, P2432, DOI 10.1021/es980731n; Goodwin KD, 1997, LIMNOL OCEANOGR, V42, P1725, DOI 10.4319/lo.1997.42.8.1725; Houghton J. T., 2001, CLIMATE CHANGE 2001; Huang S, 2001, ATMOS ENVIRON, V35, P1421, DOI 10.1016/S1352-2310(00)00368-X; Jayne JT, 2000, AEROSOL SCI TECH, V33, P49, DOI 10.1080/027868200410840; Katoshevski D, 1999, J AEROSOL SCI, V30, P503, DOI 10.1016/S0021-8502(98)00740-X; Korhonen P, 1999, J GEOPHYS RES-ATMOS, V104, P26349, DOI 10.1029/1999JD900784; Kulmala M, 2000, NATURE, V404, P66, DOI 10.1038/35003550; Laturnus F, 2000, FRESEN J ANAL CHEM, V368, P297, DOI 10.1007/s002160000491; Leck C, 1999, GEOPHYS RES LETT, V26, P3577, DOI 10.1029/1999GL010807; Lushnikov AA, 1998, PHYS REV LETT, V81, P5165, DOI 10.1103/PhysRevLett.81.5165; MAKELA JM, IN PRESS J GEOPHYS R; McFiggans G, 2000, J GEOPHYS RES-ATMOS, V105, P14371, DOI 10.1029/1999JD901187; Murphy DM, 1997, GEOPHYS RES LETT, V24, P3197, DOI 10.1029/97GL03195; ODOWD CD, IN PRESS J GEOPHYS R; Pirjola L, 2000, J GEOPHYS RES-ATMOS, V105, P26531, DOI 10.1029/2000JD900310; SLINGO A, 1990, NATURE, V343, P49, DOI 10.1038/343049a0; VAKEVA M, IN PRESS J GEOPHYS R; WIMSCHNEIDER A, 1995, FRESEN J ANAL CHEM, V353, P191, DOI 10.1007/BF00322957	30	553	565	5	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2002	417	6889					632	636		10.1038/nature00775	http://dx.doi.org/10.1038/nature00775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559AE	12050661				2022-12-24	WOS:000176001200043
J	Toft, A; Beckett, G				Toft, A; Beckett, G			Use of recombinant thyrotropin	LANCET			English	Editorial Material							THYROID-HORMONE WITHDRAWAL; CANCER; CARCINOMA		Royal Infirm, Endocrine Clin, Edinburgh EH3 9YW, Midlothian, Scotland; Univ Edinburgh, Royal Infirm, Dept Clin Biochem, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Toft, A (corresponding author), Royal Infirm, Endocrine Clin, Edinburgh EH3 9YW, Midlothian, Scotland.							*BRIT THYR ASS, 2002, GUID MAN THYR CANC; Clark PM, 2002, ANN CLIN BIOCHEM, V39, P196, DOI 10.1258/0004563021902125; Dow KH, 1997, THYROID, V7, P613, DOI 10.1089/thy.1997.7.613; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Hjiyiannakis P, 1999, CLIN ONCOL-UK, V11, P240, DOI 10.1053/clon.1999.9056; Huysmans DA, 2000, J CLIN ENDOCR METAB, V85, P3592, DOI 10.1210/jc.85.10.3592; Ladenson P W, 2001, Endocr Pract, V7, P195; Ladenson PW, 1997, NEW ENGL J MED, V337, P888, DOI 10.1056/NEJM199709253371304; Mazzaferri EL, 2002, J CLIN ENDOCR METAB, V87, P1490, DOI 10.1210/jc.87.4.1490; Robbins RJ, 2001, THYROID, V11, P865, DOI 10.1089/105072501316973127; Robbins RJ, 2001, J CLIN ENDOCR METAB, V86, P619, DOI 10.1210/jc.86.2.619; Wartofsky L, 2002, J CLIN ENDOCR METAB, V87, P1486, DOI 10.1210/jc.87.4.1486	12	7	7	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 1	2002	359	9321					1874	1875		10.1016/S0140-6736(02)08785-8	http://dx.doi.org/10.1016/S0140-6736(02)08785-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057547				2022-12-24	WOS:000175975700004
J	Herek, JL; Wohlleben, W; Cogdell, RJ; Zeidler, D; Motzkus, M				Herek, JL; Wohlleben, W; Cogdell, RJ; Zeidler, D; Motzkus, M			Quantum control of energy flow in light harvesting	NATURE			English	Article							LASER-PULSES; PHOTOSYNTHETIC UNIT; PHASE; FREQUENCY; BACTERIA; COMPLEX; DOMAIN; LH2	Coherent light sources have been widely used in control schemes that exploit quantum interference effects to direct the outcome of photochemical processes. The adaptive shaping of laser pulses is a particularly powerful tool in this context: experimental output as feedback in an iterative learning loop refines the applied laser field to render it best suited to constraints set by the experimenter(1,2). This approach has been experimentally implemented to control a variety of processes(3-9), but the extent to which coherent excitation can also be used to direct the dynamics of complex molecular systems in a condensed-phase environment remains unclear. Here we report feedback-optimized coherent control over the energy-flow pathways in the light-harvesting antenna complex LH2 from Rhodopseudomonas acidophila, a photosynthetic purple bacterium. We show that phases imprinted by the light field mediate the branching ratio of energy transfer between intra- and intermolecular channels in the complex's donor-acceptor system. This result illustrates that molecular complexity need not prevent coherent control, which can thus be extended to probe and affect biological functions.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Lund Univ, S-22100 Lund, Sweden; Vrije Univ Amsterdam, Dept Biophys, NL-1081 HV Amsterdam, Netherlands; Univ Glasgow, IBLS, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Max Planck Society; Lund University; Vrije Universiteit Amsterdam; University of Glasgow	Motzkus, M (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.			Zeidler, Dirk/0000-0003-2484-6636; Wohlleben, Wendel/0000-0003-2094-3260				AMSTRUP B, 1991, J PHYS CHEM-US, V95, P8019, DOI 10.1021/j100174a007; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Brixner T, 2001, NATURE, V414, P57, DOI 10.1038/35102037; Frank HA, 1997, PURE APPL CHEM, V69, P2117, DOI 10.1351/pac199769102117; Hornung T, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.021403; Hornung T, 2000, CHEM PHYS LETT, V326, P445, DOI 10.1016/S0009-2614(00)00810-1; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Krueger BP, 1998, J PHYS CHEM B, V102, P2284, DOI 10.1021/jp973062t; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Paulus GG, 2001, NATURE, V414, P182, DOI 10.1038/35102520; Pullerits T, 1996, ACCOUNTS CHEM RES, V29, P381, DOI 10.1021/ar950110o; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Ritz T, 2001, J PHYS CHEM B, V105, P8259, DOI 10.1021/jp011032r; Sundstrom V, 1999, J PHYS CHEM B, V103, P2327, DOI 10.1021/jp983722+; Trebino R, 1997, REV SCI INSTRUM, V68, P3277, DOI 10.1063/1.1148286; Trinkunas G, 2001, PHYS REV LETT, V86, P4167, DOI 10.1103/PhysRevLett.86.4167; WARREN WS, 1983, J CHEM PHYS, V78, P2279, DOI 10.1063/1.445083; Wefers MM, 1996, IEEE J QUANTUM ELECT, V32, P161, DOI 10.1109/3.481933; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Wilhelm T, 1997, OPT LETT, V22, P1494, DOI 10.1364/OL.22.001494; Zeidler D, 2000, APPL PHYS B-LASERS O, V70, pS125, DOI 10.1007/s003400000306; Zeidler D, 2002, J CHEM PHYS, V116, P5231, DOI 10.1063/1.1450549; Zeidler D, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.023420; Zinth W, 1996, BER BUNSEN PHYS CHEM, V100, P1962, DOI 10.1002/bbpc.19961001206	30	581	597	1	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					533	535		10.1038/417533a	http://dx.doi.org/10.1038/417533a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037563				2022-12-24	WOS:000175860300037
J	Kelly, CK; Bowler, MG				Kelly, CK; Bowler, MG			Coexistence and relative abundance in forest trees	NATURE			English	Article							LIMITING SIMILARITY; LONG-TERM; COMPETITION; TRENDS	Contemporary acceleration of biodiversity loss makes increasingly urgent the need to understand the controls of species coexistence(1,2). Tree diversity in particular plays a pivotal role in determining terrestrial biodiversity, through maintaining diversity of its dependent species(3,4) and with them, their predators and parasites. Most theories of coexistence based on the principle of limiting similarity suggest that coexistence of competing species is inherently unstable; coexistence of competitors must be maintained by external forces such as disturbance(5,6), immigration(7) or 'patchiness' of resources in space and time(8,9). In contrast, storage theory postulates stable coexistence of competing species through temporal alternation of conditions favouring recruitment of one species over the other(10,11). Here we use storage theory to develop explicit predictions for relative differences between competitors that allow us to discriminate between coexistence models. Data on tree species from a primary forest on the Mexican Pacific coast support a general dynamic of storage processes determining coexistence of similar tree species in this community, and allow us to reject all other theories of coexistence.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Dept Phys, Oxford OX1 3RH, England	University of Oxford; University of Oxford	Kelly, CK (corresponding author), Univ Southampton, Sch Biol Sci, Div Biodivers & Ecol, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	c.k.kelly@soton.ac.uk						Becerra JX, 1999, AM J BOT, V86, P1047, DOI 10.2307/2656622; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; CHESSON P, 1989, TRENDS ECOL EVOL, V4, P293, DOI 10.1016/0169-5347(89)90024-4; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Harvey PH, 1996, J ANIM ECOL, V65, P255, DOI 10.2307/5872; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kelly CK, 1999, P NATL ACAD SCI USA, V96, P8013, DOI 10.1073/pnas.96.14.8013; Kelly CK, 2001, ECOL LETT, V4, P618, DOI 10.1046/j.1461-0248.2001.00278.x; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Lusk CH, 1998, ECOLOGY, V79, P795, DOI 10.1890/0012-9658(1998)079[0795:LHDATS]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; May Robert M., 1995, P1; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Rzedowski J., 1978, VEGETACION MEXICO; Siegal S., 1956, NONPARAMETRIC STAT; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; TILMAN D, 1988; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; WOODWARD FI, 1997, PLANT FUNCTIONAL TYP	30	92	97	8	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					437	440		10.1038/417437a	http://dx.doi.org/10.1038/417437a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024212				2022-12-24	WOS:000175730900037
J	Simmonds, P; Kurtz, J; Tedder, RS				Simmonds, P; Kurtz, J; Tedder, RS			The UK blood transfusion service: over a (patent) barrel?	LANCET			English	Editorial Material							TRANSMITTED VIRAL-INFECTIONS; COST-EFFECTIVENESS; HEPATITIS-C; INTERFERON-ALPHA-2B		Univ Edinburgh, Lab Clin & Mol Biol, Edinburgh EH9 1QH, Midlothian, Scotland; Windeyer Inst Med Sci, Dept Virol, London, England; Birmingham Ctr, Natl Blood Serv, Birmingham, W Midlands, England	University of Edinburgh; University of London; University College London	Simmonds, P (corresponding author), Univ Edinburgh, Lab Clin & Mol Biol, Edinburgh EH9 1QH, Midlothian, Scotland.			Simmonds, Peter/0000-0002-7964-4700				Briggs A, 2000, BRIT MED J, V320, P246, DOI 10.1136/bmj.320.7229.246; Courouce AM, 1996, NEW ENGL J MED, V335, P1609; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; *SER HAZ TRANSF ST, 2000, SER HAZ TRANSF ANN R; VAMVAKAS EC, 1994, TRANSFUSION, V34, P471, DOI 10.1046/j.1537-2995.1994.34694295060.x; Younossi ZM, 1999, HEPATOLOGY, V30, P1318, DOI 10.1002/hep.510300518	7	32	32	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 18	2002	359	9319					1713	1714		10.1016/S0140-6736(02)08663-4	http://dx.doi.org/10.1016/S0140-6736(02)08663-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554MV	12049856				2022-12-24	WOS:000175740500004
J	Shigetani, Y; Sugahara, F; Kawakami, Y; Murakami, Y; Hirano, S; Kuratani, S				Shigetani, Y; Sugahara, F; Kawakami, Y; Murakami, Y; Hirano, S; Kuratani, S			Heterotopic shift of epithelial-mesenchymal interactions in vertebrate jaw evolution	SCIENCE			English	Article							NEURAL CREST; AGNATHAN VERTEBRATE; LAMPETRA-JAPONICA; ORIGIN; EXPRESSION; LAMPREY; EMBRYOS	Genes involved in Late specification of the mandibular arch, the source of the vertebrate jaw, are expressed with similar patterns in the oral regions of chick and lamprey embryos. However, morphological comparisons indicate that apparently orthologous homeobox genes were expressed in different subdivisions of the ectomesenchyme in the two species. Therefore, the homology and gene expression of the oral region are uncoupled during the transition from agnathan to gnathostome; we conclude that a heterotopic shift of tissue interaction was involved in the evolution of the jaw.	RIKEN, Ctr Dev Biol, Lab Evolut Morphol, Wako, Saitama 6500047, Japan; Okayama Univ, Dept Biol, Okayama 7008530, Japan; Niigata Univ, Dept Med Technol, Niigata 9518518, Japan	RIKEN; Okayama University; Niigata University	Kuratani, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Evolut Morphol, Wako, Saitama 6500047, Japan.	saizo@cdb.riken.go.jp	Sugahara, Fumiaki/C-5379-2017; Sugahara, Fumiaki/ABA-7542-2021; Kuratani, Shigeru/J-4146-2014	Sugahara, Fumiaki/0000-0001-8445-1703; Kuratani, Shigeru/0000-0001-9717-7221				COULY GF, 1993, DEVELOPMENT, V117, P409; Ferguson CA, 2000, DEVELOPMENT, V127, P403; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Haeckel E., 1875, JENAISCHE Z FR NATUR, V9, P402; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kuratani S, 1999, DEV BIOL, V210, P381, DOI 10.1006/dbio.1999.9266; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.ecolsys.22.1.229; Murakami Y, 2001, DEVELOPMENT, V128, P3521; MYOJIN M, 2001, MECH DEV EVOL, V291, P58; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Ueki T, 1998, DEV GENES EVOL, V208, P223, DOI 10.1007/s004270050176; Wagner Gunter P., 1994, P273	21	143	147	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1316	1319		10.1126/science.1068310	http://dx.doi.org/10.1126/science.1068310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016315				2022-12-24	WOS:000175713000054
J	Locher, KP; Lee, AT; Rees, DC				Locher, KP; Lee, AT; Rees, DC			The E-coli BtuCD structure: A framework for ABC transporter architecture and mechanism	SCIENCE			English	Article							ATP-BINDING-CASSETTE; CRYSTAL-STRUCTURE; CYSTIC-FIBROSIS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; ACTIVE-SITE; PROTEINS; IDENTIFICATION; NUCLEOTIDE; SUBUNIT	The ABC transporters are ubiquitous membrane proteins that couple adenosine triphosphate (ATP) hydrolysis to the translocation of diverse substrates across cell membranes. Clinically relevant examples are associated with cystic fibrosis and with multidrug resistance of pathogenic bacteria and cancer cells. Here, we report the crystal structure at 3.2 angstrom resolution of the Escherichia coli BtuCD protein, an ABC transporter mediating vitamin B-12 uptake. The two ATP-binding cassettes (BtuD) are in close contact with each other, as are the two membrane-spanning subunits (BtuC); this arrangement is distinct from that observed for the E. coli lipid flippase MsbA. The BtuC subunits provide 20 transmembrane helices grouped around a translocation pathway that is closed to the cytoplasm by a gate region whereas the dimer arrangement of the BtuD subunits resembles the ATP-bound form of the Rad50 DNA repair enzyme. A prominent cytoplasmic loop of BtuC forms the contact region with the ATP-binding cassette and appears to represent a conserved motif among the ABC transporters.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Locher, KP (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 147-75CH, Pasadena, CA 91125 USA.	locher@caltech.edu; dcrees@caltech.edu						Abele R, 1999, BBA-BIOMEMBRANES, V1461, P405, DOI 10.1016/S0005-2736(99)00171-6; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AVERBUCHPOUCHOT MT, 1994, EUR J SOL STATE INOR, V31, P567; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOOS W, 1996, ESCHERICHIA COLI SAL, V1, P1175; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Groeger W, 1998, MICROBIOL-SGM, V144, P2759, DOI 10.1099/00221287-144-10-2759; HEATH E, 1981, J CHEM SOC DALTON, P1105, DOI 10.1039/dt9810001105; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomas PJ, 2001, NAT STRUCT BIOL, V8, P920, DOI 10.1038/nsb1101-920; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200	55	915	945	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1091	1098		10.1126/science.1071142	http://dx.doi.org/10.1126/science.1071142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004122				2022-12-24	WOS:000175565000045
J	Rasmussen, B; Bengtson, S; Fletcher, IR; McNaughton, NJ				Rasmussen, B; Bengtson, S; Fletcher, IR; McNaughton, NJ			Discoidal impressions and trace-like fossils more than 1200 million years old	SCIENCE			English	Article							CAMBRIAN EXPLOSION; U-PB; WESTERN-AUSTRALIA; METAZOAN PHYLA; STIRLING RANGE; MONAZITE; FUSE	The Stirling Range Formation of southwestern Australia contains discoidal impressions and trace-like fossils in tidal sandstones. The various disks have previously been linked to the Ediacaran biota, younger than 600 million years old. From this unit, we report U-Th-Pb geochronology of detrital zircon and monazite, as well as low-grade metamorphic monazite, constraining the depositional age to between 2016+/-6 and 1215+/-20 million years old. Although nonbiological origins for the discoidal impressions cannot be completely discounted, the structures resembling trace fossils clearly have a biological origin and suggest the presence of vermiform, mucus-producing, motile organisms.	Univ Western Australia, Ctr Global Met, Dept Geol & Geophys, Crawley, WA 6009, Australia; Swedish Museum Nat Hist, Dept Palaeozool, SE-10405 Stockholm, Sweden	University of Western Australia; Swedish Museum of Natural History	Rasmussen, B (corresponding author), Univ Western Australia, Ctr Global Met, Dept Geol & Geophys, Crawley, WA 6009, Australia.		McNaughton, Neal/AAV-9941-2020; McNaughton, Neal/E-3884-2014; McNaughton, Neal/AAD-7067-2022	Bengtson, Stefan/0000-0003-0206-5791; Rasmussen, Birger/0000-0002-2745-0904				Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; BEESON J, 1991, THESIS U W AUSTR CRA; BLACK LP, 1992, PRECAMBRIAN RES, V59, P117; BOULTER CA, 1979, J STRUCT GEOL, V1, P207, DOI 10.1016/0191-8141(79)90040-3; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; Bromley R.G., 1996, TRACE FOSSILS, V2nd ed.; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; CLOUD P, 1973, Geology (Boulder), V1, P123, DOI 10.1130/0091-7613(1973)1<123:PAPFC>2.0.CO;2; Collins AG, 2000, PALEOBIOLOGY, V26, P47, DOI 10.1666/0094-8373(2000)026<0047:MMCTAT>2.0.CO;2; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; CRUSE T, 1993, AUST J EARTH SCI, V40, P293, DOI 10.1080/08120099308728081; CRUSE T, 1991, THESIS U W AUSTR CRA; DAWSON GR, UNPUB; Evans J, 1996, EARTH PLANET SC LETT, V144, P421, DOI 10.1016/S0012-821X(96)00177-X; Foster G, 2000, EARTH PLANET SC LETT, V181, P327, DOI 10.1016/S0012-821X(00)00212-0; Gehling JG, 2000, PALAEONTOLOGY, V43, P427, DOI 10.1111/j.0031-0239.2000.00134.x; GLAESSNER MF, 1969, LETHAIA, V2, P369, DOI 10.1111/j.1502-3931.1969.tb01258.x; HARRIS LB, 1994, J GEOL SOC LONDON, V151, P901, DOI 10.1144/gsjgs.151.6.0901; HARRISON JF, 1994, PHYSIOL ZOOL, V67, P1; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; KITAZATO H, 1988, J FORAMIN RES, V18, P344, DOI 10.2113/gsjfr.18.4.344; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; MYERS JS, 1990, GEOLOGY MINERAL RESO, P255; Rasmussen B, 2001, GEOLOGY, V29, P963, DOI 10.1130/0091-7613(2001)029<0963:DLGMEB>2.0.CO;2; Rauprich O, 1996, J BACTERIOL, V178, P6525, DOI 10.1128/jb.178.22.6525-6538.1996; Seilacher A, 1998, SCIENCE, V282, P80, DOI 10.1126/science.282.5386.80; Smith JB, 1998, PRECAMBRIAN RES, V88, P143, DOI 10.1016/S0301-9268(97)00067-3; Stephenson N., 1966, J GEOL SOC AUST, V13, P449; Valentine JW, 1999, DEVELOPMENT, V126, P851; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	31	107	111	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1112	1115		10.1126/science.1070166	http://dx.doi.org/10.1126/science.1070166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004128				2022-12-24	WOS:000175565000051
J	Dobrosotskaya, IY; Seegmiller, AC; Brown, MS; Goldstein, JL; Rawson, RB				Dobrosotskaya, IY; Seegmiller, AC; Brown, MS; Goldstein, JL; Rawson, RB			Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila	SCIENCE			English	Article							BOUND TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; CHOLESTEROL; METABOLISM; SPHINGOLIPIDS; PROTEOLYSIS	Animal cells exert exquisite control over the physical and chemical properties of their membranes, but the mechanisms are obscure. We show that phosphatidylethanolamine, the major phospholipid in Drosophila, controls the release of sterol regulatory element-binding protein (SREBP) from Drosophila cell membranes, exerting feedback control on the synthesis of fatty acids and phospholipids. The finding that SREBP processing is controlled by different lipids in mammals and flies (sterols and phosphatidylethanolamine, respectively) suggests that an essential function of SREBP is to monitor cell membrane composition and to adjust lipid synthesis accordingly.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NHLBI NIH HHS [HL-20948] Funding Source: Medline; NIGMS NIH HHS [GM 08014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1975, J BIOL CHEM, V250, P4025; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CULLIS PR, 1985, BIOCH LIPIDS MEMBRAN, pCH2; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; DOBROSOTSKAYA IY, UNPUB; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; JONES HE, 1992, LIPIDS, V27, P984, DOI 10.1007/BF02535576; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Lange Y, 1999, J LIPID RES, V40, P2264; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Rizzo WB, 1998, MOL GENET METAB, V65, P63, DOI 10.1006/mgme.1998.2728; Rosenberger TA, 2002, J LIPID RES, V43, P59; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; SNYDER F, 1985, BIOCH LIPIDS MEMBRAN, pCH9; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Yeagle P., 1993, MEMBRANES CELLS, P1	26	242	246	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					879	883		10.1126/science.1071124	http://dx.doi.org/10.1126/science.1071124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988566				2022-12-24	WOS:000175442500035
J	Crawford, LM				Crawford, LM			Commercial speech and public health: Request for comment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2002	288	1					36	36		10.1001/jama.288.1.36	http://dx.doi.org/10.1001/jama.288.1.36			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	568YW	12090852				2022-12-24	WOS:000176573400005
J	Dickel, H; Kuss, O; Schmidt, A; Diepgen, TL				Dickel, H; Kuss, O; Schmidt, A; Diepgen, TL			Impact of preventive strategies on trend of occupational skin disease in hairdressers: population based register study	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; LIFE-EVENTS; SURVIVAL; PROGNOSIS; STRESS; RISK; RECURRENCE; WOMEN		Univ Heidelberg Hosp, Dept Clin Social Med, Ctr Occupat & Environm Dermatol, D-69115 Heidelberg, Germany; Bavarian Hlth & Safety Execut, Dept Occupat Med, D-90429 Nurnberg, Germany	Ruprecht Karls University Heidelberg	Diepgen, TL (corresponding author), Univ Heidelberg Hosp, Dept Clin Social Med, Ctr Occupat & Environm Dermatol, D-69115 Heidelberg, Germany.			Kuss, Oliver/0000-0003-3301-5869				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; BARRACLOUGH J, 1992, BRIT MED J, V304, P1078, DOI 10.1136/bmj.304.6834.1078; BARRACLOUGH J, 1993, BRIT MED J, V307, P25; Breslow NE, 1980, STAT METHODS CANC RE; Brown G., 1978, SOCIAL ORIGINS DEPRE; Brown GW, 1989, LIFE EVENTS ILLNESS; Dickel H, 2001, BRIT J DERMATOL, V145, P453, DOI 10.1046/j.1365-2133.2001.04377.x; Edelman S, 2000, J PSYCHOSOM RES, V49, P149, DOI 10.1016/S0022-3999(00)00153-7; FAWZY FI, 1993, ARCH GEN PSYCHIAT, V50, P681; FORSEN A, 1991, PSYCHOTHER PSYCHOSOM, V55, P176, DOI 10.1159/000288427; FUNCH DP, 1983, J PSYCHOSOM RES, V27, P77, DOI 10.1016/0022-3999(83)90112-5; Giraldi T, 1997, PSYCHOTHER PSYCHOSOM, V66, P229, DOI 10.1159/000289140; HAYWARD JL, 1978, SEMIN ONCOL, V5, P445; HOGAN DJ, 1994, OCCUP MED, V9, P53; Karasek R, 1990, HLTH WORK STRESS PRO; Kiecolt-Glaser JK, 1999, EUR J CANCER, V35, P1603, DOI 10.1016/S0959-8049(99)00197-5; Kvikstad A, 1996, INT J CANCER, V67, P165, DOI 10.1002/(SICI)1097-0215(19960717)67:2<165::AID-IJC2>3.3.CO;2-4; KVIKSTAD A, 1995, BRIT J CANCER, V71, P1343, DOI 10.1038/bjc.1995.261; MAUNSELL E, 1998, PSYCHOONCOLOGY S, V7, P281; PARMAR M, 1995, SURVIVAL ANAL PRACTI; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Petticrew M, 1999, BRIT J HEALTH PSYCH, V4, P1, DOI 10.1348/135910799168434; RAMIREZ AJ, 1989, BRIT MED J, V298, P291, DOI 10.1136/bmj.298.6669.291; SCHLESINGER T, 2001, DERMATOL BERUF UMWEL, V49, P185; SPIEGEL D, 1989, LANCET, V2, P888; Spitzer RL, 1990, STRUCTURED CLIN INTE; STRESEMANN E, 1998, DERMATOSEN, V46, P166	27	45	45	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2002	324	7351					1422	1423		10.1136/bmj.324.7351.1422	http://dx.doi.org/10.1136/bmj.324.7351.1422			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565CQ	12065264	Green Published, Bronze			2022-12-24	WOS:000176351400016
J	West, SEH; Zeng, L; Lee, BL; Kosorok, MR; Laxova, A; Rock, MJ; Splaingard, MJ; Farrell, PM				West, SEH; Zeng, L; Lee, BL; Kosorok, MR; Laxova, A; Rock, MJ; Splaingard, MJ; Farrell, PM			Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis - Early detection by serology and assessment of risk factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EARLY DIAGNOSIS; YOUNG-CHILDREN; OROPHARYNGEAL CULTURES; CHANGING EPIDEMIOLOGY; PULMONARY-FUNCTION; SERUM ANTIBODIES; LUNG-DISEASE; COLONIZATION; ACQUISITION; MANAGEMENT	Context Patients with cystic fibrosis (CF) are susceptible to lower respiratory tract infections with Pseudomonas aeruginosa and typically acquire this organism in early childhood. Once P aeruginosa infection is established, eradication may be impossible, and progressive lung disease often aggravates morbidity and mortality risks. The ability to diagnose CF by genetic testing at birth makes it possible to determine the temporal sequence of events that result in P aeruginosa-associated pulmonary infections. Objective To evaluate the longitudinal relationship between the production of an antibody response against P aeruginosa and clinical factors associated with P aeruginosa pulmonary infections in patients with CF diagnosed in early life. Design, Setting, and Patients Serum samples and oropharyngeal cultures (protocol cultures) were obtained at 6-month intervals from April 15, 1985, to April 15, 2000 (or for up to 180 months depending on their enrollment date) from 68 patients at 2 centers in Madison and Milwaukee, Wis, diagnosed through the Wisconsin CF Neonatal Screening Project, a longitudinal cohort study. Additional cultures were obtained at examining physicians' discretion (all cultures). Main Outcome Measures Time to serum IgG, IgA, and IgM antibody titer of at least 1:256 against P aeruginosa, assessed by enzyme-linked immunosorbent assay using cell lysate, exotoxin A, and elastase as antigens; time to organism isolation from respiratory samples; time to Wisconsin Cystic Fibrosis Radiograph (WCXR) score of 5 or more. Results The median time to an antibody titer of at least 1:256 was 17.8, 24.2, and 70.9 months for cell lysate, exotoxin A, and elastase, respectively. The rise of anti-cell lysate and anti-exotoxin A titers to 1:256 or more occurred a mean of 11.9 (P<.001) and 5.6 (P=.04) months, respectively, before the isolation of Paeruginosa for all cultures and 18.2 (P<.001) and 11.9 (P=.006) months, respectively, before protocol cultures. There was no significant difference between the rise of anti-cell lysate and anti-exotoxin A titer and a WCXR score of 5 or more (P=.24 and.32, respectively). Treatment with long-term, non-Pseudomonas oral antibiotics and integration of CF infants with older, chronically infected patients were associated with a significantly increased risk of P aeruginosa pulmonary infection. Conclusions In CF patients diagnosed through neonatal screening, Paeruginosa pulmonary infections occurred 6 to 12 months before the organism was isolated from respiratory secretions. The longitudinal monitoring of P aeruginosa antibody titers, in concert with WCXR score, should facilitate diagnosis and treatment of P aeruginosa pulmonary infections in young children with CF.	Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI 53706 USA; Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Farrell, PM (corresponding author), Univ Wisconsin, Sch Med, Dept Pediat, 1300 Univ Ave, Madison, WI 53706 USA.	pmfarrel@facstaff.wisc.edu	Splaingard, Mark/AAL-7356-2021; Kosorok, Michael/ABB-7427-2021; Splaingard, Mark/D-9206-2012	Splaingard, Mark/0000-0002-1361-4947	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034108] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03186] Funding Source: Medline; NIDDK NIH HHS [R01 DK34108] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABMAN SH, 1991, J PEDIATR-US, V119, P211, DOI 10.1016/S0022-3476(05)80729-2; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2006, SURVIVAL ANAL TECHNI; ARMSTRONG DS, 1995, BRIT MED J, V310, P1571, DOI 10.1136/bmj.310.6994.1571; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; Bartholomew D, 1983, ENCY STAT SCI, V4, P260; BRETT MM, 1992, ARCH DIS CHILD, V67, P1086, DOI 10.1136/adc.67.9.1086; BRETT MM, 1988, J CLIN MICROBIOL, V26, P1565, DOI 10.1128/JCM.26.8.1565-1570.1988; BRETT MM, 1986, ARCH DIS CHILD, V61, P1114, DOI 10.1136/adc.61.11.1114; BRETT MM, 1990, ARCH DIS CHILD, V65, P259, DOI 10.1136/adc.65.3.259; BRETT MM, 1987, ARCH DIS CHILD, V62, P357, DOI 10.1136/adc.62.4.357; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Ciske DJ, 2001, PEDIATRICS, V107, P699, DOI 10.1542/peds.107.4.699; CORDON SM, 1992, ARCH DIS CHILD, V67, P737, DOI 10.1136/adc.67.6.737; COTTLE RW, 1992, LINEAR COMPLEMENTARI, P265; *CYST FIBR FDN, 1999, PAT REG 1998 ANN DAT; *CYST FIBR FDN, 1994, CONSENSUS C CONCEPTS, V5, P5; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; Farrell P M, 2000, Adv Pediatr, V47, P79; Farrell PM, 1998, BRIT MED J, V317, P1017, DOI 10.1136/bmj.317.7164.1017; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e2; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; FLEMING TR, 1991, COUNTING PROCESSES S, P163; FOST N, 1989, CLIN RES, V37, P495; Frederiksen B, 1999, PEDIATR PULM, V28, P159, DOI 10.1002/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.0.CO;2-1; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; GRANSTROM M, 1984, ACTA PAEDIATR SCAND, V73, P772, DOI 10.1111/j.1651-2227.1984.tb17774.x; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; HARLOW E, 1988, ANTIBODIES LAB MANUA, P563; HOIBY N, 1989, ACTA PAEDIATR SCAND, V78, P395, DOI 10.1111/j.1651-2227.1989.tb11099.x; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; HOLLSING AE, 1987, J CLIN MICROBIOL, V25, P1868, DOI 10.1128/JCM.25.10.1868-1874.1987; HOMMA JY, 1978, JPN J EXP MED, V48, P111; HUDSON VL, 1993, J PEDIATR-US, V122, P854, DOI 10.1016/S0022-3476(09)90007-5; KELLY HW, 1984, DRUG INTEL CLIN PHAR, V18, P772, DOI 10.1177/106002808401801001; KEREM E, 1990, PEDIATR INFECT DIS J, V9, P494, DOI 10.1097/00006454-199007000-00008; Koscik RE, 2000, PEDIATR PULM, V29, P457, DOI 10.1002/(SICI)1099-0496(200006)29:6<457::AID-PPUL8>3.3.CO;2-0; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Kosorok MR, 1998, PEDIATR PULM, V26, P81, DOI 10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K; LOENINGBAUCKE VA, 1979, J PEDIATR-US, V95, P630, DOI 10.1016/S0022-3476(79)80785-4; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Merelle ME, 2001, EUR RESPIR J, V18, P306, DOI 10.1183/09031936.01.00080101; MOHR CD, 1990, MOL MICROBIOL, V4, P2103, DOI 10.1111/j.1365-2958.1990.tb00571.x; Murray S, 2000, BIOMETRICS, V56, P984, DOI 10.1111/j.0006-341X.2000.0984.x; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; RAMSEY BW, 1991, AM REV RESPIR DIS, V144, P331, DOI 10.1164/ajrccm/144.2.331; Ramsey BW, 1996, NEW ENGL J MED, V335, P179, DOI 10.1056/NEJM199607183350307; Ramsey BW, 1996, PEDIATR PULM, V21, P265, DOI 10.1002/1099-0496(199605)21:5<265::AID-PPUL1950210502>3.0.CO;2-5; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Stutman HR, 2002, J PEDIATR-US, V140, P299, DOI 10.1067/mpd.2002.121930; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; Wang SS, 2001, PEDIATRICS, V107, P274, DOI 10.1542/peds.107.2.274; WINNIE GB, 1991, PEDIATR PULM, V10, P92, DOI 10.1002/ppul.1950100210; WOOD RE, 1979, SOUTHERN MED J, V72, P189, DOI 10.1097/00007611-197902000-00019; WOODS DE, 1991, J INFECT DIS, V163, P143, DOI 10.1093/infdis/163.1.143	59	140	151	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2002	287	22					2958	2967		10.1001/jama.287.22.2958	http://dx.doi.org/10.1001/jama.287.22.2958			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561EY	12052125				2022-12-24	WOS:000176128300025
J	Min, JH; Yang, HF; Ivan, M; Gertler, F; Kaelin, WG; Pavletich, NP				Min, JH; Yang, HF; Ivan, M; Gertler, F; Kaelin, WG; Pavletich, NP			Structure of an HIF-1 alpha-pVHL complex: Hydroxyproline recognition in signaling	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; PROLYL HYDROXYLATION; PROLINE HYDROXYLATION; UBIQUITIN LIGASE; HIF-ALPHA; VHL; HYPOXIA; FAMILY; GENE	The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1alpha peptide-pVHL-ElonginB-ElonginC complex shows that HIF-1alpha binds to pVHL in an extended beta strand-like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the beta sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.		Ivan, Mircea/A-8109-2012	Ivan, Mircea/0000-0003-3424-6642; Min, Jung-Hyun/0000-0002-4221-9321				ARAVIND L, 2001, GENOME BIOL, V2; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ESSAR L, COMMUNICATION; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	27	543	624	8	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1886	1889		10.1126/science.1073440	http://dx.doi.org/10.1126/science.1073440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12004076				2022-12-24	WOS:000176054300054
J	Cohen, BE; McAnaney, TB; Park, ES; Jan, YN; Boxer, SG; Jan, LY				Cohen, BE; McAnaney, TB; Park, ES; Jan, YN; Boxer, SG; Jan, LY			Probing protein electrostatics with a synthetic fluorescent amino acid	SCIENCE			English	Article							SOLVATION DYNAMICS; DIELECTRIC-CONSTANTS; SPECTROSCOPY; SOLVENT; MATRIX; SITE	Electrostatics affect virtually all aspects of protein structure and activity and are particularly important in proteins whose primary function is to stabilize charge. Here we introduce a fluorescent amino acid, Aladan, which can probe the electrostatic character of a protein at multiple sites. Aladan is exceptionally sensitive to the polarity of its surroundings and can be incorporated site-selectively at buried and exposed sites, in both soluble and membrane proteins. Steady-state and time-resolved fluorescence measurements of Aladan residues at different buried and exposed sites in the B1 domain of protein G suggest that its interior is polar and heterogeneous.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Cohen, BE (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Boxer, Steven/0000-0001-9167-4286	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027738, R01GM027738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334, R37MH065334] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27738] Funding Source: Medline; NIMH NIH HHS [MH65334] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Castner EW, 1998, J MOL LIQ, V77, P1, DOI 10.1016/S0167-7322(98)00066-X; Changenet-Barret P, 2000, J PHYS CHEM B, V104, P9322, DOI 10.1021/jp001634v; COHEN BW, UNPUB; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; HORNG ML, 1995, J PHYS CHEM-US, V99, P17311, DOI 10.1021/j100048a004; Jordanides XJ, 1999, J PHYS CHEM B, V103, P7995, DOI 10.1021/jp9910993; KING G, 1991, J CHEM PHYS, V95, P4366, DOI 10.1063/1.461760; Kobayashi N, 2000, BIOCHEMISTRY-US, V39, P6564, DOI 10.1021/bi000013p; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; MACGREGOR RB, 1986, NATURE, V319, P70, DOI 10.1038/319070a0; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mertz EL, 2000, P NATL ACAD SCI USA, V97, P2081, DOI 10.1073/pnas.050316997; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pal SK, 2002, P NATL ACAD SCI USA, V99, P1763, DOI 10.1073/pnas.042697899; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; PIERCE DW, 1992, J PHYS CHEM-US, V96, P5560, DOI 10.1021/j100192a069; Pitera JW, 2001, BIOPHYS J, V80, P2546, DOI 10.1016/S0006-3495(01)76226-1; Riter RR, 1996, J PHYS CHEM-US, V100, P14198, DOI 10.1021/jp960453j; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Simonson T, 1996, J AM CHEM SOC, V118, P8452, DOI 10.1021/ja960884f; STANLEY RJ, 1995, J PHYS CHEM-US, V99, P859, DOI 10.1021/j100003a003; STEFFEN MA, 1994, SCIENCE, V264, P810, DOI 10.1126/science.264.5160.810; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WARSHEL A, 1984, Q REV BIOPHYS, V17, P283, DOI 10.1017/S0033583500005333; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Wohlfarth C., 1991, STATIC DIELECTRIC CO	32	351	368	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1700	1703		10.1126/science.1069346	http://dx.doi.org/10.1126/science.1069346			4	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040199				2022-12-24	WOS:000175976200063
J	Boyden, LM; Mao, JH; Belsky, J; Mitzner, L; Farhi, A; Mitnick, MA; Wu, DQ; Insogna, K; Lifton, RP				Boyden, LM; Mao, JH; Belsky, J; Mitzner, L; Farhi, A; Mitnick, MA; Wu, DQ; Insogna, K; Lifton, RP			High bone density due to a mutation in LDL-receptor-related protein 5	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL DOMINANT OSTEOSCLEROSIS; PARATHYROID-HORMONE; TRANSFORMING GROWTH-FACTOR-BETA-1; MINERAL DENSITY; FIBRONECTIN; MASS; GROWTH; GENE; HYPEROSTOSIS; DICKKOPF-1	Background: Osteoporosis is a major public health problem of largely unknown cause. Loss-of-function mutations in the gene for low-density lipoprotein receptor-related protein 5 (LRP5), which acts in the Wnt signaling pathway, have been shown to cause osteoporosis-pseudoglioma. Methods: We performed genetic and biochemical analyses of a kindred with an autosomal dominant syndrome characterized by high bone density, a wide and deep mandible, and torus palatinus. Results: Genetic analysis revealed linkage of the syndrome to chromosome 11q12-13 (odds of linkage, >1 million to 1), an interval that contains LRP5. Affected members of the kindred had a mutation in this gene, with valine substituted for glycine at codon 171 (LRP5(V171)). This mutation segregated with the trait in the family and was absent in control subjects. The normal glycine lies in a so-called propeller motif that is highly conserved from fruit flies to humans. Markers of bone resorption were normal in the affected subjects, whereas markers of bone formation such as osteocalcin were markedly elevated. Levels of fibronectin, a known target of signaling by Wnt, a developmental protein, were also elevated. In vitro studies showed that the normal inhibition of Wnt signaling by another protein, Dickkopf-1 (Dkk-1), was defective in the presence of LRP5(V171) and that this resulted in increased signaling due to unopposed Wnt activity. Conclusions: The LRP5(V171) mutation causes high bone density, with a thickened mandible and torus palatinus, by impairing the action of a normal antagonist of the Wnt pathway and thus increasing Wnt signaling. These findings demonstrate the role of altered LRP5 function in high bone mass and point to Dkk as a potential target for the prevention or treatment of osteoporosis.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA	Yale University; Yale University; University of Connecticut	Lifton, RP (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06510 USA.			Insogna, Karl/0000-0001-6973-5679	NATIONAL CANCER INSTITUTE [R01CA085420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015345] Funding Source: NIH RePORTER; NCI NIH HHS [CA85420] Funding Source: Medline; NCRR NIH HHS [RR00125] Funding Source: Medline; NIAMS NIH HHS [AR46032] Funding Source: Medline; NIA NIH HHS [AG15345] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADES LC, 1994, AM J MED GENET, V51, P46, DOI 10.1002/ajmg.1320510111; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; CENTRELLA M, 1991, MOL CELL BIOL, V11, P4490, DOI 10.1128/MCB.11.9.4490; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; EIELSON C, 1994, ENDOCRINOLOGY, V135, P1639, DOI 10.1210/en.135.4.1639; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; GELMAN MI, 1977, RADIOLOGY, V125, P289, DOI 10.1148/125.2.289; Globus RK, 1998, J CELL SCI, V111, P1385; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; GORLIN RJ, 1977, RADIOLOGY, V125, P547, DOI 10.1148/125.2.547; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Heaney C, 1998, HUM MOL GENET, V7, P1407, DOI 10.1093/hmg/7.9.1407; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; Kerstetter JE, 1997, AM J CLIN NUTR, V66, P1188, DOI 10.1093/ajcn/66.5.1188; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; Lips Paul, 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)90021-8; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MAROTEAUX P, 1971, ARCH FR PEDIATR, V28, P685; MERIC F, 1990, AM J KIDNEY DIS, V16, P459, DOI 10.1016/S0272-6386(12)80059-X; Moursi AM, 1996, J CELL SCI, V109, P1369; OWEN RH, 1976, BRIT J RADIOL, V49, P126, DOI 10.1259/0007-1285-49-578-126; PEREZVICENTE JA, 1987, CLIN GENET, V31, P161; POOR G, 1995, CLIN ORTHOP RELAT R, P260; RUSSELL WJ, 1968, RADIOLOGY, V90, P70, DOI 10.1148/90.1.70; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Sun BH, 1997, ENDOCRINOLOGY, V138, P3918, DOI 10.1210/en.138.9.3918; Takacs I, 1999, AM J MED GENET, V85, P9, DOI 10.1002/(SICI)1096-8628(19990702)85:1<9::AID-AJMG4>3.0.CO;2-3; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; VERHAAR HJJ, 1995, MATURITAS, V21, P237, DOI 10.1016/0378-5122(94)00883-9; Whyte MP, 1996, J BONE MINER RES, V11, P1438, DOI 10.1002/jbmr.5650111010; Worth H M, 1966, J Can Assoc Radiol, V17, P67; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; 1996, MMWR MORB MORTAL WKL, V45, P877	40	1205	1369	1	57	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1513	1521		10.1056/NEJMoa013444	http://dx.doi.org/10.1056/NEJMoa013444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015390	Bronze			2022-12-24	WOS:000175563900002
J	Kaski, JC				Kaski, JC			"Normal" coronary arteriograms, "abnormal" haemodynamics	LANCET			English	Editorial Material							PRESSURE MEASUREMENT; STENOSES; PLAQUE; HUMANS		Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, Coronary Artery Dis Res Unit, London SW17 0RE, England	St Georges University London	Kaski, JC (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, Coronary Artery Dis Res Unit, London SW17 0RE, England.							Cox ID, 1999, J AM COLL CARDIOL, V34, P455, DOI 10.1016/S0735-1097(99)00224-7; De Bruyne B, 2001, CIRCULATION, V104, P2401, DOI 10.1161/hc4501.099316; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Hasdai D, 1997, CIRCULATION, V96, P3390; KASKI JC, 1991, J AM COLL CARDIOL, V17, P627, DOI 10.1016/S0735-1097(10)80175-5; Kern MJ, 2000, CIRCULATION, V101, P1344, DOI 10.1161/01.CIR.101.11.1344; Kern MJ, 2001, CIRCULATION, V103, P3142, DOI 10.1161/01.CIR.103.25.3142; Pijls NHJ, 2000, CIRCULATION, V102, P2371, DOI 10.1161/01.CIR.102.19.2371; Pijls NHJ, 1998, HEART, V80, P539, DOI 10.1136/hrt.80.6.539; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333	10	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1631	1632		10.1016/S0140-6736(02)08543-4	http://dx.doi.org/10.1016/S0140-6736(02)08543-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020520				2022-12-24	WOS:000175593300003
J	Skoog, I				Skoog, I			Magnetic-resonance imaging to assess Alzheimer's disease	LANCET			English	Editorial Material							FRONTOTEMPORAL DEMENTIA; ATROPHY; DIAGNOSIS; AD		Sahlgrenska Univ Hosp, Inst Clin Neurosci, Sect Psychiat, Neuropsychiat Epidemiol Unit, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Skoog, I (corresponding author), Sahlgrenska Univ Hosp, Inst Clin Neurosci, Sect Psychiat, Neuropsychiat Epidemiol Unit, S-41345 Gothenburg, Sweden.							Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; Chan D, 2001, NEUROLOGY, V57, P1756, DOI 10.1212/WNL.57.10.1756; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; O'Brien JT, 2001, NEUROLOGY, V56, P1386, DOI 10.1212/WNL.56.10.1386	9	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 4	2002	359	9317					1538	1539		10.1016/S0140-6736(02)08527-6	http://dx.doi.org/10.1016/S0140-6736(02)08527-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549RN	12047960				2022-12-24	WOS:000175460700004
J	Zhu, Y; Ghosh, P; Charnay, P; Burns, DK; Parada, LF				Zhu, Y; Ghosh, P; Charnay, P; Burns, DK; Parada, LF			Neurofibromas in NF1: Schwann cell origin and role of tumor environment	SCIENCE			English	Article							PERIPHERAL NERVOUS-SYSTEM; TYPE-1; SUPPRESSOR; SHEATH; CANCER; GAP	Neurofibromatosis type 1 (NF1) is one of the most prevalent dominantly inherited genetic diseases of the nervous system. NF1 encodes a tumor suppressor whose functional loss results in the development of benign neurofibromas that can progress to malignancy. Neurofibromas are complex tumors composed of axonal processes, Schwann cells, fibroblasts, perineurial cells, and mast cells. Through use of a conditional (cre/lox) allele, we show that loss of NF1 in the Schwann cell lineage is sufficient to generate tumors. In addition, complete NF1-mediated tumorigenicity requires both a loss of NF1 in cells destined to become neoplastic as well as heterozygosity in non-neoplastic cells. The requirement for a permissive haploinsufficient environment to allow tumorigenesis may have therapeutic implications for NF1 and other familial cancers.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Ecole Normale Super, F-75230 Paris, France	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Parada, LF (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.		Zhu, Yuan/ABF-8405-2020; Parada, luis F/B-9400-2014	Charnay, Patrick/0000-0002-3847-6042	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034296] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS034296-06, R01 NS034296] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; HALLIDAY AL, 1991, J NEUROSURG, V74, P248, DOI 10.3171/jns.1991.74.2.0248; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; KIM HA, 1995, ONCOGENE, V11, P325; KLEIHUES P, 2000, PATHOLOGY GENTICS TU; Knudson AG, 2000, ANNU REV GENET, V34, P1, DOI 10.1146/annurev.genet.34.1.1; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; MARTUZA R, COMMUNICATION; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Woodruff JM, 1999, AM J MED GENET, V89, P23, DOI 10.1002/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhu Y, 2001, EXP CELL RES, V264, P19, DOI 10.1006/excr.2000.5138	21	435	453	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					920	922		10.1126/science.1068452	http://dx.doi.org/10.1126/science.1068452			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11988578	Green Accepted			2022-12-24	WOS:000175442500047
J	Jiang, YH; Jahagirdar, BN; Reinhardt, RL; Schwartz, RE; Keene, CD; Ortiz-Gonzalez, XR; Reyes, M; Lenvik, T; Lund, T; Blackstad, M; Du, JB; Aldrich, S; Lisberg, A; Low, WC; Largaespada, DA; Verfaillie, CM				Jiang, YH; Jahagirdar, BN; Reinhardt, RL; Schwartz, RE; Keene, CD; Ortiz-Gonzalez, XR; Reyes, M; Lenvik, T; Lund, T; Blackstad, M; Du, JB; Aldrich, S; Lisberg, A; Low, WC; Largaespada, DA; Verfaillie, CM			Pluripotency of mesenchymal stem cells derived from adult marrow	NATURE			English	Article							BONE-MARROW; PROGENITOR CELLS; IN-VIVO; MOUSE; MICE; EXPRESSION; DIFFERENTIATE; MUSCLE; ENGRAFTMENT; HEPATOCYTES	We report here that cells co-purifying with mesenchymal stem cells-termed here multipotent adult progenitor cells or MAPCs-differentiate, at the single cell level, not only into mesenchymal cells, but also cells with visceral mesoderm, neuroectoderm and endoderm characteristics in vitro. When injected into an early blastocyst, single MAPCs contribute to most, if not all, somatic cell types. On transplantation into a non-irradiated host, MAPCs engraft and differentiate to the haematopoietic lineage, in addition to the epithelium of liver, lung and gut. Engraftment in the haematopoietic system as well as the gastrointestinal tract is increased when MAPCs are transplanted in a minimally irradiated host. As MAPCs proliferate extensively without obvious senescence or loss of differentiation potential, they may be an ideal cell source for therapy of inherited or degenerative diseases.	Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurosurg, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Verfaillie, CM (corresponding author), Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA.	verfa001@umn.edu	Schwartz, Robert/AAE-7153-2021; Mordwinkin, Nicholas M/A-4347-2010; Keene, Christopher D/N-1806-2015; Ortiz-Gonzalez, Xilma/AAD-2211-2021; Largaespada, David/C-9832-2014; Verfaillie, Catherine/H-5148-2013	Ortiz-Gonzalez, Xilma/0000-0002-1710-4696; Verfaillie, Catherine/0000-0001-7564-4079; Keene, Christopher/0000-0002-5291-1469				Alison M, 1998, J HEPATOL, V29, P676, DOI 10.1016/S0168-8278(98)80165-7; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BJORNSON C, 1999, SCIENCE, V283, P354; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Frankel MS, 2000, SCIENCE, V287, P1397, DOI 10.1126/science.287.5457.1397; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Kawada H, 2001, BLOOD, V98, P2008, DOI 10.1182/blood.V98.7.2008; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENVIK T, IN PRESS MOL THERAPY; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WATT F, 1997, PHIL T R SOC LOND B, V353, P831; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	49	4401	5286	10	703	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2002	418	6893					41	49		10.1038/nature00870	http://dx.doi.org/10.1038/nature00870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12077603				2022-12-24	WOS:000176599200033
J	Dian, BC; Longarte, A; Zwier, TS				Dian, BC; Longarte, A; Zwier, TS			Conformational dynamics in a dipeptide after single-mode vibrational excitation	SCIENCE			English	Article							SPECTROSCOPY; SIMULATION; MOLECULES	The dynamics of conformational isomerization are explored in methyl-capped dipeptide, N-acetyl-tryptophan methyl amide (NATMA), using infrared-ultraviolet (IR-UV) hole-filling and IR-induced population transfer spectroscopies. IR radiation selectively excites individual NH stretch vibrational fundamentals of single conformations of the molecule in the early portions of gas-phase expansion, and then this excited population is collisionally recooled into its conformational minima for subsequent conformation-specific detection. Efficient isomerization is induced by the IR excitation that redistributes population between the same conformations that have population in the absence of IR excitation. The quantum yields for transfer of the population into the various conformational minima depend uniquely on which conformation is excited and on which NH stretch vibration is excited within given conformation.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zwier, TS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.		Longarte, Asier/K-3623-2014	Longarte, Asier/0000-0001-6191-4576				CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crim FF, 1996, J PHYS CHEM-US, V100, P12725, DOI 10.1021/jp9604812; DIAN BC, UNPUB; EVANS DJF, COMMUNICATION; HEADGORDON T, 1991, J AM CHEM SOC, V113, P5989, DOI 10.1021/ja00016a010; Mortenson PN, 2001, J CHEM PHYS, V114, P6443, DOI 10.1063/1.1343486; Nesbitt DJ, 1996, J PHYS CHEM-US, V100, P12735, DOI 10.1021/jp960698w; Richards F. M., 1992, P1; TUBERGEN MJ, 1990, J CHEM PHYS, V92, P51, DOI 10.1063/1.458453; VACHEV VD, 1995, J PHYS CHEM-US, V99, P5247, DOI 10.1021/j100015a004; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+	11	172	179	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2369	2373		10.1126/science.1071563	http://dx.doi.org/10.1126/science.1071563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12029064				2022-12-24	WOS:000176467200034
J	Mitchell-Olds, T; Knight, CA				Mitchell-Olds, T; Knight, CA			Evolution: Chaperones as buffering agents?	SCIENCE			English	Editorial Material							HEAT-SHOCK; HSP90; CAPACITOR		Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Max Planck Society	Mitchell-Olds, T (corresponding author), Max Planck Inst Chem Ecol, Winzerlaer Str 10, D-07745 Jena, Germany.	tmo@ice.mpg.de	Mitchell-Olds, Thomas/K-8121-2012	Mitchell-Olds, Thomas/0000-0003-3439-9921				BETTENCOURT BR, IN PRESS EVOLUTION; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Knight CA, 2001, AM J BOT, V88, P411, DOI 10.2307/2657105; Lauter N, 2002, GENETICS, V160, P333; NECKERS L, 2002, TRENDS MOL MED S, V8, P56; Park SY, 1997, PLANT PHYSIOL, V115, P229, DOI 10.1104/pp.115.1.229; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Roberts SP, 2000, FUNCT ECOL, V14, P353, DOI 10.1046/j.1365-2435.2000.00429.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	12	33	34	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2002	296	5577					2348	2349		10.1126/science.1073846	http://dx.doi.org/10.1126/science.1073846			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12089432	Green Submitted			2022-12-24	WOS:000176467200028
J	Endre, G; Kereszt, A; Kevei, Z; Mihacea, S; Kalo, P; Kiss, GB				Endre, G; Kereszt, A; Kevei, Z; Mihacea, S; Kalo, P; Kiss, GB			A receptor kinase gene regulating symbiotic nodule development	NATURE			English	Article							MEDICAGO-TRUNCATULA; CALCIUM SPIKING; NODULATION SIGNALS; ALFALFA NODULATION; RHIZOBIUM-MELILOTI; ROOT HAIRS; TRANSDUCTION; RESPONSES; MUTANTS	Leguminous plants are able to establish a nitrogen-fixing symbiosis with soil bacteria generally known as rhizobia. Metabolites exuded by the plant root activate the production of a rhizobial signal molecule, the Nod factor, which is essential for symbiotic nodule development(1,2). This lipo-chitooligosaccharide signal is active at femtomolar concentrations, and its structure is correlated with host specificity of symbiosis(3), suggesting the involvement of a cognate perception system in the plant host. Here we describe the cloning of a gene from Medicago sativa that is essential for Nod-factor perception in alfalfa, and by genetic analogy, in the related legumes Medicago truncatula and Pisum sativum. The identified 'nodulation receptor kinase', NORK, is predicted to function in the Nod-factor perception/transduction system (the NORK system) that initiates a signal cascade leading to nodulation. The family of 'NORK extracellular-sequence-like' (NSL) genes is broadly distributed in the plant kingdom, although their biological function has not been previously ascribed. We suggest that during the evolution of symbiosis an ancestral NSL system was co-opted for transduction of an external ligand, the rhizobial Nod factor, leading to development of the symbiotic root nodule.	Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Kiss, GB (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, POB 521, H-6701 Szeged, Hungary.	kgb@nucleus.szbk.u-szeged.hu	poinssot, benoit/B-2569-2009; Kevei, Zoltan/AAF-5054-2021; Mihacea, Sorina/K-4167-2019; Kalo, Peter/A-3919-2012	poinssot, benoit/0000-0001-5890-4318; Kevei, Zoltan/0000-0002-3065-3198; Kalo, Peter/0000-0002-0404-8904; Kereszt, Attila/0000-0002-4421-6554				Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; BRADBURY SM, 1991, NEW PHYTOL, V119, P115, DOI 10.1111/j.1469-8137.1991.tb01014.x; CAETANOANOLLES G, 1993, CURR PLANT SCI BIOT, V17, P297; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Deeken R, 1997, PLANTA, V202, P479, DOI 10.1007/s004250050152; Doyle JJ, 1998, TRENDS PLANT SCI, V3, P473, DOI 10.1016/S1360-1385(98)01340-5; DUDLEY ME, 1989, PLANT CELL, V1, P65, DOI 10.1105/tpc.1.1.65; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Endre G, 2002, MOL GENET GENOMICS, V266, P1012, DOI 10.1007/s00438-001-0628-3; Felle HH, 1996, PLANT J, V10, P295, DOI 10.1046/j.1365-313X.1996.10020295.x; GianinazziPearson V, 1996, PLANT CELL, V8, P1871, DOI 10.1105/tpc.8.10.1871; Hajouj T, 2000, PLANT PHYSIOL, V124, P1305, DOI 10.1104/pp.124.3.1305; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Nam YW, 1999, THEOR APPL GENET, V98, P638, DOI 10.1007/s001220051115; PETERSON MA, 1981, CROP SCI, V21, P611, DOI 10.2135/cropsci1981.0011183X002100040033x; Pingret JL, 1998, PLANT CELL, V10, P659; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Schneider A, 1999, MOL GEN GENET, V262, P1, DOI 10.1007/s004380051053; SCHULTZE M, 1995, TRENDS MICROBIOL, V3, P370, DOI 10.1016/S0966-842X(00)88980-5; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Stougaard J, 2001, CURR OPIN PLANT BIOL, V4, P328, DOI 10.1016/S1369-5266(00)00181-3; SZABADOS L, 1995, MOL BREEDING, V1, P419, DOI 10.1007/BF01248419; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRUCHET G, 1989, MOL GEN GENET, V219, P65, DOI 10.1007/BF00261158; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097	30	543	618	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2002	417	6892					962	966		10.1038/nature00842	http://dx.doi.org/10.1038/nature00842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566RC	12087406				2022-12-24	WOS:000176441200042
J	Norhammar, A; Tenerz, A; Nilsson, G; Hamsten, A; Efendic, S; Ryden, L; Malmberg, K				Norhammar, A; Tenerz, A; Nilsson, G; Hamsten, A; Efendic, S; Ryden, L; Malmberg, K			Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study	LANCET			English	Article							CORONARY-HEART-DISEASE; STRESS HYPERGLYCEMIA; INSULIN-TREATMENT; RISK; TOLERANCE; TERM; PROGNOSIS; MORTALITY; ADMISSION; SURVIVAL	Background Glycometabolic state at hospital admission is an important risk marker for long-term mortality in patients with acute myocardial infarction, whether or not they have known diabetes mellitus. Our aim was to ascertain the prevalence of impaired glucose metabolism in patients without diagnosed diabetes but with myocardial infarction, and to assess whether such abnormalities can be identified in the early course of a myocardial infarction. Methods We did a prospective study, in which we enrolled 181 consecutive patients admitted to the coronary care units of two hospitals in Sweden with acute myocardial infarction, no diagnosis of diabetes, and a blood glucose concentration of less than 11.1 mmol/L. We recorded glucose concentrations during the hospital stay, and did standardised oral glucose tolerance tests with 75 g of glucose at discharge and again 3 months later. Findings The mean age of our cohort was 63.5 years (SD 9) and the mean blood glucose concentration at admission was 6.5 mmol/L (1.4). The mean 2-h postload blood glucose concentration was 9.2 mmol/L (2.9) at hospital discharge, and 9.0 mmol/L (3.0) 3 months later. 58 of 164 (35%, 95% CI 28-43) and 58 of 144 (40%, 32-48) individuals had impaired glucose tolerance at discharge and after 3 months, respectively, and 51 of 164 (31%, 24-38) and 36 of 144 (25%, 18-32) had previously undiagnosed diabetes mellitus. Independent predictors of abnormal glucose tolerance at 3 months were concentrations of HbA(1c) at admission (p=0.024) and fasting blood glucose concentrations on day 4 (p=0.044). Interpretation Previously undiagnosed diabetes and impaired glucose tolerance are common in patients with an acute myocardial infarction. These abnormalities can be detected early in the postinfarction period. Our results suggest that fasting and postchallenge hyperglycaemia in the early phase of an acute myocardial infarction could be used as early markers of high-risk individuals.	Karolinska Hosp, Dept Cardiol, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Endocrinol, S-17176 Stockholm, Sweden; Cent Hosp Vasteras, Dept Med, Vasteras, Sweden; Cent Hosp Vasteras, Clin Res Ctr, Vasteras, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Vasteras Central Hospital; Vasteras Central Hospital	Norhammar, A (corresponding author), Karolinska Hosp, Dept Cardiol, S-17176 Stockholm, Sweden.	anna.norhammar@ks.se		Norhammar, Anna/0000-0002-4467-0132				ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; ABBUD ZA, 1995, AM HEART J, V130, P51, DOI 10.1016/0002-8703(95)90235-X; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236; BELLODI G, 1989, AM J CARDIOL, V64, P885, DOI 10.1016/0002-9149(89)90836-9; Borch-Johnsen K, 1999, LANCET, V354, P617; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Fava S, 1996, DIABETIC MED, V13, P80, DOI 10.1002/(SICI)1096-9136(199601)13:1<80::AID-DIA10>3.3.CO;2-N; FULLER JH, 1980, LANCET, V1, P1373; Gavin JR, 1997, DIABETES CARE, V20, P1183; Jeppsson JO, 1996, DIABETES CARE, V19, P142, DOI 10.2337/diacare.19.2.142; Lindahl B, 1999, DIABETES CARE, V22, P1988, DOI 10.2337/diacare.22.12.1988; Mak K. H., 1993, Annals Academy of Medicine Singapore, V22, P291; Malmberg K, 1999, CIRCULATION, V99, P2626, DOI 10.1161/01.CIR.99.20.2626; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; MALMBERG K, 1988, EUR HEART J, V9, P259, DOI 10.1093/oxfordjournals.eurheartj.a062494; McKeigue PM, 1998, DIABETOLOGIA, V41, P1133, DOI 10.1007/s001250051042; Norhammar AM, 1999, DIABETES CARE, V22, P1827, DOI 10.2337/diacare.22.11.1827; ORLANDER PR, 1994, DIABETES, V43, P897, DOI 10.2337/diabetes.43.7.897; OSULLIVAN JJ, 1991, DIABETES CARE, V14, P758, DOI 10.2337/diacare.14.8.758; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; PYORALA K, 1979, J CHRON DIS, V32, P729, DOI 10.1016/0021-9681(79)90052-3; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Woodfield SL, 1996, J AM COLL CARDIOL, V28, P1661, DOI 10.1016/S0735-1097(96)00397-X; 2000, EUR HEART J, V21, P1502, DOI 10.1053/eurj.2000.2305	30	791	832	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2002	359	9324					2140	2144		10.1016/S0140-6736(02)09089-X	http://dx.doi.org/10.1016/S0140-6736(02)09089-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566RJ	12090978				2022-12-24	WOS:000176441800007
J	Bada, JL; Lazcano, A				Bada, JL; Lazcano, A			Origin of life - Some like it hot, but not the first biomolecules	SCIENCE			English	Editorial Material							ACID; RNA		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad Nacional Autonoma de Mexico	Bada, JL (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	alar@hp.fciencias.unam.mx		Lazcano, Antonio/0000-0001-7365-8557				BADA JL, 1994, P NATL ACAD SCI USA, V91, P1248, DOI 10.1073/pnas.91.4.1248; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Cody GD, 2001, GEOCHIM COSMOCHIM AC, V65, P3557, DOI 10.1016/S0016-7037(01)00674-3; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; FLEGMANN AW, 1979, J MOL EVOL, V12, P349, DOI 10.1007/BF01732029; Kanavarioti A, 2001, ASTROBIOLOGY, V1, P271, DOI 10.1089/15311070152757465; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Morowitz HJ, 2000, P NATL ACAD SCI USA, V97, P7704, DOI 10.1073/pnas.110153997; Nelson KE, 2000, P NATL ACAD SCI USA, V97, P3868, DOI 10.1073/pnas.97.8.3868; NIELSEN PE, 1993, ORIGINS LIFE EVOL B, V23, P323, DOI 10.1007/BF01582083; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; SCHOPF JW, 1999, CRADLE LIFE DISCOVER, P336; Sowerby SJ, 2001, ASTROBIOLOGY, V1, P481, DOI 10.1089/153110701753593883; WACHTERSHAUSER G, 1994, P NATL ACAD SCI USA, V91, P4283, DOI 10.1073/pnas.91.10.4283; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wills C., 2000, SPARK LIFE DARWIN PR; YCAS M, 1955, P NATL ACAD SCI USA, V41, P714, DOI 10.1073/pnas.41.10.714	23	166	172	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					1982	1983		10.1126/science.1069487	http://dx.doi.org/10.1126/science.1069487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12065824				2022-12-24	WOS:000176273300039
J	Shalitin, D; Yang, HY; Mockler, TC; Maymon, M; Guo, HW; Whitelam, GC; Lin, CT				Shalitin, D; Yang, HY; Mockler, TC; Maymon, M; Guo, HW; Whitelam, GC; Lin, CT			Regulation of Arabidopsis cryptochrome 2 by blue-light-dependent phosphorylation	NATURE			English	Article							FLOWERING TIME; RECEPTOR CRYPTOCHROME-2; PHYTOCHROME-B; PHOTORECEPTORS; PLANT; MUTANTS; GROWTH; CRY1; COP1	Cryptochromes are blue/ultraviolet-A light receptors that mediate various light responses in plants and animals(1,2). But the initial photochemical reaction of cryptochrome is still unclear. For example, although most photoreceptors are known to undergo light-dependent protein modification such as phosphorylation (3,4), no blue-light dependent phosphorylation has been reported for a cryptochrome. Arabidopsis cryptochrome 2 (cry2) mediates light regulation of seedling development and photoperiodic flowering(5,6). The physiological activity and cellular level of cry2 protein are light-dependent(5-8), and protein-protein interactions are important for cry2 function(9,10). Here we report that cry2 undergoes a blue-light-dependent phosphorylation, and that cry2 phosphorylation is associated with its function and regulation. Our results suggest that, in the absence of light, cry2 remains unphosphorylated, inactive and stable; absorption of blue light induces the phosphorylation of cry2, triggering photomorphogenic responses and eventually degradation of the photoreceptor.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of California System; University of California Los Angeles; University of Leicester	Lin, CT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clin@mcdb.ucla.edu	Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056265] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056265] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Buche C, 2000, PLANT CELL, V12, P547, DOI 10.1105/tpc.12.4.547; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; CHORY J, 1989, CELL, V58, P991, DOI 10.1016/0092-8674(89)90950-1; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; HOLMES MG, 1991, PHOTORECEPTOR EVOLUT; Kwok SF, 1996, PLANT PHYSIOL, V110, P731, DOI 10.1104/pp.110.3.731; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; MCNELLIS TW, 1994, PLANT CELL, V6, P487, DOI 10.1105/tpc.6.4.487; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	29	213	232	5	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					763	767		10.1038/nature00815	http://dx.doi.org/10.1038/nature00815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12066190				2022-12-24	WOS:000176154700050
J	Davies, RJ; Freeman, A; Morris, LS; Bingham, S; Dilworth, S; Scott, I; Laskey, RA; Miller, R; Coleman, N				Davies, RJ; Freeman, A; Morris, LS; Bingham, S; Dilworth, S; Scott, I; Laskey, RA; Miller, R; Coleman, N			Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool	LANCET			English	Article							DNA	Colorectal cancer Is a common disease, and more reliable screening methods are needed for early detection. We aim to develop a non-Invasive, stool-based assay that can identify colorectal cancer by detection of minichromosome maintenance protein 2 (MCM2) expression in colonocytes retrieved from the faecal surface. We devised a cell line model to investigate methods and conditions for optimum colonocyte retrieval. In our clinical evaluation study, MCM2-positive cells were retrieved from 37 of 40 patients with symptomatic colorectal cancer, but from none of 25 healthy control Individuals. These results suggest that immunocytochemical analysis of retrieved colonocytes might enable accurate detection of colorectal cancer in stool.	MRC, Canc Cell Univ, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England; Addenbrookes NHS Trust, Dept Surg, Cambridge CB2 2QQ, England; MRC, Dunn Human Nutr Unit, Cambridge, England; Hammersmith Hosp, Imperial Coll Sch Med, Dept Metab Med, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Imperial College London	Coleman, N (corresponding author), MRC, Canc Cell Univ, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England.							Freeman A, 1999, CLIN CANCER RES, V5, P2121; Loktionov A, 1998, CLIN CANCER RES, V4, P337; Mukherjee G, 2001, INT J GYNECOL CANCER, V11, P187, DOI 10.1046/j.1525-1438.2001.01014.x; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932	5	120	129	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 1	2002	359	9321					1917	1919		10.1016/S0140-6736(02)08739-1	http://dx.doi.org/10.1016/S0140-6736(02)08739-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PL	12057556				2022-12-24	WOS:000175975700013
J	Nicoll, A; Hamers, FF				Nicoll, A; Hamers, FF			Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEISSERIA-GONORRHOEAE; SURVEILLANCE; TRANSMISSION; EPIDEMIOLOGY		Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; European Ctr Epidemiol Monitoring AIDS EuroHIV, Inst Veille Sanit, F-94415 St Maurice, France	Public Health England; Institute of Public Health Surveillance	Nicoll, A (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.	anicoll@phls.org.uk						Catchpole MA, 1996, GENITOURIN MED, V72, P321; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; *COMM DIS SURV CTR, 2000, CDR WKLY, V10, P453; *COMM DIS SURV CTR, 2001, COMM DIS REP CDR WKL, V11; *DEP HLTH, 2001, NATL STRAT SEX HLTH; DOHERTY L, 2000, EUROSURVEILLANCE WEE, V4; *EUR CTR EP MON AI, 2001, HIV AIDS SURV EUR EN, V64; Fennema J S, 2000, Ned Tijdschr Geneeskd, V144, P602; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Goulet V, 2000, Euro Surveill, V5, P2; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; *JOINT UN PROGR HI, 2000, AIDS EP UPD DEC 2000; Kyriakis KP, 1999, SEX TRANSM DIS, V26, P43, DOI 10.1097/00007435-199901000-00007; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; *PUBL HLTH LAB SER, 2001, TRENDS SEX TRANSM IN; RENTON AM, 1994, SOC SCI MED, V38, P1153, DOI 10.1016/0277-9536(94)90230-5; *SWED I INF DIS CO, 2001, COMM DIS SWED 2000; van de Laar MJW, 1997, GENITOURIN MED, V73, P510; Van der Heyden JHA, 2000, SEX TRANSM INFECT, V76, P110, DOI 10.1136/sti.76.2.110; van Duynhoven YTHP, 1999, MICROBES INFECT, V1, P455, DOI 10.1016/S1286-4579(99)80049-5; WELLINGS K, 1996, STOPPING AIDS AIDS H; *WHO EUR STI TASK, 2002, OV HIV AIDS STI SIT	22	118	119	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1324	1327		10.1136/bmj.324.7349.1324	http://dx.doi.org/10.1136/bmj.324.7349.1324			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039830	Green Published			2022-12-24	WOS:000176041500023
J	Beaugrand, G; Reid, PC; Ibanez, F; Lindley, JA; Edwards, M				Beaugrand, G; Reid, PC; Ibanez, F; Lindley, JA; Edwards, M			Reorganization of North Atlantic marine copepod biodiversity and climate	SCIENCE			English	Article							CALANOID COPEPODS; SEA; RANGES; COD	We provide evidence of large-scale changes in the biogeography of calanoid copepod crustaceans in the eastern North Atlantic Ocean and European shelf seas. We demonstrate that strong biogeographical shifts in all copepod assemblages have occurred with a northward extension of more than 10degrees latitude of warm-water species associated with a decrease in the number of colder-water species. These biogeographical shifts are in agreement with recent changes in the spatial distribution and phenology detected for many taxonomic groups in terrestrial European ecosystems and are related to both the increasing trend in Northern Hemisphere temperature and the North Atlantic Oscillation.	Sir Alister Hardy Fdn Ocean Sci, Lab Citadel Hill, Plymouth PL1 2PB, Devon, England; Observ Oceanol, Lab Oceanol Biol & Ecol Plancton Marin, F-06230 Villefranche Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite	Beaugrand, G (corresponding author), Sir Alister Hardy Fdn Ocean Sci, Lab Citadel Hill, Plymouth PL1 2PB, Devon, England.			BEAUGRAND, GREGORY/0000-0002-0712-5223; Edwards, Martin/0000-0002-5716-4714				Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2001, MAR ECOL PROG SER, V219, P189, DOI 10.3354/meps219189; BEAUGRAND G, IN PRESS MAR ECOL PR; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Dickson R.R., 2000, P92; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Quero JC, 1998, OCEANOL ACTA, V21, P345, DOI 10.1016/S0399-1784(98)80021-2; Reid PC, 2001, MAR ECOL PROG SER, V215, P283, DOI 10.3354/meps215283; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6	19	864	907	4	322	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1692	1694		10.1126/science.1071329	http://dx.doi.org/10.1126/science.1071329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040196				2022-12-24	WOS:000175976200060
J	Matsuda, M; Nagahama, Y; Shinomiya, A; Sato, T; Matsuda, C; Kobayashi, T; Morrey, CE; Shibata, N; Asakawa, S; Shimizu, N; Hori, H; Hamaguchi, S; Sakaizumi, M				Matsuda, M; Nagahama, Y; Shinomiya, A; Sato, T; Matsuda, C; Kobayashi, T; Morrey, CE; Shibata, N; Asakawa, S; Shimizu, N; Hori, H; Hamaguchi, S; Sakaizumi, M			DMY is a Y-specific DM-domain gene required for male development in the medaka fish	NATURE			English	Article							SEX-CHROMOSOMES; ORYZIAS-LATIPES; TELEOST FISH; GERM-CELLS; EXPRESSION; DMRT1; DNA; DIFFERENTIATION; SPERMATOGENESIS; CONSTRUCTION	Although the sex-determining gene Sry has been identified in mammals(1), no comparable genes have been found in non-mammalian vertebrates. Here, we used recombinant breakpoint analysis to restrict the sex-determining region in medaka fish (Oryzias latipes) to a 530-kilobase (kb) stretch of the Y chromosome. Deletion analysis of the Y chromosome of a congenic XY female further shortened the region to 250 kb. Shotgun sequencing of this region predicted 27 genes. Three of these genes were expressed during sexual differentiation. However, only the DM-related(2) PG17 was Y specific; we thus named it DMY. Two naturally occurring mutations establish DMY's critical role in male development. The first heritable mutant-a single insertion in exon 3 and the subsequent truncation of DMY-resulted in all XY female offspring. Similarly, the second XY mutant female showed reduced DMY expression with a high proportion of XY female offspring. During normal development, DMY is expressed only in somatic cells of XY gonads. These findings strongly suggest that the sex-specific DMY is required for testicular development and is a prime candidate for the medaka sex-determining gene.	Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; Shinshu Univ, Fac Sci, Dept Biol, Nagano 3908621, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Niigata University; Shinshu University; Keio University; Nagoya University	Nagahama, Y (corresponding author), Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan.	nagahama@nibb.ac.jp		SHINOMIYA, Ai/0000-0003-3784-0532				Aida T, 1921, GENETICS, V6, P554; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brunner B, 2001, GENOMICS, V77, P8, DOI 10.1006/geno.2001.6615; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; Guan GJ, 2000, BIOCHEM BIOPH RES CO, V272, P662, DOI 10.1006/bbrc.2000.2840; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; HYODOTAGUCHI Y, 1993, MEDAKA, V5, P29; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Matsuda M, 1999, GENET RES, V73, P225, DOI 10.1017/S0016672399003754; Matsuda M, 1998, CYTOGENET CELL GENET, V82, P257, DOI 10.1159/000015113; Matsuda M, 1997, ZOOL SCI, V14, P517, DOI 10.2108/zsj.14.517; Matsuda M, 2001, GENES GENET SYST, V76, P61, DOI 10.1266/ggs.76.61; Matsuda M, 1997, GENES GENET SYST, V72, P263, DOI 10.1266/ggs.72.263; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; RAGOUSSIS J, 1997, GENOME MAPPING PRACT, P253; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Sato T, 2001, GENETICA, V111, P71, DOI 10.1023/A:1013755701696; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; UWA H, 1981, P JPN ACAD B-PHYS, V57, P39, DOI 10.2183/pjab.57.39; YAMAMOTO T, 1961, J EXP ZOOL, V146, P163, DOI 10.1002/jez.1401460206	27	1023	1118	17	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					559	563		10.1038/nature751	http://dx.doi.org/10.1038/nature751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037570				2022-12-24	WOS:000175860300045
J	Murdoch, WW; Kendall, BE; Nisbet, RM; Briggs, CJ; McCauley, E; Bolser, R				Murdoch, WW; Kendall, BE; Nisbet, RM; Briggs, CJ; McCauley, E; Bolser, R			Single-species models for many-species food webs	NATURE			English	Article							POPULATION-CYCLES; SPECTRAL-ANALYSIS; DYNAMICS; PATTERNS; BEHAVIOR	Most species live in species-rich food webs; yet, for a century, most mathematical models for population dynamics have included only one or two species(1-3). We ask whether such models are relevant to the real world. Two-species population models of an interacting consumer and resource collapse to one-species dynamics when recruitment to the resource population is unrelated to resource abundance, thereby weakening the coupling between consumer and resource(4-6). We predict that, in nature, generalist consumers that feed on many species should similarly show one-species dynamics. We test this prediction using cyclic populations, in which it is easier to infer underlying mechanisms(7), and which are widespread in nature(8). Here we show that one-species cycles can be distinguished from consumer-resource cycles by their periods. We then analyse a large number of time series from cyclic populations in nature and show that almost all cycling, generalist consumers examined have periods that are consistent with one-species dynamics. Thus generalist consumers indeed behave as if they were one-species populations, and a one-species model is a valid representation for generalist population dynamics in many-species food webs.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calgary, Div Ecol, Calgary, AB T2N 1N4, Canada	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; University of Calgary	Murdoch, WW (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	murdoch@lifesci.ucsb.edu	Kendall, Bruce/C-1871-2008; Briggs, Cheryl/F-7456-2013; Nisbet, Roger M/B-6951-2014	Kendall, Bruce/0000-0003-1782-8106; 				Berryman AA, 1996, TRENDS ECOL EVOL, V11, P28, DOI 10.1016/0169-5347(96)81066-4; Bjornstad ON, 2001, NATURE, V409, P1001, DOI 10.1038/35059003; BLYTHE SP, 1982, THEOR POPUL BIOL, V22, P147, DOI 10.1016/0040-5809(82)90040-5; Briggs CJ, 1999, J MATH BIOL, V38, P317, DOI 10.1007/s002850050151; BULMER MG, 1974, J ANIM ECOL, V43, P701, DOI 10.2307/3532; Finerty J. P, 1980, POPULATION ECOLOGY C; GINZBURG LR, 1994, J ANIM ECOL, V63, P79, DOI 10.2307/5585; Gurney W., 1998, ECOLOGICAL DYNAMICS; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; Higgins K, 1997, AM NAT, V149, P247, DOI 10.1086/285989; JONES AE, 1988, J MATH ANAL APPL, V135, P354, DOI 10.1016/0022-247X(88)90160-6; Kendall BE, 1998, ECOL LETT, V1, P160; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; LAUWERIER H A, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P191; LEES JM, 1995, COMPUT GEOSCI, V21, P199, DOI 10.1016/0098-3004(94)00067-5; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; LOTKA AJ, 1925, ELEMENTS PHYSICAL BI; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; *NERC, 1999, IMP COLL GLOB POP DY; NISBET RM, 1989, AM NAT, V134, P377, DOI 10.1086/284987; Nisbet RM, 1982, MODELLING FLUCTUATIN; O'Donoghue M, 2001, ECOSYSTEM DYNAMICS OF THE BOREAL FOREST, P324; PARK J, 1987, J GEOPHYS RES-SOLID, V92, P12675, DOI 10.1029/JB092iB12p12675; Persson L, 1998, THEOR POPUL BIOL, V54, P270, DOI 10.1006/tpbi.1998.1380; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433	27	130	134	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					541	543		10.1038/417541a	http://dx.doi.org/10.1038/417541a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037520				2022-12-24	WOS:000175860300040
J	Sun, JY; Wu, XS; Wu, LG				Sun, JY; Wu, XS; Wu, LG			Single and multiple vesicle fusion induce different rates of endocytosis at a central synapse	NATURE			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; CHROMAFFIN CELLS; TIME-COURSE; CALCIUM; EXOCYTOSIS; CALYX; KINETICS; CAPACITANCE	During synaptic transmission, neurotransmitter-laden vesicles fuse with the presynaptic membrane and discharge their contents into the synaptic cleft. After fusion, the vesicular membrane is retrieved by endocytosis for reuse. This recycling mechanism(1) ensures a constant supply of releasable vesicles at the nerve terminal(1). The kinetics of endocytosis have been measured mostly after intense or non-physiological stimulation(2-13). Here we use capacitance measurements to resolve the fusion and retrieval of single and multiple vesicles following mild physiological stimulation at a mammalian central synapse. The time constant of endocytosis after single vesicle fusion was 56 ms; after a single action potential or trains at less than or equal to2 Hz it was about 115 ms, but increased gradually to tens of seconds as the frequency and the number of action potentials increased. These results indicate that an increase in the rate of exocytosis at the active zone induces a decrease in the rate of endocytosis. Existing models(5,10), including inhibition of endocytosis by Ca2+, could not account for these results-our results suggest that an accumulation of unretrieved vesicles at the plasma membrane slows endocytosis. These findings may resolve the debate about the dependence of endocytosis kinetics on the stimulation frequency(2,3), and suggest a potential role of regulation of endocytosis in short-term synaptic depression.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wu, LG (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.							Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SATZLER K, 2001, SOC NEUR ABSTR, V27; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8	30	181	187	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					555	559		10.1038/417555a	http://dx.doi.org/10.1038/417555a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037569				2022-12-24	WOS:000175860300044
J	Metodiev, MV; Matheos, D; Rose, MD; Stone, DE				Metodiev, MV; Matheos, D; Rose, MD; Stone, DE			Regulation of MAPK function by direct interaction with the mating-specific G alpha in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TYROSINE-KINASE; PROTEIN; PHEROMONE; PATHWAY; SIGNAL; PHOSPHORYLATION; ADAPTATION; EXPRESSION; MUTATION	The mating response of the budding yeast Saccharomyces cerevisiae is mediated by a prototypical heterotrimeric GTP-binding protein (G protein) and mitogen-activated protein kinase (MAPK) cascade. Although signal transmission by such pathways has been modeled in detail, postreceptor down-regulation is less well understood. The pheromone-responsive G protein alpha subunit (Galpha) of yeast down-regulates the mating signal, but its targets are unknown. We have found that Galpha binds directly to the mating-specific MAPK in yeast cells responding to pheromone. This interaction contributes both to modulation of the mating signal and to the chemotropic response, and it demonstrates direct communication between the top and bottom of a Galpha-MAPK pathway.	Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Princeton University	Stone, DE (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave,M-C 567, Chicago, IL 60607 USA.			Metodiev, Metodi V/0000-0001-6810-0719; Rose, Mark/0000-0003-1112-4765	NIGMS NIH HHS [R01 GM037739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Choi YS, 1999, INT J MOD PHYS C, V10, P1, DOI 10.1142/S0129183199000024; Cismowski MJ, 2001, BIOCHEM BIOPH RES CO, V284, P247, DOI 10.1006/bbrc.2001.4959; COLE GM, 1991, CELL, V64, P703, DOI 10.1016/0092-8674(91)90500-X; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; DORER R, 1995, J CELL BIOL, V131, P854; FUJIMURA HA, 1994, J CELL SCI, V107, P2617; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Li E, 1998, GENETICS, V148, P947; Li E, 1998, MOL GEN GENET, V258, P608, DOI 10.1007/s004380050774; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; MIYAJIMA I, 1989, MOL CELL BIOL, V9, P2289, DOI 10.1128/MCB.9.6.2289; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Schrick K, 1997, GENETICS, V147, P19; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Stratton HF, 1996, MOL CELL BIOL, V16, P6325; Zhou Jianlong, 1999, Cell Biochemistry and Biophysics, V30, P193, DOI 10.1007/BF02738067	22	76	79	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1483	1486		10.1126/science.1070540	http://dx.doi.org/10.1126/science.1070540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029138				2022-12-24	WOS:000175910300053
J	Jayaram, H; Taraporewala, Z; Patton, JT; Prasad, BVV				Jayaram, H; Taraporewala, Z; Patton, JT; Prasad, BVV			Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold	NATURE			English	Article							TEMPERATURE-SENSITIVE MUTANTS; SINGLE-STRANDED RNA; NONSTRUCTURAL PROTEIN; BLUETONGUE VIRUS; BINDING-PROTEINS; NSP2; MULTIMERS; LOCALIZATION; CORE; NS2	Rotavirus, the major cause of life-threatening infantile gastroenteritis, is a member of the Reoviridae(1). Although the structures of rotavirus 2 and other members of the Reoviridae(3,4) have been extensively studied, little is known about the structures of virus-encoded non-structural proteins that are essential for genome replication and packaging. The non-structural protein NSP2 of rotavirus, which exhibits nucleoside triphosphatase, single-stranded RNA binding(5), and nucleic-acid helix-destabilizing(6) activities, is a major component of viral replicase complexes(7,8). We present here the X-ray structure of the functional octamer(9) of NSP2 determined to a resolution of 2.6 Angstrom. The NSP2 monomer has two distinct domains. The amino-terminal domain has a new fold. The carboxy-terminal domain resembles the ubiquitous cellular histidine triad (HIT) group of nucleotidyl hydrolases(10). This structural similarity suggests that the nucleotide-binding site is located inside the cleft between the two domains. Prominent grooves that run diagonally across the doughnut-shaped octamer are probable locations for RNA binding. Several RNA binding sites, resulting from the quaternary organization of NSP2 monomers, may be required for the helix destabilizing activity of NSP2 and its function during genome replication and packaging.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Prasad, BVV (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.		Patton, John T/P-1390-2014; Patton, John/V-7651-2018	Prasad, B.V.Venkataram/0000-0002-1172-2071; Patton, John/0000-0003-1572-0732	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000754, Z01AI000754] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aponte C, 1996, J VIROL, V70, P985, DOI 10.1128/JVI.70.2.985-991.1996; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN DY, 1990, VIROLOGY, V178, P143, DOI 10.1016/0042-6822(90)90387-7; Cohen J, 2001, SCIENCE, V293, P1576, DOI 10.1126/science.293.5535.1576; ESTES MK, 1996, VIROLOGY, P1625; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Gillian AL, 2000, J VIROL, V74, P5939, DOI 10.1128/JVI.74.13.5939-5948.2000; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATTOURA MD, 1994, VIROLOGY, V202, P803, DOI 10.1006/viro.1994.1402; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; LIMA CD, 1906, P NATL ACAD SCI USA, V28, P5357; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETRIE BL, 1984, VIRUS RES, V1, P133, DOI 10.1016/0168-1702(84)90069-8; Prasad BVV, 1996, NATURE, V382, P471, DOI 10.1038/382471a0; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; RAMIG RF, 1984, J VIROL, V49, P665, DOI 10.1128/JVI.49.3.665-673.1984; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Taraporewala Z, 1999, J VIROL, V73, P9934, DOI 10.1128/JVI.73.12.9934-9943.1999; Taraporewala ZF, 2001, VIROLOGY, V280, P221, DOI 10.1006/viro.2000.0764; TATAPOREWALA Z, 2001, J VIROL, V75, P4519; UITENWEERDE JM, 1995, VIROLOGY, V209, P624, DOI 10.1006/viro.1995.1294	30	73	81	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					311	315		10.1038/417311a	http://dx.doi.org/10.1038/417311a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015608				2022-12-24	WOS:000175592100053
J	Torsvik, V; Ovreas, L; Thingstad, TF				Torsvik, V; Ovreas, L; Thingstad, TF			Prokaryotic diversity - Magnitude, dynamics, and controlling factors	SCIENCE			English	Article							MICROBIAL DIVERSITY; VIRUSES; SOIL	There are probably millions of species in the microorganismal domains Bacteria and Archaea (the prokaryotes), and we are only just beginning to work out the basic principles governing their distribution and abundance in natural environments. One characteristic that has become clear is that prokaryote diversity in aquatic environments is orders of magnitude less than in sediments and soils. Hypotheses and models explaining such differences are under development and are beginning to offer promising insights into the mechanisms governing prokaryote diversity and ecosystem function.	Univ Bergen, Dept Microbiol, N-5020 Bergen, Norway	University of Bergen	Torsvik, V (corresponding author), Univ Bergen, Dept Microbiol, Jahnebakken 5, N-5020 Bergen, Norway.	vigdis.torsvik@im.uib.no	Øvreås, Lise/H-8651-2016; Thingstad, Tron Frede/B-2254-2008; Carneiro, Fernanda/E-9513-2013	Thingstad, Tron Frede/0000-0002-5593-819X; Carneiro, Fernanda/0000-0001-6389-4564				ATLAS RM, 1984, ADV MICROB ECOL, V7, P1; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; COLWELL RR, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P3; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CURTIS TP, 2001, 9 INT S MICR EC INT; DRAKE LC, 1988, AQUAT MICROB ECOL, V16, P17; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ovreas L, 1998, MICROB ECOL, V36, P303, DOI 10.1007/s002489900117; OVREAS L, 2001, 9 INT S MICR EC INT; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Ritz K, 1997, FEMS MICROBIOL LETT, V149, P151, DOI 10.1111/j.1574-6968.1997.tb10322.x; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Simek K, 1999, LIMNOL OCEANOGR, V44, P1634; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tiedje J. M., 2001, Sustainable management of soil organic matter, P393, DOI 10.1079/9780851994659.0393; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; TORSVIK V, 1995, NUCL ACIDS ENV METHO, P29; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	22	755	823	6	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1064	1066		10.1126/science.1071698	http://dx.doi.org/10.1126/science.1071698			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004116				2022-12-24	WOS:000175565000038
J	Tree, DRP; Shulman, JM; Rousset, R; Scott, MP; Gubb, D; Axelrod, JD				Tree, DRP; Shulman, JM; Rousset, R; Scott, MP; Gubb, D; Axelrod, JD			Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling	CELL			English	Article							TISSUE POLARITY; DROSOPHILA EYE; HAIR MORPHOGENESIS; NOTCH ACTIVATION; GENETIC MOSAICS; WINGLESS; PROTEIN; ENCODES; FATE; POLARIZATION	Planar cell polarity signaling in Drosophila requires the receptor Frizzled and the cytoplasmic proteins Dishevelled and Prickle. From initial, symmetric subcellular distributions in pupal wing cells, Frizzled and Dishevelled become highly enriched at the distal portion of the cell cortex. We describe a Prickle-dependent intercellular feedback loop that generates asymmetric Frizzled and Dishevelled localization. In the absence of Prickle, Frizzled and Dishevelled remain symmetrically distributed. Prickle localizes to the proximal side of pupal wing cells and binds the Dishevelled DEP domain, inhibiting Dishevelled membrane localization and antagonizing Frizzled accumulation. This activity is linked to Frizzled activity on the adjacent cell surface. Prickle therefore functions in a feedback loop that amplifies differences between Frizzled levels on adjacent cell surfaces.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Genet, Stanford, CA 94305 USA	Stanford University; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.		Gubb, David/F-9793-2011; Rousset, Raphael/E-5908-2017	Rousset, Raphael/0000-0002-4999-403X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ADLER PN, 1994, MECH DEVELOP, V46, P101, DOI 10.1016/0925-4773(94)90079-5; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; ADLER PN, 1994, GENETICS, V137, P829; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; AXELROD JD, 2002, IN PRESS SCI WORLD; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chae J, 1999, DEVELOPMENT, V126, P5421; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1998, INT J DEV BIOL, V42, P369; GUBB D, 1993, DEVELOPMENT, P269; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt H, 1999, CURR OPIN GENET DEV, V9, P442, DOI 10.1016/S0959-437X(99)80067-7; Taylor J, 1998, GENETICS, V150, P199; THIESEN H, 1994, DEVELOPMENT, V120, P347; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wolff T, 1998, DEVELOPMENT, V125, P1149; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	47	334	337	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					371	381		10.1016/S0092-8674(02)00715-8	http://dx.doi.org/10.1016/S0092-8674(02)00715-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015986	Bronze			2022-12-24	WOS:000175412100012
J	Mayberry, RI; Lock, E; Kazmi, H				Mayberry, RI; Lock, E; Kazmi, H			Development - Linguistic ability and early language exposure	NATURE			English	Article							CRITICAL PERIOD; ACQUISITION; AGE		McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ H3G 1A8, Canada; Univ Ottawa, Fac Med, Ottawa, ON K1H 8L6, Canada; Univ Western Ontario, Elborn Coll, Sch Commun Sci & Disorders, London, ON N6G 1H1, Canada	McGill University; University of Ottawa; Western University (University of Western Ontario)	Mayberry, RI (corresponding author), McGill Univ, Sch Commun Sci & Disorders, 1266 Pine Ave W, Montreal, PQ H3G 1A8, Canada.							COLOMBO J, 1982, PSYCHOL BULL, V91, P260, DOI 10.1037/0033-2909.91.2.260; EMMOREY K, 1995, APPL PSYCHOLINGUIST, V16, P1, DOI 10.1017/S0142716400006391; Goldberg MC, 2001, DEV NEUROPSYCHOL, V19, P53, DOI 10.1207/S15326942DN1901_5; GREENOUGH WT, 1992, MINN SYM CHILD PSYCH, V24, P155; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kolb B, 1998, NEUROSCI BIOBEHAV R, V22, P143, DOI 10.1016/S0149-7634(97)00008-0; Lenneberg E.H., 1967, HOSP PRACT, V2, P59, DOI [10.1080/21548331.1967.11707799, DOI 10.1080/21548331.1967.11707799]; MAYBERRY RI, 1993, J SPEECH HEAR RES, V36, P1258, DOI 10.1044/jshr.3606.1258; MAYBERRY RI, 1991, J MEM LANG, V30, P486, DOI 10.1016/0749-596X(91)90018-F; MAYBERRY RI, IN PRESS CHILD NEURO; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	12	169	171	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2002	417	6884					38	38		10.1038/417038a	http://dx.doi.org/10.1038/417038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546ZM	11986658	Bronze			2022-12-24	WOS:000175307200030
J	Soussi-Yanicostas, N; de Castro, F; Julliard, AK; Perfettini, I; Chedotal, A; Petit, C				Soussi-Yanicostas, N; de Castro, F; Julliard, AK; Perfettini, I; Chedotal, A; Petit, C			Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; MITRAL CELL AXONS; SENSORY PROJECTIONS; NEUROTROPHIC FACTOR; SEMAPHORIN-III; SYNDROME GENE; GROWTH; GUIDANCE; PROTEIN; EXPRESSION	The physiological role of anosmin-1, defective in the X chromosome-linked form of Kallmann syndrome, is not yet known. Here, we show that anti-anosmin-1 antibodies block the formation of the collateral branches of rat olfactory bulb output neurons (mitral and tufted cells) in organotypic cultures. Moreover, anosmin-1 greatly enhances axonal branching of these dissociated neurons in culture. In addition, coculture experiments with either piriform cortex or anosmin-1-producing CHO cells demonstrate that anosmin-1 is a chemoattractant for the axons of these neurons, suggesting that this protein, which is expressed in the piriform cortex, attracts their collateral branches in vivo. We conclude that anosmin-1 has a dual branch-promoting and guidance activity, which plays an essential role in the patterning of mitral and tufted cell axon collaterals to the olfactory cortex.	Inst Pasteur, Unite Genet Deficits Sensoriels, CNRS, Unite Rech Associee 1968, F-75724 Paris 15, France; Hop La Pitie Salpetriere, INSERM, U106, F-75651 Paris 13, France; Hosp Ramon & Cajal, Dept Invest, Serv Neurobiol, E-28034 Madrid, Spain; Univ Lyon 1, Lab Neurosci & Syst Sensoriels, CNRS, Unite Rech Mixte 5020, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario Ramon y Cajal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Soussi-Yanicostas, N (corresponding author), Inst Pasteur, Unite Genet Deficits Sensoriels, CNRS, Unite Rech Associee 1968, 25 Rue Dr Roux, F-75724 Paris 15, France.	nyani@pasteur.fr; cpetit@pasteur.fr	de Castro, Fernando/Q-8624-2018; Julliard, Andrée Karyn/N-8082-2017; Chedotal, Alain/F-2750-2017; Soussi-Yanicostas, Nadia/GPF-8264-2022; Soussi-Yanicostas, Nadia/U-6339-2018	de Castro, Fernando/0000-0002-7018-8032; Julliard, Andrée Karyn/0000-0002-3464-7529; Chedotal, Alain/0000-0001-7577-3794; Soussi-Yanicostas, Nadia/0000-0001-7734-9401; Petit, Christine/0000-0002-9069-002X				Ardouin O, 2000, MECH DEVELOP, V90, P89, DOI 10.1016/S0925-4773(99)00222-1; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BUELOW HE, 2002, IN PRESS P NATL ACAD; Chedotal A, 1998, DEVELOPMENT, V125, P4313; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; de Castro F, 1999, J NEUROSCI, V19, P4428; De Morster G, 1954, SCHWEIZ ARCH NEUROL, V74, P309; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Graves JAM, 1998, HUM MOL GENET, V7, P1991, DOI 10.1093/hmg/7.13.1991; Hardelin JP, 1999, DEV DYNAM, V215, P26, DOI 10.1002/(SICI)1097-0177(199905)215:1<26::AID-DVDY4>3.3.CO;2-4; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; Hirata T, 1999, J NEUROBIOL, V38, P93; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Hirata T, 2001, J NEUROSCI, V21, P2373, DOI 10.1523/JNEUROSCI.21-07-02373.2001; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Krams M, 1999, NEUROLOGY, V52, P816, DOI 10.1212/WNL.52.4.816; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEGOUIS R, 1993, GENOMICS, V17, P516, DOI 10.1006/geno.1993.1360; LEGOUIS R, 1993, P NATL ACAD SCI USA, V90, P2461, DOI 10.1073/pnas.90.6.2461; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LopezMascaraque L, 1996, NEUROSCIENCE, V70, P255, DOI 10.1016/0306-4522(95)00360-U; Maestre de San Juan A., 1856, SIGLO MED, V3, P211; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NAFTOLIN F, 1971, NATURE, V232, P496, DOI 10.1038/232496a0; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1991, DEVELOPMENT, P123; Patel K, 2001, DEVELOPMENT, V128, P5031; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Rugarli EI, 1996, HUM MOL GENET, V5, P1109, DOI 10.1093/hmg/5.8.1109; Salido EC, 1996, NAT GENET, V13, P83, DOI 10.1038/ng0596-83; Sato Y, 1998, J NEUROSCI, V18, P7800; SCHWANKHAUS JD, 1989, NEUROLOGY, V39, P223, DOI 10.1212/WNL.39.2.223; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shipley Michael T., 1995, P899; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; SoussiYanicostas N, 1996, J CELL SCI, V109, P1749; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Yang XM, 1998, J NEUROSCI, V18, P8369; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	54	151	155	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					217	228		10.1016/S0092-8674(02)00713-4	http://dx.doi.org/10.1016/S0092-8674(02)00713-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007408	Bronze			2022-12-24	WOS:000175082600011
J	Crawford, LM				Crawford, LM			Drugs-herbals workshop	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2002	288	1					36	36		10.1001/jama.288.1.36	http://dx.doi.org/10.1001/jama.288.1.36			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	568YW	12090852				2022-12-24	WOS:000176573400006
J	Crawford, LM				Crawford, LM			Pulmonary hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2002	288	1					36	36		10.1001/jama.288.1.36	http://dx.doi.org/10.1001/jama.288.1.36			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	568YW	12090852				2022-12-24	WOS:000176573400007
